-- phpMyAdmin SQL Dump
-- version 5.0.4
-- https://www.phpmyadmin.net/
--
-- Host: 127.0.0.1
-- Generation Time: Mar 18, 2022 at 11:05 AM
-- Server version: 10.4.17-MariaDB
-- PHP Version: 8.0.1

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `mirna_bd`
--

-- --------------------------------------------------------

--
-- Table structure for table `cancer`
--

CREATE TABLE `cancer` (
  `id` int(11) NOT NULL,
  `MIR-ID` varchar(16) NOT NULL,
  `Cancer` varchar(37) NOT NULL,
  `Profile` varchar(28) NOT NULL,
  `pubmed` varchar(200) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `cancer`
--

INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(2, 'hsa-mir-27a', 'acute leukemia', 'down', 'MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3?.'),
(3, 'hsa-let-7b', 'acute lymphoblastic leukemia', 'down', 'Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements.'),
(4, 'hsa-mir-124a', 'acute lymphoblastic leukemia', 'down', 'Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.'),
(5, 'hsa-mir-128', 'acute lymphoblastic leukemia', 'up', 'Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.'),
(6, 'hsa-mir-142-3p', 'acute lymphoblastic leukemia', 'down', 'MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene.'),
(7, 'hsa-mir-192', 'acute lymphoblastic leukemia', 'down', 'Tumor suppressive function of microRNA-192 in acute lymphoblastic leukemia.'),
(8, 'hsa-mir-144', 'acute lymphoblastic leukemia', 'down', 'MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.'),
(9, 'hsa-mir-9', 'acute lymphoblastic leukemia', 'down', 'MicroRNA-9 suppresses cancer proliferation and cell cycle progression in acute lymphoblastic leukemia with inverse association of neuropilin-1.'),
(10, 'hsa-mir-410', 'acute lymphoblastic leukemia', 'up', 'MiR-410 regulates malignant biological behavior of pediatric acute lymphoblastic leukemia through targeting FKBP5 and Akt signaling pathway.'),
(11, 'hsa-mir-137', 'acute lymphoblastic leukemia', 'down', 'MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.'),
(12, 'hsa-mir-153-3p', 'acute lymphoblastic leukemia', 'down', 'miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.'),
(13, 'hsa-let-7c', 'acute myeloid leukemia', 'down', 'miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia.'),
(14, 'hsa-mir-125b', 'acute myeloid leukemia', 'up', '[miR-125b promotes proliferation of human acute myeloid leukemia cells by targeting Bak1].'),
(15, 'hsa-mir-126-5p', 'acute myeloid leukemia', 'up', 'Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.'),
(16, 'hsa-mir-128', 'acute myeloid leukemia', 'up', 'Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.'),
(17, 'hsa-mir-155', 'acute myeloid leukemia', 'up', 'Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.'),
(18, 'hsa-mir-17', 'acute myeloid leukemia', 'down', 'HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.'),
(19, 'hsa-mir-181a', 'acute myeloid leukemia', 'down', 'MicroRNA 181a Influences the Expression of HMGB1 and CD4 in Acute Leukemias.'),
(20, 'hsa-mir-20a', 'acute myeloid leukemia', 'down', 'HIF-1? downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.'),
(21, 'hsa-mir-223', 'acute myeloid leukemia', 'down', 'Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.'),
(22, 'hsa-mir-26a', 'acute myeloid leukemia', 'down', 'Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.'),
(23, 'hsa-mir-29a', 'acute myeloid leukemia', 'up', 'microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.'),
(24, 'hsa-mir-29a', 'acute myeloid leukemia', 'down', 'MicroRNA29a regulates the expression of the nuclear oncogene Ski.'),
(25, 'hsa-mir-30c', 'acute myeloid leukemia', 'down', 'Transcription factor C/EBP?-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.'),
(26, 'hsa-mir-32', 'acute myeloid leukemia', 'up', 'MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.'),
(27, 'hsa-mir-331', 'acute myeloid leukemia', 'up', 'Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.'),
(28, 'hsa-mir-370', 'acute myeloid leukemia', 'up', 'Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia.'),
(29, 'hsa-mir-378', 'acute myeloid leukemia', 'up', 'Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.'),
(30, 'hsa-mir-720', 'acute myeloid leukemia', 'down', '[DNA methylation-mediated epigenetic silencing of miR-720 contributes to leukemogenesis in acute myeloid leukemia].'),
(31, 'hsa-mir-328', 'acute myeloid leukemia', 'down', 'Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.'),
(32, 'hsa-let-7a', 'acute myeloid leukemia', 'up', 'Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.'),
(33, 'hsa-mir-1', 'acute myeloid leukemia', 'up', 'Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.'),
(34, 'hsa-mir-29b', 'acute myeloid leukemia', 'down', 'The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.'),
(35, 'hsa-mir-486', 'acute myeloid leukemia', 'up', 'Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.'),
(36, 'hsa-mir-155', 'acute myeloid leukemia', 'up', 'Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.'),
(37, 'hsa-mir-199b', 'acute myeloid leukemia', 'down', 'miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.'),
(38, 'hsa-mir-181a', 'acute myeloid leukemia', 'up', '[MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM].'),
(39, 'hsa-mir-27a', 'acute myeloid leukemia', 'down', 'MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.'),
(40, 'hsa-mir-27b', 'acute myeloid leukemia', 'down', 'MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.'),
(41, 'hsa-mir-424', 'acute myeloid leukemia', 'down', 'MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.'),
(42, 'hsa-mir-155', 'acute myeloid leukemia', 'up', 'MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.'),
(43, 'hsa-mir-223', 'acute myeloid leukemia', 'down', 'miR-223 decreases cell proliferation and enhances cell apoptosis in acute myeloid leukemia via targeting FBXW7.'),
(44, 'hsa-mir-451', 'acute myeloid leukemia', 'up', 'c-Myc suppresses miR-451?YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.'),
(45, 'hsa-mir-494', 'acute myeloid leukemia', 'down', 'MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.'),
(46, 'hsa-mir-125a', 'acute myeloid leukemia', 'up', 'miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.'),
(47, 'hsa-mir-125b', 'acute myeloid leukemia', 'up', 'miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.'),
(48, 'hsa-mir-92a', 'acute myeloid leukemia', 'down', 'miR-92a inhibits proliferation and induces apoptosis by regulating Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) expression in acute myeloid leukemia.'),
(49, 'hsa-mir-125b', 'acute myeloid leukemia', 'down', 'Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-?B signaling pathway.'),
(50, 'hsa-mir-142-3p', 'acute myeloid leukemia', 'down', 'Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1.'),
(51, 'hsa-mir-192', 'acute myeloid leukemia', 'down', 'MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.'),
(52, 'hsa-mir-34a', 'acute myeloid leukemia', 'down', 'MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells.'),
(53, 'hsa-mir-101-3p', 'acute myeloid leukemia', 'up', 'Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.'),
(54, 'hsa-mir-122', 'acute myeloid leukemia', 'down', 'Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential.'),
(55, 'hsa-mir-125a-3p', 'acute myeloid leukemia', 'down', 'The miR-125a-3p Inhibits TIM-3 Expression in AML Cell Line HL-60 In Vitro.'),
(56, 'hsa-mir-143', 'acute myeloid leukemia', 'down', 'Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.'),
(57, 'hsa-mir-216b', 'acute myeloid leukemia', 'up', 'Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.'),
(58, 'hsa-mir-217', 'acute myeloid leukemia', 'down', 'MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS.'),
(59, 'hsa-mir-23b-5p', 'acute myeloid leukemia', 'down', 'Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.'),
(60, 'hsa-mir-26a-5p', 'acute myeloid leukemia', 'up', 'Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.'),
(61, 'hsa-mir-339-3p', 'acute myeloid leukemia', 'down', 'Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.'),
(62, 'hsa-mir-342', 'acute myeloid leukemia', 'down', 'Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.'),
(63, 'hsa-mir-425-5p', 'acute myeloid leukemia', 'down', 'Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.'),
(64, 'hsa-mir-650', 'acute myeloid leukemia', 'down', 'miRNA-650 exerts anti-leukemia activity by inhibiting cell proliferation through Gfi1 targeting.'),
(65, 'hsa-mir-92a', 'acute myeloid leukemia', 'down', 'Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.'),
(66, 'hsa-mir-182-5p', 'acute myeloid leukemia', 'up', 'MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.'),
(67, 'hsa-mir-19a', 'acute myeloid leukemia', 'up', 'High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.'),
(68, 'hsa-mir-19b', 'acute myeloid leukemia', 'up', 'High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.'),
(69, 'hsa-let-7a', 'acute myeloid leukemia', 'up', 'Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage.'),
(70, 'hsa-mir-193a', 'acute myeloid leukemia', 'down', 'A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.'),
(71, 'hsa-mir-29b', 'acute myeloid leukemia', 'down', 'Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.'),
(72, 'hsa-mir-600', 'acute myeloid leukemia', 'down', 'A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.'),
(73, 'hsa-mir-99a', 'acute myeloid leukemia', 'up', 'Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.'),
(74, 'hsa-mir-10a', 'acute myeloid leukemia', 'up', 'MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.'),
(75, 'hsa-mir-10b', 'acute myeloid leukemia', 'up', 'MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia.'),
(76, 'hsa-mir-143', 'acute myeloid leukemia', 'down', 'MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.'),
(77, 'hsa-mir-150-5p', 'acute myeloid leukemia', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(78, 'hsa-mir-340', 'acute myeloid leukemia', 'down', 'Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.'),
(79, 'hsa-mir-34a', 'acute myeloid leukemia', 'down', 'Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.'),
(80, 'hsa-mir-363-3p', 'acute myeloid leukemia', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(81, 'hsa-mir-451a', 'acute myeloid leukemia', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(82, 'hsa-mir-486-5p', 'acute myeloid leukemia', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(83, 'hsa-mir-496', 'acute myeloid leukemia', 'down', 'Role of circRNA-DLEU2 in human acute myeloid leukemia.'),
(84, 'hsa-let-7a', 'acute myeloid leukemia', 'up', 'Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of?CASP3by Let-7a-5p Blockage.'),
(85, 'hsa-mir-10b', 'acute myeloid leukemia', 'up', 'MiR-10b regulates the proliferation and apoptosis of pediatric acute myeloid leukemia through targeting HOXD10.'),
(86, 'hsa-mir-155', 'acute myeloid leukemia', 'up', 'Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.'),
(87, 'hsa-mir-212-5p', 'acute myeloid leukemia', 'down', 'MiR-212-5p regulates the proliferation and apoptosis of AML cells through targeting FZD5.'),
(88, 'hsa-mir-23a-3p', 'acute myeloid leukemia', 'up', 'Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.'),
(89, 'hsa-mir-382-5p', 'acute myeloid leukemia', 'up', 'miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.'),
(90, 'hsa-mir-130a', 'acute myeloid leukemia', 'up', 'Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation.'),
(91, 'hsa-mir-181b', 'acute myeloid leukemia', 'up', 'Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.'),
(92, 'hsa-mir-199a-1', 'acute myeloid leukemia', 'down', 'MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.'),
(93, 'hsa-mir-199a-2', 'acute myeloid leukemia', 'down', 'MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.'),
(94, 'hsa-mir-199b', 'acute myeloid leukemia', 'down', 'MicroRNA-199 inhibits proliferation and promotes apoptosis in children with acute myeloid leukemia by mediating caspase-3.'),
(95, 'hsa-mir-222', 'acute myeloid leukemia', 'down', 'Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.'),
(96, 'hsa-mir-29c', 'acute myeloid leukemia', 'down', 'Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.'),
(97, 'hsa-mir-326', 'acute myeloid leukemia', 'down', 'LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia.'),
(98, 'hsa-mir-340-5p', 'acute myeloid leukemia', 'down', 'High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.'),
(99, 'hsa-mir-485-5p', 'acute myeloid leukemia', 'down', 'MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4.'),
(100, 'hsa-mir-504-3p', 'acute myeloid leukemia', 'down', 'Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.'),
(101, 'hsa-mir-592', 'acute myeloid leukemia', 'down', 'MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients\' prognosis.'),
(102, 'hsa-mir-628', 'acute myeloid leukemia', 'down', 'microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R.'),
(103, 'hsa-mir-9', 'acute myeloid leukemia', 'down', 'MiR-9 functions as a tumor suppressor in acute myeloid leukemia by targeting CX chemokine receptor 4.'),
(104, 'hsa-let-7c', 'acute promyelocytic leukemia', 'down', 'A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.'),
(105, 'hsa-mir-107', 'acute promyelocytic leukemia', 'down', 'A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.'),
(106, 'hsa-mir-181a', 'acute promyelocytic leukemia', 'up', 'PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.'),
(107, 'hsa-mir-181b', 'acute promyelocytic leukemia', 'up', 'PML/RAR? -regulated miR-181a/b cluster targets the tumor suppressor RASSF1A in Acute Promyelocytic Leukemia.'),
(108, 'hsa-mir-342', 'acute promyelocytic leukemia', 'down', 'A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.'),
(109, 'hsa-mir-92a', 'acute promyelocytic leukemia', 'up', 'Inhibition of MicroRNA miR-92a Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia.'),
(110, 'hsa-mir-222', 'adenoid cystic carcinoma', 'up', 'Downregulation of miR-222 Induces Apoptosis and Cellular Migration in Adenoid Cystic Carcinoma Cells.'),
(111, 'hsa-mir-195', 'adrenal cortical carcinoma', 'down', 'miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.'),
(112, 'hsa-mir-195', 'adrenal cortical carcinoma', 'down', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(113, 'hsa-mir-1974', 'adrenal cortical carcinoma', 'down', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(114, 'hsa-mir-21', 'adrenal cortical carcinoma', 'up', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(115, 'hsa-mir-210', 'adrenal cortical carcinoma', 'up', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(116, 'hsa-mir-335', 'adrenal cortical carcinoma', 'down', 'miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.'),
(117, 'hsa-mir-483-3p', 'adrenal cortical carcinoma', 'up', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(118, 'hsa-mir-483-5p', 'adrenal cortical carcinoma', 'up', 'miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer.'),
(119, 'hsa-mir-483-5p', 'adrenal cortical carcinoma', 'up', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(120, 'hsa-mir-497', 'adrenal cortical carcinoma', 'down', 'The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.'),
(121, 'hsa-mir-205', 'adrenal cortical carcinoma', 'down', 'MicroRNA-205 suppresses the growth of adrenocortical carcinoma SW-13?cells via targeting Bcl-2.'),
(122, 'hsa-mir-101', 'adrenal cortical carcinoma', 'up', 'Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.'),
(123, 'hsa-mir-483-5p', 'adrenal cortical carcinoma', 'up', 'Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.'),
(124, 'hsa-mir-139-5p', 'adrenal cortical carcinoma', 'up', 'MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.'),
(125, 'hsa-mir-483-5p', 'adrenal cortical carcinoma', 'up', 'MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.'),
(126, 'hsa-mir-183-5p', 'adrenal cortical carcinoma', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(127, 'hsa-mir-184', 'adrenal cortical carcinoma', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(128, 'hsa-mir-483-5p', 'adrenal cortical carcinoma', 'up', 'MicroRNA expression profiling in adrenal myelolipoma.'),
(129, 'hsa-mir-150', 'adult t-cell leukemia', 'up', 'STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells.'),
(130, 'hsa-mir-21', 'ampullary adenocarcinoma', 'up', 'MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.'),
(131, 'hsa-mir-124', 'anaplastic astrocytoma', 'down', 'miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.'),
(132, 'hsa-mir-137', 'anaplastic astrocytoma', 'down', 'miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.'),
(133, 'hsa-mir-155', 'anaplastic large-cell lymphoma', 'up', 'Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.'),
(134, 'hsa-mir-138', 'anaplastic thyroid carcinoma', 'down', 'Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.'),
(135, 'hsa-mir-146b', 'anaplastic thyroid carcinoma', 'up', 'A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.'),
(136, 'hsa-mir-221', 'anaplastic thyroid carcinoma', 'up', 'A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.'),
(137, 'hsa-mir-222', 'anaplastic thyroid carcinoma', 'up', 'A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.'),
(138, 'hsa-mir-4295', 'anaplastic thyroid carcinoma', 'up', 'miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.'),
(139, 'hsa-mir-146b', 'anaplastic thyroid carcinoma', 'up', 'p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b.'),
(140, 'hsa-mir-148a', 'anaplastic thyroid carcinoma', 'down', 'miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.'),
(141, 'hsa-mir-584', 'anaplastic thyroid carcinoma', 'up', 'TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.'),
(142, 'hsa-mir-125b', 'anaplastic thyroid carcinoma', 'down', 'MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.'),
(143, 'hsa-mir-128-3p', 'anaplastic thyroid carcinoma', 'down', 'Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.'),
(144, 'hsa-mir-124-3p', 'astrocytoma', 'down', 'Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children.'),
(145, 'hsa-mir-181b-5p', 'astrocytoma', 'down', 'MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.'),
(146, 'hsa-mir-200b', 'astrocytoma', 'down', 'Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.'),
(147, 'hsa-mir-3189-3p', 'astrocytoma', 'down', 'Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.'),
(148, 'hsa-mir-335', 'astrocytoma', 'up', 'Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells.'),
(149, 'hsa-mir-25', 'astrocytoma', 'up', 'miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.'),
(150, 'hsa-mir-542-3p', 'astrocytoma', 'down', 'MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.'),
(151, 'hsa-mir-137', 'astrocytoma', 'down', 'miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.'),
(152, 'hsa-mir-183', 'astrocytoma', 'up', 'Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.'),
(153, 'hsa-mir-429', 'astrocytoma', 'down', 'miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.'),
(154, 'hsa-mir-203', 'basal cell carcinoma', 'down', 'MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma.'),
(155, 'hsa-mir-106b', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(156, 'hsa-mir-125a-5p', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(157, 'hsa-mir-130a', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(158, 'hsa-mir-139-5p', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(159, 'hsa-mir-140-3p', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(160, 'hsa-mir-145', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(161, 'hsa-mir-17', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(162, 'hsa-mir-181c', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(163, 'hsa-mir-181c*', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(164, 'hsa-mir-181d', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(165, 'hsa-mir-182', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(166, 'hsa-mir-18a', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(167, 'hsa-mir-18b', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(168, 'hsa-mir-19b', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(169, 'hsa-mir-19b-1*', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(170, 'hsa-mir-2861', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(171, 'hsa-mir-29c', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(172, 'hsa-mir-29c*', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(173, 'hsa-mir-3196', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(174, 'hsa-mir-378', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(175, 'hsa-mir-455-3p', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(176, 'hsa-mir-455-5p', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(177, 'hsa-mir-542-5p', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(178, 'hsa-mir-572', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(179, 'hsa-mir-638', 'basal cell carcinoma', 'down', 'Expression of microRNAs in basal cell carcinoma.'),
(180, 'hsa-mir-93', 'basal cell carcinoma', 'up', 'Expression of microRNAs in basal cell carcinoma.'),
(181, 'hsa-mir-451a', 'basal cell carcinoma', 'down', 'MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma.'),
(182, 'hsa-mir-34a', 'basal cell carcinoma', 'down', 'Expression of miR-34a in basal cell carcinoma patients and its relationship with prognosis.'),
(183, 'hsa-mir-17', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(184, 'hsa-mir-18a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(185, 'hsa-mir-19a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(186, 'hsa-mir-19b', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(187, 'hsa-mir-20a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(188, 'hsa-mir-34a', 'b-cell lymphoma', 'down', 'The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.'),
(189, 'hsa-mir-92a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(190, 'mir-17', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(191, 'mir-18a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(192, 'mir-19a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(193, 'mir-19b', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(194, 'mir-20a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(195, 'mir-92a', 'b-cell lymphoma', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(196, 'hsa-mir-21', 'b-cell lymphoma', 'up', 'Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.'),
(197, 'hsa-mir-26b', 'b-cell lymphoma', 'down', 'Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.'),
(198, 'hsa-mir-21', 'b-cell lymphoma', 'up', 'miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.'),
(199, 'hsa-mir-21', 'b-cell lymphoma', 'up', 'Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.'),
(200, 'hsa-mir-1', 'bladder cancer', 'down', 'The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.'),
(201, 'hsa-mir-1', 'bladder cancer', 'down', 'Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer.'),
(202, 'hsa-mir-101', 'bladder cancer', 'down', 'MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.'),
(203, 'hsa-mir-101', 'bladder cancer', 'down', 'miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.'),
(204, 'hsa-mir-103a-3p', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(205, 'hsa-mir-10b', 'bladder cancer', 'up', 'MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.'),
(206, 'hsa-mir-1180', 'bladder cancer', 'down', 'Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.'),
(207, 'hsa-mir-1236', 'bladder cancer', 'down', 'Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.'),
(208, 'hsa-mir-124-3p', 'bladder cancer', 'down', 'MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.'),
(209, 'hsa-mir-125b', 'bladder cancer', 'down', 'MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.'),
(210, 'hsa-mir-125b', 'bladder cancer', 'down', 'microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.'),
(211, 'hsa-mir-126', 'bladder cancer', 'down', 'MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.'),
(212, 'hsa-mir-1280', 'bladder cancer', 'down', 'MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer.'),
(213, 'hsa-mir-133a', 'bladder cancer', 'down', 'MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.'),
(214, 'hsa-mir-133a', 'bladder cancer', 'down', 'The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.'),
(215, 'hsa-mir-133b', 'bladder cancer', 'down', 'MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.'),
(216, 'hsa-mir-135a', 'bladder cancer', 'up', 'Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.'),
(217, 'hsa-mir-137', 'bladder cancer', 'up', 'MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.'),
(218, 'hsa-mir-141', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(219, 'hsa-mir-141', 'bladder cancer', 'up', 'Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?'),
(220, 'hsa-mir-143', 'bladder cancer', 'down', 'MicroRNA-143 as a tumor suppressor for bladder cancer.'),
(221, 'hsa-mir-143', 'bladder cancer', 'down', 'MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.'),
(222, 'hsa-mir-143', 'bladder cancer', 'down', 'Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.'),
(223, 'hsa-mir-144', 'bladder cancer', 'down', 'miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.'),
(224, 'hsa-mir-145', 'bladder cancer', 'down', 'MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.'),
(225, 'hsa-mir-145', 'bladder cancer', 'down', 'Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.'),
(226, 'hsa-mir-145', 'bladder cancer', 'down', 'socs7, a target gene of microRNA-145, regulates interferon-? induction through STAT3 nuclear translocation in bladder cancer cells.'),
(227, 'hsa-mir-145', 'bladder cancer', 'down', 'Aberrant expression of microRNAs in bladder cancer.'),
(228, 'hsa-mir-145', 'bladder cancer', 'down', 'miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.'),
(229, 'hsa-mir-145', 'bladder cancer', 'down', 'miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors.'),
(230, 'hsa-mir-155', 'bladder cancer', 'up', 'Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.'),
(231, 'hsa-mir-155', 'bladder cancer', 'up', 'MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.'),
(232, 'hsa-mir-155', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(233, 'hsa-mir-16', 'bladder cancer', 'down', 'MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1.'),
(234, 'hsa-mir-17-5p', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(235, 'hsa-mir-182', 'bladder cancer', 'up', 'Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.'),
(236, 'hsa-mir-182-5p', 'bladder cancer', 'up', 'Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.'),
(237, 'hsa-mir-183', 'bladder cancer', 'up', 'MicroRNA expression signatures of bladder cancer revealed by deep sequencing.'),
(238, 'hsa-mir-183', 'bladder cancer', 'up', 'Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.'),
(239, 'hsa-mir-185', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(240, 'hsa-mir-18a', 'bladder cancer', 'down', 'microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.'),
(241, 'hsa-mir-192', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(242, 'hsa-mir-192', 'bladder cancer', 'down', 'Regulation of growth of human bladder cancer by miR-192.'),
(243, 'hsa-mir-195', 'bladder cancer', 'down', 'Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.'),
(244, 'hsa-mir-19a', 'bladder cancer', 'up', 'miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer.'),
(245, 'hsa-mir-200a', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(246, 'hsa-mir-200b', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(247, 'hsa-mir-200c', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(248, 'hsa-mir-203', 'bladder cancer', 'down', 'microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.'),
(249, 'hsa-mir-203', 'bladder cancer', 'down', 'Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.'),
(250, 'hsa-mir-203', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(251, 'hsa-mir-205', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(252, 'hsa-mir-205', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(253, 'hsa-mir-210', 'bladder cancer', 'up', 'Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.'),
(254, 'hsa-mir-214', 'bladder cancer', 'down', 'MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.'),
(255, 'hsa-mir-218', 'bladder cancer', 'down', 'MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.'),
(256, 'hsa-mir-221', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(257, 'hsa-mir-221', 'bladder cancer', 'up', 'MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL.'),
(258, 'hsa-mir-222', 'bladder cancer', 'up', 'Increased expression of miR-222 is associated with poor prognosis in bladder cancer.'),
(259, 'hsa-mir-223', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(260, 'hsa-mir-23a', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(261, 'hsa-mir-23b', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(262, 'hsa-mir-23b', 'bladder cancer', 'down', 'MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.'),
(263, 'hsa-mir-26a', 'bladder cancer', 'down', 'miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.'),
(264, 'hsa-mir-26b', 'bladder cancer', 'up', 'Micro-RNA profiling in kidney and bladder cancers.'),
(265, 'hsa-mir-29c', 'bladder cancer', 'down', 'Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway.'),
(266, 'hsa-mir-320c', 'bladder cancer', 'down', 'MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.'),
(267, 'hsa-mir-34a', 'bladder cancer', 'down', 'MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.'),
(268, 'hsa-mir-370', 'bladder cancer', 'down', 'Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells.'),
(269, 'hsa-mir-409-3p', 'bladder cancer', 'down', 'MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.'),
(270, 'hsa-mir-429', 'bladder cancer', 'down', 'Expression of microRNAs in the Urine of Patients With Bladder Cancer.'),
(271, 'hsa-mir-451', 'bladder cancer', 'down', 'miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.'),
(272, 'hsa-mir-490-5p', 'bladder cancer', 'down', 'MicroRNA expression signatures of bladder cancer revealed by deep sequencing.'),
(273, 'hsa-mir-490-5p', 'bladder cancer', 'down', 'MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos.'),
(274, 'hsa-mir-493', 'bladder cancer', 'down', 'Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.'),
(275, 'hsa-mir-576-3p', 'bladder cancer', 'down', 'MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1.'),
(276, 'hsa-mir-639', 'bladder cancer', 'up', 'Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?'),
(277, 'hsa-mir-96', 'bladder cancer', 'up', 'MicroRNA expression signatures of bladder cancer revealed by deep sequencing.'),
(278, 'hsa-mir-96', 'bladder cancer', 'up', 'Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.'),
(279, 'hsa-mir-99a', 'bladder cancer', 'down', 'microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer.'),
(280, 'hsa-mir-99a', 'bladder cancer', 'down', 'microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.'),
(281, 'hsa-mir-124', 'bladder cancer', 'down', 'MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.'),
(282, 'hsa-mir-145', 'bladder cancer', 'down', 'Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.'),
(283, 'hsa-mir-186', 'bladder cancer', 'down', 'MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.'),
(284, 'hsa-mir-20b', 'bladder cancer', 'down', 'MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.'),
(285, 'hsa-mir-24', 'bladder cancer', 'down', 'MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.'),
(286, 'hsa-mir-424', 'bladder cancer', 'down', 'DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.'),
(287, 'hsa-mir-490-5p', 'bladder cancer', 'down', 'MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.'),
(288, 'hsa-mir-9', 'bladder cancer', 'up', 'miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.'),
(289, 'hsa-mir-205', 'bladder cancer', 'down', 'Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.'),
(290, 'hsa-mir-96', 'bladder cancer', 'up', 'Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.'),
(291, 'hsa-mir-100', 'bladder cancer', 'down', 'Prognostic role of microRNA-100 in patients with bladder cancer.'),
(292, 'hsa-mir-125b', 'bladder cancer', 'down', 'MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.'),
(293, 'hsa-mir-148a', 'bladder cancer', 'down', 'MicroRNA-148a represents an independent prognostic marker in bladder cancer.'),
(294, 'hsa-mir-194-5p', 'bladder cancer', 'down', 'Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.'),
(295, 'hsa-mir-195', 'bladder cancer', 'down', 'microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.'),
(296, 'hsa-mir-200c', 'bladder cancer', 'down', 'miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.'),
(297, 'hsa-mir-205', 'bladder cancer', 'up', 'Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.'),
(298, 'hsa-mir-222', 'bladder cancer', 'up', 'miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.'),
(299, 'hsa-mir-542-3p', 'bladder cancer', 'down', 'MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.'),
(300, 'hsa-mir-146a-5p', 'bladder cancer', 'up', 'Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.'),
(301, 'hsa-mir-194', 'bladder cancer', 'down', 'MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.'),
(302, 'hsa-mir-122', 'bladder cancer', 'down', 'MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.'),
(303, 'hsa-mir-200c', 'bladder cancer', 'up', 'MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.'),
(304, 'hsa-mir-26a-5p', 'bladder cancer', 'down', 'Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.'),
(305, 'hsa-mir-26b-5p', 'bladder cancer', 'down', 'Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.'),
(306, 'hsa-mir-335', 'bladder cancer', 'down', 'MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.'),
(307, 'hsa-mir-451', 'bladder cancer', 'down', 'miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.'),
(308, 'hsa-mir-148a-3p', 'bladder cancer', 'down', 'miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.'),
(309, 'hsa-mir-199a-5p', 'bladder cancer', 'down', 'miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.'),
(310, 'hsa-mir-206', 'bladder cancer', 'down', 'MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.'),
(311, 'hsa-mir-223-3p', 'bladder cancer', 'down', 'Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p.'),
(312, 'hsa-mir-3658', 'bladder cancer', 'up', 'Upregulation of miR-3658 in bladder cancer and tumor progression.'),
(313, 'hsa-mir-4295', 'bladder cancer', 'up', 'MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.'),
(314, 'hsa-mir-92', 'bladder cancer', 'up', 'MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3? and activating Wnt signaling in bladder cancer cells.'),
(315, 'hsa-mir-130b-3p', 'bladder cancer', 'up', 'Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin ?1 Signaling Pathways in Bladder Carcinoma.'),
(316, 'hsa-mir-138-5p', 'bladder cancer', 'down', 'miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.'),
(317, 'hsa-mir-143', 'bladder cancer', 'down', 'miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.'),
(318, 'hsa-mir-145', 'bladder cancer', 'down', 'Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.'),
(319, 'hsa-mir-223-3p', 'bladder cancer', 'down', 'MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.'),
(320, 'hsa-mir-24-3p', 'bladder cancer', 'up', 'miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.'),
(321, 'hsa-mir-495', 'bladder cancer', 'up', 'microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.'),
(322, 'hsa-mir-4295', 'bladder cancer', 'up', 'Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(323, 'hsa-mir-556-3p', 'bladder cancer', 'up', 'miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.'),
(324, 'hsa-mir-576-3p', 'bladder cancer', 'down', 'MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.'),
(325, 'hsa-mir-613', 'bladder cancer', 'down', 'miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.'),
(326, 'hsa-mir-940', 'bladder cancer', 'up', 'MicroRNA-940 Targets INPP4A or GSK3? and Activates the Wnt/?-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.'),
(327, 'hsa-mir-139-5p', 'bladder cancer', 'down', 'MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.'),
(328, 'hsa-mir-200c', 'bladder cancer', 'down', 'MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.'),
(329, 'hsa-mir-203', 'bladder cancer', 'down', 'MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1.'),
(330, 'hsa-mir-20b', 'bladder cancer', 'down', 'MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ?cells via the targeting of cell?cycle regulation and Sp-1-mediated MMP-2 expression.'),
(331, 'hsa-mir-224', 'bladder cancer', 'up', 'Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.'),
(332, 'hsa-mir-429', 'bladder cancer', 'up', 'Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.'),
(333, 'hsa-mir-99a', 'bladder cancer', 'down', 'Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.'),
(334, 'hsa-mir-143', 'bladder cancer', 'down', 'LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.'),
(335, 'hsa-mir-17', 'bladder cancer', 'up', '[Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].'),
(336, 'hsa-mir-373', 'bladder cancer', 'down', 'Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.'),
(337, 'hsa-mir-1-3p', 'bladder cancer', 'down', 'MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.'),
(338, 'hsa-mir-130b', 'bladder cancer', 'up', 'miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.'),
(339, 'hsa-mir-202', 'bladder cancer', 'down', 'miR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancer.'),
(340, 'hsa-mir-22', 'bladder cancer', 'down', 'MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.'),
(341, 'hsa-mir-124-3p', 'bladder cancer', 'down', 'MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B.'),
(342, 'hsa-mir-1247', 'bladder cancer', 'down', 'Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.'),
(343, 'hsa-mir-183', 'bladder cancer', 'up', 'MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2.'),
(344, 'hsa-mir-192-5p', 'bladder cancer', 'down', 'MiR-192-5p suppresses the growth of bladder cancer cells via targeting Yin Yang 1.'),
(345, 'hsa-mir-302b', 'bladder cancer', 'down', 'MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer.'),
(346, 'hsa-mir-325', 'bladder cancer', 'down', 'MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.'),
(347, 'hsa-mir-3658', 'bladder cancer', 'up', 'Hsa-miR-3658 Promotes Cell Proliferation, Migration and Invasion by Effecting LASS2 in Bladder Cancer.'),
(348, 'hsa-mir-374a', 'bladder cancer', 'down', 'MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/?-Catenin Signaling.'),
(349, 'hsa-mir-1-3p', 'bladder cancer', 'down', 'miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells.'),
(350, 'hsa-mir-124', 'bladder cancer', 'down', 'MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.'),
(351, 'hsa-mir-125a-5p', 'bladder cancer', 'down', 'MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.'),
(352, 'hsa-mir-133b', 'bladder cancer', 'down', 'MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.'),
(353, 'hsa-mir-194-5p', 'bladder cancer', 'down', 'MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.'),
(354, 'hsa-mir-203a', 'bladder cancer', 'down', 'MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4.'),
(355, 'hsa-mir-3619-5p', 'bladder cancer', 'down', 'MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting ?-catenin and CDK2 and activating p21.'),
(356, 'hsa-mir-374b-5p', 'bladder cancer', 'down', 'MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.'),
(357, 'hsa-mir-454-3p', 'bladder cancer', 'down', 'MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.'),
(358, 'hsa-mir-93', 'bladder cancer', 'up', 'MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF.'),
(359, 'hsa-mir-98', 'bladder cancer', 'up', 'MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.'),
(360, 'hsa-mir-99a-5p', 'bladder cancer', 'down', 'MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival.'),
(361, 'hsa-mir-101', 'bladder cancer', 'down', 'MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.'),
(362, 'hsa-mir-101', 'bladder cancer', 'down', 'MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.'),
(363, 'hsa-mir-124-3p', 'bladder cancer', 'down', 'MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.'),
(364, 'hsa-mir-132', 'bladder cancer', 'down', 'MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGF?1/Smad2 signaling pathway in human bladder cancer.'),
(365, 'hsa-mir-143', 'bladder cancer', 'down', 'MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.'),
(366, 'hsa-mir-146b', 'bladder cancer', 'up', 'MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.'),
(367, 'hsa-mir-153', 'bladder cancer', 'down', 'MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.'),
(368, 'hsa-mir-155', 'bladder cancer', 'up', 'MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3?/?-catenin pathway.'),
(369, 'hsa-mir-205-5p', 'bladder cancer', 'down', 'Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.'),
(370, 'hsa-mir-214-3p', 'bladder cancer', 'up', 'LncRNA MT1JP functions as a tumor suppressor via regulating miR-214-3p expression in bladder cancer.'),
(371, 'hsa-mir-30e-5p', 'bladder cancer', 'down', 'miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.'),
(372, 'hsa-mir-335', 'bladder cancer', 'down', 'MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.'),
(373, 'hsa-mir-432-5p', 'bladder cancer', 'up', 'Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/?-catenin feedback loop.'),
(374, 'hsa-mir-506', 'bladder cancer', 'down', 'MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.'),
(375, 'hsa-mir-532-5p', 'bladder cancer', 'down', 'Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/?-catenin signaling.'),
(376, 'hsa-mir-621', 'bladder cancer', 'down', 'MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/?-catenin signaling.'),
(377, 'hsa-mir-708', 'bladder cancer', 'up', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(378, 'hsa-mir-758-3p', 'bladder cancer', 'down', 'miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.'),
(379, 'hsa-mir-934', 'bladder cancer', 'up', 'Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.'),
(380, 'hsa-mir-16', 'brain cancer', 'up', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(381, 'hsa-mir-17', 'brain cancer', 'up', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(382, 'hsa-mir-21', 'brain cancer', 'up', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(383, 'hsa-mir-221', 'brain cancer', 'up', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(384, 'hsa-mir-34a', 'brain cancer', 'down', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(385, 'hsa-mir-375', 'brain cancer', 'up', 'MicroRNA-target cross-talks: Key players in glioblastoma multiforme.'),
(386, 'hsa-let-7a', 'breast cancer', 'down', 'Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.'),
(387, 'hsa-let-7a', 'breast cancer', 'down', 'MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.'),
(388, 'hsa-let-7a', 'breast cancer', 'down', 'The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.'),
(389, 'hsa-let-7a-1', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(390, 'hsa-let-7a-2', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(391, 'hsa-let-7a-3', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(392, 'hsa-let-7b', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(393, 'hsa-let-7b', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(394, 'hsa-let-7b', 'breast cancer', 'down', 'The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.'),
(395, 'hsa-let-7c', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(396, 'hsa-let-7d', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(397, 'hsa-let-7e', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(398, 'hsa-let-7f-1', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(399, 'hsa-let-7f-2', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(400, 'hsa-let-7g', 'breast cancer', 'down', 'The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.'),
(401, 'hsa-let-7g', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(402, 'hsa-let-7i', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(403, 'hsa-mir-100', 'breast cancer', 'down', 'miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling.'),
(404, 'hsa-mir-100', 'breast cancer', 'down', 'miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion.'),
(405, 'hsa-mir-107', 'breast cancer', 'down', 'MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer.'),
(406, 'hsa-mir-10a', 'breast cancer', 'down', 'MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.'),
(407, 'hsa-mir-10b', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(408, 'hsa-mir-10b', 'breast cancer', 'up', 'Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.'),
(409, 'hsa-mir-122', 'breast cancer', 'down', 'MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R.'),
(410, 'hsa-mir-122', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(411, 'hsa-mir-124', 'breast cancer', 'down', 'miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.'),
(412, 'hsa-mir-124', 'breast cancer', 'down', 'miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.'),
(413, 'hsa-mir-124', 'breast cancer', 'down', 'Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.'),
(414, 'hsa-mir-124', 'breast cancer', 'down', 'MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.'),
(415, 'hsa-mir-124', 'breast cancer', 'down', 'MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151.'),
(416, 'hsa-mir-124', 'breast cancer', 'down', 'Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.'),
(417, 'hsa-mir-124', 'breast cancer', 'down', 'MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.'),
(418, 'hsa-mir-1258', 'breast cancer', 'down', 'MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.'),
(419, 'hsa-mir-1258', 'breast cancer', 'down', 'The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.'),
(420, 'hsa-mir-125a', 'breast cancer', 'up', 'MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway.'),
(421, 'hsa-mir-125a-5p', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(422, 'hsa-mir-125b', 'breast cancer', 'down', 'MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.'),
(423, 'hsa-mir-125b', 'breast cancer', 'down', 'miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.'),
(424, 'hsa-mir-125b', 'breast cancer', 'down', 'MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells.'),
(425, 'hsa-mir-125b', 'breast cancer', 'down', 'Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.'),
(426, 'hsa-mir-125b', 'breast cancer', 'down', 'The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.'),
(427, 'hsa-mir-126', 'breast cancer', 'down', 'Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.'),
(428, 'hsa-mir-127', 'breast cancer', 'down', 'MicroRNA-127 is Downregulated by Tudor-SN Protein and Contributes to Metastasis and Proliferation in Breast Cancer Cell Line MDA-MB-231.'),
(429, 'hsa-mir-127', 'breast cancer', 'down', 'miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6.'),
(430, 'hsa-mir-129', 'breast cancer', 'down', '[The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility].'),
(431, 'hsa-mir-130a', 'breast cancer', 'down', 'MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.'),
(432, 'hsa-mir-132', 'breast cancer', 'down', 'MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1.'),
(433, 'hsa-mir-133a', 'breast cancer', 'down', 'microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.'),
(434, 'hsa-mir-135a', 'breast cancer', 'up', 'miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.'),
(435, 'hsa-mir-140', 'breast cancer', 'up', 'Examining estrogen regulation of cancer stem cells through multicolor lineage tracing.'),
(436, 'hsa-mir-141', 'breast cancer', 'up', 'Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.'),
(437, 'hsa-mir-142', 'breast cancer', 'up', 'miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.'),
(438, 'hsa-mir-143', 'breast cancer', 'down', 'MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.'),
(439, 'hsa-mir-145', 'breast cancer', 'down', 'miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.'),
(440, 'hsa-mir-145', 'breast cancer', 'down', 'MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.'),
(441, 'hsa-mir-145', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(442, 'hsa-mir-145', 'breast cancer', 'down', 'miR-145 inhibits breast cancer cell growth through RTKN.'),
(443, 'hsa-mir-146a', 'breast cancer', 'down', 'Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.'),
(444, 'hsa-mir-146a', 'breast cancer', 'down', 'Clinical significance of miR-146a in gastric cancer cases.'),
(445, 'hsa-mir-146b', 'breast cancer', 'down', 'STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-?B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes.'),
(446, 'hsa-mir-146b', 'breast cancer', 'down', 'Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.'),
(447, 'hsa-mir-147', 'breast cancer', 'down', 'Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.'),
(448, 'hsa-mir-148a', 'breast cancer', 'down', 'A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.'),
(449, 'hsa-mir-149', 'breast cancer', 'down', 'MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis.'),
(450, 'hsa-mir-150', 'breast cancer', 'up', 'miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.'),
(451, 'hsa-mir-150', 'breast cancer', 'up', 'miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.'),
(452, 'hsa-mir-152', 'breast cancer', 'down', 'A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.'),
(453, 'hsa-mir-153', 'breast cancer', 'down', 'MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.'),
(454, 'hsa-mir-155', 'breast cancer', 'up', 'Clinical significance of MicoRNA-155 expression in human breast cancer.'),
(455, 'hsa-mir-155', 'breast cancer', 'up', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(456, 'hsa-mir-155', 'breast cancer', 'up', '17?-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.'),
(457, 'hsa-mir-155', 'breast cancer', 'up', 'MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.'),
(458, 'hsa-mir-155', 'breast cancer', 'up', 'miR-155 drives telomere fragility in human breast cancer by targeting TRF1.'),
(459, 'hsa-mir-155', 'breast cancer', 'up', 'MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.'),
(460, 'hsa-mir-155', 'breast cancer', 'up', 'Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.'),
(461, 'hsa-mir-155', 'breast cancer', 'up', '[Expression and its clinical significance of miR-155 in human primary breast cancer].'),
(462, 'hsa-mir-15a', 'breast cancer', 'down', 'MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.'),
(463, 'hsa-mir-16', 'breast cancer', 'down', 'Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.'),
(464, 'hsa-mir-16', 'breast cancer', 'down', 'Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.'),
(465, 'hsa-mir-17', 'breast cancer', 'up', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(466, 'hsa-mir-17-5p', 'breast cancer', 'down', 'Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.'),
(467, 'hsa-mir-17-5p', 'breast cancer', 'up', 'miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.'),
(468, 'hsa-mir-181a', 'breast cancer', 'down', 'Decreased serum miR-181a is a potential new tool for breast cancer screening.'),
(469, 'hsa-mir-181a', 'breast cancer', 'up', 'Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.'),
(470, 'hsa-mir-181b', 'breast cancer', 'up', 'Transforming growth factor-? regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.'),
(471, 'hsa-mir-182', 'breast cancer', 'up', 'Up-regulation of miR-182 by ?-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.'),
(472, 'hsa-mir-182', 'breast cancer', 'up', 'Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.'),
(473, 'hsa-mir-182', 'breast cancer', 'up', 'Higher expression of circulating miR-182 as a novel biomarker for breast cancer.'),
(474, 'hsa-mir-1826', 'breast cancer', 'down', 'MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.'),
(475, 'hsa-mir-183', 'breast cancer', 'down', 'Dysregulated miR-183 inhibits migration in breast cancer cells.'),
(476, 'hsa-mir-185', 'breast cancer', 'down', 'MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.'),
(477, 'hsa-mir-185', 'breast cancer', 'down', 'MiR-185 is involved in human breast carcinogenesis by targeting Vegfa.'),
(478, 'hsa-mir-18a', 'breast cancer', 'up', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(479, 'hsa-mir-18b', 'breast cancer', 'up', 'microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.'),
(480, 'hsa-mir-191', 'breast cancer', 'up', 'Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.'),
(481, 'hsa-mir-191', 'breast cancer', 'down', 'Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.'),
(482, 'hsa-mir-191', 'breast cancer', 'up', 'HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGF?-signaling in hypoxic microenvironment.'),
(483, 'hsa-mir-193a-3p', 'breast cancer', 'down', 'Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer.'),
(484, 'hsa-mir-193b', 'breast cancer', 'down', 'Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.'),
(485, 'hsa-mir-193b', 'breast cancer', 'cell lines:MDA-MB-231,MCF-7;', 'Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.'),
(486, 'hsa-mir-195', 'breast cancer', 'down', 'Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.'),
(487, 'hsa-mir-195', 'breast cancer', 'down', 'Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.'),
(488, 'hsa-mir-195', 'breast cancer', 'down', 'Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.'),
(489, 'hsa-mir-196a', 'breast cancer', 'up', 'MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.'),
(490, 'hsa-mir-197', 'breast cancer', 'up', 'Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.'),
(491, 'hsa-mir-199b-5p', 'breast cancer', 'down', 'MiR-199b-5p targets HER2 in breast cancer cells.'),
(492, 'hsa-mir-19a', 'breast cancer', 'up', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(493, 'hsa-mir-19a-3p', 'breast cancer', 'down', 'MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.'),
(494, 'hsa-mir-19b', 'breast cancer', 'up', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(495, 'hsa-mir-200a', 'breast cancer', 'up', 'Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.'),
(496, 'hsa-mir-200a', 'breast cancer', 'up', 'MicroRNA-200a Promotes Anoikis Resistance and Metastasis by Targeting YAP1 in Human Breast Cancer.'),
(497, 'hsa-mir-200a', 'breast cancer', 'down', 'microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer.'),
(498, 'hsa-mir-200b', 'breast cancer', 'up', 'Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.'),
(499, 'hsa-mir-200b', 'breast cancer', 'down', 'Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis.'),
(500, 'hsa-mir-200b', 'breast cancer', 'down', 'miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.'),
(501, 'hsa-mir-200c', 'breast cancer', 'up', 'Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.'),
(502, 'hsa-mir-200c', 'breast cancer', 'down', 'MiR-200c suppresses TGF-? signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.'),
(503, 'hsa-mir-203', 'breast cancer', 'up', 'Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity.'),
(504, 'hsa-mir-205', 'breast cancer', 'down', 'Suppression of cell growth and invasion by miR-205 in breast cancer.'),
(505, 'hsa-mir-205', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(506, 'hsa-mir-205', 'breast cancer', 'down', 'miRNA-205 affects infiltration and metastasis of breast cancer.'),
(507, 'hsa-mir-205', 'breast cancer', 'up', 'Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.'),
(508, 'hsa-mir-206', 'breast cancer', 'down', 'miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.'),
(509, 'hsa-mir-20a', 'breast cancer', 'up', 'Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.'),
(510, 'hsa-mir-20a', 'breast cancer', 'up', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(511, 'hsa-mir-20b', 'breast cancer', 'up', 'MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN).'),
(512, 'hsa-mir-21', 'breast cancer', 'up', 'Next-generation sequencing of microRNAs for breast cancer detection.'),
(513, 'hsa-mir-21', 'breast cancer', 'up', 'Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females.'),
(514, 'hsa-mir-21', 'breast cancer', 'up', 'Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.'),
(515, 'hsa-mir-21', 'breast cancer', 'up', 'Tissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.'),
(516, 'hsa-mir-21', 'breast cancer', 'up', 'Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.'),
(517, 'hsa-mir-21', 'breast cancer', 'up', 'BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.'),
(518, 'hsa-mir-21', 'breast cancer', 'up', 'Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.'),
(519, 'hsa-mir-21', 'breast cancer', 'up', 'Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.'),
(520, 'hsa-mir-21', 'breast cancer', 'up', 'The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.'),
(521, 'hsa-mir-21', 'breast cancer', 'up', 'MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.'),
(522, 'hsa-mir-21', 'breast cancer', 'up', 'Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.'),
(523, 'hsa-mir-211', 'breast cancer', 'down', 'MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells\' growth and migration.'),
(524, 'hsa-mir-216b', 'breast cancer', 'down', 'Regulation of the P2X7R by microRNA-216b in human breast cancer.'),
(525, 'hsa-mir-217', 'breast cancer', 'up', 'MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.'),
(526, 'hsa-mir-218', 'breast cancer', 'down', 'Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway.'),
(527, 'hsa-mir-22', 'breast cancer', 'down', 'A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.'),
(528, 'hsa-mir-22', 'breast cancer', 'down', 'miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.'),
(529, 'hsa-mir-221', 'breast cancer', 'up', 'TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.'),
(530, 'hsa-mir-221', 'breast cancer', 'up', 'From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review).'),
(531, 'hsa-mir-221', 'breast cancer', 'up', 'miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.'),
(532, 'hsa-mir-222', 'breast cancer', 'up', 'Analysis of serum genome-wide microRNAs for breast cancer detection.'),
(533, 'hsa-mir-222', 'breast cancer', 'up', 'miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.'),
(534, 'hsa-mir-222', 'breast cancer', 'up', 'TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.'),
(535, 'hsa-mir-224', 'breast cancer', 'up', 'MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.'),
(536, 'hsa-mir-23a', 'breast cancer', 'up', 'c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.'),
(537, 'hsa-mir-24', 'breast cancer', 'up', 'Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.'),
(538, 'hsa-mir-24-2-5p', 'breast cancer', 'up', 'c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.'),
(539, 'hsa-mir-24-3p', 'breast cancer', 'up', 'miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.'),
(540, 'hsa-mir-26a', 'breast cancer', 'down', 'Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.'),
(541, 'hsa-mir-26a', 'breast cancer', 'down', 'MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1.'),
(542, 'hsa-mir-26a', 'breast cancer', 'down', 'MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.'),
(543, 'hsa-mir-26b', 'breast cancer', 'down', 'MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer.'),
(544, 'hsa-mir-26b', 'breast cancer', 'down', 'MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer.'),
(545, 'hsa-mir-26b', 'breast cancer', 'down', 'MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.'),
(546, 'hsa-mir-27a', 'breast cancer', 'up', 'c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2.'),
(547, 'hsa-mir-29a', 'breast cancer', 'up', 'Next-generation sequencing of microRNAs for breast cancer detection.'),
(548, 'hsa-mir-29a', 'breast cancer', 'up', 'microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.'),
(549, 'hsa-mir-29b-1', 'breast cancer', 'up', 'microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.'),
(550, 'hsa-mir-29b-2', 'breast cancer', 'up', 'microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.'),
(551, 'hsa-mir-29c', 'breast cancer', 'up', 'microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.'),
(552, 'hsa-mir-300', 'breast cancer', 'down', 'miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.'),
(553, 'hsa-mir-30a', 'breast cancer', 'down', 'miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.'),
(554, 'hsa-mir-30a', 'breast cancer', 'down', 'MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.'),
(555, 'hsa-mir-30a', 'breast cancer', 'down', 'Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.'),
(556, 'hsa-mir-30a', 'breast cancer', 'down', 'MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.'),
(557, 'hsa-mir-31', 'breast cancer', 'down', 'Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.'),
(558, 'hsa-mir-31', 'breast cancer', 'down', 'miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.'),
(559, 'hsa-mir-335', 'breast cancer', 'down', 'MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.'),
(560, 'hsa-mir-335', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(561, 'hsa-mir-335', 'breast cancer', 'down', 'MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.'),
(562, 'hsa-mir-339-5p', 'breast cancer', 'down', 'MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.'),
(563, 'hsa-mir-33b', 'breast cancer', 'down', 'MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.'),
(564, 'hsa-mir-34a', 'breast cancer', 'down', 'MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway.'),
(565, 'hsa-mir-34a', 'breast cancer', 'down', 'Circulating miR-34a levels are reduced in colorectal cancer.'),
(566, 'hsa-mir-34a', 'breast cancer', 'down', 'MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.'),
(567, 'hsa-mir-34a', 'breast cancer', 'down', 'Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion.'),
(568, 'hsa-mir-34a', 'breast cancer', 'down', 'MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line.'),
(569, 'hsa-mir-34b', 'breast cancer', 'down', 'MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.'),
(570, 'hsa-mir-34b', 'breast cancer', 'down', 'The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.'),
(571, 'hsa-mir-34c', 'breast cancer', 'down', 'The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer.'),
(572, 'hsa-mir-34c', 'breast cancer', 'down', 'MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.'),
(573, 'hsa-mir-34c', 'breast cancer', 'down', 'Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells.'),
(574, 'hsa-mir-373', 'breast cancer', 'up', 'The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.'),
(575, 'hsa-mir-374a', 'breast cancer', 'down', 'Effects of Differential Distribution of Microvessel Density, Possibly Regulated by miR-374a, on Breast Cancer Prognosis.'),
(576, 'hsa-mir-378', 'breast cancer', 'up', 'Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.'),
(577, 'hsa-mir-379', 'breast cancer', 'down', 'miR-379 regulates cyclin B1 expression and is decreased in breast cancer.'),
(578, 'hsa-mir-381', 'breast cancer', 'down', 'Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.'),
(579, 'hsa-mir-383', 'breast cancer', 'down', 'MicroRNA-383 Regulates the Apoptosis of Tumor Cells through Targeting Gadd45g.'),
(580, 'hsa-mir-423', 'breast cancer', 'up', 'Genetic analysis and preliminary function study of miR-423 in breast cancer.'),
(581, 'hsa-mir-425', 'breast cancer', 'down', 'Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.'),
(582, 'hsa-mir-429', 'breast cancer', 'up', 'Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.'),
(583, 'hsa-mir-429', 'breast cancer', 'down', 'miR-429 inhibits migration and invasion of breast cancer cells in vitro.'),
(584, 'hsa-mir-450b-3p', 'breast cancer', 'down', 'Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation.'),
(585, 'hsa-mir-494', 'breast cancer', 'down', 'miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/?-catenin signaling pathway.'),
(586, 'hsa-mir-495', 'breast cancer', 'up', 'miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.'),
(587, 'hsa-mir-495', 'breast cancer', 'down', 'Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer.'),
(588, 'hsa-mir-497', 'breast cancer', 'down', 'Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.'),
(589, 'hsa-mir-502-5p', 'breast cancer', 'down', 'Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.'),
(590, 'hsa-mir-503', 'breast cancer', 'up', 'MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.'),
(591, 'hsa-mir-510', 'breast cancer', 'up', 'MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.'),
(592, 'hsa-mir-517a', 'breast cancer', 'down', 'Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.'),
(593, 'hsa-mir-520c', 'breast cancer', 'up', 'The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.'),
(594, 'hsa-mir-526b', 'breast cancer', 'up', 'COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.'),
(595, 'hsa-mir-574-3p', 'breast cancer', 'down', 'Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.'),
(596, 'hsa-mir-638', 'breast cancer', 'down', 'miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple negative breast cancer.'),
(597, 'hsa-mir-7', 'breast cancer', 'down', 'MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.'),
(598, 'hsa-mir-720', 'breast cancer', 'down', 'miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.'),
(599, 'hsa-mir-873', 'breast cancer', 'down', 'MiR-873 regulates ER? transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.'),
(600, 'hsa-mir-874', 'breast cancer', 'down', 'MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9.'),
(601, 'hsa-mir-92a', 'breast cancer', 'down', 'Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.'),
(602, 'hsa-mir-92a', 'breast cancer', 'down', 'MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment.'),
(603, 'hsa-mir-92a', 'breast cancer', 'down', 'Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration.'),
(604, 'hsa-mir-96', 'breast cancer', 'up', 'Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.'),
(605, 'hsa-mir-96', 'breast cancer', 'up', 'miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.'),
(606, 'hsa-mir-98', 'breast cancer', 'down', 'Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122.'),
(607, 'hsa-mir-99a', 'breast cancer', 'down', 'MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.'),
(608, 'mmu-mir-290-3p', 'breast cancer', 'down', 'Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.'),
(609, 'mmu-mir-290-5p', 'breast cancer', 'down', 'Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.'),
(610, 'hsa-mir-1', 'breast cancer', 'down', 'Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.'),
(611, 'hsa-mir-1228', 'breast cancer', 'up', 'MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.'),
(612, 'hsa-mir-126', 'breast cancer', 'down', 'miR-126 regulated breast cancer cell invasion by targeting ADAM9.'),
(613, 'hsa-mir-139-5p', 'breast cancer', 'down', 'MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.'),
(614, 'hsa-mir-148b-3p', 'breast cancer', 'down', 'Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.'),
(615, 'hsa-mir-204', 'breast cancer', 'down', 'MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.'),
(616, 'hsa-mir-205', 'breast cancer', 'down', 'MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.'),
(617, 'hsa-mir-206', 'breast cancer', 'down', 'Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.'),
(618, 'hsa-mir-29a', 'breast cancer', 'down', 'MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.'),
(619, 'hsa-mir-329', 'breast cancer', 'down', 'Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.'),
(620, 'hsa-mir-362-3p', 'breast cancer', 'down', 'Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.'),
(621, 'hsa-mir-373', 'breast cancer', 'up', 'MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1?-TWIST signaling axis in breast cancer.'),
(622, 'hsa-mir-373', 'breast cancer', 'up', 'Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer.'),
(623, 'hsa-mir-451a', 'breast cancer', 'down', 'miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor.'),
(624, 'hsa-mir-497', 'breast cancer', 'down26338045', 'microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.'),
(625, 'hsa-mir-519d', 'breast cancer', 'down', 'miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.'),
(626, 'hsa-mir-652-3p', 'breast cancer', 'down', 'Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.'),
(627, 'hsa-mir-802', 'breast cancer', 'down', 'MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.'),
(628, 'hsa-mir-944', 'breast cancer', 'up', 'MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.'),
(629, 'hsa-mir-100', 'breast cancer', 'down', 'MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/?-catenin signaling pathway.'),
(630, 'hsa-mir-101', 'breast cancer', 'down', 'MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.'),
(631, 'hsa-mir-124', 'breast cancer', 'down', 'Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.'),
(632, 'hsa-mir-129-5p', 'breast cancer', 'down', 'Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.'),
(633, 'hsa-mir-181b', 'breast cancer', 'up', 'miR-181b promotes chemoresistance in breast cancer by regulating Bim expression.'),
(634, 'hsa-mir-200c', 'breast cancer', 'down', 'miR-200c inhibits breast cancer proliferation by targeting KRAS.'),
(635, 'hsa-mir-204-5p', 'breast cancer', 'down', 'MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.'),
(636, 'hsa-mir-21', 'breast cancer', 'up', 'miR-21: A gene of dual regulation in breast cancer.'),
(637, 'hsa-mir-21', 'breast cancer', 'up', 'MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-? pathways.'),
(638, 'hsa-mir-221', 'breast cancer', 'down', 'Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.'),
(639, 'hsa-mir-223', 'breast cancer', 'down', 'Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.'),
(640, 'hsa-mir-27a', 'breast cancer', 'up', 'Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.'),
(641, 'hsa-mir-33a', 'breast cancer', 'down', 'MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1.'),
(642, 'hsa-mir-340', 'breast cancer', 'down', 'miR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.'),
(643, 'hsa-mir-381', 'breast cancer', 'down', 'miR-381 suppresses C/EBP?-dependent Cx43 expression in breast cancer cells.'),
(644, 'hsa-mir-506', 'breast cancer', 'down', 'Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.'),
(645, 'hsa-mir-630', 'breast cancer', 'down', 'MiR-630 suppresses breast cancer progression by targeting metadherin.'),
(646, 'hsa-mir-671-5p', 'breast cancer', 'down', 'miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.'),
(647, 'hsa-mir-675', 'breast cancer', 'up', 'Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.'),
(648, 'hsa-mir-762', 'breast cancer', 'up', 'microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.'),
(649, 'hsa-mir-99a', 'breast cancer', 'down', 'MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.'),
(650, 'hsa-let-7a', 'breast cancer', 'down', 'Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.'),
(651, 'hsa-let-7a', 'breast cancer', 'down', 'Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.'),
(652, 'hsa-mir-101', 'breast cancer', 'down', 'MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1? mediated apoptosis and cell cycle arrest in normoxia condition.'),
(653, 'hsa-mir-10b', 'breast cancer', 'up', 'Critical role of miR-10b in transforming growth factor-?1-induced epithelial-mesenchymal transition in breast cancer.'),
(654, 'hsa-mir-1229', 'breast cancer', 'up', 'MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/?-catenin signaling in breast cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(655, 'hsa-mir-142-3p', 'breast cancer', 'down', 'microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.'),
(656, 'hsa-mir-143', 'breast cancer', 'down', 'miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.'),
(657, 'hsa-mir-145', 'breast cancer', 'down', 'MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.'),
(658, 'hsa-mir-147', 'breast cancer', 'down', 'MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer.'),
(659, 'hsa-mir-148a', 'breast cancer', 'down', 'MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.'),
(660, 'hsa-mir-155', 'breast cancer', 'up', 'MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.'),
(661, 'hsa-mir-16', 'breast cancer', 'down', 'MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.'),
(662, 'hsa-mir-193b', 'breast cancer', 'cell line:MDA-MB-231,MCF-7;', 'Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.'),
(663, 'hsa-mir-195', 'breast cancer', 'down', 'MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.'),
(664, 'hsa-mir-205', 'breast cancer', 'down', 'MicroRNA-205 increases the sensitivity of docetaxel in breast cancer.'),
(665, 'hsa-mir-20a', 'breast cancer', 'up', 'MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.'),
(666, 'hsa-mir-20b', 'breast cancer', 'up', 'MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.'),
(667, 'hsa-mir-21', 'breast cancer', 'up', 'Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.'),
(668, 'hsa-mir-21', 'breast cancer', 'up', 'Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.'),
(669, 'hsa-mir-221', 'breast cancer', 'up', 'Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.'),
(670, 'hsa-mir-26a', 'breast cancer', 'down', 'miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.'),
(671, 'hsa-mir-27a', 'breast cancer', 'up', 'miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.'),
(672, 'hsa-mir-30a', 'breast cancer', 'down', 'MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.'),
(673, 'hsa-mir-34a', 'breast cancer', 'down', 'Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.'),
(674, 'hsa-mir-34a', 'breast cancer', 'down', 'The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.'),
(675, 'hsa-mir-370', 'breast cancer', 'up', 'High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer.'),
(676, 'hsa-mir-409-3p', 'breast cancer', 'down', 'miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.'),
(677, 'hsa-mir-449a', 'breast cancer', 'up', 'MiR-449a promotes breast cancer progression by targeting CRIP2.'),
(678, 'hsa-mir-489', 'breast cancer', 'down', 'A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.'),
(679, 'hsa-mir-489-5p', 'breast cancer', 'down', 'GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.'),
(680, 'hsa-mir-498', 'breast cancer', 'down', 'MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.'),
(681, 'hsa-mir-520g', 'breast cancer', 'up', 'Study on the relationship between miR-520g and the development of breast cancer.'),
(682, 'hsa-mir-625', 'breast cancer', 'down', 'miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer.'),
(683, 'hsa-mir-892b', 'breast cancer', 'down', 'miR-892b Silencing Activates NF-?B and Promotes Aggressiveness in Breast Cancer.'),
(684, 'hsa-mir-146a', 'breast cancer', 'down', 'MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.'),
(685, 'hsa-mir-155', 'breast cancer', 'up', 'Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells.'),
(686, 'hsa-mir-182', 'breast cancer', 'up', 'High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.'),
(687, 'hsa-mir-183', 'breast cancer', 'up', 'High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.'),
(688, 'hsa-mir-221', 'breast cancer', 'up', 'Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.'),
(689, 'hsa-mir-30e', 'breast cancer', 'down', 'Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.'),
(690, 'hsa-mir-320a', 'breast cancer', 'down', 'MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.'),
(691, 'hsa-mir-3646', 'breast cancer', 'up', 'miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.'),
(692, 'hsa-mir-410-3p', 'breast cancer', 'down', 'miR-410-3p suppresses breast cancer progression by targeting Snail.'),
(693, 'hsa-mir-411-5p', 'breast cancer', 'down', 'miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.'),
(694, 'hsa-mir-485-3p', 'breast cancer', 'down', 'MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.'),
(695, 'hsa-mir-485-5p', 'breast cancer', 'down', 'MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1? expression.'),
(696, 'hsa-mir-5003-3p', 'breast cancer', 'up', 'miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin.'),
(697, 'hsa-mir-544', 'breast cancer', 'down', 'MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.'),
(698, 'hsa-mir-96', 'breast cancer', 'up', 'High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer.'),
(699, 'hsa-mir-99a', 'breast cancer', 'down', 'MiR-99a suppress proliferation, migration and invasion through regulating insulin-like growth factor 1 receptor in breast cancer.'),
(700, 'hsa-mir-101', 'breast cancer', 'down', 'MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.'),
(701, 'hsa-mir-106b', 'breast cancer', 'up', 'MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.'),
(702, 'hsa-mir-10b', 'breast cancer', 'up', 'Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.'),
(703, 'hsa-mir-124-3p', 'breast cancer', 'down', 'Decreased miR-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1.'),
(704, 'hsa-mir-132', 'breast cancer', 'down', 'Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.'),
(705, 'hsa-mir-133a', 'breast cancer', 'down', 'Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.'),
(706, 'hsa-mir-143', 'breast cancer', 'down', 'MicroRNA?143 targets CD44 to inhibit breast cancer progression and stem cell-like properties.'),
(707, 'hsa-mir-145', 'breast cancer', 'down', 'miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.'),
(708, 'hsa-mir-153', 'breast cancer', 'up', 'MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.'),
(709, 'hsa-mir-154', 'breast cancer', 'down', 'MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.'),
(710, 'hsa-mir-181b-3p', 'breast cancer', 'up', 'miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.'),
(711, 'hsa-mir-183-5p', 'breast cancer', 'up', 'MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.'),
(712, 'hsa-mir-195', 'breast cancer', 'down', 'miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.'),
(713, 'hsa-mir-203', 'breast cancer', 'up', 'Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.'),
(714, 'hsa-mir-212', 'breast cancer', 'down', 'Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues.'),
(715, 'hsa-mir-214', 'breast cancer', 'down', 'miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade.'),
(716, 'hsa-mir-214', 'breast cancer', 'down', 'Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.'),
(717, 'hsa-mir-218', 'breast cancer', 'down', 'Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.'),
(718, 'hsa-mir-29a', 'breast cancer', 'up', 'Mir-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1.'),
(719, 'hsa-mir-33a', 'breast cancer', 'down', 'MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.'),
(720, 'hsa-mir-340', 'breast cancer', 'down', 'miR-340 and ZEB1 negative feedback loop regulates TGF-?- mediated breast cancer progression.'),
(721, 'hsa-mir-34a', 'breast cancer', 'down', 'MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/?-Catenin Signaling Pathway.'),
(722, 'hsa-mir-421', 'breast cancer', 'down', 'MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1.'),
(723, 'hsa-mir-490', 'breast cancer', 'down', 'MicroRNA-490 inhibits tumorigenesis and progression in breast cancer.'),
(724, 'hsa-mir-544a', 'breast cancer', 'up', 'miR-544a Promotes Breast Cancer Cell Migration and Invasion Reducing Cadherin 1 Expression.'),
(725, 'hsa-mir-601', 'breast cancer', 'down', 'miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.'),
(726, 'hsa-mir-613', 'breast cancer', 'down', 'miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA.'),
(727, 'hsa-mir-107', 'breast cancer', 'down', 'MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating BDNF.'),
(728, 'hsa-mir-124', 'breast cancer', 'down', 'MicroRNA-124 inhibits cell proliferation and migration by regulating SNAI2 in breast cancer.'),
(729, 'hsa-mir-124-3p', 'breast cancer', 'down', 'miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.'),
(730, 'hsa-mir-129-5p', 'breast cancer', 'down', 'MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance.'),
(731, 'hsa-mir-139', 'breast cancer', 'down', 'Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.'),
(732, 'hsa-mir-144', 'breast cancer', 'down', 'miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.'),
(733, 'hsa-mir-182', 'breast cancer', 'up', 'MiR-182 promotes proliferation and invasion and elevates the HIF-1?-VEGF-A axis in breast cancer cells by targeting FBXW7.'),
(734, 'hsa-mir-199b-5p', 'breast cancer', 'down', 'Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.'),
(735, 'hsa-mir-19b', 'breast cancer', 'up', 'MiR-19b suppresses PTPRG to promote breast tumorigenesis.'),
(736, 'hsa-mir-203', 'breast cancer', 'up', 'miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer.'),
(737, 'hsa-mir-210', 'breast cancer', 'down', 'MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer.'),
(738, 'hsa-mir-216b', 'breast cancer', 'down', 'miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.'),
(739, 'hsa-mir-27b-3p', 'breast cancer', 'down', 'Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.'),
(740, 'hsa-mir-346', 'breast cancer', 'up', 'MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.'),
(741, 'hsa-mir-34c', 'breast cancer', 'down', 'MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.'),
(742, 'hsa-mir-365', 'breast cancer', 'down', 'Overexpression of microRNA-365 inhibits breast cancer cell growth and chemo-resistance through GALNT4.'),
(743, 'hsa-mir-520e', 'breast cancer', 'up', 'miR-520e regulates cell proliferation, apoptosis and migration in breast cancer.'),
(744, 'hsa-mir-96', 'breast cancer', 'up', 'miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.'),
(745, 'hsa-mir-99a', 'breast cancer', 'down', 'Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer.'),
(746, 'hsa-mir-1207-5p', 'breast cancer', 'up', 'PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.'),
(747, 'hsa-mir-1246', 'breast cancer', 'up', 'miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.'),
(748, 'hsa-mir-141', 'breast cancer', 'down', 'Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.'),
(749, 'hsa-mir-155', 'breast cancer', 'up', 'A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.'),
(750, 'hsa-mir-17-5p', 'breast cancer', 'down', 'STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells.'),
(751, 'hsa-mir-182-5p', 'breast cancer', 'up', 'Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer.'),
(752, 'hsa-mir-21', 'breast cancer', 'up', 'A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.'),
(753, 'hsa-mir-214', 'breast cancer', 'down', 'MiR-214 negatively regulates proliferation and WNT/?-catenin signaling in breast cancer.'),
(754, 'hsa-mir-214-3p', 'breast cancer', 'up', 'Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.'),
(755, 'hsa-mir-32', 'breast cancer', 'up', 'MicroRNA-32 promotes cell proliferation, migration and suppresses apoptosis in breast cancer cells by targeting FBXW7.'),
(756, 'hsa-mir-320a', 'breast cancer', 'down', 'Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.'),
(757, 'hsa-mir-365', 'breast cancer', 'down', 'A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.'),
(758, 'hsa-mir-375', 'breast cancer', 'down', 'miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.'),
(759, 'hsa-mir-376b', 'breast cancer', 'up', 'MicroRNA-376b promotes breast cancer metastasis by targeting Hoxd10 directly.'),
(760, 'hsa-mir-494', 'breast cancer', 'down', 'MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.'),
(761, 'hsa-mir-503-3p', 'breast cancer', 'up', 'miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.'),
(762, 'hsa-mir-520a-3p', 'breast cancer', 'down', 'Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.'),
(763, 'hsa-mir-567', 'breast cancer', 'down', 'MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration.'),
(764, 'hsa-mir-590-5p', 'breast cancer', 'down', 'MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.'),
(765, 'hsa-mir-660-5p', 'breast cancer', 'up', 'Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.'),
(766, 'hsa-mir-761', 'breast cancer', 'up', 'microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.'),
(767, 'hsa-mir-106b', 'breast cancer', 'up', 'MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.'),
(768, 'hsa-mir-125b', 'breast cancer', 'up', 'Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.'),
(769, 'hsa-mir-125b', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(770, 'hsa-mir-134', 'breast cancer', 'down', 'MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.'),
(771, 'hsa-mir-145', 'breast cancer', 'down', 'miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-?1 expression.'),
(772, 'hsa-mir-155', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(773, 'hsa-mir-191', 'breast cancer', 'up', 'P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer.'),
(774, 'hsa-mir-198', 'breast cancer', 'down', 'miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.'),
(775, 'hsa-mir-19a', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(776, 'hsa-mir-204', 'breast cancer', 'down', 'miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.'),
(777, 'hsa-mir-205', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(778, 'hsa-mir-21', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(779, 'hsa-mir-30a-5p', 'breast cancer', 'down', 'miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.'),
(780, 'hsa-mir-330-3p', 'breast cancer', 'up', 'Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.'),
(781, 'hsa-mir-373', 'breast cancer', 'up', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(782, 'hsa-mir-451', 'breast cancer', 'down', 'Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.'),
(783, 'hsa-mir-455', 'breast cancer', 'down', 'miR-455 inhibits breast cancer cell proliferation through targeting CDK14.'),
(784, 'hsa-mir-495', 'breast cancer', 'down', 'Demethylation of miR-495 inhibits cell proliferation, migration and promotes apoptosis by targeting STAT-3 in breast cancer.'),
(785, 'hsa-mir-597', 'breast cancer', 'down', 'miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2.'),
(786, 'hsa-mir-7', 'breast cancer', 'down', 'Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.'),
(787, 'hsa-mir-9', 'breast cancer', 'down', 'Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.'),
(788, 'hsa-mir-9', 'breast cancer', 'up', 'MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.'),
(789, 'hsa-mir-93-5p', 'breast cancer', 'up', 'MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.'),
(790, 'hsa-let-7g', 'breast cancer', 'down', 'MicroRNA Let-7g Directly Targets Forkhead Box C2 (FOXC2) to Modulate Bone Metastasis in Breast Cancer.'),
(791, 'hsa-mir-132', 'breast cancer', 'down', 'MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.'),
(792, 'hsa-mir-138', 'breast cancer', 'down', 'CREPT regulated by miR-138 promotes breast cancer progression.'),
(793, 'hsa-mir-140-5p', 'breast cancer', 'down', 'MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.'),
(794, 'hsa-mir-143', 'breast cancer', 'down', 'MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.'),
(795, 'hsa-mir-143-3p', 'breast cancer', 'down', 'miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.'),
(796, 'hsa-mir-152', 'breast cancer', 'down', 'Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.'),
(797, 'hsa-mir-155', 'breast cancer', 'up', 'MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.'),
(798, 'hsa-mir-183', 'breast cancer', 'up', 'Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines.'),
(799, 'hsa-mir-193a', 'breast cancer', 'down', 'MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.'),
(800, 'hsa-mir-19b', 'breast cancer', 'up', 'miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules.'),
(801, 'hsa-mir-200a', 'breast cancer', 'down', 'A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.'),
(802, 'hsa-mir-20a', 'breast cancer', 'up', 'MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability.'),
(803, 'hsa-mir-215', 'breast cancer', 'down', 'MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1.'),
(804, 'hsa-mir-22', 'breast cancer', 'down', 'miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1.'),
(805, 'hsa-mir-22', 'breast cancer', 'down', 'MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1.'),
(806, 'hsa-mir-223', 'breast cancer', 'up', 'miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.'),
(807, 'hsa-mir-30c', 'breast cancer', 'down', 'Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.'),
(808, 'hsa-mir-3188', 'breast cancer', 'up', 'MiR-3188 Regulates Cell Proliferation, Apoptosis, and Migration in Breast Cancer By Targeting TUSC5 and Regulating the p38 MAPK Signaling Pathway.'),
(809, 'hsa-mir-335', 'breast cancer', 'down', 'MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.'),
(810, 'hsa-mir-33a', 'breast cancer', 'down', 'MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in?Breast Cancer.'),
(811, 'hsa-mir-340', 'breast cancer', 'down', 'MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells.'),
(812, 'hsa-mir-346', 'breast cancer', 'up', 'When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper\'s author.'),
(813, 'hsa-mir-375', 'breast cancer', 'down', 'MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.'),
(814, 'hsa-mir-451', 'breast cancer', 'down', 'Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.'),
(815, 'hsa-mir-452', 'breast cancer', 'down', 'Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.'),
(816, 'hsa-mir-494', 'breast cancer', 'up', 'Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines.'),
(817, 'hsa-mir-599', 'breast cancer', 'down', 'Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer.'),
(818, 'hsa-mir-9', 'breast cancer', 'down', 'Her-2 expression regulated by downregulation of miR-9 and which affects chemotherapeutic effect in breast cancer.'),
(819, 'hsa-mir-10a', 'breast cancer', 'down', 'MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.'),
(820, 'hsa-mir-1246', 'breast cancer', 'up', 'Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.'),
(821, 'hsa-mir-1296-5p', 'breast cancer', 'down', 'miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer.'),
(822, 'hsa-mir-133a', 'breast cancer', 'down', 'MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.'),
(823, 'hsa-mir-154', 'breast cancer', 'down', 'MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.'),
(824, 'hsa-mir-193b', 'breast cancer', 'down', 'Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.'),
(825, 'hsa-mir-19b', 'breast cancer', 'up', 'Over-expression of long non-coding RNA PTENP1 inhibits cell proliferation and migration via suppression of miR-19b in breast cancer cells.'),
(826, 'hsa-mir-200c', 'breast cancer', 'down', 'HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL.'),
(827, 'hsa-mir-204', 'breast cancer', 'down', 'Angiogenesis Analysis by In Vitro Coculture Assays in Transwell Chambers in Ovarian Cancer.'),
(828, 'hsa-mir-20a', 'breast cancer', 'down', 'A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.'),
(829, 'hsa-mir-20b', 'breast cancer', 'down', 'A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.'),
(830, 'hsa-mir-219a-5p', 'breast cancer', 'down', 'miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.'),
(831, 'hsa-mir-23a', 'breast cancer', 'up', 'MiR-23a promotes TGF-?1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/?-catenin signaling.'),
(832, 'hsa-mir-296-5p', 'breast cancer', 'down', 'Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.'),
(833, 'hsa-mir-30e', 'breast cancer', 'down', 'MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.'),
(834, 'hsa-mir-329', 'breast cancer', 'down', 'Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.'),
(835, 'hsa-mir-361-5p', 'breast cancer', 'down', 'MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.'),
(836, 'hsa-mir-4301', 'breast cancer', 'down', 'A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells.'),
(837, 'hsa-mir-4469', 'breast cancer', 'up', 'CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt/?-catenin pathway.'),
(838, 'hsa-mir-452', 'breast cancer', 'down', 'Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.'),
(839, 'hsa-mir-495', 'breast cancer', 'down', 'Lnc RNA SNHG20 participated in proliferation, invasion and migration of breast cancer cells via miR-495.'),
(840, 'hsa-mir-497', 'breast cancer', 'down', 'microRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer.'),
(841, 'hsa-mir-512-5p', 'breast cancer', 'down', 'Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.'),
(842, 'hsa-mir-519d-3p', 'breast cancer', 'down', 'MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.'),
(843, 'hsa-mir-588', 'breast cancer', 'down', 'MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer.'),
(844, 'hsa-mir-592', 'breast cancer', 'down', 'Suppressive role of miR-592 in breast cancer by repressing TGF-?2.'),
(845, 'hsa-mir-630', 'breast cancer', 'down', 'MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.'),
(846, 'hsa-mir-645', 'breast cancer', 'up', 'Downregulation of microRNA-645 suppresses breast cancer cell metastasis via targeting DCDC2.'),
(847, 'hsa-let-7a-1', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(848, 'hsa-let-7a-2', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(849, 'hsa-let-7a-3', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(850, 'hsa-let-7b', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(851, 'hsa-let-7c', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(852, 'hsa-let-7d', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(853, 'hsa-let-7e', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(854, 'hsa-let-7f-1', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(855, 'hsa-let-7f-2', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(856, 'hsa-let-7g', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(857, 'hsa-let-7i', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(858, 'hsa-mir-1271', 'breast cancer', 'down', 'miR-1271 inhibits ER? expression and confers letrozole resistance in breast cancer.'),
(859, 'hsa-mir-129', 'breast cancer', 'down', 'MiR-129 blocks estrogen induction of NOTCH signaling activity in breast cancer stem-like cells.'),
(860, 'hsa-mir-130a', 'breast cancer', 'down', 'microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1.'),
(861, 'hsa-mir-143-3p', 'breast cancer', 'down', 'MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7.'),
(862, 'hsa-mir-190', 'breast cancer', 'down', 'miR-190 suppresses breast cancer metastasis by regulation of TGF-?-induced epithelial-mesenchymal transition.'),
(863, 'hsa-mir-200a', 'breast cancer', 'up', 'MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer.'),
(864, 'hsa-mir-205', 'breast cancer', 'down', 'The association between differentially expressed micro RNAs in breast cancer cell lines and the micro RNA-205 gene polymorphism in breast cancer tissue.'),
(865, 'hsa-mir-26b', 'breast cancer', 'down', 'MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.'),
(866, 'hsa-mir-27b-3p', 'breast cancer', 'down', 'miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.'),
(867, 'hsa-mir-320', 'breast cancer', 'down', 'MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4.'),
(868, 'hsa-mir-34a', 'breast cancer', 'down', 'miR-34a expression in human breast cancer is associated with drug resistance.'),
(869, 'hsa-mir-372', 'breast cancer', 'up', 'miR-372 promotes breast cancer cell proliferation by directly targeting LATS2.'),
(870, 'hsa-mir-448', 'breast cancer', 'down', 'miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.'),
(871, 'hsa-mir-489', 'breast cancer', 'down', 'Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.'),
(872, 'hsa-mir-519d', 'breast cancer', 'down', 'MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.'),
(873, 'hsa-mir-539', 'breast cancer', 'down', 'miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer.'),
(874, 'hsa-mir-613', 'breast cancer', 'down', 'miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.'),
(875, 'hsa-mir-96', 'breast cancer', 'up', 'miR-96 promotes breast cancer metastasis by suppressing MTSS1.'),
(876, 'hsa-mir-98', 'breast cancer', 'down', 'Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.'),
(877, 'hsa-let-7d', 'breast cancer', 'down', 'Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.'),
(878, 'hsa-mir-101', 'breast cancer', 'up', 'Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities.'),
(879, 'hsa-mir-10b', 'breast cancer', 'up', 'Enhanced motility and proliferation by miR-10b/FUT8/p-AKT axis in breast cancer cells.'),
(880, 'hsa-mir-125b-5p', 'breast cancer', 'down', 'miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522.'),
(881, 'hsa-mir-1271', 'breast cancer', 'down', 'MiR-1271 as a tumor suppressor in breast cancer proliferation and progression via targeting SPIN1.'),
(882, 'hsa-mir-1284', 'breast cancer', 'down', 'MiR-1284 inhibits the growth and invasion of breast cancer cells by targeting ZIC2.'),
(883, 'hsa-mir-129-5p', 'breast cancer', 'down', 'miR-129-5p suppresses breast cancer proliferation by targeting CBX4.'),
(884, 'hsa-mir-129-5p', 'breast cancer', 'down', 'microRNA-129-5p suppresses Adriamycin resistance in breast cancer by targeting SOX2.'),
(885, 'hsa-mir-1301-3p', 'breast cancer', 'down', 'MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.'),
(886, 'hsa-mir-130a-3p', 'breast cancer', 'down', 'MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.'),
(887, 'hsa-mir-133b', 'breast cancer', 'down', 'MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.'),
(888, 'hsa-mir-135a', 'breast cancer', 'down', 'Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.'),
(889, 'hsa-mir-135a', 'breast cancer', 'down', 'Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer.'),
(890, 'hsa-mir-140-5p', 'breast cancer', 'down', 'miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.'),
(891, 'hsa-mir-142-3p', 'breast cancer', 'down', 'Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.'),
(892, 'hsa-mir-144', 'breast cancer', 'down', 'MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.'),
(893, 'hsa-mir-153', 'breast cancer', 'down', 'miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells.'),
(894, 'hsa-mir-1915-3p', 'breast cancer', 'up', 'Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.'),
(895, 'hsa-mir-19b-3p', 'breast cancer', 'down', 'miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathway.'),
(896, 'hsa-mir-204', 'breast cancer', 'down', 'Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.'),
(897, 'hsa-mir-205-5p', 'breast cancer', 'up', 'MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells.'),
(898, 'hsa-mir-221', 'breast cancer', 'up', 'MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.'),
(899, 'hsa-mir-222', 'breast cancer', 'up', 'MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines.'),
(900, 'hsa-mir-29c', 'breast cancer', 'down', 'miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.'),
(901, 'hsa-mir-301a-3p', 'breast cancer', 'up', 'MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ER? Positive Breast Cancer.'),
(902, 'hsa-mir-328-5p', 'breast cancer', 'down', 'miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by targeting RAGE.'),
(903, 'hsa-mir-330-3p', 'breast cancer', 'up', 'Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.'),
(904, 'hsa-mir-361-5p', 'breast cancer', 'down', 'Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/ PI3K/Akt pathway.'),
(905, 'hsa-mir-374a', 'breast cancer', 'up', 'Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer.'),
(906, 'hsa-mir-384', 'breast cancer', 'down', 'MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.'),
(907, 'hsa-mir-433', 'breast cancer', 'down', 'MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.'),
(908, 'hsa-mir-433', 'breast cancer', 'down', 'miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.'),
(909, 'hsa-mir-449a', 'breast cancer', 'down', 'MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer.'),
(910, 'hsa-mir-449a', 'breast cancer', 'up', '[Effects of miR-449a on proliferation and migration of human breast cancer cell line MCF-7].'),
(911, 'hsa-mir-455-3p', 'breast cancer', 'down', 'Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.'),
(912, 'hsa-mir-485-5p', 'breast cancer', 'down', 'miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.'),
(913, 'hsa-mir-489', 'breast cancer', 'down', 'Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.'),
(914, 'hsa-mir-497', 'breast cancer', 'down', 'LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2.'),
(915, 'hsa-mir-498', 'breast cancer', 'up', 'MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.'),
(916, 'hsa-mir-520d-3p', 'breast cancer', 'down', 'MiR-520d-3p antitumor activity in human breast cancer via post-transcriptional regulation of spindle and kinetochore associated 2 expression.'),
(917, 'hsa-mir-590-3p', 'breast cancer', 'down', 'MiR-590-3p Inhibits Proliferation and Promotes Apoptosis by Targeting Activating Transcription Factor 3 in Human Breast Cancer Cells.'),
(918, 'hsa-mir-590-5p', 'breast cancer', 'down', 'MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-?-catenin si'),
(919, 'hsa-mir-708-3p', 'breast cancer', 'down', 'MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.'),
(920, 'hsa-mir-92a-3p', 'breast cancer', 'up', 'Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.'),
(921, 'hsa-mir-98', 'breast cancer', 'down', 'microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2.'),
(922, 'hsa-let-7a', 'breast cancer', 'down', 'Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.'),
(923, 'hsa-let-7a', 'breast cancer', 'down', 'Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.'),
(924, 'hsa-let-7a', 'breast cancer', 'down', 'Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1.'),
(925, 'hsa-mir-1', 'breast cancer', 'down', 'miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1.'),
(926, 'hsa-mir-106a', 'breast cancer', 'up', 'miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.'),
(927, 'hsa-mir-107', 'breast cancer', 'down', 'microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1.'),
(928, 'hsa-mir-10b', 'breast cancer', 'up', 'Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.'),
(929, 'hsa-mir-1179', 'breast cancer', 'down', 'Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis.'),
(930, 'hsa-mir-1247-5p', 'breast cancer', 'down', 'Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/?-catenin signaling in breast cancer.'),
(931, 'hsa-mir-133a-1', 'breast cancer', 'down', 'Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.'),
(932, 'hsa-mir-133a-2', 'breast cancer', 'down', 'Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.'),
(933, 'hsa-mir-133b', 'breast cancer', 'down', 'Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.'),
(934, 'hsa-mir-135a', 'breast cancer', 'down', 'Loss of Estrogen-Regulated?MIR135A1?at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer.'),
(935, 'hsa-mir-145', 'breast cancer', 'down', 'Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.'),
(936, 'hsa-mir-153', 'breast cancer', 'down', 'Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-?) signaling pathway.'),
(937, 'hsa-mir-155', 'breast cancer', 'up', 'Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.'),
(938, 'hsa-mir-17', 'breast cancer', 'up', 'Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.'),
(939, 'hsa-mir-186', 'breast cancer', 'down', 'miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1.'),
(940, 'hsa-mir-193b', 'breast cancer', 'down', 'Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.'),
(941, 'hsa-mir-194-5p', 'breast cancer', 'down', 'Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/?-catenin signaling pathway.'),
(942, 'hsa-mir-196b-5p', 'breast cancer', 'down', 'Downregulation of MiR-196b-5p impedes cell proliferation and metastasis in breast cancer through regulating COL1A1.'),
(943, 'hsa-mir-206', 'breast cancer', 'up', 'Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.'),
(944, 'hsa-mir-21', 'breast cancer', 'up', 'MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.'),
(945, 'hsa-mir-21', 'breast cancer', 'up', 'Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.'),
(946, 'hsa-mir-211', 'breast cancer', 'down', 'Targeting PDK4 inhibits breast cancer metabolism.'),
(947, 'hsa-mir-22', 'breast cancer', 'down', 'MicroRNA-22 Suppresses Breast Cancer Cell Growth and Increases Paclitaxel Sensitivity by Targeting NRAS.'),
(948, 'hsa-mir-22', 'breast cancer', 'down', 'MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ER?.'),
(949, 'hsa-mir-221', 'breast cancer', 'up', 'miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer.'),
(950, 'hsa-mir-222', 'breast cancer', 'up', 'miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer.'),
(951, 'hsa-mir-224-5p', 'breast cancer', 'up', 'MiRNA-224-5p inhibits autophagy in breast cancer cells via targeting Smad4.'),
(952, 'hsa-mir-25', 'breast cancer', 'down', 'Expression of circulating miR-17, miR-25, and miR-133 in breast cancer patients.'),
(953, 'hsa-mir-3136-3p', 'breast cancer', 'up', 'Identification of chemoresistance-associated miRNAs in breast cancer.'),
(954, 'hsa-mir-34a', 'breast cancer', 'down', 'MicroRNA-34a suppresses breast cancer cell proliferation and invasion by targeting Notch1.'),
(955, 'hsa-mir-376a', 'breast cancer', 'down', 'miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR.'),
(956, 'hsa-mir-4282', 'breast cancer', 'down', 'MiR-4282 inhibits proliferation, invasion and metastasis of human breast cancer by targeting Myc.'),
(957, 'hsa-mir-520b', 'breast cancer', 'down', 'Identification of chemoresistance-associated miRNAs in breast cancer.'),
(958, 'hsa-mir-638', 'breast cancer', 'down', 'Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients.'),
(959, 'hsa-mir-93', 'breast cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(960, 'hsa-mir-99a-5p', 'breast cancer', 'down', 'MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.'),
(961, 'hsa-mir-1-3p', 'breast cancer', 'down', 'Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.'),
(962, 'hsa-mir-106a', 'breast cancer', 'up', 'MiRNA-106a promotes breast cancer progression by regulating DAX-1.'),
(963, 'hsa-mir-107', 'breast cancer', 'down', 'miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel.'),
(964, 'hsa-mir-10a-5p', 'breast cancer', 'down', 'S-equol inhibits proliferation and promotes apoptosis of human breast cancer MCF-7?cells via regulating miR-10a-5p and PI3K/AKT pathway.'),
(965, 'hsa-mir-124-3p', 'breast cancer', 'down', 'Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.'),
(966, 'hsa-mir-126', 'breast cancer', 'down', 'Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.'),
(967, 'hsa-mir-1271', 'breast cancer', 'down', 'Estrogen receptor-?-miR-1271-SNAI2 feedback loop regulates transforming growth factor-?-induced breast cancer progression.'),
(968, 'hsa-mir-1307-3p', 'breast cancer', 'up', 'miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4.'),
(969, 'hsa-mir-132-3p', 'breast cancer', 'down', 'MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.'),
(970, 'hsa-mir-133b', 'breast cancer', 'down', 'LncRNA NEAT1 Silenced miR-133b Promotes Migration and Invasion of Breast Cancer Cells.'),
(971, 'hsa-mir-138', 'breast cancer', 'down', 'Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer.'),
(972, 'hsa-mir-138-5p', 'breast cancer', 'down', 'MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.'),
(973, 'hsa-mir-140-3p', 'breast cancer', 'down', 'miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28.'),
(974, 'hsa-mir-140-5p', 'breast cancer', 'down', 'Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1.'),
(975, 'hsa-mir-145-5p', 'breast cancer', 'down', 'miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2.'),
(976, 'hsa-mir-150-5p', 'breast cancer', 'up', 'Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer.'),
(977, 'hsa-mir-152', 'breast cancer', 'down', 'microRNA-152 inhibits cell proliferation, migration and invasion in breast cancer.'),
(978, 'hsa-mir-153', 'breast cancer', 'down', 'MicroRNA-153 inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition in breast cancer via direct targeting of RUNX2.'),
(979, 'hsa-mir-154-5p', 'breast cancer', 'down', 'SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis.'),
(980, 'hsa-mir-155', 'breast cancer', 'up', 'Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(981, 'hsa-mir-155-3p', 'breast cancer', 'down', 'MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.'),
(982, 'hsa-mir-16-5p', 'breast cancer', 'down', 'MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-?B pathway.'),
(983, 'hsa-mir-200a-3p', 'breast cancer', 'up', 'Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.'),
(984, 'hsa-mir-202', 'breast cancer', 'down', 'MiR-202 inhibits cell proliferation, invasion, and migration in breast cancer by targeting ROCK1 gene.'),
(985, 'hsa-mir-204-5p', 'breast cancer', 'down', 'Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.'),
(986, 'hsa-mir-21', 'breast cancer', 'up', ''),
(987, 'hsa-mir-21', 'breast cancer', 'up', 'Overexpression of MicroRNA-21 in the Serum of Breast Cancer Patients.'),
(988, 'hsa-mir-21', 'breast cancer', 'up', 'Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.'),
(989, 'hsa-mir-21', 'breast cancer', 'up', 'Interrelation of the Circulating and Tissue MicroRNA-21 with Tissue PDCD4 Expression and the Invasiveness of Iraqi Female Breast Tumors.'),
(990, 'hsa-mir-216a', 'breast cancer', 'down', 'MicroRNA-216a suppresses the proliferation and migration of human breast cancer cells via the Wnt/?-catenin signaling pathway.'),
(991, 'hsa-mir-218', 'breast cancer', 'down', 'CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.'),
(992, 'hsa-mir-22', 'breast cancer', 'down', 'Serum miR-22 Could be a Potential Biomarker for the Prognosis of Breast Cancer.'),
(993, 'hsa-mir-224', 'breast cancer', 'up', 'MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer.'),
(994, 'hsa-mir-23b', 'breast cancer', 'up', 'miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.'),
(995, 'hsa-mir-26a-5p', 'breast cancer', 'down', 'MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression.'),
(996, 'hsa-mir-27b', 'breast cancer', 'up', 'miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.'),
(997, 'hsa-mir-29c', 'breast cancer', 'down', 'LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis.'),
(998, 'hsa-mir-326', 'breast cancer', 'down', 'MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway.'),
(999, 'hsa-mir-326', 'breast cancer', 'down', 'Functional analyses of microRNA-326 in breast cancer development.'),
(1000, 'hsa-mir-370', 'breast cancer', 'up', 'microRNA-370 Promotes Cell Growth by Targeting WNK2 in Breast Cancer.'),
(1001, 'hsa-mir-4458', 'breast cancer', 'down', 'miR-4458 inhibits breast cancer cell growth, migration, and invasion by targeting CPSF4.'),
(1002, 'hsa-mir-449b-5p', 'breast cancer', 'down', 'MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/?-catenin signaling.'),
(1003, 'hsa-mir-4513', 'breast cancer', 'up', 'miR-4513 promotes breast cancer progression through targeting TRIM3.'),
(1004, 'hsa-mir-4732-5p', 'breast cancer', 'up', 'miR-4732-5p promotes breast cancer progression by targeting TSPAN13.'),
(1005, 'hsa-mir-483', 'breast cancer', 'down', 'MiR-483 suppresses cell proliferation and promotes cell apoptosis by targeting SOX3 in breast cancer.'),
(1006, 'hsa-mir-486-3p', 'breast cancer', 'down', 'Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.'),
(1007, 'hsa-mir-489-5p', 'breast cancer', 'down', 'Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis.'),
(1008, 'hsa-mir-497-5p', 'breast cancer', 'down', 'HOXC13-AS promotes breast cancer cell growth through regulating miR-497-5p/PTEN axis.'),
(1009, 'hsa-mir-505', 'breast cancer', 'down', 'Downregulation of miR-505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer.'),
(1010, 'hsa-mir-516a-3p', 'breast cancer', 'down', 'miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.'),
(1011, 'hsa-mir-526b', 'breast cancer', 'up', 'miR526b and miR655 Induce Oxidative Stress in Breast Cancer.'),
(1012, 'hsa-mir-591', 'breast cancer', 'down', 'MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway.'),
(1013, 'hsa-mir-638', 'breast cancer', 'down', 'miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.'),
(1014, 'hsa-mir-653', 'breast cancer', 'down', 'Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.'),
(1015, 'hsa-mir-655', 'breast cancer', 'up', 'miR526b and miR655 Induce Oxidative Stress in Breast Cancer.'),
(1016, 'hsa-mir-665', 'breast cancer', 'up', 'miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.'),
(1017, 'hsa-mir-7', 'breast cancer', 'down', 'Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.'),
(1018, 'hsa-mir-876', 'breast cancer', 'down', 'MicroRNA-876 is sponged by long noncoding RNA LINC00707 and directly targets metadherin to inhibit breast cancer malignancy.'),
(1019, 'hsa-mir-876-5p', 'breast cancer', 'down', 'miR-876-5p suppresses breast cancer progression through targeting TFAP2A.'),
(1020, 'hsa-mir-937', 'breast cancer', 'up', 'miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.'),
(1021, 'hsa-mir-96-5p', 'breast cancer', 'up', 'Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.'),
(1022, 'hsa-mir-17', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1023, 'hsa-mir-18a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1024, 'hsa-mir-19a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1025, 'hsa-mir-19b', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1026, 'hsa-mir-20a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1027, 'hsa-mir-24', 'breast carcinoma', 'up', 'MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.'),
(1028, 'hsa-mir-92a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1029, 'mir-17', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1030, 'mir-18a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1031, 'mir-19a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1032, 'mir-19b', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1033, 'mir-20a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1034, 'mir-92a', 'breast carcinoma', 'up', 'MiR-93 enhances angiogenesis and metastasis by targeting LATS2.'),
(1035, 'hsa-mir-497', 'breast carcinoma', 'down', 'miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1?.'),
(1036, 'hsa-mir-497', 'breast carcinoma', 'down', 'miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.'),
(1037, 'hsa-mir-130b-3p', 'breast carcinoma', 'down', 'miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.'),
(1038, 'hsa-mir-4530', 'breast carcinoma', 'up', 'MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells.'),
(1039, 'hsa-mir-16-5p', 'breast carcinoma', 'down', 'MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma.'),
(1040, 'hsa-mir-10b', 'breast carcinoma', 'down', 'Different molecular subtypes of breast invasive ductal carcinoma.'),
(1041, 'hsa-mir-372-3p', 'breast carcinoma', 'up', 'MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.'),
(1042, 'hsa-let-7a-1', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1043, 'hsa-let-7a-2', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1044, 'hsa-let-7a-3', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1045, 'hsa-let-7b', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1046, 'hsa-let-7c', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1047, 'hsa-let-7d', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1048, 'hsa-let-7e', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1049, 'hsa-let-7f-1', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1050, 'hsa-let-7f-2', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1051, 'hsa-let-7g', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1052, 'hsa-let-7i', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1053, 'hsa-mir-98', 'bronchioloalveolar carcinoma', 'down', 'let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.'),
(1054, 'hsa-mir-150', 'Burkitt lymphoma', 'down', 'miR-150 might inhibit cell proliferation and promote cell apoptosis by targeting LMO4 in Burkitt lymphoma.'),
(1055, 'mirId', 'Cancer', 'Profile', 'PubMed Article'),
(1056, 'mirId ?', 'Cancer', 'Profile', 'PubMed Article'),
(1057, 'mirId??', 'Cancer', 'Profile', 'PubMed Article'),
(1058, 'hsa-mir-9', 'cervical adenocarcinoma', 'down', 'Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.'),
(1059, 'hsa-mir-27a', 'cervical adenocarcinoma', 'down', 'miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-?RI signaling pathway.'),
(1060, 'hsa-mir-362-3p', 'cervical adenocarcinoma', 'down', 'MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.'),
(1061, 'hsa-mir-10a', 'cervical cancer', 'up', 'MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.'),
(1062, 'hsa-mir-143', 'cervical cancer', 'down', 'miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.'),
(1063, 'hsa-mir-145', 'cervical cancer', 'down', 'Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.'),
(1064, 'hsa-mir-145', 'cervical cancer', 'down', 'Glucocorticoid regulation of a novel HPV E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.'),
(1065, 'hsa-mir-155', 'cervical cancer', 'up', 'Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1.'),
(1066, 'hsa-mir-17-5p', 'cervical cancer', 'down', 'MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.'),
(1067, 'hsa-mir-181a', 'cervical cancer', 'up', 'MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.'),
(1068, 'hsa-mir-181b', 'cervical cancer', 'up', 'miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.'),
(1069, 'hsa-mir-196a', 'cervical cancer', 'up', 'MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27(Kip1.).'),
(1070, 'hsa-mir-19a', 'cervical cancer', 'up', 'MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.'),
(1071, 'hsa-mir-19b', 'cervical cancer', 'up', 'MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.'),
(1072, 'hsa-mir-203', 'cervical cancer', 'down', 'miR-203 Suppresses Tumor Growth and Angiogenesis by Targeting VEGFA in Cervical Cancer.'),
(1073, 'hsa-mir-203', 'cervical cancer', 'down', 'BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer.'),
(1074, 'hsa-mir-205', 'cervical cancer', 'up', 'Serum microRNA-205 as a novel biomarker for cervical cancer patients.'),
(1075, 'hsa-mir-205', 'cervical cancer', 'up', 'miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells.'),
(1076, 'hsa-mir-20a', 'cervical cancer', 'up', 'miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.'),
(1077, 'hsa-mir-20a', 'cervical cancer', 'up', 'Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer.'),
(1078, 'hsa-mir-20a', 'cervical cancer', 'up', 'MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo.'),
(1079, 'hsa-mir-21', 'cervical cancer', 'up', 'Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN.'),
(1080, 'hsa-mir-214', 'cervical cancer', 'down', 'MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells.'),
(1081, 'hsa-mir-214', 'cervical cancer', 'down', 'MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.'),
(1082, 'hsa-mir-215', 'cervical cancer', 'up', 'MicroRNA-215 is a potential prognostic marker for cervical cancer.'),
(1083, 'hsa-mir-218', 'cervical cancer', 'down', 'Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.'),
(1084, 'hsa-mir-218', 'cervical cancer', 'down', 'MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.'),
(1085, 'hsa-mir-224', 'cervical cancer', 'up', 'Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.'),
(1086, 'hsa-mir-31', 'cervical cancer', 'up', 'miR-31 functions as an oncogene in cervical cancer.'),
(1087, 'hsa-mir-31', 'cervical cancer', 'up', 'MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.'),
(1088, 'hsa-mir-335', 'cervical cancer', 'down', 'MicroRNA-335 represents an independent prognostic marker in cervical cancer.'),
(1089, 'hsa-mir-342-3p', 'cervical cancer', 'down', 'miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.'),
(1090, 'hsa-mir-372', 'cervical cancer', 'down', 'MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis.'),
(1091, 'hsa-mir-424', 'cervical cancer', 'down', 'Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.'),
(1092, 'hsa-mir-491-5p', 'cervical cancer', 'down', 'MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT.'),
(1093, 'hsa-mir-494', 'cervical cancer', 'up', 'MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.'),
(1094, 'hsa-mir-497', 'cervical cancer', 'down', 'MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.'),
(1095, 'hsa-mir-590-5p', 'cervical cancer', 'up', 'MicroRNA-590 Promotes Cervical Cancer Cell Growth and Invasion by Targeting CHL1.'),
(1096, 'hsa-mir-7', 'cervical cancer', 'down', 'MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.'),
(1097, 'hsa-mir-92a', 'cervical cancer', 'up', 'miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.'),
(1098, 'hsa-mir-944', 'cervical cancer', 'up', 'Novel functions and targets of miR-944 in human cervical cancer cells.'),
(1099, 'hsa-mir-99a', 'cervical cancer', 'down', 'miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.'),
(1100, 'hsa-mir-99b', 'cervical cancer', 'down', 'miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway.'),
(1101, 'hsa-mir-1246', 'cervical cancer', 'down', 'Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.'),
(1102, 'hsa-mir-133a', 'cervical cancer', 'down', 'miR-133a inhibits cervical cancer growth by targeting EGFR.'),
(1103, 'hsa-mir-143', 'cervical cancer', 'down', 'A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.'),
(1104, 'hsa-mir-145', 'cervical cancer', 'down', 'A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.'),
(1105, 'hsa-mir-544', 'cervical cancer', 'down', 'Transcription factor KLF4 regulates microRNA-544 that targets YWHAZ in cervical cancer.'),
(1106, 'hsa-mir-101', 'cervical cancer', 'down', 'MicroRNA-101 regulates the viability and invasion of cervical cancer cells.'),
(1107, 'hsa-mir-10a', 'cervical cancer', 'up', 'Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.'),
(1108, 'hsa-mir-125a', 'cervical cancer', 'down', 'MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.'),
(1109, 'hsa-mir-135b', 'cervical cancer', 'up', 'Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.'),
(1110, 'hsa-mir-203', 'cervical cancer', 'down', 'Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.'),
(1111, 'hsa-mir-20a', 'cervical cancer', 'up', 'Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer.'),
(1112, 'hsa-mir-221', 'cervical cancer', 'up', 'MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.'),
(1113, 'hsa-mir-223', 'cervical cancer', 'down', 'MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.'),
(1114, 'hsa-mir-33a', 'cervical cancer', 'up', '[MicroRNA-33a regulates the invasion of cervical cancer cells via targeting Twist1].'),
(1115, 'hsa-mir-634', 'cervical cancer', 'down', 'MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells.'),
(1116, 'hsa-mir-7', 'cervical cancer', 'down', 'Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.'),
(1117, 'hsa-mir-720', 'cervical cancer', 'up', 'MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells.'),
(1118, 'hsa-mir-124', 'cervical cancer', 'down', 'Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.'),
(1119, 'hsa-mir-150', 'cervical cancer', 'up', 'microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.'),
(1120, 'hsa-mir-183', 'cervical cancer', 'down', 'MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.'),
(1121, 'hsa-mir-193b', 'cervical cancer', 'up', 'Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.'),
(1122, 'hsa-mir-195', 'cervical cancer', 'down', 'microRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression.'),
(1123, 'hsa-mir-196a', 'cervical cancer', 'up', 'Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.'),
(1124, 'hsa-mir-206', 'cervical cancer', 'down', 'Decreased microRNA-206 and its function in cervical cancer.'),
(1125, 'hsa-mir-218', 'cervical cancer', 'down', 'Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.'),
(1126, 'hsa-mir-23b', 'cervical cancer', 'down', 'miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer.'),
(1127, 'hsa-mir-27a', 'cervical cancer', 'up', 'B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells.'),
(1128, 'hsa-mir-27b', 'cervical cancer', 'up', 'miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.'),
(1129, 'hsa-mir-27b', 'cervical cancer', 'up', 'MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.'),
(1130, 'hsa-mir-320', 'cervical cancer', 'down', 'Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer.'),
(1131, 'hsa-mir-34a', 'cervical cancer', 'down', 'MicroRNA-34a-Upregulated Retinoic Acid-Inducible Gene-I Promotes Apoptosis and Delays Cell Cycle Transition in Cervical Cancer Cells.'),
(1132, 'hsa-mir-506', 'cervical cancer', 'down', 'Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.'),
(1133, 'hsa-mir-664', 'cervical cancer', 'down', 'Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.'),
(1134, 'hsa-mir-195', 'cervical cancer', 'down', 'MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.'),
(1135, 'hsa-mir-218', 'cervical cancer', 'down', 'MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.'),
(1136, 'hsa-mir-328', 'cervical cancer', 'down', 'microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2.'),
(1137, 'hsa-mir-34a', 'cervical cancer', 'down', 'HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.'),
(1138, 'hsa-mir-425-5p', 'cervical cancer', 'up', 'MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.'),
(1139, 'hsa-mir-664', 'cervical cancer', 'down', 'Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.'),
(1140, 'hsa-mir-138', 'cervical cancer', 'down', 'MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.'),
(1141, 'hsa-mir-145', 'cervical cancer', 'down', 'Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.'),
(1142, 'hsa-mir-21', 'cervical cancer', 'up', 'Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.'),
(1143, 'hsa-mir-22', 'cervical cancer', 'down', 'miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.'),
(1144, 'hsa-mir-2861', 'cervical cancer', 'down', 'miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.'),
(1145, 'hsa-mir-331-3p', 'cervical cancer', 'down', 'MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.'),
(1146, 'hsa-mir-376c', 'cervical cancer', 'down', 'miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1.'),
(1147, 'hsa-mir-9', 'cervical cancer', 'up', 'Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.'),
(1148, 'hsa-mir-1', 'cervical cancer', 'down', 'miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.'),
(1149, 'hsa-mir-138', 'cervical cancer', 'down', 'MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer.'),
(1150, 'hsa-mir-203', 'cervical cancer', 'down', 'Effect of miRNA-203 on cervical cancer cells and its underlying mechanism.'),
(1151, 'hsa-mir-224', 'cervical cancer', 'up', 'Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.'),
(1152, 'hsa-mir-362', 'cervical cancer', 'down', 'MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.'),
(1153, 'hsa-mir-429', 'cervical cancer', 'down', 'miR-429 is involved in regulation of NF-?B activity by targeting IKK? and suppresses oncogenic activity in cervical cancer cells.'),
(1154, 'hsa-mir-181a', 'cervical cancer', 'down', 'MiR-181a Inhibits Cervical Cancer Development Via Downregulating GRP78.'),
(1155, 'hsa-mir-212', 'cervical cancer', 'down', 'Effect of miR-212 targeting TCF7L2 on the proliferation and metastasis of cervical cancer.'),
(1156, 'hsa-mir-224-3p', 'cervical cancer', 'up', 'miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200.'),
(1157, 'hsa-mir-484', 'cervical cancer', 'down', 'miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.'),
(1158, 'hsa-mir-92a', 'cervical cancer', 'up', 'MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.'),
(1159, 'hsa-mir-126-5p', 'cervical cancer', 'down', 'miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.'),
(1160, 'hsa-mir-186', 'cervical cancer', 'down', 'Long Noncoding RNA ANRIL Promotes Cervical Cancer Development By Acting as a Sponge of miR-186.'),
(1161, 'hsa-mir-186', 'cervical cancer', 'down', 'Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.'),
(1162, 'hsa-mir-23b', 'cervical cancer', 'down', 'MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.'),
(1163, 'hsa-mir-106a', 'cervical cancer', 'up', 'MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.'),
(1164, 'hsa-mir-10b', 'cervical cancer', 'down', 'MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.'),
(1165, 'hsa-mir-138-5p', 'cervical cancer', 'down', 'Decreased Expression of MiR-138-5p by LncRNA H19 in Cervical Cancer Promotes Tumor Proliferation.'),
(1166, 'hsa-mir-155', 'cervical cancer', 'up', 'MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.'),
(1167, 'hsa-mir-17-5p', 'cervical cancer', 'down', 'Long Noncoding RNA HOTAIR: An Oncogene in Human Cervical Cancer Interacting with MicroRNA-17-5p.'),
(1168, 'hsa-mir-181a-5p', 'cervical cancer', 'up', 'MiR-181a-5p Promotes Proliferation and Invasion, and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).'),
(1169, 'hsa-mir-187', 'cervical cancer', 'down', 'miR-187 inhibits the growth of cervical cancer cells by targeting FGF9.'),
(1170, 'hsa-mir-195', 'cervical cancer', 'down', 'MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.'),
(1171, 'hsa-mir-205', 'cervical cancer', 'down', 'MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.'),
(1172, 'hsa-mir-20b', 'cervical cancer', 'up', 'Human papillomavirus E6-regulated microRNA-20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.'),
(1173, 'hsa-mir-21', 'cervical cancer', 'up', 'MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.'),
(1174, 'hsa-mir-214', 'cervical cancer', 'down', 'MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.'),
(1175, 'hsa-mir-216b', 'cervical cancer', 'down', 'MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.'),
(1176, 'hsa-mir-320', 'cervical cancer', 'down', 'MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.'),
(1177, 'hsa-mir-326', 'cervical cancer', 'down', 'LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer.'),
(1178, 'hsa-mir-337', 'cervical cancer', 'down', 'MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.'),
(1179, 'hsa-mir-374c-5p', 'cervical cancer', 'down', 'MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.'),
(1180, 'hsa-mir-758', 'cervical cancer', 'down', 'Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.'),
(1181, 'hsa-mir-9', 'cervical cancer', 'up', 'MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.'),
(1182, 'hsa-mir-92a', 'cervical cancer', 'up', 'MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.'),
(1183, 'hsa-mir-101', 'cervical cancer', 'down', 'Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.'),
(1184, 'hsa-mir-1297', 'cervical cancer', 'down', 'MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer.'),
(1185, 'hsa-mir-150', 'cervical cancer', 'up', 'MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.'),
(1186, 'hsa-mir-21', 'cervical cancer', 'up', 'MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.'),
(1187, 'hsa-mir-221-3p', 'cervical cancer', 'up', 'MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.'),
(1188, 'hsa-mir-296', 'cervical cancer', 'down', 'MicroRNA-296 targets specificity protein 1 to suppress cell proliferation and invasion in cervical cancer.'),
(1189, 'hsa-mir-31', 'cervical cancer', 'up', 'miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.'),
(1190, 'hsa-mir-329-3p', 'cervical cancer', 'down', 'Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.'),
(1191, 'hsa-mir-338-3p', 'cervical cancer', 'down', 'MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway.'),
(1192, 'hsa-mir-433', 'cervical cancer', 'down', 'MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and ?-catenin signalling pathways.'),
(1193, 'hsa-mir-124-3p', 'cervical cancer', 'down', 'MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.'),
(1194, 'hsa-mir-143-3p', 'cervical cancer', 'down', 'Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.'),
(1195, 'hsa-mir-144', 'cervical cancer', 'down', 'miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.'),
(1196, 'hsa-mir-200c', 'cervical cancer', 'down', 'MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.'),
(1197, 'hsa-mir-204', 'cervical cancer', 'down', 'MicroRNA-204 inhibits cell migration and invasion in human cervical cancer by regulating transcription factor 12.'),
(1198, 'hsa-mir-206', 'cervical cancer', 'down', 'miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer.'),
(1199, 'hsa-mir-30a', 'cervical cancer', 'down', 'Downregulation of miR-30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.'),
(1200, 'hsa-mir-377', 'cervical cancer', 'down', 'MicroRNA-377 targets zinc finger E-box-binding homeobox 2 to inhibit cell proliferation and invasion of cervical cancer.'),
(1201, 'hsa-mir-379', 'cervical cancer', 'down', 'MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).'),
(1202, 'hsa-mir-486-5p', 'cervical cancer', 'up', 'Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.'),
(1203, 'hsa-mir-494', 'cervical cancer', 'down', 'miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.'),
(1204, 'hsa-mir-501', 'cervical cancer', 'up', 'miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.'),
(1205, 'hsa-mir-519d-3p', 'cervical cancer', 'down', 'MicroRNA-519d-3p Inhibits Proliferation and Promotes Apoptosis by Targeting HIF-2? in Cervical Cancer Under Hypoxic Conditions.'),
(1206, 'hsa-mir-638', 'cervical cancer', 'down', 'MiR-638 inhibits cervical cancer metastasis through Wnt/?-catenin signaling pathway and correlates with prognosis of cervical cancer patients.'),
(1207, 'hsa-mir-1254', 'cervical cancer', 'down', 'Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.'),
(1208, 'hsa-mir-1297', 'cervical cancer', 'down', 'MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN.'),
(1209, 'hsa-mir-146a', 'cervical cancer', 'up', 'miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.'),
(1210, 'hsa-mir-155-5p', 'cervical cancer', 'down', 'MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.'),
(1211, 'hsa-mir-15a-3p', 'cervical cancer', 'down', 'Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.'),
(1212, 'hsa-mir-17-5p', 'cervical cancer', 'up', 'MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-? receptor 2.'),
(1213, 'hsa-mir-182', 'cervical cancer', 'up', '[miR-182 promotes cell proliferation of cervical cancer cells by targeting adenomatous polyposis coli (APC) gene].'),
(1214, 'hsa-mir-197', 'cervical cancer', 'down', 'miR-197 is downregulated in cervical carcinogenesis and suppresses cell proliferation and invasion through targeting forkhead box M1.'),
(1215, 'hsa-mir-199b-5p', 'cervical cancer', 'up', 'MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.'),
(1216, 'hsa-mir-211', 'cervical cancer', 'down', 'miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC.'),
(1217, 'hsa-mir-214', 'cervical cancer', 'down', 'Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.'),
(1218, 'hsa-mir-302a', 'cervical cancer', 'down', 'MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.'),
(1219, 'hsa-mir-302b', 'cervical cancer', 'down', 'MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.'),
(1220, 'hsa-mir-302c', 'cervical cancer', 'down', 'MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.'),
(1221, 'hsa-mir-302d', 'cervical cancer', 'down', 'MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.'),
(1222, 'hsa-mir-302f', 'cervical cancer', 'down', 'MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.'),
(1223, 'hsa-mir-338', 'cervical cancer', 'down', 'miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.'),
(1224, 'hsa-mir-340', 'cervical cancer', 'down', 'MiR-340 suppresses the metastasis by targeting EphA3 in cervical cancer.'),
(1225, 'hsa-mir-374b', 'cervical cancer', 'down', 'MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.'),
(1226, 'hsa-mir-411', 'cervical cancer', 'down', 'MicroRNA-411 inhibits cervical cancer progression by directly targeting STAT3.'),
(1227, 'hsa-mir-454-3p', 'cervical cancer', 'down', 'MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.'),
(1228, 'hsa-mir-489', 'cervical cancer', 'down', 'miRNA-489 as a biomarker in diagnosis and treatment of cervical cancer.'),
(1229, 'hsa-mir-506', 'cervical cancer', 'down', 'miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo.'),
(1230, 'hsa-mir-613', 'cervical cancer', 'up', 'MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9.'),
(1231, 'hsa-mir-106b-5p', 'cervical cancer', 'up', 'The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism.'),
(1232, 'hsa-mir-1266', 'cervical cancer', 'up', 'MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.'),
(1233, 'hsa-mir-129-5p', 'cervical cancer', 'down', 'Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer.'),
(1234, 'hsa-mir-141', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1235, 'hsa-mir-141-3p', 'cervical cancer', 'up', 'microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.'),
(1236, 'hsa-mir-143', 'cervical cancer', 'down', 'MicroRNA-143 regulates cell migration and invasion by targeting GOLM1 in cervical cancer.'),
(1237, 'hsa-mir-146b-3p', 'cervical cancer', 'up', 'Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.'),
(1238, 'hsa-mir-183*', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1239, 'hsa-mir-183-5p', 'cervical cancer', 'down', 'MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).'),
(1240, 'hsa-mir-20a', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1241, 'hsa-mir-210', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1242, 'hsa-mir-217', 'cervical cancer', 'down', 'MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1.'),
(1243, 'hsa-mir-218', 'cervical cancer', 'down', 'MiR-218 produces anti-tumor effects on cervical cancer cells in vitro.'),
(1244, 'hsa-mir-218-5p', 'cervical cancer', 'down', 'MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via?LYN/NF-?B signaling pathway.'),
(1245, 'hsa-mir-22', 'cervical cancer', 'down', 'Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.'),
(1246, 'hsa-mir-331-3p', 'cervical cancer', 'down', 'LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.'),
(1247, 'hsa-mir-338-3p', 'cervical cancer', 'down', 'LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p.'),
(1248, 'hsa-mir-641', 'cervical cancer', 'down', 'miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting?ZEB1.'),
(1249, 'hsa-mir-802', 'cervical cancer', 'down', 'microRNA-802 inhibits cell proliferation and induces apoptosis in human cervical cancer by targeting serine/arginine-rich splicing factor 9.'),
(1250, 'hsa-mir-92a', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1251, 'hsa-mir-944', 'cervical cancer', 'up', 'Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.'),
(1252, 'hsa-mir-99b', 'cervical cancer', 'down', 'MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.'),
(1253, 'hsa-mir-1', 'cervical cancer', 'down', 'Correlation the between the regulation of miRNA-1 in c-Met-induced EMT and cervical cancer progression.'),
(1254, 'hsa-mir-101', 'cervical cancer', 'down', 'MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.'),
(1255, 'hsa-mir-126', 'cervical cancer', 'down', 'The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.'),
(1256, 'hsa-mir-130a', 'cervical cancer', 'up', 'MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.'),
(1257, 'hsa-mir-133a', 'cervical cancer', 'down', 'Involvement of NEAT1/miR-133a axis in promoting cervical cancer progression via targeting SOX4.'),
(1258, 'hsa-mir-134', 'cervical cancer', 'down', 'Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.'),
(1259, 'hsa-mir-140-5p', 'cervical cancer', 'down', 'Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.'),
(1260, 'hsa-mir-148a', 'cervical cancer', 'down', 'Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.'),
(1261, 'hsa-mir-152', 'cervical cancer', 'up', 'miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer.'),
(1262, 'hsa-mir-155-5p', 'cervical cancer', 'up', 'MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1.'),
(1263, 'hsa-mir-181a', 'cervical cancer', 'down', 'MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.'),
(1264, 'hsa-mir-181a-5p', 'cervical cancer', 'down', 'Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p/TGF?I axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells.'),
(1265, 'hsa-mir-21', 'cervical cancer', 'up', 'Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells.'),
(1266, 'hsa-mir-215-3p', 'cervical cancer', 'down', 'MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.'),
(1267, 'hsa-mir-218-5p', 'cervical cancer', 'down', 'MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-?B signaling pathway.'),
(1268, 'hsa-mir-221', 'cervical cancer', 'up', 'Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.'),
(1269, 'hsa-mir-222', 'cervical cancer', 'up', 'Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.'),
(1270, 'hsa-mir-23b', 'cervical cancer', 'down', 'MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.'),
(1271, 'hsa-mir-26b', 'cervical cancer', 'down', 'MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.'),
(1272, 'hsa-mir-29a', 'cervical cancer', 'down', 'MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.'),
(1273, 'hsa-mir-329-3p', 'cervical cancer', 'down', 'LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis.'),
(1274, 'hsa-mir-374b', 'cervical cancer', 'down', 'MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.'),
(1275, 'hsa-mir-425-5p', 'cervical cancer', 'up', 'Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1.'),
(1276, 'hsa-mir-432', 'cervical cancer', 'down', 'MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.'),
(1277, 'hsa-mir-454-3p', 'cervical cancer', 'up', 'miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.'),
(1278, 'hsa-mir-498', 'cervical cancer', 'down', 'Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.'),
(1279, 'hsa-mir-503', 'cervical cancer', 'down', 'miR-503 expression is downregulated in cervical cancer and suppresses tumor growth by targeting AKT2.'),
(1280, 'hsa-mir-505-5p', 'cervical cancer', 'down', 'MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.'),
(1281, 'hsa-mir-526b', 'cervical cancer', 'down', 'By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells.'),
(1282, 'hsa-mir-641', 'cervical cancer', 'down', 'miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1.'),
(1283, 'hsa-mir-664', 'cervical cancer', 'down', 'MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.'),
(1284, 'hsa-mir-758', 'cervical cancer', 'down', 'MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/?-catenin signaling pathway.'),
(1285, 'hsa-mir-889', 'cervical cancer', 'down', 'MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion.'),
(1286, 'hsa-mir-93-5p', 'cervical cancer', 'up', 'MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway.'),
(1287, 'hsa-mir-100', 'cervical carcinoma', 'down', 'miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.'),
(1288, 'hsa-mir-101', 'cervical carcinoma', 'down', 'MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.'),
(1289, 'hsa-mir-133b', 'cervical carcinoma', 'up', 'MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.'),
(1290, 'hsa-mir-15a', 'cervical carcinoma', 'down', 'MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.'),
(1291, 'hsa-mir-16', 'cervical carcinoma', 'down', 'MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin.'),
(1292, 'hsa-mir-21', 'cervical carcinoma', 'up', 'MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.'),
(1293, 'hsa-mir-25', 'cervical carcinoma', 'up', '[miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells].'),
(1294, 'hsa-mir-34a', 'cervical carcinoma', 'down', 'MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.'),
(1295, 'hsa-mir-373', 'cervical carcinoma', 'up', 'MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.'),
(1296, 'hsa-mir-886-5p', 'cervical carcinoma', 'down', 'MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells.'),
(1297, 'hsa-mir-99a', 'cervical carcinoma', 'down', 'miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.'),
(1298, 'hsa-mir-99b', 'cervical carcinoma', 'down', 'miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(1299, 'hsa-mir-27b', 'cervical carcinoma', 'up', 'Elevation of miR-27b by HPV16 E7 inhibits PPAR? expression and promotes proliferation and invasion in cervical carcinoma cells.'),
(1300, 'hsa-mir-106b', 'cervical carcinoma', 'up', 'MicroRNA-106b is involved in transforming growth factor ?1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.'),
(1301, 'hsa-mir-200b', 'cervical carcinoma', 'down', 'MicroRNA-200b suppresses cell invasion and metastasis by inhibiting the epithelial-mesenchymal transition in cervical carcinoma.'),
(1302, 'hsa-mir-15b', 'cervical carcinoma', 'up', 'Increased expression of miR-15b is associated with clinicopathological features and poor prognosis in cervical carcinoma.'),
(1303, 'hsa-mir-30e', 'cervical carcinoma', 'down', 'MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.'),
(1304, 'hsa-mir-136', 'cervical carcinoma', 'down', 'microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-?B pathway by targeting E2F1.'),
(1305, 'hsa-mir-409-3p', 'cervical carcinoma', 'down', 'MicroRNA-409 inhibits the proliferative ability of cervical carcinoma cells by regulating AKT.'),
(1306, 'hsa-mir-20a', 'cervical carcinoma', 'up', 'Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.'),
(1307, 'hsa-mir-145', 'cervical carcinoma', 'down', 'miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1.'),
(1308, 'hsa-mir-199a-5p', 'cervical carcinoma', 'up', 'miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma.'),
(1309, 'hsa-mir-106a', 'cervical squamous cell carcinoma', 'down', 'MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.'),
(1310, 'hsa-mir-124', 'cervical squamous cell carcinoma', 'down', 'Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.'),
(1311, 'hsa-mir-148a', 'cervical squamous cell carcinoma', 'down', 'MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma.'),
(1312, 'hsa-mir-205', 'cervical squamous cell carcinoma', 'up', 'miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.'),
(1313, 'hsa-mir-214', 'cervical squamous cell carcinoma', 'down', 'Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.'),
(1314, 'hsa-mir-218', 'cervical squamous cell carcinoma', 'down', 'Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.'),
(1315, 'hsa-mir-29a', 'cervical squamous cell carcinoma', 'down', 'Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.'),
(1316, 'hsa-mir-375', 'cervical squamous cell carcinoma', 'down', 'miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.'),
(1317, 'hsa-mir-221-3p', 'cervical squamous cell carcinoma', 'up', 'Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.'),
(1318, 'hsa-mir-101', 'cholangiocarcinoma', 'down', 'miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).'),
(1319, 'hsa-mir-144', 'cholangiocarcinoma', 'down', 'MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.'),
(1320, 'hsa-mir-17', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1321, 'hsa-mir-18a', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1322, 'hsa-mir-19a', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1323, 'hsa-mir-19b', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1324, 'hsa-mir-200b', 'cholangiocarcinoma', 'down', 'Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.'),
(1325, 'hsa-mir-200c', 'cholangiocarcinoma', 'down', 'Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.'),
(1326, 'hsa-mir-20a', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1327, 'hsa-mir-21', 'cholangiocarcinoma', 'up', 'MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.'),
(1328, 'hsa-mir-21', 'cholangiocarcinoma', 'up', 'PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.'),
(1329, 'hsa-mir-21', 'cholangiocarcinoma', 'up', 'miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth.'),
(1330, 'hsa-mir-21', 'cholangiocarcinoma', 'up', 'miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.'),
(1331, 'hsa-mir-26a', 'cholangiocarcinoma', 'up', 'MicroRNA-26a promotes cholangiocarcinoma growth by activating ?-catenin.'),
(1332, 'hsa-mir-92a', 'cholangiocarcinoma', 'up', 'miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.'),
(1333, 'hsa-mir-34a', 'cholangiocarcinoma', 'down', 'microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.'),
(1334, 'hsa-mir-34a', 'cholangiocarcinoma', 'up', 'miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.'),
(1335, 'hsa-mir-29a', 'cholangiocarcinoma', 'up', 'Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma.'),
(1336, 'hsa-let-7c', 'cholangiocarcinoma', 'down', 'Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.'),
(1337, 'hsa-mir-365', 'cholangiocarcinoma', 'down', 'MiR-365 suppresses cholangiocarcinoma cell proliferation and induces apoptosis by targeting E2F2.'),
(1338, 'hsa-mir-30e', 'cholangiocarcinoma', 'down', 'Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition.'),
(1339, 'hsa-mir-383', 'cholangiocarcinoma', 'up', 'miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.'),
(1340, 'hsa-mir-92b', 'cholangiocarcinoma', 'up', 'The role of miR-92b in cholangiocarcinoma patients.'),
(1341, 'hsa-mir-29b', 'cholangiocarcinoma', 'down', '[Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].'),
(1342, 'hsa-mir-329', 'cholangiocarcinoma', 'down', 'microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3.'),
(1343, 'hsa-let-7a', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1344, 'hsa-mir-100', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1345, 'hsa-mir-100', 'chondrosarcoma', 'down', 'MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR.'),
(1346, 'hsa-mir-136', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1347, 'hsa-mir-145', 'chondrosarcoma', 'down', 'The Epigenetic Regulation of SOX9 by miR-145 in Human Chondrosarcoma.'),
(1348, 'hsa-mir-199a', 'chondrosarcoma', 'down', 'CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.'),
(1349, 'hsa-mir-222', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1350, 'hsa-mir-30a', 'chondrosarcoma', 'down', 'Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma.'),
(1351, 'hsa-mir-335', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1352, 'hsa-mir-376a', 'chondrosarcoma', 'down', 'Analysis of microRNAs expressions in chondrosarcoma.'),
(1353, 'hsa-mir-181a', 'chondrosarcoma', 'up', 'The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma.'),
(1354, 'hsa-mir-185', 'chondrosarcoma', 'down', 'Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.'),
(1355, 'hsa-mir-218', 'chondrosarcoma', 'up', 'Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.'),
(1356, 'hsa-mir-23b', 'chondrosarcoma', 'down', 'Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.'),
(1357, 'hsa-mir-129-5p', 'chondrosarcoma', 'down', 'MiR-129-5p Inhibits Proliferation and Invasion of Chondrosarcoma Cells by Regulating SOX4/Wnt/?-Catenin Signaling Pathway.'),
(1358, 'hsa-mir-1', 'chordoma', 'down', 'Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.'),
(1359, 'hsa-mir-1', 'chordoma', 'down', 'MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.'),
(1360, 'hsa-mir-140-3p', 'chordoma', 'up', 'MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.'),
(1361, 'hsa-mir-140-3p', 'chordoma', 'up', 'Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.'),
(1362, 'hsa-mir-148a', 'chordoma', 'up', 'MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.'),
(1363, 'hsa-mir-222', 'chordoma', 'down', 'MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.'),
(1364, 'hsa-mir-31', 'chordoma', 'down', 'MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.'),
(1365, 'hsa-mir-34a', 'chordoma', 'down', 'MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.'),
(1366, 'hsa-mir-608', 'chordoma', 'down', 'MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.'),
(1367, 'hsa-mir-219-5p', 'chordoma', 'down', 'miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence.'),
(1368, 'hsa-mir-16-5p', 'chordoma', 'down', 'miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3.'),
(1369, 'hsa-mir-199b', 'choriocarcinoma', 'down', 'Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.'),
(1370, 'hsa-mir-218', 'choriocarcinoma', 'down', 'MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8.'),
(1371, 'hsa-mir-34a', 'choriocarcinoma', 'down', 'MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.'),
(1372, 'hsa-mir-34a', 'choriocarcinoma', 'down', 'MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.'),
(1373, 'hsa-mir-125b', 'chronic lymphocytic leukemia', 'down', 'The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.'),
(1374, 'hsa-mir-138', 'chronic lymphocytic leukemia', 'down', 'miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.'),
(1375, 'hsa-mir-150', 'chronic lymphocytic leukemia', 'up', 'Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.'),
(1376, 'hsa-mir-155', 'chronic lymphocytic leukemia', 'up', 'Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia.'),
(1377, 'hsa-mir-15a', 'chronic lymphocytic leukemia', 'down', 'Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.'),
(1378, 'hsa-mir-15a', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1379, 'hsa-mir-15a', 'chronic lymphocytic leukemia', 'down', 'Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.'),
(1380, 'hsa-mir-15a', 'chronic lymphocytic leukemia', 'down', 'miR-15 and miR-16 induce apoptosis by targeting BCL2.'),
(1381, 'hsa-mir-15b', 'chronic lymphocytic leukemia', 'down', 'miR-15 and miR-16 induce apoptosis by targeting BCL2.'),
(1382, 'hsa-mir-15b', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1383, 'hsa-mir-16', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1384, 'hsa-mir-16-1', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1385, 'hsa-mir-16-1', 'chronic lymphocytic leukemia', 'down', 'miR-15 and miR-16 induce apoptosis by targeting BCL2.'),
(1386, 'hsa-mir-16-1-3p', 'chronic lymphocytic leukemia', 'down', 'Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.'),
(1387, 'hsa-mir-16-2', 'chronic lymphocytic leukemia', 'down', 'miR-15 and miR-16 induce apoptosis by targeting BCL2.'),
(1388, 'hsa-mir-16-2', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1389, 'hsa-mir-181a', 'chronic lymphocytic leukemia', 'down', 'Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.'),
(1390, 'hsa-mir-181a', 'chronic lymphocytic leukemia', 'down', 'miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.'),
(1391, 'hsa-mir-181b', 'chronic lymphocytic leukemia', 'down', 'Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.'),
(1392, 'hsa-mir-181b', 'chronic lymphocytic leukemia', 'down', 'miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.'),
(1393, 'hsa-mir-195', 'chronic lymphocytic leukemia', 'down', 'miR-15 and miR-16 induce apoptosis by targeting BCL2.'),
(1394, 'hsa-mir-195', 'chronic lymphocytic leukemia', 'down', 'Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.'),
(1395, 'hsa-mir-223', 'chronic lymphocytic leukemia', 'down', 'MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.'),
(1396, 'hsa-mir-223', 'chronic lymphocytic leukemia', 'down', '[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].'),
(1397, 'hsa-mir-29b', 'chronic lymphocytic leukemia', 'down', 'Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.'),
(1398, 'hsa-mir-34b', 'chronic lymphocytic leukemia', 'down', 'Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.'),
(1399, 'hsa-mir-34c', 'chronic lymphocytic leukemia', 'down', 'Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.'),
(1400, 'hsa-mir-424', 'chronic lymphocytic leukemia', 'down', 'miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia.'),
(1401, 'hsa-mir-15a', 'chronic lymphocytic leukemia', 'down', 'Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia.'),
(1402, 'hsa-mir-155', 'chronic lymphocytic leukemia', 'up', 'MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.'),
(1403, 'hsa-mir-192', 'chronic lymphocytic leukemia', 'down', 'Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.'),
(1404, 'hsa-mir-155', 'chronic lymphocytic leukemia', 'up', 'LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.'),
(1405, 'hsa-mir-21', 'chronic lymphocytic leukemia', 'up', 'Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia.'),
(1406, 'hsa-mir-28-5p', 'chronic lymphocytic leukemia', 'down', 'NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.'),
(1407, 'hsa-mir-650', 'chronic lymphocytic leukemia', 'up', 'NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.'),
(1408, 'hsa-mir-10a', 'chronic myelogenous leukemia', 'down', 'Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.'),
(1409, 'hsa-mir-138', 'chronic myelogenous leukemia', 'down', 'BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.'),
(1410, 'hsa-mir-146a', 'chronic myelogenous leukemia', 'down', 'ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.'),
(1411, 'hsa-mir-150', 'chronic myelogenous leukemia', 'down', 'Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.'),
(1412, 'hsa-mir-151', 'chronic myelogenous leukemia', 'down', 'Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.'),
(1413, 'hsa-mir-155', 'chronic myelogenous leukemia', 'down', 'Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.'),
(1414, 'hsa-mir-16', 'chronic myelogenous leukemia', 'down', 'ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.'),
(1415, 'hsa-mir-2278', 'chronic myelogenous leukemia', 'down', 'Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted \"hsa-miR-2278\" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeti'),
(1416, 'hsa-mir-26a', 'chronic myelogenous leukemia', 'down', 'ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.'),
(1417, 'hsa-mir-30e', 'chronic myelogenous leukemia', 'down', 'MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.'),
(1418, 'hsa-mir-31', 'chronic myelogenous leukemia', 'down', 'Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.'),
(1419, 'hsa-mir-326', 'chronic myelogenous leukemia', 'down', 'Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34(+) CML stem/progenitor cells.'),
(1420, 'hsa-mir-424', 'chronic myelogenous leukemia', 'up', 'Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.'),
(1421, 'hsa-mir-564', 'chronic myelogenous leukemia', 'down', 'Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.'),
(1422, 'hsa-mir-96', 'chronic myelogenous leukemia', 'up', 'Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.'),
(1423, 'hsa-let-7d', 'chronic myelogenous leukemia', 'down', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1424, 'hsa-mir-130a', 'chronic myelogenous leukemia', 'down', 'Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.'),
(1425, 'hsa-mir-155', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1426, 'hsa-mir-17', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1427, 'hsa-mir-18a', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1428, 'hsa-mir-205', 'chronic myelogenous leukemia', 'down', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1429, 'hsa-mir-20a', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1430, 'hsa-mir-21', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1431, 'hsa-mir-27a', 'chronic myelogenous leukemia', 'up', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1432, 'hsa-mir-320', 'chronic myelogenous leukemia', 'down', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1433, 'hsa-mir-451', 'chronic myelogenous leukemia', 'down', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1434, 'hsa-mir-574', 'chronic myelogenous leukemia', 'down', 'microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia.'),
(1435, 'hsa-mir-125b', 'chronic myelogenous leukemia', 'up', 'miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1.'),
(1436, 'hsa-mir-223', 'chronic myelogenous leukemia', 'down', 'MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression.'),
(1437, 'hsa-mir-17', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1438, 'hsa-mir-18a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1439, 'hsa-mir-19a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1440, 'hsa-mir-19b', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1441, 'hsa-mir-20a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1442, 'hsa-mir-92a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1443, 'mir-17', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1444, 'mir-18a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1445, 'mir-19a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1446, 'mir-19b', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1447, 'mir-20a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1448, 'mir-92a', 'chronic myelogenous leukemia', 'up', 'miR-17-92 promotes leukemogenesis in chronic myeloid leukemia via targeting A20 and activation of NF-?B signaling.'),
(1449, 'hsa-mir-15a-5p', 'chronic myelogenous leukemia', 'down', 'MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.'),
(1450, 'hsa-mir-570', 'chronic myelogenous leukemia', 'down', 'MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia.'),
(1451, 'hsa-mir-126', 'chronic myelogenous leukemia', 'up', 'Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.'),
(1452, 'hsa-let-7b-5p', 'chronic myelogenous leukemia', 'down', 'Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.'),
(1453, 'hsa-mir-451a', 'chronic myelogenous leukemia', 'down', 'Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.'),
(1454, 'hsa-mir-574-3p', 'chronic myelogenous leukemia', 'down', 'Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.'),
(1455, 'hsa-mir-1275', 'chronic myelogenous leukemia', 'up', 'LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.'),
(1456, 'hsa-mir-140-5p', 'chronic myelogenous leukemia', 'down', 'miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.'),
(1457, 'hsa-mir-302a', 'chronic myelogenous leukemia', 'down', 'miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.'),
(1458, 'hsa-mir-302b', 'chronic myelogenous leukemia', 'down', 'miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.'),
(1459, 'hsa-mir-302c', 'chronic myelogenous leukemia', 'down', 'miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.'),
(1460, 'hsa-mir-302d', 'chronic myelogenous leukemia', 'down', 'miR-302 cluster inhibits angiogenesis and growth of K562 leukemia cells by targeting VEGFA.'),
(1461, 'hsa-mir-378', 'chronic myelogenous leukemia', 'up', 'MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells.'),
(1462, 'hsa-mir-106a-5p', 'clear cell renal cell cancer', 'down', 'Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.'),
(1463, 'hsa-mir-135a-5p', 'clear cell renal cell cancer', 'down', 'Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.'),
(1464, 'hsa-mir-142-5p', 'clear cell renal cell cancer', 'up', 'Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.'),
(1465, 'hsa-mir-155', 'clear cell renal cell cancer', 'up', 'microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.'),
(1466, 'hsa-mir-206', 'clear cell renal cell cancer', 'down', 'Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.'),
(1467, 'hsa-mir-21-5p', 'clear cell renal cell cancer', 'up', 'Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.'),
(1468, 'hsa-mir-34a', 'clear cell renal cell cancer', 'up', 'The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.'),
(1469, 'hsa-mir-199a-3p', 'clear cell renal cell cancer', 'up', 'MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma.'),
(1470, 'hsa-mir-223-3p', 'clear cell renal cell cancer', 'up', 'MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma.'),
(1471, 'hsa-let-7a-1', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1472, 'hsa-let-7a-2', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1473, 'hsa-let-7a-3', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1474, 'hsa-let-7b', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1475, 'hsa-let-7c', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1476, 'hsa-let-7d', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1477, 'hsa-let-7e', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1478, 'hsa-let-7f-1', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1479, 'hsa-let-7f-2', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1480, 'hsa-let-7g', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1481, 'hsa-let-7i', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1482, 'hsa-mir-100', 'colon cancer', 'down', 'MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells.'),
(1483, 'hsa-mir-101', 'colon cancer', 'down', 'Loss of miR-101 Expression Promotes Wnt/?-Catenin Signalling Pathway Activation and Malignancy in Colon Cancer Cells.'),
(1484, 'hsa-mir-101', 'colon cancer', 'down', 'MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.'),
(1485, 'hsa-mir-126', 'colon cancer', 'down', 'Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.'),
(1486, 'hsa-mir-126', 'colon cancer', 'down', '[miR-126 inhibits colon cancer proliferation and invasion through targeting IRS1, SLC7A5 and TOM1 gene].'),
(1487, 'hsa-mir-126', 'colon cancer', 'down', 'MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway.'),
(1488, 'hsa-mir-1290', 'colon cancer', 'up', 'Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells.'),
(1489, 'hsa-mir-142-3p', 'colon cancer', 'down', 'MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.'),
(1490, 'hsa-mir-143', 'colon cancer', 'down', 'The Evi1, microRNA-143, K-Ras axis in colon cancer.'),
(1491, 'hsa-mir-143', 'colon cancer', 'down', 'miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation.'),
(1492, 'hsa-mir-143', 'colon cancer', 'down', 'Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.'),
(1493, 'hsa-mir-143', 'colon cancer', 'down', 'Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.'),
(1494, 'hsa-mir-143', 'colon cancer', 'down', 'MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.'),
(1495, 'hsa-mir-145', 'colon cancer', 'down', 'Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.'),
(1496, 'hsa-mir-145', 'colon cancer', 'down', 'Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.'),
(1497, 'hsa-mir-145', 'colon cancer', 'up', 'miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.'),
(1498, 'hsa-mir-145', 'colon cancer', 'down', 'Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.'),
(1499, 'hsa-mir-145', 'colon cancer', 'down', 'MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.'),
(1500, 'hsa-mir-155', 'colon cancer', 'up', 'Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast.'),
(1501, 'hsa-mir-181a', 'colon cancer', 'up', 'miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway.'),
(1502, 'hsa-mir-18a', 'colon cancer', 'up', 'MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer.'),
(1503, 'hsa-mir-192', 'colon cancer', 'down', 'Prognostic significance of miR-215 in colon cancer.'),
(1504, 'hsa-mir-200c', 'colon cancer', 'down', 'miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.'),
(1505, 'hsa-mir-200c', 'colon cancer', 'up', 'The roles of miR-200c in colon cancer and associated molecular mechanisms.'),
(1506, 'hsa-mir-21', 'colon cancer', 'down', 'miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.'),
(1507, 'hsa-mir-214', 'colon cancer', 'down', 'microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.'),
(1508, 'hsa-mir-215', 'colon cancer', 'down', 'Prognostic significance of miR-215 in colon cancer.'),
(1509, 'hsa-mir-22', 'colon cancer', 'down', 'MicroRNA-22 regulates hypoxia signaling in colon cancer cells.'),
(1510, 'hsa-mir-22', 'colon cancer', 'down', 'MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.'),
(1511, 'hsa-mir-22', 'colon cancer', 'down', 'miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.'),
(1512, 'hsa-mir-25', 'colon cancer', 'down', 'MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.'),
(1513, 'hsa-mir-302a', 'colon cancer', 'down', 'MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt.'),
(1514, 'hsa-mir-31', 'colon cancer', 'up', 'The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.'),
(1515, 'hsa-mir-320', 'colon cancer', 'down', 'miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.'),
(1516, 'hsa-mir-320a', 'colon cancer', 'down', 'MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting ?-catenin.'),
(1517, 'hsa-mir-34a', 'colon cancer', 'down', 'MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.'),
(1518, 'hsa-mir-34a', 'colon cancer', 'down', 'Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.'),
(1519, 'hsa-mir-34c', 'colon cancer', 'down', 'Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.'),
(1520, 'hsa-mir-365', 'colon cancer', 'down', 'microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.'),
(1521, 'hsa-mir-373', 'colon cancer', 'down', 'Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.'),
(1522, 'hsa-mir-424', 'colon cancer', 'down', 'MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.'),
(1523, 'hsa-mir-429', 'colon cancer', 'down', 'MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.'),
(1524, 'hsa-mir-455', 'colon cancer', 'down', 'MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.'),
(1525, 'hsa-mir-484', 'colon cancer', 'down', 'MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.'),
(1526, 'hsa-mir-502', 'colon cancer', 'down', 'Inhibition of autophagy and tumor growth in colon cancer by miR-502.'),
(1527, 'hsa-mir-503', 'colon cancer', 'down', 'MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression.'),
(1528, 'hsa-mir-675', 'colon cancer', 'up', 'Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.'),
(1529, 'hsa-mir-93', 'colon cancer', 'down', 'Clinical significance of microRNA-93 downregulation in human colon cancer.'),
(1530, 'hsa-mir-98', 'colon cancer', 'down', 'let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.'),
(1531, 'hsa-mir-125a-5p', 'colon cancer', 'down', 'miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.'),
(1532, 'hsa-mir-381', 'colon cancer', 'down', 'Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.'),
(1533, 'hsa-mir-204', 'colon cancer', 'down', '[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].'),
(1534, 'hsa-mir-211', 'colon cancer', 'down', '[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].'),
(1535, 'hsa-mir-214', 'colon cancer', 'down', '[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].'),
(1536, 'hsa-mir-381', 'colon cancer', 'down', '[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].'),
(1537, 'hsa-mir-4458', 'colon cancer', 'down', 'miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells.'),
(1538, 'hsa-mir-506', 'colon cancer', 'down', 'MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.'),
(1539, 'hsa-mir-590-3p', 'colon cancer', 'up', '[Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].'),
(1540, 'hsa-mir-126', 'colon cancer', 'down', 'miR-126: A novel regulator in colon cancer.'),
(1541, 'hsa-mir-143', 'colon cancer', 'down', 'miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.'),
(1542, 'hsa-mir-145', 'colon cancer', 'down', 'Inhibition of SW620 human colon cancer cells by upregulating miRNA-145.'),
(1543, 'hsa-mir-145', 'colon cancer', 'down', 'miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.'),
(1544, 'hsa-mir-183', 'colon cancer', 'up', 'miR-183 functions as an oncogene by targeting ABCA1 in colon cancer.'),
(1545, 'hsa-mir-21', 'colon cancer', 'up', 'Folate status, folate-related genes and serum miR-21 expression: Implications for miR-21 as a biomarker.'),
(1546, 'hsa-mir-342-5p', 'colon cancer', 'down', 'microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.'),
(1547, 'hsa-mir-34a', 'colon cancer', 'down', 'MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor ?.'),
(1548, 'hsa-mir-375', 'colon cancer', 'down', 'Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.'),
(1549, 'hsa-mir-409-3p', 'colon cancer', 'down', 'miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.'),
(1550, 'hsa-mir-451', 'colon cancer', 'down', 'miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer.'),
(1551, 'hsa-mir-608', 'colon cancer', 'down', 'microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10.'),
(1552, 'hsa-mir-181a', 'colon cancer', 'up', 'IL-1?/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis.'),
(1553, 'hsa-mir-374a', 'colon cancer', 'down', 'microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.'),
(1554, 'hsa-let-7a', 'colon cancer', 'down', 'Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.'),
(1555, 'hsa-mir-126', 'colon cancer', 'down', 'MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway.'),
(1556, 'hsa-mir-30a-5p', 'colon cancer', 'down', 'MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.'),
(1557, 'hsa-mir-526b-3p', 'colon cancer', 'down', 'miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1?.'),
(1558, 'hsa-mir-145', 'colon cancer', 'down', 'Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.'),
(1559, 'hsa-mir-215', 'colon cancer', 'down', 'MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1.'),
(1560, 'hsa-mir-193a', 'colon cancer', 'down', 'MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression.'),
(1561, 'hsa-mir-675-5p', 'colon cancer', 'up', 'MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells.'),
(1562, 'hsa-mir-98', 'colon cancer', 'down', 'MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells.'),
(1563, 'hsa-mir-141', 'colon cancer', 'up', 'miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4.'),
(1564, 'hsa-mir-146a', 'colon cancer', 'up', 'MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells.'),
(1565, 'hsa-mir-186-5p', 'colon cancer', 'up', 'MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.'),
(1566, 'hsa-mir-199a', 'colon cancer', 'down', 'Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.'),
(1567, 'hsa-mir-199b-5p', 'colon cancer', 'down', 'Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.'),
(1568, 'hsa-mir-200b', 'colon cancer', 'down', 'MicroRNA-200b is downregulated in colon cancer budding cells.'),
(1569, 'hsa-mir-26a', 'colon cancer', 'up', 'MiR-26a downregulates retinoblastoma in colorectal cancer.'),
(1570, 'hsa-mir-29c-3p', 'colon cancer', 'down', 'p53 target miR-29c-3p suppresses colon cancer cell invasion and migration through inhibition of PHLDB2.'),
(1571, 'hsa-mir-455-5p', 'colon cancer', 'up', 'miR-455-5p functions as a potential oncogene by targeting galectin-9 in colon cancer.'),
(1572, 'hsa-mir-590-3p', 'colon cancer', 'up', 'Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR S'),
(1573, 'hsa-mir-944', 'colon cancer', 'down', 'miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.'),
(1574, 'hsa-mir-101', 'colon cancer', 'down', 'Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.'),
(1575, 'hsa-mir-136', 'colon cancer', 'down', 'MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling.'),
(1576, 'hsa-mir-19b-3p', 'colon cancer', 'up', 'miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.'),
(1577, 'hsa-mir-223', 'colon cancer', 'up', 'miR-223 promotes colon cancer by directly targeting p120 catenin.'),
(1578, 'hsa-mir-30d', 'colon cancer', 'down', 'Mir-30d suppresses cell proliferation of colon cancer cells by inhibiting cell autophagy and promoting cell apoptosis.'),
(1579, 'hsa-mir-590-3p', 'colon cancer', 'up', 'MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.'),
(1580, 'hsa-mir-129-5p', 'colon cancer', 'down', 'LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis.'),
(1581, 'hsa-mir-193a', 'colon cancer', 'down', 'Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.'),
(1582, 'hsa-mir-374b', 'colon cancer', 'down', 'MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.'),
(1583, 'hsa-mir-410', 'colon cancer', 'up', 'Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells.'),
(1584, 'hsa-mir-433', 'colon cancer', 'down', 'MicroRNA-433 Represses Proliferation and Invasion of Colon Cancer Cells by Targeting Homeobox A1.'),
(1585, 'hsa-mir-590-3p', 'colon cancer', 'up', 'miR-590-3p promotes colon cancer cell proliferation via Wnt/?-catenin signaling pathway by inhibiting WIF1 and DKK1.'),
(1586, 'hsa-mir-136', 'colon cancer', 'down', 'miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.'),
(1587, 'hsa-mir-147', 'colon cancer', 'down', 'Ectopic expression of miR-147 inhibits stem cell marker and epithelial-mesenchymal transition (EMT)-related protein expression in colon cancer cells.'),
(1588, 'hsa-mir-15a', 'colon cancer', 'down', 'Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.'),
(1589, 'hsa-mir-15b', 'colon cancer', 'down', 'Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.'),
(1590, 'hsa-mir-16-1', 'colon cancer', 'down', 'Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.'),
(1591, 'hsa-mir-16-2', 'colon cancer', 'down', 'Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.'),
(1592, 'hsa-mir-185', 'colon cancer', 'down', 'miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.'),
(1593, 'hsa-mir-192', 'colon cancer', 'down', 'SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.'),
(1594, 'hsa-mir-192-3p', 'colon cancer', 'down', 'MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.'),
(1595, 'hsa-mir-192-5p', 'colon cancer', 'down', 'MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.'),
(1596, 'hsa-mir-195', 'colon cancer', 'down', 'Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-?B signalling pathway and inducing apoptosis.'),
(1597, 'hsa-mir-215', 'colon cancer', 'down', 'SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.'),
(1598, 'hsa-mir-3120-5p', 'colon cancer', 'up', 'miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.'),
(1599, 'hsa-mir-328', 'colon cancer', 'down', 'miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.'),
(1600, 'hsa-mir-383', 'colon cancer', 'down', 'Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.'),
(1601, 'hsa-mir-137', 'colon cancer', 'down', 'miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4.'),
(1602, 'hsa-mir-153', 'colon cancer', 'down', 'miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.'),
(1603, 'hsa-mir-29a', 'colon cancer', 'down', 'miRNA-29a inhibits colon cancer growth by regulation of the PTEN/Akt/GSK3? and Wnt/?-catenin signaling pathways.'),
(1604, 'hsa-mir-383', 'colon cancer', 'down', 'MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.'),
(1605, 'hsa-mir-423-5p', 'colon cancer', 'down', 'MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis.'),
(1606, 'hsa-mir-483', 'colon cancer', 'down', 'Mir-483 inhibits colon cancer cell proliferation and migration by targeting TRAF1.'),
(1607, 'hsa-mir-203', 'colon cancer', 'up', 'Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203.'),
(1608, 'hsa-mir-205', 'colon cancer', 'up', 'Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(1609, 'hsa-mir-506', 'colon cancer', 'up', 'Expression levels of miR-205 and miR-506 in colon cancer tissues and their relationships with clinicopathological features.'),
(1610, 'hsa-mir-613', 'colon cancer', 'up', 'MicroRNA-613 promotes colon cancer cell proliferation, invasion and migration by targeting ATOH1.'),
(1611, 'hsa-let-7a', 'colon cancer', 'down', '[Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].'),
(1612, 'hsa-mir-143', 'colon cancer', 'down', 'Overexpression of miRNA-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake.'),
(1613, 'hsa-mir-193b', 'colon cancer', 'down', 'MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.'),
(1614, 'hsa-mir-21', 'colon cancer', 'up', 'Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis.'),
(1615, 'hsa-mir-3653', 'colon cancer', 'down', 'MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.'),
(1616, 'hsa-mir-451', 'colon cancer', 'down', 'The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.'),
(1617, 'hsa-mir-454-3p', 'colon cancer', 'up', '[Expression of miR-454-3p and its effect on proliferation, invasion and metastasis of colon cancer].'),
(1618, 'hsa-mir-593', 'colon cancer', 'down', '[miR-593 inhibits proliferation of colon cancer cells in vitro by down-regulating PLK1].'),
(1619, 'hsa-mir-597-5p', 'colon cancer', 'down', 'MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).'),
(1620, 'hsa-mir-766', 'colon cancer', 'down', 'miRNA-766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4.'),
(1621, 'hsa-mir-873-5p', 'colon cancer', 'down', 'miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.'),
(1622, 'hsa-mir-98', 'colon cancer', 'down', '[Periostin regulated by let-7/miR-98 family mediates the apoptosis and epithelial-mesenchymal transition of colon cancer].'),
(1623, 'hsa-mir-186', 'colon carcinoma', 'down', '[Expression of hsa-miR-186 and its role in human colon carcinoma cells].'),
(1624, 'hsa-mir-221', 'colon carcinoma', 'up', '[MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].'),
(1625, 'hsa-mir-23a', 'colon carcinoma', 'up', '[Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].'),
(1626, 'hsa-mir-30a-5p', 'colon carcinoma', 'down', 'MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.'),
(1627, 'hsa-mir-299-3p', 'colon carcinoma', 'down', 'MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma.'),
(1628, 'hsa-mir-195', 'colon carcinoma', 'down', 'MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A.'),
(1629, 'hsa-mir-627', 'colonic adenocarcinoma', 'down', 'MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice.'),
(1630, 'hsa-mir-135b', 'colonic adenocarcinoma', 'down', 'Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-? receptor I kinase inhibitor (SD-208).'),
(1631, 'hsa-mir-487b-3p', 'colonic adenocarcinoma', 'down', 'The miR-487b-3p/GRM3/TGF? signaling axis is an important regulator of colon cancer tumorigenesis.'),
(1632, 'hsa-mir-627', 'colonic adenocarcinoma', 'down', 'MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of?Xenograft Tumors in Mice.'),
(1633, 'hsa-mir-223', 'colonic adenocarcinoma', 'up', 'miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma.'),
(1634, 'hsa-mir-370', 'colonic adenocarcinoma', 'down', 'Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells.'),
(1635, 'hsa-mir-150-5p', 'colonic adenocarcinoma', 'up', 'miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma.'),
(1636, 'hsa-mir-627', 'colonic adenocarcinoma', 'down', 'MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of?Xenograft Tumors in Mice.'),
(1637, 'hsa-mir-627', 'colonic adenocarcinoma', 'down', 'MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of??Xenograft Tumors in Mice.'),
(1638, 'hsa-mir-182', 'colorectal adenocarcinoma', 'up', 'Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.'),
(1639, 'hsa-mir-16', 'colorectal adenocarcinoma', 'up', 'Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.'),
(1640, 'hsa-let-7a', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1641, 'hsa-let-7a', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1642, 'hsa-mir-1', 'colorectal cancer', 'down', 'Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.'),
(1643, 'hsa-mir-100', 'colorectal cancer', 'down', 'Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.'),
(1644, 'hsa-mir-100', 'colorectal cancer', 'down', 'MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B.'),
(1645, 'hsa-mir-101', 'colorectal cancer', 'down', 'Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.'),
(1646, 'hsa-mir-103', 'colorectal cancer', 'up', 'PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro.'),
(1647, 'hsa-mir-103', 'colorectal cancer', 'up', 'MicroRNA-103 Promotes Colorectal Cancer by Targeting Tumor Suppressor DICER and PTEN.'),
(1648, 'hsa-mir-106a', 'colorectal cancer', 'up', '[Expression of plasma miR-106a in colorectal cancer and its clinical significance].'),
(1649, 'hsa-mir-106a', 'colorectal cancer', 'up', 'Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.'),
(1650, 'hsa-mir-10b', 'colorectal cancer', 'up', 'MicroRNA-10b is upregulated and has an invasive role in colorectal cancer through enhanced Rhoc expression.'),
(1651, 'hsa-mir-1179', 'colorectal cancer', 'up', 'MicroRNA expression profiles in human colorectal cancers with liver metastases.'),
(1652, 'hsa-mir-1229', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1653, 'hsa-mir-124', 'colorectal cancer', 'down', 'MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3.'),
(1654, 'hsa-mir-124', 'colorectal cancer', 'down', 'MiR-124 Radiosensitizes Human Colorectal Cancer Cells by Targeting PRRX1.'),
(1655, 'hsa-mir-124', 'colorectal cancer', 'down', 'KITENIN-targeting MicroRNA-124 Suppresses Colorectal Cancer Cell Motility and Tumorigenesis.'),
(1656, 'hsa-mir-124', 'colorectal cancer', 'down', 'Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.'),
(1657, 'hsa-mir-124', 'colorectal cancer', 'down', 'Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.'),
(1658, 'hsa-mir-124', 'colorectal cancer', 'down', 'MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.'),
(1659, 'hsa-mir-124', 'colorectal cancer', 'down', 'MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by Targeting iASPP.'),
(1660, 'hsa-mir-124', 'colorectal cancer', 'down', 'Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.'),
(1661, 'hsa-mir-1246', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1662, 'hsa-mir-125a', 'colorectal cancer', 'down', 'Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.'),
(1663, 'hsa-mir-125b-2*', 'colorectal cancer', 'up', 'MicroRNA expression profiles in human colorectal cancers with liver metastases.'),
(1664, 'hsa-mir-126', 'colorectal cancer', 'down', 'Low expression of MicroRNA-126 is associated with poor prognosis in colorectal cancer.'),
(1665, 'hsa-mir-126', 'colorectal cancer', 'down', 'Down-regulation of miR-126 expression in colorectal cancer and its clinical significance.'),
(1666, 'hsa-mir-126', 'colorectal cancer', 'down', 'Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.'),
(1667, 'hsa-mir-126', 'colorectal cancer', 'down', 'MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.'),
(1668, 'hsa-mir-1269a', 'colorectal cancer', 'up', 'miR-1269 promotes metastasis and forms a positive feedback loop with TGF-?.'),
(1669, 'hsa-mir-129', 'colorectal cancer', 'down', 'miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.'),
(1670, 'hsa-mir-1295b-3p', 'colorectal cancer', 'down', 'Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.'),
(1671, 'hsa-mir-1307', 'colorectal cancer', 'down', 'The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment.'),
(1672, 'hsa-mir-130b', 'colorectal cancer', 'up', 'MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer.'),
(1673, 'hsa-mir-130b', 'colorectal cancer', 'down', 'Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin ?1.'),
(1674, 'hsa-mir-132', 'colorectal cancer', 'down', 'miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.'),
(1675, 'hsa-mir-133a', 'colorectal cancer', 'down', 'The clinicopathological significance of miR-133a in colorectal cancer.'),
(1676, 'hsa-mir-133a', 'colorectal cancer', 'down', 'Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.'),
(1677, 'hsa-mir-133a', 'colorectal cancer', 'down', 'MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.'),
(1678, 'hsa-mir-133a', 'colorectal cancer', 'down', 'Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.'),
(1679, 'hsa-mir-133a', 'colorectal cancer', 'down', 'Tumor suppressor functions of miR-133a in colorectal cancer.'),
(1680, 'hsa-mir-133b', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1681, 'hsa-mir-133b', 'colorectal cancer', 'down', 'miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.'),
(1682, 'hsa-mir-135a', 'colorectal cancer', 'up', 'MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.'),
(1683, 'hsa-mir-135a', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1684, 'hsa-mir-135a-1', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1685, 'hsa-mir-135a-2', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1686, 'hsa-mir-135b', 'colorectal cancer', 'up', 'MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.'),
(1687, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.'),
(1688, 'hsa-mir-135b', 'colorectal cancer', 'up', 'MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.'),
(1689, 'hsa-mir-135b', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1690, 'hsa-mir-135b', 'colorectal cancer', 'up', 'miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.'),
(1691, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Identification and functional screening of microRNAs highly deregulated in colorectal cancer.'),
(1692, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.'),
(1693, 'hsa-mir-137', 'colorectal cancer', 'down', 'MicroRNA-137, an HMGA1 Target, Suppresses Colorectal Cancer Cell Invasion and Metastasis in Mice by Directly Targeting FMNL2.'),
(1694, 'hsa-mir-137', 'colorectal cancer', 'down', 'Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.'),
(1695, 'hsa-mir-138', 'colorectal cancer', 'down', 'Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.'),
(1696, 'hsa-mir-139', 'colorectal cancer', 'down', 'Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.'),
(1697, 'hsa-mir-139', 'colorectal cancer', 'down', 'Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.'),
(1698, 'hsa-mir-139-3p', 'colorectal cancer', 'up', 'MicroRNA expression profiles in human colorectal cancers with liver metastases.'),
(1699, 'hsa-mir-139-5p', 'colorectal cancer', 'down', 'MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.'),
(1700, 'hsa-mir-140-5p', 'colorectal cancer', 'down', 'Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.'),
(1701, 'hsa-mir-143', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1702, 'hsa-mir-143', 'colorectal cancer', 'down', 'MicroRNA signatures: novel biomarker for colorectal cancer?'),
(1703, 'hsa-mir-143', 'colorectal cancer', 'down', 'Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.'),
(1704, 'hsa-mir-143', 'colorectal cancer', 'down', 'RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.'),
(1705, 'hsa-mir-143', 'colorectal cancer', 'down', 'MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.'),
(1706, 'hsa-mir-143', 'colorectal cancer', 'down', 'The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells.'),
(1707, 'hsa-mir-145', 'colorectal cancer', 'up', 'Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer.'),
(1708, 'hsa-mir-145', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1709, 'hsa-mir-145', 'colorectal cancer', 'down', 'Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.'),
(1710, 'hsa-mir-145', 'colorectal cancer', 'down', 'MicroRNA signatures: novel biomarker for colorectal cancer?'),
(1711, 'hsa-mir-145', 'colorectal cancer', 'down', 'MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.'),
(1712, 'hsa-mir-145', 'colorectal cancer', 'down', 'Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.'),
(1713, 'hsa-mir-145', 'colorectal cancer', 'down', 'RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.'),
(1714, 'hsa-mir-145', 'colorectal cancer', 'down', 'MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.'),
(1715, 'hsa-mir-148a', 'colorectal cancer', 'down', 'MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.'),
(1716, 'hsa-mir-148b', 'colorectal cancer', 'down', 'MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.'),
(1717, 'hsa-mir-149', 'colorectal cancer', 'down', 'MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1.'),
(1718, 'hsa-mir-150', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1719, 'hsa-mir-150*', 'colorectal cancer', 'up', 'MicroRNA expression profiles in human colorectal cancers with liver metastases.'),
(1720, 'hsa-mir-150-5p', 'colorectal cancer', 'down', 'MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4.'),
(1721, 'hsa-mir-154', 'colorectal cancer', 'down', 'miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.'),
(1722, 'hsa-mir-155', 'colorectal cancer', 'up', 'Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.'),
(1723, 'hsa-mir-15a', 'colorectal cancer', 'down', 'Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1724, 'hsa-mir-15b', 'colorectal cancer', 'down', 'Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1725, 'hsa-mir-16', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1726, 'hsa-mir-16', 'colorectal cancer', 'down', 'Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1727, 'hsa-mir-16', 'colorectal cancer', 'down', 'microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway.'),
(1728, 'hsa-mir-16', 'colorectal cancer', 'down', 'Prognostic Significance of MicroRNA-16 Expression in Human Colorectal Cancer.'),
(1729, 'hsa-mir-17', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1730, 'hsa-mir-17', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1731, 'hsa-mir-181a', 'colorectal cancer', 'up', 'MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.'),
(1732, 'hsa-mir-182', 'colorectal cancer', 'up', 'miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.'),
(1733, 'hsa-mir-182', 'colorectal cancer', 'up', 'Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.'),
(1734, 'hsa-mir-182', 'colorectal cancer', 'up', 'microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.'),
(1735, 'hsa-mir-182', 'colorectal cancer', 'up', 'Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression.'),
(1736, 'hsa-mir-182', 'colorectal cancer', 'up', 'SATB1 and 2 in colorectal cancer.'),
(1737, 'hsa-mir-183', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1738, 'hsa-mir-183', 'colorectal cancer', 'up', 'Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.'),
(1739, 'hsa-mir-183', 'colorectal cancer', 'up', 'Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.'),
(1740, 'hsa-mir-18a', 'colorectal cancer', 'up', 'microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.'),
(1741, 'hsa-mir-18a', 'colorectal cancer', 'up', 'Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.'),
(1742, 'hsa-mir-18a', 'colorectal cancer', 'down', 'miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells.'),
(1743, 'hsa-mir-18a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1744, 'hsa-mir-191', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1745, 'hsa-mir-191', 'colorectal cancer', 'up', 'miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBP?.'),
(1746, 'hsa-mir-192', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1747, 'hsa-mir-192', 'colorectal cancer', 'down', 'microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.'),
(1748, 'hsa-mir-193a-5p', 'colorectal cancer', 'down', 'Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1749, 'hsa-mir-194', 'colorectal cancer', 'down', 'microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.'),
(1750, 'hsa-mir-194', 'colorectal cancer', 'down', 'MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.'),
(1751, 'hsa-mir-195', 'colorectal cancer', 'down', 'microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.'),
(1752, 'hsa-mir-195', 'colorectal cancer', 'down', 'Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1753, 'hsa-mir-195', 'colorectal cancer', 'down', 'MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3.'),
(1754, 'hsa-mir-196a', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1755, 'hsa-mir-196a', 'colorectal cancer', 'up', 'Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.'),
(1756, 'hsa-mir-196b', 'colorectal cancer', 'up', 'Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer.'),
(1757, 'hsa-mir-198', 'colorectal cancer', 'down', 'MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8.'),
(1758, 'hsa-mir-199a-5p', 'colorectal cancer', 'down', 'The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.'),
(1759, 'hsa-mir-19a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1760, 'hsa-mir-19b', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1761, 'hsa-mir-200b', 'colorectal cancer', 'up', 'microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.'),
(1762, 'hsa-mir-200c', 'colorectal cancer', 'down', 'miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.'),
(1763, 'hsa-mir-200c', 'colorectal cancer', 'up', 'MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.'),
(1764, 'hsa-mir-200c', 'colorectal cancer', 'up', 'Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.'),
(1765, 'hsa-mir-200c', 'colorectal cancer', 'up', 'microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.'),
(1766, 'hsa-mir-203', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1767, 'hsa-mir-203', 'colorectal cancer', 'down', 'MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity.'),
(1768, 'hsa-mir-204-5p', 'colorectal cancer', 'up', 'miR-204-5p expression in colorectal cancer: an autophagy-associated gene.'),
(1769, 'hsa-mir-204-5p', 'colorectal cancer', 'down', 'miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.'),
(1770, 'hsa-mir-206', 'colorectal cancer', 'down', 'microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.'),
(1771, 'hsa-mir-20a', 'colorectal cancer', 'up', 'MicroRNA signatures: novel biomarker for colorectal cancer?'),
(1772, 'hsa-mir-20a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1773, 'hsa-mir-20a-5p', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1774, 'hsa-mir-21', 'colorectal cancer', 'up', 'Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.'),
(1775, 'hsa-mir-21', 'colorectal cancer', 'up', 'MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.'),
(1776, 'hsa-mir-21', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1777, 'hsa-mir-21', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1778, 'hsa-mir-21', 'colorectal cancer', 'up', 'Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.'),
(1779, 'hsa-mir-21', 'colorectal cancer', 'up', 'Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages.'),
(1780, 'hsa-mir-21', 'colorectal cancer', 'up', 'Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer.'),
(1781, 'hsa-mir-21', 'colorectal cancer', 'up', 'MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation.'),
(1782, 'hsa-mir-21', 'colorectal cancer', 'up', 'Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.'),
(1783, 'hsa-mir-210', 'colorectal cancer', 'up', 'Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.'),
(1784, 'hsa-mir-211', 'colorectal cancer', 'up', 'MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.'),
(1785, 'hsa-mir-212', 'colorectal cancer', 'down', 'Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD.'),
(1786, 'hsa-mir-215', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1787, 'hsa-mir-215', 'colorectal cancer', 'down', 'Identification and functional screening of microRNAs highly deregulated in colorectal cancer.'),
(1788, 'hsa-mir-215', 'colorectal cancer', 'down', 'microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.'),
(1789, 'hsa-mir-218', 'colorectal cancer', 'down', 'MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer by Downregulating BMI1 Polycomb Ring Finger Oncogene.'),
(1790, 'hsa-mir-218', 'colorectal cancer', 'down', 'Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.'),
(1791, 'hsa-mir-22', 'colorectal cancer', 'down', 'Clinical significance of miR-22 expression in patients with colorectal cancer.'),
(1792, 'hsa-mir-221', 'colorectal cancer', 'up', 'MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.'),
(1793, 'hsa-mir-221', 'colorectal cancer', 'up', '[MicroRNA-221 controls CDKN1C/P57 expression in human colorectal carcinoma].'),
(1794, 'hsa-mir-221', 'colorectal cancer', 'up', 'MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.'),
(1795, 'hsa-mir-223', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1796, 'hsa-mir-223', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1797, 'hsa-mir-223', 'colorectal cancer', 'up', 'MicroRNA-223 functions as an oncogene in human colorectal cancer cells.'),
(1798, 'hsa-mir-223', 'colorectal cancer', 'up', 'Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.'),
(1799, 'hsa-mir-223', 'colorectal cancer', 'up', 'C/EBP-?-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.'),
(1800, 'hsa-mir-224', 'colorectal cancer', 'up', 'Up-regulation of miR-224 promotes cancer cell proliferation and invasion and predicts relapse of colorectal cancer.'),
(1801, 'hsa-mir-224', 'colorectal cancer', 'up', 'Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer.'),
(1802, 'hsa-mir-224', 'colorectal cancer', 'down', 'MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.'),
(1803, 'hsa-mir-224', 'colorectal cancer', 'up', 'The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.'),
(1804, 'hsa-mir-224', 'colorectal cancer', 'up', 'microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2.'),
(1805, 'hsa-mir-23a', 'colorectal cancer', 'up', 'Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.'),
(1806, 'hsa-mir-24-3p', 'colorectal cancer', 'down', 'Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.'),
(1807, 'hsa-mir-25', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1808, 'hsa-mir-25', 'colorectal cancer', 'up', 'The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.'),
(1809, 'hsa-mir-26b', 'colorectal cancer', 'down', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1810, 'hsa-mir-27a', 'colorectal cancer', 'down', 'Tumor Suppressor MicroRNA-27a in Colorectal Carcinogenesis and Progression by Targeting SGPP1 and Smad2.'),
(1811, 'hsa-mir-27a', 'colorectal cancer', 'up', 'Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.'),
(1812, 'hsa-mir-28-3p', 'colorectal cancer', 'down', 'Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.'),
(1813, 'hsa-mir-28-5p', 'colorectal cancer', 'down', 'Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.'),
(1814, 'hsa-mir-29a', 'colorectal cancer', 'up', 'microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers.'),
(1815, 'hsa-mir-29a', 'colorectal cancer', 'up', 'MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4.'),
(1816, 'hsa-mir-29a', 'colorectal cancer', 'up', 'Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.'),
(1817, 'hsa-mir-29b', 'colorectal cancer', 'down', 'miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.'),
(1818, 'hsa-mir-301a', 'colorectal cancer', 'up', 'MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.'),
(1819, 'hsa-mir-301a', 'colorectal cancer', 'up', 'MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6.'),
(1820, 'hsa-mir-30a-3p', 'colorectal cancer', 'down', 'Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation.'),
(1821, 'hsa-mir-30b', 'colorectal cancer', 'down', 'MiR-30b regulates migration and invasion of human colorectal cancer via SIX1.'),
(1822, 'hsa-mir-31', 'colorectal cancer', 'up', 'MicroRNA signatures: novel biomarker for colorectal cancer?'),
(1823, 'hsa-mir-31', 'colorectal cancer', 'up', 'Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.'),
(1824, 'hsa-mir-31', 'colorectal cancer', 'up', 'Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.'),
(1825, 'hsa-mir-31', 'colorectal cancer', 'up', 'Identification of microRNA-135b in Stool as a Potential Noninvasive Biomarker for Colorectal Cancer and Adenoma.'),
(1826, 'hsa-mir-31', 'colorectal cancer', 'up', 'Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.'),
(1827, 'hsa-mir-31', 'colorectal cancer', 'up', 'SATB1 and 2 in colorectal cancer.'),
(1828, 'hsa-mir-31', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1829, 'hsa-mir-32', 'colorectal cancer', 'up', 'The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.'),
(1830, 'hsa-mir-320a', 'colorectal cancer', 'down', 'microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer.'),
(1831, 'hsa-mir-320a', 'colorectal cancer', 'down', 'miR-320a suppresses colorectal cancer progression by targeting Rac1.'),
(1832, 'hsa-mir-320a', 'colorectal cancer', 'down', '[Corrigendum] microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.'),
(1833, 'hsa-mir-320b', 'colorectal cancer', 'up', 'MicroRNA-320b promotes colorectal cancer proliferation and invasion by competing with its homologous microRNA-320a.'),
(1834, 'hsa-mir-326', 'colorectal cancer', 'up', 'MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.'),
(1835, 'hsa-mir-328', 'colorectal cancer', 'down', 'MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.'),
(1836, 'hsa-mir-338-3p', 'colorectal cancer', 'down', 'Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.'),
(1837, 'hsa-mir-342', 'colorectal cancer', 'down', 'MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.'),
(1838, 'hsa-mir-345', 'colorectal cancer', 'down', 'MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.'),
(1839, 'hsa-mir-34a', 'colorectal cancer', 'down', 'Circulating miR-34a levels are reduced in colorectal cancer.'),
(1840, 'hsa-mir-34a', 'colorectal cancer', 'down', 'Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF.'),
(1841, 'hsa-mir-34a', 'colorectal cancer', 'down', 'Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer.'),
(1842, 'hsa-mir-34a-5p', 'colorectal cancer', 'down', 'miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.'),
(1843, 'hsa-mir-361-5p', 'colorectal cancer', 'down', 'MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.'),
(1844, 'hsa-mir-375', 'colorectal cancer', 'down', 'Expression levels of microRNA-375 in colorectal carcinoma.'),
(1845, 'hsa-mir-375', 'colorectal cancer', 'down', 'Identification and functional screening of microRNAs highly deregulated in colorectal cancer.'),
(1846, 'hsa-mir-375', 'colorectal cancer', 'down', 'MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.'),
(1847, 'hsa-mir-378', 'colorectal cancer', 'down', 'Identification and functional screening of microRNAs highly deregulated in colorectal cancer.'),
(1848, 'hsa-mir-378', 'colorectal cancer', 'down', 'MicroRNA-378 inhibits cell growth and enhances l-OHP-induced apoptosis in human colorectal cancer.'),
(1849, 'hsa-mir-378a-3p', 'colorectal cancer', 'down', 'Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.'),
(1850, 'hsa-mir-378a-5p', 'colorectal cancer', 'down', 'Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.'),
(1851, 'hsa-mir-409-3p', 'colorectal cancer', 'down', 'MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.'),
(1852, 'hsa-mir-422a', 'colorectal cancer', 'down', 'Identification and functional screening of microRNAs highly deregulated in colorectal cancer.'),
(1853, 'hsa-mir-424', 'colorectal cancer', 'up', 'Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.'),
(1854, 'hsa-mir-429', 'colorectal cancer', 'up', 'MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.'),
(1855, 'hsa-mir-4487', 'colorectal cancer', 'down', 'Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.'),
(1856, 'hsa-mir-483', 'colorectal cancer', 'down', 'Extracellular metabolic energetics can promote cancer progression.'),
(1857, 'hsa-mir-494', 'colorectal cancer', 'up', 'miR?494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN.'),
(1858, 'hsa-mir-497', 'colorectal cancer', 'down', 'MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.'),
(1859, 'hsa-mir-497', 'colorectal cancer', 'up', 'MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis.'),
(1860, 'hsa-mir-497', 'colorectal cancer', 'up', 'MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.'),
(1861, 'hsa-mir-497', 'colorectal cancer', 'down', 'MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.'),
(1862, 'hsa-mir-498', 'colorectal cancer', 'down', 'Downregulation of microRNA-498 in colorectal cancers and its cellular effects.'),
(1863, 'hsa-mir-499-5p', 'colorectal cancer', 'up', 'MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4.'),
(1864, 'hsa-mir-518a-3p', 'colorectal cancer', 'down', 'Downregulation of miR-518a-3p activates the NIK-dependent NF-?B pathway in colorectal cancer.'),
(1865, 'hsa-mir-551a', 'colorectal cancer', 'down', 'Extracellular metabolic energetics can promote cancer progression.'),
(1866, 'hsa-mir-574-5p', 'colorectal cancer', 'down', 'Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis.'),
(1867, 'hsa-mir-592', 'colorectal cancer', 'up', 'Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer.'),
(1868, 'hsa-mir-625', 'colorectal cancer', 'down', 'Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.'),
(1869, 'hsa-mir-630', 'colorectal cancer', 'up', 'MicroRNA-630 is a prognostic marker for patients with colorectal cancer.'),
(1870, 'hsa-mir-638', 'colorectal cancer', 'down', 'MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma.'),
(1871, 'hsa-mir-7', 'colorectal cancer', 'down', 'miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2.'),
(1872, 'hsa-mir-720', 'colorectal cancer', 'up', 'Evaluation of miR-720 prognostic significance in patients with colorectal cancer.'),
(1873, 'hsa-mir-892a', 'colorectal cancer', 'up', 'miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.'),
(1874, 'hsa-mir-92', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1875, 'hsa-mir-92a', 'colorectal cancer', 'up', 'MicroRNA signatures: novel biomarker for colorectal cancer?'),
(1876, 'hsa-mir-92a', 'colorectal cancer', 'up', 'Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.'),
(1877, 'hsa-mir-92a', 'colorectal cancer', 'up', 'Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.'),
(1878, 'hsa-mir-92a', 'colorectal cancer', 'up', 'MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN.'),
(1879, 'hsa-mir-92a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1880, 'hsa-mir-93', 'colorectal cancer', 'up', 'Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.'),
(1881, 'hsa-mir-95', 'colorectal cancer', 'up', 'MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.'),
(1882, 'hsa-mir-96', 'colorectal cancer', 'up', 'Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.'),
(1883, 'hsa-mir-96', 'colorectal cancer', 'up', 'MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.'),
(1884, 'hsa-mir-96-5p', 'colorectal cancer', 'down', 'MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.'),
(1885, 'mir-17', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1886, 'mir-18a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1887, 'mir-19a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1888, 'mir-19b', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1889, 'mir-20a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1890, 'mir-92a', 'colorectal cancer', 'up', 'MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.'),
(1891, 'hsa-mir-101', 'colorectal cancer', 'down', 'MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.'),
(1892, 'hsa-mir-106b', 'colorectal cancer', 'up', 'MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.'),
(1893, 'hsa-mir-124', 'colorectal cancer', 'down', 'MicroRNA-124 Reduces Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells.'),
(1894, 'hsa-mir-125b', 'colorectal cancer', 'up', 'MicroRNA miR-125b is a prognostic marker in human colorectal cancer.'),
(1895, 'hsa-mir-141', 'colorectal cancer', 'down', 'MiR-200 suppresses metastases of colorectal cancer through ZEB1.'),
(1896, 'hsa-mir-141', 'colorectal cancer', 'up', 'MicroRNA-141 regulates the tumour suppressor DLC-1 in colorectal cancer.'),
(1897, 'hsa-mir-15a-3p', 'colorectal cancer', 'up', 'Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.'),
(1898, 'hsa-mir-19a', 'colorectal cancer', 'up', 'Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-? induced epithelial-to-mesenchymal transition in colorectal cancer.'),
(1899, 'hsa-mir-200a', 'colorectal cancer', 'down', 'MiR-200 suppresses metastases of colorectal cancer through ZEB1.'),
(1900, 'hsa-mir-200b', 'colorectal cancer', 'down', 'MiR-200 suppresses metastases of colorectal cancer through ZEB1.'),
(1901, 'hsa-mir-200c', 'colorectal cancer', 'down', 'MiR-200 suppresses metastases of colorectal cancer through ZEB1.'),
(1902, 'hsa-mir-24', 'colorectal cancer', 'down', 'Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.'),
(1903, 'hsa-mir-31', 'colorectal cancer', 'up', 'The potential role of microRNA-31 expression in early colorectal cancer.'),
(1904, 'hsa-mir-320a', 'colorectal cancer', 'down', 'Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.'),
(1905, 'hsa-mir-33b', 'colorectal cancer', 'down', 'MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.'),
(1906, 'hsa-mir-34a', 'colorectal cancer', 'down', 'MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.'),
(1907, 'hsa-mir-372', 'colorectal cancer', 'up', 'Serum miR-372 is a diagnostic and prognostic biomarker in patients with early colorectal cancer.'),
(1908, 'hsa-mir-423-5p', 'colorectal cancer', 'down', 'Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.'),
(1909, 'hsa-mir-429', 'colorectal cancer', 'down', 'MiR-200 suppresses metastases of colorectal cancer through ZEB1.'),
(1910, 'hsa-mir-520d-5p', 'colorectal cancer', 'down', 'SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1.'),
(1911, 'hsa-mir-124', 'colorectal cancer', 'down', 'miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.'),
(1912, 'hsa-mir-128', 'colorectal cancer', 'down', 'MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.'),
(1913, 'hsa-mir-139-5p', 'colorectal cancer', 'down', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1914, 'hsa-mir-142-3p', 'colorectal cancer', 'down', 'Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.'),
(1915, 'hsa-mir-145-5p', 'colorectal cancer', 'down', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1916, 'hsa-mir-148a', 'colorectal cancer', 'down', 'Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.'),
(1917, 'hsa-mir-17-5p', 'colorectal cancer', 'up', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1918, 'hsa-mir-183-5p', 'colorectal cancer', 'up', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1919, 'hsa-mir-206', 'colorectal cancer', 'down', 'MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.'),
(1920, 'hsa-mir-206', 'colorectal cancer', 'down', 'miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.'),
(1921, 'hsa-mir-20a-5p', 'colorectal cancer', 'up', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1922, 'hsa-mir-21-5p', 'colorectal cancer', 'up', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1923, 'hsa-mir-218', 'colorectal cancer', 'down', 'MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.'),
(1924, 'hsa-mir-219-5p', 'colorectal cancer', 'down', 'MicroRNA-219-5p functions as a?tumor suppressor partially by targeting platelet-derived growth factor receptor alpha in colorectal cancer.'),
(1925, 'hsa-mir-26a-5p', 'colorectal cancer', 'down', 'Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma.'),
(1926, 'hsa-mir-378a-5p', 'colorectal cancer', 'down', 'Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.'),
(1927, 'hsa-mir-409-3p', 'colorectal cancer', 'down', 'Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.'),
(1928, 'hsa-mir-423-3p', 'colorectal cancer', 'up', 'MiR-423-3p Enhances Cell Growth Through Inhibition of p21Cip1/Waf1 in Colorectal Cancer.'),
(1929, 'hsa-mir-506', 'colorectal cancer', 'down', 'miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(1930, 'hsa-mir-582-5p', 'colorectal cancer', 'down', 'Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.'),
(1931, 'hsa-mir-766', 'colorectal cancer', 'up', 'MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer.'),
(1932, 'hsa-mir-125a', 'colorectal cancer', 'down', 'Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.'),
(1933, 'hsa-mir-125b', 'colorectal cancer', 'down', 'Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer.'),
(1934, 'hsa-mir-132', 'colorectal cancer', 'down', 'Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.'),
(1935, 'hsa-mir-132', 'colorectal cancer', 'down', 'Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer.'),
(1936, 'hsa-mir-133b', 'colorectal cancer', 'down', 'DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.'),
(1937, 'hsa-mir-134', 'colorectal cancer', 'down', 'Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.'),
(1938, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Correction: miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.'),
(1939, 'hsa-mir-142-5p', 'colorectal cancer', 'down', 'Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.'),
(1940, 'hsa-mir-145', 'colorectal cancer', 'down', 'Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.'),
(1941, 'hsa-mir-152', 'colorectal cancer', 'down', 'miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.'),
(1942, 'hsa-mir-15b', 'colorectal cancer', 'up', 'Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.'),
(1943, 'hsa-mir-1827', 'colorectal cancer', 'down', 'microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.'),
(1944, 'hsa-mir-183', 'colorectal cancer', 'up', 'miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG.'),
(1945, 'hsa-mir-187', 'colorectal cancer', 'down', 'MicroRNA-187, a downstream effector of TGF? pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.'),
(1946, 'hsa-mir-195', 'colorectal cancer', 'down', 'Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR.'),
(1947, 'hsa-mir-205', 'colorectal cancer', 'down', 'MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).'),
(1948, 'hsa-mir-20a', 'colorectal cancer', 'up', 'microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases.'),
(1949, 'hsa-mir-21', 'colorectal cancer', 'up', 'Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.'),
(1950, 'hsa-mir-210', 'colorectal cancer', 'up', 'Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer.'),
(1951, 'hsa-mir-331-3p', 'colorectal cancer', 'down', 'miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.'),
(1952, 'hsa-mir-335', 'colorectal cancer', 'up', 'Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells.'),
(1953, 'hsa-mir-339-3p', 'colorectal cancer', 'down', 'miR-339-3p inhibits proliferation and metastasis of colorectal cancer.'),
(1954, 'hsa-mir-34c', 'colorectal cancer', 'down', 'Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation.'),
(1955, 'hsa-mir-382', 'colorectal cancer', 'down', 'MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer.'),
(1956, 'hsa-mir-450b-5p', 'colorectal cancer', 'down', 'miR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer.'),
(1957, 'hsa-mir-490-3p', 'colorectal cancer', 'down', 'MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGF?R1.'),
(1958, 'hsa-mir-497', 'colorectal cancer', 'down', 'MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.'),
(1959, 'hsa-mir-503', 'colorectal cancer', 'up', 'miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.'),
(1960, 'hsa-mir-503', 'colorectal cancer', 'down', 'miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.'),
(1961, 'hsa-mir-542-3p', 'colorectal cancer', 'down', 'miR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin.'),
(1962, 'hsa-mir-543', 'colorectal cancer', 'down', 'MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.'),
(1963, 'hsa-mir-610', 'colorectal cancer', 'down', 'MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.'),
(1964, 'hsa-mir-874', 'colorectal cancer', 'down', 'MiR-874 inhibits cell growth and induces apoptosis by targeting STAT3 in human colorectal cancer cells.'),
(1965, 'hsa-mir-9', 'colorectal cancer', 'down', 'MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.'),
(1966, 'hsa-let-7a', 'colorectal cancer', 'down', 'Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.'),
(1967, 'hsa-mir-124', 'colorectal cancer', 'down', 'MicroRNA-124 (MiR-124) Inhibits Cell Proliferation, Metastasis and Invasion in Colorectal Cancer by Downregulating Rho-Associated Protein Kinase 1(ROCK1).'),
(1968, 'hsa-mir-126', 'colorectal cancer', 'down', 'Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.'),
(1969, 'hsa-mir-138-5p', 'colorectal cancer', 'down', 'The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.'),
(1970, 'hsa-mir-139-5p', 'colorectal cancer', 'down', 'miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.'),
(1971, 'hsa-mir-17', 'colorectal cancer', 'up', 'Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.'),
(1972, 'hsa-mir-199b', 'colorectal cancer', 'down', 'Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.'),
(1973, 'hsa-mir-19a', 'colorectal cancer', 'up', 'Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.'),
(1974, 'hsa-mir-205', 'colorectal cancer', 'down', 'Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.'),
(1975, 'hsa-mir-20a', 'colorectal cancer', 'up', 'Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.'),
(1976, 'hsa-mir-20a-5p', 'colorectal cancer', 'up', 'MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.'),
(1977, 'hsa-mir-21', 'colorectal cancer', 'down', 'Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.'),
(1978, 'hsa-mir-223', 'colorectal cancer', 'up', 'Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.'),
(1979, 'hsa-mir-342', 'colorectal cancer', 'down', 'FOXM1 and FOXQ1 are promising prognostic biomarkers and novel targets of tumor suppressive miR-342 in human colorectal cancer.'),
(1980, 'hsa-mir-34a', 'colorectal cancer', 'down', 'Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer.'),
(1981, 'hsa-mir-375', 'colorectal cancer', 'down', 'MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8.'),
(1982, 'hsa-mir-375', 'colorectal cancer', 'down', 'miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.'),
(1983, 'hsa-mir-592', 'colorectal cancer', 'up', 'An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).'),
(1984, 'hsa-mir-874', 'colorectal cancer', 'down', 'MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.'),
(1985, 'hsa-mir-874', 'colorectal cancer', 'down', 'Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer.'),
(1986, 'hsa-mir-10b', 'colorectal cancer', 'up', 'miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.'),
(1987, 'hsa-mir-124', 'colorectal cancer', 'down', '[miR-124 regulates radiosensitivity of colorectal cancer cells by targeting PRRX1].'),
(1988, 'hsa-mir-145', 'colorectal cancer', 'down', 'miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.'),
(1989, 'hsa-mir-185', 'colorectal cancer', 'down', 'MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt/?-catenin pathway in human colorectal cancer.'),
(1990, 'hsa-mir-187', 'colorectal cancer', 'down', 'MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.'),
(1991, 'hsa-mir-203', 'colorectal cancer', 'down', 'MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.'),
(1992, 'hsa-mir-218', 'colorectal cancer', 'down', 'MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.'),
(1993, 'hsa-mir-29b', 'colorectal cancer', 'down', '[Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features].'),
(1994, 'hsa-mir-30a-5p', 'colorectal cancer', 'down', 'MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.'),
(1995, 'hsa-mir-320', 'colorectal cancer', 'down', 'MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.'),
(1996, 'hsa-mir-363-3p', 'colorectal cancer', 'down', 'MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.'),
(1997, 'hsa-mir-381', 'colorectal cancer', 'down', 'MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.'),
(1998, 'hsa-mir-422a', 'colorectal cancer', 'down', 'miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.'),
(1999, 'hsa-mir-429', 'colorectal cancer', 'up', 'Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer.'),
(2000, 'hsa-mir-448', 'colorectal cancer', 'down', 'miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.'),
(2001, 'hsa-mir-449a', 'colorectal cancer', 'down', 'miR-449a inhibits colorectal cancer progression by targeting SATB2.'),
(2002, 'hsa-mir-450b-5p', 'colorectal cancer', 'up', 'miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.'),
(2003, 'hsa-mir-452', 'colorectal cancer', 'down', 'Decreased miR-452 expression in human colorectal cancer and its tumor suppressive function.'),
(2004, 'hsa-mir-490-3p', 'colorectal cancer', 'down', 'Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/?-catenin signaling pathway.'),
(2005, 'hsa-mir-506', 'colorectal cancer', 'down', 'miR-506 inhibits cell proliferation and invasion by targeting TET family in colorectal cancer.'),
(2006, 'hsa-mir-517a', 'colorectal cancer', 'up', 'miR-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer.'),
(2007, 'hsa-mir-92a', 'colorectal cancer', 'up', 'MicroRNA-92a Promotes Colorectal Cancer Cell Growth and Migration by Inhibiting KLF4.'),
(2008, 'hsa-mir-96', 'colorectal cancer', 'up', 'High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.'),
(2009, 'hsa-mir-10b', 'colorectal cancer', 'up', 'Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.'),
(2010, 'hsa-mir-137', 'colorectal cancer', 'down', 'Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.'),
(2011, 'hsa-mir-139-5p', 'colorectal cancer', 'down', 'MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.'),
(2012, 'hsa-mir-140', 'colorectal cancer', 'down', 'microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.'),
(2013, 'hsa-mir-141', 'colorectal cancer', 'down', 'Role of microRNA-141 in colorectal cancer with lymph node metastasis.'),
(2014, 'hsa-mir-143', 'colorectal cancer', 'down', 'Down-regulation of microRNA-143 is associated with colorectal cancer progression.'),
(2015, 'hsa-mir-143', 'colorectal cancer', 'down', 'MicroRNA-143 inhibits colorectal cancer cell proliferation through targeting MMP7.'),
(2016, 'hsa-mir-152', 'colorectal cancer', 'down', '[Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].'),
(2017, 'hsa-mir-16', 'colorectal cancer', 'down', 'Deregulation of the miR-16-KRAS axis promotes colorectal cancer.'),
(2018, 'hsa-mir-193b', 'colorectal cancer', 'down', 'miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.'),
(2019, 'hsa-mir-195', 'colorectal cancer', 'down', 'MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/?-catenin pathway.'),
(2020, 'hsa-mir-203', 'colorectal cancer', 'down', 'miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.'),
(2021, 'hsa-mir-210', 'colorectal cancer', 'up', 'Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210.'),
(2022, 'hsa-mir-214', 'colorectal cancer', 'down', 'The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.'),
(2023, 'hsa-mir-218', 'colorectal cancer', 'down', 'Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.'),
(2024, 'hsa-mir-384', 'colorectal cancer', 'down', 'MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.'),
(2025, 'hsa-mir-486', 'colorectal cancer', 'down', 'Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.'),
(2026, 'hsa-mir-497', 'colorectal cancer', 'down', 'miR-497 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1.'),
(2027, 'hsa-mir-582-5p', 'colorectal cancer', 'up', 'miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli.'),
(2028, 'hsa-mir-590-5p', 'colorectal cancer', 'down', 'MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.'),
(2029, 'hsa-mir-92a', 'colorectal cancer', 'down', 'Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations.'),
(2030, 'hsa-mir-100', 'colorectal cancer', 'down', 'Downregulation of miR-100/miR-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion.'),
(2031, 'hsa-mir-106a', 'colorectal cancer', 'down', 'miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.'),
(2032, 'hsa-mir-1254', 'colorectal cancer', 'down', 'MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10.'),
(2033, 'hsa-mir-125b', 'colorectal cancer', 'up', 'CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.'),
(2034, 'hsa-mir-125b', 'colorectal cancer', 'down', 'Downregulation of miR-100/miR-125b is associated with lymph node metastasis in early colorectal cancer with submucosal invasion.'),
(2035, 'hsa-mir-128', 'colorectal cancer', 'down', 'Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.'),
(2036, 'hsa-mir-141', 'colorectal cancer', 'down', 'MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer.'),
(2037, 'hsa-mir-146a', 'colorectal cancer', 'up', 'MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.'),
(2038, 'hsa-mir-194', 'colorectal cancer', 'up', 'MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasis.'),
(2039, 'hsa-mir-196b', 'colorectal cancer', 'up', 'The diagnostic effect of serum miR-196b as biomarker in colorectal cancer.'),
(2040, 'hsa-mir-19a', 'colorectal cancer', 'up', 'miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.'),
(2041, 'hsa-mir-19a-3p', 'colorectal cancer', 'up', 'A panel of microRNA signature in serum for colorectal cancer diagnosis.'),
(2042, 'hsa-mir-200c', 'colorectal cancer', 'down', 'Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.'),
(2043, 'hsa-mir-20a', 'colorectal cancer', 'up', 'miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.'),
(2044, 'hsa-mir-21-5p', 'colorectal cancer', 'up', 'A panel of microRNA signature in serum for colorectal cancer diagnosis.'),
(2045, 'hsa-mir-216a', 'colorectal cancer', 'down', 'Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.'),
(2046, 'hsa-mir-217', 'colorectal cancer', 'down', 'miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.'),
(2047, 'hsa-mir-23b', 'colorectal cancer', 'down', 'Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer.'),
(2048, 'hsa-mir-296', 'colorectal cancer', 'down', 'miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.'),
(2049, 'hsa-mir-375', 'colorectal cancer', 'down', 'microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.'),
(2050, 'hsa-mir-425-5p', 'colorectal cancer', 'up', 'A panel of microRNA signature in serum for colorectal cancer diagnosis.'),
(2051, 'hsa-mir-433', 'colorectal cancer', 'down', 'miR-433 reduces cell viability and promotes cell apoptosis by regulating MACC1 in colorectal cancer.'),
(2052, 'hsa-mir-4775', 'colorectal cancer', 'up', 'miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGF?-mediated epithelial to mesenchymal transition.'),
(2053, 'hsa-mir-542-3p', 'colorectal cancer', 'down', 'miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1.'),
(2054, 'hsa-mir-577', 'colorectal cancer', 'down', 'microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer.'),
(2055, 'hsa-mir-598', 'colorectal cancer', 'down', 'miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.'),
(2056, 'hsa-mir-613', 'colorectal cancer', 'down', 'MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer.'),
(2057, 'hsa-mir-622', 'colorectal cancer', 'up', 'Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells.'),
(2058, 'hsa-mir-7', 'colorectal cancer', 'up', 'MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.'),
(2059, 'hsa-mir-1', 'colorectal cancer', 'down', 'MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.'),
(2060, 'hsa-mir-10a', 'colorectal cancer', 'down', 'miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis.'),
(2061, 'hsa-mir-10b', 'colorectal cancer', 'up', 'Overexpression of miR-10b in colorectal cancer patients: Correlation with TWIST-1 and E-cadherin expression.'),
(2062, 'hsa-mir-1280', 'colorectal cancer', 'down', 'tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in Colorectal Cancer.'),
(2063, 'hsa-mir-139-3p', 'colorectal cancer', 'down', 'Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.'),
(2064, 'hsa-mir-145', 'colorectal cancer', 'down', 'MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.'),
(2065, 'hsa-mir-149', 'colorectal cancer', 'down', 'EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells.'),
(2066, 'hsa-mir-1826', 'colorectal cancer', 'up', 'Circulating miR-1826 in plasma correlates with circulating tumor cells and is a prognostic marker in colorectal cancer.'),
(2067, 'hsa-mir-195', 'colorectal cancer', 'down', 'Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.'),
(2068, 'hsa-mir-219-5p', 'colorectal cancer', 'down', 'miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.'),
(2069, 'hsa-mir-27a', 'colorectal cancer', 'up', 'Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.'),
(2070, 'hsa-mir-30a', 'colorectal cancer', 'down', 'MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.'),
(2071, 'hsa-mir-30a', 'colorectal cancer', 'down', 'MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.'),
(2072, 'hsa-mir-330', 'colorectal cancer', 'down', 'MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase.'),
(2073, 'hsa-mir-429', 'colorectal cancer', 'up', 'miR-429 mediates tumor growth and metastasis in colorectal cancer.'),
(2074, 'hsa-mir-455', 'colorectal cancer', 'down', 'MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer.'),
(2075, 'hsa-mir-520b', 'colorectal cancer', 'down', 'MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting DCUN1D1.'),
(2076, 'hsa-mir-622', 'colorectal cancer', 'up', 'Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.'),
(2077, 'hsa-mir-645', 'colorectal cancer', 'up', 'MicroRNA-645 is an oncogenic regulator in colon cancer.'),
(2078, 'hsa-mir-938', 'colorectal cancer', 'up', 'miR-938 promotes colorectal cancer cell proliferation via targeting tumor suppressor PHLPP2.'),
(2079, 'hsa-let-7e', 'colorectal cancer', 'down', 'MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.'),
(2080, 'hsa-mir-103a', 'colorectal cancer', 'up', 'Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.'),
(2081, 'hsa-mir-106a', 'colorectal cancer', 'up', 'Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.'),
(2082, 'hsa-mir-10a', 'colorectal cancer', 'up', 'TUSC7 acts as a tumor suppressor in colorectal cancer.'),
(2083, 'hsa-mir-130a', 'colorectal cancer', 'up', 'MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2.'),
(2084, 'hsa-mir-133a-3p', 'colorectal cancer', 'down', 'MiR-133a-3p Targets SUMO-Specific Protease 1 to Inhibit Cell Proliferation and Cell Cycle Progress in Colorectal Cancer.'),
(2085, 'hsa-mir-133b', 'colorectal cancer', 'down', 'miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer.'),
(2086, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.'),
(2087, 'hsa-mir-137', 'colorectal cancer', 'down', 'Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.'),
(2088, 'hsa-mir-141', 'colorectal cancer', 'down', 'miR-141 Inhibits Proliferation and Migration of Colorectal Cancer SW480 Cells.'),
(2089, 'hsa-mir-142-5p', 'colorectal cancer', 'up', 'miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.'),
(2090, 'hsa-mir-146b-5p', 'colorectal cancer', 'up', 'miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.'),
(2091, 'hsa-mir-148a', 'colorectal cancer', 'down', 'Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.'),
(2092, 'hsa-mir-15b-5p', 'colorectal cancer', 'down', 'miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-?B/XIAP axis.'),
(2093, 'hsa-mir-16', 'colorectal cancer', 'down', 'microRNA-16 represses colorectal cancer cell growth in?vitro by regulating the p53/survivin signaling pathway.'),
(2094, 'hsa-mir-182', 'colorectal cancer', 'up', 'Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.'),
(2095, 'hsa-mir-1827', 'colorectal cancer', 'up', 'Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma.'),
(2096, 'hsa-mir-184', 'colorectal cancer', 'down', 'MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.'),
(2097, 'hsa-mir-18a', 'colorectal cancer', 'down', '[Study on the Effect of Overexpression of miR-18a on Cellular Proliferation and Migration by Targeting ATM in Human Colorectal Cancer Cells].'),
(2098, 'hsa-mir-18b', 'colorectal cancer', 'up', 'Upregulation of microRNA-18b contributes to the development of colorectal cancer through inhibiting CDKN2B.'),
(2099, 'hsa-mir-196b-5p', 'colorectal cancer', 'up', 'Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.'),
(2100, 'hsa-mir-21', 'colorectal cancer', 'up', 'MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.'),
(2101, 'hsa-mir-216a-3p', 'colorectal cancer', 'down', 'MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.'),
(2102, 'hsa-mir-219-5p', 'colorectal cancer', 'down', 'microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.'),
(2103, 'hsa-mir-224', 'colorectal cancer', 'up', 'miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.'),
(2104, 'hsa-mir-26a', 'colorectal cancer', 'down', 'Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.'),
(2105, 'hsa-mir-26b', 'colorectal cancer', 'down', 'Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.'),
(2106, 'hsa-mir-30a', 'colorectal cancer', 'down', 'MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor.'),
(2107, 'hsa-mir-30e-5p', 'colorectal cancer', 'down', 'P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.'),
(2108, 'hsa-mir-320a', 'colorectal cancer', 'down', '[Corrigendum] microRNA-320a inhibits tumor invasion by targeting neuropilin?1 and is associated with liver metastasis in colorectal cancer.'),
(2109, 'hsa-mir-33a', 'colorectal cancer', 'down', 'MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.'),
(2110, 'hsa-mir-340', 'colorectal cancer', 'down', 'miR-340 suppresses tumor growth and enhances chemosensitivity of colorectal cancer by targeting RLIP76.'),
(2111, 'hsa-mir-34a', 'colorectal cancer', 'down', 'MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling.'),
(2112, 'hsa-mir-375', 'colorectal cancer', 'down', 'The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.'),
(2113, 'hsa-mir-377-3p', 'colorectal cancer', 'up', 'miR-377-3p drives malignancy characteristics via upregulating GSK-3? expression and activating NF-?B pathway in hCRC cells.'),
(2114, 'hsa-mir-4260', 'colorectal cancer', 'up', 'Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.'),
(2115, 'hsa-mir-4261', 'colorectal cancer', 'up', 'Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC.'),
(2116, 'hsa-mir-539', 'colorectal cancer', 'down', 'miR-539 inhibits human colorectal cancer progression by targeting RUNX2.'),
(2117, 'hsa-mir-543', 'colorectal cancer', 'up', 'miR-543 promotes colorectal cancer proliferation and metastasis by targeting KLF4.'),
(2118, 'hsa-mir-552', 'colorectal cancer', 'up', 'MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/?-catenin signaling pathway in colorectal cancer.'),
(2119, 'hsa-mir-582', 'colorectal cancer', 'up', 'MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer.'),
(2120, 'hsa-mir-625-3p', 'colorectal cancer', 'down', 'Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.'),
(2121, 'hsa-mir-760', 'colorectal cancer', 'down', 'The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.'),
(2122, 'hsa-mir-92a', 'colorectal cancer', 'up', 'The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.'),
(2123, 'hsa-mir-96', 'colorectal cancer', 'up', 'MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein?1, forkhead box protein O1 (FOXO1) and FOXO3a.'),
(2124, 'hsa-mir-1207-5p', 'colorectal cancer', 'down', 'The Role of MicroRNA-1207-5p in Colorectal Cancer.'),
(2125, 'hsa-mir-149*', 'colorectal cancer', 'down', 'miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells.'),
(2126, 'hsa-mir-150', 'colorectal cancer', 'down', 'MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.'),
(2127, 'hsa-mir-194', 'colorectal cancer', 'down', 'Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.'),
(2128, 'hsa-mir-19a', 'colorectal cancer', 'down', 'Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.'),
(2129, 'hsa-mir-215-5p', 'colorectal cancer', 'down', 'MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.'),
(2130, 'hsa-mir-216b', 'colorectal cancer', 'down', 'MiR-216b functions as a tumor suppressor by targeting HMGB1-mediated JAK2/STAT3 signaling way in colorectal cancer.'),
(2131, 'hsa-mir-26b', 'colorectal cancer', 'up', 'MicroRNA 26b promotes colorectal cancer metastasis by down-regulating PTEN and WNT5A.'),
(2132, 'hsa-mir-27a-3p', 'colorectal cancer', 'up', 'miR-27a-3p targeting RXR? promotes colorectal cancer progression by activating Wnt/?-catenin pathway.'),
(2133, 'hsa-mir-34a', 'colorectal cancer', 'down', 'S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.'),
(2134, 'hsa-mir-411', 'colorectal cancer', 'down', 'MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.'),
(2135, 'hsa-mir-422a', 'colorectal cancer', 'down', 'miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.'),
(2136, 'hsa-mir-489', 'colorectal cancer', 'down', 'MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.'),
(2137, 'hsa-mir-495', 'colorectal cancer', 'down', 'The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.'),
(2138, 'hsa-mir-497', 'colorectal cancer', 'down', 'MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.'),
(2139, 'hsa-mir-590-5p', 'colorectal cancer', 'up', 'Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.'),
(2140, 'hsa-mir-6883-5p', 'colorectal cancer', 'down', 'miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells.'),
(2141, 'hsa-mir-92a', 'colorectal cancer', 'up', 'MiR-92a promotes stem cell-like properties by activating Wnt/?-catenin signaling in colorectal cancer.'),
(2142, 'hsa-mir-101', 'colorectal cancer', 'down', 'Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.'),
(2143, 'hsa-mir-1271', 'colorectal cancer', 'down', 'Suppression of Capn4 by microRNA-1271 impedes the proliferation and invasion of colorectal cancer cells.'),
(2144, 'hsa-mir-1271', 'colorectal cancer', 'down', 'MicroRNA-1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.'),
(2145, 'hsa-mir-140', 'colorectal cancer', 'down', 'MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.'),
(2146, 'hsa-mir-142-5p', 'colorectal cancer', 'up', 'MiR-142-5p act as an oncogenic microRNA in colorectal cancer: Clinicopathological and functional insights.'),
(2147, 'hsa-mir-181d', 'colorectal cancer', 'down', 'PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d.'),
(2148, 'hsa-mir-200c', 'colorectal cancer', 'up', 'Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer.'),
(2149, 'hsa-mir-22', 'colorectal cancer', 'down', 'The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer.'),
(2150, 'hsa-mir-221', 'colorectal cancer', 'up', 'miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.'),
(2151, 'hsa-mir-27b', 'colorectal cancer', 'down', 'MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer.'),
(2152, 'hsa-mir-29c-3p', 'colorectal cancer', 'down', 'hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC.'),
(2153, 'hsa-mir-324-5p', 'colorectal cancer', 'down', 'Up-regulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1.'),
(2154, 'hsa-mir-335', 'colorectal cancer', 'down', 'microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.'),
(2155, 'hsa-mir-375', 'colorectal cancer', 'down', 'The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation.'),
(2156, 'hsa-mir-383', 'colorectal cancer', 'down', 'MicroRNA-383 suppresses cell proliferation and invasion in colorectal cancer by directly targeting paired box 6.'),
(2157, 'hsa-mir-466', 'colorectal cancer', 'down', 'MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).'),
(2158, 'hsa-mir-494', 'colorectal cancer', 'up', 'MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.'),
(2159, 'hsa-mir-494', 'colorectal cancer', 'up', 'Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis.'),
(2160, 'hsa-mir-511', 'colorectal cancer', 'down', 'MicroRNA-511 inhibits cellular proliferation and invasion in colorectal cancer by directly targeting hepatoma-derived growth factor.'),
(2161, 'hsa-mir-522-3p', 'colorectal cancer', 'up', 'miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein.'),
(2162, 'hsa-mir-544', 'colorectal cancer', 'up', 'MicroRNA-544 promotes colorectal cancer progression by targeting forkhead box O1.'),
(2163, 'hsa-mir-552', 'colorectal cancer', 'up', 'Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.'),
(2164, 'hsa-mir-646', 'colorectal cancer', 'down', 'Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression.'),
(2165, 'hsa-mir-744', 'colorectal cancer', 'down', 'MicroRNA-744 inhibits cellular proliferation and invasion of colorectal cancer by directly targeting oncogene Notch1.'),
(2166, 'hsa-mir-761', 'colorectal cancer', 'down', 'MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1.'),
(2167, 'hsa-let-7a', 'colorectal cancer', 'down', 'IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.'),
(2168, 'hsa-let-7b', 'colorectal cancer', 'down', 'IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.'),
(2169, 'hsa-let-7e', 'colorectal cancer', 'down', 'IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.'),
(2170, 'hsa-mir-103', 'colorectal cancer', 'up', 'Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.'),
(2171, 'hsa-mir-106a', 'colorectal cancer', 'down', 'MicroRNA-106a inhibits cell proliferation and induces apoptosis in colorectal cancer cells.'),
(2172, 'hsa-mir-106b-5p', 'colorectal cancer', 'down', 'miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.'),
(2173, 'hsa-mir-1258', 'colorectal cancer', 'down', 'Upregulated miR-1258 regulates cell cycle and inhibits cell proliferation by directly targeting E2F8 in CRC.'),
(2174, 'hsa-mir-1296', 'colorectal cancer', 'up', 'MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.'),
(2175, 'hsa-mir-135b', 'colorectal cancer', 'up', 'Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.'),
(2176, 'hsa-mir-141', 'colorectal cancer', 'up', 'MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.'),
(2177, 'hsa-mir-142-3p', 'colorectal cancer', 'up', 'MicroRNA-142-3p Promotes Cellular Invasion of Colorectal Cancer Cells by Activation of RAC1.'),
(2178, 'hsa-mir-152', 'colorectal cancer', 'down', 'Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.'),
(2179, 'hsa-mir-155', 'colorectal cancer', 'up', 'Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.'),
(2180, 'hsa-mir-155', 'colorectal cancer', 'down', 'MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.'),
(2181, 'hsa-mir-15a', 'colorectal cancer', 'down', 'LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer.'),
(2182, 'hsa-mir-181a', 'colorectal cancer', 'up', 'MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.'),
(2183, 'hsa-mir-182', 'colorectal cancer', 'up', 'Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.'),
(2184, 'hsa-mir-194', 'colorectal cancer', 'down', 'Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGF?.'),
(2185, 'hsa-mir-199a-5p', 'colorectal cancer', 'down', 'MiR-199a-5p Inhibits the Growth and Metastasis of Colorectal Cancer Cells by Targeting ROCK1.'),
(2186, 'hsa-mir-200b', 'colorectal cancer', 'up', 'Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-?1 exposure.'),
(2187, 'hsa-mir-200c', 'colorectal cancer', 'down', 'miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.'),
(2188, 'hsa-mir-200c', 'colorectal cancer', 'down', 'Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.'),
(2189, 'hsa-mir-206', 'colorectal cancer', 'down', 'MicroRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targeting TM4SF1.'),
(2190, 'hsa-mir-20a', 'colorectal cancer', 'up', 'Knockdown of MiR-20a Enhances Sensitivity of Colorectal Cancer Cells to Cisplatin by Increasing ASK1 Expression.'),
(2191, 'hsa-mir-20a', 'colorectal cancer', 'up', 'Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.'),
(2192, 'hsa-mir-21', 'colorectal cancer', 'up', '[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].'),
(2193, 'hsa-mir-21-3p', 'colorectal cancer', 'up', 'Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated pr'),
(2194, 'hsa-mir-216b', 'colorectal cancer', 'down', 'MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1.'),
(2195, 'hsa-mir-218', 'colorectal cancer', 'down', 'MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF.'),
(2196, 'hsa-mir-32', 'colorectal cancer', 'up', 'MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5.'),
(2197, 'hsa-mir-329', 'colorectal cancer', 'down', 'miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1.'),
(2198, 'hsa-mir-340-5p', 'colorectal cancer', 'down', 'MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.'),
(2199, 'hsa-mir-34c-5p', 'colorectal cancer', 'down', 'SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.'),
(2200, 'hsa-mir-363-3p', 'colorectal cancer', 'down', 'MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2.'),
(2201, 'hsa-mir-378', 'colorectal cancer', 'down', '[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].'),
(2202, 'hsa-mir-382', 'colorectal cancer', 'down', 'MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer.'),
(2203, 'hsa-mir-422a', 'colorectal cancer', 'down', 'MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells.'),
(2204, 'hsa-mir-431', 'colorectal cancer', 'down', 'MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.'),
(2205, 'hsa-mir-433', 'colorectal cancer', 'down', 'Reduced miR-433 expression is associated with advanced stages and early relapse of colorectal cancer and restored miR-433 expression suppresses the migration, invasion and proliferation of tumor cells'),
(2206, 'hsa-mir-455', 'colorectal cancer', 'down', 'MiR-455 functions as a tumor suppressor through targeting GATA6 in colorectal cancer.'),
(2207, 'hsa-mir-485', 'colorectal cancer', 'down', 'MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.'),
(2208, 'hsa-mir-485-5p', 'colorectal cancer', 'down', 'MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation.'),
(2209, 'hsa-mir-485-5p', 'colorectal cancer', 'down', 'microRNA-485-5p Functions as a Tumor Suppressor in Colorectal Cancer Cells by Targeting CD147.'),
(2210, 'hsa-mir-490-3p', 'colorectal cancer', 'down', 'MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer.'),
(2211, 'hsa-mir-503', 'colorectal cancer', 'up', 'MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.'),
(2212, 'hsa-mir-514b-3p', 'colorectal cancer', 'down', 'The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis.'),
(2213, 'hsa-mir-519d-3p', 'colorectal cancer', 'down', 'MicroRNA-519d-3p inhibits cell proliferation and migration by targeting TROAP in colorectal cancer.'),
(2214, 'hsa-mir-532', 'colorectal cancer', 'down', 'microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.'),
(2215, 'hsa-mir-532-5p', 'colorectal cancer', 'up', 'Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5\'UTR of RUNX3.'),
(2216, 'hsa-mir-539', 'colorectal cancer', 'down', 'MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.'),
(2217, 'hsa-mir-600', 'colorectal cancer', 'down', 'LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.'),
(2218, 'hsa-mir-650', 'colorectal cancer', 'up', 'MicroRNA-650 targets inhibitor of growth 4 to promote colorectal cancer progression via mitogen activated protein kinase signaling.'),
(2219, 'hsa-mir-760', 'colorectal cancer', 'down', 'MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.'),
(2220, 'hsa-mir-7702', 'colorectal cancer', 'down', 'Species-specific function of microRNA-7702 in human colorectal cancer cells via targeting TADA1.'),
(2221, 'hsa-mir-888', 'colorectal cancer', 'up', 'miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer.'),
(2222, 'hsa-mir-96', 'colorectal cancer', 'up', 'MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.'),
(2223, 'hsa-mir-101', 'colorectal cancer', 'down', 'Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.'),
(2224, 'hsa-mir-103a-3p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2225, 'hsa-mir-125a-5p', 'colorectal cancer', 'down', 'miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA.'),
(2226, 'hsa-mir-126', 'colorectal cancer', 'down', 'Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.'),
(2227, 'hsa-mir-1266', 'colorectal cancer', 'down', 'Low expression of microRNA-1266 promotes colorectal cancer progression via targeting FTO.'),
(2228, 'hsa-mir-127-3p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2229, 'hsa-mir-142-3p', 'colorectal cancer', 'down', 'miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.'),
(2230, 'hsa-mir-143-3p', 'colorectal cancer', 'down', 'MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.'),
(2231, 'hsa-mir-145', 'colorectal cancer', 'down', 'microRNA-145 regulates tumor suppressor candidate 3 and mitogen-activated protein kinase pathway to inhibit the progression of colorectal cancer.'),
(2232, 'hsa-mir-147b', 'colorectal cancer', 'down', 'LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.'),
(2233, 'hsa-mir-150', 'colorectal cancer', 'down', 'Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.'),
(2234, 'hsa-mir-150', 'colorectal cancer', 'down', 'Circ-ZNF609 promotes migration of colorectal cancer by inhibiting Gli1 expression via microRNA-150.'),
(2235, 'hsa-mir-150-5p', 'colorectal cancer', 'down', 'miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer.'),
(2236, 'hsa-mir-151a-5p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2237, 'hsa-mir-155', 'colorectal cancer', 'down', 'MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1?in vitro.'),
(2238, 'hsa-mir-17-5p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2239, 'hsa-mir-181a-5p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2240, 'hsa-mir-18a-5p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2241, 'hsa-mir-18b-5p', 'colorectal cancer', 'up', 'A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.'),
(2242, 'hsa-mir-199a', 'colorectal cancer', 'down', 'Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.'),
(2243, 'hsa-mir-21', 'colorectal cancer', 'up', 'Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.'),
(2244, 'hsa-mir-210', 'colorectal cancer', 'up', 'Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1?-VEGF signaling pathway.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(2245, 'hsa-mir-23a', 'colorectal cancer', 'up', 'MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4.'),
(2246, 'hsa-mir-296', 'colorectal cancer', 'down', 'MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.'),
(2247, 'hsa-mir-301a-3p', 'colorectal cancer', 'up', 'Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.'),
(2248, 'hsa-mir-31-5p', 'colorectal cancer', 'up', 'MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB.'),
(2249, 'hsa-mir-34a', 'colorectal cancer', 'down', 'TGF-? secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis.'),
(2250, 'hsa-mir-382', 'colorectal cancer', 'down', 'MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1.'),
(2251, 'hsa-mir-424', 'colorectal cancer', 'down', 'miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.'),
(2252, 'hsa-mir-433', 'colorectal cancer', 'down', 'A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer.'),
(2253, 'hsa-mir-452', 'colorectal cancer', 'up', 'MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/?-catenin positive feedback loop.'),
(2254, 'hsa-mir-486-5p', 'colorectal cancer', 'down', 'DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/?-catenin signal pathways.'),
(2255, 'hsa-mir-532-5p', 'colorectal cancer', 'up', 'Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5\'UTR ofRUNX3.'),
(2256, 'hsa-mir-6868-5p', 'colorectal cancer', 'down', 'Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.'),
(2257, 'hsa-mir-7', 'colorectal cancer', 'down', 'MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.'),
(2258, 'hsa-mir-769', 'colorectal cancer', 'down', 'MiR-769 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Targeting HEY1.'),
(2259, 'hsa-mir-769', 'colorectal cancer', 'down', 'microRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1.'),
(2260, 'hsa-mir-873', 'colorectal cancer', 'down', 'MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4.'),
(2261, 'hsa-mir-873-5p', 'colorectal cancer', 'down', 'MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.'),
(2262, 'hsa-mir-944', 'colorectal cancer', 'down', 'Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers.'),
(2263, 'hsa-mir-96', 'colorectal cancer', 'up', 'MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer?via?RECK.'),
(2264, 'hsa-mir-106a', 'colorectal cancer', 'up', 'Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.'),
(2265, 'hsa-mir-107', 'colorectal cancer', 'down', 'MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1.'),
(2266, 'hsa-mir-1185', 'colorectal cancer', 'down', 'miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.'),
(2267, 'hsa-mir-124', 'colorectal cancer', 'down', 'MicroRNA-124 inhibits colorectal cancer cell proliferation and suppresses tumor growth by interacting with PLCB1 and regulating Wnt/?-catenin signaling pathway.'),
(2268, 'hsa-mir-125a-5p', 'colorectal cancer', 'down', 'miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ.'),
(2269, 'hsa-mir-1271', 'colorectal cancer', 'down', 'miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin.'),
(2270, 'hsa-mir-132', 'colorectal cancer', 'down', 'miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1.'),
(2271, 'hsa-mir-141-3p', 'colorectal cancer', 'down', 'MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.'),
(2272, 'hsa-mir-142-3p', 'colorectal cancer', 'down', 'Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.'),
(2273, 'hsa-mir-143', 'colorectal cancer', 'down', 'miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro.'),
(2274, 'hsa-mir-143-3p', 'colorectal cancer', 'down', 'MicroRNA-143-3p suppresses tumorigenesis by targeting catenin-?1 in colorectal cancer.'),
(2275, 'hsa-mir-145', 'colorectal cancer', 'down', 'Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC.'),
(2276, 'hsa-mir-147b', 'colorectal cancer', 'down', 'MicroRNA-147b Promotes Proliferation and Invasion of Human Colorectal Cancer by Targeting RAS Oncogene Family (RAP2B).'),
(2277, 'hsa-mir-148a', 'colorectal cancer', 'down', 'Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.'),
(2278, 'hsa-mir-148a', 'colorectal cancer', 'down', 'miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.'),
(2279, 'hsa-mir-150-5p', 'colorectal cancer', 'down', 'Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.'),
(2280, 'hsa-mir-17', 'colorectal cancer', 'up', 'MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1.'),
(2281, 'hsa-mir-182', 'colorectal cancer', 'up', 'miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.'),
(2282, 'hsa-mir-195', 'colorectal cancer', 'down', 'Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells.'),
(2283, 'hsa-mir-195-5p', 'colorectal cancer', 'down', 'miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization.'),
(2284, 'hsa-mir-198', 'colorectal cancer', 'down', 'MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.'),
(2285, 'hsa-mir-19a', 'colorectal cancer', 'up', 'MiR-19a enhances cell proliferation, migration and invasion through improving lymphangiogenesis via targeting thrombospondin-1 in colorectal cancer.'),
(2286, 'hsa-mir-202', 'colorectal cancer', 'down', 'MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.'),
(2287, 'hsa-mir-203a-3p', 'colorectal cancer', 'up', 'miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D.'),
(2288, 'hsa-mir-208a-3p', 'colorectal cancer', 'up', 'MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4.'),
(2289, 'hsa-mir-20a', 'colorectal cancer', 'up', 'Mir20a/106a-WTX axis regulates RhoGDIa/CDC42 signaling and colon cancer progression.'),
(2290, 'hsa-mir-20a', 'colorectal cancer', 'up', 'miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA.'),
(2291, 'hsa-mir-20a', 'colorectal cancer', 'up', 'MicroRNA-related transcription factor regulatory networks in human colorectal cancer.'),
(2292, 'hsa-mir-20a', 'colorectal cancer', 'up', 'The Efficacy of miR-20a as a Diagnostic and Prognostic Biomarker for Colorectal Cancer: A Systematic Review and Meta-Analysis.'),
(2293, 'hsa-mir-216a', 'colorectal cancer', 'down', 'Overexpression of microRNA-216a inhibits autophagy by targeting regulated MAP1S in colorectal cancer.'),
(2294, 'hsa-mir-216a-5p', 'colorectal cancer', 'down', 'Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression.'),
(2295, 'hsa-mir-221', 'colorectal cancer', 'up', 'miR-221 targets QKI to enhance the tumorigenic capacity of human colorectal cancer stem cells.'),
(2296, 'hsa-mir-222', 'colorectal cancer', 'up', 'microRNA-222 promotes colorectal cancer cell migration and invasion by targeting MST3.'),
(2297, 'hsa-mir-224', 'colorectal cancer', 'up', 'Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma.'),
(2298, 'hsa-mir-23a', 'colorectal cancer', 'up', 'Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.'),
(2299, 'hsa-mir-23a', 'colorectal cancer', 'up', 'MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1.'),
(2300, 'hsa-mir-26a', 'colorectal cancer', 'down', 'LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis.'),
(2301, 'hsa-mir-29a-3p', 'colorectal cancer', 'down', 'Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma.'),
(2302, 'hsa-mir-301a', 'colorectal cancer', 'up', 'Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.'),
(2303, 'hsa-mir-30a-5p', 'colorectal cancer', 'down', 'Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.'),
(2304, 'hsa-mir-30c', 'colorectal cancer', 'down', 'MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9.'),
(2305, 'hsa-mir-30d', 'colorectal cancer', 'down', 'miRNA-30d serves a critical function in colorectal cancer initiation, progression and invasion via directly targeting the GNA13 gene.'),
(2306, 'hsa-mir-3183', 'colorectal cancer', 'down', 'miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.'),
(2307, 'hsa-mir-3191', 'colorectal cancer', 'up', 'MicroRNA-3191 promotes migration and invasion by downregulating TGFBR2 in colorectal cancer.'),
(2308, 'hsa-mir-32', 'colorectal cancer', 'up', 'Analysis of promoter methylation and epigenetic regulation of miR-32 in colorectal cancer cells.'),
(2309, 'hsa-mir-32', 'colorectal cancer', 'up', 'MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.'),
(2310, 'hsa-mir-330', 'colorectal cancer', 'down', 'miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.'),
(2311, 'hsa-mir-335-5p', 'colorectal cancer', 'down', 'MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.'),
(2312, 'hsa-mir-338-3p', 'colorectal cancer', 'down', 'miR-338-3p regulates the proliferation, apoptosis and migration of SW480 cells by targeting MACC1.'),
(2313, 'hsa-mir-338-5p', 'colorectal cancer', 'up', 'MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway.'),
(2314, 'hsa-mir-33a-5p', 'colorectal cancer', 'down', 'MicroRNA-33a-5p suppresses colorectal cancer cell growth by inhibiting MTHFD2.'),
(2315, 'hsa-mir-362', 'colorectal cancer', 'down', 'MicroRNA-362 Inhibits Cell Proliferation and Invasion by Directly Targeting SIX1 in Colorectal Cancer.'),
(2316, 'hsa-mir-375', 'colorectal cancer', 'up', 'MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK.'),
(2317, 'hsa-mir-410', 'colorectal cancer', 'up', 'miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/?-catenin signaling pathway.'),
(2318, 'hsa-mir-4319', 'colorectal cancer', 'down', 'MiR-4319 suppresses colorectal cancer progression by targeting ABTB1.'),
(2319, 'hsa-mir-451a', 'colorectal cancer', 'down', 'MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.'),
(2320, 'hsa-mir-455-5p', 'colorectal cancer', 'down', 'Expression profile and biological function of miR-455-5p in colorectal carcinoma.'),
(2321, 'hsa-mir-487b', 'colorectal cancer', 'down', 'DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, SUZ12, and KRAS.'),
(2322, 'hsa-mir-491-5p', 'colorectal cancer', 'down', 'miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.'),
(2323, 'hsa-mir-495', 'colorectal cancer', 'down', 'miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.'),
(2324, 'hsa-mir-496', 'colorectal cancer', 'down', 'miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.'),
(2325, 'hsa-mir-496', 'colorectal cancer', 'up', 'MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer.'),
(2326, 'hsa-mir-497', 'colorectal cancer', 'down', 'Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.'),
(2327, 'hsa-mir-497-5p', 'colorectal cancer', 'down', 'Up-regulation of microRNA-497-5p inhibits colorectal cancer cell proliferation and invasion via targeting PTPN3.'),
(2328, 'hsa-mir-500a-5p', 'colorectal cancer', 'down', 'The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.'),
(2329, 'hsa-mir-506', 'colorectal cancer', 'down', 'MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression.'),
(2330, 'hsa-mir-511-5p', 'colorectal cancer', 'down', 'MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.'),
(2331, 'hsa-mir-519b-3p', 'colorectal cancer', 'down', 'MiR-519b-3p Inhibits the Proliferation and Invasion in Colorectal Cancer via Modulating the uMtCK/Wnt Signaling Pathway.'),
(2332, 'hsa-mir-548c-5p', 'colorectal cancer', 'down', 'miR-548c-5p inhibits colorectal cancer cell proliferation by targeting PGK1.'),
(2333, 'hsa-mir-551b', 'colorectal cancer', 'down', 'Decreased expression of miR-551b predicts poor prognosis and promotes tumorigenesis by targeting PTP4A3 in human colorectal cancer.'),
(2334, 'hsa-mir-552', 'colorectal cancer', 'up', 'miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.'),
(2335, 'hsa-mir-574-5p', 'colorectal cancer', 'up', 'Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.'),
(2336, 'hsa-mir-584-3p', 'colorectal cancer', 'down', 'A novel lncRNA LOC101927746 accelerates progression of colorectal cancer via inhibiting miR-584-3p and activating SSRP1.'),
(2337, 'hsa-mir-622', 'colorectal cancer', 'down', 'miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.'),
(2338, 'hsa-mir-654', 'colorectal cancer', 'down', 'miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.'),
(2339, 'hsa-mir-6716-5p', 'colorectal cancer', 'up', 'miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression.'),
(2340, 'hsa-mir-6778-5p', 'colorectal cancer', 'up', 'CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778-5p in colorectal cancer.'),
(2341, 'hsa-mir-7', 'colorectal cancer', 'down', 'TRIP6, as a target of miR-7, regulates the proliferation and metastasis of colorectal cancer cells.'),
(2342, 'hsa-mir-7-5p', 'colorectal cancer', 'down', 'Long Non-coding RNA Zinc Finger Antisense 1 (ZFAS1) Regulates Proliferation, Migration, Invasion, and Apoptosis by Targeting MiR-7-5p in Colorectal Cancer.'),
(2343, 'hsa-mir-7-5p', 'colorectal cancer', 'down', 'miR-7-5p regulates the proliferation and migration of colorectal cancer cells by negatively regulating the expression of Kr?ppel-like factor 4.'),
(2344, 'hsa-mir-708', 'colorectal cancer', 'up', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(2345, 'hsa-mir-761', 'colorectal cancer', 'down', 'MicroRNA-761 is downregulated in colorectal cancer and regulates tumor progression by targeting Rab3D.'),
(2346, 'hsa-mir-761', 'colorectal cancer', 'down', 'MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1.'),
(2347, 'hsa-mir-873-5p', 'colorectal cancer', 'down', 'MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-?B pathway in colorectal cancer.'),
(2348, 'hsa-mir-889', 'colorectal cancer', 'up', 'MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.'),
(2349, 'hsa-mir-9', 'colorectal cancer', 'down', 'Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.'),
(2350, 'hsa-mir-9-5p', 'colorectal cancer', 'down', 'MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.'),
(2351, 'hsa-mir-92a-3p', 'colorectal cancer', 'up', 'CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.'),
(2352, 'hsa-mir-940', 'colorectal cancer', 'down', 'MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer.'),
(2353, 'hsa-mir-942', 'colorectal cancer', 'up', 'Hsa-miR-942 fingerprint in colorectal cancer through Wnt signaling pathway.'),
(2354, 'hsa-mir-944', 'colorectal cancer', 'down', 'Ectopic expression of miR-944 impairs colorectal cancer cell proliferation and invasion by targeting GATA binding protein 6.'),
(2355, 'hsa-mir-16', 'colorectal cancer', 'down', 'microRNA-16 represses colorectal cancer cell growth in?vitro by regulating the p53/survivin signaling pathway.'),
(2356, 'hsa-mir-16', 'colorectal cancer', 'down', 'microRNA-16 represses colorectal cancer cell growth in??vitro by regulating the p53/survivin signaling pathway.'),
(2357, 'hsa-mir-320a', 'colorectal cancer', 'down', 'microRNA-320a inhibits tumor invasion by targeting neuropilin???1 and is associated with liver metastasis in colorectal cancer.'),
(2358, 'hsa-mir-139', 'colorectal carcinoma', 'down', 'Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation.'),
(2359, 'hsa-mir-143', 'colorectal carcinoma', 'down', 'MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.'),
(2360, 'hsa-mir-143', 'colorectal carcinoma', 'down', 'Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.'),
(2361, 'hsa-mir-143', 'colorectal carcinoma', 'down', '[Effect of microRNA143 expression on cell proliferation in colonic carcinoma].'),
(2362, 'hsa-mir-145', 'colorectal carcinoma', 'down', 'Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.'),
(2363, 'hsa-mir-17', 'colorectal carcinoma', 'up', 'Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.'),
(2364, 'hsa-mir-182', 'colorectal carcinoma', 'up', 'Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissue-specific prognostic factor.'),
(2365, 'hsa-mir-191', 'colorectal carcinoma', 'up', 'MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3.'),
(2366, 'hsa-mir-202-3p', 'colorectal carcinoma', 'down', 'MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma.'),
(2367, 'hsa-mir-21', 'colorectal carcinoma', 'up', 'Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.'),
(2368, 'hsa-mir-30a', 'colorectal carcinoma', 'down', 'miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.'),
(2369, 'hsa-mir-338-3p', 'colorectal carcinoma', 'down', 'MicroRNA-338-3p Inhibits Colorectal Carcinoma Cell Invasion and Migration by Targeting Smoothened.'),
(2370, 'hsa-mir-429', 'colorectal carcinoma', 'down', 'miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.'),
(2371, 'hsa-mir-451', 'colorectal carcinoma', 'down', 'MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway.'),
(2372, 'hsa-mir-93', 'colorectal carcinoma', 'down', 'MicroRNA-93 suppress colorectal cancer development via Wnt/?-catenin pathway downregulating.'),
(2373, 'hsa-mir-95', 'colorectal carcinoma', 'up', 'MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma.'),
(2374, 'hsa-mir-155-5p', 'colorectal carcinoma', 'up', 'Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.'),
(2375, 'hsa-mir-625-3p', 'colorectal carcinoma', 'up', 'MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.'),
(2376, 'hsa-mir-21', 'colorectal carcinoma', 'up', 'MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.'),
(2377, 'hsa-mir-4282', 'colorectal carcinoma', 'down', 'MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E.'),
(2378, 'hsa-mir-202-5p', 'colorectal carcinoma', 'down', 'MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.'),
(2379, 'hsa-mir-92b-3p', 'colorectal carcinoma', 'up', 'miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.'),
(2380, 'hsa-mir-125a', 'colorectal carcinoma', 'down', 'MicroRNA-125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma.'),
(2381, 'hsa-mir-140-5p', 'colorectal carcinoma', 'down', 'miR-140-5p inhibits cell proliferation and invasion in colorectal carcinoma by targeting SOX4.'),
(2382, 'hsa-mir-155', 'cutaneous t-cell lymphoma', 'up', 'STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.'),
(2383, 'hsa-mir-150', 'cutaneous t-cell lymphoma', 'down', 'Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.'),
(2384, 'hsa-mir-185-5p', 'cutaneous t-cell lymphoma', 'down', 'Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.'),
(2385, 'hsa-mir-155', 'cutaneous t-cell lymphoma', 'up', 'Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma.'),
(2386, 'hsa-mir-337', 'cutaneous t-cell lymphoma', 'down', 'miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.'),
(2387, 'hsa-mir-155', 'diffuse large B-cell lymphoma', 'up', 'Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.'),
(2388, 'hsa-mir-21', 'diffuse large B-cell lymphoma', 'up', 'Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma.'),
(2389, 'hsa-mir-10a', 'diffuse large B-cell lymphoma', 'down', 'miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.'),
(2390, 'hsa-mir-101', 'endometrial cancer', 'down', 'MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.'),
(2391, 'hsa-mir-106a', 'endometrial cancer', 'up', 'TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.'),
(2392, 'hsa-mir-130a', 'endometrial cancer', 'down', 'Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.'),
(2393, 'hsa-mir-130b', 'endometrial cancer', 'down', 'Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.'),
(2394, 'hsa-mir-134', 'endometrial cancer', 'down', 'MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.'),
(2395, 'hsa-mir-143', 'endometrial cancer', 'down', 'Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.'),
(2396, 'hsa-mir-145', 'endometrial cancer', 'up', 'Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.'),
(2397, 'hsa-mir-145', 'endometrial cancer', 'down', 'Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.'),
(2398, 'hsa-mir-152', 'endometrial cancer', 'down', 'miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.'),
(2399, 'hsa-mir-155', 'endometrial cancer', 'up', 'Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.'),
(2400, 'hsa-mir-182', 'endometrial cancer', 'up', 'MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma.'),
(2401, 'hsa-mir-200b', 'endometrial cancer', 'up', 'MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.'),
(2402, 'hsa-mir-200c', 'endometrial cancer', 'up', 'The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.'),
(2403, 'hsa-mir-205', 'endometrial cancer', 'up', 'miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma.'),
(2404, 'hsa-mir-205', 'endometrial cancer', 'down', 'MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.'),
(2405, 'hsa-mir-21', 'endometrial cancer', 'up', 'Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.'),
(2406, 'hsa-mir-222-3p', 'endometrial cancer', 'up', 'Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ER?.'),
(2407, 'hsa-mir-223', 'endometrial cancer', 'down', 'MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R.'),
(2408, 'hsa-mir-25', 'endometrial cancer', 'up', 'TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.'),
(2409, 'hsa-mir-301a', 'endometrial cancer', 'down', 'Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.'),
(2410, 'hsa-mir-301b', 'endometrial cancer', 'down', 'Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.'),
(2411, 'hsa-mir-30c', 'endometrial cancer', 'down', 'microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.'),
(2412, 'hsa-mir-30c', 'endometrial cancer', 'down', 'Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.'),
(2413, 'hsa-mir-34a', 'endometrial cancer', 'down', 'Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.'),
(2414, 'hsa-mir-34c', 'endometrial cancer', 'down', 'MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis.'),
(2415, 'hsa-mir-34c', 'endometrial cancer', 'down', 'miR-34c plays a role of tumor suppressor in HEC?1-B cells by targeting E2F3 protein.'),
(2416, 'hsa-mir-424', 'endometrial cancer', 'down', 'MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.'),
(2417, 'hsa-mir-449a', 'endometrial cancer', 'down', 'MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A.'),
(2418, 'hsa-mir-543', 'endometrial cancer', 'down', 'MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.'),
(2419, 'hsa-mir-93', 'endometrial cancer', 'up', 'TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC.'),
(2420, 'hsa-mir-205', 'endometrial cancer', 'up', 'miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.'),
(2421, 'hsa-mir-106b', 'endometrial cancer', 'down', 'Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.'),
(2422, 'hsa-mir-34a', 'endometrial cancer', 'down', 'The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers.'),
(2423, 'hsa-mir-372', 'endometrial cancer', 'down', 'MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).'),
(2424, 'hsa-mir-424', 'endometrial cancer', 'down', 'MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.'),
(2425, 'hsa-mir-505', 'endometrial cancer', 'down', 'MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-?.'),
(2426, 'hsa-mir-152', 'endometrial cancer', 'down', 'Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.'),
(2427, 'hsa-mir-340', 'endometrial cancer', 'down', 'MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.'),
(2428, 'hsa-mir-495', 'endometrial cancer', 'down', 'Role of MicroRNAs in carcinogenesis that potential for biomarker of endometrial cancer.'),
(2429, 'hsa-mir-887-5p', 'endometrial cancer', 'up', 'Changes in the Expression of Serum MiR-887-5p in Patients With Endometrial Cancer.'),
(2430, 'hsa-mir-99a', 'endometrial cancer', 'down', 'A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.'),
(2431, 'hsa-mir-10b', 'endometrial cancer', 'up', 'miR-10b Inhibits Apoptosis and Promotes Proliferation and Invasion of Endometrial Cancer Cells via Targeting HOXB3.'),
(2432, 'hsa-mir-204', 'endometrial cancer', 'down', 'The dual regulatory role of miR-204 in cancer.'),
(2433, 'hsa-mir-92a', 'endometrial cancer', 'up', 'In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.'),
(2434, 'hsa-mir-93', 'endometrial cancer', 'up', 'MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.'),
(2435, 'hsa-mir-183', 'endometrial cancer', 'up', 'The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.'),
(2436, 'hsa-mir-205', 'endometrial cancer', 'up', 'Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.'),
(2437, 'hsa-mir-29b', 'endometrial cancer', 'down', 'MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.'),
(2438, 'hsa-mir-944', 'endometrial cancer', 'up', 'miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.'),
(2439, 'hsa-mir-205', 'endometrial cancer', 'up', 'miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.'),
(2440, 'hsa-mir-1271', 'endometrial cancer', 'down', 'Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.'),
(2441, 'hsa-mir-23b', 'endometrial cancer', 'up', 'Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b.'),
(2442, 'hsa-mir-101', 'endometrial cancer', 'down', 'MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.'),
(2443, 'hsa-mir-106a', 'endometrial cancer', 'up', 'MiR-106a promotes tumor growth, migration, and invasion by targeting BCL2L11 in human endometrial adenocarcinoma.'),
(2444, 'hsa-mir-143', 'endometrial cancer', 'down', 'MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.'),
(2445, 'hsa-mir-15a-5p', 'endometrial cancer', 'down', 'miR-15a-5p suppresses endometrial cancer cell growth via Wnt/?-catenin signaling pathway by inhibiting WNT3A.'),
(2446, 'hsa-mir-200c', 'endometrial cancer', 'down', 'MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.'),
(2447, 'hsa-mir-381', 'endometrial cancer', 'down', 'MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.'),
(2448, 'hsa-mir-101', 'endometrial cancer', 'down', 'MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.'),
(2449, 'hsa-mir-148b', 'endometrial cancer', 'down', 'MiR-148b functions as a tumor suppressor by targeting endoplasmic reticulum metallo protease 1 in human endometrial cancer cells.'),
(2450, 'hsa-mir-152', 'endometrial cancer', 'down', 'miR-152 inhibits proliferation of human endometrial cancer cells via inducing G2/M phase arrest by suppressing CDC25B expression.'),
(2451, 'hsa-mir-200a', 'endometrial cancer', 'up', 'MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.'),
(2452, 'hsa-mir-34a', 'endometrial cancer', 'down', 'MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer.'),
(2453, 'hsa-mir-137', 'endometrial cancer', 'down', 'miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.'),
(2454, 'hsa-mir-139-5p', 'endometrial cancer', 'down', 'Tumor-suppressor role of miR-139-5p in endometrial cancer.'),
(2455, 'hsa-mir-29a-5p', 'endometrial cancer', 'down', 'MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.'),
(2456, 'hsa-mir-424', 'endometrial cancer', 'down', 'MicroRNA-424 regulates epithelial-mesenchymal transition of endometrial carcinoma by directly targeting insulin-like growth factor 1 receptor.'),
(2457, 'hsa-mir-652', 'endometrial cancer', 'up', 'miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer.'),
(2458, 'hsa-mir-142', 'endometrial cancer', 'down', 'miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1.'),
(2459, 'hsa-mir-373', 'endometrial cancer', 'up', 'MicroRNA-373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/?-Catenin pathway.'),
(2460, 'hsa-mir-652', 'endometrial cancer', 'up', 'miR-652 Promotes Tumor Proliferation and Metastasis by Targeting?RORA?in Endometrial Cancer.'),
(2461, 'hsa-mir-93', 'endometrial cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(2462, 'hsa-mir-1271', 'endometrial cancer', 'down', 'MiR-1271 inhibits cell proliferation and metastasis by targeting LDHA in endometrial cancer.'),
(2463, 'hsa-mir-181a-5p', 'endometrial cancer', 'down', 'LncRNA CCAT1 negatively regulates miR-181a-5p to promote endometrial carcinoma cell proliferation and migration.'),
(2464, 'hsa-mir-184', 'endometrial cancer', 'down', 'Decreased expression of miR-184 restrains the growth and invasion of endometrial carcinoma cells through CDC25A-dependent Notch signaling pathway.'),
(2465, 'hsa-mir-204-5p', 'endometrial cancer', 'down', 'Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.'),
(2466, 'hsa-mir-449a', 'endometrial cancer', 'down', 'Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.'),
(2467, 'hsa-mir-449a', 'endometrial cancer', 'down', 'MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer.'),
(2468, 'hsa-mir-522', 'endometrial cancer', 'up', 'miR-522 facilitates the prosperities of endometrial carcinoma cells by directly binding to monoamine oxidase B.'),
(2469, 'hsa-mir-589-5p', 'endometrial cancer', 'down', 'Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.'),
(2470, 'hsa-mir-34b', 'endometrial serous adenocarcinoma', 'down', 'MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.'),
(2471, 'hsa-mir-10a', 'ependymoma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(2472, 'hsa-mir-10b', 'ependymoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(2473, 'hsa-mir-29a', 'ependymoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(2474, 'hsa-mir-124a', 'epithelial ovarian cancer', 'down', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2475, 'hsa-mir-192', 'epithelial ovarian cancer', 'down', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2476, 'hsa-mir-193a', 'epithelial ovarian cancer', 'down', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2477, 'hsa-mir-372', 'epithelial ovarian cancer', 'up', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2478, 'hsa-mir-373', 'epithelial ovarian cancer', 'up', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2479, 'hsa-mir-7', 'epithelial ovarian cancer', 'down', 'Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.'),
(2480, 'hsa-mir-196a', 'esophageal adenocarcinoma', 'up', 'MicroRNAs in Barrett\'s esophagus and esophageal adenocarcinoma.'),
(2481, 'hsa-mir-199a-3p', 'esophageal adenocarcinoma', 'up', 'MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett\'s Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.'),
(2482, 'hsa-mir-199a-5p', 'esophageal adenocarcinoma', 'up', 'MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett\'s Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.'),
(2483, 'hsa-mir-199b-3p', 'esophageal adenocarcinoma', 'up', 'MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett\'s Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.'),
(2484, 'hsa-mir-200a', 'esophageal adenocarcinoma', 'up', 'Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.'),
(2485, 'hsa-mir-203', 'esophageal adenocarcinoma', 'down', 'Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma.'),
(2486, 'hsa-mir-223', 'esophageal adenocarcinoma', 'up', 'MicroRNA 223 is Up-regulated in the Multistep Progression of Barrett\'s Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1.'),
(2487, 'hsa-mir-133a-3p', 'esophageal adenocarcinoma', 'down', 'Profiling of circulating microRNAs in patients with Barrett\'s esophagus and esophageal adenocarcinoma.'),
(2488, 'hsa-mir-382-5p', 'esophageal adenocarcinoma', 'up', 'Profiling of circulating microRNAs in patients with Barrett\'s esophagus and esophageal adenocarcinoma.'),
(2489, 'hsa-mir-100-5p', 'esophageal adenocarcinoma', 'down', 'Circulating miRNA profile in esophageal adenocarcinoma.'),
(2490, 'hsa-mir-151a-3p', 'esophageal adenocarcinoma', 'up', 'Circulating miRNA profile in esophageal adenocarcinoma.'),
(2491, 'hsa-mir-375', 'esophageal adenocarcinoma', 'down', 'Circulating miRNA profile in esophageal adenocarcinoma.'),
(2492, 'hsa-mir-17', 'esophageal adenocarcinoma', 'down', 'MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.'),
(2493, 'hsa-mir-202', 'esophageal adenocarcinoma', 'down', 'miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.'),
(2494, 'hsa-mir-101', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2495, 'hsa-mir-10b', 'esophageal cancer', 'up', 'MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.'),
(2496, 'hsa-mir-124', 'esophageal cancer', 'down', 'STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.'),
(2497, 'hsa-mir-126', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2498, 'hsa-mir-130a', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2499, 'hsa-mir-140', 'esophageal cancer', 'down', 'Down-Regulation of miR-140 Induces EMT and Promotes Invasion by Targeting Slug in Esophageal Cancer.'),
(2500, 'hsa-mir-141', 'esophageal cancer', 'up', 'miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.'),
(2501, 'hsa-mir-143', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2502, 'hsa-mir-143', 'esophageal cancer', 'up', 'Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.'),
(2503, 'hsa-mir-146b', 'esophageal cancer', 'up', 'Transcriptional regulation of miR-146b by C/EBP? LAP2 in esophageal cancer cells.'),
(2504, 'hsa-mir-15a', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2505, 'hsa-mir-183', 'esophageal cancer', 'up', 'miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4.'),
(2506, 'hsa-mir-196b', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2507, 'hsa-mir-197', 'esophageal cancer', 'down', 'Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis.'),
(2508, 'hsa-mir-200a', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2509, 'hsa-mir-200a', 'esophageal cancer', 'up', 'miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.'),
(2510, 'hsa-mir-203', 'esophageal cancer', 'up', 'Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.'),
(2511, 'hsa-mir-203', 'esophageal cancer', 'down', 'MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.'),
(2512, 'hsa-mir-203', 'esophageal cancer', 'down', 'miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1.'),
(2513, 'hsa-mir-205', 'esophageal cancer', 'up', 'Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.'),
(2514, 'hsa-mir-205', 'esophageal cancer', 'up', 'miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.'),
(2515, 'hsa-mir-21', 'esophageal cancer', 'up', 'The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.'),
(2516, 'hsa-mir-21', 'esophageal cancer', 'up', '[Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer].'),
(2517, 'hsa-mir-21', 'esophageal cancer', 'up', 'Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.'),
(2518, 'hsa-mir-210', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2519, 'hsa-mir-218', 'esophageal cancer', 'down', 'Serum microRNA-218 is a potential biomarker for esophageal cancer.'),
(2520, 'hsa-mir-221', 'esophageal cancer', 'up', 'Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.'),
(2521, 'hsa-mir-223', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2522, 'hsa-mir-27a', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2523, 'hsa-mir-28-3p', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2524, 'hsa-mir-30b', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2525, 'hsa-mir-31', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2526, 'hsa-mir-375', 'esophageal cancer', 'down', 'Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.'),
(2527, 'hsa-mir-375', 'esophageal cancer', 'down', 'The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.'),
(2528, 'hsa-mir-452', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2529, 'hsa-mir-454', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2530, 'hsa-mir-486', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2531, 'hsa-mir-574-3p', 'esophageal cancer', 'down', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2532, 'hsa-mir-96', 'esophageal cancer', 'up', 'MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer.'),
(2533, 'hsa-mir-99b', 'esophageal cancer', 'up', 'Differential expression of miRNAs in esophageal cancer tissue.'),
(2534, 'hsa-mir-214-3p', 'esophageal cancer', 'down', 'Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.'),
(2535, 'hsa-mir-374a', 'esophageal cancer', 'up', 'MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression.'),
(2536, 'hsa-mir-491', 'esophageal cancer', 'down', 'Low Expression of miR-491 Promotes Esophageal Cancer Cell Invasion by Targeting TPX2.'),
(2537, 'hsa-mir-503', 'esophageal cancer', 'up', 'MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancer.'),
(2538, 'hsa-mir-203a', 'esophageal cancer', 'down', 'Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.'),
(2539, 'hsa-mir-506', 'esophageal cancer', 'down', 'MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.'),
(2540, 'hsa-mir-124', 'esophageal cancer', 'down', 'Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.'),
(2541, 'hsa-mir-126', 'esophageal cancer', 'down', 'MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.'),
(2542, 'hsa-mir-199a-5p', 'esophageal cancer', 'down', 'Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).'),
(2543, 'hsa-mir-204', 'esophageal cancer', 'down', 'miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.'),
(2544, 'hsa-mir-214', 'esophageal cancer', 'down', 'Regulation of ?-catenin-mediated esophageal cancer growth and invasion by miR-214.'),
(2545, 'hsa-mir-328', 'esophageal cancer', 'down', 'MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1.'),
(2546, 'hsa-mir-34a', 'esophageal cancer', 'down', 'miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.'),
(2547, 'hsa-mir-21', 'esophageal cancer', 'up', 'MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.'),
(2548, 'hsa-mir-100', 'esophageal cancer', 'down', 'miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7.'),
(2549, 'hsa-mir-145', 'esophageal cancer', 'down', 'Episomal lentiviral vector-mediated miR-145 overexpression inhibits proliferation and induces apoptosis of human esophageal carcinoma cells.'),
(2550, 'hsa-mir-21', 'esophageal cancer', 'up', 'Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(2551, 'hsa-mir-20b', 'esophageal cancer', 'up', 'MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression.'),
(2552, 'hsa-mir-30b', 'esophageal cancer', 'down', 'miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.'),
(2553, 'hsa-mir-195', 'esophageal cancer', 'down', 'miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.'),
(2554, 'hsa-mir-302b', 'esophageal cancer', 'down', 'miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.'),
(2555, 'hsa-mir-375', 'esophageal cancer', 'down', 'MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression.'),
(2556, 'hsa-mir-1', 'esophageal cancer', 'down', 'miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.'),
(2557, 'hsa-mir-145', 'esophageal cancer', 'down', 'miR-145 targets the SOX11 3\'UTR to suppress endometrial cancer growth.'),
(2558, 'hsa-mir-150', 'esophageal cancer', 'down', 'Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.'),
(2559, 'hsa-mir-203', 'esophageal cancer', 'up', 'Evaluation of mir-203 Expression Levels and DNA Promoter Methylation Status in Serum of Patients with Endometrial Cancer.'),
(2560, 'hsa-mir-138', 'esophageal cancer', 'up', '?-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA?138 expression.'),
(2561, 'hsa-mir-646', 'esophageal cancer', 'down', 'Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis.'),
(2562, 'hsa-mir-101-3p', 'esophageal cancer', 'down', 'miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2.'),
(2563, 'hsa-mir-124', 'esophageal cancer', 'down', 'MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.'),
(2564, 'hsa-mir-145', 'esophageal cancer', 'up', 'MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5.'),
(2565, 'hsa-mir-155', 'esophageal cancer', 'down', 'MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression.'),
(2566, 'hsa-mir-183', 'esophageal cancer', 'up', 'MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.'),
(2567, 'hsa-mir-199a-3p', 'esophageal cancer', 'down', 'MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.'),
(2568, 'hsa-mir-21-5p', 'esophageal cancer', 'up', 'Increased miR-203-3p and reduced miR-21-5p synergistically inhibit proliferation, migration, and invasion in esophageal cancer cells.'),
(2569, 'hsa-mir-214', 'esophageal cancer', 'up', 'LncRNA BDNF-AS inhibits proliferation, migration, invasion and EMT in oesophageal cancer cells by targeting miR-214.'),
(2570, 'hsa-mir-302b-3p', 'esophageal cancer', 'down', 'MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.'),
(2571, 'hsa-mir-302c-3p', 'esophageal cancer', 'down', 'MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.'),
(2572, 'hsa-mir-302d-3p', 'esophageal cancer', 'down', 'MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells.'),
(2573, 'hsa-mir-34a', 'esophageal cancer', 'down', 'miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.'),
(2574, 'hsa-mir-424', 'esophageal cancer', 'down', 'miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.'),
(2575, 'hsa-mir-513', 'esophageal cancer', 'down', 'miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.'),
(2576, 'hsa-mir-873', 'esophageal cancer', 'down', 'MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.'),
(2577, 'hsa-mir-365', 'esophageal cancer', 'down', 'MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1.'),
(2578, 'hsa-mir-494', 'esophageal cancer', 'down', 'Long non-coding RNA XIST promotes the development of esophageal cancer by sponging miR-494 to regulate CDK6 expression.'),
(2579, 'hsa-mir-556-3p', 'esophageal cancer', 'up', 'MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.'),
(2580, 'hsa-mir-93', 'esophageal cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(2581, 'hsa-mir-10b', 'esophageal cancer', 'up', 'microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPAR? in esophageal cancer.'),
(2582, 'hsa-mir-148a-3p', 'esophageal cancer', 'down', 'miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.'),
(2583, 'hsa-mir-193b', 'esophageal cancer', 'down', 'MicroRNA-193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS.'),
(2584, 'hsa-mir-205-5p', 'esophageal cancer', 'up', 'miR-205-5p contributes to paclitaxel resistance and progression of endometrial cancer by downregulating FOXO1.'),
(2585, 'hsa-mir-218', 'esophageal cancer', 'down', 'MiR-218 suppresses metastasis and invasion of endometrial cancer via negatively regulating ADD2.'),
(2586, 'hsa-mir-485-5p', 'esophageal cancer', 'down', 'MiRNA-485-5p, inhibits esophageal cancer cells proliferation and invasion by down-regulating O-linked N-acetylglucosamine transferase.'),
(2587, 'hsa-mir-487a', 'esophageal cancer', 'up', 'MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.'),
(2588, 'hsa-mir-93-5p', 'esophageal cancer', 'up', 'MicroRNA-93-5p/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway.'),
(2589, 'hsa-mir-940', 'esophageal cancer', 'up', 'miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.'),
(2590, 'hsa-mir-451', 'esophageal carcinoma', 'down', 'Effect of miR-451 on the Biological Behavior of the Esophageal Carcinoma Cell Line EC9706.'),
(2591, 'hsa-mir-4286', 'esophageal carcinoma', 'up', 'MicroRNA-4286 promotes esophageal carcinoma development by targeting INPP4A to evoke the JAK2/STAT3 pathway activation.'),
(2592, 'hsa-let-7a', 'esophageal squamous cell carcinoma', 'down', '[Expressions and correlations of let-7a and IL-6 in esophageal squamous cell carcinoma].'),
(2593, 'hsa-let-7a-1', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2594, 'hsa-let-7a-1', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2595, 'hsa-let-7a-2', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2596, 'hsa-let-7a-2', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2597, 'hsa-let-7a-3', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2598, 'hsa-let-7a-3', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2599, 'hsa-let-7b', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2600, 'hsa-let-7b', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2601, 'hsa-let-7c', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2602, 'hsa-let-7c', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2603, 'hsa-let-7d', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2604, 'hsa-let-7d', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2605, 'hsa-let-7e', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2606, 'hsa-let-7e', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2607, 'hsa-let-7f-1', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2608, 'hsa-let-7f-1', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2609, 'hsa-let-7f-2', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2610, 'hsa-let-7f-2', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2611, 'hsa-let-7g', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2612, 'hsa-let-7g', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2613, 'hsa-let-7i', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2614, 'hsa-let-7i', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2615, 'hsa-mir-1', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion.'),
(2616, 'hsa-mir-100', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.'),
(2617, 'hsa-mir-100', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma.'),
(2618, 'hsa-mir-100', 'esophageal squamous cell carcinoma', 'down', 'Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.'),
(2619, 'hsa-mir-101', 'esophageal squamous cell carcinoma', 'down', 'miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.'),
(2620, 'hsa-mir-1179', 'esophageal squamous cell carcinoma', 'up', 'miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma.'),
(2621, 'hsa-mir-126', 'esophageal squamous cell carcinoma', 'down', 'Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR?126 in esophageal squamous cell carcinoma.'),
(2622, 'hsa-mir-1290', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.'),
(2623, 'hsa-mir-1294', 'esophageal squamous cell carcinoma', 'down', 'Down-Regulation of MiR-1294 is Related to Dismal Prognosis of Patients with Esophageal Squamous Cell Carcinoma through Elevating C-MYC Expression.'),
(2624, 'hsa-mir-130b', 'esophageal squamous cell carcinoma', 'up', 'MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.'),
(2625, 'hsa-mir-133a', 'esophageal squamous cell carcinoma', 'down', 'miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.'),
(2626, 'hsa-mir-133a', 'esophageal squamous cell carcinoma', 'down', 'CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.'),
(2627, 'hsa-mir-133b', 'esophageal squamous cell carcinoma', 'down', 'miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.'),
(2628, 'hsa-mir-138', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of miR-138 Sustains NF-?B Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma.'),
(2629, 'hsa-mir-143', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.'),
(2630, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.'),
(2631, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'Evaluating the miR-302b and miR-145 expression in formalin-fixed paraffin-embedded samples of esophageal squamous cell carcinoma.'),
(2632, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.'),
(2633, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'up', 'Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.'),
(2634, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.'),
(2635, 'hsa-mir-150', 'esophageal squamous cell carcinoma', 'down', 'MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducers ZEB1.'),
(2636, 'hsa-mir-16', 'esophageal squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(2637, 'hsa-mir-17', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2638, 'hsa-mir-183', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.'),
(2639, 'hsa-mir-185', 'esophageal squamous cell carcinoma', 'down', '[Molecular mechanism and effect of microRNA185 on proliferation, migration and invasion of esophageal squamous cell carcinoma].'),
(2640, 'hsa-mir-18a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2641, 'hsa-mir-18a', 'esophageal squamous cell carcinoma', 'up', 'Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.'),
(2642, 'hsa-mir-195', 'esophageal squamous cell carcinoma', 'down', 'Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42.'),
(2643, 'hsa-mir-19a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2644, 'hsa-mir-19b', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2645, 'hsa-mir-200b', 'esophageal squamous cell carcinoma', 'down', 'miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.'),
(2646, 'hsa-mir-203', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-203 inhibits cell proliferation by repressing ?Np63 expression in human esophageal squamous cell carcinoma.'),
(2647, 'hsa-mir-203', 'esophageal squamous cell carcinoma', 'down', 'miR-203 is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells.'),
(2648, 'hsa-mir-208', 'esophageal squamous cell carcinoma', 'up', 'Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma.'),
(2649, 'hsa-mir-20a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2650, 'hsa-mir-20a', 'esophageal squamous cell carcinoma', 'up', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2651, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma.'),
(2652, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(2653, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.'),
(2654, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.'),
(2655, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma.'),
(2656, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.'),
(2657, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Down-Regulation of PTEN Expression Modulated by Dysregulated miR-21 Contributes to the Progression of Esophageal Cancer.'),
(2658, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'down', 'Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.'),
(2659, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.'),
(2660, 'hsa-mir-210', 'esophageal squamous cell carcinoma', 'down', 'MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.'),
(2661, 'hsa-mir-210', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).'),
(2662, 'hsa-mir-210', 'esophageal squamous cell carcinoma', 'down', 'The Role of MicroRNA-210 in Esophageal Squamous Cell Carcinoma.'),
(2663, 'hsa-mir-214', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.'),
(2664, 'hsa-mir-218', 'esophageal squamous cell carcinoma', 'up', 'miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.'),
(2665, 'hsa-mir-218', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.'),
(2666, 'hsa-mir-22', 'esophageal squamous cell carcinoma', 'down', 'Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation.'),
(2667, 'hsa-mir-22', 'esophageal squamous cell carcinoma', 'down', 'miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion.'),
(2668, 'hsa-mir-223', 'esophageal squamous cell carcinoma', 'up', 'Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.'),
(2669, 'hsa-mir-25', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.'),
(2670, 'hsa-mir-25', 'esophageal squamous cell carcinoma', 'up', 'Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.'),
(2671, 'hsa-mir-27a', 'esophageal squamous cell carcinoma', 'down', 'microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.'),
(2672, 'hsa-mir-27a', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.'),
(2673, 'hsa-mir-29b', 'esophageal squamous cell carcinoma', 'down', 'miR-29b inhibits the progression of esophageal squamous cell carcinoma by targeting MMP-2.'),
(2674, 'hsa-mir-29c', 'esophageal squamous cell carcinoma', 'down', 'miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression.'),
(2675, 'hsa-mir-302b', 'esophageal squamous cell carcinoma', 'down', 'miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.'),
(2676, 'hsa-mir-30a-5p', 'esophageal squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(2677, 'hsa-mir-31', 'esophageal squamous cell carcinoma', 'up', 'The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.'),
(2678, 'hsa-mir-330-3p', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.'),
(2679, 'hsa-mir-34a', 'esophageal squamous cell carcinoma', 'down', 'miR-34a inhibits the migration and invasion of esophageal squamous cell carcinoma by targeting Yin Yang-1.'),
(2680, 'hsa-mir-373', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.'),
(2681, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.'),
(2682, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.'),
(2683, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.'),
(2684, 'hsa-mir-494', 'esophageal squamous cell carcinoma', 'down', 'Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.'),
(2685, 'hsa-mir-518b', 'esophageal squamous cell carcinoma', 'down', 'miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.'),
(2686, 'hsa-mir-655', 'esophageal squamous cell carcinoma', 'down', 'Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.'),
(2687, 'hsa-mir-9', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.'),
(2688, 'hsa-mir-92a', 'esophageal squamous cell carcinoma', 'up', 'microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.'),
(2689, 'hsa-mir-92a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2690, 'hsa-mir-942', 'esophageal squamous cell carcinoma', 'up', 'miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/?-catenin signalling pathway.'),
(2691, 'hsa-mir-98', 'esophageal squamous cell carcinoma', 'down', 'Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.'),
(2692, 'hsa-mir-98', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.'),
(2693, 'hsa-mir-98', 'esophageal squamous cell carcinoma', 'down', 'Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.'),
(2694, 'hsa-mir-99a', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.'),
(2695, 'mir-17', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2696, 'mir-18a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2697, 'mir-19a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2698, 'mir-19b', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2699, 'mir-20a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2700, 'mir-92a', 'esophageal squamous cell carcinoma', 'up', 'TNF-? is a novel target of miR-19a.'),
(2701, 'hsa-mir-126', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.'),
(2702, 'hsa-mir-185', 'esophageal squamous cell carcinoma', 'down', 'Plasma miR-185 is decreased in esophageal squamous cell carcinoma patients and might suppress tumor migration and invasion by targeting RAGE.'),
(2703, 'hsa-mir-192', 'esophageal squamous cell carcinoma', 'up', 'Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.'),
(2704, 'hsa-mir-200b', 'esophageal squamous cell carcinoma', 'down', 'Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin ?1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.'),
(2705, 'hsa-mir-224', 'esophageal squamous cell carcinoma', 'tissue;', 'Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.'),
(2706, 'hsa-mir-340', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.'),
(2707, 'hsa-mir-93', 'esophageal squamous cell carcinoma', 'up', 'Micro ribonucleic acid-93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2.'),
(2708, 'hsa-mir-101', 'esophageal squamous cell carcinoma', 'down', 'Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.'),
(2709, 'hsa-mir-101-3p', 'esophageal squamous cell carcinoma', 'down', 'Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway.'),
(2710, 'hsa-mir-186', 'esophageal squamous cell carcinoma', 'down', 'microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2.'),
(2711, 'hsa-mir-205', 'esophageal squamous cell carcinoma', 'down', 'Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.'),
(2712, 'hsa-mir-29c', 'esophageal squamous cell carcinoma', 'down', 'Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.'),
(2713, 'hsa-mir-613', 'esophageal squamous cell carcinoma', 'down', 'MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.'),
(2714, 'hsa-mir-1290', 'esophageal squamous cell carcinoma', 'up', 'MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC).'),
(2715, 'hsa-mir-143', 'esophageal squamous cell carcinoma', 'down', 'miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.'),
(2716, 'hsa-mir-143', 'esophageal squamous cell carcinoma', 'down', 'MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.'),
(2717, 'hsa-mir-144', 'esophageal squamous cell carcinoma', 'down', 'MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.'),
(2718, 'hsa-mir-146a', 'esophageal squamous cell carcinoma', 'down', 'Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.'),
(2719, 'hsa-mir-216a', 'esophageal squamous cell carcinoma', 'down', 'Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.'),
(2720, 'hsa-mir-216b', 'esophageal squamous cell carcinoma', 'down', 'Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.'),
(2721, 'hsa-mir-26a', 'esophageal squamous cell carcinoma', 'down', 'MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.'),
(2722, 'hsa-mir-27a-3p', 'esophageal squamous cell carcinoma', 'up', 'MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.'),
(2723, 'hsa-mir-335', 'esophageal squamous cell carcinoma', 'down', 'Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.'),
(2724, 'hsa-mir-425', 'esophageal squamous cell carcinoma', 'up', 'Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2.'),
(2725, 'hsa-mir-483-3p', 'esophageal squamous cell carcinoma', 'up', 'miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.'),
(2726, 'hsa-mir-718', 'esophageal squamous cell carcinoma', 'down', 'Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma.'),
(2727, 'hsa-mir-143-3p', 'esophageal squamous cell carcinoma', 'down', 'MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.'),
(2728, 'hsa-mir-181d', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.'),
(2729, 'hsa-mir-194', 'esophageal squamous cell carcinoma', 'down', 'miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells.'),
(2730, 'hsa-mir-202', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma.'),
(2731, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.'),
(2732, 'hsa-mir-373', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.'),
(2733, 'hsa-mir-373', 'esophageal squamous cell carcinoma', 'up', 'Erratum: MicroRNA-373 promotes migration and invasion in human esophageal squamous cell carcinoma by inhibiting TIMP3 expression.'),
(2734, 'hsa-mir-495', 'esophageal squamous cell carcinoma', 'down', 'MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1.'),
(2735, 'hsa-mir-622', 'esophageal squamous cell carcinoma', 'down', 'MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.'),
(2736, 'hsa-mir-630', 'esophageal squamous cell carcinoma', 'down', 'MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.'),
(2737, 'hsa-mir-644a', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem-cell-like Phenotype via Dysregulation of PITX2.'),
(2738, 'hsa-mir-106b', 'esophageal squamous cell carcinoma', 'up', 'MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh\'s esophageal squamous cell carcinoma.'),
(2739, 'hsa-mir-127', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.'),
(2740, 'hsa-mir-1288', 'esophageal squamous cell carcinoma', 'up', 'Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.'),
(2741, 'hsa-mir-141-3p', 'esophageal squamous cell carcinoma', 'up', 'Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.'),
(2742, 'hsa-mir-143', 'esophageal squamous cell carcinoma', 'down', 'Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.'),
(2743, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.'),
(2744, 'hsa-mir-153', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1.'),
(2745, 'hsa-mir-214', 'esophageal squamous cell carcinoma', 'down', 'miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.'),
(2746, 'hsa-mir-33b', 'esophageal squamous cell carcinoma', 'down', '[The expression and significance of miR-33b and HMGA2 in esophageal squamous cell carcinoma].'),
(2747, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.'),
(2748, 'hsa-mir-424-5p', 'esophageal squamous cell carcinoma', 'down', 'MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.'),
(2749, 'hsa-mir-486-5p', 'esophageal squamous cell carcinoma', 'down', 'Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma.'),
(2750, 'hsa-mir-106b', 'esophageal squamous cell carcinoma', 'up', '[Expression of mir-106b in esophageal squamous cell carcinoma].'),
(2751, 'hsa-mir-192-5p', 'esophageal squamous cell carcinoma', 'up', 'A novel serum microRNA signature to screen esophageal squamous cell carcinoma.'),
(2752, 'hsa-mir-193a-3p', 'esophageal squamous cell carcinoma', 'up', 'Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.'),
(2753, 'hsa-mir-196a', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.'),
(2754, 'hsa-mir-20b-5p', 'esophageal squamous cell carcinoma', 'up', 'A novel serum microRNA signature to screen esophageal squamous cell carcinoma.'),
(2755, 'hsa-mir-223-3p', 'esophageal squamous cell carcinoma', 'up', 'A novel serum microRNA signature to screen esophageal squamous cell carcinoma.'),
(2756, 'hsa-mir-26a', 'esophageal squamous cell carcinoma', 'down', 'Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.'),
(2757, 'hsa-mir-28-3p', 'esophageal squamous cell carcinoma', 'up', 'A novel serum microRNA signature to screen esophageal squamous cell carcinoma.'),
(2758, 'hsa-mir-296-5p', 'esophageal squamous cell carcinoma', 'up', 'A novel serum microRNA signature to screen esophageal squamous cell carcinoma.'),
(2759, 'hsa-mir-370', 'esophageal squamous cell carcinoma', 'down', 'Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling.'),
(2760, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.'),
(2761, 'hsa-mir-498', 'esophageal squamous cell carcinoma', 'down', 'MiR-498 in oesophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.'),
(2762, 'hsa-mir-638', 'esophageal squamous cell carcinoma', 'up', 'MiRNA-638 promotes autophagy and malignant phenotypes of cancer cells via directly suppressing DACT3.'),
(2763, 'hsa-mir-106a', 'esophageal squamous cell carcinoma', 'up', 'A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.'),
(2764, 'hsa-mir-107', 'esophageal squamous cell carcinoma', 'down', 'miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42.'),
(2765, 'hsa-mir-125a', 'esophageal squamous cell carcinoma', 'up', 'ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma.'),
(2766, 'hsa-mir-26a', 'esophageal squamous cell carcinoma', 'down', 'miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.'),
(2767, 'hsa-mir-26b', 'esophageal squamous cell carcinoma', 'down', 'miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway.'),
(2768, 'hsa-mir-34a', 'esophageal squamous cell carcinoma', 'down', 'Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.'),
(2769, 'hsa-mir-381', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.'),
(2770, 'hsa-mir-584', 'esophageal squamous cell carcinoma', 'up', 'A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.'),
(2771, 'hsa-mir-9', 'esophageal squamous cell carcinoma', 'up', 'Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.'),
(2772, 'hsa-mir-99b', 'esophageal squamous cell carcinoma', 'up', 'ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma.'),
(2773, 'hsa-mir-1', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced?clinical?stage and its overexpression inhibits cell migration and invasion.'),
(2774, 'hsa-mir-125b-5p', 'esophageal squamous cell carcinoma', 'down', 'miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.'),
(2775, 'hsa-mir-126', 'esophageal squamous cell carcinoma', 'down', 'Insulin receptor substrate-1 and Golgi phosphoprotein?3 are downstream targets of miR?126 in esophageal squamous cell carcinoma.'),
(2776, 'hsa-mir-1290', 'esophageal squamous cell carcinoma', 'up', 'Prognostic value of combined and individual expression of microRNA-1290 and its target gene nuclear factor I/X in human esophageal squamous cell carcinoma.'),
(2777, 'hsa-mir-138', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.'),
(2778, 'hsa-mir-145-5p', 'esophageal squamous cell carcinoma', 'down', 'miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-?B Signaling Pathway in Esophageal Squamous Cell Carcinoma.'),
(2779, 'hsa-mir-150-3p', 'esophageal squamous cell carcinoma', 'down', 'Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.'),
(2780, 'hsa-mir-150-5p', 'esophageal squamous cell carcinoma', 'down', 'Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.'),
(2781, 'hsa-mir-19a', 'esophageal squamous cell carcinoma', 'up', 'Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.'),
(2782, 'hsa-mir-203', 'esophageal squamous cell carcinoma', 'down', 'Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.'),
(2783, 'hsa-mir-432-3p', 'esophageal squamous cell carcinoma', 'up', 'miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1.'),
(2784, 'hsa-mir-455-3p', 'esophageal squamous cell carcinoma', 'up', 'Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.'),
(2785, 'hsa-mir-455-3p', 'esophageal squamous cell carcinoma', 'up', 'MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.'),
(2786, 'hsa-mir-503', 'esophageal squamous cell carcinoma', 'down', 'Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.'),
(2787, 'hsa-mir-655', 'esophageal squamous cell carcinoma', 'down', 'Analysis of the correlation between the expression of miR-655 and esophageal cancer prognosis.'),
(2788, 'hsa-mir-9', 'esophageal squamous cell carcinoma', 'up', 'Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.'),
(2789, 'hsa-mir-99a', 'esophageal squamous cell carcinoma', 'down', 'MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.'),
(2790, 'hsa-mir-129', 'esophageal squamous cell carcinoma', 'down', 'LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.'),
(2791, 'hsa-mir-148a', 'esophageal squamous cell carcinoma', 'down', 'MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma.'),
(2792, 'hsa-mir-191', 'esophageal squamous cell carcinoma', 'up', 'Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.'),
(2793, 'hsa-mir-196a', 'esophageal squamous cell carcinoma', 'up', 'Negative regulation of lncRNA GAS5 by miR-196a inhibits esophageal squamous cell carcinoma growth.'),
(2794, 'hsa-mir-25', 'esophageal squamous cell carcinoma', 'up', 'miR-25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma.'),
(2795, 'hsa-mir-34a', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.'),
(2796, 'hsa-mir-548k', 'esophageal squamous cell carcinoma', 'up', 'Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.'),
(2797, 'hsa-let-7a', 'esophageal squamous cell carcinoma', 'down', 'Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt signaling in esophageal squamous cell carcinoma.'),
(2798, 'hsa-mir-1', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib.'),
(2799, 'hsa-mir-1470', 'esophageal squamous cell carcinoma', 'up', 'Overexpression of microRNA-1470 promotes proliferation and migration, and inhibits senescence of esophageal squamous carcinoma cells.'),
(2800, 'hsa-mir-224', 'esophageal squamous cell carcinoma', 'up', 'LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.'),
(2801, 'hsa-mir-30c', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.'),
(2802, 'hsa-mir-1', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.'),
(2803, 'hsa-mir-106b', 'esophageal squamous cell carcinoma', 'up', 'miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.'),
(2804, 'hsa-mir-125b', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF.'),
(2805, 'hsa-mir-133b', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma.'),
(2806, 'hsa-mir-135a-1', 'esophageal squamous cell carcinoma', 'up', 'miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.'),
(2807, 'hsa-mir-135a-2', 'esophageal squamous cell carcinoma', 'up', 'miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.'),
(2808, 'hsa-mir-135b', 'esophageal squamous cell carcinoma', 'up', 'miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG.'),
(2809, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.'),
(2810, 'hsa-mir-21', 'esophageal squamous cell carcinoma', 'up', 'Downregulation of microRNA-21 inhibited radiation-resistance of esophageal squamous cell carcinoma.'),
(2811, 'hsa-mir-223', 'esophageal squamous cell carcinoma', 'up', 'Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.'),
(2812, 'hsa-mir-371', 'esophageal squamous cell carcinoma', 'up', 'Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.'),
(2813, 'hsa-mir-372', 'esophageal squamous cell carcinoma', 'up', 'Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.'),
(2814, 'hsa-mir-373', 'esophageal squamous cell carcinoma', 'up', 'Upregulation of miR-371-373 cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma.'),
(2815, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma.'),
(2816, 'hsa-mir-516b', 'esophageal squamous cell carcinoma', 'down', 'miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.'),
(2817, 'hsa-mir-765', 'esophageal squamous cell carcinoma', 'up', 'Up-regulation of miR-765 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.'),
(2818, 'hsa-mir-10a', 'esophageal squamous cell carcinoma', 'down', 'Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma.'),
(2819, 'hsa-mir-10b-3p', 'esophageal squamous cell carcinoma', 'up', 'Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).'),
(2820, 'hsa-mir-133a-3p', 'esophageal squamous cell carcinoma', 'down', 'miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.'),
(2821, 'hsa-mir-133b', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth.'),
(2822, 'hsa-mir-32', 'esophageal squamous cell carcinoma', 'up', 'miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.'),
(2823, 'hsa-mir-338-5p', 'esophageal squamous cell carcinoma', 'down', 'miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.'),
(2824, 'hsa-mir-365', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1.'),
(2825, 'hsa-mir-384', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.'),
(2826, 'hsa-mir-424', 'esophageal squamous cell carcinoma', 'up', 'miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation.'),
(2827, 'hsa-mir-455-5p', 'esophageal squamous cell carcinoma', 'down', 'Inhibitory effect of microRNA-455-5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31.'),
(2828, 'hsa-mir-6775-3p', 'esophageal squamous cell carcinoma', 'down', 'Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins.'),
(2829, 'hsa-mir-124', 'esophageal squamous cell carcinoma', 'down', 'Hypermethylation-mediated inactivation of miR-124 predicts poor prognosis and promotes tumor growth at least partially through targeting EZH2/H3K27me3 in ESCC.'),
(2830, 'hsa-mir-124-3p', 'esophageal squamous cell carcinoma', 'down', 'The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(2831, 'hsa-mir-134', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.'),
(2832, 'hsa-mir-141', 'esophageal squamous cell carcinoma', 'up', 'Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma.'),
(2833, 'hsa-mir-145', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.'),
(2834, 'hsa-mir-148a', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-148a regulates the MAPK/ERK signaling pathway and suppresses the development of esophagus squamous cell carcinoma via targeting MAP3K9.'),
(2835, 'hsa-mir-219-5p', 'esophageal squamous cell carcinoma', 'down', 'MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.'),
(2836, 'hsa-mir-27a', 'esophageal squamous cell carcinoma', 'up', 'Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.'),
(2837, 'hsa-mir-27a', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-27a downregulates the expression of Hsp90 and enhances the radiosensitivity in esophageal squamous cell carcinoma.'),
(2838, 'hsa-mir-296-5p', 'esophageal squamous cell carcinoma', 'down', 'MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.'),
(2839, 'hsa-mir-326', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-326 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through targeting LIM and SH3 protein 1.'),
(2840, 'hsa-mir-33a-5p', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1.'),
(2841, 'hsa-mir-34a', 'esophageal squamous cell carcinoma', 'down', 'miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1.'),
(2842, 'hsa-mir-373-3p', 'esophageal squamous cell carcinoma', 'up', 'MicroRNA-373 promotes the development of esophageal squamous cell carcinoma by targeting LATS2 and OXR1.'),
(2843, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'Study of expression levels and clinical significance of miR-503 and miR-375 in patients with esophageal squamous cell carcinoma.'),
(2844, 'hsa-mir-375', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1.'),
(2845, 'hsa-mir-488-3p', 'esophageal squamous cell carcinoma', 'down', 'MicroRNA-488-3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma.'),
(2846, 'hsa-mir-503', 'esophageal squamous cell carcinoma', 'up', 'Study of expression levels and clinical significance of miR-503 and miR-375 in patients with esophageal squamous cell carcinoma.'),
(2847, 'hsa-mir-601', 'esophageal squamous cell carcinoma', 'down', 'MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.'),
(2848, 'hsa-mir-655', 'esophageal squamous cell carcinoma', 'down', 'Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma.'),
(2849, 'hsa-mir-126', 'esophageal squamous cell carcinoma', 'down', 'Insulin receptor substrate-1 and Golgi phosphoprotein??3 are downstream targets of miR?126 in esophageal squamous cell carcinoma.'),
(2850, 'hsa-mir-34a', 'extrahepatic cholangiocarcinoma', 'down', 'microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.'),
(2851, 'hsa-mir-221', 'extrahepatic cholangiocarcinoma', 'up', 'miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with ?-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.'),
(2852, 'hsa-mir-125b', 'follicular cancer', 'up', 'MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.'),
(2853, 'hsa-mir-202', 'follicular lymphoma', 'down', 'Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.'),
(2854, 'hsa-mir-106a*', 'follicular lymphoma', 'down', 'miR-106a* inhibits the proliferation of esophageal carcinoma cells by targeting CDK2-associated Cullin 1 (CACUL1).'),
(2855, 'hsa-mir-146b', 'follicular thyroid carcinoma', 'up', 'Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.'),
(2856, 'hsa-mir-183', 'follicular thyroid carcinoma', 'up', 'Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.'),
(2857, 'hsa-mir-197', 'follicular thyroid carcinoma', 'up', 'A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.'),
(2858, 'hsa-mir-199b', 'follicular thyroid carcinoma', 'down', 'Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.'),
(2859, 'hsa-mir-221', 'follicular thyroid carcinoma', 'up', 'Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.'),
(2860, 'hsa-mir-346', 'follicular thyroid carcinoma', 'up', 'A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.'),
(2861, 'hsa-mir-146a', 'follicular thyroid carcinoma', 'up', 'miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.'),
(2862, 'hsa-mir-146b', 'follicular thyroid carcinoma', 'up', 'miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.'),
(2863, 'hsa-mir-146b-5p', 'gallbladder carcinoma', 'down', 'MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.'),
(2864, 'hsa-mir-155', 'gallbladder carcinoma', 'up', 'High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma.'),
(2865, 'hsa-mir-182', 'gallbladder carcinoma', 'up', 'TGF-? upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1.'),
(2866, 'hsa-mir-122', 'gallbladder carcinoma', 'down', 'miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.'),
(2867, 'hsa-mir-145', 'gallbladder carcinoma', 'up', 'miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.'),
(2868, 'hsa-mir-223', 'gallbladder carcinoma', 'down', 'miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.'),
(2869, 'hsa-mir-146b-5p', 'gallbladder carcinoma', 'down', 'Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.'),
(2870, 'hsa-mir-29c-5p', 'gallbladder carcinoma', 'down', 'MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.'),
(2871, 'hsa-mir-218-5p', 'gallbladder carcinoma', 'down', 'miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.'),
(2872, 'hsa-mir-143-3p', 'gallbladder carcinoma', 'down', 'miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.'),
(2873, 'hsa-mir-139-5p', 'gallbladder carcinoma', 'down', 'MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.'),
(2874, 'hsa-mir-136', 'gallbladder carcinoma', 'down', 'Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.'),
(2875, 'hsa-mir-181b', 'gastric adenocarcinoma', 'down', 'MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.'),
(2876, 'hsa-mir-182', 'gastric adenocarcinoma', 'down', 'MicroRNA-182 targets cAMP-responsive element-binding protein?1 and suppresses cell growth in human gastric adenocarcinoma.'),
(2877, 'hsa-mir-200a', 'gastric adenocarcinoma', 'down', 'Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/?-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.'),
(2878, 'hsa-mir-200a', 'gastric adenocarcinoma', 'down', 'Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.'),
(2879, 'hsa-mir-23a', 'gastric adenocarcinoma', 'up', 'MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor.'),
(2880, 'hsa-mir-23a', 'gastric adenocarcinoma', 'up', 'miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells.'),
(2881, 'hsa-mir-27a', 'gastric adenocarcinoma', 'up', 'MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.'),
(2882, 'hsa-mir-302b', 'gastric adenocarcinoma', 'down', 'Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma.'),
(2883, 'hsa-mir-373', 'gastric adenocarcinoma', 'up', 'MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis.'),
(2884, 'hsa-mir-449a', 'gastric adenocarcinoma', 'down', 'microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2.'),
(2885, 'hsa-mir-9', 'gastric adenocarcinoma', 'down', 'Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.'),
(2886, 'hsa-mir-216b', 'gastric adenocarcinoma', 'down', 'MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.'),
(2887, 'hsa-mir-9', 'gastric adenocarcinoma', 'down', 'Analyses of methylation status of CpG islands in promoters of miR-9 genes family in human gastric adenocarcinoma.'),
(2888, 'hsa-mir-216b', 'gastric adenocarcinoma', 'down', 'Retraction Note to: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.'),
(2889, 'hsa-mir-376c-3p', 'gastric adenocarcinoma', 'down', 'hsa-miR-376c-3p Regulates Gastric Tumor Growth Both In Vitro and In Vivo.'),
(2890, 'hsa-mir-124', 'gastric adenocarcinoma', 'down', 'Expression of miR-124 in gastric adenocarcinoma and the effect on proliferation and invasion of gastric adenocarcinoma SCG-7901 cells.'),
(2891, 'hsa-let-7a', 'gastric cancer', 'down', 'Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo.'),
(2892, 'hsa-let-7a', 'gastric cancer', 'down', 'Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.'),
(2893, 'hsa-let-7a', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2894, 'hsa-let-7a', 'gastric cancer', 'down', 'Investigation and identification of let-7a related functional proteins in gastric carcinoma by proteomics.'),
(2895, 'hsa-let-7a', 'gastric cancer', 'down', 'Differentially expressed proteins identified in overexpressed let-7a gastric carcinoma cells by two-dimensional polyacrylamide gel electrophoresis.'),
(2896, 'hsa-let-7a', 'gastric cancer', 'down', 'Circulating microRNAs in plasma of patients with gastric cancers.'),
(2897, 'hsa-let-7b', 'gastric cancer', 'down', 'Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.'),
(2898, 'hsa-let-7b', 'gastric cancer', 'down', 'MicroRNA let-7b suppresses human gastric cancer malignancy by targeting ING1.'),
(2899, 'hsa-let-7b', 'gastric cancer', 'down', 'let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.'),
(2900, 'hsa-let-7g', 'gastric cancer', 'down', 'let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.'),
(2901, 'hsa-mir-1', 'gastric cancer', 'down', 'MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.'),
(2902, 'hsa-mir-100', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2903, 'hsa-mir-101', 'gastric cancer', 'down', 'MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.'),
(2904, 'hsa-mir-101', 'gastric cancer', 'down', 'Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.'),
(2905, 'hsa-mir-101', 'gastric cancer', 'down', 'Down-regulation of miR-101 in gastric cancer correlates with COX-2 overexpression and tumor growth.'),
(2906, 'hsa-mir-103', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2907, 'hsa-mir-103a', 'gastric cancer', 'down', 'MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.'),
(2908, 'hsa-mir-106a', 'gastric cancer', 'up', 'Circulating microRNAs in plasma of patients with gastric cancers.'),
(2909, 'hsa-mir-106a', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2910, 'hsa-mir-106a', 'gastric cancer', 'up', 'miR-106a Is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.'),
(2911, 'hsa-mir-106a', 'gastric cancer', 'up', 'Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.'),
(2912, 'hsa-mir-106a', 'gastric cancer', 'up', 'miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells.'),
(2913, 'hsa-mir-106a', 'gastric cancer', 'up', 'MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.'),
(2914, 'hsa-mir-106b', 'gastric cancer', 'up', 'Circulating microRNAs in plasma of patients with gastric cancers.'),
(2915, 'hsa-mir-106b', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2916, 'hsa-mir-106b', 'gastric cancer', 'up', 'Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.'),
(2917, 'hsa-mir-107', 'gastric cancer', 'up', 'MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8.'),
(2918, 'hsa-mir-107', 'gastric cancer', 'up', 'MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.'),
(2919, 'hsa-mir-107', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2920, 'hsa-mir-107', 'gastric cancer', 'up', 'Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1.'),
(2921, 'hsa-mir-10a', 'gastric cancer', 'up', 'miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes.'),
(2922, 'hsa-mir-10a', 'gastric cancer', 'down', 'MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells.'),
(2923, 'hsa-mir-10b', 'gastric cancer', 'up', 'miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.'),
(2924, 'hsa-mir-10b', 'gastric cancer', 'up', 'Clinicopathologic significance of miR-10b expression in gastric carcinoma.'),
(2925, 'hsa-mir-10b', 'gastric cancer', 'down', 'DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.'),
(2926, 'hsa-mir-1207-5p', 'gastric cancer', 'down', 'miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.'),
(2927, 'hsa-mir-122', 'gastric cancer', 'down', 'Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.'),
(2928, 'hsa-mir-1228*', 'gastric cancer', 'down', 'Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.'),
(2929, 'hsa-mir-124', 'gastric cancer', 'down', 'microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.'),
(2930, 'hsa-mir-124', 'gastric cancer', 'down', 'miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.'),
(2931, 'hsa-mir-124', 'gastric cancer', 'down', '[miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism].'),
(2932, 'hsa-mir-124-3p', 'gastric cancer', 'down', 'The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.'),
(2933, 'hsa-mir-1259', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2934, 'hsa-mir-125a-3p', 'gastric cancer', 'down', 'Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.'),
(2935, 'hsa-mir-125b', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2936, 'hsa-mir-125b', 'gastric cancer', 'up', 'MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis.'),
(2937, 'hsa-mir-126', 'gastric cancer', 'down', 'miR-126 functions as a tumour suppressor in human gastric cancer.'),
(2938, 'hsa-mir-126', 'gastric cancer', 'up', 'MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.'),
(2939, 'hsa-mir-126', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2940, 'hsa-mir-126', 'gastric cancer', 'down', 'Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2.'),
(2941, 'hsa-mir-126', 'gastric cancer', 'down', 'Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A.'),
(2942, 'hsa-mir-126', 'gastric cancer', 'down', 'MicroRNA-126 inhibits cell proliferation in gastric cancer by targeting LAT-1.'),
(2943, 'hsa-mir-1266', 'gastric cancer', 'down', 'miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.'),
(2944, 'hsa-mir-127', 'gastric cancer', 'down', 'The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.'),
(2945, 'hsa-mir-1271', 'gastric cancer', 'down', 'miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2.'),
(2946, 'hsa-mir-1274a', 'gastric cancer', 'up', 'The role of microRNA-1274a in the tumorigenesis of gastric cancer: accelerating cancer cell proliferation and migration via directly targeting FOXO4.'),
(2947, 'hsa-mir-129-1-3p', 'gastric cancer', 'down', 'Growth inhibitory effects of three miR-129 family members on gastric cancer.'),
(2948, 'hsa-mir-129-2-3p', 'gastric cancer', 'down', 'Growth inhibitory effects of three miR-129 family members on gastric cancer.'),
(2949, 'hsa-mir-129-3p', 'gastric cancer', 'down', 'Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.'),
(2950, 'hsa-mir-129-5p', 'gastric cancer', 'down', 'Growth inhibitory effects of three miR-129 family members on gastric cancer.'),
(2951, 'hsa-mir-129-5p', 'gastric cancer', 'down', 'lncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis.'),
(2952, 'hsa-mir-1303', 'gastric cancer', 'up', 'miR-1303 Targets Claudin-18 Gene to Modulate Proliferation and Invasion of Gastric Cancer Cells.'),
(2953, 'hsa-mir-130b*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2954, 'hsa-mir-133a', 'gastric cancer', 'down', 'MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.'),
(2955, 'hsa-mir-133a', 'gastric cancer', 'down', 'MicroRNA-133a functions as a tumor suppressor in gastric cancer.'),
(2956, 'hsa-mir-133a', 'gastric cancer', 'down', 'Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.'),
(2957, 'hsa-mir-133a', 'gastric cancer', 'down', 'MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.'),
(2958, 'hsa-mir-133b', 'gastric cancer', 'down', 'MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.'),
(2959, 'hsa-mir-133b', 'gastric cancer', 'down', 'The role of microRNA-133b and its target gene FSCN1 in gastric cancer.'),
(2960, 'hsa-mir-133b', 'gastric cancer', 'down', 'miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.'),
(2961, 'hsa-mir-133b', 'gastric cancer', 'down', 'MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.'),
(2962, 'hsa-mir-135a-5p', 'gastric cancer', 'up', 'Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p.'),
(2963, 'hsa-mir-135b', 'gastric cancer', 'up', '[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].'),
(2964, 'hsa-mir-137', 'gastric cancer', 'down', 'miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.'),
(2965, 'hsa-mir-138', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2966, 'hsa-mir-141', 'gastric cancer', 'down', 'Down-regulation of miR-141 in gastric cancer and its involvement in cell growth.'),
(2967, 'hsa-mir-141', 'gastric cancer', 'down', 'miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.'),
(2968, 'hsa-mir-141', 'gastric cancer', 'down', 'The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.'),
(2969, 'hsa-mir-141', 'gastric cancer', 'down', 'MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.'),
(2970, 'hsa-mir-143', 'gastric cancer', 'down', 'Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.'),
(2971, 'hsa-mir-143', 'gastric cancer', 'down', '[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].'),
(2972, 'hsa-mir-143', 'gastric cancer', 'up', 'Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.'),
(2973, 'hsa-mir-143', 'gastric cancer', 'down', 'MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.'),
(2974, 'hsa-mir-144', 'gastric cancer', 'down', 'MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression.'),
(2975, 'hsa-mir-145', 'gastric cancer', 'down', 'MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.'),
(2976, 'hsa-mir-145', 'gastric cancer', 'down', '[Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].'),
(2977, 'hsa-mir-146a', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(2978, 'hsa-mir-146a', 'gastric cancer', 'down', 'Clinical significance of miR-146a in gastric cancer cases.'),
(2979, 'hsa-mir-146a', 'gastric cancer', 'down', 'microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.'),
(2980, 'hsa-mir-146a', 'gastric cancer', 'up', 'microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer.'),
(2981, 'hsa-mir-146a', 'gastric cancer', 'down', 'MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.'),
(2982, 'hsa-mir-146a-5p', 'gastric cancer', 'down', 'The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.'),
(2983, 'hsa-mir-147', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2984, 'hsa-mir-148a', 'gastric cancer', 'down', 'The role of miR-148a in gastric cancer.'),
(2985, 'hsa-mir-148a', 'gastric cancer', 'up', 'miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.'),
(2986, 'hsa-mir-148a', 'gastric cancer', 'down', '[Impact of miR-148a on the proliferation of gastric carcinoma MKN45 cells and its mechanism].'),
(2987, 'hsa-mir-148a', 'gastric cancer', 'down', 'MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.'),
(2988, 'hsa-mir-148a', 'gastric cancer', 'down', 'MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.'),
(2989, 'hsa-mir-148a', 'gastric cancer', 'down', 'microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.'),
(2990, 'hsa-mir-148a', 'gastric cancer', 'down', 'MiR-148a is down-regulated in gastric cancer, targets MMP7 and indicates tumor invasiveness and poor prognosis.'),
(2991, 'hsa-mir-148b', 'gastric cancer', 'down', 'MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.'),
(2992, 'hsa-mir-149', 'gastric cancer', 'down', 'MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.'),
(2993, 'hsa-mir-150', 'gastric cancer', 'up', 'MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.'),
(2994, 'hsa-mir-152', 'gastric cancer', 'down', 'miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151.'),
(2995, 'hsa-mir-155', 'gastric cancer', 'down', 'microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.'),
(2996, 'hsa-mir-155', 'gastric cancer', 'down', 'Downregulation of microRNA-155 accelerates cell growth and invasion by targeting c-myc in human gastric carcinoma cells.'),
(2997, 'hsa-mir-155-5p', 'gastric cancer', 'down', 'The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.'),
(2998, 'hsa-mir-17', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(2999, 'hsa-mir-17', 'gastric cancer', 'up', 'Overexpression of miR-17 in gastric cancer is correlated with proliferation-associated oncogene amplification.'),
(3000, 'hsa-mir-17', 'gastric cancer', 'up', 'Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression.'),
(3001, 'hsa-mir-17-5p', 'gastric cancer', 'up', 'Circulating microRNAs in plasma of patients with gastric cancers.'),
(3002, 'hsa-mir-17-5p', 'gastric cancer', 'up', 'Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.'),
(3003, 'hsa-mir-17-5p', 'gastric cancer', 'up', 'miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.'),
(3004, 'hsa-mir-181a', 'gastric cancer', 'up', 'MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.'),
(3005, 'hsa-mir-181a', 'gastric cancer', 'up', 'Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.'),
(3006, 'hsa-mir-181a', 'gastric cancer', 'down', 'MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer.'),
(3007, 'hsa-mir-181a-2*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3008, 'hsa-mir-181a-5p', 'gastric cancer', 'up', 'Hsa-miR-181a-5p Expression and Effects on Cell Proliferation in Gastric Cancer.'),
(3009, 'hsa-mir-181b', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3010, 'hsa-mir-181c', 'gastric cancer', 'up', 'Upregulation of MicroRNA 181c Expression in Gastric Cancer Tissues and Plasma.'),
(3011, 'hsa-mir-182', 'gastric cancer', 'down', 'MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.'),
(3012, 'hsa-mir-183', 'gastric cancer', 'down', 'miR-183 inhibits invasion of gastric cancer by targeting Ezrin.'),
(3013, 'hsa-mir-183', 'gastric cancer', 'up', 'MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4.'),
(3014, 'hsa-mir-183', 'gastric cancer', 'down', 'MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1.'),
(3015, 'hsa-mir-185', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3016, 'hsa-mir-185', 'gastric cancer', 'down', 'miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer.'),
(3017, 'hsa-mir-18a', 'gastric cancer', 'up', 'Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.'),
(3018, 'hsa-mir-18a', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3019, 'hsa-mir-191', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3020, 'hsa-mir-192', 'gastric cancer', 'up', 'MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.'),
(3021, 'hsa-mir-192', 'gastric cancer', 'up', 'Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.'),
(3022, 'hsa-mir-192', 'gastric cancer', 'up', 'MiR-215/192 participates in gastric cancer progression.'),
(3023, 'hsa-mir-194', 'gastric cancer', 'down', 'miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells.'),
(3024, 'hsa-mir-194', 'gastric cancer', 'down', 'MicroRNA-194 Inhibits the Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1.'),
(3025, 'hsa-mir-195', 'gastric cancer', 'down', 'MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.'),
(3026, 'hsa-mir-196a', 'gastric cancer', 'up', 'MiR-196a Is Up-regulated in Gastric cancer and Promotes Cell proliferation by Down-regulating p27kip1.'),
(3027, 'hsa-mir-196a*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3028, 'hsa-mir-196a-5p', 'gastric cancer', 'up', 'Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.'),
(3029, 'hsa-mir-196b', 'gastric cancer', 'up', 'Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.'),
(3030, 'hsa-mir-196b', 'gastric cancer', 'up', 'Epigenetic regulation of miR-196b expression in gastric cancer.'),
(3031, 'hsa-mir-197', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3032, 'hsa-mir-199a', 'gastric cancer', 'up', 'miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer.'),
(3033, 'hsa-mir-199a-3p', 'gastric cancer', 'down', 'MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation.'),
(3034, 'hsa-mir-199a-3p', 'gastric cancer', 'up', 'MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.'),
(3035, 'hsa-mir-199a-5p', 'gastric cancer', 'up', 'Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho.'),
(3036, 'hsa-mir-19a', 'gastric cancer', 'up', 'MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.'),
(3037, 'hsa-mir-19a', 'gastric cancer', 'up', 'miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer.'),
(3038, 'hsa-mir-19a', 'gastric cancer', 'up', 'MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.'),
(3039, 'hsa-mir-19a', 'gastric cancer', 'up', 'MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.'),
(3040, 'hsa-mir-19b', 'gastric cancer', 'up', 'MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.'),
(3041, 'hsa-mir-19b', 'gastric cancer', 'up', 'MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.'),
(3042, 'hsa-mir-200b', 'gastric cancer', 'up', 'MicroRNA-200b Regulates Cell Proliferation, Invasion, and Migration by Directly Targeting ZEB2 in Gastric Carcinoma.'),
(3043, 'hsa-mir-200b', 'gastric cancer', 'down', 'miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.'),
(3044, 'hsa-mir-200c', 'gastric cancer', 'down', 'miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.'),
(3045, 'hsa-mir-200c', 'gastric cancer', 'down', 'The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.'),
(3046, 'hsa-mir-202-3p', 'gastric cancer', 'down', 'Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer.'),
(3047, 'hsa-mir-204', 'gastric cancer', 'down', 'MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.'),
(3048, 'hsa-mir-204-5p', 'gastric cancer', 'down', 'MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.'),
(3049, 'hsa-mir-205', 'gastric cancer', 'down', 'Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation.'),
(3050, 'hsa-mir-206', 'gastric cancer', 'down', 'MicroRNA-206 suppresses gastric cancer cell growth and metastasis.'),
(3051, 'hsa-mir-206', 'gastric cancer', 'down', 'Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.'),
(3052, 'hsa-mir-206', 'gastric cancer', 'down', 'MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2.'),
(3053, 'hsa-mir-206', 'gastric cancer', 'down', 'Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.'),
(3054, 'hsa-mir-20a', 'gastric cancer', 'up', 'Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2).'),
(3055, 'hsa-mir-21', 'gastric cancer', 'up', 'Oxidative Stress Upregulates PDCD4 Expression in Patients with Gastric Cancer via miR-21.'),
(3056, 'hsa-mir-21', 'gastric cancer', 'up', 'microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.'),
(3057, 'hsa-mir-21', 'gastric cancer', 'up', 'Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.'),
(3058, 'hsa-mir-21', 'gastric cancer', 'up', 'MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.'),
(3059, 'hsa-mir-21', 'gastric cancer', 'up', 'MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.'),
(3060, 'hsa-mir-21', 'gastric cancer', 'up', 'miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.'),
(3061, 'hsa-mir-21', 'gastric cancer', 'up', 'miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.'),
(3062, 'hsa-mir-21', 'gastric cancer', 'up', 'Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer.'),
(3063, 'hsa-mir-21', 'gastric cancer', 'up', 'Circulating microRNAs in plasma of patients with gastric cancers.'),
(3064, 'hsa-mir-21', 'gastric cancer', 'up', 'Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.'),
(3065, 'hsa-mir-21', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3066, 'hsa-mir-21', 'gastric cancer', 'up', 'Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.'),
(3067, 'hsa-mir-210', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3068, 'hsa-mir-212', 'gastric cancer', 'down', 'miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.'),
(3069, 'hsa-mir-212', 'gastric cancer', 'down', 'Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.'),
(3070, 'hsa-mir-214', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3071, 'hsa-mir-214', 'gastric cancer', 'up', 'Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein.'),
(3072, 'hsa-mir-214', 'gastric cancer', 'up', 'Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.'),
(3073, 'hsa-mir-214', 'gastric cancer', 'up', 'Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.'),
(3074, 'hsa-mir-215', 'gastric cancer', 'up', 'MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro.'),
(3075, 'hsa-mir-215', 'gastric cancer', 'up', 'MiR-215 modulates gastric cancer cell proliferation by targeting RB1.'),
(3076, 'hsa-mir-215', 'gastric cancer', 'up', 'MiR-215/192 participates in gastric cancer progression.'),
(3077, 'hsa-mir-217', 'gastric cancer', 'down', 'microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.'),
(3078, 'hsa-mir-218', 'gastric cancer', 'down', 'Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.'),
(3079, 'hsa-mir-218', 'gastric cancer', 'down', 'Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis.'),
(3080, 'hsa-mir-218', 'gastric cancer', 'down', 'MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin.'),
(3081, 'hsa-mir-218', 'gastric cancer', 'down', 'Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin.'),
(3082, 'hsa-mir-218', 'gastric cancer', 'down', 'Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.'),
(3083, 'hsa-mir-218', 'gastric cancer', 'down', '[Reduced expression of miR-218 and its significance in gastric cancer].'),
(3084, 'hsa-mir-22', 'gastric cancer', 'down', 'miR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.'),
(3085, 'hsa-mir-22', 'gastric cancer', 'down', 'microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.'),
(3086, 'hsa-mir-22', 'gastric cancer', 'down', 'miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.'),
(3087, 'hsa-mir-22', 'gastric cancer', 'down', 'Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis.'),
(3088, 'hsa-mir-221', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3089, 'hsa-mir-221', 'gastric cancer', 'up', 'Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.'),
(3090, 'hsa-mir-221', 'gastric cancer', 'up', 'Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.'),
(3091, 'hsa-mir-221*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3092, 'hsa-mir-222', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3093, 'hsa-mir-222', 'gastric cancer', 'up', 'Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.'),
(3094, 'hsa-mir-222', 'gastric cancer', 'up', 'Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.'),
(3095, 'hsa-mir-222', 'gastric cancer', 'up', 'Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.'),
(3096, 'hsa-mir-222', 'gastric cancer', 'up', 'miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.'),
(3097, 'hsa-mir-223', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3098, 'hsa-mir-223', 'gastric cancer', 'up', 'MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.'),
(3099, 'hsa-mir-223', 'gastric cancer', 'up', 'Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.'),
(3100, 'hsa-mir-223', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3101, 'hsa-mir-224', 'gastric cancer', 'up', '[Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis].'),
(3102, 'hsa-mir-23a', 'gastric cancer', 'up', 'MiR-23a in Amplified 19p13.13 Loci Targets Metallothionein 2A and Promotes Growth in Gastric Cancer Cells.'),
(3103, 'hsa-mir-23a', 'gastric cancer', 'up', 'Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.'),
(3104, 'hsa-mir-23a', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3105, 'hsa-mir-23b', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3106, 'hsa-mir-23b', 'gastric cancer', 'up', 'Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.'),
(3107, 'hsa-mir-23b', 'gastric cancer', 'down', 'The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.'),
(3108, 'hsa-mir-24', 'gastric cancer', 'down', 'Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV.'),
(3109, 'hsa-mir-25', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3110, 'hsa-mir-25', 'gastric cancer', 'up', 'miR-25 promotes gastric cancer cells growth and motility by targeting RECK.'),
(3111, 'hsa-mir-25', 'gastric cancer', 'up', 'MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.'),
(3112, 'hsa-mir-26a', 'gastric cancer', 'down', 'miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer.'),
(3113, 'hsa-mir-27a', 'gastric cancer', 'up', 'Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells.'),
(3114, 'hsa-mir-27a', 'gastric cancer', 'up', 'miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.'),
(3115, 'hsa-mir-27b', 'gastric cancer', 'up', 'miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.'),
(3116, 'hsa-mir-296-5p', 'gastric cancer', 'up', 'MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1.'),
(3117, 'hsa-mir-29a', 'gastric cancer', 'down', 'MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout homolog 1 in gastric cancer cells.'),
(3118, 'hsa-mir-29a', 'gastric cancer', 'down', 'Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.'),
(3119, 'hsa-mir-29a', 'gastric cancer', 'down', 'MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer.'),
(3120, 'hsa-mir-29a', 'gastric cancer', 'down', 'miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.'),
(3121, 'hsa-mir-29a', 'gastric cancer', 'down', 'MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.'),
(3122, 'hsa-mir-29a-3p', 'gastric cancer', 'down', 'Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.'),
(3123, 'hsa-mir-29b', 'gastric cancer', 'down', 'MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.'),
(3124, 'hsa-mir-29b', 'gastric cancer', 'down25428377', 'MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.'),
(3125, 'hsa-mir-29b', 'gastric cancer', 'down', 'Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.'),
(3126, 'hsa-mir-29b-1', 'gastric cancer', 'down', 'Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.'),
(3127, 'hsa-mir-29b-2', 'gastric cancer', 'down', 'Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.'),
(3128, 'hsa-mir-29c', 'gastric cancer', 'down', 'MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.'),
(3129, 'hsa-mir-29c', 'gastric cancer', 'down', 'MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.'),
(3130, 'hsa-mir-29c', 'gastric cancer', 'down', 'Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.'),
(3131, 'hsa-mir-29c', 'gastric cancer', 'down', 'Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.'),
(3132, 'hsa-mir-29c', 'gastric cancer', 'down', 'The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.'),
(3133, 'hsa-mir-29c', 'gastric cancer', 'down', 'MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2.'),
(3134, 'hsa-mir-29c', 'gastric cancer', 'down', '[Relationship between the expression level of miR-29c and biological behavior of gastric cancer].'),
(3135, 'hsa-mir-301a', 'gastric cancer', 'up', 'Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.'),
(3136, 'hsa-mir-301a', 'gastric cancer', 'up', 'Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.'),
(3137, 'hsa-mir-302f', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3138, 'hsa-mir-30a-5p', 'gastric cancer', 'down', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3139, 'hsa-mir-30b', 'gastric cancer', 'down', 'miR-30b, Down-Regulated in Gastric Cancer, Promotes Apoptosis and Suppresses Tumor Growth by Targeting Plasminogen Activator Inhibitor-1.'),
(3140, 'hsa-mir-31', 'gastric cancer', 'down', 'Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance.'),
(3141, 'hsa-mir-328', 'gastric cancer', 'down', 'Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.'),
(3142, 'hsa-mir-329', 'gastric cancer', 'down', 'By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.'),
(3143, 'hsa-mir-331-3p', 'gastric cancer', 'down', 'miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.'),
(3144, 'hsa-mir-335-5p', 'gastric cancer', 'down', 'The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.'),
(3145, 'hsa-mir-337-3p', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3146, 'hsa-mir-338', 'gastric cancer', 'down', 'MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression.'),
(3147, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.'),
(3148, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a.'),
(3149, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.'),
(3150, 'hsa-mir-340*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3151, 'hsa-mir-34a', 'gastric cancer', 'down', 'Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.'),
(3152, 'hsa-mir-34a', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3153, 'hsa-mir-34a', 'gastric cancer', 'down', 'The prognostic value of miR-34a expression in completely resected gastric cancer: tumor recurrence and overall survival.'),
(3154, 'hsa-mir-34a', 'gastric cancer', 'down', 'Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.'),
(3155, 'hsa-mir-34a', 'gastric cancer', 'down', 'Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(3156, 'hsa-mir-34a', 'gastric cancer', 'down', 'microRNA-34a Inhibits the Growth, Invasion and Metastasis of Gastric Cancer by Targeting PDGFR and MET Expression.'),
(3157, 'hsa-mir-34a', 'gastric cancer', 'down', 'MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.'),
(3158, 'hsa-mir-34b', 'gastric cancer', 'down', 'Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.'),
(3159, 'hsa-mir-34c', 'gastric cancer', 'down', 'Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.'),
(3160, 'hsa-mir-361-5p', 'gastric cancer', 'down', 'MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.'),
(3161, 'hsa-mir-362-3p', 'gastric cancer', 'up', 'Erratum to: Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.'),
(3162, 'hsa-mir-362-3p', 'gastric cancer', 'up', 'Anti-miR-362-3p Inhibits Migration and Invasion of Human Gastric Cancer Cells by Its Target CD82.'),
(3163, 'hsa-mir-367', 'gastric cancer', 'down', 'The microRNA-367 Inhibits the Invasion and Metastasis of Gastric Cancer by Directly Repressing Rab23.'),
(3164, 'hsa-mir-370', 'gastric cancer', 'up', 'Overexpression of miR-370 and downregulation of its novel target TGF?-RII contribute to the progression of gastric carcinoma.'),
(3165, 'hsa-mir-370', 'gastric cancer', 'up', 'Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.'),
(3166, 'hsa-mir-374a', 'gastric cancer', 'up', 'miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.'),
(3167, 'hsa-mir-375', 'gastric cancer', 'down', 'MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.'),
(3168, 'hsa-mir-375', 'gastric cancer', 'down', 'MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.'),
(3169, 'hsa-mir-375', 'gastric cancer', 'down', 'miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression.'),
(3170, 'hsa-mir-375', 'gastric cancer', 'down', 'Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.'),
(3171, 'hsa-mir-377', 'gastric cancer', 'up', 'MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.'),
(3172, 'hsa-mir-378', 'gastric cancer', 'down', 'MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.'),
(3173, 'hsa-mir-378', 'gastric cancer', 'down', 'MicroRNA profiling of human gastric cancer.'),
(3174, 'hsa-mir-409-3p', 'gastric cancer', 'down', 'MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.'),
(3175, 'hsa-mir-409-3p', 'gastric cancer', 'down', 'MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.'),
(3176, 'hsa-mir-410', 'gastric cancer', 'down', 'MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.'),
(3177, 'hsa-mir-421', 'gastric cancer', 'up', 'Increased expression of miR-421 in human gastric carcinoma and its clinical association.'),
(3178, 'hsa-mir-421', 'gastric cancer', 'up', 'MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3.'),
(3179, 'hsa-mir-421', 'gastric cancer', 'up', 'MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.'),
(3180, 'hsa-mir-425', 'gastric cancer', 'up', 'NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1? induction.'),
(3181, 'hsa-mir-429', 'gastric cancer', 'down', 'miR-429 modulates the expression of c-myc in human gastric carcinoma cells.'),
(3182, 'hsa-mir-433', 'gastric cancer', 'down', 'Down-regulated miR-9 and miR-433 in human gastric carcinoma.'),
(3183, 'hsa-mir-433', 'gastric cancer', 'down', 'The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer.'),
(3184, 'hsa-mir-449', 'gastric cancer', 'down', 'miR-449 inhibits cell proliferation and is down-regulated in gastric cancer.'),
(3185, 'hsa-mir-449a', 'gastric cancer', 'down', 'miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells.'),
(3186, 'hsa-mir-449a', 'gastric cancer', 'down', 'miR-449a and CDK6 in gastric carcinoma.'),
(3187, 'hsa-mir-490-3p', 'gastric cancer', 'down', 'Epigenetic Silencing of miR-490-3p Reactivates the Chromatin Remodeler SMARCD1 to Promote Helicobacter pylori-Induced Gastric Carcinogenesis.'),
(3188, 'hsa-mir-494', 'gastric cancer', 'down', 'miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.'),
(3189, 'hsa-mir-497', 'gastric cancer', 'down', 'The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.'),
(3190, 'hsa-mir-500', 'gastric cancer', 'up', 'MicroRNA-500 sustains nuclear factor-?B activation and induces gastric cancer cell proliferation and resistance to apoptosis.'),
(3191, 'hsa-mir-503', 'gastric cancer', 'down', 'MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.'),
(3192, 'hsa-mir-503', 'gastric cancer', 'down', 'microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition.'),
(3193, 'hsa-mir-506', 'gastric cancer', 'down', 'MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.'),
(3194, 'hsa-mir-513b', 'gastric cancer', 'down', 'Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.'),
(3195, 'hsa-mir-520c-3p', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3196, 'hsa-mir-520d-3p', 'gastric cancer', 'down', 'MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.'),
(3197, 'hsa-mir-542-3p', 'gastric cancer', 'down', 'MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1.'),
(3198, 'hsa-mir-544', 'gastric cancer', 'up', 'Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer.'),
(3199, 'hsa-mir-575', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3200, 'hsa-mir-601', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3201, 'hsa-mir-616*', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3202, 'hsa-mir-622', 'gastric cancer', 'down', 'Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene.'),
(3203, 'hsa-mir-625', 'gastric cancer', 'down', 'Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.'),
(3204, 'hsa-mir-638', 'gastric cancer', 'down', 'miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2.'),
(3205, 'hsa-mir-638', 'gastric cancer', 'down', 'MicroRNA profiling of human gastric cancer.'),
(3206, 'hsa-mir-650', 'gastric cancer', 'up', 'MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.'),
(3207, 'hsa-mir-663', 'gastric cancer', 'down', 'Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.'),
(3208, 'hsa-mir-7', 'gastric cancer', 'down', 'MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.'),
(3209, 'hsa-mir-874', 'gastric cancer', 'down', 'miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer.'),
(3210, 'hsa-mir-874', 'gastric cancer', 'down', 'miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.'),
(3211, 'hsa-mir-9', 'gastric cancer', 'down', 'Down-regulated miR-9 and miR-433 in human gastric carcinoma.'),
(3212, 'hsa-mir-9', 'gastric cancer', 'down', 'Aberrant hypermethylation of miR-9 genes in gastric cancer.'),
(3213, 'hsa-mir-9', 'gastric cancer', 'down', 'Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.'),
(3214, 'hsa-mir-9', 'gastric cancer', 'down', 'microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1.'),
(3215, 'hsa-mir-9', 'gastric cancer', 'down', 'Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.'),
(3216, 'hsa-mir-92', 'gastric cancer', 'up', 'MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR.'),
(3217, 'hsa-mir-92', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3218, 'hsa-mir-98', 'gastric cancer', 'up', 'MicroRNA profiling of human gastric cancer.'),
(3219, 'hsa-mir-99a', 'gastric cancer', 'up', 'miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.'),
(3220, 'hsa-mir-100-5p', 'gastric cancer', 'down', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3221, 'hsa-mir-10b', 'gastric cancer', 'up', 'Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma.'),
(3222, 'hsa-mir-10b', 'gastric cancer', 'up', 'MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.'),
(3223, 'hsa-mir-1271', 'gastric cancer', 'down', 'MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.'),
(3224, 'hsa-mir-132', 'gastric cancer', 'up', 'Upregulation of microRNA-132 in gastric cancer promotes cell proliferation via retinoblastoma 1 targeting.'),
(3225, 'hsa-mir-132', 'gastric cancer', 'up', 'miR-132 upregulation promotes gastric cancer cell growth through suppression of FoxO1 translation.'),
(3226, 'hsa-mir-133b', 'gastric cancer', 'down', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3227, 'hsa-mir-141', 'gastric cancer', 'down', 'MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.'),
(3228, 'hsa-mir-153', 'gastric cancer', 'down', 'MiR-153 regulates metastases of gastric cancer through Snail.'),
(3229, 'hsa-mir-18a', 'gastric cancer', 'up', 'MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.'),
(3230, 'hsa-mir-200a-3p', 'gastric cancer', 'up', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3231, 'hsa-mir-203', 'gastric cancer', 'down', 'Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.'),
(3232, 'hsa-mir-206', 'gastric cancer', 'down', 'MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.'),
(3233, 'hsa-mir-20a', 'gastric cancer', 'up', 'miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.'),
(3234, 'hsa-mir-20b', 'gastric cancer', 'up', 'miR-20b overexpression is predictive of poor prognosis in gastric cancer.'),
(3235, 'hsa-mir-215', 'gastric cancer', 'up', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3236, 'hsa-mir-217', 'gastric cancer', 'down', 'The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.'),
(3237, 'hsa-mir-30b', 'gastric cancer', 'down', 'MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.'),
(3238, 'hsa-mir-363-3p', 'gastric cancer', 'down', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3239, 'hsa-mir-425-5p', 'gastric cancer', 'up', 'microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo.'),
(3240, 'hsa-mir-429', 'gastric cancer', 'up', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3241, 'hsa-mir-449c', 'gastric cancer', 'down', 'MiR-449c inhibits gastric carcinoma growth.'),
(3242, 'hsa-mir-551b-3p', 'gastric cancer', 'down', 'Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.'),
(3243, 'hsa-mir-638', 'gastric cancer', 'down', 'MicroRNA-638 inhibits cell proliferation by targeting phospholipase D1 in human gastric carcinoma.'),
(3244, 'hsa-mir-940', 'gastric cancer', 'up', 'MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.'),
(3245, 'hsa-mir-100', 'gastric cancer', 'down', 'C/EBP?-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.'),
(3246, 'hsa-mir-101', 'gastric cancer', 'down', 'MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.'),
(3247, 'hsa-mir-107', 'gastric cancer', 'up', 'Increased levels of serum and tissue miR-107 in human gastric cancer: Correlation with tumor hypoxia.'),
(3248, 'hsa-mir-124', 'gastric cancer', 'down', 'miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.'),
(3249, 'hsa-mir-125b', 'gastric cancer', 'down', 'miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.'),
(3250, 'hsa-mir-128', 'gastric cancer', 'down', 'MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.'),
(3251, 'hsa-mir-128b', 'gastric cancer', 'down', 'MicroRNA-128b suppresses tumor growth and promotes apoptosis by targeting A2bR in gastric cancer.'),
(3252, 'hsa-mir-130a', 'gastric cancer', 'up', 'Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.'),
(3253, 'hsa-mir-137', 'gastric cancer', 'down', 'Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.'),
(3254, 'hsa-mir-21', 'gastric cancer', 'up', 'miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells.'),
(3255, 'hsa-mir-216b', 'gastric cancer', 'down', 'MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.'),
(3256, 'hsa-mir-22', 'gastric cancer', 'down', 'MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.'),
(3257, 'hsa-mir-25', 'gastric cancer', 'up', 'MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.'),
(3258, 'hsa-mir-27a', 'gastric cancer', 'up', 'Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer.'),
(3259, 'hsa-mir-27b', 'gastric cancer', 'down', 'MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.'),
(3260, 'hsa-mir-27b-3p', 'gastric cancer', 'down', 'miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.'),
(3261, 'hsa-mir-31', 'gastric cancer', 'down', 'Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.'),
(3262, 'hsa-mir-32', 'gastric cancer', 'up', 'MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4.'),
(3263, 'hsa-mir-326', 'gastric cancer', 'down', 'Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.'),
(3264, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'miR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17.'),
(3265, 'hsa-mir-339', 'gastric cancer', 'down', 'MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1.'),
(3266, 'hsa-mir-34a', 'gastric cancer', 'down', 'Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.'),
(3267, 'hsa-mir-34a', 'gastric cancer', 'down', 'MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.'),
(3268, 'hsa-mir-429', 'gastric cancer', 'down', 'MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins.'),
(3269, 'hsa-mir-429', 'gastric cancer', 'down', 'MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2.'),
(3270, 'hsa-mir-495', 'gastric cancer', 'up', 'Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.'),
(3271, 'hsa-mir-506', 'gastric cancer', 'down', 'miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.'),
(3272, 'hsa-mir-543', 'gastric cancer', 'up', 'miR-543 promotes gastric cancer cell proliferation by targeting SIRT1.'),
(3273, 'hsa-mir-627', 'gastric cancer', 'up', 'A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.'),
(3274, 'hsa-mir-629', 'gastric cancer', 'up', 'A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.'),
(3275, 'hsa-mir-652', 'gastric cancer', 'up', 'A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.'),
(3276, 'hsa-mir-940', 'gastric cancer', 'down', 'Plasma miR-940 may serve as a novel biomarker for gastric cancer.'),
(3277, 'hsa-mir-106a', 'gastric cancer', 'up', 'Diagnostic significance of miR-106a in gastric cancer.'),
(3278, 'hsa-mir-1225-5p', 'gastric cancer', 'down', 'MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of ?-catenin signaling.'),
(3279, 'hsa-mir-1284', 'gastric cancer', 'down', 'miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.'),
(3280, 'hsa-mir-128b', 'gastric cancer', 'down', 'MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-?B axis.'),
(3281, 'hsa-mir-1290', 'gastric cancer', 'up', 'sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells.'),
(3282, 'hsa-mir-148a', 'gastric cancer', 'down', 'miR-148a downregulates the expression of transforming growth factor-?2 and SMAD2 in gastric cancer.'),
(3283, 'hsa-mir-15a', 'gastric cancer', 'down', 'Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.'),
(3284, 'hsa-mir-183', 'gastric cancer', 'up', 'MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer.'),
(3285, 'hsa-mir-203', 'gastric cancer', 'down', 'MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.'),
(3286, 'hsa-mir-204', 'gastric cancer', 'down', 'miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer.'),
(3287, 'hsa-mir-211', 'gastric cancer', 'down', 'MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.'),
(3288, 'hsa-mir-23b', 'gastric cancer', 'up', 'Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.'),
(3289, 'hsa-mir-31', 'gastric cancer', 'down', 'Upregulation of microRNA-31 targeting integrin ?5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells.'),
(3290, 'hsa-mir-340', 'gastric cancer', 'up', 'Effect of miR-340 on gastric cancer cell proliferation and apoptosis.'),
(3291, 'hsa-mir-448', 'gastric cancer', 'down', 'miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.'),
(3292, 'hsa-mir-448', 'gastric cancer', 'up', 'MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.'),
(3293, 'hsa-mir-449a', 'gastric cancer', 'down', 'MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.'),
(3294, 'hsa-mir-485-5p', 'gastric cancer', 'down', 'miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.'),
(3295, 'hsa-mir-488', 'gastric cancer', 'down', 'miR-488 acts as a tumor suppressor gene in gastric cancer.'),
(3296, 'hsa-mir-490', 'gastric cancer', 'down', 'The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1.'),
(3297, 'hsa-mir-493', 'gastric cancer', 'up', 'miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.'),
(3298, 'hsa-mir-493', 'gastric cancer', 'down', 'MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.'),
(3299, 'hsa-mir-508-3p', 'gastric cancer', 'down', 'miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-?B signaling in gastric carcinogenesis.'),
(3300, 'hsa-mir-524-5p', 'gastric cancer', 'down', 'MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.'),
(3301, 'hsa-mir-577', 'gastric cancer', 'down', 'MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3.'),
(3302, 'hsa-mir-935', 'gastric cancer', 'down', 'miR-935 suppresses gastric signet ring cell carcinoma tumorigenesis by targeting Notch1 expression.'),
(3303, 'hsa-mir-106a', 'gastric cancer', 'up', 'MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.'),
(3304, 'hsa-mir-125b', 'gastric cancer', 'up', 'MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1.'),
(3305, 'hsa-mir-145-5p', 'gastric cancer', 'down', 'MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.'),
(3306, 'hsa-mir-151-5p', 'gastric cancer', 'up', 'Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.'),
(3307, 'hsa-mir-186', 'gastric cancer', 'down', 'MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1? regulation.'),
(3308, 'hsa-mir-203', 'gastric cancer', 'down', 'MiRNA-203 suppresses tumor cell proliferation, migration and invasion by targeting Slug in gastric cancer.'),
(3309, 'hsa-mir-204', 'gastric cancer', 'down', 'Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.'),
(3310, 'hsa-mir-223', 'gastric cancer', 'down', 'miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1.'),
(3311, 'hsa-mir-29a', 'gastric cancer', 'down', 'Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.'),
(3312, 'hsa-mir-29c', 'gastric cancer', 'down', 'Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.'),
(3313, 'hsa-mir-31', 'gastric cancer', 'down', 'Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.'),
(3314, 'hsa-mir-337-3p', 'gastric cancer', 'down', 'miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.'),
(3315, 'hsa-mir-363', 'gastric cancer', 'up', 'miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.'),
(3316, 'hsa-mir-371-5p', 'gastric cancer', 'up', 'MicroRNA-371-5p targets SOX2 in gastric cancer.'),
(3317, 'hsa-mir-421', 'gastric cancer', 'up', 'MicroRNA-421 regulated by HIF-1? promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.'),
(3318, 'hsa-mir-485-5p', 'gastric cancer', 'down', 'Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.'),
(3319, 'hsa-mir-130a', 'gastric cancer', 'up', 'Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.'),
(3320, 'hsa-mir-130b', 'gastric cancer', 'up', 'Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.'),
(3321, 'hsa-mir-135a', 'gastric cancer', 'down', 'miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.'),
(3322, 'hsa-mir-137', 'gastric cancer', 'down', 'miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.'),
(3323, 'hsa-mir-140', 'gastric cancer', 'down', 'MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4.'),
(3324, 'hsa-mir-145-5p', 'gastric cancer', 'down', 'Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.'),
(3325, 'hsa-mir-148a', 'gastric cancer', 'down', 'MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.'),
(3326, 'hsa-mir-190', 'gastric cancer', 'up', 'MicroRNA-190 regulates FOXP2 genes in human gastric cancer.'),
(3327, 'hsa-mir-193b', 'gastric cancer', 'down', 'MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.'),
(3328, 'hsa-mir-196a', 'gastric cancer', 'up', 'Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.'),
(3329, 'hsa-mir-196b', 'gastric cancer', 'up', 'Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.'),
(3330, 'hsa-mir-203', 'gastric cancer', 'down', 'MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.'),
(3331, 'hsa-mir-21', 'gastric cancer', 'up', 'Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.'),
(3332, 'hsa-mir-214', 'gastric cancer', 'up', 'MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer.'),
(3333, 'hsa-mir-218', 'gastric cancer', 'down', 'miR-218 tissue expression level is associated with aggressive progression of gastric cancer.'),
(3334, 'hsa-mir-26b', 'gastric cancer', 'down', 'MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.'),
(3335, 'hsa-mir-27a-3p', 'gastric cancer', 'up', 'MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.'),
(3336, 'hsa-mir-29b', 'gastric cancer', 'down', 'RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.'),
(3337, 'hsa-mir-301a', 'gastric cancer', 'up', 'Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.'),
(3338, 'hsa-mir-301b', 'gastric cancer', 'up', 'Onco-miR-130 promotes cell proliferation and migration by targeting TGF?R2 in gastric cancer.'),
(3339, 'hsa-mir-302b', 'gastric cancer', 'down', 'miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer.'),
(3340, 'hsa-mir-320a', 'gastric cancer', 'down', 'MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.'),
(3341, 'hsa-mir-33b', 'gastric cancer', 'down', 'Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer.'),
(3342, 'hsa-mir-370', 'gastric cancer', 'down', 'Upregulation of microRNA-370 promotes cell apoptosis and inhibits proliferation by targeting PTEN in human gastric cancer.'),
(3343, 'hsa-mir-429', 'gastric cancer', 'down', 'miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.'),
(3344, 'hsa-mir-455-5p', 'gastric cancer', 'down', 'MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18.'),
(3345, 'hsa-mir-520f', 'gastric cancer', 'down', 'MicroRNA-520f suppresses growth of gastric carcinoma cells by target ATPase family AAA domain-containing protein 2 (ATAD2).'),
(3346, 'hsa-mir-935', 'gastric cancer', 'up', 'miR-935 promotes gastric cancer cell proliferation by targeting SOX7.'),
(3347, 'hsa-mir-107', 'gastric cancer', 'up', 'miR-107 regulates tumor progression by targeting NF1 in gastric cancer.'),
(3348, 'hsa-mir-10b-5p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3349, 'hsa-mir-132-3p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3350, 'hsa-mir-133b', 'gastric cancer', 'down', 'MiR-133b inhibits growth of human gastric cancer cells by silencing PKM-splicer PTBP1.'),
(3351, 'hsa-mir-134', 'gastric cancer', 'down', 'MicroRNA-134 functions as a tumor suppressor gene in gastric cancer.'),
(3352, 'hsa-mir-135a', 'gastric cancer', 'up', 'miR-135a promotes gastric cancer progression and resistance to oxaliplatin.'),
(3353, 'hsa-mir-141', 'gastric cancer', 'down', 'Anti-proliferative role and prognostic implication of miR-141 in gastric cancer.'),
(3354, 'hsa-mir-149-3p', 'gastric cancer', 'down', '18?-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.'),
(3355, 'hsa-mir-17-5p', 'gastric cancer', 'up', 'MicroRNA-17-5p promotes gastric cancer proliferation, migration and invasion by directly targeting early growth response 2.'),
(3356, 'hsa-mir-185-5p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3357, 'hsa-mir-187', 'gastric cancer', 'up', 'MicroRNA-187 regulates gastric cancer progression by targeting the tumor suppressor CRMP1.'),
(3358, 'hsa-mir-194', 'gastric cancer', 'down', 'miR-194 inhibits gastric cancer cell proliferation and tumorigenesis by targeting KDM5B.'),
(3359, 'hsa-mir-194', 'gastric cancer', 'up', 'MiRNA-194 activates the Wnt/?-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.'),
(3360, 'hsa-mir-195-5p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3361, 'hsa-mir-206', 'gastric cancer', 'down', 'Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.'),
(3362, 'hsa-mir-208a-3p', 'gastric cancer', 'down', 'miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.'),
(3363, 'hsa-mir-20a-3p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3364, 'hsa-mir-21', 'gastric cancer', 'up', 'MicroRNA-21 promotes TGF-?1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression.'),
(3365, 'hsa-mir-218', 'gastric cancer', 'down', 'miR-218 inhibits proliferation, migration, and EMT of gastric cancer cells by targeting WASF3.'),
(3366, 'hsa-mir-27b', 'gastric cancer', 'down', 'miR-27b inhibits gastric cancer metastasis by targeting NR2F2.'),
(3367, 'hsa-mir-296-5p', 'gastric cancer', 'up', 'Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.'),
(3368, 'hsa-mir-30a', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3369, 'hsa-mir-30b', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3370, 'hsa-mir-30c-1', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3371, 'hsa-mir-30c-2', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3372, 'hsa-mir-30d', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3373, 'hsa-mir-30e', 'gastric cancer', 'up', 'miR-30 functions as an oncomiR in gastric cancer cells through regulation of P53-mediated mitochondrial apoptotic pathway.'),
(3374, 'hsa-mir-326', 'gastric cancer', 'down', 'MiR-326 inhibits gastric cancer cell growth through down regulating NOB1.'),
(3375, 'hsa-mir-330-3p', 'gastric cancer', 'down', 'MiR-330-3p inhibits gastric cancer progression through targeting MSI1.'),
(3376, 'hsa-mir-375', 'gastric cancer', 'down', 'MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d\'Origine Nantais.'),
(3377, 'hsa-mir-424-5p', 'gastric cancer', 'up', 'miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-? signaling pathway.'),
(3378, 'hsa-mir-501-5p', 'gastric cancer', 'up', 'Upregulation of miR-501-5p activates the wnt/?-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.'),
(3379, 'hsa-mir-502-5p', 'gastric cancer', 'up', 'Rs56288038 (C/G) in 3\'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.'),
(3380, 'hsa-mir-509-3p', 'gastric cancer', 'down', 'MicroRNA-509-3p inhibits cancer cell proliferation and migration via upregulation of XIAP in gastric cancer cells.'),
(3381, 'hsa-mir-524-5p', 'gastric cancer', 'down', 'Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.'),
(3382, 'hsa-mir-558', 'gastric cancer', 'up', 'miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.'),
(3383, 'hsa-mir-561', 'gastric cancer', 'down', 'MicroRNA-561 inhibits gastric cancercell proliferation and invasion by downregulating c-Myc expression.'),
(3384, 'hsa-mir-590-5p', 'gastric cancer', 'up', 'miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway.'),
(3385, 'hsa-mir-101-3p', 'gastric cancer', 'down', 'MiR-101-3p Suppresses HOX Transcript Antisense RNA (HOTAIR)-induced Proliferation and Invasion Through Directly Targeting SRF in Gastric Carcinoma Cells.'),
(3386, 'hsa-mir-126', 'gastric cancer', 'down', 'ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.'),
(3387, 'hsa-mir-1296-5p', 'gastric cancer', 'down', 'miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.'),
(3388, 'hsa-mir-134', 'gastric cancer', 'down', 'MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.'),
(3389, 'hsa-mir-144-3p', 'gastric cancer', 'down', 'MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3.'),
(3390, 'hsa-mir-15a-3p', 'gastric cancer', 'down', 'miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.'),
(3391, 'hsa-mir-16-1-3p', 'gastric cancer', 'down', 'miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.'),
(3392, 'hsa-mir-187', 'gastric cancer', 'up', 'MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.'),
(3393, 'hsa-mir-218', 'gastric cancer', 'down', 'miR-218 suppresses gastric cancer cell proliferation and invasion via regulation of angiopoietin-2.'),
(3394, 'hsa-mir-224', 'gastric cancer', 'up', 'Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.'),
(3395, 'hsa-mir-29c', 'gastric cancer', 'down', 'microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.'),
(3396, 'hsa-mir-320', 'gastric cancer', 'down', 'MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells.'),
(3397, 'hsa-mir-340', 'gastric cancer', 'down', 'miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway.'),
(3398, 'hsa-mir-381', 'gastric cancer', 'down', 'MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.'),
(3399, 'hsa-mir-495', 'gastric cancer', 'down', 'MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).'),
(3400, 'hsa-mir-644a', 'gastric cancer', 'down', 'miR-644a inhibits cellular proliferation and invasion via suppression of CtBP1 in gastric cancer cells.'),
(3401, 'hsa-mir-647', 'gastric cancer', 'down', 'Role of miR-647 in human gastric cancer suppression.'),
(3402, 'hsa-mir-1', 'gastric cancer', 'down', 'MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.'),
(3403, 'hsa-mir-103', 'gastric cancer', 'up', 'miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.'),
(3404, 'hsa-mir-122', 'gastric cancer', 'down', 'MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.'),
(3405, 'hsa-mir-1228', 'gastric cancer', 'down', 'microRNA-1228(?) impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor.'),
(3406, 'hsa-mir-128', 'gastric cancer', 'down', 'The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer.'),
(3407, 'hsa-mir-129-5p', 'gastric cancer', 'down', 'MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1.'),
(3408, 'hsa-mir-135b-5p', 'gastric cancer', 'up', 'Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.'),
(3409, 'hsa-mir-143-3p', 'gastric cancer', 'down', 'MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.'),
(3410, 'hsa-mir-145', 'gastric cancer', 'down', 'MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer.'),
(3411, 'hsa-mir-145-5p', 'gastric cancer', 'down', 'Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.'),
(3412, 'hsa-mir-146a', 'gastric cancer', 'down', 'Clinicopathological significance of the microRNA-146a/WASP-family verprolin-homologous protein-2 axis in gastric cancer.'),
(3413, 'hsa-mir-195', 'gastric cancer', 'down', 'MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.'),
(3414, 'hsa-mir-196a-5p', 'gastric cancer', 'up', 'Differential MicroRNA Expression Between Gastric Cancer Tissue and Non-cancerous Gastric Mucosa According to Helicobacter pylori Status.'),
(3415, 'hsa-mir-200c-3p', 'gastric cancer', 'down', 'A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.'),
(3416, 'hsa-mir-203', 'gastric cancer', 'down', 'Retraction Note: MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.'),
(3417, 'hsa-mir-215', 'gastric cancer', 'up', 'miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1.'),
(3418, 'hsa-mir-217', 'gastric cancer', 'down', 'MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.'),
(3419, 'hsa-mir-218', 'gastric cancer', 'down', 'miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.'),
(3420, 'hsa-mir-2392', 'gastric cancer', 'down', 'MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.'),
(3421, 'hsa-mir-26b-5p', 'gastric cancer', 'down', 'A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients.'),
(3422, 'hsa-mir-27a', 'gastric cancer', 'up', 'MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/?-catenin signaling pathway.'),
(3423, 'hsa-mir-376c', 'gastric cancer', 'up', 'miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma.'),
(3424, 'hsa-mir-425-5p', 'gastric cancer', 'up', 'MiR-425-5p promotes tumor progression via modulation of CYLD in gastric cancer.'),
(3425, 'hsa-mir-429', 'gastric cancer', 'down', 'MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.'),
(3426, 'hsa-mir-455', 'gastric cancer', 'down', 'miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer.'),
(3427, 'hsa-mir-532', 'gastric cancer', 'up', 'miR-532 promoted gastric cancer migration and invasion by targeting NKD1.'),
(3428, 'hsa-mir-551b', 'gastric cancer', 'down', 'miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.'),
(3429, 'hsa-mir-874', 'gastric cancer', 'down', 'Correction: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.'),
(3430, 'hsa-mir-9-3p', 'gastric cancer', 'down', 'Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer.'),
(3431, 'hsa-mir-101', 'gastric cancer', 'down', 'miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.'),
(3432, 'hsa-mir-105', 'gastric cancer', 'down', 'DNMT3A-mediated down-regulation of microRNA-105 promotes gastric cancer cell proliferation.'),
(3433, 'hsa-mir-124', 'gastric cancer', 'down', 'In vivo and in vitro effects of microRNA-124 on human gastric cancer by targeting JAG1 through the Notch signaling pathway.'),
(3434, 'hsa-mir-124', 'gastric cancer', 'down', 'MicroRNA-124 inhibits cell invasion and epithelial-mesenchymal transition by directly repressing Snail2 in gastric cancer.'),
(3435, 'hsa-mir-129-5p', 'gastric cancer', 'down', 'MiR-129-5p influences the progression of gastric cancer cells through interacting with SPOCK1.'),
(3436, 'hsa-mir-133b', 'gastric cancer', 'down', 'miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPAR? in gastric cancer.'),
(3437, 'hsa-mir-133b', 'gastric cancer', 'down', 'MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression.'),
(3438, 'hsa-mir-136', 'gastric cancer', 'down', 'MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.'),
(3439, 'hsa-mir-138', 'gastric cancer', 'down', 'miR-138 inhibits gastric cancer growth by suppressing SOX4.'),
(3440, 'hsa-mir-140-5p', 'gastric cancer', 'down', 'miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.'),
(3441, 'hsa-mir-143', 'gastric cancer', 'down', 'MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.'),
(3442, 'hsa-mir-143', 'gastric cancer', 'down', 'miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.'),
(3443, 'hsa-mir-145', 'gastric cancer', 'down', 'miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.'),
(3444, 'hsa-mir-146a', 'gastric cancer', 'down', 'MiR-146a functions as a small silent player in gastric cancer.'),
(3445, 'hsa-mir-146a', 'gastric cancer', 'up', 'MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor ?-activated kinase 1.'),
(3446, 'hsa-mir-147', 'gastric cancer', 'up', 'Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN.'),
(3447, 'hsa-mir-154', 'gastric cancer', 'down', 'MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling.'),
(3448, 'hsa-mir-154', 'gastric cancer', 'down', 'MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH.'),
(3449, 'hsa-mir-15b-5p', 'gastric cancer', 'up', 'Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.'),
(3450, 'hsa-mir-200c', 'gastric cancer', 'down', 'MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer.'),
(3451, 'hsa-mir-204', 'gastric cancer', 'down', 'SNP rs3202538 in 3\'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.'),
(3452, 'hsa-mir-205', 'gastric cancer', 'down', 'miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.'),
(3453, 'hsa-mir-211', 'gastric cancer', 'down', 'SNP rs3202538 in 3\'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.'),
(3454, 'hsa-mir-215', 'gastric cancer', 'up', 'miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1.'),
(3455, 'hsa-mir-218', 'gastric cancer', 'down', 'miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.'),
(3456, 'hsa-mir-221', 'gastric cancer', 'up', 'miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.'),
(3457, 'hsa-mir-222', 'gastric cancer', 'up', 'miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.'),
(3458, 'hsa-mir-23a', 'gastric cancer', 'up', 'miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.'),
(3459, 'hsa-mir-23b', 'gastric cancer', 'up', 'miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.'),
(3460, 'hsa-mir-26a', 'gastric cancer', 'down', 'miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.'),
(3461, 'hsa-mir-26b', 'gastric cancer', 'down', 'miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.'),
(3462, 'hsa-mir-29a', 'gastric cancer', 'down', 'MicroRNA-29a inhibits cell migration and invasion via targeting Roundabout?homolog 1 in gastric cancer cells.'),
(3463, 'hsa-mir-302b-3p', 'gastric cancer', 'down', 'MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.'),
(3464, 'hsa-mir-30a-5p', 'gastric cancer', 'down', 'MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor.'),
(3465, 'hsa-mir-31', 'gastric cancer', 'down', 'MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.'),
(3466, 'hsa-mir-31', 'gastric cancer', 'down', 'MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.'),
(3467, 'hsa-mir-320a', 'gastric cancer', 'down', 'miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14.'),
(3468, 'hsa-mir-379', 'gastric cancer', 'down', 'MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.'),
(3469, 'hsa-mir-381', 'gastric cancer', 'down', 'MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4.'),
(3470, 'hsa-mir-421', 'gastric cancer', 'up', 'MicroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11.'),
(3471, 'hsa-mir-425-5p', 'gastric cancer', 'up', 'Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.'),
(3472, 'hsa-mir-4317', 'gastric cancer', 'down', 'miRNA-4317 Suppresses Human Gastric Cancer Cell Proliferation by Targeting ZNF322.'),
(3473, 'hsa-mir-451', 'gastric cancer', 'down', 'MiR-451 as a new tumor marker for gastric cancer.'),
(3474, 'hsa-mir-495-3p', 'gastric cancer', 'down', 'MicroRNA-495-3p functions as a tumour suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.'),
(3475, 'hsa-mir-508-5p', 'gastric cancer', 'down', 'MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase?associated protein 2.'),
(3476, 'hsa-mir-519d', 'gastric cancer', 'down', 'MIR-519d suppresses the gastric cancer epithelial-mesenchymal transition via Twist1 and inhibits Wnt/?-catenin signaling pathway.'),
(3477, 'hsa-mir-564', 'gastric cancer', 'down', 'miR-564 is downregulated in gastric carcinoma and targets E2F3.'),
(3478, 'hsa-mir-584-3p', 'gastric cancer', 'down', 'miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.'),
(3479, 'hsa-mir-613', 'gastric cancer', 'down', 'MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9.'),
(3480, 'hsa-mir-630', 'gastric cancer', 'down', 'MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.'),
(3481, 'hsa-mir-638', 'gastric cancer', 'down', 'MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.'),
(3482, 'hsa-mir-646', 'gastric cancer', 'down', 'MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.'),
(3483, 'hsa-mir-647', 'gastric cancer', 'down', 'MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer.'),
(3484, 'hsa-mir-675', 'gastric cancer', 'up', 'Long Noncoding RNA H19/miR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(3485, 'hsa-mir-93-5p', 'gastric cancer', 'up', 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.'),
(3486, 'hsa-mir-126', 'gastric cancer', 'down', 'Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.'),
(3487, 'hsa-mir-130a-3p', 'gastric cancer', 'down', 'MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma.'),
(3488, 'hsa-mir-139-5p', 'gastric cancer', 'down', 'LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1.'),
(3489, 'hsa-mir-155', 'gastric cancer', 'up', 'MiR-155 promotes gastric cancer growth and invasion by negatively regulating Transforming Growth Factor Beta Receptor 2.'),
(3490, 'hsa-mir-185', 'gastric cancer', 'down', 'XIST promotes gastric cancer (GC) progression through TGF-?1 via targeting miR-185.'),
(3491, 'hsa-mir-197', 'gastric cancer', 'down', 'MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin.'),
(3492, 'hsa-mir-203', 'gastric cancer', 'down', 'The expression level of miR-203 in patients with gastric cancer and its clinical significance.'),
(3493, 'hsa-mir-21', 'gastric cancer', 'up', 'miR-21 modulates prostaglandin signaling and promotes gastric tumorigenesis by targeting 15-PGDH.'),
(3494, 'hsa-mir-216a', 'gastric cancer', 'down', 'MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.'),
(3495, 'hsa-mir-216a', 'gastric cancer', 'up', 'Disregulation of miR-216a and miR-217 in Gastric Cancer and Their Clinical Significance.'),
(3496, 'hsa-mir-222', 'gastric cancer', 'up', 'The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.'),
(3497, 'hsa-mir-28', 'gastric cancer', 'up', 'MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.'),
(3498, 'hsa-mir-29b', 'gastric cancer', 'down', 'Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1.'),
(3499, 'hsa-mir-3174', 'gastric cancer', 'down', 'miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.'),
(3500, 'hsa-mir-324-3p', 'gastric cancer', 'up', 'miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.'),
(3501, 'hsa-mir-329', 'gastric cancer', 'down', 'MicroRNA-329 inhibits cell proliferation and tumor growth while facilitates apoptosis via negative regulation of KDM1A in gastric cancer.'),
(3502, 'hsa-mir-335-5p', 'gastric cancer', 'down', 'Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.'),
(3503, 'hsa-mir-335-5p', 'gastric cancer', 'down', 'MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.'),
(3504, 'hsa-mir-345', 'gastric cancer', 'down', 'MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.'),
(3505, 'hsa-mir-373', 'gastric cancer', 'down', 'miR-373 suppresses gastric cancer metastasis by downregulating vimentin.'),
(3506, 'hsa-mir-377', 'gastric cancer', 'down', 'MiR-377 suppresses cell proliferation and metastasis in gastric cancer via repressing the expression of VEGFA.'),
(3507, 'hsa-mir-454', 'gastric cancer', 'down', 'MicroRNA-454 inhibits tumor cell proliferation, migration and invasion by downregulating zinc finger E?box?binding homeobox 1 in gastric cancer.'),
(3508, 'hsa-mir-454', 'gastric cancer', 'up', 'Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.'),
(3509, 'hsa-mir-582-5p', 'gastric cancer', 'down', 'MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.'),
(3510, 'hsa-mir-599', 'gastric cancer', 'down', 'MicroRNA-599 inhibits metastasis and epithelial-mesenchymal transition via targeting EIF5A2 in gastric cancer.'),
(3511, 'hsa-mir-802', 'gastric cancer', 'down', 'Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.'),
(3512, 'hsa-mir-93', 'gastric cancer', 'up', 'MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2.'),
(3513, 'hsa-mir-93-5p', 'gastric cancer', 'up', 'MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.'),
(3514, 'hsa-mir-937', 'gastric cancer', 'down', 'MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2.'),
(3515, 'hsa-mir-100', 'gastric cancer', 'down', 'MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.'),
(3516, 'hsa-mir-101', 'gastric cancer', 'down', 'Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.'),
(3517, 'hsa-mir-122-5p', 'gastric cancer', 'down', 'MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.'),
(3518, 'hsa-mir-122-5p', 'gastric cancer', 'down', 'miR-122-5p inhibits tumor cell proliferation and induces apoptosis by targeting MYC in gastric cancer cells.'),
(3519, 'hsa-mir-125b', 'gastric cancer', 'down', 'The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.'),
(3520, 'hsa-mir-126', 'gastric cancer', 'down', 'MiR-126 functions as a tumor suppressor by targeting SRPK1 in human gastric cancer.'),
(3521, 'hsa-mir-135b-5p', 'gastric cancer', 'up', 'miR-135b-5p promotes gastric cancer progression by targeting CMTM3.'),
(3522, 'hsa-mir-143', 'gastric cancer', 'down', 'miR-143 Inhibits Cell Proliferation of Gastric Cancer Cells Through Targeting GATA6.'),
(3523, 'hsa-mir-144', 'gastric cancer', 'down', 'MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2.'),
(3524, 'hsa-mir-188-5p', 'gastric cancer', 'down', 'MiR-188-5p suppresses gastric cancer cell proliferation and invasion via targeting ZFP91.'),
(3525, 'hsa-mir-196b-5p', 'gastric cancer', 'up', 'Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.'),
(3526, 'hsa-mir-200c', 'gastric cancer', 'down', 'miR-200c inhibits TGF-?-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.'),
(3527, 'hsa-mir-203a', 'gastric cancer', 'down', 'miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer.'),
(3528, 'hsa-mir-204', 'gastric cancer', 'down', 'Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.'),
(3529, 'hsa-mir-21', 'gastric cancer', 'up', 'Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.'),
(3530, 'hsa-mir-223-3p', 'gastric cancer', 'up', 'NF-?B/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression.'),
(3531, 'hsa-mir-302b', 'gastric cancer', 'down', 'miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ ?-catenin/EMT signaling cascade in gastric cancer.'),
(3532, 'hsa-mir-31', 'gastric cancer', 'down', 'MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer.'),
(3533, 'hsa-mir-375', 'gastric cancer', 'down', 'miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.'),
(3534, 'hsa-mir-377', 'gastric cancer', 'up', 'The regulation and function of microRNA-377/RASSF8 signaling axis in gastric cancer.'),
(3535, 'hsa-mir-491-5p', 'gastric cancer', 'down', 'MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer.'),
(3536, 'hsa-mir-519d-3p', 'gastric cancer', 'down', 'miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6.'),
(3537, 'hsa-mir-532-5p', 'gastric cancer', 'down', 'LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.'),
(3538, 'hsa-mir-613', 'gastric cancer', 'down', 'miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor.'),
(3539, 'hsa-mir-615-3p', 'gastric cancer', 'up', 'miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.'),
(3540, 'hsa-mir-630', 'gastric cancer', 'down', 'miR-630 inhibits epithelial-to-mesenchymal transition (EMT) by regulating Wnt/betacatenin pathway in gastric cancer cells.'),
(3541, 'hsa-mir-638', 'gastric cancer', 'down', 'MiR-638 acts as a tumor suppressor gene in gastric cancer.'),
(3542, 'hsa-mir-7', 'gastric cancer', 'down', 'Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer.'),
(3543, 'hsa-mir-708', 'gastric cancer', 'down', 'Tumor suppressive microRNA-708 targets Notch1 to suppress cell proliferation and invasion in gastric cancer.'),
(3544, 'hsa-mir-873-5p', 'gastric cancer', 'down', 'MiR-873-5P controls gastric cancer progression by targeting hedgehog-GLI signaling.'),
(3545, 'hsa-let-7a-1', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3546, 'hsa-let-7a-2', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3547, 'hsa-let-7a-3', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3548, 'hsa-let-7b', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3549, 'hsa-let-7c', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3550, 'hsa-let-7d', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3551, 'hsa-let-7e', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3552, 'hsa-let-7f-1', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3553, 'hsa-let-7f-2', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3554, 'hsa-let-7g', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3555, 'hsa-let-7i', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3556, 'hsa-mir-103a-3p', 'gastric cancer', 'up', 'miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.'),
(3557, 'hsa-mir-106b', 'gastric cancer', 'up', 'Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer'),
(3558, 'hsa-mir-107', 'gastric cancer', 'up', 'Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3559, 'hsa-mir-107', 'gastric cancer', 'down', 'microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway.'),
(3560, 'hsa-mir-10b', 'gastric cancer', 'up', 'Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3561, 'hsa-mir-1236-3p', 'gastric cancer', 'down', 'miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2.'),
(3562, 'hsa-mir-124', 'gastric cancer', 'down', 'The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.'),
(3563, 'hsa-mir-124', 'gastric cancer', 'down', 'Lentivirus-mediated overexpression of miR-124 suppresses growth and invasion by targeting JAG1 and EZH2 in gastric cancer.'),
(3564, 'hsa-mir-124-3p', 'gastric cancer', 'down', 'miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer.'),
(3565, 'hsa-mir-125a-5p', 'gastric cancer', 'down', 'MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.'),
(3566, 'hsa-mir-126', 'gastric cancer', 'down', 'Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.'),
(3567, 'hsa-mir-129-5p', 'gastric cancer', 'down', 'MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.'),
(3568, 'hsa-mir-1292-5p', 'gastric cancer', 'down', 'MicroRNA-1292-5p inhibits cell growth, migration and invasion of gastric carcinoma by targeting DEK.'),
(3569, 'hsa-mir-1297', 'gastric cancer', 'down', 'Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1.'),
(3570, 'hsa-mir-1298', 'gastric cancer', 'down', 'MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.'),
(3571, 'hsa-mir-133a', 'gastric cancer', 'down', 'MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.'),
(3572, 'hsa-mir-135b-5p', 'gastric cancer', 'up', 'Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.'),
(3573, 'hsa-mir-142-3p', 'gastric cancer', 'down', 'Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.'),
(3574, 'hsa-mir-144', 'gastric cancer', 'down', 'The role of miR-144/GSPT1 axis in gastric cancer.'),
(3575, 'hsa-mir-146a', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3576, 'hsa-mir-146b', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3577, 'hsa-mir-148a', 'gastric cancer', 'down', 'miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.'),
(3578, 'hsa-mir-148b-3p', 'gastric cancer', 'down', 'miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.'),
(3579, 'hsa-mir-153', 'gastric cancer', 'down', 'MicroRNA-153 functions as a tumor suppressor in gastric cancer via targeting Kruppel-like factor 5.'),
(3580, 'hsa-mir-155-5p', 'gastric cancer', 'down', 'The tumor suppressor role of miR-155-5p in gastric cancer.'),
(3581, 'hsa-mir-17', 'gastric cancer', 'up', 'MicroRNA-17 as a promising diagnostic biomarker of gastric cancer: An investigation combining TCGA, GEO, meta-analysis, and bioinformatics.'),
(3582, 'hsa-mir-187', 'gastric cancer', 'down', 'Effects of downregulated expression of microRNA-187 in gastric cancer.'),
(3583, 'hsa-mir-193a-5p', 'gastric cancer', 'down', 'MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.'),
(3584, 'hsa-mir-194', 'gastric cancer', 'down', 'Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.'),
(3585, 'hsa-mir-19a', 'gastric cancer', 'up', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3586, 'hsa-mir-19b-1', 'gastric cancer', 'up', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3587, 'hsa-mir-19b-2', 'gastric cancer', 'up', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3588, 'hsa-mir-208a', 'gastric cancer', 'up', 'MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3.'),
(3589, 'hsa-mir-21', 'gastric cancer', 'up', 'Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3590, 'hsa-mir-21', 'gastric cancer', 'up', 'Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer'),
(3591, 'hsa-mir-21', 'gastric cancer', 'up', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3592, 'hsa-mir-21', 'gastric cancer', 'up', 'miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2.'),
(3593, 'hsa-mir-21', 'gastric cancer', 'up', '[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].'),
(3594, 'hsa-mir-217', 'gastric cancer', 'down', 'HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression.'),
(3595, 'hsa-mir-218', 'gastric cancer', 'down', 'The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.'),
(3596, 'hsa-mir-23a', 'gastric cancer', 'up', 'microRNA-23a promotes cell growth and metastasis in gastric cancer via targeting SPRY2-mediated ERK signaling.'),
(3597, 'hsa-mir-25', 'gastric cancer', 'up', 'Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer'),
(3598, 'hsa-mir-28-5p', 'gastric cancer', 'down', 'MicroRNA-28-5p inhibits the migration and invasion of gastric cancer cells by suppressing AKT phosphorylation.'),
(3599, 'hsa-mir-29a', 'gastric cancer', 'down', 'Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.'),
(3600, 'hsa-mir-29b-1', 'gastric cancer', 'down', 'Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.'),
(3601, 'hsa-mir-29b-2', 'gastric cancer', 'down', 'Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.'),
(3602, 'hsa-mir-29c', 'gastric cancer', 'down', 'Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer.'),
(3603, 'hsa-mir-3129', 'gastric cancer', 'up', 'microRNA-3129 promotes cell proliferation in gastric cancer cell line SGC7901 via positive regulation of pRb.'),
(3604, 'hsa-mir-324-5p', 'gastric cancer', 'down', 'MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8.'),
(3605, 'hsa-mir-335', 'gastric cancer', 'down', 'The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.'),
(3606, 'hsa-mir-338', 'gastric cancer', 'down', 'MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/?-catenin signaling pathway.'),
(3607, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.'),
(3608, 'hsa-mir-340', 'gastric cancer', 'up', 'MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.'),
(3609, 'hsa-mir-340-5p', 'gastric cancer', 'down', 'LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.'),
(3610, 'hsa-mir-34a', 'gastric cancer', 'down', 'MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1.'),
(3611, 'hsa-mir-361-5p', 'gastric cancer', 'down', 'MiR-361-5p inhibits the mobility of gastric cancer cells through suppressing epithelial-mesenchymal transition via the Wnt/?-catenin pathway.'),
(3612, 'hsa-mir-375', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3613, 'hsa-mir-378', 'gastric cancer', 'down', '[Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].'),
(3614, 'hsa-mir-4455', 'gastric cancer', 'down', 'Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.'),
(3615, 'hsa-mir-449c', 'gastric cancer', 'down', 'miR-449c inhibits migration and invasion of gastric cancer cells by targeting PFKFB3.'),
(3616, 'hsa-mir-483', 'gastric cancer', 'down', 'miR-483 is down-regulated in gastric cancer and suppresses cell proliferation, invasion and protein O-GlcNAcylation by targeting OGT.'),
(3617, 'hsa-mir-484', 'gastric cancer', 'down', 'The clinical significance of miR-335, miR-124, miR-218 and miR-484 downregulation in gastric cancer.'),
(3618, 'hsa-mir-491-5p', 'gastric cancer', 'down', 'Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4.'),
(3619, 'hsa-mir-495', 'gastric cancer', 'down', 'MicroRNA-495 inhibits proliferation, metastasis and promotes apoptosis by targeting Twist1 in gastric cancer cells.'),
(3620, 'hsa-mir-543', 'gastric cancer', 'up', 'miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer.'),
(3621, 'hsa-mir-545', 'gastric cancer', 'down', 'MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.'),
(3622, 'hsa-mir-5590-3p', 'gastric cancer', 'down', 'miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.'),
(3623, 'hsa-mir-585', 'gastric cancer', 'down', 'MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1.'),
(3624, 'hsa-mir-589', 'gastric cancer', 'up', 'miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop.'),
(3625, 'hsa-mir-592', 'gastric cancer', 'up', 'MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.'),
(3626, 'hsa-mir-598', 'gastric cancer', 'down', 'miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R.'),
(3627, 'hsa-mir-616-3p', 'gastric cancer', 'up', 'MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway.'),
(3628, 'hsa-mir-718', 'gastric cancer', 'up', 'High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer.'),
(3629, 'hsa-mir-761', 'gastric cancer', 'up', 'microRNA-761 regulates glycogen synthase kinase 3? expression and promotes the proliferation and cell cycle of human gastric cancer cells.'),
(3630, 'hsa-mir-92', 'gastric cancer', 'down', 'MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer.'),
(3631, 'hsa-mir-93', 'gastric cancer', 'up', 'Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3632, 'hsa-mir-93', 'gastric cancer', 'up', 'Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer'),
(3633, 'hsa-mir-98', 'gastric cancer', 'down', 'Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.'),
(3634, 'hsa-mir-101', 'gastric cancer', 'down', 'Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer.'),
(3635, 'hsa-mir-103a-3p', 'gastric cancer', 'up', 'miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7?in vitro.'),
(3636, 'hsa-mir-107', 'gastric cancer', 'up', 'Tumor Expression of?miR-10b, miR-21, miR-143and?miR-145?Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3637, 'hsa-mir-10b', 'gastric cancer', 'up', 'Tumor Expression of?miR-10b, miR-21, miR-143and?miR-145?Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3638, 'hsa-mir-1179', 'gastric cancer', 'down', 'Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.'),
(3639, 'hsa-mir-1236-3p', 'gastric cancer', 'down', 'Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.'),
(3640, 'hsa-mir-126', 'gastric cancer', 'down', 'miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.'),
(3641, 'hsa-mir-1294', 'gastric cancer', 'down', 'Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.'),
(3642, 'hsa-mir-1296-5p', 'gastric cancer', 'down', 'The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer.'),
(3643, 'hsa-mir-130a-5p', 'gastric cancer', 'down', 'miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/?-catenin signaling pathway in gastric carcinoma.'),
(3644, 'hsa-mir-136', 'gastric cancer', 'down', 'MiR-136 triggers apoptosis in human gastric cancer cells by targeting AEG-1 and BCL2.'),
(3645, 'hsa-mir-140-5p', 'gastric cancer', 'down', 'MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/?-catenin signaling pathway.'),
(3646, 'hsa-mir-141-3p', 'gastric cancer', 'down', 'MiR-141-3p suppresses gastric cancer induced transition of normal fibroblast and BMSC to cancer-associated fibroblasts via targeting STAT4.'),
(3647, 'hsa-mir-141-3p', 'gastric cancer', 'down', 'Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.'),
(3648, 'hsa-mir-143', 'gastric cancer', 'down', 'Study of miR-143 expression in stomach cancer.'),
(3649, 'hsa-mir-148a-3p', 'gastric cancer', 'down', 'Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.'),
(3650, 'hsa-mir-183', 'gastric cancer', 'up', 'miR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene.'),
(3651, 'hsa-mir-193b-3p', 'gastric cancer', 'down', 'Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.'),
(3652, 'hsa-mir-194-5p', 'gastric cancer', 'down', 'The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition.'),
(3653, 'hsa-mir-19a', 'gastric cancer', 'up', 'MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5.'),
(3654, 'hsa-mir-21', 'gastric cancer', 'up', 'Tumor Expression of?miR-10b, miR-21, miR-143and?miR-145?Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3655, 'hsa-mir-214', 'gastric cancer', 'up', 'MicroRNA-214 promotes the proliferation, migration and invasion of gastric cancer MKN28 cells by suppressing the expression of Dact2.'),
(3656, 'hsa-mir-214-3p', 'gastric cancer', 'up', 'The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.'),
(3657, 'hsa-mir-217', 'gastric cancer', 'down', 'Long non-coding RNA Hotair promotes gastric cancer progression via miR-217-GPC5 axis.'),
(3658, 'hsa-mir-23b-3p', 'gastric cancer', 'down', 'miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/?-catenin signaling pathway in gastric carcinoma.'),
(3659, 'hsa-mir-24', 'gastric cancer', 'up', 'Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer.'),
(3660, 'hsa-mir-338-3p', 'gastric cancer', 'down', 'Hypermethylation of miR-338-3p and Impact of its Suppression on Cell Metastasis Through N-Cadherin Accumulation at the Cell -Cell Junction and Degradation of MMP in Gastric Cancer.'),
(3661, 'hsa-mir-34a', 'gastric cancer', 'down', 'A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer.'),
(3662, 'hsa-mir-370', 'gastric cancer', 'down', 'MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4.'),
(3663, 'hsa-mir-375', 'gastric cancer', 'down', 'Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.'),
(3664, 'hsa-mir-376a', 'gastric cancer', 'down', 'Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.'),
(3665, 'hsa-mir-4295', 'gastric cancer', 'up', 'Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.'),
(3666, 'hsa-mir-494', 'gastric cancer', 'down', 'miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.'),
(3667, 'hsa-mir-498', 'gastric cancer', 'down', 'Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1.'),
(3668, 'hsa-mir-588', 'gastric cancer', 'down', 'MicroRNA-588 regulates invasion, migration and epithelial-mesenchymal transition via targeting EIF5A2 pathway in gastric cancer.'),
(3669, 'hsa-mir-593-5p', 'gastric cancer', 'down', 'Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer.'),
(3670, 'hsa-mir-671-5p', 'gastric cancer', 'down', 'miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP.'),
(3671, 'hsa-mir-675-5p', 'gastric cancer', 'up', 'Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.'),
(3672, 'hsa-mir-744', 'gastric cancer', 'up', 'MicroRNA-744 promotes cell apoptosis via targeting B cell lymphoma-2 in gastric cancer cell line SGC-7901.'),
(3673, 'hsa-mir-93', 'gastric cancer', 'up', 'Tumor Expression of?miR-10b, miR-21, miR-143and?miR-145?Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population.'),
(3674, 'hsa-mir-95', 'gastric cancer', 'down', 'Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.'),
(3675, 'hsa-mir-1', 'gastric cancer', 'up', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3676, 'hsa-mir-105', 'gastric cancer', 'down', 'MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9.'),
(3677, 'hsa-mir-105', 'gastric cancer', 'down', 'Up-regulation of miRNA-105 inhibits the progression of gastric carcinoma by directly targeting SOX9.'),
(3678, 'hsa-mir-106b', 'gastric cancer', 'up', 'miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo.'),
(3679, 'hsa-mir-107', 'gastric cancer', 'up', 'miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.'),
(3680, 'hsa-mir-1236-3p', 'gastric cancer', 'down', 'MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.'),
(3681, 'hsa-mir-125a-5p', 'gastric cancer', 'down', 'Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer.'),
(3682, 'hsa-mir-1265', 'gastric cancer', 'down', 'MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.'),
(3683, 'hsa-mir-127', 'gastric cancer', 'down', 'miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a.'),
(3684, 'hsa-mir-1273e', 'gastric cancer', 'down', 'Long Intergenic Non-Protein-Coding RNA 01138 Accelerates Tumor Growth and Invasion in Gastric Cancer by Regulating miR-1273e.'),
(3685, 'hsa-mir-1275', 'gastric cancer', 'down', 'MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.'),
(3686, 'hsa-mir-128', 'gastric cancer', 'down', 'Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.'),
(3687, 'hsa-mir-1284', 'gastric cancer', 'down', 'MiR-1284 suppresses gastric cancer progression by targeting EIF4A1.'),
(3688, 'hsa-mir-128b', 'gastric cancer', 'down', 'PGC-1?/SNAI1 axis regulates tumor growth and metastasis by targeting miR-128b in gastric cancer.'),
(3689, 'hsa-mir-129', 'gastric cancer', 'down', 'MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.'),
(3690, 'hsa-mir-1290', 'gastric cancer', 'up', 'Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1.'),
(3691, 'hsa-mir-1306-3p', 'gastric cancer', 'down', 'Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis.'),
(3692, 'hsa-mir-133a', 'gastric cancer', 'up', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3693, 'hsa-mir-135a', 'gastric cancer', 'down', 'miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-?B activation.'),
(3694, 'hsa-mir-140-5p', 'gastric cancer', 'down', 'MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling.'),
(3695, 'hsa-mir-142-3p', 'gastric cancer', 'up', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3696, 'hsa-mir-143', 'gastric cancer', 'down', 'Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.'),
(3697, 'hsa-mir-144', 'gastric cancer', 'down', 'miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.'),
(3698, 'hsa-mir-149-3p', 'gastric cancer', 'down', 'ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression.'),
(3699, 'hsa-mir-155-5p', 'gastric cancer', 'down', 'Decreased miR-155-5p, miR-15a, and miR-186 Expression in Gastric Cancer Is Associated with Advanced Tumor Grade and Metastasis'),
(3700, 'hsa-mir-16', 'gastric cancer', 'down', 'Oncogenic role of long non-coding RNA SNHG12 in gastric cancer cells by targeting miR-16.'),
(3701, 'hsa-mir-181a', 'gastric cancer', 'up', 'MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1.'),
(3702, 'hsa-mir-181d', 'gastric cancer', 'up', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3703, 'hsa-mir-188-5p', 'gastric cancer', 'up', 'miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4.'),
(3704, 'hsa-mir-188-5p', 'gastric cancer', 'up', 'Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/?-catenin signaling.'),
(3705, 'hsa-mir-196a-5p', 'gastric cancer', 'up', 'MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.'),
(3706, 'hsa-mir-198', 'gastric cancer', 'down', 'MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer.'),
(3707, 'hsa-mir-199a-3p', 'gastric cancer', 'up', 'miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.'),
(3708, 'hsa-mir-203', 'gastric cancer', 'down', 'MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1.'),
(3709, 'hsa-mir-203', 'gastric cancer', 'down', 'miR-203 Inhibits the Invasion and EMT of Gastric Cancer Cells by Directly Targeting Annexin A4.'),
(3710, 'hsa-mir-205-5p', 'gastric cancer', 'up', 'Micro-RNA 205-5p is Involved in the Progression of Gastric Cancer and Targets Phosphatase and Tensin Homolog (PTEN) in SGC-7901 Human Gastric Cancer Cells.'),
(3711, 'hsa-mir-206', 'gastric cancer', 'down', 'MiR-206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the MUC1 gene.'),
(3712, 'hsa-mir-21', 'gastric cancer', 'up', 'Targeting MicroRNA-21 Suppresses Gastric Cancer Cell Proliferation and Migration via PTEN/Akt Signaling Axis.'),
(3713, 'hsa-mir-21', 'gastric cancer', 'up', 'Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.'),
(3714, 'hsa-mir-214', 'gastric cancer', 'up', 'Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.'),
(3715, 'hsa-mir-222', 'gastric cancer', 'up', 'Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.'),
(3716, 'hsa-mir-25', 'gastric cancer', 'up', 'Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.'),
(3717, 'hsa-mir-26b', 'gastric cancer', 'down', 'Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer.'),
(3718, 'hsa-mir-30c', 'gastric cancer', 'down', 'Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.'),
(3719, 'hsa-mir-31', 'gastric cancer', 'down', 'MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolo'),
(3720, 'hsa-mir-340', 'gastric cancer', 'down', 'Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.'),
(3721, 'hsa-mir-340', 'gastric cancer', 'down', '[Role of miRNA-340 in modulating gastric cancer cell proliferation and bioinformatic analysis].'),
(3722, 'hsa-mir-374a-5p', 'gastric cancer', 'down', 'MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.'),
(3723, 'hsa-mir-375', 'gastric cancer', 'down', 'MicroRNA expression profiling provides novel insights into immune-related pathways involved in gastric cancer.'),
(3724, 'hsa-mir-375', 'gastric cancer', 'down', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3725, 'hsa-mir-375', 'gastric cancer', 'down', 'Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ.'),
(3726, 'hsa-mir-383', 'gastric cancer', 'down', 'miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2.'),
(3727, 'hsa-mir-383-5p', 'gastric cancer', 'down', 'MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression.'),
(3728, 'hsa-mir-384', 'gastric cancer', 'down', 'miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells.'),
(3729, 'hsa-mir-411', 'gastric cancer', 'down', 'MiR-411 inhibits gastric cancer proliferation and migration through targeting SETD6.'),
(3730, 'hsa-mir-4268', 'gastric cancer', 'down', 'MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer.'),
(3731, 'hsa-mir-4317', 'gastric cancer', 'down', 'Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.'),
(3732, 'hsa-mir-4513', 'gastric cancer', 'up', 'miR-4513 promotes gastric cancer cell proliferation and epithelial-mesenchymal transition through targeting KAT6B.'),
(3733, 'hsa-mir-490-3p', 'gastric cancer', 'down', 'MicroRNA-490-3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1.'),
(3734, 'hsa-mir-494', 'gastric cancer', 'down', 'MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D.'),
(3735, 'hsa-mir-497', 'gastric cancer', 'down', 'FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression.'),
(3736, 'hsa-mir-497-5p', 'gastric cancer', 'down', 'miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3.'),
(3737, 'hsa-mir-503', 'gastric cancer', 'down', 'MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway.'),
(3738, 'hsa-mir-505', 'gastric cancer', 'down', 'MicroRNA-505 suppresses gastric cancer cell proliferation and invasion by directly targeting Polo-like kinase-1.'),
(3739, 'hsa-mir-506', 'gastric cancer', 'down', 'Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2.'),
(3740, 'hsa-mir-526b', 'gastric cancer', 'down', 'Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.'),
(3741, 'hsa-mir-539', 'gastric cancer', 'down', 'Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.'),
(3742, 'hsa-mir-551b-3p', 'gastric cancer', 'down', 'Serum miR-551b-3p is a potential diagnostic biomarker for gastric cancer.'),
(3743, 'hsa-mir-574-3p', 'gastric cancer', 'down', 'MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.'),
(3744, 'hsa-mir-577', 'gastric cancer', 'up', 'miR-577 Regulates TGF-? Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-?B in Gastric Cancer.'),
(3745, 'hsa-mir-596', 'gastric cancer', 'down', 'MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.'),
(3746, 'hsa-mir-613', 'gastric cancer', 'down', 'MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.'),
(3747, 'hsa-mir-613', 'gastric cancer', 'down', 'miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2.'),
(3748, 'hsa-mir-618', 'gastric cancer', 'down', 'miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-?2.'),
(3749, 'hsa-mir-625', 'gastric cancer', 'down', 'miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1.'),
(3750, 'hsa-mir-632', 'gastric cancer', 'up', 'miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.'),
(3751, 'hsa-mir-654-5p', 'gastric cancer', 'down', 'A positive feedback loop consisting of C12orf59/NF-?B/CDH11 promotes gastric cancer invasion and metastasis.'),
(3752, 'hsa-mir-660', 'gastric cancer', 'down', 'RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated inhibition of cell proliferation in gastric cancer.'),
(3753, 'hsa-mir-664a-3p', 'gastric cancer', 'up', 'miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer.'),
(3754, 'hsa-mir-675', 'gastric cancer', 'up', 'MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.'),
(3755, 'hsa-mir-708', 'gastric cancer', 'down', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(3756, 'hsa-mir-876-3p', 'gastric cancer', 'down', 'MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.'),
(3757, 'hsa-mir-876-5p', 'gastric cancer', 'down', 'MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF.'),
(3758, 'hsa-mir-92b-3p', 'gastric cancer', 'up', 'Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.'),
(3759, 'hsa-mir-95', 'gastric cancer', 'up', 'microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5.'),
(3760, 'hsa-mir-95', 'gastric cancer', 'up', 'miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.'),
(3761, 'hsa-mir-122a', 'gastrointestinal cancer', 'down', 'MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.'),
(3762, 'hsa-mir-148a', 'gastrointestinal cancer', 'down', 'MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.'),
(3763, 'hsa-mir-152', 'gastrointestinal cancer', 'down', 'MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.'),
(3764, 'hsa-mir-196a', 'gastrointestinal stromal tumor', 'up', 'Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors.'),
(3765, 'hsa-mir-218', 'gastrointestinal stromal tumor', 'down', 'MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.'),
(3766, 'hsa-mir-221', 'gastrointestinal stromal tumor', 'down', 'Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.'),
(3767, 'hsa-mir-221', 'gastrointestinal stromal tumor', 'down', 'Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.'),
(3768, 'hsa-mir-222', 'gastrointestinal stromal tumor', 'down', 'Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.'),
(3769, 'hsa-mir-222', 'gastrointestinal stromal tumor', 'down', 'Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.'),
(3770, 'hsa-mir-21', 'gastrointestinal stromal tumor', 'down', 'miRNA-21 sensitizes gastrointestinal stromal tumors (GISTs) cells to Imatinib via targeting B-cell lymphoma 2 (Bcl-2).'),
(3771, 'hsa-mir-186', 'gastrointestinal stromal tumor', 'down', 'Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors.'),
(3772, 'hsa-mir-152', 'gastrointestinal stromal tumor', 'down', 'MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor.'),
(3773, 'hsa-mir-494', 'gastrointestinal stromal tumor', 'down', 'Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.'),
(3774, 'hsa-mir-148b-3p', 'gastrointestinal stromal tumor', 'down', 'miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.'),
(3775, 'hsa-mir-374b', 'gastrointestinal stromal tumor', 'up', 'MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.'),
(3776, 'hsa-let-7g-5p', 'glioblastoma', 'down', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3777, 'hsa-mir-100', 'glioblastoma', 'down', 'microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models.'),
(3778, 'hsa-mir-101', 'glioblastoma', 'down', 'miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.'),
(3779, 'hsa-mir-101', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3780, 'hsa-mir-106a', 'glioblastoma', 'down', 'Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.'),
(3781, 'hsa-mir-10b', 'glioblastoma', 'up', 'Oncogenic effects of miR-10b in glioblastoma stem cells.'),
(3782, 'hsa-mir-10b', 'glioblastoma', 'up', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3783, 'hsa-mir-124', 'glioblastoma', 'down', 'miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.'),
(3784, 'hsa-mir-124', 'glioblastoma', 'down', 'Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L.'),
(3785, 'hsa-mir-124a', 'glioblastoma', 'down', 'miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.'),
(3786, 'hsa-mir-125a', 'glioblastoma', 'down', 'miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.'),
(3787, 'hsa-mir-125a-5p', 'glioblastoma', 'down', 'MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ.'),
(3788, 'hsa-mir-125b', 'glioblastoma', 'down', 'Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.'),
(3789, 'hsa-mir-125b', 'glioblastoma', 'up', 'miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b.'),
(3790, 'hsa-mir-127-3p', 'glioblastoma', 'up', 'MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.'),
(3791, 'hsa-mir-127-3p', 'glioblastoma', 'down', 'Next Generation Sequencing Analysis of miRNAs: MiR-127-3p Inhibits Glioblastoma Proliferation and Activates TGF-? Signaling by Targeting SKI.'),
(3792, 'hsa-mir-128', 'glioblastoma', 'down', 'Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation.'),
(3793, 'hsa-mir-128', 'glioblastoma', 'down', 'PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(3794, 'hsa-mir-128', 'glioblastoma', 'down', 'miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.'),
(3795, 'hsa-mir-129', 'glioblastoma', 'down', 'Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.'),
(3796, 'hsa-mir-136', 'glioblastoma', 'down', 'Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.'),
(3797, 'hsa-mir-137', 'glioblastoma', 'down', 'miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.'),
(3798, 'hsa-mir-137', 'glioblastoma', 'down', 'miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.'),
(3799, 'hsa-mir-137', 'glioblastoma', 'down', 'MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.'),
(3800, 'hsa-mir-137', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3801, 'hsa-mir-137', 'glioblastoma', 'down', 'MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.'),
(3802, 'hsa-mir-139-5p', 'glioblastoma', 'down', 'miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.'),
(3803, 'hsa-mir-142-3p', 'glioblastoma', 'down', 'Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.'),
(3804, 'hsa-mir-143', 'glioblastoma', 'down', 'miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.'),
(3805, 'hsa-mir-145', 'glioblastoma', 'down', 'NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.'),
(3806, 'hsa-mir-145', 'glioblastoma', 'down', 'Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.'),
(3807, 'hsa-mir-146b-5p', 'glioblastoma', 'down', 'MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.'),
(3808, 'hsa-mir-148a', 'glioblastoma', 'up', 'microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma.'),
(3809, 'hsa-mir-149', 'glioblastoma', 'down', 'miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.'),
(3810, 'hsa-mir-152', 'glioblastoma', 'down', 'MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr?ppel-like factor 4.'),
(3811, 'hsa-mir-153', 'glioblastoma', 'down', 'MicroRNA-153 is tumor suppressive in glioblastoma stem cells.'),
(3812, 'hsa-mir-18a', 'glioblastoma', 'up', 'MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.'),
(3813, 'hsa-mir-195', 'glioblastoma', 'down', 'MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.'),
(3814, 'hsa-mir-196a', 'glioblastoma', 'up', 'MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of I?B? both in vitro and in vivo.'),
(3815, 'hsa-mir-196a-1', 'glioblastoma', 'up', 'MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.'),
(3816, 'hsa-mir-196a-2', 'glioblastoma', 'up', 'MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.'),
(3817, 'hsa-mir-196b', 'glioblastoma', 'up', 'MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.'),
(3818, 'hsa-mir-196b', 'glioblastoma', 'up', 'Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype.'),
(3819, 'hsa-mir-21', 'glioblastoma', 'up', 'Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4.'),
(3820, 'hsa-mir-21', 'glioblastoma', 'up', 'Sulforaphane enhances temozolomide-induced apoptosis due to downregulation of miR-21 via Wnt/?-catenin signaling in glioblastoma.'),
(3821, 'hsa-mir-21', 'glioblastoma', 'up', 'MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.'),
(3822, 'hsa-mir-21', 'glioblastoma', 'up', 'PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.'),
(3823, 'hsa-mir-21', 'glioblastoma', 'up', 'Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.'),
(3824, 'hsa-mir-21', 'glioblastoma', 'up', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3825, 'hsa-mir-21', 'glioblastoma', 'up', 'Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.'),
(3826, 'hsa-mir-21', 'glioblastoma', 'up', 'MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3).'),
(3827, 'hsa-mir-21', 'glioblastoma', 'up', 'Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.'),
(3828, 'hsa-mir-21', 'glioblastoma', 'up', 'MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.'),
(3829, 'hsa-mir-21', 'glioblastoma', 'up', 'MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.'),
(3830, 'hsa-mir-21', 'glioblastoma', 'down', 'MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.'),
(3831, 'hsa-mir-21', 'glioblastoma', 'up', 'Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy.'),
(3832, 'hsa-mir-21', 'glioblastoma', 'up', 'MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.'),
(3833, 'hsa-mir-210', 'glioblastoma', 'up', 'Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids.'),
(3834, 'hsa-mir-210-3p', 'glioblastoma', 'up', 'Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.'),
(3835, 'hsa-mir-212-3p', 'glioblastoma', 'down', 'MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.'),
(3836, 'hsa-mir-219-5p', 'glioblastoma', 'down', 'miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.'),
(3837, 'hsa-mir-222', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3838, 'hsa-mir-223', 'glioblastoma', 'up', 'microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6.'),
(3839, 'hsa-mir-29b', 'glioblastoma', 'down', 'miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.'),
(3840, 'hsa-mir-31', 'glioblastoma', 'down', 'Human miR-31 targets radixin and inhibits migration and invasion of glioma cells.'),
(3841, 'hsa-mir-31', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3842, 'hsa-mir-3189-3p', 'glioblastoma', 'down', 'Anti-Tumoral Effects of miR-3189-3p in Glioblastoma.'),
(3843, 'hsa-mir-320', 'glioblastoma', 'down', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3844, 'hsa-mir-320a', 'glioblastoma', 'down', 'MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.'),
(3845, 'hsa-mir-326', 'glioblastoma', 'down', 'Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.'),
(3846, 'hsa-mir-330', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3847, 'hsa-mir-331-3p', 'glioblastoma', 'down', 'miR-331-3p regulates expression of neuropilin-2 in glioblastoma.'),
(3848, 'hsa-mir-340', 'glioblastoma', 'down', 'miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.'),
(3849, 'hsa-mir-340', 'glioblastoma', 'down', 'miR-340 suppresses glioblastoma multiforme.'),
(3850, 'hsa-mir-340', 'glioblastoma', 'up', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3851, 'hsa-mir-342', 'glioblastoma', 'down', 'Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.'),
(3852, 'hsa-mir-34a', 'glioblastoma', 'down', 'MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.'),
(3853, 'hsa-mir-34a', 'glioblastoma', 'down', 'MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme.'),
(3854, 'hsa-mir-34a', 'glioblastoma', 'down', 'miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.'),
(3855, 'hsa-mir-376a', 'glioblastoma', 'down', 'Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.'),
(3856, 'hsa-mir-449a', 'glioblastoma', 'down', 'MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.'),
(3857, 'hsa-mir-483-5p', 'glioblastoma', 'down', 'MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.'),
(3858, 'hsa-mir-503', 'glioblastoma', 'down', 'MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.'),
(3859, 'hsa-mir-576-5p', 'glioblastoma', 'up', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3860, 'hsa-mir-577', 'glioblastoma', 'down', 'miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.'),
(3861, 'hsa-mir-626', 'glioblastoma', 'up', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3862, 'hsa-mir-663', 'glioblastoma', 'down', 'miR-663 suppresses oncogenic function of CXCR4 in glioblastoma.'),
(3863, 'hsa-mir-7', 'glioblastoma', 'down', 'microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.'),
(3864, 'hsa-mir-7', 'glioblastoma', 'down', 'Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.'),
(3865, 'hsa-mir-7', 'glioblastoma', 'down', 'miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.'),
(3866, 'hsa-mir-7-5p', 'glioblastoma', 'down', 'MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1.'),
(3867, 'hsa-mir-7-5p', 'glioblastoma', 'down', 'miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.'),
(3868, 'hsa-mir-873', 'glioblastoma', 'down', 'MiRNA-873 Inhibits Glioblastoma Tumorigenesis and Metastasis by Suppressing the Expression of IGF2BP1.'),
(3869, 'hsa-mir-92b', 'glioblastoma', 'up', 'The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.'),
(3870, 'hsa-mir-130b', 'glioblastoma', 'up', 'Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.'),
(3871, 'hsa-mir-135b', 'glioblastoma', 'up', 'MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.'),
(3872, 'hsa-mir-137', 'glioblastoma', 'down', 'Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells.'),
(3873, 'hsa-mir-181b', 'glioblastoma', 'down', 'Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.'),
(3874, 'hsa-mir-1908', 'glioblastoma', 'up', 'MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.'),
(3875, 'hsa-mir-21', 'glioblastoma', 'up', 'Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.'),
(3876, 'hsa-mir-25', 'glioblastoma', 'up', 'miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.'),
(3877, 'hsa-mir-29b', 'glioblastoma', 'down', 'miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.'),
(3878, 'hsa-mir-29b', 'glioblastoma', 'down', 'Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme.'),
(3879, 'hsa-mir-454', 'glioblastoma', 'down', 'MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.'),
(3880, 'hsa-mir-542-3p', 'glioblastoma', 'down', 'MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.'),
(3881, 'hsa-mir-100', 'glioblastoma', 'down', 'Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3.'),
(3882, 'hsa-mir-124', 'glioblastoma', 'down', 'miR-124 suppresses the migration and invasion of glioma cells in?vitro via Capn4.'),
(3883, 'hsa-mir-135b', 'glioblastoma', 'down', 'miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.'),
(3884, 'hsa-mir-210', 'glioblastoma', 'up', 'MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.'),
(3885, 'hsa-mir-429', 'glioblastoma', 'down', 'MiR-429 induces apoptosis of glioblastoma cell through Bcl-2.'),
(3886, 'hsa-mir-517c', 'glioblastoma', 'down', 'MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.'),
(3887, 'hsa-mir-590-3p', 'glioblastoma', 'down', 'miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.'),
(3888, 'hsa-mir-622', 'glioblastoma', 'down', 'Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma.'),
(3889, 'hsa-mir-124', 'glioblastoma', 'down', 'miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.'),
(3890, 'hsa-mir-124', 'glioblastoma', 'down', 'MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma.'),
(3891, 'hsa-mir-126', 'glioblastoma', 'down', 'MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion.'),
(3892, 'hsa-mir-133b', 'glioblastoma', 'down', 'MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma.'),
(3893, 'hsa-mir-138', 'glioblastoma', 'up', 'MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.'),
(3894, 'hsa-mir-181c', 'glioblastoma', 'down', 'MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-? pathway.'),
(3895, 'hsa-mir-181c', 'glioblastoma', 'down', 'Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.'),
(3896, 'hsa-mir-183', 'glioblastoma', 'up', 'Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL.'),
(3897, 'hsa-mir-22', 'glioblastoma', 'down', 'miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.'),
(3898, 'hsa-mir-296-5p', 'glioblastoma', 'down', 'Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.'),
(3899, 'hsa-mir-506', 'glioblastoma', 'down', 'miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma.'),
(3900, 'hsa-mir-519a', 'glioblastoma', 'down', 'MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.'),
(3901, 'hsa-mir-663', 'glioblastoma', 'down', 'MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-?1.'),
(3902, 'hsa-mir-153', 'glioblastoma', 'down', 'MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation.'),
(3903, 'hsa-mir-154', 'glioblastoma', 'down', 'MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a.'),
(3904, 'hsa-mir-181a', 'glioblastoma', 'down', 'The correlation of microRNA-181a and target genes with poor prognosis of glioblastoma patients.'),
(3905, 'hsa-mir-300', 'glioblastoma', 'down', 'MicroRNA-300 inhibited glioblastoma progression through ROCK1.'),
(3906, 'hsa-let-7e', 'glioblastoma', 'down', 'Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e.'),
(3907, 'hsa-mir-128', 'glioblastoma', 'down', 'Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy: Down-regulation of miR-128 induces glioma-associated seizure.'),
(3908, 'hsa-mir-128', 'glioblastoma', 'down', 'MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.'),
(3909, 'hsa-mir-137', 'glioblastoma', 'down', 'PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.'),
(3910, 'hsa-mir-143', 'glioblastoma', 'down', 'miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.'),
(3911, 'hsa-mir-197', 'glioblastoma', 'down', 'MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.'),
(3912, 'hsa-mir-206', 'glioblastoma', 'down', 'MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.'),
(3913, 'hsa-mir-21', 'glioblastoma', 'up', 'Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.'),
(3914, 'hsa-mir-31', 'glioblastoma', 'down', 'MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.'),
(3915, 'hsa-mir-323a-3p', 'glioblastoma', 'down', 'Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.'),
(3916, 'hsa-mir-369-3p', 'glioblastoma', 'down', 'Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.'),
(3917, 'hsa-mir-595', 'glioblastoma', 'up', 'MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.'),
(3918, 'hsa-mir-137', 'glioblastoma', 'down', 'Circulating microRNA-137 is a potential biomarker for human glioblastoma.'),
(3919, 'hsa-mir-149', 'glioblastoma', 'down', 'MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin?D1 in human glioblastoma multiforme.'),
(3920, 'hsa-mir-15b', 'glioblastoma', 'down', 'miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1.'),
(3921, 'hsa-mir-26b', 'glioblastoma', 'down', 'MiR-26b suppresses cell proliferation and invasion by targeting cyclooxygenase 2 in human glioblastoma.'),
(3922, 'hsa-mir-422a', 'glioblastoma', 'down', 'MiR-422a acts as a tumor suppressor in glioblastoma by targeting PIK3CA.'),
(3923, 'hsa-mir-564', 'glioblastoma', 'down', 'MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-?1.'),
(3924, 'hsa-mir-124', 'glioblastoma', 'down', 'miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA.'),
(3925, 'hsa-mir-126', 'glioblastoma', 'down', 'Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study.'),
(3926, 'hsa-mir-129-5p', 'glioblastoma', 'down', 'Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.'),
(3927, 'hsa-mir-153', 'glioblastoma', 'down', 'MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.'),
(3928, 'hsa-mir-18a', 'glioblastoma', 'up', 'The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.'),
(3929, 'hsa-mir-217', 'glioblastoma', 'up', 'MiR-217 promoted the proliferation and invasion of glioblastoma by repressing YWHAG.'),
(3930, 'hsa-mir-223', 'glioblastoma', 'up', 'Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.'),
(3931, 'hsa-mir-338-5p', 'glioblastoma', 'down', 'MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1.'),
(3932, 'hsa-mir-10b', 'glioblastoma', 'up', 'MicroRNA-10b mediates TGF-?1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition.'),
(3933, 'hsa-mir-16', 'glioblastoma', 'down', 'Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-?B and FGF2.'),
(3934, 'hsa-mir-181a', 'glioblastoma', 'down', 'Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.'),
(3935, 'hsa-mir-198', 'glioblastoma', 'down', 'MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.'),
(3936, 'hsa-mir-211', 'glioblastoma', 'down', 'Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/?-catenin pathway in GBM.'),
(3937, 'hsa-mir-221', 'glioblastoma', 'up', 'Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.'),
(3938, 'hsa-mir-299', 'glioblastoma', 'up', 'Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2.'),
(3939, 'hsa-mir-302b', 'glioblastoma', 'down', 'The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.'),
(3940, 'hsa-mir-302d', 'glioblastoma', 'down', 'Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-?B and FGF2.'),
(3941, 'hsa-mir-30b', 'glioblastoma', 'up', 'Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2.'),
(3942, 'hsa-mir-330-5p', 'glioblastoma', 'down', 'miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5.'),
(3943, 'hsa-mir-3908', 'glioblastoma', 'down', 'AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.'),
(3944, 'hsa-mir-4484', 'glioblastoma', 'down', 'Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor.'),
(3945, 'hsa-mir-504', 'glioblastoma', 'down', 'Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.'),
(3946, 'hsa-mir-608', 'glioblastoma', 'down', 'Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.'),
(3947, 'hsa-mir-1179', 'glioblastoma', 'down', 'MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5.'),
(3948, 'hsa-mir-152-3p', 'glioblastoma', 'down', 'Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.'),
(3949, 'hsa-mir-154-5p', 'glioblastoma', 'down', 'MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.'),
(3950, 'hsa-mir-184', 'glioblastoma', 'down', 'MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.'),
(3951, 'hsa-mir-203', 'glioblastoma', 'down', 'Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.'),
(3952, 'hsa-mir-205', 'glioblastoma', 'down', 'Epigenetic Modification of MicroRNA-205 and its Association with Glioblastoma Multiform.'),
(3953, 'hsa-mir-429', 'glioblastoma', 'down', 'MiR-429 suppresses glioblastoma multiforme by targeting SOX2.'),
(3954, 'hsa-mir-485-3p', 'glioblastoma', 'down', 'Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.'),
(3955, 'hsa-mir-503', 'glioblastoma', 'up', 'TGF-?1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.'),
(3956, 'hsa-mir-590-3p', 'glioblastoma', 'up', 'MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.'),
(3957, 'hsa-mir-9', 'glioblastoma', 'down', 'MiR-9 Promotes Apoptosis Via Suppressing SMC1A Expression in GBM Cell Lines.'),
(3958, 'hsa-mir-141-3p', 'glioblastoma', 'up', 'MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.'),
(3959, 'hsa-mir-145', 'glioblastoma', 'down', 'MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.'),
(3960, 'hsa-mir-503', 'glioblastoma', 'up', 'TGF-?1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.'),
(3961, 'hsa-mir-101', 'glioblastoma', 'down', 'Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.'),
(3962, 'hsa-mir-129-3p', 'glioblastoma', 'down', 'MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.'),
(3963, 'hsa-mir-135a', 'glioblastoma', 'down', 'MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.'),
(3964, 'hsa-mir-30c', 'glioblastoma', 'down', 'MiR-30c impedes glioblastoma cell proliferation and migration by targeting SOX9.'),
(3965, 'hsa-mir-373', 'glioblastoma', 'down', 'Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.'),
(3966, 'hsa-mir-503', 'glioblastoma', 'up', 'TGF-??1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.'),
(3967, 'hsa-mir-598', 'glioblastoma', 'down', 'MicroRNA-598 Inhibits Cell Proliferation and Invasion of Glioblastoma by Directly Targeting Metastasis Associated in Colon Cancer-1 (MACC1).'),
(3968, 'hsa-mir-940', 'glioblastoma', 'down', 'Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma.'),
(3969, 'hsa-mir-107', 'glioblastoma', 'down', 'LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.'),
(3970, 'hsa-mir-134', 'glioblastoma', 'down', 'Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.'),
(3971, 'hsa-mir-146b', 'glioblastoma', 'up', 'The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence.'),
(3972, 'hsa-mir-204', 'glioblastoma', 'down', 'miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.'),
(3973, 'hsa-mir-223-3p', 'glioblastoma', 'down', 'MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas.'),
(3974, 'hsa-mir-485-5p', 'glioblastoma', 'down', 'Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.'),
(3975, 'hsa-mir-505', 'glioblastoma', 'down', 'Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/?-catenin signaling pathway.'),
(3976, 'hsa-mir-519a', 'glioblastoma', 'down', 'miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.'),
(3977, 'hsa-mir-615', 'glioblastoma', 'down', 'MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.'),
(3978, 'hsa-mir-7-5p', 'glioblastoma', 'down', 'Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway.'),
(3979, 'hsa-mir-758-5p', 'glioblastoma', 'down', 'Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.'),
(3980, 'hsa-mir-100', 'glioblastoma', 'down', 'Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.'),
(3981, 'hsa-mir-143', 'glioblastoma', 'up', 'Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression.'),
(3982, 'hsa-mir-145', 'glioblastoma', 'down', 'miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.'),
(3983, 'hsa-mir-193a-5p', 'glioblastoma', 'down', 'MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.'),
(3984, 'hsa-mir-203', 'glioblastoma', 'down', 'Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive RNA-sequencing transcriptome profiling.'),
(3985, 'hsa-mir-214-5p', 'glioblastoma', 'up', 'Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5.'),
(3986, 'hsa-mir-744', 'glioblastoma', 'down', 'Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.'),
(3987, 'hsa-mir-744', 'glioblastoma', 'down', 'microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.'),
(3988, 'hsa-mir-145', 'glioblastoma', 'down', 'MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma.'),
(3989, 'hsa-mir-181a-1', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3990, 'hsa-mir-181a-2', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3991, 'hsa-mir-181b-1', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3992, 'hsa-mir-181b-2', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3993, 'hsa-mir-181c', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3994, 'hsa-mir-181d', 'glioblastoma', 'down', 'MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.'),
(3995, 'hsa-mir-191', 'glioblastoma', 'up', 'MiRNA-191 functions as an oncogene in primary glioblastoma by directly targeting NDST1.'),
(3996, 'hsa-mir-196b', 'glioblastoma', 'up', 'Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy.'),
(3997, 'hsa-mir-21', 'glioblastoma', 'up', 'Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.'),
(3998, 'hsa-mir-21', 'glioblastoma', 'up', 'The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma.'),
(3999, 'hsa-mir-210', 'glioblastoma', 'down', 'miR-210 inhibits cell migration and invasion by targeting the brain-derived neurotrophic factor in glioblastoma.'),
(4000, 'hsa-mir-26a', 'glioblastoma', 'up', 'The influence of distinct regulatory miRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma.'),
(4001, 'hsa-mir-29a', 'glioblastoma', 'up', 'MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.'),
(4002, 'hsa-mir-340-5p', 'glioblastoma', 'down', 'An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.'),
(4003, 'hsa-mir-340-5p', 'glioblastoma', 'down', 'miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.'),
(4004, 'hsa-mir-365', 'glioblastoma', 'down', 'MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.'),
(4005, 'hsa-mir-485-3p', 'glioblastoma', 'down', 'Downregulation of miR-485-3p promotes glioblastoma cell proliferation and migration via targeting RNF135.'),
(4006, 'hsa-mir-504', 'glioblastoma', 'down', 'miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-?-catenin pathway.'),
(4007, 'hsa-mir-562', 'glioblastoma', 'down', 'MicroRNA-562 negatively regulated c-MET/AKT pathway in the growth of glioblastoma cells.'),
(4008, 'hsa-mir-605', 'glioblastoma', 'down', 'microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.'),
(4009, 'hsa-mir-652', 'glioblastoma', 'down', 'MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.'),
(4010, 'hsa-mir-7-5p', 'glioblastoma', 'down', 'miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1.'),
(4011, 'hsa-mir-152', 'glioblastoma', 'down', 'MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr???ppel-like factor 4.'),
(4012, 'hsa-let-7a', 'glioma', 'down', 'Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN.'),
(4013, 'hsa-let-7f', 'glioma', 'down', 'Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin.'),
(4014, 'hsa-mir-106a', 'glioma', 'down', 'MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.'),
(4015, 'hsa-mir-106b', 'glioma', 'up', 'Down-regulation of miR-106b suppresses the growth of human glioma cells.'),
(4016, 'hsa-mir-106b-5p', 'glioma', 'up', 'MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.'),
(4017, 'hsa-mir-107', 'glioma', 'down', 'P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2.'),
(4018, 'hsa-mir-107', 'glioma', 'down', 'MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.'),
(4019, 'hsa-mir-107', 'glioma', 'down', 'Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.'),
(4020, 'hsa-mir-10b', 'glioma', 'up', 'MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10.'),
(4021, 'hsa-mir-122', 'glioma', 'down', 'miR-122/Wnt/?-catenin regulatory circuitry sustains glioma progression.'),
(4022, 'hsa-mir-124', 'glioma', 'down', 'microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma.'),
(4023, 'hsa-mir-124', 'glioma', 'down', 'MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.'),
(4024, 'hsa-mir-124', 'glioma', 'down', 'Downregulation of microRNA-124 predicts poor prognosis in glioma patients.'),
(4025, 'hsa-mir-124-5p', 'glioma', 'down', 'MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.'),
(4026, 'hsa-mir-124a', 'glioma', 'down', 'miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and ?-catenin.'),
(4027, 'hsa-mir-125b', 'glioma', 'up', 'miR-125b Inhibits Connexin43 and Promotes Glioma Growth.'),
(4028, 'hsa-mir-125b', 'glioma', 'down', 'Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.'),
(4029, 'hsa-mir-125b', 'glioma', 'up', 'MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.'),
(4030, 'hsa-mir-128', 'glioma', 'down', 'MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.'),
(4031, 'hsa-mir-128', 'glioma', 'down', 'Proteomic screening and identification of microRNA-128 targets in glioma cells.'),
(4032, 'hsa-mir-128', 'glioma', 'down', 'Serum microRNA-128 as a biomarker for diagnosis of glioma.'),
(4033, 'hsa-mir-128', 'glioma', 'down', 'MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a.'),
(4034, 'hsa-mir-128', 'glioma', 'down', 'Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.'),
(4035, 'hsa-mir-128', 'glioma', 'down', 'MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.'),
(4036, 'hsa-mir-132', 'glioma', 'up', 'Upregulation of miR-132 expression in glioma and its clinical significance.'),
(4037, 'hsa-mir-136', 'glioma', 'down', 'MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.'),
(4038, 'hsa-mir-137', 'glioma', 'down', 'Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1.'),
(4039, 'hsa-mir-139', 'glioma', 'down', 'MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma.'),
(4040, 'hsa-mir-143', 'glioma', 'down', 'miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.'),
(4041, 'hsa-mir-145', 'glioma', 'down', 'NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.'),
(4042, 'hsa-mir-145', 'glioma', 'down', 'MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.'),
(4043, 'hsa-mir-145', 'glioma', 'down', 'ROCK1, a novel target of miR-145, promotes glioma cell invasion.'),
(4044, 'hsa-mir-145', 'glioma', 'down', 'miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2.'),
(4045, 'hsa-mir-146a', 'glioma', 'down', 'MicroRNA-146a inhibits glioma development by targeting Notch1.'),
(4046, 'hsa-mir-146b', 'glioma', 'down', 'microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.'),
(4047, 'hsa-mir-146b-5p', 'glioma', 'down', 'miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.'),
(4048, 'hsa-mir-152', 'glioma', 'down', 'MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.'),
(4049, 'hsa-mir-155', 'glioma', 'up', 'MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1.'),
(4050, 'hsa-mir-155', 'glioma', 'up', 'Overexpression of microRNA-155 predicts poor prognosis in glioma patients.'),
(4051, 'hsa-mir-15b', 'glioma', 'down', 'MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3.'),
(4052, 'hsa-mir-16', 'glioma', 'down', 'MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-?B1/MMP9 signaling pathway.'),
(4053, 'hsa-mir-17', 'glioma', 'up', 'Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.'),
(4054, 'hsa-mir-17', 'glioma', 'up', 'Increased expression of microRNA-17 predicts poor prognosis in human glioma.'),
(4055, 'hsa-mir-181a', 'glioma', 'down', 'hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.'),
(4056, 'hsa-mir-181a', 'glioma', 'up', 'MiR-181a regulates blood-tumor barrier permeability by targeting Kr?ppel-like factor 6.'),
(4057, 'hsa-mir-181a-1', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4058, 'hsa-mir-181a-2', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4059, 'hsa-mir-181b', 'glioma', 'down', 'hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.'),
(4060, 'hsa-mir-181b', 'glioma', 'down', 'MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.'),
(4061, 'hsa-mir-181b', 'glioma', 'down', 'MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells.'),
(4062, 'hsa-mir-181b-1', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4063, 'hsa-mir-181b-2', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4064, 'hsa-mir-181c', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4065, 'hsa-mir-181d', 'glioma', 'down', 'MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.'),
(4066, 'hsa-mir-181d', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell?proliferation by targeting cyclin B1.'),
(4067, 'hsa-mir-182', 'glioma', 'up', 'The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.'),
(4068, 'hsa-mir-182', 'glioma', 'up', 'miR-182 as a prognostic marker for glioma progression and patient survival.'),
(4069, 'hsa-mir-183', 'glioma', 'up', 'The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.'),
(4070, 'hsa-mir-184', 'glioma', 'down', 'Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.'),
(4071, 'hsa-mir-184', 'glioma', 'down', 'MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.'),
(4072, 'hsa-mir-185', 'glioma', 'down', 'LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.'),
(4073, 'hsa-mir-193b', 'glioma', 'up', 'miR-193b promotes cell proliferation by targeting Smad3 in human glioma.'),
(4074, 'hsa-mir-195', 'glioma', 'down', 'MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1.'),
(4075, 'hsa-mir-199a-3p', 'glioma', 'down', 'MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway.'),
(4076, 'hsa-mir-19a', 'glioma', 'up', 'miR-19a and miR-19b Overexpression in Gliomas.'),
(4077, 'hsa-mir-19a', 'glioma', 'up', 'MicroRNA-19a promotes glioma cell growth by repressing LRIG1.'),
(4078, 'hsa-mir-19b', 'glioma', 'up', 'miR-19a and miR-19b Overexpression in Gliomas.'),
(4079, 'hsa-mir-200a', 'glioma', 'down', 'MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.'),
(4080, 'hsa-mir-200b', 'glioma', 'down', 'miR-200b as a prognostic factor targets multiple members of RAB family in glioma.'),
(4081, 'hsa-mir-200b', 'glioma', 'down', 'Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.'),
(4082, 'hsa-mir-200b', 'glioma', 'down', '[miR-200b suppresses glioma cell invasion by targeting PROM1].'),
(4083, 'hsa-mir-203', 'glioma', 'down', 'MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.'),
(4084, 'hsa-mir-204', 'glioma', 'down', 'Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.'),
(4085, 'hsa-mir-205', 'glioma', 'down', 'Identification of microRNA-205 as a potential prognostic indicator for human glioma.'),
(4086, 'hsa-mir-205', 'glioma', 'down', 'MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A.'),
(4087, 'hsa-mir-20a', 'glioma', 'up', '[Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro].'),
(4088, 'hsa-mir-210', 'glioma', 'up', 'MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.'),
(4089, 'hsa-mir-210', 'glioma', 'up', 'MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.'),
(4090, 'hsa-mir-214', 'glioma', 'up', 'Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma.'),
(4091, 'hsa-mir-218', 'glioma', 'down', 'Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.'),
(4092, 'hsa-mir-218', 'glioma', 'down', 'MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation and Cancer Stem-like Cell Self-renewal by Targeting the Polycomb Group Gene Bmi1.'),
(4093, 'hsa-mir-219-5p', 'glioma', 'down', 'miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma.'),
(4094, 'hsa-mir-221', 'glioma', 'up', 'MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma.'),
(4095, 'hsa-mir-221', 'glioma', 'up', 'MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.'),
(4096, 'hsa-mir-221', 'glioma', 'up', 'Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.'),
(4097, 'hsa-mir-221', 'glioma', 'up', 'MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.'),
(4098, 'hsa-mir-221', 'glioma', 'up', 'Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.'),
(4099, 'hsa-mir-222', 'glioma', 'up', 'Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo.'),
(4100, 'hsa-mir-222', 'glioma', 'up', 'MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.'),
(4101, 'hsa-mir-222', 'glioma', 'up', 'MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.'),
(4102, 'hsa-mir-224', 'glioma', 'up', 'Upregulation of microRNA-224 confers a poor prognosis in glioma patients.'),
(4103, 'hsa-mir-23a', 'glioma', 'up', 'Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10.'),
(4104, 'hsa-mir-23b', 'glioma', 'down', 'miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.'),
(4105, 'hsa-mir-24', 'glioma', 'up', 'MiR-24 regulates the proliferation and invasion of glioma by ST7L via ?-catenin/Tcf-4 signaling.'),
(4106, 'hsa-mir-24-3p', 'glioma', 'up', 'miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.'),
(4107, 'hsa-mir-25', 'glioma', 'up', 'miR-25 promotes glioma cell proliferation by targeting CDKN1C.'),
(4108, 'hsa-mir-26a', 'glioma', 'up', 'MicroRNA-26a Promotes Tumor Growth and Angiogenesis in Glioma by Directly Targeting Prohibitin.'),
(4109, 'hsa-mir-26b', 'glioma', 'down', 'Role of microRNA-26b in glioma development and its mediated regulation on EphA2.'),
(4110, 'hsa-mir-27a', 'glioma', 'down', 'Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin.'),
(4111, 'hsa-mir-27a-3p', 'glioma', 'up', 'miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1.'),
(4112, 'hsa-mir-27b', 'glioma', 'up', 'Expression and function of miR-27b in human glioma.'),
(4113, 'hsa-mir-27b', 'glioma', 'up', 'MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells.'),
(4114, 'hsa-mir-29c', 'glioma', 'down', 'MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis.'),
(4115, 'hsa-mir-30a-5p', 'glioma', 'up', 'Analysis of hsa-miR-30a-5p Expression in Human Gliomas.'),
(4116, 'hsa-mir-30e', 'glioma', 'up', 'Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.'),
(4117, 'hsa-mir-30e*', 'glioma', 'up', 'MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-?B/I?B? negative feedback loop.'),
(4118, 'hsa-mir-320', 'glioma', 'down', 'MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1.'),
(4119, 'hsa-mir-326', 'glioma', 'down', 'Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness.'),
(4120, 'hsa-mir-326', 'glioma', 'down', 'The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.'),
(4121, 'hsa-mir-326', 'glioma', 'down', 'MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).'),
(4122, 'hsa-mir-328', 'glioma', 'up', 'MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.'),
(4123, 'hsa-mir-328', 'glioma', 'down', 'microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.'),
(4124, 'hsa-mir-335', 'glioma', 'up', 'Tumor microRNA-335 expression is associated with poor prognosis in human glioma.'),
(4125, 'hsa-mir-33a', 'glioma', 'up', 'miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.'),
(4126, 'hsa-mir-34a', 'glioma', 'down', 'MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.'),
(4127, 'hsa-mir-34a', 'glioma', 'down', 'microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.'),
(4128, 'hsa-mir-34a', 'glioma', 'down', 'MicroRNA-34a induces apoptosis in the human glioma cell line, A172, through enhanced ROS production and NOX2 expression.'),
(4129, 'hsa-mir-34c-3p', 'glioma', 'down', 'Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.'),
(4130, 'hsa-mir-34c-5p', 'glioma', 'down', 'Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.'),
(4131, 'hsa-mir-372', 'glioma', 'up', 'Correlation of microrna-372 upregulation with poor prognosis in human glioma.'),
(4132, 'hsa-mir-375', 'glioma', 'down', 'Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.'),
(4133, 'hsa-mir-383', 'glioma', 'down', 'Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.'),
(4134, 'hsa-mir-383', 'glioma', 'down', 'MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.'),
(4135, 'hsa-mir-383', 'glioma', 'down', 'MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.'),
(4136, 'hsa-mir-451', 'glioma', 'down', 'MiRNA-451 plays a role as tumor suppressor in human glioma cells.'),
(4137, 'hsa-mir-451', 'glioma', 'down', 'MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(4138, 'hsa-mir-452', 'glioma', 'down', 'Downregulation of miR-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas.'),
(4139, 'hsa-mir-483-5p', 'glioma', 'down', 'MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.'),
(4140, 'hsa-mir-486', 'glioma', 'up', 'miR-486 sustains NF-?B activity by disrupting multiple NF-?B-negative feedback loops.'),
(4141, 'hsa-mir-494', 'glioma', 'up', 'Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B RhoGAP.'),
(4142, 'hsa-mir-495', 'glioma', 'down', 'MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6.'),
(4143, 'hsa-mir-497', 'glioma', 'up', 'Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.'),
(4144, 'hsa-mir-566', 'glioma', 'up', 'MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.'),
(4145, 'hsa-mir-584', 'glioma', 'down', 'MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.'),
(4146, 'hsa-mir-603', 'glioma', 'up', 'miR-603 promotes glioma cell growth via Wnt/?-catenin pathway by inhibiting WIF1 and CTNNBIP1.'),
(4147, 'hsa-mir-622', 'glioma', 'down', 'miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells.'),
(4148, 'hsa-mir-650', 'glioma', 'up', 'MicroRNA-650 expression in glioma is associated with prognosis of patients.'),
(4149, 'hsa-mir-656', 'glioma', 'down', 'miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.'),
(4150, 'hsa-mir-675', 'glioma', 'up', 'Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675.'),
(4151, 'hsa-mir-7', 'glioma', 'down', 'MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.'),
(4152, 'hsa-mir-7', 'glioma', 'down', 'MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.'),
(4153, 'hsa-mir-9', 'glioma', 'up', 'Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.'),
(4154, 'hsa-mir-9', 'glioma', 'up', '[MiR-9 regulates the expression of CBX7 in human glioma].'),
(4155, 'hsa-mir-9', 'glioma', 'up', 'The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.'),
(4156, 'hsa-mir-92b', 'glioma', 'up', 'MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway.'),
(4157, 'hsa-mir-93', 'glioma', 'up', '[Overexpressed microRNA-93 inhibits the proliferation and promotes apoptosis of A172 glioma cells].'),
(4158, 'hsa-mir-93', 'glioma', 'up', 'miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.'),
(4159, 'hsa-mir-96', 'glioma', 'up', 'The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas.'),
(4160, 'hsa-mir-96', 'glioma', 'up', 'miR-96/HBP1/Wnt/?-catenin regulatory circuitry promotes glioma growth.'),
(4161, 'hsa-mir-98', 'glioma', 'down', 'Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.'),
(4162, 'hsa-mir-107', 'glioma', 'down', 'Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.'),
(4163, 'hsa-mir-144-3p', 'glioma', 'down', 'miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.'),
(4164, 'hsa-mir-205', 'glioma', 'down', 'Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.'),
(4165, 'hsa-mir-20a', 'glioma', 'up', 'DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.'),
(4166, 'hsa-mir-215', 'glioma', 'up', 'MiR-215, an activator of the CTNNBIP1/?-catenin pathway, is a marker of poor prognosis in human glioma.'),
(4167, 'hsa-mir-218', 'glioma', 'down', 'miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway.'),
(4168, 'hsa-mir-27a', 'glioma', 'up', 'MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma.'),
(4169, 'hsa-mir-30a-5p', 'glioma', 'up', 'MiR-30a-5p is induced by Wnt/?-catenin pathway and promotes glioma cell invasion by repressing NCAM.'),
(4170, 'hsa-mir-326', 'glioma', 'down', 'Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.'),
(4171, 'hsa-mir-378', 'glioma', 'down', 'Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.'),
(4172, 'hsa-mir-429', 'glioma', 'down', 'miR-429 inhibits glioma invasion through BMK1 suppression.'),
(4173, 'hsa-mir-495', 'glioma', 'down', 'miR-495 mediates metabolic shift in glioma cells via targeting Glut1.'),
(4174, 'hsa-mir-106a', 'glioma', 'up', 'microRNA-106a induces the proliferation and apoptosis of glioma cells through regulating JNK/MAPK pathway.'),
(4175, 'hsa-mir-126', 'glioma', 'down', 'MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1).'),
(4176, 'hsa-mir-139-5p', 'glioma', 'down', 'MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.'),
(4177, 'hsa-mir-16', 'glioma', 'down', 'Up-regulation of microRNA-16 in glioblastoma inhibits the function of endothelial cells and tumor angiogenesis by targeting Bmi-1.'),
(4178, 'hsa-mir-218-5p', 'glioma', 'down', 'miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells.'),
(4179, 'hsa-mir-221', 'glioma', 'down', 'Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.'),
(4180, 'hsa-mir-3175', 'glioma', 'up', 'HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.'),
(4181, 'hsa-mir-506', 'glioma', 'down', 'miR-506 functions as a tumor suppressor in glioma by targeting STAT3.'),
(4182, 'hsa-mir-661', 'glioma', 'down', 'MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT.'),
(4183, 'hsa-mir-98', 'glioma', 'down', 'Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKK?.'),
(4184, 'hsa-mir-101', 'glioma', 'down', 'miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.'),
(4185, 'hsa-mir-129', 'glioma', 'down', 'MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.'),
(4186, 'hsa-mir-130b', 'glioma', 'up', 'MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.'),
(4187, 'hsa-mir-21', 'glioma', 'up', 'miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study.'),
(4188, 'hsa-mir-218', 'glioma', 'down', 'miR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1.'),
(4189, 'hsa-mir-338-3p', 'glioma', 'down', 'Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.'),
(4190, 'hsa-mir-373', 'glioma', 'down', 'miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.'),
(4191, 'hsa-mir-429', 'glioma', 'up', 'The Potential Prognostic Value of MicroRNA-429 for Human Gliomas.'),
(4192, 'hsa-mir-4295', 'glioma', 'up', 'RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.'),
(4193, 'hsa-mir-503', 'glioma', 'down', 'miR-503 inhibits cell proliferation and invasion in glioma by targeting L1CAM.'),
(4194, 'hsa-mir-519a', 'glioma', 'down', 'MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.'),
(4195, 'hsa-mir-96', 'glioma', 'up', 'MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.'),
(4196, 'hsa-mir-133a', 'glioma', 'down', 'miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.'),
(4197, 'hsa-mir-133b', 'glioma', 'down', 'miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.'),
(4198, 'hsa-mir-134', 'glioma', 'down', 'MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway.'),
(4199, 'hsa-mir-150-5p', 'glioma', 'down', 'miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.'),
(4200, 'hsa-mir-183', 'glioma', 'up', 'Upregulation of miR-183 expression and its clinical significance in human brain glioma.'),
(4201, 'hsa-mir-217', 'glioma', 'down', 'MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.'),
(4202, 'hsa-mir-370-3p', 'glioma', 'down', 'MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting ?-catenin.'),
(4203, 'hsa-mir-495', 'glioma', 'down', 'Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB.'),
(4204, 'hsa-mir-544', 'glioma', 'down', 'MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7.'),
(4205, 'hsa-mir-93', 'glioma', 'up', 'MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide.'),
(4206, 'hsa-mir-100', 'glioma', 'down', 'Roles of microRNA-99 family in human glioma.'),
(4207, 'hsa-mir-1297', 'glioma', 'down', 'Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro.'),
(4208, 'hsa-mir-130b', 'glioma', 'up', 'MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-? in human glioma cells.'),
(4209, 'hsa-mir-141', 'glioma', 'down', 'Epigenetic modification of miR-141 regulates SKA2 by an endogenous \'sponge\' HOTAIR in glioma.'),
(4210, 'hsa-mir-154', 'glioma', 'down', 'Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance.'),
(4211, 'hsa-mir-198', 'glioma', 'down', 'Decreased microRNA-198 expression and its prognostic significance in human glioma.'),
(4212, 'hsa-mir-200b', 'glioma', 'down', 'miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.'),
(4213, 'hsa-mir-200b-3p', 'glioma', 'down', 'MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.'),
(4214, 'hsa-mir-204-3p', 'glioma', 'down', 'The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.'),
(4215, 'hsa-mir-205', 'glioma', 'down', 'TGF-?1 regulating miR-205/miR-195 expression affects the TGF-? signal pathway by respectively targeting SMAD2/SMAD7.'),
(4216, 'hsa-mir-384', 'glioma', 'down', 'CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.'),
(4217, 'hsa-mir-423-5p', 'glioma', 'up', 'miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.'),
(4218, 'hsa-mir-451', 'glioma', 'down', 'miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.'),
(4219, 'hsa-mir-497', 'glioma', 'down', 'Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.'),
(4220, 'hsa-mir-610', 'glioma', 'down', 'MicroRNA-610 is downregulated in glioma cells, and inhibits proliferation and motility by directly targeting MDM2.'),
(4221, 'hsa-mir-99a', 'glioma', 'down', 'Roles of microRNA-99 family in human glioma.'),
(4222, 'hsa-mir-99b', 'glioma', 'down', 'Roles of microRNA-99 family in human glioma.'),
(4223, 'hsa-mir-101', 'glioma', 'down', 'miR-101 inhibits glioma cell invasion via the downregulation of COX-2.'),
(4224, 'hsa-mir-101', 'glioma', 'down', 'MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.'),
(4225, 'hsa-mir-105', 'glioma', 'down', 'MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.'),
(4226, 'hsa-mir-141', 'glioma', 'down', 'MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.'),
(4227, 'hsa-mir-141', 'glioma', 'down', 'MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-?2.'),
(4228, 'hsa-mir-200c', 'glioma', 'down', 'MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration.'),
(4229, 'hsa-mir-215', 'glioma', 'up', 'MicroRNA-215 enhances invasion and migration by targeting retinoblastoma tumor suppressor gene 1 in high-grade glioma.'),
(4230, 'hsa-mir-23b', 'glioma', 'up', 'Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas.'),
(4231, 'hsa-mir-320d', 'glioma', 'down', 'Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma.'),
(4232, 'hsa-mir-548b', 'glioma', 'down', 'miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.'),
(4233, 'hsa-mir-92a-3p', 'glioma', 'up', 'miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/?-Catenin and Notch-1/Akt Signaling Pathways.'),
(4234, 'hsa-let-7a', 'glioma', 'down', 'Let-7a suppresses glioma cell proliferation and invasion through TGF-?/Smad3 signaling pathway by targeting HMGA2.'),
(4235, 'hsa-mir-124', 'glioma', 'down', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4236, 'hsa-mir-15a', 'glioma', 'up', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4237, 'hsa-mir-16', 'glioma', 'up', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4238, 'hsa-mir-181b', 'glioma', 'down', 'MicroRNA-181b inhibits cellular proliferation and invasion of glioma cells via targeting Sal-like protein 4.'),
(4239, 'hsa-mir-194', 'glioma', 'down', 'MicroRNA-194 represses glioma cell epithelial?to?mesenchymal transition by targeting Bmi1.'),
(4240, 'hsa-mir-199a-3p', 'glioma', 'down', 'Circulating miR-199a-3p in plasma and its potential diagnostic and prognostic value in glioma.'),
(4241, 'hsa-mir-204', 'glioma', 'down', 'Downregulation of miR-204 expression correlates with poor clinical outcome of glioma patients.'),
(4242, 'hsa-mir-21', 'glioma', 'up', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4243, 'hsa-mir-214', 'glioma', 'down', 'miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase-1 involved in pyroptosis.'),
(4244, 'hsa-mir-216a', 'glioma', 'down', 'Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells By Targeting Leucine-rich Repeat-containing G Protein-coupled Receptor 5.'),
(4245, 'hsa-mir-217', 'glioma', 'down', 'TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1?/Derlin-1 pathway.'),
(4246, 'hsa-mir-23a', 'glioma', 'up', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4247, 'hsa-mir-320a', 'glioma', 'down', 'miR-320a functions as a suppressor for gliomas by targeting SND1 and ?-catenin, and predicts the prognosis of patients.'),
(4248, 'hsa-mir-361-5p', 'glioma', 'down', 'MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.'),
(4249, 'hsa-mir-409-3p', 'glioma', 'down', 'MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-mobility Group Nucleosome Binding Domain 5.'),
(4250, 'hsa-mir-422a', 'glioma', 'down', 'miR-422a Inhibits Glioma Proliferation and Invasion by Targeting IGF1 and IGF1R.'),
(4251, 'hsa-mir-433-3p', 'glioma', 'down', 'MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma.'),
(4252, 'hsa-mir-508-5p', 'glioma', 'down', 'MiR-508-5p is a prognostic marker and inhibits cell proliferation and migration in glioma.'),
(4253, 'hsa-mir-520c', 'glioma', 'down', 'MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-? receptor type 2.'),
(4254, 'hsa-mir-9', 'glioma', 'up', 'Identification of microRNAs associated with glioma diagnosis and prognosis.'),
(4255, 'hsa-mir-101', 'glioma', 'down', 'Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.'),
(4256, 'hsa-mir-1202', 'glioma', 'down', 'MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A.'),
(4257, 'hsa-mir-124', 'glioma', 'down', 'Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.'),
(4258, 'hsa-mir-130b', 'glioma', 'up', 'miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD.'),
(4259, 'hsa-mir-130b', 'glioma', 'up', 'MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-? in human glioma.'),
(4260, 'hsa-mir-133a-1', 'glioma', 'down', 'Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.'),
(4261, 'hsa-mir-133a-2', 'glioma', 'down', 'Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.'),
(4262, 'hsa-mir-133b', 'glioma', 'down', 'Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.'),
(4263, 'hsa-mir-137', 'glioma', 'down', 'Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137.'),
(4264, 'hsa-mir-140-5p', 'glioma', 'down', 'MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma.'),
(4265, 'hsa-mir-1468-5p', 'glioma', 'down', 'MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.'),
(4266, 'hsa-mir-148a', 'glioma', 'up', 'MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.'),
(4267, 'hsa-mir-181b', 'glioma', 'down', 'lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.'),
(4268, 'hsa-mir-200c', 'glioma', 'down', 'MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin.'),
(4269, 'hsa-mir-211', 'glioma', 'down', 'MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.'),
(4270, 'hsa-mir-29b', 'glioma', 'down', 'MiR-29b inhibits the growth of glioma via MYCN dependent way.'),
(4271, 'hsa-mir-370', 'glioma', 'down', 'Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells\' Malignancy by Activating miR-370/CCNE2 Axis.'),
(4272, 'hsa-mir-421', 'glioma', 'down', 'MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D.'),
(4273, 'hsa-mir-424', 'glioma', 'down', 'MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.'),
(4274, 'hsa-mir-548c-3p', 'glioma', 'down', 'MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb.'),
(4275, 'hsa-mir-630', 'glioma', 'down', 'Inhibition of miR-630 enhances the cell resistance to radiation by directly targeting CDC14A in human glioma.'),
(4276, 'hsa-mir-103a-3p', 'glioma', 'down', 'Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.'),
(4277, 'hsa-mir-105', 'glioma', 'down', 'MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.'),
(4278, 'hsa-mir-130a', 'glioma', 'down', 'Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.'),
(4279, 'hsa-mir-133b', 'glioma', 'down', 'MicroRNA-133b expression associates with clinicopathological features and prognosis in glioma.'),
(4280, 'hsa-mir-141-3p', 'glioma', 'down', 'miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.'),
(4281, 'hsa-mir-148b-3p', 'glioma', 'down', 'The Role of HOTAIR/miR-148b-3p/USF1 on Regulating the Permeability of BTB.'),
(4282, 'hsa-mir-155', 'glioma', 'up', 'MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma cells.'),
(4283, 'hsa-mir-202', 'glioma', 'down', 'MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.'),
(4284, 'hsa-mir-203', 'glioma', 'down', 'Silencing of lncRNA-CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo Via Targeting miR-203.'),
(4285, 'hsa-mir-216b', 'glioma', 'down', 'miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1.'),
(4286, 'hsa-mir-30a', 'glioma', 'down', 'miR-30a inhibits glioma progression and stem cell?like properties by repression of Wnt5a.'),
(4287, 'hsa-mir-338', 'glioma', 'down', 'MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma.'),
(4288, 'hsa-mir-338-5p', 'glioma', 'up', 'MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.'),
(4289, 'hsa-mir-34a', 'glioma', 'down', 'miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.'),
(4290, 'hsa-mir-373', 'glioma', 'down', 'Down-expression of miR-373 predicts poor prognosis of glioma and could be a potential therapeutic target.'),
(4291, 'hsa-mir-485-5p', 'glioma', 'down', 'A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.'),
(4292, 'hsa-mir-489', 'glioma', 'down', 'miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.'),
(4293, 'hsa-mir-520b', 'glioma', 'down', 'MiR-520b inhibits the development of glioma by directly targeting MBD2.'),
(4294, 'hsa-mir-520c', 'glioma', 'down', 'MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-? receptor type?2.'),
(4295, 'hsa-mir-539', 'glioma', 'down', 'MicroRNA-539 inhibits glioma cell proliferation and invasion by targeting DIXDC1.'),
(4296, 'hsa-mir-543', 'glioma', 'down', 'miR-543 functions as a tumor suppressor in glioma in vitro and in vivo.'),
(4297, 'hsa-mir-592', 'glioma', 'down', 'MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2.'),
(4298, 'hsa-mir-599', 'glioma', 'down', 'miR-599 inhibits proliferation and invasion of glioma by targeting periostin.'),
(4299, 'hsa-mir-625', 'glioma', 'down', 'MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.'),
(4300, 'hsa-mir-103', 'glioma', 'down', 'MicroRNA-103 suppresses glioma cell proliferation and invasion by targeting the brain-derived neurotrophic factor.'),
(4301, 'hsa-mir-122', 'glioma', 'down', 'Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.'),
(4302, 'hsa-mir-1301', 'glioma', 'down', 'Association between downexpression of miR-1301 and poor prognosis in patients with glioma.'),
(4303, 'hsa-mir-130b', 'glioma', 'up', 'Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.'),
(4304, 'hsa-mir-1908', 'glioma', 'up', 'miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.'),
(4305, 'hsa-mir-194-5p', 'glioma', 'down', 'Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.'),
(4306, 'hsa-mir-203', 'glioma', 'down', 'Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma.'),
(4307, 'hsa-mir-301a', 'glioma', 'up', 'Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.'),
(4308, 'hsa-mir-375', 'glioma', 'down', 'Knockdown of long non-coding RNA LUCAT1 inhibits cell viability and invasion by regulating miR-375 in glioma.'),
(4309, 'hsa-mir-520d-5p', 'glioma', 'down', 'MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.'),
(4310, 'hsa-mir-936', 'glioma', 'down', 'MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.'),
(4311, 'hsa-let-7c', 'glioma', 'down', 'Let-7c Inhibits the Proliferation, Invasion, and Migration of Glioma Cells via Targeting E2F5.'),
(4312, 'hsa-mir-129-5p', 'glioma', 'down', 'MiR-129-5p inhibits glioma cell progression in vitro and in vivo by targeting TGIF2.'),
(4313, 'hsa-mir-1294', 'glioma', 'down', 'MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2.'),
(4314, 'hsa-mir-17', 'glioma', 'down', 'Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt.'),
(4315, 'hsa-mir-184', 'glioma', 'up', 'Expression of microRNA-184 in glioma.'),
(4316, 'hsa-mir-188', 'glioma', 'down', 'miR-188 Inhibits Glioma Cell Proliferation and Cell Cycle Progression Through Targeting ?-Catenin.'),
(4317, 'hsa-mir-21', 'glioma', 'up', 'MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.'),
(4318, 'hsa-mir-211', 'glioma', 'down', 'The Effect of MCM3AP-AS1/miR-211/KLF5/AGGF1 Axis Regulating Glioblastoma Angiogenesis.'),
(4319, 'hsa-mir-219', 'glioma', 'down', 'MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4.'),
(4320, 'hsa-mir-320a', 'glioma', 'down', 'miRNA-320a inhibits glioma cell invasion and migration by directly targeting aquaporin 4.'),
(4321, 'hsa-mir-320c', 'glioma', 'down', 'Down-regulation of miRNA-320c promotes tumor growth and metastasis and predicts poor prognosis in human glioma.'),
(4322, 'hsa-mir-375', 'glioma', 'down', 'MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.'),
(4323, 'hsa-mir-379', 'glioma', 'down', 'MicroRNA-379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.'),
(4324, 'hsa-mir-509-3p', 'glioma', 'down', 'MicroRNA-509-3p inhibits cell proliferation and invasion via downregulation of X-linked inhibitor of apoptosis in glioma.'),
(4325, 'hsa-mir-539-5p', 'glioma', 'down', 'Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.'),
(4326, 'hsa-mir-599', 'glioma', 'down', 'MiR-599 as a potential biomarker for prognosis of glioma.'),
(4327, 'hsa-mir-613', 'glioma', 'down', 'MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14.'),
(4328, 'hsa-mir-616', 'glioma', 'up', 'MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway.'),
(4329, 'hsa-mir-634', 'glioma', 'down', 'MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.'),
(4330, 'hsa-mir-93', 'glioma', 'down', 'Evaluation Expression of Microrna-93 and Integrin ?8 in Different Types of Glioma Tumors'),
(4331, 'hsa-mir-98', 'glioma', 'down', 'Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.'),
(4332, 'hsa-mir-98', 'glioma', 'down', 'MiR-98 Promotes Apoptosis of Glioma Cells via Suppressing IKBKE/NF-?B Pathway.'),
(4333, 'hsa-mir-101-3p', 'glioma', 'down', 'Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.'),
(4334, 'hsa-mir-122', 'glioma', 'down', 'MiR-122 inhibits cell proliferation and induces apoptosis by targeting runt-related transcription factors 2 in human glioma.'),
(4335, 'hsa-mir-1231', 'glioma', 'down', 'MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.'),
(4336, 'hsa-mir-124-3p', 'glioma', 'down', 'MicroRNA-124-3p represses cell growth and cell motility by targeting EphA2 in glioma.'),
(4337, 'hsa-mir-124-3p', 'glioma', 'down', 'Amentoflavone induces apoptosis and suppresses glycolysis in glioma cells by targeting miR-124-3p.'),
(4338, 'hsa-mir-124a', 'glioma', 'down', 'microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.'),
(4339, 'hsa-mir-128-3p', 'glioma', 'down', 'LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway.'),
(4340, 'hsa-mir-1283', 'glioma', 'down', 'Overexpression of miR-1283 inhibits cell proliferation and invasion of glioma cells by targeting ATF4.'),
(4341, 'hsa-mir-129', 'glioma', 'down', 'LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2.'),
(4342, 'hsa-mir-132', 'glioma', 'down', 'miR-132 weakens proliferation and invasion of glioma cells via the inhibition of Gli1.'),
(4343, 'hsa-mir-132', 'glioma', 'down', 'Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.'),
(4344, 'hsa-mir-132-3p', 'glioma', 'up', 'miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.'),
(4345, 'hsa-mir-133b', 'glioma', 'down', 'miR-133b acts as a tumor suppressor and negatively regulates EMP2 in glioma.'),
(4346, 'hsa-mir-135a', 'glioma', 'down', 'miR-135a inhibits glioma cell proliferation and invasion by directly targeting FOXO1.'),
(4347, 'hsa-mir-139-5p', 'glioma', 'down', 'Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).'),
(4348, 'hsa-mir-146a', 'glioma', 'down', 'Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.'),
(4349, 'hsa-mir-181a', 'glioma', 'down', 'Kaiso (ZBTB33) Downregulation by Mirna-181a Inhibits Cell Proliferation, Invasion, and the Epithelial-Mesenchymal Transition in Glioma Cells.'),
(4350, 'hsa-mir-18a-5p', 'glioma', 'up', 'Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p.'),
(4351, 'hsa-mir-19a', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4352, 'hsa-mir-19b', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4353, 'hsa-mir-200b', 'glioma', 'down', 'MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas.'),
(4354, 'hsa-mir-20a-5p', 'glioma', 'down', 'Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1.'),
(4355, 'hsa-mir-216b', 'glioma', 'down', 'Downregulation of microRNA-216b contributes to glioma cell growth and migration by promoting AEG-1-mediated signaling.'),
(4356, 'hsa-mir-24', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4357, 'hsa-mir-26a', 'glioma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4358, 'hsa-mir-27a', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4359, 'hsa-mir-29a', 'glioma', 'down', 'MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling.'),
(4360, 'hsa-mir-30b-5p', 'glioma', 'down', 'MiR-30b-5p modulates glioma cell proliferation by direct targeting MTDH.'),
(4361, 'hsa-mir-33a-5p', 'glioma', 'down', 'Long non-coding RNA DANCR facilitates glioma malignancy by sponging miR-33a-5p.'),
(4362, 'hsa-mir-3663-3p', 'glioma', 'up', 'MiR-363-3p modulates cell growth and invasion in glioma by directly targeting pyruvate dehydrogenase B.'),
(4363, 'hsa-mir-423-3p', 'glioma', 'up', 'MicroRNA-423-3p promotes glioma growth by targeting PANX2.'),
(4364, 'hsa-mir-451', 'glioma', 'down', 'miRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1?/VEGF signaling pathway by targeting CAB39.'),
(4365, 'hsa-mir-497', 'glioma', 'down', 'miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells.'),
(4366, 'hsa-mir-527', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4367, 'hsa-mir-5582-3p', 'glioma', 'down', 'Hsa-miR-5582-3P regulatory effect on TGF? signaling through targeting of TGF?-R1, TGF?-R2, SMAD3, and SMAD4 transcripts.'),
(4368, 'hsa-mir-584', 'glioma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(4369, 'hsa-mir-592', 'glioma', 'down', 'MiR-592 suppresses the development of glioma by regulating Rho-associated protein kinase.'),
(4370, 'hsa-mir-599', 'glioma', 'down', 'MicroRNA-599 suppresses glioma progression by targeting RAB27B.'),
(4371, 'hsa-mir-613', 'glioma', 'down', 'Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9.'),
(4372, 'hsa-mir-92a-3p', 'glioma', 'up', 'The long non-coding RNA SNHG14 inhibits cell proliferation and invasion and promotes apoptosis by sponging miR-92a-3p in glioma.'),
(4373, 'hsa-mir-93', 'glioma', 'up', 'MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2.'),
(4374, 'hsa-mir-107', 'glioma', 'down', 'Knockdown of NEAT1 repressed the malignant progression of glioma through sponging miR-107 and inhibiting CDK14.'),
(4375, 'hsa-mir-10b', 'glioma', 'up', 'Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b.'),
(4376, 'hsa-mir-124-3p', 'glioma', 'down', 'MiR-124-3p suppresses glioma aggressiveness via targeting of Fra-2.'),
(4377, 'hsa-mir-129-5p', 'glioma', 'down', 'MiR-129-5p inhibits glioma cell progression in?vitro and in?vivo by targeting TGIF2.'),
(4378, 'hsa-mir-129-5p', 'glioma', 'down', 'MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A.'),
(4379, 'hsa-mir-138-5p', 'glioma', 'down', 'MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.'),
(4380, 'hsa-mir-139-3p', 'glioma', 'down', 'MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin.'),
(4381, 'hsa-mir-144-3p', 'glioma', 'down', 'The Inhibition of miR-144-3p on Cell Proliferation and Metastasis by Targeting TOP2A in HCMV-Positive Glioblastoma Cells.'),
(4382, 'hsa-mir-145', 'glioma', 'down', 'miR-145 is a potential biomarker for predicting clinical outcome in glioblastomas.'),
(4383, 'hsa-mir-153-3p', 'glioma', 'down', 'MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma.'),
(4384, 'hsa-mir-16-5p', 'glioma', 'down', 'MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.'),
(4385, 'hsa-mir-181a', 'glioma', 'down', 'Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression.'),
(4386, 'hsa-mir-185-5p', 'glioma', 'down', 'Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.'),
(4387, 'hsa-mir-193a-5p', 'glioma', 'down', 'MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.'),
(4388, 'hsa-mir-20a', 'glioma', 'up', 'MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.'),
(4389, 'hsa-mir-218-5p', 'glioma', 'down', 'MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.'),
(4390, 'hsa-mir-338-5p', 'glioma', 'down', 'MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.'),
(4391, 'hsa-mir-361-5p', 'glioma', 'down', 'miR-361-5p inhibits glioma migration and invasion by targeting SND1.'),
(4392, 'hsa-mir-375', 'glioma', 'down', 'MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in?vitro.'),
(4393, 'hsa-mir-410', 'glioma', 'down', 'Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.'),
(4394, 'hsa-mir-424', 'glioma', 'down', 'MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.'),
(4395, 'hsa-mir-454-3p', 'glioma', 'down', 'miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma.'),
(4396, 'hsa-mir-7-5p', 'glioma', 'down', 'Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p.'),
(4397, 'hsa-mir-770', 'glioma', 'down', 'MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.'),
(4398, 'hsa-let-7b', 'glioma', 'down', 'Decreased let-7b is associated with poor prognosis in glioma.'),
(4399, 'hsa-mir-10a', 'glioma', 'up', 'MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/?-catenin signaling pathway.'),
(4400, 'hsa-mir-1261', 'glioma', 'down', 'MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion.'),
(4401, 'hsa-mir-128-3p', 'glioma', 'down', 'miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway.'),
(4402, 'hsa-mir-133a', 'glioma', 'down', 'Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.'),
(4403, 'hsa-mir-153', 'glioma', 'down', 'MicroRNA-153 suppresses cell invasion by targeting SNAI1 and predicts patient prognosis in glioma.'),
(4404, 'hsa-mir-185-5p', 'glioma', 'down', 'FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.'),
(4405, 'hsa-mir-195', 'glioma', 'down', 'Effects of microRNA-195 on the Prognosis of Glioma Patients and the Proliferation and Apoptosis of Human Glioma Cells.'),
(4406, 'hsa-mir-199a-5p', 'glioma', 'down', 'microRNA-199a-5p suppresses glioma progression by inhibiting MAGT1.'),
(4407, 'hsa-mir-200a', 'glioma', 'down', 'microRNA-200a functions as a tumor suppressor by targeting FOXA1 in glioma.'),
(4408, 'hsa-mir-204', 'glioma', 'down', 'Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.'),
(4409, 'hsa-mir-205', 'glioma', 'down', 'MiR-205 suppresses epithelial-mesenchymal transition and inhibits tumor growth of human glioma through down-regulation of HOXD9.'),
(4410, 'hsa-mir-206', 'glioma', 'down', 'MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/?-catenin pathway via direct targeting of Frizzled 7 mRNA.'),
(4411, 'hsa-mir-216a', 'glioma', 'down', 'Differentiation antagonizing non-protein coding RNA modulates the proliferation, migration, and angiogenesis of glioma cells by targeting the miR-216a/LGR5 axis and the PI3K/AKT signaling pathway.'),
(4412, 'hsa-mir-25-3p', 'glioma', 'up', 'miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3.'),
(4413, 'hsa-mir-26a', 'glioma', 'up', 'Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.'),
(4414, 'hsa-mir-28-5p', 'glioma', 'down', 'MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.'),
(4415, 'hsa-mir-301b', 'glioma', 'up', 'MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/?-catenin signaling via targeting Glypican-5.'),
(4416, 'hsa-mir-30a-5p', 'glioma', 'up', 'A positive feedback loop of miR-30a-5p-WWP1-NF-?B in the regulation of glioma development.'),
(4417, 'hsa-mir-30b-3p', 'glioma', 'up', 'Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.'),
(4418, 'hsa-mir-32', 'glioma', 'down', 'MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.'),
(4419, 'hsa-mir-34a-5p', 'glioma', 'down', 'MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.'),
(4420, 'hsa-mir-362-3p', 'glioma', 'down', 'MicroRNA-362-3p Targets PAX3 to Inhibit the Development of Glioma through Mediating Wnt/?-Catenin Pathway.'),
(4421, 'hsa-mir-374a', 'glioma', 'up', 'miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1.'),
(4422, 'hsa-mir-374a', 'glioma', 'down', 'Downregulation of microRNA-374a predicts poor prognosis in human glioma.'),
(4423, 'hsa-mir-374b', 'glioma', 'down', 'MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.'),
(4424, 'hsa-mir-374b', 'glioma', 'up', 'MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B.'),
(4425, 'hsa-mir-382-5p', 'glioma', 'down', 'The role of miR-382-5p in glioma cell proliferation, migration and invasion.'),
(4426, 'hsa-mir-448', 'glioma', 'down', 'Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.'),
(4427, 'hsa-mir-4493', 'glioma', 'down', 'Circ-ZNF264 Promotes the Growth of Glioma Cells by Upregulating the Expression of miR-4493 Target Gene Apelin.'),
(4428, 'hsa-mir-4500', 'glioma', 'down', 'microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1.'),
(4429, 'hsa-mir-490-3p', 'glioma', 'down', 'miR-490-3p functions as a tumor suppressor in glioma by inhibiting high-mobility group AT-hook 2 expression.'),
(4430, 'hsa-mir-499a-5p', 'glioma', 'down', 'Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.'),
(4431, 'hsa-mir-517a', 'glioma', 'up', 'miR-517a is up-regulated in glioma and promotes glioma tumorigenesis in vitro and in vivo.'),
(4432, 'hsa-mir-520e', 'glioma', 'down', 'MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/?-catenin signaling by targeting fibroblast growth factor 19.'),
(4433, 'hsa-mir-524', 'glioma', 'down', 'MicroRNA-524 inhibits the progress of glioma via the direct targeting of NCF2.'),
(4434, 'hsa-mir-526b-3p', 'glioma', 'down', 'miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1.'),
(4435, 'hsa-mir-590-3p', 'glioma', 'down', 'Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.'),
(4436, 'hsa-mir-605-3p', 'glioma', 'down', 'LncRNA BLACAT1 regulates VASP expression via binding to miR-605-3p and promotes giloma development.'),
(4437, 'hsa-mir-627-5p', 'glioma', 'down', 'NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.'),
(4438, 'hsa-mir-628-5p', 'glioma', 'down', 'MicroRNA-628-5p inhibits cell proliferation in glioma by targeting DDX59.'),
(4439, 'hsa-mir-760', 'glioma', 'down', 'Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA.'),
(4440, 'hsa-mir-770', 'glioma', 'down', 'Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.'),
(4441, 'hsa-mir-9', 'glioma', 'up', 'MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.'),
(4442, 'hsa-mir-92a', 'glioma', 'up', 'MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.'),
(4443, 'hsa-mir-940', 'glioma', 'down', 'MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2.'),
(4444, 'hsa-mir-181a', 'glioma', 'up', 'MiR-181a regulates blood-tumor barrier permeability by targeting Kr???ppel-like factor 6.'),
(4445, 'hsa-mir-181a-1', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4446, 'hsa-mir-181a-2', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4447, 'hsa-mir-181b-1', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4448, 'hsa-mir-181b-2', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4449, 'hsa-mir-181c', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4450, 'hsa-mir-181d', 'glioma', 'down', 'MicroRNA-181 inhibits glioma cell???proliferation by targeting cyclin B1.'),
(4451, 'hsa-mir-21', 'head and neck cancer', 'up', 'MicroRNA alterations in head and neck squamous cell carcinoma.'),
(4452, 'hsa-mir-21', 'head and neck cancer', 'up', '[Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].'),
(4453, 'hsa-mir-363', 'head and neck cancer', 'down', 'MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.'),
(4454, 'hsa-mir-139-3p', 'head and neck cancer', 'down', 'Role of host-microRNA Hsa-miR-139-3p in HPV-16 induced carcinomas.'),
(4455, 'hsa-let-7d', 'head and neck squamous cell carcinoma', 'down', 'Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.'),
(4456, 'hsa-mir-1', 'head and neck squamous cell carcinoma', 'down', 'Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.'),
(4457, 'hsa-mir-1', 'head and neck squamous cell carcinoma', 'down', 'miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.'),
(4458, 'hsa-mir-106b', 'head and neck squamous cell carcinoma', 'up', 'Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.'),
(4459, 'hsa-mir-107', 'head and neck squamous cell carcinoma', 'down', 'microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C?'),
(4460, 'hsa-mir-107', 'head and neck squamous cell carcinoma', 'down', 'Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.'),
(4461, 'hsa-mir-128', 'head and neck squamous cell carcinoma', 'down', 'Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.'),
(4462, 'hsa-mir-133a', 'head and neck squamous cell carcinoma', 'down', 'Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.'),
(4463, 'hsa-mir-133a', 'head and neck squamous cell carcinoma', 'down', 'Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.'),
(4464, 'hsa-mir-134', 'head and neck squamous cell carcinoma', 'up', 'miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.'),
(4465, 'hsa-mir-138', 'head and neck squamous cell carcinoma', 'down', 'MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines.'),
(4466, 'hsa-mir-138', 'head and neck squamous cell carcinoma', 'down', 'Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.'),
(4467, 'hsa-mir-138', 'head and neck squamous cell carcinoma', 'down', 'Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk(1/2) signaling pathway in head and neck squamous cell carcinoma.'),
(4468, 'hsa-mir-149', 'head and neck squamous cell carcinoma', 'down', 'The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma.'),
(4469, 'hsa-mir-16', 'head and neck squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(4470, 'hsa-mir-184', 'head and neck squamous cell carcinoma', 'up', 'Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.'),
(4471, 'hsa-mir-196a', 'head and neck squamous cell carcinoma', 'up', 'MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.'),
(4472, 'hsa-mir-200c', 'head and neck squamous cell carcinoma', 'down', 'MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.'),
(4473, 'hsa-mir-205', 'head and neck squamous cell carcinoma', 'down', 'Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.'),
(4474, 'hsa-mir-21', 'head and neck squamous cell carcinoma', 'up', 'Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell Carcinoma.'),
(4475, 'hsa-mir-21', 'head and neck squamous cell carcinoma', 'up', 'Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.'),
(4476, 'hsa-mir-21', 'head and neck squamous cell carcinoma', 'up', 'Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(4477, 'hsa-mir-21', 'head and neck squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(4478, 'hsa-mir-218', 'head and neck squamous cell carcinoma', 'down', 'Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.'),
(4479, 'hsa-mir-25', 'head and neck squamous cell carcinoma', 'up', 'Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.'),
(4480, 'hsa-mir-27a*', 'head and neck squamous cell carcinoma', 'down', 'Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*'),
(4481, 'hsa-mir-29a', 'head and neck squamous cell carcinoma', 'down', 'Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.'),
(4482, 'hsa-mir-29b-1', 'head and neck squamous cell carcinoma', 'down', 'Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.'),
(4483, 'hsa-mir-29b-2', 'head and neck squamous cell carcinoma', 'down', 'Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.'),
(4484, 'hsa-mir-29c', 'head and neck squamous cell carcinoma', 'down', 'Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.'),
(4485, 'hsa-mir-300', 'head and neck squamous cell carcinoma', 'down', 'miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.'),
(4486, 'hsa-mir-30a-5p', 'head and neck squamous cell carcinoma', 'up', 'Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.'),
(4487, 'hsa-mir-31', 'head and neck squamous cell carcinoma', 'up', 'Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.'),
(4488, 'hsa-mir-34a', 'head and neck squamous cell carcinoma', 'down', 'Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.'),
(4489, 'hsa-mir-363', 'head and neck squamous cell carcinoma', 'down', 'Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin.'),
(4490, 'hsa-mir-372', 'head and neck squamous cell carcinoma', 'up', 'miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo.'),
(4491, 'hsa-mir-375', 'head and neck squamous cell carcinoma', 'down', 'Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.'),
(4492, 'hsa-mir-874', 'head and neck squamous cell carcinoma', 'down', 'Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.'),
(4493, 'hsa-mir-93', 'head and neck squamous cell carcinoma', 'up', 'Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.'),
(4494, 'hsa-mir-93', 'head and neck squamous cell carcinoma', 'up', 'Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.'),
(4495, 'hsa-mir-375', 'head and neck squamous cell carcinoma', 'down', 'MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.'),
(4496, 'hsa-mir-451', 'head and neck squamous cell carcinoma', 'down', 'MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.'),
(4497, 'hsa-mir-203', 'head and neck squamous cell carcinoma', 'down', 'microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.'),
(4498, 'hsa-mir-1', 'head and neck squamous cell carcinoma', 'down', 'Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.'),
(4499, 'hsa-mir-206', 'head and neck squamous cell carcinoma', 'down', 'Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.'),
(4500, 'hsa-mir-422a', 'head and neck squamous cell carcinoma', 'down', 'MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.'),
(4501, 'hsa-mir-182', 'head and neck squamous cell carcinoma', 'up', 'Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.'),
(4502, 'hsa-mir-675', 'head and neck squamous cell carcinoma', 'up', 'Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma.'),
(4503, 'hsa-mir-206', 'head and neck squamous cell carcinoma', 'down', 'MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.'),
(4504, 'hsa-mir-223-3p', 'head and neck squamous cell carcinoma', 'up', 'MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma.'),
(4505, 'hsa-mir-150-3p', 'head and neck squamous cell carcinoma', 'down', 'Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.'),
(4506, 'hsa-mir-150-5p', 'head and neck squamous cell carcinoma', 'down', 'Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.'),
(4507, 'hsa-mir-204', 'head and neck squamous cell carcinoma', 'down', 'miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling.'),
(4508, 'hsa-mir-125a-5p', 'head and neck squamous cell carcinoma', 'up', 'Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.'),
(4509, 'hsa-mir-375', 'head and neck squamous cell carcinoma', 'down', 'miR-375 inhibits IFN-?-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.'),
(4510, 'hsa-mir-876-5p', 'head and neck squamous cell carcinoma', 'down', 'MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin.'),
(4511, 'hsa-mir-9', 'head and neck squamous cell carcinoma', 'down', 'MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.'),
(4512, 'hsa-mir-204', 'head and neck squamous cell carcinoma', 'down', 'miR-204 enhances p27 mRNA stability by targeting Brd4 in head and neck squamous cell carcinoma.'),
(4513, 'hsa-mir-375', 'head and neck squamous cell carcinoma', 'down', 'miR-375 inhibits IFN-?-induced programmed death 1 ligand?1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.'),
(4514, 'hsa-let-7d', 'head and neck squamous cell carcinoma', 'up', 'Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.'),
(4515, 'hsa-mir-141', 'head and neck squamous cell carcinoma', 'down', 'MicroRNA-141 suppresses growth and metastatic potential of head and neck squamous cell carcinoma.'),
(4516, 'hsa-mir-205', 'head and neck squamous cell carcinoma', 'up', 'Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.'),
(4517, 'hsa-mir-96-5p', 'head and neck squamous cell carcinoma', 'up', 'miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.'),
(4518, 'hsa-mir-492', 'hepatoblastoma', 'up', 'MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.'),
(4519, 'hsa-mir-21', 'hepatoblastoma', 'up', 'Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.'),
(4520, 'hsa-mir-34a', 'hepatoblastoma', 'down', 'Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.'),
(4521, 'hsa-mir-34b', 'hepatoblastoma', 'down', 'Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.'),
(4522, 'hsa-mir-34c', 'hepatoblastoma', 'down', 'Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.'),
(4523, 'hsa-let-7a-1', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4524, 'hsa-let-7a-2', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4525, 'hsa-let-7a-3', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4526, 'hsa-let-7b', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4527, 'hsa-let-7c', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4528, 'hsa-let-7c', 'hepatocellular carcinoma', 'down', 'MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.'),
(4529, 'hsa-let-7d', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4530, 'hsa-let-7e', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4531, 'hsa-let-7f', 'hepatocellular carcinoma', 'down', 'Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.'),
(4532, 'hsa-let-7f-1', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4533, 'hsa-let-7f-2', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4534, 'hsa-let-7g', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4535, 'hsa-let-7g', 'hepatocellular carcinoma', 'down', 'MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.'),
(4536, 'hsa-let-7i', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4537, 'hsa-let-7i', 'hepatocellular carcinoma', 'down', 'MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large.'),
(4538, 'hsa-mir-1', 'hepatocellular carcinoma', 'down', 'MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.'),
(4539, 'hsa-mir-100', 'hepatocellular carcinoma', 'down', 'Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.'),
(4540, 'hsa-mir-100', 'hepatocellular carcinoma', 'down', 'Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.'),
(4541, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.'),
(4542, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets.'),
(4543, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.'),
(4544, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4545, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.'),
(4546, 'hsa-mir-105', 'hepatocellular carcinoma', 'down', 'MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.'),
(4547, 'hsa-mir-106b', 'hepatocellular carcinoma', 'up', 'Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.'),
(4548, 'hsa-mir-106b', 'hepatocellular carcinoma', 'up', 'Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.'),
(4549, 'hsa-mir-10b', 'hepatocellular carcinoma', 'up', 'miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs.'),
(4550, 'hsa-mir-10b', 'hepatocellular carcinoma', 'up', 'MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.'),
(4551, 'hsa-mir-122', 'hepatocellular carcinoma', 'up', 'Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.'),
(4552, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3.'),
(4553, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.'),
(4554, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.'),
(4555, 'hsa-mir-122', 'hepatocellular carcinoma', 'up', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4556, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.'),
(4557, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/?-catenin pathway.'),
(4558, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.'),
(4559, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4560, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.'),
(4561, 'hsa-mir-122', 'hepatocellular carcinoma', 'up', 'Epigenetic regulation of miR-122 by PPAR? and hepatitis B virus X protein in hepatocellular carcinoma cells.'),
(4562, 'hsa-mir-1228', 'hepatocellular carcinoma', 'up', 'miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.'),
(4563, 'hsa-mir-122a', 'hepatocellular carcinoma', 'down', 'Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.'),
(4564, 'hsa-mir-122a', 'hepatocellular carcinoma', 'down', '[MicroRNA profiling in patients with hepatocellular carcinoma].'),
(4565, 'hsa-mir-122a', 'hepatocellular carcinoma', 'down', 'Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.'),
(4566, 'hsa-mir-1236', 'hepatocellular carcinoma', 'down', 'miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.'),
(4567, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.'),
(4568, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.'),
(4569, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.'),
(4570, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells.'),
(4571, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'Histone lysine methyltransferase, SUV39H1, promotes HCC progression and is negatively regulated by microRNA-125b.'),
(4572, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.'),
(4573, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.'),
(4574, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.'),
(4575, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.'),
(4576, 'hsa-mir-126', 'hepatocellular carcinoma', 'down', 'Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma.'),
(4577, 'hsa-mir-126', 'hepatocellular carcinoma', 'down', 'miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2.'),
(4578, 'hsa-mir-1269', 'hepatocellular carcinoma', 'up', 'Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance.'),
(4579, 'hsa-mir-1269', 'hepatocellular carcinoma', 'up', 'MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.'),
(4580, 'hsa-mir-127', 'hepatocellular carcinoma', 'down', 'A Feedback Inhibition between miRNA-127 and TGF?/c-Jun Cascade in HCC Cell Migration via MMP13.'),
(4581, 'hsa-mir-127', 'hepatocellular carcinoma', 'down', 'MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells.'),
(4582, 'hsa-mir-1271', 'hepatocellular carcinoma', 'down', 'A functional screening identifies five miRNAs controlling glypican-3: Role of miR-1271 down-regulation in hepatocellular carcinoma.'),
(4583, 'hsa-mir-128-3p', 'hepatocellular carcinoma', 'down', 'miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.'),
(4584, 'hsa-mir-128a', 'hepatocellular carcinoma', 'up', '[miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].'),
(4585, 'hsa-mir-129-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.'),
(4586, 'hsa-mir-130a', 'hepatocellular carcinoma', 'up', 'Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.'),
(4587, 'hsa-mir-130a', 'hepatocellular carcinoma', 'down', 'MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.'),
(4588, 'hsa-mir-130b', 'hepatocellular carcinoma', 'down', 'Repression of microRNA-130b by thyroid hormone enhances cell motility.'),
(4589, 'hsa-mir-130b', 'hepatocellular carcinoma', 'up', 'Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.'),
(4590, 'hsa-mir-130b', 'hepatocellular carcinoma', 'up', 'High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.'),
(4591, 'hsa-mir-133a', 'hepatocellular carcinoma', 'down', 'MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.'),
(4592, 'hsa-mir-134', 'hepatocellular carcinoma', 'down', 'Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin ?1 in Hepatocellular Carcinoma.'),
(4593, 'hsa-mir-137', 'hepatocellular carcinoma', 'down', 'FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.'),
(4594, 'hsa-mir-137', 'hepatocellular carcinoma', 'down', 'EDIL3 is a novel regulator of epithelial mesenchymal transition controlling early recurrence of hepatocellular carcinoma.'),
(4595, 'hsa-mir-138', 'hepatocellular carcinoma', 'down', 'MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.'),
(4596, 'hsa-mir-139', 'hepatocellular carcinoma', 'down', 'The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.'),
(4597, 'hsa-mir-139', 'hepatocellular carcinoma', 'down', 'Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.'),
(4598, 'hsa-mir-139', 'hepatocellular carcinoma', 'down', 'miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.'),
(4599, 'hsa-mir-139-5p', 'hepatocellular carcinoma', 'down', 'miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.'),
(4600, 'hsa-mir-140-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.'),
(4601, 'hsa-mir-141', 'hepatocellular carcinoma', 'down', 'miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.'),
(4602, 'hsa-mir-141', 'hepatocellular carcinoma', 'down', 'microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3beta in hepatocellular carcinoma cells.'),
(4603, 'hsa-mir-141', 'hepatocellular carcinoma', 'down', 'Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.'),
(4604, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells.'),
(4605, 'hsa-mir-143', 'hepatocellular carcinoma', 'down', '[miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].'),
(4606, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.'),
(4607, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.'),
(4608, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17.'),
(4609, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC).'),
(4610, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.'),
(4611, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.'),
(4612, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4613, 'hsa-mir-146a', 'hepatocellular carcinoma', 'down', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4614, 'hsa-mir-146a', 'hepatocellular carcinoma', 'down', 'Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.'),
(4615, 'hsa-mir-146a', 'hepatocellular carcinoma', 'down', 'microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.'),
(4616, 'hsa-mir-146a', 'hepatocellular carcinoma', 'up', 'Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.'),
(4617, 'hsa-mir-148a', 'hepatocellular carcinoma', 'down', 'MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.'),
(4618, 'hsa-mir-148a', 'hepatocellular carcinoma', 'down', 'microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.'),
(4619, 'hsa-mir-148b', 'hepatocellular carcinoma', 'down', 'MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis.'),
(4620, 'hsa-mir-148b', 'hepatocellular carcinoma', 'down', 'MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/?-catenin pathway.'),
(4621, 'hsa-mir-150-5p', 'hepatocellular carcinoma', 'down', 'miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.'),
(4622, 'hsa-mir-153', 'hepatocellular carcinoma', 'up', 'MicroRNA-153 promotes Wnt/?-catenin activation in hepatocellular carcinoma through suppression of WWOX.'),
(4623, 'hsa-mir-155', 'hepatocellular carcinoma', 'up', 'Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.'),
(4624, 'hsa-mir-155', 'hepatocellular carcinoma', 'up', '[Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].'),
(4625, 'hsa-mir-15b', 'hepatocellular carcinoma', 'down', 'Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.'),
(4626, 'hsa-mir-16', 'hepatocellular carcinoma', 'down', 'Circulating microRNAs as biomarkers for hepatocellular carcinoma.'),
(4627, 'hsa-mir-16', 'hepatocellular carcinoma', 'down', 'Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.'),
(4628, 'hsa-mir-17-5p', 'hepatocellular carcinoma', 'up', 'miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.'),
(4629, 'hsa-mir-17-5p', 'hepatocellular carcinoma', 'up', 'miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.'),
(4630, 'hsa-mir-181a', 'hepatocellular carcinoma', 'up', 'Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5.'),
(4631, 'hsa-mir-181a', 'hepatocellular carcinoma', 'up', 'Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.'),
(4632, 'hsa-mir-181a-1', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4633, 'hsa-mir-181a-2', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4634, 'hsa-mir-181a-5p', 'hepatocellular carcinoma', 'down', 'miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.'),
(4635, 'hsa-mir-181b', 'hepatocellular carcinoma', 'up', 'Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.'),
(4636, 'hsa-mir-181b-1', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4637, 'hsa-mir-181b-2', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4638, 'hsa-mir-181c', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4639, 'hsa-mir-181d', 'hepatocellular carcinoma', 'up', 'Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.'),
(4640, 'hsa-mir-181d', 'hepatocellular carcinoma', 'up', 'Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.'),
(4641, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.'),
(4642, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.'),
(4643, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.'),
(4644, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.'),
(4645, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.'),
(4646, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.'),
(4647, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.'),
(4648, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma.'),
(4649, 'hsa-mir-184', 'hepatocellular carcinoma', 'up', 'Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma.'),
(4650, 'hsa-mir-184', 'hepatocellular carcinoma', 'up', 'MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.'),
(4651, 'hsa-mir-185', 'hepatocellular carcinoma', 'down', 'miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.'),
(4652, 'hsa-mir-188-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-188-5p Suppresses Tumor Cell Proliferation and Metastasis by Directly Targeting FGF5 in Hepatocellular Carcinoma.'),
(4653, 'hsa-mir-190b', 'hepatocellular carcinoma', 'up', 'Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma.'),
(4654, 'hsa-mir-191', 'hepatocellular carcinoma', 'up', 'Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.'),
(4655, 'hsa-mir-193b', 'hepatocellular carcinoma', 'down', 'miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy.'),
(4656, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2 and CDC42.'),
(4657, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.'),
(4658, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'microRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.'),
(4659, 'hsa-mir-195-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma.'),
(4660, 'hsa-mir-197', 'hepatocellular carcinoma', 'down', 'Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82.'),
(4661, 'hsa-mir-198', 'hepatocellular carcinoma', 'down', 'miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.'),
(4662, 'hsa-mir-199a', 'hepatocellular carcinoma', 'down', '[MicroRNA profiling in patients with hepatocellular carcinoma].'),
(4663, 'hsa-mir-199a', 'hepatocellular carcinoma', 'down', 'Circulating microRNAs as biomarkers for hepatocellular carcinoma.'),
(4664, 'hsa-mir-199a', 'hepatocellular carcinoma', 'down', 'Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.'),
(4665, 'hsa-mir-199a', 'hepatocellular carcinoma', 'down', 'MiR-199a regulates cell proliferation and survival by targeting FZD7.'),
(4666, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.'),
(4667, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.'),
(4668, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.'),
(4669, 'hsa-mir-199b', 'hepatocellular carcinoma', 'down', '[MicroRNA profiling in patients with hepatocellular carcinoma].'),
(4670, 'hsa-mir-199b', 'hepatocellular carcinoma', 'down', 'Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1? in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.'),
(4671, 'hsa-mir-199b-5p', 'hepatocellular carcinoma', 'down', 'Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.'),
(4672, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.'),
(4673, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?'),
(4674, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.'),
(4675, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'MicroRNA-200a suppresses metastatic potential of side population cells in human hepatocellular carcinoma by decreasing ZEB2.'),
(4676, 'hsa-mir-200b', 'hepatocellular carcinoma', 'down', 'The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?'),
(4677, 'hsa-mir-200c', 'hepatocellular carcinoma', 'down', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4678, 'hsa-mir-200c', 'hepatocellular carcinoma', 'down', 'Expression Profile of MicroRNA-200 Family in Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.'),
(4679, 'hsa-mir-202', 'hepatocellular carcinoma', 'down', 'miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.'),
(4680, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'miR-203 inhibits proliferation of HCC cells by targeting survivin.'),
(4681, 'hsa-mir-204-3p', 'hepatocellular carcinoma', 'down', 'Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.'),
(4682, 'hsa-mir-205', 'hepatocellular carcinoma', 'down', 'MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.'),
(4683, 'hsa-mir-205', 'hepatocellular carcinoma', 'down', 'Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.'),
(4684, 'hsa-mir-206', 'hepatocellular carcinoma', 'down', 'MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.'),
(4685, 'hsa-mir-20a', 'hepatocellular carcinoma', 'down', 'Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.'),
(4686, 'hsa-mir-20a', 'hepatocellular carcinoma', 'up', 'MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.'),
(4687, 'hsa-mir-20b', 'hepatocellular carcinoma', 'up', 'Crucial Role for Early Growth Response-1 in the Transcriptional Regulation of miR-20b in Breast Cancer.'),
(4688, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.'),
(4689, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.'),
(4690, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.'),
(4691, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.'),
(4692, 'hsa-mir-21', 'hepatocellular carcinoma', 'down', 'Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.'),
(4693, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.'),
(4694, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4695, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor ? and androgen receptor.'),
(4696, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells.'),
(4697, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.'),
(4698, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.'),
(4699, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.'),
(4700, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'miR-21 expression predicts prognosis in hepatocellular carcinoma.'),
(4701, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.'),
(4702, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.'),
(4703, 'hsa-mir-21-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2A and 2B and inhibits hepatoma cell growth.'),
(4704, 'hsa-mir-210', 'hepatocellular carcinoma', 'up', 'Effects of knockdown of miR-210 in combination with ionizing radiation on human hepatoma xenograft in nude mice.'),
(4705, 'hsa-mir-210', 'hepatocellular carcinoma', 'up', 'Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.'),
(4706, 'hsa-mir-211', 'hepatocellular carcinoma', 'down', 'miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.'),
(4707, 'hsa-mir-212', 'hepatocellular carcinoma', 'down', 'Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212.'),
(4708, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.'),
(4709, 'hsa-mir-214', 'hepatocellular carcinoma', 'up', 'MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.'),
(4710, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin.'),
(4711, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.'),
(4712, 'hsa-mir-215', 'hepatocellular carcinoma', 'up', 'Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.'),
(4713, 'hsa-mir-216a', 'hepatocellular carcinoma', 'up', 'Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.'),
(4714, 'hsa-mir-216a', 'hepatocellular carcinoma', 'up', 'MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.'),
(4715, 'hsa-mir-217', 'hepatocellular carcinoma', 'up', 'MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.'),
(4716, 'hsa-mir-217', 'hepatocellular carcinoma', 'down', 'miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.'),
(4717, 'hsa-mir-218', 'hepatocellular carcinoma', 'down', 'miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.'),
(4718, 'hsa-mir-218', 'hepatocellular carcinoma', 'down', 'Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET'),
(4719, 'hsa-mir-218', 'hepatocellular carcinoma', 'down', 'MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.'),
(4720, 'hsa-mir-219-5p', 'hepatocellular carcinoma', 'down', 'MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.'),
(4721, 'hsa-mir-22', 'hepatocellular carcinoma', 'down', 'microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.'),
(4722, 'hsa-mir-22', 'hepatocellular carcinoma', 'down', 'MicroRNA-22 expression in hepatocellular carcinoma and its correlation with ezrin protein.'),
(4723, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.'),
(4724, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.'),
(4725, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(4726, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4727, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4728, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.'),
(4729, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma.'),
(4730, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice.'),
(4731, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(4732, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4733, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4734, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', '[Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].'),
(4735, 'hsa-mir-223', 'hepatocellular carcinoma', 'up', 'Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.'),
(4736, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', '[Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis.]'),
(4737, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4738, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', 'Sulfatide Epigenetically Regulates miR-223 and Promotes the Migration of Human Hepatocellular Carcinoma Cells.'),
(4739, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'Transcriptional regulation of miR-224 upregulated in human HCCs by NF?B inflammatory pathways.'),
(4740, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.'),
(4741, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.'),
(4742, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'miR-224 promotes cell migration and invasion by modulating p-PAK4 and MMP-9 via targeting HOXD10 in human hepatocellular carcinoma.'),
(4743, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.'),
(4744, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.'),
(4745, 'hsa-mir-23a', 'hepatocellular carcinoma', 'up', 'Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1?'),
(4746, 'hsa-mir-24', 'hepatocellular carcinoma', 'up', 'MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis.'),
(4747, 'hsa-mir-24', 'hepatocellular carcinoma', 'up', 'miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.'),
(4748, 'hsa-mir-25', 'hepatocellular carcinoma', 'up', 'Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.'),
(4749, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2?/Akt/HIF-1? Pathway in Hepatocellular Carcinoma.'),
(4750, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-cmet pathway.'),
(4751, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.'),
(4752, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.'),
(4753, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.'),
(4754, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells.'),
(4755, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway.'),
(4756, 'hsa-mir-26b', 'hepatocellular carcinoma', 'down', 'MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.'),
(4757, 'hsa-mir-27a', 'hepatocellular carcinoma', 'up', 'MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor ?.'),
(4758, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.'),
(4759, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.'),
(4760, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(4761, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4762, 'hsa-mir-29b-1', 'hepatocellular carcinoma', 'down', 'Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4763, 'hsa-mir-29b-1', 'hepatocellular carcinoma', 'down', 'Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.'),
(4764, 'hsa-mir-29b-1', 'hepatocellular carcinoma', 'down', 'Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4765, 'hsa-mir-29b-2', 'hepatocellular carcinoma', 'down', 'Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.'),
(4766, 'hsa-mir-29b-2', 'hepatocellular carcinoma', 'down', 'Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4767, 'hsa-mir-29b-2', 'hepatocellular carcinoma', 'down', 'Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4768, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.'),
(4769, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.'),
(4770, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4771, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.'),
(4772, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.'),
(4773, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.'),
(4774, 'hsa-mir-301a', 'hepatocellular carcinoma', 'up', 'miR-301a Is a Candidate Oncogene that Targets the Homeobox Gene Gax in Human Hepatocellular Carcinoma.'),
(4775, 'hsa-mir-302b', 'hepatocellular carcinoma', 'down', 'MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.'),
(4776, 'hsa-mir-302b', 'hepatocellular carcinoma', 'down', 'miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2.'),
(4777, 'hsa-mir-302c', 'hepatocellular carcinoma', 'down', 'MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells.'),
(4778, 'hsa-mir-30a', 'hepatocellular carcinoma', 'down', 'Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.'),
(4779, 'hsa-mir-30a-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.'),
(4780, 'hsa-mir-30d', 'hepatocellular carcinoma', 'up', 'MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.'),
(4781, 'hsa-mir-31', 'hepatocellular carcinoma', 'up', 'Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its progno'),
(4782, 'hsa-mir-3127', 'hepatocellular carcinoma', 'up', 'MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.'),
(4783, 'hsa-mir-32', 'hepatocellular carcinoma', 'up', 'MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.'),
(4784, 'hsa-mir-331-3p', 'hepatocellular carcinoma', 'up', 'Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.'),
(4785, 'hsa-mir-335', 'hepatocellular carcinoma', 'down', 'Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma.'),
(4786, 'hsa-mir-335', 'hepatocellular carcinoma', 'down', 'MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.'),
(4787, 'hsa-mir-338-3p', 'hepatocellular carcinoma', 'down', 'miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3\'-UTR Region of CyclinD1.'),
(4788, 'hsa-mir-338-3p', 'hepatocellular carcinoma', 'down', 'MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1?.'),
(4789, 'hsa-mir-338-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).'),
(4790, 'hsa-mir-33a', 'hepatocellular carcinoma', 'down', 'Aflatoxin B1 Negatively Regulates Wnt/?-Catenin Signaling Pathway through Activating miR-33a.'),
(4791, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.'),
(4792, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.'),
(4793, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment.'),
(4794, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.'),
(4795, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.'),
(4796, 'hsa-mir-34b', 'hepatocellular carcinoma', 'down', 'Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.'),
(4797, 'hsa-mir-362-3p', 'hepatocellular carcinoma', 'up', 'Upregulation of miR-362-3p modulates proliferation and anchorage-independent growth by directly targeting Tob2 in hepatocellular carcinoma.'),
(4798, 'hsa-mir-362-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.'),
(4799, 'hsa-mir-365', 'hepatocellular carcinoma', 'down', 'Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.'),
(4800, 'hsa-mir-370', 'hepatocellular carcinoma', 'down', 'Perturbation of miR-370-LIN28A-NF-?B regulatory circuit contributes to the development of hepatocellular carcinoma.'),
(4801, 'hsa-mir-371-5p', 'hepatocellular carcinoma', 'up', 'miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells.'),
(4802, 'hsa-mir-372', 'hepatocellular carcinoma', 'up', 'Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.'),
(4803, 'hsa-mir-372', 'hepatocellular carcinoma', 'down', 'miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.'),
(4804, 'hsa-mir-373', 'hepatocellular carcinoma', 'up', 'MicroRNA-373, a new regulator of protein phosphatase?6, functions as an oncogene in hepatocellular carcinoma.'),
(4805, 'hsa-mir-375', 'hepatocellular carcinoma', 'down', 'MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.'),
(4806, 'hsa-mir-375', 'hepatocellular carcinoma', 'down', 'miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.'),
(4807, 'hsa-mir-376a', 'hepatocellular carcinoma', 'down', 'miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma.'),
(4808, 'hsa-mir-377', 'hepatocellular carcinoma', 'down', 'MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma.'),
(4809, 'hsa-mir-422a', 'hepatocellular carcinoma', 'down', 'A double-negative feedback loop between MicroRNA-422a and FOXG1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.'),
(4810, 'hsa-mir-423', 'hepatocellular carcinoma', 'up', 'MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.'),
(4811, 'hsa-mir-424', 'hepatocellular carcinoma', 'down', 'MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.'),
(4812, 'hsa-mir-424-5p', 'hepatocellular carcinoma', 'down', 'MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.'),
(4813, 'hsa-mir-429', 'hepatocellular carcinoma', 'up', 'MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.'),
(4814, 'hsa-mir-429', 'hepatocellular carcinoma', 'up', 'Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.'),
(4815, 'hsa-mir-433', 'hepatocellular carcinoma', 'down', 'MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).'),
(4816, 'hsa-mir-4458', 'hepatocellular carcinoma', 'down', 'Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma.'),
(4817, 'hsa-mir-448', 'hepatocellular carcinoma', 'down', 'Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma.'),
(4818, 'hsa-mir-450a', 'hepatocellular carcinoma', 'down', 'microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.'),
(4819, 'hsa-mir-451', 'hepatocellular carcinoma', 'down', 'MicroRNA-451 regulates activating transcription factor?2 expression and inhibits liver cancer cell migration.'),
(4820, 'hsa-mir-451', 'hepatocellular carcinoma', 'down', 'miR-451 Inhibits Cell Proliferation in Human Hepatocellular Carcinoma through Direct Suppression of IKK-?'),
(4821, 'hsa-mir-451', 'hepatocellular carcinoma', 'down', 'miR-451: Potential role as tumor suppressor of human hepatoma cell growth and invasion.'),
(4822, 'hsa-mir-452', 'hepatocellular carcinoma', 'up', 'MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B.'),
(4823, 'hsa-mir-483-3p', 'hepatocellular carcinoma', 'up', 'Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.'),
(4824, 'hsa-mir-483-5p', 'hepatocellular carcinoma', 'up', 'Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-? stimulated HSCs in transgenic mice.'),
(4825, 'hsa-mir-485-3p', 'hepatocellular carcinoma', 'up', 'MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.'),
(4826, 'hsa-mir-485-5p', 'hepatocellular carcinoma', 'down', 'Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.'),
(4827, 'hsa-mir-486-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.'),
(4828, 'hsa-mir-490-3p', 'hepatocellular carcinoma', 'up', 'miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3).'),
(4829, 'hsa-mir-494', 'hepatocellular carcinoma', 'up', 'MiR-494 within an oncogenic MicroRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of MCC.'),
(4830, 'hsa-mir-494', 'hepatocellular carcinoma', 'up', 'MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors.'),
(4831, 'hsa-mir-494', 'hepatocellular carcinoma', 'up', 'miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.'),
(4832, 'hsa-mir-495', 'hepatocellular carcinoma', 'up', 'MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.'),
(4833, 'hsa-mir-497', 'hepatocellular carcinoma', 'down', 'Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.'),
(4834, 'hsa-mir-500', 'hepatocellular carcinoma', 'up', 'MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.'),
(4835, 'hsa-mir-501', 'hepatocellular carcinoma', 'up', 'MicroRNA-501 promotes HBV replication by targeting HBXIP.'),
(4836, 'hsa-mir-501-5p', 'hepatocellular carcinoma', 'up', 'MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.'),
(4837, 'hsa-mir-503', 'hepatocellular carcinoma', 'down', 'MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.'),
(4838, 'hsa-mir-506', 'hepatocellular carcinoma', 'down', 'MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3\'UTR.'),
(4839, 'hsa-mir-519d', 'hepatocellular carcinoma', 'down', 'MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703.'),
(4840, 'hsa-mir-519d', 'hepatocellular carcinoma', 'up', 'In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.'),
(4841, 'hsa-mir-520a', 'hepatocellular carcinoma', 'down', 'MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.'),
(4842, 'hsa-mir-520b', 'hepatocellular carcinoma', 'down', 'MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.'),
(4843, 'hsa-mir-520c-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.'),
(4844, 'hsa-mir-520g', 'hepatocellular carcinoma', 'up', 'MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.'),
(4845, 'hsa-mir-574-3p', 'hepatocellular carcinoma', 'up', 'Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.'),
(4846, 'hsa-mir-582-5p', 'hepatocellular carcinoma', 'down', 'miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.'),
(4847, 'hsa-mir-590-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-? RII.'),
(4848, 'hsa-mir-590-5p', 'hepatocellular carcinoma', 'down', 'MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt Pathway.'),
(4849, 'hsa-mir-610', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/?-catenin signaling in human hepatocellular carcinoma.'),
(4850, 'hsa-mir-612', 'hepatocellular carcinoma', 'down', 'miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.'),
(4851, 'hsa-mir-625', 'hepatocellular carcinoma', 'down', 'miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.'),
(4852, 'hsa-mir-630', 'hepatocellular carcinoma', 'up', 'miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.'),
(4853, 'hsa-mir-637', 'hepatocellular carcinoma', 'down', 'Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.'),
(4854, 'hsa-mir-650', 'hepatocellular carcinoma', 'up', 'Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.'),
(4855, 'hsa-mir-657', 'hepatocellular carcinoma', 'up', 'MiR-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through NF-?B pathways.'),
(4856, 'hsa-mir-664', 'hepatocellular carcinoma', 'up', 'MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.'),
(4857, 'hsa-mir-675', 'hepatocellular carcinoma', 'down', 'Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3?/Cdc25A signaling pathway.'),
(4858, 'hsa-mir-7', 'hepatocellular carcinoma', 'down', 'miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma.'),
(4859, 'hsa-mir-7', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.'),
(4860, 'hsa-mir-7', 'hepatocellular carcinoma', 'down', 'MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.'),
(4861, 'hsa-mir-877', 'hepatocellular carcinoma', 'down', 'Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.'),
(4862, 'hsa-mir-885-5p', 'hepatocellular carcinoma', 'up', 'Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.'),
(4863, 'hsa-mir-9', 'hepatocellular carcinoma', 'up', 'Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.'),
(4864, 'hsa-mir-92a', 'hepatocellular carcinoma', 'up', 'Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.'),
(4865, 'hsa-mir-940', 'hepatocellular carcinoma', 'down', 'MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.'),
(4866, 'hsa-mir-941', 'hepatocellular carcinoma', 'down', 'DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells.'),
(4867, 'hsa-mir-96', 'hepatocellular carcinoma', 'up', 'OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.'),
(4868, 'hsa-mir-96', 'hepatocellular carcinoma', 'up', 'Wnt/?-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.'),
(4869, 'hsa-mir-96', 'hepatocellular carcinoma', 'up', 'Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.'),
(4870, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'MicroRNAs in Hepatobiliary and Pancreatic Cancers.'),
(4871, 'hsa-mir-99a', 'hepatocellular carcinoma', 'down', 'MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.'),
(4872, 'hsa-mir-99a', 'hepatocellular carcinoma', 'down', 'Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.'),
(4873, 'hsa-mir-107', 'hepatocellular carcinoma', 'up', 'miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2.'),
(4874, 'hsa-mir-129', 'hepatocellular carcinoma', 'down', 'miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.'),
(4875, 'hsa-mir-133a', 'hepatocellular carcinoma', 'down', 'MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.'),
(4876, 'hsa-mir-133a', 'hepatocellular carcinoma', 'down', 'MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.'),
(4877, 'hsa-mir-140-5p', 'hepatocellular carcinoma', 'down', 'miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.'),
(4878, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.'),
(4879, 'hsa-mir-142-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.'),
(4880, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.'),
(4881, 'hsa-mir-145-5p', 'hepatocellular carcinoma', 'down', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4882, 'hsa-mir-148b', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker.'),
(4883, 'hsa-mir-148b', 'hepatocellular carcinoma', 'down', 'Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.'),
(4884, 'hsa-mir-150', 'hepatocellular carcinoma', 'down', 'microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.'),
(4885, 'hsa-mir-150-5p', 'hepatocellular carcinoma', 'down', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4886, 'hsa-mir-153', 'hepatocellular carcinoma', 'up', 'MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.'),
(4887, 'hsa-mir-16', 'hepatocellular carcinoma', 'down', 'Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.'),
(4888, 'hsa-mir-17', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4889, 'hsa-mir-182', 'hepatocellular carcinoma', 'up', 'Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.'),
(4890, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4891, 'hsa-mir-194', 'hepatocellular carcinoma', 'down', 'NF-?B signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1?.'),
(4892, 'hsa-mir-195-5p', 'hepatocellular carcinoma', 'down', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4893, 'hsa-mir-199a-3p', 'hepatocellular carcinoma', 'down', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4894, 'hsa-mir-19a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4895, 'hsa-mir-19b', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4896, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.'),
(4897, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'miR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULC.'),
(4898, 'hsa-mir-20a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4899, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3.'),
(4900, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.'),
(4901, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.'),
(4902, 'hsa-mir-21-5p', 'hepatocellular carcinoma', 'up', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4903, 'hsa-mir-214-3p', 'hepatocellular carcinoma', 'down', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4904, 'hsa-mir-221-3p', 'hepatocellular carcinoma', 'up', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4905, 'hsa-mir-224-5p', 'hepatocellular carcinoma', 'up', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4906, 'hsa-mir-25', 'hepatocellular carcinoma', 'up', 'Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma.'),
(4907, 'hsa-mir-26b', 'hepatocellular carcinoma', 'down', 'MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.'),
(4908, 'hsa-mir-26b', 'hepatocellular carcinoma', 'down', 'Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.'),
(4909, 'hsa-mir-302b', 'hepatocellular carcinoma', 'down', 'miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells.'),
(4910, 'hsa-mir-324-5p', 'hepatocellular carcinoma', 'down', 'MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.'),
(4911, 'hsa-mir-325', 'hepatocellular carcinoma', 'down', 'The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.'),
(4912, 'hsa-mir-331-3p', 'hepatocellular carcinoma', 'up', 'Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3\'-UTR in HCC cell lines.'),
(4913, 'hsa-mir-339-5p', 'hepatocellular carcinoma', 'down', 'Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma.'),
(4914, 'hsa-mir-363', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.'),
(4915, 'hsa-mir-424', 'hepatocellular carcinoma', 'down', 'MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.'),
(4916, 'hsa-mir-451', 'hepatocellular carcinoma', 'down', 'MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.'),
(4917, 'hsa-mir-454', 'hepatocellular carcinoma', 'up', 'miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.'),
(4918, 'hsa-mir-483-5p', 'hepatocellular carcinoma', 'up', 'Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.'),
(4919, 'hsa-mir-497', 'hepatocellular carcinoma', 'down', 'MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.'),
(4920, 'hsa-mir-500a', 'hepatocellular carcinoma', 'up', 'Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.'),
(4921, 'hsa-mir-502', 'hepatocellular carcinoma', 'down', 'miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.'),
(4922, 'hsa-mir-503', 'hepatocellular carcinoma', 'down', 'miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1.'),
(4923, 'hsa-mir-573', 'hepatocellular carcinoma', 'up', 'The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis.'),
(4924, 'hsa-mir-708', 'hepatocellular carcinoma', 'down', 'MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.'),
(4925, 'hsa-mir-92a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4926, 'hsa-mir-92a', 'hepatocellular carcinoma', 'up', 'MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.'),
(4927, 'hsa-mir-93-5p', 'hepatocellular carcinoma', 'up', 'Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.'),
(4928, 'hsa-mir-99b', 'hepatocellular carcinoma', 'up', 'miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.'),
(4929, 'mir-17', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4930, 'mir-18a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4931, 'mir-19a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4932, 'mir-19b', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4933, 'mir-20a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4934, 'mir-92a', 'hepatocellular carcinoma', 'up', 'MiR-17-92 cluster promotes hepatocarcinogenesis.'),
(4935, 'hsa-mir-1', 'hepatocellular carcinoma', 'down', 'Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.'),
(4936, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4937, 'hsa-mir-106b', 'hepatocellular carcinoma', 'down', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4938, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4939, 'hsa-mir-128', 'hepatocellular carcinoma', 'down', 'miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.'),
(4940, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.'),
(4941, 'hsa-mir-149', 'hepatocellular carcinoma', 'down', 'miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.'),
(4942, 'hsa-mir-154', 'hepatocellular carcinoma', 'down', 'miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.'),
(4943, 'hsa-mir-15a-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.'),
(4944, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.'),
(4945, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4946, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4947, 'hsa-mir-197', 'hepatocellular carcinoma', 'down', 'Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma.'),
(4948, 'hsa-mir-199a', 'hepatocellular carcinoma', 'down', 'Suppression of miR-199a maturation by HuR is?crucial for hypoxia-induced glycolytic switch in?hepatocellular carcinoma.'),
(4949, 'hsa-mir-19b', 'hepatocellular carcinoma', 'up', 'Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.'),
(4950, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.'),
(4951, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.'),
(4952, 'hsa-mir-211', 'hepatocellular carcinoma', 'up', '[MiR-211 promotes invasion of hepatoma cells by targeting estrogen receptor alpha].'),
(4953, 'hsa-mir-212', 'hepatocellular carcinoma', 'down', 'MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1.'),
(4954, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.'),
(4955, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4956, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4957, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.'),
(4958, 'hsa-mir-25', 'hepatocellular carcinoma', 'up', 'miR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1.'),
(4959, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.'),
(4960, 'hsa-mir-29b-1', 'hepatocellular carcinoma', 'down', 'Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.'),
(4961, 'hsa-mir-29b-2', 'hepatocellular carcinoma', 'down', 'Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.'),
(4962, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.'),
(4963, 'hsa-mir-329', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.'),
(4964, 'hsa-mir-375', 'hepatocellular carcinoma', 'down', 'Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.'),
(4965, 'hsa-mir-383', 'hepatocellular carcinoma', 'down', 'miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.'),
(4966, 'hsa-mir-506', 'hepatocellular carcinoma', 'down', 'MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.'),
(4967, 'hsa-mir-506', 'hepatocellular carcinoma', 'down', 'microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1).'),
(4968, 'hsa-mir-548p', 'hepatocellular carcinoma', 'down', 'MicroRNA-548p suppresses hepatitis B virus X protein associated hepatocellular carcinoma by downregulating oncoprotein HBXIP.'),
(4969, 'hsa-mir-577', 'hepatocellular carcinoma', 'down', 'Inhibition effect of miR-577 on hepatocellular carcinoma cell growth via targeting ?-catenin.'),
(4970, 'hsa-mir-622', 'hepatocellular carcinoma', 'down', 'microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.'),
(4971, 'hsa-mir-770', 'hepatocellular carcinoma', 'up', 'Wnt/?-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.'),
(4972, 'hsa-mir-9', 'hepatocellular carcinoma', 'down', 'Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.'),
(4973, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells.'),
(4974, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin.'),
(4975, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.'),
(4976, 'hsa-mir-103', 'hepatocellular carcinoma', 'up', 'MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.'),
(4977, 'hsa-mir-1180', 'hepatocellular carcinoma', 'up', 'MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-?B signaling pathway.'),
(4978, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(4979, 'hsa-mir-125b', 'hepatocellular carcinoma', 'down', 'miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7.'),
(4980, 'hsa-mir-127-5p', 'hepatocellular carcinoma', 'down', 'MiR-127-5p targets the biliverdin reductase B/NF-?B pathway to suppress cell growth in hepatocellular carcinoma cells.'),
(4981, 'hsa-mir-130a', 'hepatocellular carcinoma', 'down', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(4982, 'hsa-mir-130b', 'hepatocellular carcinoma', 'up', 'MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1? signaling.'),
(4983, 'hsa-mir-133a-1', 'hepatocellular carcinoma', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(4984, 'hsa-mir-133a-2', 'hepatocellular carcinoma', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(4985, 'hsa-mir-133b', 'hepatocellular carcinoma', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(4986, 'hsa-mir-150', 'hepatocellular carcinoma', 'down', 'MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.'),
(4987, 'hsa-mir-155', 'hepatocellular carcinoma', 'up', 'Clinical significance of microRNA-155 expression in hepatocellular carcinoma.'),
(4988, 'hsa-mir-192', 'hepatocellular carcinoma', 'down', 'miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.'),
(4989, 'hsa-mir-194', 'hepatocellular carcinoma', 'down', 'MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.'),
(4990, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'miR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.'),
(4991, 'hsa-mir-200b', 'hepatocellular carcinoma', 'down', 'Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.'),
(4992, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.'),
(4993, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.'),
(4994, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(4995, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.'),
(4996, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(4997, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', 'Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.'),
(4998, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(4999, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.'),
(5000, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.'),
(5001, 'hsa-mir-26b-5p', 'hepatocellular carcinoma', 'down', 'Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.'),
(5002, 'hsa-mir-27a-3p', 'hepatocellular carcinoma', 'down', 'miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.'),
(5003, 'hsa-mir-28-5p', 'hepatocellular carcinoma', 'down', 'miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.'),
(5004, 'hsa-mir-30e', 'hepatocellular carcinoma', 'down', 'Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.'),
(5005, 'hsa-mir-34a-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells.'),
(5006, 'hsa-mir-34c-3p', 'hepatocellular carcinoma', 'down', 'miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.'),
(5007, 'hsa-mir-361-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.'),
(5008, 'hsa-mir-367', 'hepatocellular carcinoma', 'up', 'miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.'),
(5009, 'hsa-mir-379-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.'),
(5010, 'hsa-mir-381', 'hepatocellular carcinoma', 'down', 'MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.'),
(5011, 'hsa-mir-424', 'hepatocellular carcinoma', 'down', 'Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma.'),
(5012, 'hsa-mir-4262', 'hepatocellular carcinoma', 'up', 'MicroRNA-4262 activates the NF-?B and enhances the proliferation of hepatocellular carcinoma cells.'),
(5013, 'hsa-mir-431', 'hepatocellular carcinoma', 'down', 'MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.'),
(5014, 'hsa-mir-485-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.'),
(5015, 'hsa-mir-519a', 'hepatocellular carcinoma', 'up', 'MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.'),
(5016, 'hsa-mir-522', 'hepatocellular carcinoma', 'up', 'miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.'),
(5017, 'hsa-mir-545', 'hepatocellular carcinoma', 'up', 'Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.'),
(5018, 'hsa-mir-570', 'hepatocellular carcinoma', 'up', 'MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma.'),
(5019, 'hsa-mir-592', 'hepatocellular carcinoma', 'down', 'MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.'),
(5020, 'hsa-mir-615-5p', 'hepatocellular carcinoma', 'up', 'miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.'),
(5021, 'hsa-mir-630', 'hepatocellular carcinoma', 'down', 'MicroRNA-630 suppresses tumor metastasis through the TGF-?- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.'),
(5022, 'hsa-mir-761', 'hepatocellular carcinoma', 'up', 'MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting Mitofusin-2.'),
(5023, 'hsa-mir-9', 'hepatocellular carcinoma', 'down', 'Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-?B in hepatocellular carcinoma.'),
(5024, 'hsa-mir-9', 'hepatocellular carcinoma', 'up', 'MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.'),
(5025, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.'),
(5026, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'MicroRNA-98 suppresses cell proliferation, migration and invasion by targeting collagen triple helix repeat containing 1 in hepatocellular carcinoma.'),
(5027, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.'),
(5028, 'hsa-mir-1258', 'hepatocellular carcinoma', 'down', 'Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.'),
(5029, 'hsa-mir-185', 'hepatocellular carcinoma', 'down', 'MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.'),
(5030, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells.'),
(5031, 'hsa-mir-203a', 'hepatocellular carcinoma', 'down', 'EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.'),
(5032, 'hsa-mir-211', 'hepatocellular carcinoma', 'down', 'MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma.'),
(5033, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma.'),
(5034, 'hsa-mir-23a', 'hepatocellular carcinoma', 'up', 'MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.'),
(5035, 'hsa-mir-33a-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.'),
(5036, 'hsa-mir-377', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.'),
(5037, 'hsa-mir-449a', 'hepatocellular carcinoma', 'down', 'Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype.'),
(5038, 'hsa-mir-454', 'hepatocellular carcinoma', 'up', 'Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.'),
(5039, 'hsa-mir-497', 'hepatocellular carcinoma', 'down', 'microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.'),
(5040, 'hsa-mir-505', 'hepatocellular carcinoma', 'down', 'MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1.'),
(5041, 'hsa-mir-592', 'hepatocellular carcinoma', 'down', 'miR-592/WSB1/HIF-1? axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth.'),
(5042, 'hsa-mir-655-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and ?-catenin pathway in Hepatocellular Carcinoma.'),
(5043, 'hsa-mir-663a', 'hepatocellular carcinoma', 'down', 'miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.'),
(5044, 'hsa-let-7i', 'hepatocellular carcinoma', 'down', 'Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growth.'),
(5045, 'hsa-mir-101', 'hepatocellular carcinoma', 'up', 'Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.'),
(5046, 'hsa-mir-106b', 'hepatocellular carcinoma', 'up', 'miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.'),
(5047, 'hsa-mir-107', 'hepatocellular carcinoma', 'up', '[Expression of microRNA-107 in hepatocellular carcinoma and its clinical significance].'),
(5048, 'hsa-mir-1180', 'hepatocellular carcinoma', 'up', 'MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.'),
(5049, 'hsa-mir-1207-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.'),
(5050, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis.'),
(5051, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.'),
(5052, 'hsa-mir-122*', 'hepatocellular carcinoma', 'down', 'The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry.'),
(5053, 'hsa-mir-1269b', 'hepatocellular carcinoma', 'up', 'HBx-induced MiR-1269b in NF-?B dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(5054, 'hsa-mir-1299', 'hepatocellular carcinoma', 'down', 'miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.'),
(5055, 'hsa-mir-133b', 'hepatocellular carcinoma', 'down', 'MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.'),
(5056, 'hsa-mir-135a', 'hepatocellular carcinoma', 'up', 'miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1.'),
(5057, 'hsa-mir-135a-5p', 'hepatocellular carcinoma', 'up', 'Down-reguation of Kr?ppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-?1.'),
(5058, 'hsa-mir-138', 'hepatocellular carcinoma', 'down', 'miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma.'),
(5059, 'hsa-mir-141', 'hepatocellular carcinoma', 'down', '[Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].'),
(5060, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.'),
(5061, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4.'),
(5062, 'hsa-mir-155-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.'),
(5063, 'hsa-mir-187-3p', 'hepatocellular carcinoma', 'down', 'miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.'),
(5064, 'hsa-mir-196a', 'hepatocellular carcinoma', 'up', 'HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.'),
(5065, 'hsa-mir-198', 'hepatocellular carcinoma', 'down', 'Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.'),
(5066, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.'),
(5067, 'hsa-mir-216b', 'hepatocellular carcinoma', 'down', 'MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.'),
(5068, 'hsa-mir-22', 'hepatocellular carcinoma', 'down', 'MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.'),
(5069, 'hsa-mir-224', 'hepatocellular carcinoma', 'up', 'Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.'),
(5070, 'hsa-mir-25', 'hepatocellular carcinoma', 'up', 'miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.'),
(5071, 'hsa-mir-26b-5p', 'hepatocellular carcinoma', 'down', 'Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.'),
(5072, 'hsa-mir-29c', 'hepatocellular carcinoma', 'down', 'Low miR-29c expression is a prognostic marker in hepatocellular carcinoma.'),
(5073, 'hsa-mir-30a-5p', 'hepatocellular carcinoma', 'down', 'Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis.'),
(5074, 'hsa-mir-30b', 'hepatocellular carcinoma', 'down', 'MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.'),
(5075, 'hsa-mir-338-3p', 'hepatocellular carcinoma', 'down', 'miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells.'),
(5076, 'hsa-mir-384', 'hepatocellular carcinoma', 'down', 'MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.'),
(5077, 'hsa-mir-449a', 'hepatocellular carcinoma', 'down', 'miR-449a inhibits proliferation and invasion by regulating ADAM10 in hepatocellular carcinoma.'),
(5078, 'hsa-mir-491', 'hepatocellular carcinoma', 'down', '[miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].'),
(5079, 'hsa-mir-502-3p', 'hepatocellular carcinoma', 'down', 'MiR-502-3P suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SET.'),
(5080, 'hsa-mir-503', 'hepatocellular carcinoma', 'down', 'MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.'),
(5081, 'hsa-mir-522', 'hepatocellular carcinoma', 'up', 'Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma.'),
(5082, 'hsa-mir-548a-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.'),
(5083, 'hsa-mir-599', 'hepatocellular carcinoma', 'down', 'Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.'),
(5084, 'hsa-mir-613', 'hepatocellular carcinoma', 'down', 'miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.'),
(5085, 'hsa-mir-615-5p', 'hepatocellular carcinoma', 'down', 'KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells.'),
(5086, 'hsa-mir-638', 'hepatocellular carcinoma', 'down', 'Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.'),
(5087, 'hsa-mir-663', 'hepatocellular carcinoma', 'up', 'miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.'),
(5088, 'hsa-mir-7', 'hepatocellular carcinoma', 'down', 'The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.'),
(5089, 'hsa-mir-7', 'hepatocellular carcinoma', 'up', 'Suppression of miR-7 biogenesis by NF90-NF45 controls cell proliferation in hepatocellular carcinoma.'),
(5090, 'hsa-mir-765', 'hepatocellular carcinoma', 'up', 'Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.'),
(5091, 'hsa-mir-92b', 'hepatocellular carcinoma', 'up', 'MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.'),
(5092, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.'),
(5093, 'hsa-mir-107', 'hepatocellular carcinoma', 'down', 'MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3\'UTR.'),
(5094, 'hsa-mir-10b', 'hepatocellular carcinoma', 'up', 'miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).'),
(5095, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.'),
(5096, 'hsa-mir-132', 'hepatocellular carcinoma', 'down', 'Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.'),
(5097, 'hsa-mir-139-5p', 'hepatocellular carcinoma', 'down', 'Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.'),
(5098, 'hsa-mir-146a', 'hepatocellular carcinoma', 'down', 'MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6.'),
(5099, 'hsa-mir-155', 'hepatocellular carcinoma', 'up', 'MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/?-catenin signaling pathways.'),
(5100, 'hsa-mir-199a-3p', 'hepatocellular carcinoma', 'down', 'miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.'),
(5101, 'hsa-mir-204-5p', 'hepatocellular carcinoma', 'down', 'miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.'),
(5102, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.'),
(5103, 'hsa-mir-210', 'hepatocellular carcinoma', 'up', 'MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma.'),
(5104, 'hsa-mir-217', 'hepatocellular carcinoma', 'down', 'Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.'),
(5105, 'hsa-mir-22', 'hepatocellular carcinoma', 'down', 'miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.'),
(5106, 'hsa-mir-22-3p', 'hepatocellular carcinoma', 'down', 'Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1.'),
(5107, 'hsa-mir-24', 'hepatocellular carcinoma', 'up', 'MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.'),
(5108, 'hsa-mir-24-3p', 'hepatocellular carcinoma', 'up', 'MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M.'),
(5109, 'hsa-mir-26a-5p', 'hepatocellular carcinoma', 'down', 'miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.'),
(5110, 'hsa-mir-27b', 'hepatocellular carcinoma', 'up', 'MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.'),
(5111, 'hsa-mir-296', 'hepatocellular carcinoma', 'down', 'miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma.'),
(5112, 'hsa-mir-3117', 'hepatocellular carcinoma', 'up', 'miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.'),
(5113, 'hsa-mir-338-3p', 'hepatocellular carcinoma', 'down', 'Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.'),
(5114, 'hsa-mir-33b', 'hepatocellular carcinoma', 'down', '[MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4].'),
(5115, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.'),
(5116, 'hsa-mir-34c-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.'),
(5117, 'hsa-mir-361-5p', 'hepatocellular carcinoma', 'down', 'miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.'),
(5118, 'hsa-mir-375', 'hepatocellular carcinoma', 'down', 'Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.'),
(5119, 'hsa-mir-384', 'hepatocellular carcinoma', 'down', 'LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.'),
(5120, 'hsa-mir-455', 'hepatocellular carcinoma', 'up', 'MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2.'),
(5121, 'hsa-mir-487a', 'hepatocellular carcinoma', 'up', 'miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma.'),
(5122, 'hsa-mir-508-5p', 'hepatocellular carcinoma', 'down', 'miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.'),
(5123, 'hsa-mir-539', 'hepatocellular carcinoma', 'down', 'microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.'),
(5124, 'hsa-mir-542-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway.'),
(5125, 'hsa-mir-589-5p', 'hepatocellular carcinoma', 'down', 'miR-589-5p inhibits MAP3K8 and suppresses CD90(+) cancer stem cells in hepatocellular carcinoma.'),
(5126, 'hsa-mir-634', 'hepatocellular carcinoma', 'down', 'miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.'),
(5127, 'hsa-mir-638', 'hepatocellular carcinoma', 'down', 'Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.'),
(5128, 'hsa-mir-675', 'hepatocellular carcinoma', 'up', 'MiR-675 Promotes the Growth of Hepatocellular Carcinoma Cells Through the Cdc25A Pathway.'),
(5129, 'hsa-mir-885-5p', 'hepatocellular carcinoma', 'down', 'miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/?-catenin signaling pathway.'),
(5130, 'hsa-mir-892a', 'hepatocellular carcinoma', 'up', 'MiR-892a Promotes Hepatocellular Carcinoma Cells Proliferation and Invasion Through Targeting CD226.'),
(5131, 'hsa-mir-940', 'hepatocellular carcinoma', 'down', 'miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma.'),
(5132, 'hsa-mir-95-3p', 'hepatocellular carcinoma', 'up', 'Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.'),
(5133, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/?-catenin signaling pathway.'),
(5134, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.'),
(5135, 'hsa-let-7c', 'hepatocellular carcinoma', 'down', 'MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.'),
(5136, 'hsa-mir-1269a', 'hepatocellular carcinoma', 'down', 'A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6.'),
(5137, 'hsa-mir-130a', 'hepatocellular carcinoma', 'down', 'Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.'),
(5138, 'hsa-mir-133b', 'hepatocellular carcinoma', 'down', 'MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion Via Targeting LASP1 in Hepatocarcinoma Cells.'),
(5139, 'hsa-mir-138', 'hepatocellular carcinoma', 'down', 'HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.'),
(5140, 'hsa-mir-142', 'hepatocellular carcinoma', 'down', 'Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.'),
(5141, 'hsa-mir-142', 'hepatocellular carcinoma', 'down', 'Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.'),
(5142, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.'),
(5143, 'hsa-mir-147', 'hepatocellular carcinoma', 'down', 'MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.'),
(5144, 'hsa-mir-152', 'hepatocellular carcinoma', 'down', 'MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.'),
(5145, 'hsa-mir-152-3p', 'hepatocellular carcinoma', 'down', 'Function of MiR-152 As a Tumor Suppressor in Human Breast Cancer By Targeting PIK3CA.'),
(5146, 'hsa-mir-155-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.'),
(5147, 'hsa-mir-15b-5p', 'hepatocellular carcinoma', 'down', 'OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and ?-catenin signaling pathways.'),
(5148, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.'),
(5149, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.'),
(5150, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'MicroRNA-200a Suppresses Cell Invasion and Migration by Directly Targeting GAB1 in Hepatocellular Carcinoma.'),
(5151, 'hsa-mir-217', 'hepatocellular carcinoma', 'down', 'miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.'),
(5152, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.'),
(5153, 'hsa-mir-23b', 'hepatocellular carcinoma', 'down', 'microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2.'),
(5154, 'hsa-mir-26b', 'hepatocellular carcinoma', 'down', 'MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.'),
(5155, 'hsa-mir-30e', 'hepatocellular carcinoma', 'down', 'MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.'),
(5156, 'hsa-mir-3131', 'hepatocellular carcinoma', 'up', 'An Indel Polymorphism within pre-miR3131 Confers Risk for Hepatocellular Carcinoma.'),
(5157, 'hsa-mir-320a', 'hepatocellular carcinoma', 'down', 'miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.'),
(5158, 'hsa-mir-33a-5p', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.'),
(5159, 'hsa-mir-340', 'hepatocellular carcinoma', 'down', 'MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.'),
(5160, 'hsa-mir-345', 'hepatocellular carcinoma', 'down', 'miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.'),
(5161, 'hsa-mir-34a', 'hepatocellular carcinoma', 'up', 'miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.'),
(5162, 'hsa-mir-365', 'hepatocellular carcinoma', 'down', 'miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.'),
(5163, 'hsa-mir-455', 'hepatocellular carcinoma', 'down', 'Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.'),
(5164, 'hsa-mir-489', 'hepatocellular carcinoma', 'down', 'microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.'),
(5165, 'hsa-mir-505', 'hepatocellular carcinoma', 'down', 'Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies.'),
(5166, 'hsa-mir-874-3p', 'hepatocellular carcinoma', 'down', 'miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.'),
(5167, 'hsa-mir-922', 'hepatocellular carcinoma', 'up', 'miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma.'),
(5168, 'hsa-mir-98-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-98-5p inhibits cell proliferation and induces cell apoptosis in hepatocellular carcinoma via targeting IGF2BP1.'),
(5169, 'hsa-mir-137', 'hepatocellular carcinoma', 'up', 'Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.'),
(5170, 'hsa-mir-140-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.'),
(5171, 'hsa-mir-141-3p', 'hepatocellular carcinoma', 'down', 'A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.'),
(5172, 'hsa-mir-146a-5p', 'hepatocellular carcinoma', 'down', 'Down-regulation of miR-146a-5p and its potential targets in hepatocellular carcinoma validated by a TCGA- and GEO-based study.'),
(5173, 'hsa-mir-146b-5p', 'hepatocellular carcinoma', 'down', 'Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis.'),
(5174, 'hsa-mir-15a', 'hepatocellular carcinoma', 'down', 'MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb.'),
(5175, 'hsa-mir-181a', 'hepatocellular carcinoma', 'up', 'Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.'),
(5176, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.'),
(5177, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.'),
(5178, 'hsa-mir-199a-5p', 'hepatocellular carcinoma', 'down', 'Mutual Regulation of MiR-199a-5p and HIF-1? Modulates the Warburg Effect in Hepatocellular Carcinoma.'),
(5179, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma.'),
(5180, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'Upregulation of RASAL2 promotes proliferation and metastasis, and is targeted by miR-203 in hepatocellular carcinoma.'),
(5181, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.'),
(5182, 'hsa-mir-211-5p', 'hepatocellular carcinoma', 'down', 'Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.'),
(5183, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1.'),
(5184, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway.'),
(5185, 'hsa-mir-23b', 'hepatocellular carcinoma', 'up', 'MicroRNA-23b functions as an oncogene and activates AKT/GSK3?/?-catenin signaling by targeting ST7L in hepatocellular carcinoma.'),
(5186, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.'),
(5187, 'hsa-mir-340', 'hepatocellular carcinoma', 'down', 'Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression.'),
(5188, 'hsa-mir-342-3p', 'hepatocellular carcinoma', 'down', 'Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.'),
(5189, 'hsa-mir-429', 'hepatocellular carcinoma', 'down', 'Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-?B pathway.'),
(5190, 'hsa-mir-4417', 'hepatocellular carcinoma', 'up', 'miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells'),
(5191, 'hsa-mir-493-5p', 'hepatocellular carcinoma', 'down', 'miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.'),
(5192, 'hsa-mir-500a', 'hepatocellular carcinoma', 'up', 'MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/?-catenin signaling pathway.'),
(5193, 'hsa-mir-539', 'hepatocellular carcinoma', 'down', 'miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.'),
(5194, 'hsa-mir-590-3p', 'hepatocellular carcinoma', 'down', 'MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1.'),
(5195, 'hsa-mir-592', 'hepatocellular carcinoma', 'down', 'MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.'),
(5196, 'hsa-mir-888-5p', 'hepatocellular carcinoma', 'up', 'Up-regulation of miR-888-5p in hepatocellular carcinoma cell lines and its effect on malignant characteristics of cells.'),
(5197, 'hsa-mir-99a', 'hepatocellular carcinoma', 'down', 'PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.'),
(5198, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines.'),
(5199, 'hsa-mir-101-3p', 'hepatocellular carcinoma', 'down', 'Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.'),
(5200, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/?-cadherin signaling pathway.'),
(5201, 'hsa-mir-1247-5p', 'hepatocellular carcinoma', 'down', 'miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3.'),
(5202, 'hsa-mir-125a', 'hepatocellular carcinoma', 'down', 'The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.'),
(5203, 'hsa-mir-126', 'hepatocellular carcinoma', 'up', 'Effects of microRNA-126 on cell proliferation, apoptosis and tumor angiogenesis via the down-regulating ERK signaling pathway by targeting EGFL7 in hepatocellular carcinoma.'),
(5204, 'hsa-mir-1269', 'hepatocellular carcinoma', 'up', 'Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.'),
(5205, 'hsa-mir-1296', 'hepatocellular carcinoma', 'down', 'MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.'),
(5206, 'hsa-mir-1301', 'hepatocellular carcinoma', 'down', 'miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/?-catenin signaling through targeting BCL9.'),
(5207, 'hsa-mir-133b', 'hepatocellular carcinoma', 'down', 'Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.'),
(5208, 'hsa-mir-135a-5p', 'hepatocellular carcinoma', 'up', 'Down-reguation of Kr?ppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-?1.'),
(5209, 'hsa-mir-138', 'hepatocellular carcinoma', 'down', 'MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.'),
(5210, 'hsa-mir-143', 'hepatocellular carcinoma', 'down', 'MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.'),
(5211, 'hsa-mir-144-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma.'),
(5212, 'hsa-mir-144-3p', 'hepatocellular carcinoma', 'down', 'A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma.'),
(5213, 'hsa-mir-155', 'hepatocellular carcinoma', 'up', 'Crosstalk between liver-related microRNAs and Wnt/?-catenin pathway in hepatocellular carcinoma patients.'),
(5214, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'Crosstalk between liver-related microRNAs and Wnt/?-catenin pathway in hepatocellular carcinoma patients.'),
(5215, 'hsa-mir-187', 'hepatocellular carcinoma', 'down', 'MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma.'),
(5216, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.'),
(5217, 'hsa-mir-199b-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-199b-5p attenuates TGF-?1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.'),
(5218, 'hsa-mir-206', 'hepatocellular carcinoma', 'down', 'miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.'),
(5219, 'hsa-mir-210', 'hepatocellular carcinoma', 'up', 'MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like?1 in hepatocellular carcinoma.'),
(5220, 'hsa-mir-217', 'hepatocellular carcinoma', 'up', 'miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.'),
(5221, 'hsa-mir-23a', 'hepatocellular carcinoma', 'up', 'MicroRNAs and clinical implications in hepatocellular carcinoma.'),
(5222, 'hsa-mir-30a', 'hepatocellular carcinoma', 'down', 'MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.'),
(5223, 'hsa-mir-31-5p', 'hepatocellular carcinoma', 'down', 'Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.'),
(5224, 'hsa-mir-326', 'hepatocellular carcinoma', 'down', 'MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.'),
(5225, 'hsa-mir-33a', 'hepatocellular carcinoma', 'up', 'MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPAR? in human hepatocellular carcinoma.'),
(5226, 'hsa-mir-345', 'hepatocellular carcinoma', 'down', 'MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.'),
(5227, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', '0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.'),
(5228, 'hsa-mir-363-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.'),
(5229, 'hsa-mir-365', 'hepatocellular carcinoma', 'down', 'miR-365 induces hepatocellular carcinoma cell apoptosis through targeting Bcl-2.'),
(5230, 'hsa-mir-374a', 'hepatocellular carcinoma', 'up', 'MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene-6 (MIG-6).'),
(5231, 'hsa-mir-384', 'hepatocellular carcinoma', 'down', 'Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.'),
(5232, 'hsa-mir-3910', 'hepatocellular carcinoma', 'up', 'MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.'),
(5233, 'hsa-mir-486-5p', 'hepatocellular carcinoma', 'down', 'MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.'),
(5234, 'hsa-mir-490-5p', 'hepatocellular carcinoma', 'down', 'MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells.'),
(5235, 'hsa-mir-490-5p', 'hepatocellular carcinoma', 'down', 'MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1.'),
(5236, 'hsa-mir-493', 'hepatocellular carcinoma', 'down', 'MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2).'),
(5237, 'hsa-mir-500a-3p', 'hepatocellular carcinoma', 'up', 'miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.'),
(5238, 'hsa-mir-708', 'hepatocellular carcinoma', 'down', 'miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.'),
(5239, 'hsa-mir-874', 'hepatocellular carcinoma', 'down', 'MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12.'),
(5240, 'hsa-mir-9', 'hepatocellular carcinoma', 'up', 'LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism.'),
(5241, 'hsa-mir-9-3p', 'hepatocellular carcinoma', 'down', 'Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma.'),
(5242, 'hsa-mir-92a', 'hepatocellular carcinoma', 'up', 'miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting.'),
(5243, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'The miR-93 promotes proliferation by directly targeting PDCD4 in hepatocellular carcinoma.'),
(5244, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4.'),
(5245, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'MicroRNA-98 suppresses cell proliferation, migration and invasion by targeting collagen triple helix repeat containing?1 in hepatocellular carcinoma.'),
(5246, 'hsa-mir-99b', 'hepatocellular carcinoma', 'up', 'miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin?11 expression and may serve as a prognostic marker.'),
(5247, 'hsa-mir-1202', 'hepatocellular carcinoma', 'down', 'MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14.'),
(5248, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.'),
(5249, 'hsa-mir-122-5p', 'hepatocellular carcinoma', 'down', 'Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.'),
(5250, 'hsa-mir-125a', 'hepatocellular carcinoma', 'down', 'Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.'),
(5251, 'hsa-mir-1260b', 'hepatocellular carcinoma', 'up', 'miR-1260b promotes cell migration and invasion of hepatocellular carcinoma by targeting the regulator of G-protein signaling 22.'),
(5252, 'hsa-mir-135a', 'hepatocellular carcinoma', 'up', 'Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.'),
(5253, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.'),
(5254, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.'),
(5255, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.'),
(5256, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.'),
(5257, 'hsa-mir-214-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.'),
(5258, 'hsa-mir-221-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.'),
(5259, 'hsa-mir-222-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.'),
(5260, 'hsa-mir-26a-5p', 'hepatocellular carcinoma', 'down', 'Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.'),
(5261, 'hsa-mir-27a-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.'),
(5262, 'hsa-mir-29a-3p', 'hepatocellular carcinoma', 'down', 'miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.'),
(5263, 'hsa-mir-30a', 'hepatocellular carcinoma', 'down', 'MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.'),
(5264, 'hsa-mir-30a-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1.'),
(5265, 'hsa-mir-324-3p', 'hepatocellular carcinoma', 'up', 'MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/?-catenin pathway in hepatocellular carcinoma.'),
(5266, 'hsa-mir-346', 'hepatocellular carcinoma', 'down', 'MiR-346 suppresses cell proliferation through SMYD3 dependent approach in hepatocellular carcinoma.'),
(5267, 'hsa-mir-363', 'hepatocellular carcinoma', 'down', 'miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.'),
(5268, 'hsa-mir-363', 'hepatocellular carcinoma', 'down', 'Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.'),
(5269, 'hsa-mir-429', 'hepatocellular carcinoma', 'down', 'MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23.'),
(5270, 'hsa-mir-483-5p', 'hepatocellular carcinoma', 'up', 'MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.'),
(5271, 'hsa-mir-485', 'hepatocellular carcinoma', 'down', 'The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.'),
(5272, 'hsa-mir-488', 'hepatocellular carcinoma', 'down', 'MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.'),
(5273, 'hsa-mir-526b', 'hepatocellular carcinoma', 'down', 'microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.'),
(5274, 'hsa-mir-589-5p', 'hepatocellular carcinoma', 'up', 'Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.'),
(5275, 'hsa-mir-93-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.'),
(5276, 'hsa-mir-101', 'hepatocellular carcinoma', 'down', 'Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.'),
(5277, 'hsa-mir-106b-5p', 'hepatocellular carcinoma', 'up', 'miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.'),
(5278, 'hsa-mir-10b', 'hepatocellular carcinoma', 'up', 'MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma.'),
(5279, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma.'),
(5280, 'hsa-mir-1271', 'hepatocellular carcinoma', 'down', 'MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the PTP4A1/c-Src axis.'),
(5281, 'hsa-mir-132', 'hepatocellular carcinoma', 'down', 'Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.'),
(5282, 'hsa-mir-135a-5p', 'hepatocellular carcinoma', 'up', 'Down-reguation of Kr??ppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-?1.'),
(5283, 'hsa-mir-139-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-139-3p suppresses tumor growth and metastasis in hepatocellular carcinoma by repressing ANXA2R.'),
(5284, 'hsa-mir-139-5p', 'hepatocellular carcinoma', 'down', 'miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.'),
(5285, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.'),
(5286, 'hsa-mir-1468', 'hepatocellular carcinoma', 'up', 'MicroRNA-1468 promotes tumor progression by activating PPAR-?-mediated AKT signaling in human hepatocellular carcinoma.'),
(5287, 'hsa-mir-147b', 'hepatocellular carcinoma', 'up', 'MicroRNA miR-147b promotes tumor growth via targeting UBE2N in hepatocellular carcinoma.'),
(5288, 'hsa-mir-182-5p', 'hepatocellular carcinoma', 'up', 'miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.'),
(5289, 'hsa-mir-185', 'hepatocellular carcinoma', 'down', 'Integrin-?5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating ?-catenin stability.'),
(5290, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'Identification of a TGF-?-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells.'),
(5291, 'hsa-mir-19a', 'hepatocellular carcinoma', 'up', 'Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.'),
(5292, 'hsa-mir-203a', 'hepatocellular carcinoma', 'down', 'HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.'),
(5293, 'hsa-mir-204-5p', 'hepatocellular carcinoma', 'down', 'miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression.'),
(5294, 'hsa-mir-212', 'hepatocellular carcinoma', 'down', 'Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.'),
(5295, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', 'miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells.'),
(5296, 'hsa-mir-340', 'hepatocellular carcinoma', 'down', 'Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.'),
(5297, 'hsa-mir-346', 'hepatocellular carcinoma', 'up', 'miR-346 Promotes HCC Progression by Suppressing Breast Cancer Metastasis Suppressor 1 Expression.'),
(5298, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.'),
(5299, 'hsa-mir-429', 'hepatocellular carcinoma', 'down', 'miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.'),
(5300, 'hsa-mir-495', 'hepatocellular carcinoma', 'down', 'MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.'),
(5301, 'hsa-mir-520f', 'hepatocellular carcinoma', 'up', 'MiR-520f promotes cell aggressiveness by regulating fibroblast growth factor 16 in hepatocellular carcinoma.'),
(5302, 'hsa-mir-564', 'hepatocellular carcinoma', 'down', 'miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.'),
(5303, 'hsa-mir-590-3p', 'hepatocellular carcinoma', 'down', 'Identifying key regulating miRNAs in hepatocellular carcinomas by an omics\' method.'),
(5304, 'hsa-mir-874', 'hepatocellular carcinoma', 'down', 'microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.'),
(5305, 'hsa-mir-93-5p', 'hepatocellular carcinoma', 'up', 'MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.'),
(5306, 'hsa-let-7b', 'hepatocellular carcinoma', 'down', 'Let-7b contributes to hepatocellular cancer progression through Wnt/?-catenin signaling.'),
(5307, 'hsa-mir-101-3p', 'hepatocellular carcinoma', 'down', 'LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.'),
(5308, 'hsa-mir-106b', 'hepatocellular carcinoma', 'up', 'MiR-106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain-containing protein 7A (Zbtb7a).'),
(5309, 'hsa-mir-10b-3p', 'hepatocellular carcinoma', 'up', 'Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.'),
(5310, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation.'),
(5311, 'hsa-mir-124-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.'),
(5312, 'hsa-mir-125a', 'hepatocellular carcinoma', 'down', 'Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.'),
(5313, 'hsa-mir-1277', 'hepatocellular carcinoma', 'down', 'MicroRNA-1277 inhibits proliferation and migration of hepatocellular carcinoma HepG2 cells by targeting and suppressing BMP4 expression and reflects the significant indicative role in hepatocellular c'),
(5314, 'hsa-mir-1287', 'hepatocellular carcinoma', 'down', 'Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3.'),
(5315, 'hsa-mir-133a', 'hepatocellular carcinoma', 'down', 'MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-?/Smad3 signaling pathway.'),
(5316, 'hsa-mir-138', 'hepatocellular carcinoma', 'down', 'LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.'),
(5317, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.'),
(5318, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.'),
(5319, 'hsa-mir-150', 'hepatocellular carcinoma', 'down', 'Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.'),
(5320, 'hsa-mir-16', 'hepatocellular carcinoma', 'down', 'Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-?B signaling pathway in hepatocellular carcinoma.'),
(5321, 'hsa-mir-181b', 'hepatocellular carcinoma', 'up', 'Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5.'),
(5322, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.'),
(5323, 'hsa-mir-190', 'hepatocellular carcinoma', 'up', 'miR-190 promotes HCC proliferation and metastasis by targeting PHLPP1.'),
(5324, 'hsa-mir-199a-1', 'hepatocellular carcinoma', 'down', 'MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.'),
(5325, 'hsa-mir-199a-2', 'hepatocellular carcinoma', 'down', 'MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.'),
(5326, 'hsa-mir-199b', 'hepatocellular carcinoma', 'down', 'MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma.'),
(5327, 'hsa-mir-19a-3p', 'hepatocellular carcinoma', 'up', 'microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.'),
(5328, 'hsa-mir-200a', 'hepatocellular carcinoma', 'down', 'MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.'),
(5329, 'hsa-mir-200a-3p', 'hepatocellular carcinoma', 'down', 'Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6.'),
(5330, 'hsa-mir-205', 'hepatocellular carcinoma', 'down', 'MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma.'),
(5331, 'hsa-mir-205', 'hepatocellular carcinoma', 'down', 'MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.'),
(5332, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma.'),
(5333, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.'),
(5334, 'hsa-mir-214-3p', 'hepatocellular carcinoma', 'down', 'LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.'),
(5335, 'hsa-mir-214-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.'),
(5336, 'hsa-mir-214-5p', 'hepatocellular carcinoma', 'down', 'miR-214-5p targets KLF5 and suppresses proliferation of human hepatocellular carcinoma cells.'),
(5337, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.'),
(5338, 'hsa-mir-223', 'hepatocellular carcinoma', 'down', 'Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(5339, 'hsa-mir-23c', 'hepatocellular carcinoma', 'down', 'miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP.'),
(5340, 'hsa-mir-25', 'hepatocellular carcinoma', 'up', 'A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.'),
(5341, 'hsa-mir-26a', 'hepatocellular carcinoma', 'down', 'microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma.'),
(5342, 'hsa-mir-27a', 'hepatocellular carcinoma', 'up', 'Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1.'),
(5343, 'hsa-mir-298', 'hepatocellular carcinoma', 'down', 'MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt/?-catenin signaling.'),
(5344, 'hsa-mir-299-3p', 'hepatocellular carcinoma', 'down', 'MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.'),
(5345, 'hsa-mir-29a', 'hepatocellular carcinoma', 'down', 'MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.'),
(5346, 'hsa-mir-300', 'hepatocellular carcinoma', 'down', 'miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.'),
(5347, 'hsa-mir-302c-3p', 'hepatocellular carcinoma', 'down', 'The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4.'),
(5348, 'hsa-mir-32', 'hepatocellular carcinoma', 'up', 'Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.'),
(5349, 'hsa-mir-337-3p', 'hepatocellular carcinoma', 'down', 'miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2.'),
(5350, 'hsa-mir-33a', 'hepatocellular carcinoma', 'down', 'MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.'),
(5351, 'hsa-mir-342-3p', 'hepatocellular carcinoma', 'down', 'miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.'),
(5352, 'hsa-mir-365', 'hepatocellular carcinoma', 'down', 'miR-365 Regulates Liver Cancer Stem Cells via RAC1 pathway.'),
(5353, 'hsa-mir-3662', 'hepatocellular carcinoma', 'down', 'MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1?-mediated Warburg effect.'),
(5354, 'hsa-mir-375', 'hepatocellular carcinoma', 'down', 'The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.'),
(5355, 'hsa-mir-449a', 'hepatocellular carcinoma', 'down', 'Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis.'),
(5356, 'hsa-mir-449a', 'hepatocellular carcinoma', 'down', 'MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.'),
(5357, 'hsa-mir-490-3p', 'hepatocellular carcinoma', 'down', 'MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.'),
(5358, 'hsa-mir-490-3p', 'hepatocellular carcinoma', 'down', 'Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.'),
(5359, 'hsa-mir-493', 'hepatocellular carcinoma', 'down', 'MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.'),
(5360, 'hsa-mir-494-3p', 'hepatocellular carcinoma', 'up', 'MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.'),
(5361, 'hsa-mir-501-3p', 'hepatocellular carcinoma', 'down', 'microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.'),
(5362, 'hsa-mir-505', 'hepatocellular carcinoma', 'down', 'miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1.'),
(5363, 'hsa-mir-542-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.'),
(5364, 'hsa-mir-542-3p', 'hepatocellular carcinoma', 'down', 'Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-?/Smad signaling in hepatocellular carcinoma.'),
(5365, 'hsa-mir-5692a', 'hepatocellular carcinoma', 'up', 'MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.'),
(5366, 'hsa-mir-575', 'hepatocellular carcinoma', 'up', 'Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.'),
(5367, 'hsa-mir-608', 'hepatocellular carcinoma', 'down', 'microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.'),
(5368, 'hsa-mir-613', 'hepatocellular carcinoma', 'down', 'MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ.'),
(5369, 'hsa-mir-644a', 'hepatocellular carcinoma', 'down', 'MicroRNA-644a promotes apoptosis of hepatocellular carcinoma cells by downregulating the expression of heat shock factor 1.'),
(5370, 'hsa-mir-760', 'hepatocellular carcinoma', 'down', 'MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.'),
(5371, 'hsa-mir-766', 'hepatocellular carcinoma', 'up', 'MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.'),
(5372, 'hsa-mir-766-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.'),
(5373, 'hsa-mir-873', 'hepatocellular carcinoma', 'up', 'MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma.'),
(5374, 'hsa-mir-875-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.'),
(5375, 'hsa-mir-877-5p', 'hepatocellular carcinoma', 'down', 'MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.'),
(5376, 'hsa-mir-877-5p', 'hepatocellular carcinoma', 'down', 'Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.'),
(5377, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.'),
(5378, 'hsa-mir-96-5p', 'hepatocellular carcinoma', 'up', 'Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.'),
(5379, 'hsa-mir-98', 'hepatocellular carcinoma', 'down', 'MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10.'),
(5380, 'hsa-mir-99b', 'hepatocellular carcinoma', 'up', 'The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.'),
(5381, 'hsa-mir-101-3p', 'hepatocellular carcinoma', 'down', 'Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.'),
(5382, 'hsa-mir-122', 'hepatocellular carcinoma', 'down', 'miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/?-catenin pathway.'),
(5383, 'hsa-mir-122-5p', 'hepatocellular carcinoma', 'down', 'Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data.'),
(5384, 'hsa-mir-124-3p', 'hepatocellular carcinoma', 'down', 'Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma.'),
(5385, 'hsa-mir-126', 'hepatocellular carcinoma', 'down', 'MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway.'),
(5386, 'hsa-mir-128-3p', 'hepatocellular carcinoma', 'down', 'MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.'),
(5387, 'hsa-mir-137', 'hepatocellular carcinoma', 'down', 'MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.'),
(5388, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma.'),
(5389, 'hsa-mir-15b', 'hepatocellular carcinoma', 'down', 'LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.'),
(5390, 'hsa-mir-17-5p', 'hepatocellular carcinoma', 'up', 'DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1.'),
(5391, 'hsa-mir-181a-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-?/Smad pathway in hepatocellular carcinoma.'),
(5392, 'hsa-mir-183', 'hepatocellular carcinoma', 'down', 'Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.'),
(5393, 'hsa-mir-183', 'hepatocellular carcinoma', 'up', 'Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma'),
(5394, 'hsa-mir-18a', 'hepatocellular carcinoma', 'up', 'MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.'),
(5395, 'hsa-mir-193a-5p', 'hepatocellular carcinoma', 'up', 'Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.'),
(5396, 'hsa-mir-197', 'hepatocellular carcinoma', 'up', 'MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/?-Catenin Signaling.'),
(5397, 'hsa-mir-200b', 'hepatocellular carcinoma', 'down', 'Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.'),
(5398, 'hsa-mir-203', 'hepatocellular carcinoma', 'down', 'LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.'),
(5399, 'hsa-mir-206', 'hepatocellular carcinoma', 'down', 'LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14.'),
(5400, 'hsa-mir-210', 'hepatocellular carcinoma', 'up', 'Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma.'),
(5401, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.'),
(5402, 'hsa-mir-27b', 'hepatocellular carcinoma', 'down', 'Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.'),
(5403, 'hsa-mir-299-5p', 'hepatocellular carcinoma', 'up', 'Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.'),
(5404, 'hsa-mir-301a-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.'),
(5405, 'hsa-mir-302a-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion.'),
(5406, 'hsa-mir-32', 'hepatocellular carcinoma', 'up', 'MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis.'),
(5407, 'hsa-mir-326', 'hepatocellular carcinoma', 'down', 'Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.'),
(5408, 'hsa-mir-328', 'hepatocellular carcinoma', 'up', 'Downregulated miR-328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting PTEN.'),
(5409, 'hsa-mir-346', 'hepatocellular carcinoma', 'up', 'LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.'),
(5410, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma'),
(5411, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'MicroRNA-34a inhibit hepatocellular carcinoma progression by repressing hexokinase-1.'),
(5412, 'hsa-mir-384', 'hepatocellular carcinoma', 'down', 'Long noncoding RNA NEAT1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma through interacting with miR-384.'),
(5413, 'hsa-mir-431-5p', 'hepatocellular carcinoma', 'down', 'miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting?UROC28?in hepatoma cells.'),
(5414, 'hsa-mir-448', 'hepatocellular carcinoma', 'down', 'miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma.'),
(5415, 'hsa-mir-517a', 'hepatocellular carcinoma', 'up', 'miR-517a promotes Warburg effect in HCC by directly targeting FBP1.'),
(5416, 'hsa-mir-520c-3p', 'hepatocellular carcinoma', 'down', 'HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.'),
(5417, 'hsa-mir-520d-3p', 'hepatocellular carcinoma', 'down', 'Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation.'),
(5418, 'hsa-mir-532-3p', 'hepatocellular carcinoma', 'up', 'miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.'),
(5419, 'hsa-mir-539', 'hepatocellular carcinoma', 'down', 'Down-regulation of MAP2K1 by miR-539 inhibits hepatocarcinoma progression.'),
(5420, 'hsa-mir-552', 'hepatocellular carcinoma', 'up', 'MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.'),
(5421, 'hsa-mir-621', 'hepatocellular carcinoma', 'down', 'Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma.'),
(5422, 'hsa-mir-621', 'hepatocellular carcinoma', 'down', 'MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma.'),
(5423, 'hsa-mir-663a', 'hepatocellular carcinoma', 'down', 'miR-663a inhibits tumor growth and invasion by regulating TGF-?1 in hepatocellular carcinoma.'),
(5424, 'hsa-mir-665', 'hepatocellular carcinoma', 'up', 'miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.'),
(5425, 'hsa-mir-93', 'hepatocellular carcinoma', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(5426, 'hsa-mir-1-3p', 'hepatocellular carcinoma', 'down', 'miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.'),
(5427, 'hsa-mir-101-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.'),
(5428, 'hsa-mir-106a', 'hepatocellular carcinoma', 'up', 'Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.'),
(5429, 'hsa-mir-106b-5p', 'hepatocellular carcinoma', 'up', 'MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2.'),
(5430, 'hsa-mir-1179', 'hepatocellular carcinoma', 'down', 'MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.'),
(5431, 'hsa-mir-1204', 'hepatocellular carcinoma', 'up', 'miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418.'),
(5432, 'hsa-mir-122', 'hepatocellular carcinoma', 'up', 'Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.'),
(5433, 'hsa-mir-124', 'hepatocellular carcinoma', 'down', 'MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1.'),
(5434, 'hsa-mir-1246', 'hepatocellular carcinoma', 'up', 'Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.'),
(5435, 'hsa-mir-125a-5p', 'hepatocellular carcinoma', 'down', 'miRNA-125a-5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl-2-like-2 protein.'),
(5436, 'hsa-mir-125a-5p', 'hepatocellular carcinoma', 'up', 'Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.'),
(5437, 'hsa-mir-125b-5p', 'hepatocellular carcinoma', 'down', 'miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.'),
(5438, 'hsa-mir-1291', 'hepatocellular carcinoma', 'up', 'Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.'),
(5439, 'hsa-mir-1323', 'hepatocellular carcinoma', 'up', 'LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma.'),
(5440, 'hsa-mir-135b', 'hepatocellular carcinoma', 'up', 'GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b.'),
(5441, 'hsa-mir-139', 'hepatocellular carcinoma', 'down', 'MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.'),
(5442, 'hsa-mir-139', 'hepatocellular carcinoma', 'down', 'MicroRNA-139 suppresses hepatocellular carcinoma cell proliferation and migration by directly targeting Topoisomerase I.'),
(5443, 'hsa-mir-139-5p', 'hepatocellular carcinoma', 'down', 'Up-regulation of SNHG6 activates SERPINH1 expression by competitive binding to miR-139-5p to promote hepatocellular carcinoma progression.'),
(5444, 'hsa-mir-141-3p', 'hepatocellular carcinoma', 'down', 'Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.'),
(5445, 'hsa-mir-142-3p', 'hepatocellular carcinoma', 'down', 'MALAT1 functions as a competing endogenous RNA to regulate SMAD5 expression by acting as a sponge for miR-142-3p in hepatocellular carcinoma.'),
(5446, 'hsa-mir-143', 'hepatocellular carcinoma', 'down', 'Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.'),
(5447, 'hsa-mir-144', 'hepatocellular carcinoma', 'down', 'MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1.'),
(5448, 'hsa-mir-145', 'hepatocellular carcinoma', 'down', 'MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-?B signaling pathway.'),
(5449, 'hsa-mir-145-5p', 'hepatocellular carcinoma', 'down', 'miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18.'),
(5450, 'hsa-mir-148a', 'hepatocellular carcinoma', 'down', 'Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma.'),
(5451, 'hsa-mir-152-3p', 'hepatocellular carcinoma', 'down', 'miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8.'),
(5452, 'hsa-mir-182-5p', 'hepatocellular carcinoma', 'up', 'LINC01018 confers a novel tumor suppressor role in hepatocellular carcinoma through sponging microRNA-182-5p.'),
(5453, 'hsa-mir-185-5p', 'hepatocellular carcinoma', 'down', 'miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma.'),
(5454, 'hsa-mir-186', 'hepatocellular carcinoma', 'down', 'miR-186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1-mediated Wnt/?-catenin signaling.'),
(5455, 'hsa-mir-187-3p', 'hepatocellular carcinoma', 'down', 'MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells.'),
(5456, 'hsa-mir-191', 'hepatocellular carcinoma', 'up', 'MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.'),
(5457, 'hsa-mir-192', 'hepatocellular carcinoma', 'down', 'miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.'),
(5458, 'hsa-mir-194', 'hepatocellular carcinoma', 'down', 'MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/?-catenin signaling pathway.'),
(5459, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'Clinical significance of miR-195 in hepatocellular carcinoma and its biological function in tumor progression.'),
(5460, 'hsa-mir-195', 'hepatocellular carcinoma', 'down', 'Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.'),
(5461, 'hsa-mir-197-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma.'),
(5462, 'hsa-mir-200c', 'hepatocellular carcinoma', 'down', 'MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.'),
(5463, 'hsa-mir-204', 'hepatocellular carcinoma', 'down', 'MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.'),
(5464, 'hsa-mir-2053', 'hepatocellular carcinoma', 'down', 'MicroRNA-2053 overexpression inhibits the development and progression of hepatocellular carcinoma.'),
(5465, 'hsa-mir-206', 'hepatocellular carcinoma', 'down', 'MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression.'),
(5466, 'hsa-mir-206', 'hepatocellular carcinoma', 'down', 'miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.'),
(5467, 'hsa-mir-20b', 'hepatocellular carcinoma', 'up', 'MicroRNA-20b promotes proliferation of H22 hepatocellular carcinoma cells by targeting PTEN.'),
(5468, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.'),
(5469, 'hsa-mir-21', 'hepatocellular carcinoma', 'up', 'Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation.'),
(5470, 'hsa-mir-212-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression.'),
(5471, 'hsa-mir-214', 'hepatocellular carcinoma', 'down', 'MicroRNA-214 suppresses cell proliferation and migration and cell metabolism by targeting PDK2 and PHF6 in hepatocellular carcinoma.'),
(5472, 'hsa-mir-215', 'hepatocellular carcinoma', 'down', 'Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.'),
(5473, 'hsa-mir-215', 'hepatocellular carcinoma', 'up', 'Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carc'),
(5474, 'hsa-mir-219-5p', 'hepatocellular carcinoma', 'down', 'Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/?-catenin signalling activation.'),
(5475, 'hsa-mir-22-3p', 'hepatocellular carcinoma', 'down', 'Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.'),
(5476, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.'),
(5477, 'hsa-mir-221-3p', 'hepatocellular carcinoma', 'up', 'Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.'),
(5478, 'hsa-mir-221-3p', 'hepatocellular carcinoma', 'up', 'C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.'),
(5479, 'hsa-mir-26a', 'hepatocellular carcinoma', 'up', 'miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.'),
(5480, 'hsa-mir-26b-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma.'),
(5481, 'hsa-mir-29a-3p', 'hepatocellular carcinoma', 'down', 'XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.'),
(5482, 'hsa-mir-29c-3p', 'hepatocellular carcinoma', 'down', 'miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.'),
(5483, 'hsa-mir-301b-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.'),
(5484, 'hsa-mir-302a', 'hepatocellular carcinoma', 'down', 'miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.'),
(5485, 'hsa-mir-339', 'hepatocellular carcinoma', 'down', 'MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689.'),
(5486, 'hsa-mir-342', 'hepatocellular carcinoma', 'down', 'MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/?-catenin signaling pathway.'),
(5487, 'hsa-mir-34a', 'hepatocellular carcinoma', 'down', 'miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma.'),
(5488, 'hsa-mir-3650', 'hepatocellular carcinoma', 'down', 'Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma.'),
(5489, 'hsa-mir-3691-5p', 'hepatocellular carcinoma', 'up', 'miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.'),
(5490, 'hsa-mir-371', 'hepatocellular carcinoma', 'up', 'MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN.'),
(5491, 'hsa-mir-423-5p', 'hepatocellular carcinoma', 'up', 'Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.'),
(5492, 'hsa-mir-424-5p', 'hepatocellular carcinoma', 'down', 'MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.'),
(5493, 'hsa-mir-431-5p', 'hepatocellular carcinoma', 'down', 'miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells.'),
(5494, 'hsa-mir-450b-3p', 'hepatocellular carcinoma', 'down', 'MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.'),
(5495, 'hsa-mir-451a', 'hepatocellular carcinoma', 'down', 'MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.'),
(5496, 'hsa-mir-454-3p', 'hepatocellular carcinoma', 'up', 'High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma.'),
(5497, 'hsa-mir-466', 'hepatocellular carcinoma', 'down', 'MicroRNA-466 inhibits cancer cell migration and invasion in hepatocellular carcinoma by indirectly mediating the downregulation of ROCK2.'),
(5498, 'hsa-mir-497-5p', 'hepatocellular carcinoma', 'down', 'MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1.'),
(5499, 'hsa-mir-497-5p', 'hepatocellular carcinoma', 'up', 'lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4.'),
(5500, 'hsa-mir-501', 'hepatocellular carcinoma', 'up', 'miR-501 acts as an independent prognostic factor that promotes the epithelial-mesenchymal transition through targeting JDP2 in hepatocellular carcinoma.'),
(5501, 'hsa-mir-505', 'hepatocellular carcinoma', 'down', 'MiR-505 suppressed the growth of hepatocellular carcinoma cells via targeting IGF-1R.'),
(5502, 'hsa-mir-511', 'hepatocellular carcinoma', 'down', 'circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.'),
(5503, 'hsa-mir-519c-3p', 'hepatocellular carcinoma', 'up', 'MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.'),
(5504, 'hsa-mir-548b-3p', 'hepatocellular carcinoma', 'down', 'miR-548b-3p Regulates Proliferation, Apoptosis, and Mitochondrial Function by Targeting CIP2A in Hepatocellular Carcinoma.'),
(5505, 'hsa-mir-552', 'hepatocellular carcinoma', 'up', 'MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.'),
(5506, 'hsa-mir-5692a', 'hepatocellular carcinoma', 'up', 'MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma.'),
(5507, 'hsa-mir-591', 'hepatocellular carcinoma', 'down', 'MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt'),
(5508, 'hsa-mir-613', 'hepatocellular carcinoma', 'down', 'miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.'),
(5509, 'hsa-mir-620', 'hepatocellular carcinoma', 'up', 'Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.'),
(5510, 'hsa-mir-623', 'hepatocellular carcinoma', 'down', 'Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.'),
(5511, 'hsa-mir-629-5p', 'hepatocellular carcinoma', 'up', 'miR-629-5p promotes growth and metastasis of hepatocellular carcinoma by activating ?-catenin.'),
(5512, 'hsa-mir-637', 'hepatocellular carcinoma', 'up', 'MiR-637 inhibits proliferation and invasion of hepatoma cells by targeted degradation of AKT1.'),
(5513, 'hsa-mir-664', 'hepatocellular carcinoma', 'up', 'Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma.'),
(5514, 'hsa-mir-708', 'hepatocellular carcinoma', 'down', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(5515, 'hsa-mir-873', 'hepatocellular carcinoma', 'up', 'The miR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT/mTOR-mediated Warburg effect.'),
(5516, 'hsa-mir-888', 'hepatocellular carcinoma', 'up', 'MiR-888 promotes cell migration and invasion of hepatocellular carcinoma by targeting SMAD4.'),
(5517, 'hsa-mir-9-3p', 'hepatocellular carcinoma', 'down', 'LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values.'),
(5518, 'hsa-mir-944', 'hepatocellular carcinoma', 'down', 'microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.'),
(5519, 'hsa-mir-99b-3p', 'hepatocellular carcinoma', 'up', 'miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19.'),
(5520, 'hsa-mir-221', 'hepatocellular carcinoma', 'up', 'miR-221&amp;222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(5521, 'hsa-mir-222', 'hepatocellular carcinoma', 'up', 'miR-221&amp;222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(5522, 'hsa-mir-451', 'hepatocellular carcinoma', 'down', 'MicroRNA-451 regulates activating transcription factor???2 expression and inhibits liver cancer cell migration.'),
(5523, 'hsa-mir-24-3p', 'Hodgkin\'s lymphoma', 'up', 'miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.'),
(5524, 'hsa-mir-203', 'hypopharyngeal cancer', 'up', 'Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma.'),
(5525, 'hsa-mir-192', 'hypopharyngeal cancer', 'up', 'NF-?B inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.'),
(5526, 'hsa-mir-451a', 'hypopharyngeal cancer', 'down', 'NF-?B inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells.'),
(5527, 'hsa-mir-140-5p', 'hypopharyngeal carcinoma', 'down', '[miR-140-5p affects the migration and invasion of hypopharyngeal carcinoma cells by downregulating ADAM10 expression].'),
(5528, 'hsa-mir-21', 'hypopharyngeal squamous cell carcinom', 'up', 'Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.'),
(5529, 'hsa-mir-451a', 'hypopharyngeal squamous cell carcinom', 'down', 'Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.'),
(5530, 'hsa-mir-504', 'hypopharyngeal squamous cell carcinom', 'down', 'microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.'),
(5531, 'hsa-mir-504', 'hypopharyngeal squamous cell carcinom', 'down', 'Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.'),
(5532, 'hsa-mir-140-5p', 'hypopharyngeal squamous cell carcinom', 'down', 'MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.'),
(5533, 'hsa-mir-145', 'intrahepatic cholangiocarcinoma', 'down', 'MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma.'),
(5534, 'hsa-mir-204', 'intrahepatic cholangiocarcinoma', 'down', 'miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.'),
(5535, 'hsa-mir-31', 'intrahepatic cholangiocarcinoma', 'up', 'miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.'),
(5536, 'hsa-mir-150', 'intrahepatic cholangiocarcinoma', 'down', 'Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.'),
(5537, 'hsa-mir-191', 'intrahepatic cholangiocarcinoma', 'up', 'MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.'),
(5538, 'hsa-mir-26b-5p', 'intrahepatic cholangiocarcinoma', 'down', 'MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.'),
(5539, 'hsa-mir-142-5p', 'intrahepatic cholangiocarcinoma', 'up', 'Enhanced plasma miR-142-5p promotes the progression of intrahepatic cholangiocarcinoma via targeting PTEN.'),
(5540, 'hsa-mir-424-5p', 'intrahepatic cholangiocarcinoma', 'down', 'miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.'),
(5541, 'hsa-mir-671-5p', 'invasive ductal carcinoma', 'down', 'miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.'),
(5542, 'hsa-mir-1', 'kidney cancer', 'down', 'MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.'),
(5543, 'hsa-mir-145', 'kidney cancer', 'down', 'MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients.'),
(5544, 'hsa-mir-1826', 'kidney cancer', 'down', 'MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.'),
(5545, 'hsa-mir-183', 'kidney cancer', 'up', 'microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells.'),
(5546, 'hsa-mir-199a', 'kidney cancer', 'down', 'Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3?.'),
(5547, 'hsa-mir-199a-3p', 'kidney cancer', 'down', 'miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.'),
(5548, 'hsa-mir-203', 'kidney cancer', 'down', 'miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.'),
(5549, 'hsa-mir-205', 'kidney cancer', 'down', 'MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.'),
(5550, 'hsa-mir-21', 'kidney cancer', 'up', 'miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.'),
(5551, 'hsa-mir-210', 'kidney cancer', 'up', 'miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.'),
(5552, 'hsa-mir-223', 'kidney cancer', 'up', '[Expression of miR-223 in clear cell renal cell carcinoma and its significance].'),
(5553, 'hsa-mir-497', 'kidney cancer', 'down', 'Down-regulation of miR-497 is associated with poor prognosis in renal cancer.'),
(5554, 'hsa-mir-508-3p', 'kidney cancer', 'down', 'Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.'),
(5555, 'hsa-mir-509-3p', 'kidney cancer', 'down', 'Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.'),
(5556, 'hsa-mir-22', 'kidney cancer', 'down', 'MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.'),
(5557, 'hsa-mir-630', 'kidney cancer', 'up', 'miR-630 functions as a tumor oncogene in renal cell carcinoma.'),
(5558, 'hsa-mir-148a', 'kidney cancer', 'down', 'miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells.'),
(5559, 'hsa-mir-211-5p', 'kidney cancer', 'down', 'miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer.'),
(5560, 'hsa-mir-200c', 'kidney cancer', 'down', 'MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells.'),
(5561, 'hsa-mir-375', 'kidney cancer', 'down', 'MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression.'),
(5562, 'hsa-mir-532-5p', 'kidney cancer', 'down', 'MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.'),
(5563, 'hsa-mir-23a', 'laryngeal cancer', 'up', 'High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.'),
(5564, 'hsa-mir-200c', 'laryngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(5565, 'hsa-mir-21', 'laryngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(5566, 'hsa-mir-34a', 'laryngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(5567, 'hsa-mir-375', 'laryngeal cancer', 'down', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(5568, 'hsa-mir-139-3p', 'laryngeal cancer', 'down', 'New miRNA expression abnormalities in laryngeal squamous cell carcinoma.'),
(5569, 'hsa-mir-21-3p', 'laryngeal cancer', 'up', 'New miRNA expression abnormalities in laryngeal squamous cell carcinoma.'),
(5570, 'hsa-mir-525-5p', 'laryngeal cancer', 'up', 'New miRNA expression abnormalities in laryngeal squamous cell carcinoma.'),
(5571, 'hsa-mir-885-5p', 'laryngeal cancer', 'down', 'New miRNA expression abnormalities in laryngeal squamous cell carcinoma.'),
(5572, 'hsa-mir-196a', 'laryngeal cancer', 'up', 'Upregulation of MiR-196a promotes cell proliferation by downregulating p27(kip1) in laryngeal cancer.'),
(5573, 'hsa-mir-217', 'laryngeal cancer', 'down', 'miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.'),
(5574, 'hsa-mir-632', 'laryngeal cancer', 'up', 'MiR-632 promotes laryngeal carcinoma cell proliferation, migration and invasion through negative regulation of GSK3?.'),
(5575, 'hsa-mir-93', 'laryngeal cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(5576, 'hsa-let-7a', 'laryngeal cancer', 'down', '[Diagnostic value of serum miRNA let-7a for laryngeal carcinoma and effects of let-7a on proliferation and apoptosis of laryngeal carcinoma cells].'),
(5577, 'hsa-mir-181a', 'laryngeal cancer', 'down', 'MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.'),
(5578, 'hsa-mir-106b', 'laryngeal carcinoma', 'up', 'MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.'),
(5579, 'hsa-mir-106b', 'laryngeal carcinoma', 'up', 'MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells.'),
(5580, 'hsa-mir-16', 'laryngeal carcinoma', 'up', 'MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.'),
(5581, 'hsa-mir-21', 'laryngeal carcinoma', 'up', 'Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.'),
(5582, 'hsa-mir-27a', 'laryngeal carcinoma', 'up', 'MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma.'),
(5583, 'hsa-mir-423-3p', 'laryngeal carcinoma', 'up', 'microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.'),
(5584, 'hsa-mir-205', 'laryngeal carcinoma', 'up', '[Effect of microRNA-205 on proliferation of laryngeal carcinoma cell line Hep-2].'),
(5585, 'hsa-mir-23a', 'laryngeal carcinoma', 'up', 'Upregulation of microRNA-23a regulates proliferation and apoptosis by targeting APAF-1 in laryngeal carcinoma.'),
(5586, 'hsa-mir-34a', 'laryngeal carcinoma', 'down', 'Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.'),
(5587, 'hsa-mir-125a', 'laryngeal carcinoma', 'down', 'Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.'),
(5588, 'hsa-mir-195', 'laryngeal carcinoma', 'down', 'Expression of miR-195 in laryngeal squamous cell carcinoma and its effect on proliferation and apoptosis of Hep-2.'),
(5589, 'hsa-mir-26b', 'laryngeal carcinoma', 'up', 'Downregulation of miRNA-26b inhibits cancer proliferation of laryngeal carcinoma through autophagy by targeting ULK2 and inactivation of the PTEN/AKT pathway.'),
(5590, 'hsa-mir-503', 'laryngeal carcinoma', 'down', 'MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.'),
(5591, 'hsa-mir-138', 'laryngeal carcinoma', 'down', 'MicroRNA-138 inhibits proliferation and induces apoptosis of laryngeal carcinoma via targeting MAPK6.'),
(5592, 'hsa-mir-379', 'laryngeal carcinoma', 'down', 'MicroRNA-379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF-4.'),
(5593, 'hsa-mir-129-5p', 'laryngeal squamous cell carcinoma', 'down', 'Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC.'),
(5594, 'hsa-mir-203', 'laryngeal squamous cell carcinoma', 'down', 'MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.'),
(5595, 'hsa-mir-205', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.'),
(5596, 'hsa-mir-206', 'laryngeal squamous cell carcinoma', 'down', 'Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.'),
(5597, 'hsa-mir-21', 'laryngeal squamous cell carcinoma', 'up', 'Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma.'),
(5598, 'hsa-mir-21', 'laryngeal squamous cell carcinoma', 'up', 'Altered Expression of miR-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.'),
(5599, 'hsa-mir-24', 'laryngeal squamous cell carcinoma', 'down', 'miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.'),
(5600, 'hsa-mir-370', 'laryngeal squamous cell carcinoma', 'down', 'miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).'),
(5601, 'hsa-mir-375', 'laryngeal squamous cell carcinoma', 'down', 'miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma.'),
(5602, 'hsa-mir-9', 'laryngeal squamous cell carcinoma', 'up', 'MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.'),
(5603, 'hsa-mir-93', 'laryngeal squamous cell carcinoma', 'up', 'MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma.'),
(5604, 'hsa-mir-101', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.'),
(5605, 'hsa-mir-206', 'laryngeal squamous cell carcinoma', 'down', 'miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2.'),
(5606, 'hsa-mir-205', 'laryngeal squamous cell carcinoma', 'up', 'miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.'),
(5607, 'hsa-mir-155', 'laryngeal squamous cell carcinoma', 'up', 'The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.'),
(5608, 'hsa-mir-19a', 'laryngeal squamous cell carcinoma', 'up', 'MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.'),
(5609, 'hsa-mir-301a-3p', 'laryngeal squamous cell carcinoma', 'up', 'Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4.'),
(5610, 'hsa-mir-365a-3p', 'laryngeal squamous cell carcinoma', 'up', 'MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.'),
(5611, 'hsa-mir-153', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5.'),
(5612, 'hsa-mir-144', 'laryngeal squamous cell carcinoma', 'down', 'miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.'),
(5613, 'hsa-mir-148a', 'laryngeal squamous cell carcinoma', 'up', 'miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.'),
(5614, 'hsa-mir-203', 'laryngeal squamous cell carcinoma', 'down', 'miR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2.'),
(5615, 'hsa-mir-21', 'laryngeal squamous cell carcinoma', 'up', 'MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features.'),
(5616, 'hsa-mir-375', 'laryngeal squamous cell carcinoma', 'up', 'miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.'),
(5617, 'hsa-mir-300', 'laryngeal squamous cell carcinoma', 'down', 'MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1.'),
(5618, 'hsa-mir-194', 'laryngeal squamous cell carcinoma', 'down', 'MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1.'),
(5619, 'hsa-mir-300', 'laryngeal squamous cell carcinoma', 'up', 'Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.'),
(5620, 'hsa-mir-221', 'laryngeal squamous cell carcinoma', 'up', 'Up-regulated miR-221 expression as a molecular diagnostic marker in laryngeal squamous cell carcinoma and its correlation with Apaf-1 expression.'),
(5621, 'hsa-mir-138', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.'),
(5622, 'hsa-mir-195', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.'),
(5623, 'hsa-mir-218', 'laryngeal squamous cell carcinoma', 'down', 'Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer.'),
(5624, 'hsa-mir-125a', 'laryngeal squamous cell carcinoma', 'down', 'miR-125a suppresses viability and glycolysis and induces apoptosis by targeting Hexokinase 2 in laryngeal squamous cell carcinoma.'),
(5625, 'hsa-mir-21-5p', 'laryngeal squamous cell carcinoma', 'up', 'Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.'),
(5626, 'hsa-mir-26a', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.'),
(5627, 'hsa-mir-613', 'laryngeal squamous cell carcinoma', 'down', 'MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.'),
(5628, 'hsa-mir-155', 'laryngeal squamous cell carcinoma', 'up', 'YB-1 promotes laryngeal squamous cell carcinoma progression by inducing miR-155 expression via c-Myb.'),
(5629, 'hsa-mir-181a', 'laryngeal squamous cell carcinoma', 'down', 'miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(5630, 'hsa-mir-125b-5p', 'laryngeal squamous cell carcinoma', 'down', 'MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.'),
(5631, 'hsa-mir-145', 'laryngeal squamous cell carcinoma', 'down', 'MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma.'),
(5632, 'hsa-mir-145', 'laryngeal squamous cell carcinoma', 'down', 'Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.'),
(5633, 'hsa-mir-31', 'laryngeal squamous cell carcinoma', 'down', 'Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.'),
(5634, 'hsa-mir-4497', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.'),
(5635, 'hsa-mir-7', 'laryngeal squamous cell carcinoma', 'up', 'CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour\'s progression via miR-7 signals.'),
(5636, 'hsa-mir-143-3p', 'laryngeal squamous cell carcinoma', 'down', 'MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma.'),
(5637, 'hsa-mir-145', 'laryngeal squamous cell carcinoma', 'down', 'Long noncoding RNA LINC00339 promotes laryngeal squamous cell carcinoma cell proliferation and invasion via sponging miR-145.'),
(5638, 'hsa-mir-145-5p', 'laryngeal squamous cell carcinoma', 'down', 'Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.'),
(5639, 'hsa-mir-153', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-153 suppresses human laryngeal squamous cell carcinoma migration and invasion by targeting the SNAI1 gene.'),
(5640, 'hsa-mir-625', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.'),
(5641, 'hsa-mir-101', 'laryngeal squamous cell carcinoma', 'down', 'MicroRNA-101 regulates autophagy, proliferation and apoptosis via targeting EZH2 in laryngeal squamous cell carcinoma.'),
(5642, 'hsa-mir-320a', 'leiomyosarcoma', 'up', 'Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.'),
(5643, 'hsa-mir-101', 'liver cancer', 'down', 'MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer.'),
(5644, 'hsa-mir-122', 'liver cancer', 'down', 'MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.'),
(5645, 'hsa-mir-1301', 'liver cancer', 'up', 'Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.'),
(5646, 'hsa-mir-132', 'liver cancer', 'down', 'Effects of MicroRNA-132 Transfection on the Proliferation and Apoptosis of Human Liver Cancer Cells in vitro and in vivo.'),
(5647, 'hsa-mir-140-5p', 'liver cancer', 'down', 'MicroRNA-140-5p suppresses tumor growth and metastasis by targeting TGFBR1 and FGF9 in hepatocellular carcinoma.'),
(5648, 'hsa-mir-145', 'liver cancer', 'down', 'MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer.'),
(5649, 'hsa-mir-148b', 'liver cancer', 'down', 'microRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.'),
(5650, 'hsa-mir-155', 'liver cancer', 'up', 'TGF-?1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.'),
(5651, 'hsa-mir-21', 'liver cancer', 'up', 'microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.'),
(5652, 'hsa-mir-221', 'liver cancer', 'up', 'Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.'),
(5653, 'hsa-mir-27a', 'liver cancer', 'up', 'Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals.'),
(5654, 'hsa-mir-31', 'liver cancer', 'down', 'MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.'),
(5655, 'hsa-mir-338-3p', 'liver cancer', 'down', 'miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.'),
(5656, 'hsa-mir-433', 'liver cancer', 'down', 'The microRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element binding protein.'),
(5657, 'hsa-mir-525-3p', 'liver cancer', 'up', 'MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395.'),
(5658, 'hsa-mir-22', 'liver cancer', 'down', 'microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.'),
(5659, 'hsa-mir-30a-5p', 'liver cancer', 'down', 'Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.'),
(5660, 'hsa-mir-449a', 'liver cancer', 'down', 'miR-449a promotes liver cancer cell apoptosis by down-regulation of Calpain6 and POU2F1.'),
(5661, 'hsa-mir-506', 'liver cancer', 'down', 'MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.'),
(5662, 'hsa-mir-30e', 'liver cancer', 'down', 'MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.'),
(5663, 'hsa-mir-370', 'liver cancer', 'down', 'MiR-370 promotes cell death of liver cancer cells by Akt/FoxO3a signalling pathway.'),
(5664, 'hsa-mir-935', 'liver cancer', 'up', 'MiR-935 promotes liver cancer cell proliferation and migration by targeting SOX7.'),
(5665, 'hsa-mir-1297', 'liver cancer', 'up', 'miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer.'),
(5666, 'hsa-mir-32', 'liver cancer', 'up', 'Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression By MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells.'),
(5667, 'hsa-mir-196a', 'liver cancer', 'up', 'Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1.'),
(5668, 'hsa-mir-203', 'liver cancer', 'down', 'MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling.'),
(5669, 'hsa-mir-221', 'liver cancer', 'up', 'Expression and prognostic significance of miR-375 and miR-221 in liver cancer.'),
(5670, 'hsa-mir-346', 'liver cancer', 'up', 'miRNA-346 promotes proliferation, migration and invasion in liver cancer.'),
(5671, 'hsa-mir-126', 'liver cancer', 'down', 'Experimental study on the prevention of liver cancer angiogenesis via miR-126.'),
(5672, 'hsa-mir-124a', 'liver cancer', 'down', 'MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.'),
(5673, 'hsa-mir-193b', 'liver cancer', 'down', 'Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1.'),
(5674, 'hsa-mir-493-5p', 'liver cancer', 'down', 'MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.'),
(5675, 'hsa-mir-10a-5p', 'liver cancer', 'down', 'Hsa-miR-10a-5p downregulation in mutant UQCRB-expressing cells promotes the cholesterol biosynthesis pathway.'),
(5676, 'hsa-mir-21', 'liver cancer', 'up', 'Suppression of miR-21 Expression Inhibits Cell Proliferation and Migration of Liver Cancer Cells by Targeting Phosphatase and Tensin Homolog (PTEN).'),
(5677, 'hsa-mir-217', 'liver cancer', 'down', 'HOTAIR contributes to the growth of liver cancer via targeting miR-217.'),
(5678, 'hsa-mir-374b', 'liver cancer', 'down', 'MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.'),
(5679, 'hsa-mir-375', 'liver cancer', 'down', 'Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2.'),
(5680, 'hsa-mir-544', 'liver cancer', 'up', 'MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer.'),
(5681, 'hsa-mir-34a', 'liver cancer', 'down', 'MicroRNA-34a inhibits metastasis in liver cancer cells.'),
(5682, 'hsa-mir-194', 'liver cancer', 'down', 'miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.'),
(5683, 'hsa-mir-21-3p', 'liver cancer', 'up', 'Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K/Akt/Bad cascade via regulating PTEN.'),
(5684, 'hsa-mir-330-3p', 'liver cancer', 'down', 'miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1.'),
(5685, 'hsa-mir-424-5p', 'liver cancer', 'down', 'miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.'),
(5686, 'hsa-mir-543', 'liver cancer', 'down', 'MicroRNA-543 suppresses liver cancer growth and induces apoptosis via the JAK2/STAT3 signaling pathway.'),
(5687, 'hsa-mir-590-5p', 'liver cancer', 'up', 'miR-590-5p promotes liver cancer growth and chemotherapy resistance through directly targeting FOXO1.'),
(5688, 'hsa-mir-99a', 'liver cancer', 'down', 'miRNA-99a inhibits cell invasion and migration in liver cancer by directly targeting HOXA1.'),
(5689, 'hsa-mir-1297', 'lung adenocarcinoma', 'down', 'miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.'),
(5690, 'hsa-mir-141', 'lung adenocarcinoma', 'down', 'miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.'),
(5691, 'hsa-mir-145', 'lung adenocarcinoma', 'down', 'Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.'),
(5692, 'hsa-mir-145', 'lung adenocarcinoma', 'down', 'MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1.'),
(5693, 'hsa-mir-145', 'lung adenocarcinoma', 'down', 'microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.'),
(5694, 'hsa-mir-145', 'lung adenocarcinoma', 'down', '[miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene].'),
(5695, 'hsa-mir-145', 'lung adenocarcinoma', 'down', 'MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.'),
(5696, 'hsa-mir-150', 'lung adenocarcinoma', 'up', 'Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.'),
(5697, 'hsa-mir-155', 'lung adenocarcinoma', 'up', 'Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients.'),
(5698, 'hsa-mir-16', 'lung adenocarcinoma', 'down', 'Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.'),
(5699, 'hsa-mir-200a', 'lung adenocarcinoma', 'down', 'miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.'),
(5700, 'hsa-mir-200b', 'lung adenocarcinoma', 'down', 'miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.'),
(5701, 'hsa-mir-200c', 'lung adenocarcinoma', 'down', 'miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.'),
(5702, 'hsa-mir-29b', 'lung adenocarcinoma', 'down', 'MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.'),
(5703, 'hsa-mir-31', 'lung adenocarcinoma', 'up', 'MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma.'),
(5704, 'hsa-mir-381', 'lung adenocarcinoma', 'down', 'MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma.'),
(5705, 'hsa-mir-409-3p', 'lung adenocarcinoma', 'down', 'MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.'),
(5706, 'hsa-mir-429', 'lung adenocarcinoma', 'down', 'miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.'),
(5707, 'hsa-mir-451', 'lung adenocarcinoma', 'down', 'Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.'),
(5708, 'hsa-mir-511', 'lung adenocarcinoma', 'down', 'miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.'),
(5709, 'hsa-mir-99a', 'lung adenocarcinoma', 'down', 'Clinic significance of microRNA-99a expression in human lung adenocarcinoma.'),
(5710, 'hsa-mir-31', 'lung adenocarcinoma', 'down', 'MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.'),
(5711, 'hsa-mir-214', 'lung adenocarcinoma', 'up', 'microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).'),
(5712, 'hsa-mir-33b', 'lung adenocarcinoma', 'down', 'MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/?-catenin/ZEB1 signaling.'),
(5713, 'hsa-mir-124', 'lung adenocarcinoma', 'down', 'miR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.'),
(5714, 'hsa-mir-30a', 'lung adenocarcinoma', 'down', 'Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.'),
(5715, 'hsa-mir-31', 'lung adenocarcinoma', 'up', 'MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.'),
(5716, 'hsa-mir-432', 'lung adenocarcinoma', 'down', 'MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.'),
(5717, 'hsa-mir-99a', 'lung adenocarcinoma', 'down', 'miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.'),
(5718, 'hsa-mir-374a', 'lung adenocarcinoma', 'down', 'MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.'),
(5719, 'hsa-mir-485', 'lung adenocarcinoma', 'down', 'MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2.'),
(5720, 'hsa-mir-206', 'lung adenocarcinoma', 'down', 'MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET.'),
(5721, 'hsa-mir-297', 'lung adenocarcinoma', 'up', 'miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma.'),
(5722, 'hsa-mir-203', 'lung adenocarcinoma', 'down', 'Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance.'),
(5723, 'hsa-mir-623', 'lung adenocarcinoma', 'down', 'Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.'),
(5724, 'hsa-mir-145', 'lung adenocarcinoma', 'down', 'MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.'),
(5725, 'hsa-mir-29c', 'lung adenocarcinoma', 'down', 'MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.'),
(5726, 'hsa-mir-133a-1', 'lung adenocarcinoma', 'down', 'miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.'),
(5727, 'hsa-mir-133a-2', 'lung adenocarcinoma', 'down', 'miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.'),
(5728, 'hsa-mir-133b', 'lung adenocarcinoma', 'down', 'miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2.'),
(5729, 'hsa-mir-363-3p', 'lung adenocarcinoma', 'down', 'miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.'),
(5730, 'hsa-mir-501-5p', 'lung adenocarcinoma', 'up', '[Expression profile of miR-501-5p in lung adenocarcinoma patients from Xuanwei area].'),
(5731, 'hsa-mir-519d', 'lung adenocarcinoma', 'down', 'Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.'),
(5732, 'hsa-mir-1236-3p', 'lung adenocarcinoma', 'down', 'miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549?cells.'),
(5733, 'hsa-mir-125a-5p', 'lung adenocarcinoma', 'down', 'miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9.'),
(5734, 'hsa-mir-141', 'lung adenocarcinoma', 'down', 'HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.'),
(5735, 'hsa-mir-218', 'lung adenocarcinoma', 'down', 'miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells.'),
(5736, 'hsa-mir-30e-5p', 'lung adenocarcinoma', 'up', 'MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma.'),
(5737, 'hsa-mir-3607', 'lung adenocarcinoma', 'up', 'Upregulation of miR-3607 promotes lung adenocarcinoma proliferation by suppressing APC expression.'),
(5738, 'hsa-mir-96', 'lung adenocarcinoma', 'up', 'Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.'),
(5739, 'hsa-mir-1236-3p', 'lung adenocarcinoma', 'down', 'miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells.'),
(5740, 'hsa-mir-135b', 'lung adenocarcinoma', 'up', 'Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.'),
(5741, 'hsa-mir-767-3p', 'lung adenocarcinoma', 'down', 'miR-767-3p inhibits growth and migration of lung adenocarcinoma cells by regulating CLDN18.'),
(5742, 'hsa-mir-136-5p', 'lung adenocarcinoma', 'up', 'Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.'),
(5743, 'hsa-mir-204', 'lung adenocarcinoma', 'down', 'MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 path'),
(5744, 'hsa-mir-373-3p', 'lung adenocarcinoma', 'up', 'miR-373-3p promotes lung adenocarcinoma cell proliferation via APP.'),
(5745, 'hsa-mir-1290', 'lung adenocarcinoma', 'up', 'miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4.'),
(5746, 'hsa-mir-206', 'lung adenocarcinoma', 'down', 'MicroRNA-206 suppresses TGF-? signalling to limit tumor growth and metastasis in lung adenocarcinoma.'),
(5747, 'hsa-mir-214', 'lung adenocarcinoma', 'up', 'TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.'),
(5748, 'hsa-mir-216b-3p', 'lung adenocarcinoma', 'down', 'MicroRNA-216b-3p inhibits lung adenocarcinoma cell growth via regulating PDZ binding kinase/T-LAK-cell-originated protein kinase.'),
(5749, 'hsa-mir-24-3p', 'lung adenocarcinoma', 'up', 'Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/ DEDD.'),
(5750, 'hsa-mir-365a-3p', 'lung adenocarcinoma', 'up', 'MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway.'),
(5751, 'hsa-mir-425', 'lung adenocarcinoma', 'down', 'MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9).'),
(5752, 'hsa-mir-623', 'lung adenocarcinoma', 'down', 'Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.'),
(5753, 'hsa-mir-148a', 'lung adenocarcinoma', 'down', 'MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.'),
(5754, 'hsa-mir-339-5p', 'lung adenocarcinoma', 'down', 'miR-339-5p inhibits lung adenocarcinoma invasion and migration by directly targeting BCL6.'),
(5755, 'hsa-mir-1-3p', 'lung adenocarcinoma', 'down', 'MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1.'),
(5756, 'hsa-mir-1205', 'lung adenocarcinoma', 'up', 'microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma.'),
(5757, 'hsa-mir-138-5p', 'lung adenocarcinoma', 'down', 'MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.'),
(5758, 'hsa-mir-142-3p', 'lung adenocarcinoma', 'down', 'MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma.'),
(5759, 'hsa-mir-195', 'lung adenocarcinoma', 'down', 'MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.'),
(5760, 'hsa-mir-204', 'lung adenocarcinoma', 'down', 'MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma.'),
(5761, 'hsa-mir-21-5p', 'lung adenocarcinoma', 'up', 'miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-I?.'),
(5762, 'hsa-mir-210', 'lung adenocarcinoma', 'up', 'miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4.'),
(5763, 'hsa-mir-363-3p', 'lung adenocarcinoma', 'down', 'miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer.'),
(5764, 'hsa-mir-499a-5p', 'lung adenocarcinoma', 'up', 'Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma.'),
(5765, 'hsa-mir-944', 'lung adenocarcinoma', 'down', 'miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting STAT1 interaction.'),
(5766, 'hsa-let-7a-1', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5767, 'hsa-let-7a-1', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5768, 'hsa-let-7a-1', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5769, 'hsa-let-7a-2', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5770, 'hsa-let-7a-2', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5771, 'hsa-let-7a-2', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5772, 'hsa-let-7a-3', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5773, 'hsa-let-7a-3', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5774, 'hsa-let-7a-3', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5775, 'hsa-let-7b', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5776, 'hsa-let-7b', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5777, 'hsa-let-7b', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5778, 'hsa-let-7c', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5779, 'hsa-let-7c', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5780, 'hsa-let-7c', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5781, 'hsa-let-7d', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5782, 'hsa-let-7d', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5783, 'hsa-let-7d', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5784, 'hsa-let-7e', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5785, 'hsa-let-7e', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5786, 'hsa-let-7e', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5787, 'hsa-let-7f-1', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5788, 'hsa-let-7f-1', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5789, 'hsa-let-7f-1', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5790, 'hsa-let-7f-2', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5791, 'hsa-let-7f-2', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5792, 'hsa-let-7f-2', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5793, 'hsa-let-7g', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5794, 'hsa-let-7g', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5795, 'hsa-let-7g', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5796, 'hsa-let-7i', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5797, 'hsa-let-7i', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5798, 'hsa-let-7i', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5799, 'hsa-mir-1', 'lung cancer', 'down', 'Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.'),
(5800, 'hsa-mir-101', 'lung cancer', 'down', 'microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2.'),
(5801, 'hsa-mir-10b', 'lung cancer', 'up', 'microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.'),
(5802, 'hsa-mir-133b', 'lung cancer', 'down', 'MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.'),
(5803, 'hsa-mir-135b', 'lung cancer', 'up', 'MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.'),
(5804, 'hsa-mir-138', 'lung cancer', 'down', 'Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.'),
(5805, 'hsa-mir-142-5p', 'lung cancer', 'down', 'Uncovering growth-suppressive MicroRNAs in lung cancer.'),
(5806, 'hsa-mir-144', 'lung cancer', 'down', 'MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR.'),
(5807, 'hsa-mir-145', 'lung cancer', 'down', 'Uncovering growth-suppressive MicroRNAs in lung cancer.'),
(5808, 'hsa-mir-145', 'lung cancer', 'down', 'MicroRNA-145 inhibits lung cancer cell metastasis.'),
(5809, 'hsa-mir-1469', 'lung cancer', 'down', 'MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.'),
(5810, 'hsa-mir-146a', 'lung cancer', 'down', 'Regulation of COX-2 expression by miR-146a in lung cancer cells.'),
(5811, 'hsa-mir-150', 'lung cancer', 'up', 'miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.'),
(5812, 'hsa-mir-153', 'lung cancer', 'down', 'Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.'),
(5813, 'hsa-mir-155', 'lung cancer', 'up', 'Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.'),
(5814, 'hsa-mir-155', 'lung cancer', 'up', 'Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells.'),
(5815, 'hsa-mir-155', 'lung cancer', 'up', 'MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression.'),
(5816, 'hsa-mir-15a', 'lung cancer', 'down', 'Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.'),
(5817, 'hsa-mir-15b', 'lung cancer', 'down', 'Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.'),
(5818, 'hsa-mir-16-1', 'lung cancer', 'down', 'Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.'),
(5819, 'hsa-mir-16-2', 'lung cancer', 'down', 'Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.'),
(5820, 'hsa-mir-17', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5821, 'hsa-mir-17', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5822, 'hsa-mir-17', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5823, 'hsa-mir-182', 'lung cancer', 'up', 'Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.'),
(5824, 'hsa-mir-182', 'lung cancer', 'up', 'Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells.'),
(5825, 'hsa-mir-182', 'lung cancer', 'down', '[Methylation Status of miR-182 Promoter in Lung Cancer Cell Lines].'),
(5826, 'hsa-mir-183-3p', 'lung cancer', 'up', 'Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.'),
(5827, 'hsa-mir-18a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5828, 'hsa-mir-18a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5829, 'hsa-mir-18a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5830, 'hsa-mir-192', 'lung cancer', 'down', 'MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells.'),
(5831, 'hsa-mir-193a-3p', 'lung cancer', 'down', 'miR-193a-3p functions as a tumor suppressor in lung cancer by downregulating ERBB4.'),
(5832, 'hsa-mir-194', 'lung cancer', 'down', 'miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1.)'),
(5833, 'hsa-mir-195', 'lung cancer', 'down', 'Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.'),
(5834, 'hsa-mir-195', 'lung cancer', 'down', 'MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.'),
(5835, 'hsa-mir-197', 'lung cancer', 'up', 'Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.'),
(5836, 'hsa-mir-198', 'lung cancer', 'down', 'MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1.'),
(5837, 'hsa-mir-19a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5838, 'hsa-mir-19a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5839, 'hsa-mir-19a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5840, 'hsa-mir-19b', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5841, 'hsa-mir-19b', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5842, 'hsa-mir-19b', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5843, 'hsa-mir-203', 'lung cancer', 'down', 'miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC.'),
(5844, 'hsa-mir-203', 'lung cancer', 'down', 'The expression and function of microRNA-203 in lung cancer.'),
(5845, 'hsa-mir-205', 'lung cancer', 'up', 'Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.'),
(5846, 'hsa-mir-205', 'lung cancer', 'up', 'miR-205 regulates A549 cells proliferation by targeting PTEN.'),
(5847, 'hsa-mir-20a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5848, 'hsa-mir-20a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5849, 'hsa-mir-20a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5850, 'hsa-mir-21', 'lung cancer', 'up', 'Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.'),
(5851, 'hsa-mir-21', 'lung cancer', 'up', 'Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia.'),
(5852, 'hsa-mir-21', 'lung cancer', 'up', 'Expression and significance of miRNA-21 and BTG2 in lung cancer.'),
(5853, 'hsa-mir-210', 'lung cancer', 'up', 'MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.'),
(5854, 'hsa-mir-217', 'lung cancer', 'down', 'MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.'),
(5855, 'hsa-mir-218', 'lung cancer', 'down', 'MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.'),
(5856, 'hsa-mir-218', 'lung cancer', 'down', 'MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.'),
(5857, 'hsa-mir-22', 'lung cancer', 'down', 'Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.'),
(5858, 'hsa-mir-223', 'lung cancer', 'down', 'miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2.'),
(5859, 'hsa-mir-24', 'lung cancer', 'up', 'Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.'),
(5860, 'hsa-mir-26a', 'lung cancer', 'down', 'MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.'),
(5861, 'hsa-mir-26b', 'lung cancer', 'down', 'MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis and Prognosis by Targeting CDC6 in Lung Cancer.'),
(5862, 'hsa-mir-29c', 'lung cancer', 'down', 'miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin ?1 and Matrix Metalloproteinase2 (MMP2).'),
(5863, 'hsa-mir-30d', 'lung cancer', 'up', 'Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients.'),
(5864, 'hsa-mir-33a', 'lung cancer', 'down', 'MicroRNA-33a inhibits lung cancer cell proliferation and invasion by regulating the expression of ?-catenin.'),
(5865, 'hsa-mir-34a', 'lung cancer', 'down', 'Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.'),
(5866, 'hsa-mir-34b', 'lung cancer', 'down', 'Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.'),
(5867, 'hsa-mir-34c', 'lung cancer', 'down', 'Uncovering growth-suppressive MicroRNAs in lung cancer.'),
(5868, 'hsa-mir-34c', 'lung cancer', 'down', 'Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.'),
(5869, 'hsa-mir-365', 'lung cancer', 'down', 'MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.'),
(5870, 'hsa-mir-4423', 'lung cancer', 'up', 'MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis.'),
(5871, 'hsa-mir-449a', 'lung cancer', 'down', 'Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.'),
(5872, 'hsa-mir-449a', 'lung cancer', 'down', 'MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1.'),
(5873, 'hsa-mir-449b', 'lung cancer', 'down', 'Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.'),
(5874, 'hsa-mir-486-5p', 'lung cancer', 'down', 'Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.'),
(5875, 'hsa-mir-5100', 'lung cancer', 'up', 'miR-5100 promotes tumor growth in lung cancer by targeting Rab6.'),
(5876, 'hsa-mir-545', 'lung cancer', 'down', 'MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells.'),
(5877, 'hsa-mir-570', 'lung cancer', 'up', 'MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.'),
(5878, 'hsa-mir-610', 'lung cancer', 'down', '[miR-610 suppresses lung cancer cell proliferation and invasion by targeting GJA3].'),
(5879, 'hsa-mir-614', 'lung cancer', 'down', '[MiR-614 Inhibited Lung Cancer Cell Invasion and Proliferation via Targeting PSA].'),
(5880, 'hsa-mir-630', 'lung cancer', 'down', 'MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.'),
(5881, 'hsa-mir-660', 'lung cancer', 'down', 'Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.'),
(5882, 'hsa-mir-663', 'lung cancer', 'up', 'MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation.'),
(5883, 'hsa-mir-7', 'lung cancer', 'up', 'EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.'),
(5884, 'hsa-mir-7515', 'lung cancer', 'down', 'The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met.'),
(5885, 'hsa-mir-92a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5886, 'hsa-mir-92a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5887, 'hsa-mir-92a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5888, 'hsa-mir-9500', 'lung cancer', 'down', 'The novel miR-9500 regulates the proliferation and migration of human lung cancer cells by targeting Akt1.'),
(5889, 'hsa-mir-98', 'lung cancer', 'down', 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.'),
(5890, 'hsa-mir-98', 'lung cancer', 'down', 'Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells.'),
(5891, 'hsa-mir-98', 'lung cancer', 'down', 'Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.'),
(5892, 'hsa-mir-99b', 'lung cancer', 'down', 'microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3.'),
(5893, 'mir-17', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5894, 'mir-17', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5895, 'mir-17', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5896, 'mir-18a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5897, 'mir-18a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5898, 'mir-18a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5899, 'mir-19a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5900, 'mir-19a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5901, 'mir-19a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5902, 'mir-19b', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5903, 'mir-19b', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5904, 'mir-19b', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5905, 'mir-20a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5906, 'mir-20a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5907, 'mir-20a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5908, 'mir-92a', 'lung cancer', 'up', 'A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.'),
(5909, 'mir-92a', 'lung cancer', 'up', 'Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.'),
(5910, 'mir-92a', 'lung cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(5911, 'hsa-mir-135a', 'lung cancer', 'down', 'MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.'),
(5912, 'hsa-mir-137', 'lung cancer', 'down', 'Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.'),
(5913, 'hsa-mir-141', 'lung cancer', 'up', 'MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.'),
(5914, 'hsa-mir-145', 'lung cancer', 'down', 'MicroRNA-145 inhibits migration and invasion by down-regulating FSCN1 in lung cancer.'),
(5915, 'hsa-mir-200a', 'lung cancer', 'up', 'MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.'),
(5916, 'hsa-mir-200b', 'lung cancer', 'up', 'MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.'),
(5917, 'hsa-mir-200c', 'lung cancer', 'up', 'MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.'),
(5918, 'hsa-mir-206', 'lung cancer', 'down', 'Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.'),
(5919, 'hsa-mir-206', 'lung cancer', 'down', 'Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.'),
(5920, 'hsa-mir-33a', 'lung cancer', 'down', 'MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer.'),
(5921, 'hsa-mir-3662', 'lung cancer', 'up', 'Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.'),
(5922, 'hsa-mir-429', 'lung cancer', 'up', 'MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.'),
(5923, 'hsa-mir-944', 'lung cancer', 'up', 'Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.'),
(5924, 'hsa-mir-101', 'lung cancer', 'down', 'Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2.'),
(5925, 'hsa-mir-125b', 'lung cancer', 'down', 'Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells.'),
(5926, 'hsa-mir-132', 'lung cancer', 'down', 'miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.'),
(5927, 'hsa-mir-143', 'lung cancer', 'up', 'Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.'),
(5928, 'hsa-mir-145', 'lung cancer', 'up', 'Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.'),
(5929, 'hsa-mir-218', 'lung cancer', 'down', 'ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.'),
(5930, 'hsa-mir-411', 'lung cancer', 'up', 'miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1.'),
(5931, 'hsa-mir-564', 'lung cancer', 'down', 'MiR-564 functions as a tumor suppressor in human lung cancer by targeting ZIC3.'),
(5932, 'hsa-mir-93', 'lung cancer', 'up', 'miR-93 promotes TGF-?-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.'),
(5933, 'hsa-mir-101', 'lung cancer', 'down', 'The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer.'),
(5934, 'hsa-mir-133a-1', 'lung cancer', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(5935, 'hsa-mir-133a-2', 'lung cancer', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(5936, 'hsa-mir-133b', 'lung cancer', 'down', 'Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.'),
(5937, 'hsa-mir-137', 'lung cancer', 'down', 'MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.'),
(5938, 'hsa-mir-140-3p', 'lung cancer', 'down', 'MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.'),
(5939, 'hsa-mir-148b', 'lung cancer', 'down', 'Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b.'),
(5940, 'hsa-mir-206', 'lung cancer', 'down', 'MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway.'),
(5941, 'hsa-mir-208a', 'lung cancer', 'up', 'Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.'),
(5942, 'hsa-mir-26b', 'lung cancer', 'down', 'MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer.'),
(5943, 'hsa-mir-31', 'lung cancer', 'up', 'BAP1 suppresses lung cancer progression and is inhibited by miR-31.'),
(5944, 'hsa-mir-7', 'lung cancer', 'down', 'Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.'),
(5945, 'hsa-mir-302b', 'lung cancer', 'down', 'Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration via TGF?RII Inhibition.'),
(5946, 'hsa-mir-326', 'lung cancer', 'down', 'MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(5947, 'hsa-mir-937', 'lung cancer', 'up', 'miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.'),
(5948, 'hsa-mir-1207-5p', 'lung cancer', 'down', 'miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.'),
(5949, 'hsa-mir-1246', 'lung cancer', 'up', 'Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5.'),
(5950, 'hsa-mir-130b', 'lung cancer', 'up', 'MicroRNA-130b promotes lung cancer progression via PPAR?/VEGF-A/BCL-2-mediated suppression of apoptosis.'),
(5951, 'hsa-mir-144', 'lung cancer', 'down', 'Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression.'),
(5952, 'hsa-mir-186', 'lung cancer', 'down', 'MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer.'),
(5953, 'hsa-mir-202', 'lung cancer', 'down', 'MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.'),
(5954, 'hsa-mir-214', 'lung cancer', 'down', 'microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.'),
(5955, 'hsa-mir-22', 'lung cancer', 'down', 'miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.'),
(5956, 'hsa-mir-29a', 'lung cancer', 'down', 'Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.'),
(5957, 'hsa-mir-301b', 'lung cancer', 'up', 'Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.'),
(5958, 'hsa-mir-127', 'lung cancer', 'up', 'miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.'),
(5959, 'hsa-mir-196a', 'lung cancer', 'up', 'Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.'),
(5960, 'hsa-mir-383', 'lung cancer', 'down', 'MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.'),
(5961, 'hsa-mir-490-3p', 'lung cancer', 'up', 'MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.'),
(5962, 'hsa-mir-129-5p', 'lung cancer', 'down', 'miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin.'),
(5963, 'hsa-mir-218', 'lung cancer', 'down', 'Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.'),
(5964, 'hsa-mir-223', 'lung cancer', 'up', 'MicroRNA-223 Promotes Tumor Progression in Lung Cancer A549 Cells via Activation of the NF-?B Signaling Pathway.'),
(5965, 'hsa-mir-96', 'lung cancer', 'up', 'Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7.'),
(5966, 'hsa-mir-128', 'lung cancer', 'down', 'MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.'),
(5967, 'hsa-mir-138', 'lung cancer', 'down', 'miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.'),
(5968, 'hsa-mir-145', 'lung cancer', 'down', 'Interaction of lincRNA ROR and p53/miR-145 correlates with lung cancer stem cell signatures.'),
(5969, 'hsa-mir-18a-5p', 'lung cancer', 'up', 'MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer.'),
(5970, 'hsa-mir-218', 'lung cancer', 'down', 'Inhibition of pulmonary carcinoma proliferation or metastasis of miR-218 via down-regulating CDCP1 expression.'),
(5971, 'hsa-mir-27a', 'lung cancer', 'up', 'MIR-27a regulates the TGF-? signaling pathway by targeting SMAD2 and SMAD4 in lung cancer.'),
(5972, 'hsa-mir-361-5p', 'lung cancer', 'down', 'miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.'),
(5973, 'hsa-mir-1254', 'lung cancer', 'up', 'miR-1254 promotes lung cancer cell proliferation by targeting SFRP1.'),
(5974, 'hsa-mir-125a-5p', 'lung cancer', 'down', 'MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.'),
(5975, 'hsa-mir-137', 'lung cancer', 'up', 'Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.'),
(5976, 'hsa-mir-218', 'lung cancer', 'down', 'MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.'),
(5977, 'hsa-mir-22', 'lung cancer', 'down', 'MiR-22 inhibits lung cancer cell EMT and invasion through targeting Snail.'),
(5978, 'hsa-mir-26b', 'lung cancer', 'down', '[MiR-26b regulates invasion and migration of lung cancer cells through targeting hENT1 depending on RhoA/ROCK-1 pathway].'),
(5979, 'hsa-mir-32', 'lung cancer', 'down', 'Inhibition of miR-32 activity promoted EMT induced by PM2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells.'),
(5980, 'hsa-mir-33a', 'lung cancer', 'down', 'miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.'),
(5981, 'hsa-mir-449a', 'lung cancer', 'down', 'MiR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation.'),
(5982, 'hsa-mir-503-3p', 'lung cancer', 'down', 'miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression.'),
(5983, 'hsa-mir-641', 'lung cancer', 'down', 'MiR-641 Functions as a Tumor Suppressor by Targeting MDM2 in Human Lung Cancer.'),
(5984, 'hsa-mir-1246', 'lung cancer', 'down', 'MicroRNA-1246 inhibits cell invasion and epithelial mesenchymal transition process by targeting CXCR4 in lung cancer cells.'),
(5985, 'hsa-mir-186', 'lung cancer', 'down', 'MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.'),
(5986, 'hsa-mir-24-3p', 'lung cancer', 'up', 'miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7.'),
(5987, 'hsa-mir-29b', 'lung cancer', 'down', 'ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.'),
(5988, 'hsa-mir-4326', 'lung cancer', 'up', 'miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2.'),
(5989, 'hsa-mir-5100', 'lung cancer', 'up', 'MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.'),
(5990, 'hsa-mir-103a', 'lung cancer', 'up', 'Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN.'),
(5991, 'hsa-mir-122-3p', 'lung cancer', 'down', 'MicroRNA-122-3p inhibits tumor cell proliferation and induces apoptosis by targeting Forkhead box O in A549 cells.'),
(5992, 'hsa-mir-29a', 'lung cancer', 'down', 'MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer.'),
(5993, 'hsa-mir-30a', 'lung cancer', 'down', 'miR-30a suppresses lung cancer progression by targeting SIRT1.'),
(5994, 'hsa-mir-544a', 'lung cancer', 'up', 'TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.'),
(5995, 'hsa-mir-1269', 'lung cancer', 'up', 'miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer.'),
(5996, 'hsa-mir-138', 'lung cancer', 'down', 'TGF?1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells.'),
(5997, 'hsa-mir-143', 'lung cancer', 'down', 'Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.'),
(5998, 'hsa-mir-143', 'lung cancer', 'down', 'Effects of miR-143 overexpression on proliferation, apoptosis, EGFR and downstream signaling pathways in PC9/GR cell line.'),
(5999, 'hsa-mir-196b', 'lung cancer', 'up', 'miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6.'),
(6000, 'hsa-mir-19b-3p', 'lung cancer', 'up', 'miR-19 in blood plasma reflects lung cancer occurrence but is not specifically associated with radon exposure.'),
(6001, 'hsa-mir-203', 'lung cancer', 'down', '[miR-203 inhibits lung cancer cell metastasis by targeting fatty acid binding protein 4].'),
(6002, 'hsa-mir-330-3p', 'lung cancer', 'up', 'miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b.'),
(6003, 'hsa-mir-362', 'lung cancer', 'up', 'Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.'),
(6004, 'hsa-mir-373', 'lung cancer', 'up', 'Down-regulation of miR-373 increases the radiosensitivity of lung cancer cells by targeting TIMP2.'),
(6005, 'hsa-mir-495', 'lung cancer', 'down', 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.'),
(6006, 'hsa-mir-503', 'lung cancer', 'down', 'CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression.'),
(6007, 'hsa-mir-506', 'lung cancer', 'down', 'Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.'),
(6008, 'hsa-mir-520b', 'lung cancer', 'down', 'MiR-520b restrains cell growth by targeting HDAC4 in lung cancer.'),
(6009, 'hsa-mir-124', 'lung cancer', 'down', 'Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer.'),
(6010, 'hsa-mir-128-3p', 'lung cancer', 'down', 'A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.'),
(6011, 'hsa-mir-181b', 'lung cancer', 'down', 'microRNA-181b suppresses the metastasis of lung cancer cells by targeting sex determining region Y-related high mobility group-box 6 (Sox6).'),
(6012, 'hsa-mir-182', 'lung cancer', 'up', 'MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3.'),
(6013, 'hsa-mir-183-5p', 'lung cancer', 'down', 'miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition.'),
(6014, 'hsa-mir-33a-5p', 'lung cancer', 'down', 'A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer.'),
(6015, 'hsa-mir-3666', 'lung cancer', 'down', 'MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF.'),
(6016, 'hsa-mir-377-5p', 'lung cancer', 'down', 'miR-377-5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling.'),
(6017, 'hsa-mir-93', 'lung cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(6018, 'hsa-mir-10a', 'lung cancer', 'up', 'miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.'),
(6019, 'hsa-mir-1236-3p', 'lung cancer', 'down', 'microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells.'),
(6020, 'hsa-mir-125b', 'lung cancer', 'up', 'Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.'),
(6021, 'hsa-mir-129-5p', 'lung cancer', 'down', 'Tumor suppressor function of miR-129-5p in lung cancer.'),
(6022, 'hsa-mir-1307-3p', 'lung cancer', 'up', 'MicroRNA-1307-3p promotes lung cancer cell proliferation by targeting EGFR.'),
(6023, 'hsa-mir-135a-5p', 'lung cancer', 'up', 'Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.'),
(6024, 'hsa-mir-146a', 'lung cancer', 'down', 'miR-146a and miR-196a-2 genes polymorphisms and its circulating levels in lung cancer patients.'),
(6025, 'hsa-mir-210', 'lung cancer', 'up', 'miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4.'),
(6026, 'hsa-mir-378', 'lung cancer', 'up', 'Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378.'),
(6027, 'hsa-mir-423-3p', 'lung cancer', 'up', 'Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.'),
(6028, 'hsa-mir-4301', 'lung cancer', 'down', 'An Inventive Report of Inducing Apoptosis in Non-Small Cell Lung Cancer (NSCLC) Cell Lines by Transfection of MiR-4301.'),
(6029, 'hsa-mir-431', 'lung cancer', 'down', 'MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating DDX5.'),
(6030, 'hsa-mir-520f', 'lung cancer', 'down', 'MiR-520f acts as a biomarker for the diagnosis of lung cancer.'),
(6031, 'hsa-mir-544a', 'lung cancer', 'down', 'LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.'),
(6032, 'hsa-mir-600', 'lung cancer', 'down', 'miR-600 inhibits lung cancer via downregulating the expression of METTL3.'),
(6033, 'hsa-mir-660', 'lung cancer', 'down', 'Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.'),
(6034, 'hsa-mir-708', 'lung cancer', 'up', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(6035, 'hsa-mir-939-3p', 'lung cancer', 'up', 'Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer.'),
(6036, 'hsa-mir-203', 'lung carcinoma', 'down', 'miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.'),
(6037, 'hsa-mir-1244', 'lung carcinoma', 'down', 'miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma.'),
(6038, 'hsa-mir-31', 'lung carcinoma', 'down', 'MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.'),
(6039, 'hsa-mir-204', 'lung carcinoma', 'down', 'miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.'),
(6040, 'hsa-mir-30e', 'lung carcinoma', 'down', 'MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma.'),
(6041, 'hsa-mir-23b', 'lung carcinoma', 'down', 'miR-23b suppresses lung carcinoma cell proliferation through CCNG1.'),
(6042, 'hsa-mir-24', 'lung carcinoma', 'up', 'MiR-24 promotes the proliferation and apoptosis of lung carcinoma via targeting MAPK7.'),
(6043, 'hsa-mir-133a', 'lung squamous cell carcinoma', 'down', 'Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.'),
(6044, 'hsa-mir-218', 'lung squamous cell carcinoma', 'down', 'MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.'),
(6045, 'hsa-mir-588', 'lung squamous cell carcinoma', 'down', 'MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma.'),
(6046, 'hsa-mir-218', 'lung squamous cell carcinoma', 'down', 'Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.'),
(6047, 'hsa-mir-372-3p', 'lung squamous cell carcinoma', 'up', 'MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma.'),
(6048, 'hsa-mir-448', 'lung squamous cell carcinoma', 'down', 'miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.'),
(6049, 'hsa-mir-223-3p', 'lung squamous cell carcinoma', 'down', 'MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.'),
(6050, 'hsa-let-7b', 'malignant melanoma', 'down', 'MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.'),
(6051, 'hsa-mir-101', 'malignant melanoma', 'down', 'MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.'),
(6052, 'hsa-mir-125b', 'malignant melanoma', 'down', 'MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.'),
(6053, 'hsa-mir-125b', 'malignant melanoma', 'down', 'miR-125b induces cellular senescence in malignant melanoma.'),
(6054, 'hsa-mir-126', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6055, 'hsa-mir-1280', 'malignant melanoma', 'down', 'Anti-tumor activity of miR-1280 in melanoma by regulation of Src.'),
(6056, 'hsa-mir-141', 'malignant melanoma', 'up', 'MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.'),
(6057, 'hsa-mir-143', 'malignant melanoma', 'down', 'MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.'),
(6058, 'hsa-mir-146a', 'malignant melanoma', 'down', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6059, 'hsa-mir-146b', 'malignant melanoma', 'down', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6060, 'hsa-mir-155', 'malignant melanoma', 'down', 'MicroRNA-155 targets the SKI gene in human melanoma cell lines.'),
(6061, 'hsa-mir-155', 'malignant melanoma', 'down', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6062, 'hsa-mir-15b', 'malignant melanoma', 'up', 'MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.'),
(6063, 'hsa-mir-17', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6064, 'hsa-mir-17', 'malignant melanoma', 'down', 'MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune response.'),
(6065, 'hsa-mir-17-5p', 'malignant melanoma', 'up', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6066, 'hsa-mir-17-5p', 'malignant melanoma', 'up', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6067, 'hsa-mir-182', 'malignant melanoma', 'up', 'Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.'),
(6068, 'hsa-mir-182', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6069, 'hsa-mir-184', 'malignant melanoma', 'down', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6070, 'hsa-mir-185', 'malignant melanoma', 'down', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6071, 'hsa-mir-18a', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6072, 'hsa-mir-18a', 'malignant melanoma', 'up', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6073, 'hsa-mir-18b', 'malignant melanoma', 'down', 'The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression.'),
(6074, 'hsa-mir-193b', 'malignant melanoma', 'up', 'miR-193b Regulates Mcl-1 in Melanoma.'),
(6075, 'hsa-mir-193b', 'malignant melanoma', 'down', 'Stathmin 1 is a potential novel oncogene in melanoma.'),
(6076, 'hsa-mir-200a', 'malignant melanoma', 'up', 'MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.'),
(6077, 'hsa-mir-200b', 'malignant melanoma', 'up', 'MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.'),
(6078, 'hsa-mir-200c', 'malignant melanoma', 'up', 'MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.'),
(6079, 'hsa-mir-200c', 'malignant melanoma', 'down', 'Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.'),
(6080, 'hsa-mir-200c', 'malignant melanoma', 'down', 'miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1.'),
(6081, 'hsa-mir-200c', 'malignant melanoma', 'down', 'miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.'),
(6082, 'hsa-mir-203', 'malignant melanoma', 'down', 'Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.'),
(6083, 'hsa-mir-203', 'malignant melanoma', 'down', 'MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.'),
(6084, 'hsa-mir-203', 'malignant melanoma', 'down', 'Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 in Human Melanoma Cells.'),
(6085, 'hsa-mir-203', 'malignant melanoma', 'down', 'MicroRNA-203 inhibits malignant melanoma cell migration by targeting versican.'),
(6086, 'hsa-mir-204', 'malignant melanoma', 'down', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6087, 'hsa-mir-205', 'malignant melanoma', 'down', 'miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.'),
(6088, 'hsa-mir-205', 'malignant melanoma', 'down', 'Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.'),
(6089, 'hsa-mir-205', 'malignant melanoma', 'down', 'Chemically Modified Synthetic microRNA-205 Inhibits the Growth of Melanoma Cells In Vitro and In Vivo.'),
(6090, 'hsa-mir-206', 'malignant melanoma', 'down', 'MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.'),
(6091, 'hsa-mir-20a', 'malignant melanoma', 'up', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6092, 'hsa-mir-20a', 'malignant melanoma', 'down', 'Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex.'),
(6093, 'hsa-mir-21', 'malignant melanoma', 'up', 'microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells.'),
(6094, 'hsa-mir-21', 'malignant melanoma', 'up', 'MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.'),
(6095, 'hsa-mir-210', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6096, 'hsa-mir-210', 'malignant melanoma', 'up', 'MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.'),
(6097, 'hsa-mir-211', 'malignant melanoma', 'down', 'The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.'),
(6098, 'hsa-mir-211', 'malignant melanoma', 'down', 'Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.'),
(6099, 'hsa-mir-211', 'malignant melanoma', 'down', 'Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.'),
(6100, 'hsa-mir-211', 'malignant melanoma', 'down', 'Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.'),
(6101, 'hsa-mir-214', 'malignant melanoma', 'up', 'Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.'),
(6102, 'hsa-mir-218', 'malignant melanoma', 'down', 'Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma.'),
(6103, 'hsa-mir-221', 'malignant melanoma', 'up', 'The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.'),
(6104, 'hsa-mir-222', 'malignant melanoma', 'up', 'The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway.'),
(6105, 'hsa-mir-26a', 'malignant melanoma', 'down', 'MicroRNA-26a Is Strongly Downregulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD).'),
(6106, 'hsa-mir-31', 'malignant melanoma', 'down', 'Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.'),
(6107, 'hsa-mir-31', 'malignant melanoma', 'down', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6108, 'hsa-mir-33a', 'malignant melanoma', 'down', 'miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1?.'),
(6109, 'hsa-mir-34a', 'malignant melanoma', 'down', 'MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.'),
(6110, 'hsa-mir-34a', 'malignant melanoma', 'down', 'Regulation of cancer aggressive features in melanoma cells by microRNAs.'),
(6111, 'hsa-mir-34a', 'malignant melanoma', 'down', 'Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.'),
(6112, 'hsa-mir-34a', 'malignant melanoma', 'down', 'Identification of FLOT2 as a novel target for microRNA-34a in melanoma.'),
(6113, 'hsa-mir-34c', 'malignant melanoma', 'down', 'Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene.'),
(6114, 'hsa-mir-376a', 'malignant melanoma', 'down', 'Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.'),
(6115, 'hsa-mir-376c', 'malignant melanoma', 'down', 'Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.'),
(6116, 'hsa-mir-429', 'malignant melanoma', 'up', 'MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion.'),
(6117, 'hsa-mir-455-5p', 'malignant melanoma', 'up', 'Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.'),
(6118, 'hsa-mir-532-5p', 'malignant melanoma', 'up', 'Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.'),
(6119, 'hsa-mir-573', 'malignant melanoma', 'down', 'miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.'),
(6120, 'hsa-mir-638', 'malignant melanoma', 'up', 'miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.'),
(6121, 'hsa-mir-7-5p', 'malignant melanoma', 'down', 'miRNA-7-5p inhibits melanoma cell migration and invasion.'),
(6122, 'hsa-mir-9', 'malignant melanoma', 'down', 'MicroRNA-9 up-regulates E-cadherin through inhibition of NF-?B1-Snail1 pathway in melanoma.'),
(6123, 'hsa-mir-92a', 'malignant melanoma', 'up', 'Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.'),
(6124, 'hsa-mir-98', 'malignant melanoma', 'down', 'miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.'),
(6125, 'hsa-mir-125a-5p', 'malignant melanoma', 'down', 'Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.'),
(6126, 'hsa-mir-135a', 'malignant melanoma', 'up', 'MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.'),
(6127, 'hsa-mir-203', 'malignant melanoma', 'down', 'DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.'),
(6128, 'hsa-mir-21', 'malignant melanoma', 'up', 'Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.'),
(6129, 'hsa-mir-210', 'malignant melanoma', 'up', 'A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.'),
(6130, 'hsa-mir-365', 'malignant melanoma', 'down', 'MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.'),
(6131, 'hsa-mir-125b', 'malignant melanoma', 'down', 'MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.'),
(6132, 'hsa-mir-425', 'malignant melanoma', 'down', 'miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.'),
(6133, 'hsa-mir-10b', 'malignant melanoma', 'down', 'The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis.'),
(6134, 'hsa-mir-203', 'malignant melanoma', 'down', 'Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.'),
(6135, 'hsa-mir-211', 'malignant melanoma', 'down', 'microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.'),
(6136, 'hsa-mir-26b', 'malignant melanoma', 'down', 'MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation.'),
(6137, 'hsa-mir-137', 'malignant melanoma', 'down', 'miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.'),
(6138, 'hsa-mir-138', 'malignant melanoma', 'down', 'MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1?.'),
(6139, 'hsa-mir-339-3p', 'malignant melanoma', 'down', 'miR-339-3p Is a Tumor Suppressor in Melanoma.'),
(6140, 'hsa-mir-7-5p', 'malignant melanoma', 'down', 'microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-?B.'),
(6141, 'hsa-mir-199a-5p', 'malignant melanoma', 'down', 'MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1?.'),
(6142, 'hsa-mir-21', 'malignant melanoma', 'up', 'MicroRNA-21 regulates the ERK/NF-?B signaling pathway to affect the proliferation, migration and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4 and PTEN.'),
(6143, 'hsa-mir-22', 'malignant melanoma', 'down', 'Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.'),
(6144, 'hsa-mir-33a', 'malignant melanoma', 'down', 'miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1.'),
(6145, 'hsa-mir-542-3p', 'malignant melanoma', 'down', 'miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.'),
(6146, 'hsa-mir-769', 'malignant melanoma', 'up', 'MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.'),
(6147, 'hsa-mir-124', 'malignant melanoma', 'down', 'Upregulation of miR-124 by physcion 8-O-?-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76.'),
(6148, 'hsa-mir-186', 'malignant melanoma', 'up', 'miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma.'),
(6149, 'hsa-mir-203', 'malignant melanoma', 'down', 'RAB22A overexpression promotes the tumor growth of melanoma.'),
(6150, 'hsa-mir-25', 'malignant melanoma', 'up', 'Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/?-Catenin Pathway.'),
(6151, 'hsa-mir-9', 'malignant melanoma', 'down', 'MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1.'),
(6152, 'hsa-mir-204-5p', 'malignant melanoma', 'down', 'miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.'),
(6153, 'hsa-mir-216b', 'malignant melanoma', 'down', 'microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.'),
(6154, 'hsa-mir-34b-5p', 'malignant melanoma', 'up', 'MiR-34b-5p Suppresses Melanoma Differentiation-Associated Gene 5 (MDA5) Signaling Pathway to Promote Avian Leukosis Virus Subgroup J (ALV-J)-Infected Cells Proliferaction and ALV-J Replication.'),
(6155, 'hsa-mir-590-5p', 'malignant melanoma', 'down', '[miR-590-5p inhibits A375 cell invasion and migration in malignant melanoma by directly inhibiting YAP1 expression].'),
(6156, 'hsa-mir-625', 'malignant melanoma', 'down', 'microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma.'),
(6157, 'hsa-mir-137', 'malignant melanoma', 'down', 'Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma.'),
(6158, 'hsa-mir-153-3p', 'malignant melanoma', 'down', 'MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma.'),
(6159, 'hsa-mir-200a', 'malignant melanoma', 'down', 'MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.'),
(6160, 'hsa-mir-370', 'malignant melanoma', 'up', 'MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B.'),
(6161, 'hsa-mir-485-5p', 'malignant melanoma', 'down', 'MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.'),
(6162, 'hsa-mir-493', 'malignant melanoma', 'down', 'Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.'),
(6163, 'hsa-mir-10b', 'malignant melanoma', 'up', 'Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma.'),
(6164, 'hsa-mir-136', 'malignant melanoma', 'down', 'Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.'),
(6165, 'hsa-mir-200a', 'malignant melanoma', 'down', 'MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic?Melanoma.'),
(6166, 'hsa-mir-21', 'malignant melanoma', 'up', 'Quantification of microRNA-21 and microRNA-125b in melanoma tissue.'),
(6167, 'hsa-mir-33b', 'malignant melanoma', 'down', 'MicroRNA-33b inhibits cell proliferation and glycolysis by targeting hypoxia-inducible factor-1? in malignant melanoma.'),
(6168, 'hsa-mir-605', 'malignant melanoma', 'down', 'MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.'),
(6169, 'hsa-mir-9', 'malignant melanoma', 'down', 'MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.'),
(6170, 'hsa-mir-124', 'malignant melanoma', 'down', 'miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican.'),
(6171, 'hsa-mir-137', 'malignant melanoma', 'down', 'miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.'),
(6172, 'hsa-mir-152-3p', 'malignant melanoma', 'down', 'Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p.'),
(6173, 'hsa-mir-181a', 'malignant melanoma', 'down', 'Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.'),
(6174, 'hsa-mir-204', 'malignant melanoma', 'down', 'BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR?204.'),
(6175, 'hsa-mir-326', 'malignant melanoma', 'down', 'MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.'),
(6176, 'hsa-mir-519d', 'malignant melanoma', 'up', 'MicroRNA-519d promotes melanoma progression by downregulating EphA4.'),
(6177, 'hsa-mir-610', 'malignant melanoma', 'down', 'MicroRNA-610 inhibits tumor growth of melanoma by targeting LRP6.'),
(6178, 'hsa-mir-767', 'malignant melanoma', 'up', 'MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.'),
(6179, 'hsa-mir-137', 'malignant melanoma', 'up', 'miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.'),
(6180, 'hsa-mir-137', 'malignant melanoma', 'down', 'miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.'),
(6181, 'hsa-mir-150', 'malignant melanoma', 'up', 'MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.'),
(6182, 'hsa-mir-331', 'malignant melanoma', 'down', 'MicroRNA-331 inhibits proliferation and invasion of melanoma cells by targeting astrocyte-elevated gene-1.'),
(6183, 'hsa-mir-342', 'malignant melanoma', 'down', 'MicroRNA-342 prohibits proliferation and invasion of melanoma cells by directly targeting Zinc-finger E-box binding homeobox 1.'),
(6184, 'hsa-mir-612', 'malignant melanoma', 'down', 'Overexpression of microRNA-612 Restrains the Growth, Invasion, and Tumorigenesis of Melanoma Cells by Targeting Espin.'),
(6185, 'hsa-mir-129-5p', 'malignant melanoma', 'down', 'Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.'),
(6186, 'hsa-mir-143-3p', 'malignant melanoma', 'down', 'MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.'),
(6187, 'hsa-mir-146a', 'malignant melanoma', 'up', 'miR-146a promotes cell migration and invasion in melanoma by directly targeting SMAD4.'),
(6188, 'hsa-mir-150', 'malignant melanoma', 'down', 'MiR-150 suppresses tumor growth in melanoma through downregulation of MYB.'),
(6189, 'hsa-mir-185-5p', 'malignant melanoma', 'down', 'Long non-coding RNA UCA1 targets miR-185-5p and regulates cell mobility by affecting epithelial-mesenchymal transition in melanoma via Wnt/?-catenin signaling pathway.'),
(6190, 'hsa-mir-195-5p', 'malignant melanoma', 'down', 'MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.'),
(6191, 'hsa-mir-199a-3p', 'malignant melanoma', 'down', 'Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling.'),
(6192, 'hsa-mir-19b-3p', 'malignant melanoma', 'up', 'Matrine exerts inhibitory effects in melanoma through the regulation of miR-19b-3p/PTEN.'),
(6193, 'hsa-mir-214', 'malignant melanoma', 'up', 'Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.'),
(6194, 'hsa-mir-31', 'malignant melanoma', 'down', 'The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway.'),
(6195, 'hsa-mir-338-5p', 'malignant melanoma', 'up', 'MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.'),
(6196, 'hsa-mir-365', 'malignant melanoma', 'down', 'MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).'),
(6197, 'hsa-mir-455-3p', 'malignant melanoma', 'down', 'MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.'),
(6198, 'hsa-mir-495', 'malignant melanoma', 'down', 'miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells.'),
(6199, 'hsa-mir-497-5p', 'malignant melanoma', 'down', 'MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.'),
(6200, 'hsa-mir-122-5p', 'malignant melanoma', 'up', '[miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].'),
(6201, 'hsa-mir-135b', 'malignant melanoma', 'up', 'MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.'),
(6202, 'hsa-mir-137', 'malignant melanoma', 'down', 'Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene.'),
(6203, 'hsa-mir-23a', 'malignant melanoma', 'down', 'MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway.'),
(6204, 'hsa-mir-25', 'malignant melanoma', 'up', 'miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47.'),
(6205, 'hsa-mir-373', 'malignant melanoma', 'up', 'MicroRNA-373 promotes cell migration via targeting salt-inducible kinase 1 expression in melanoma.'),
(6206, 'hsa-mir-637', 'malignant melanoma', 'down', 'MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.'),
(6207, 'hsa-mir-106a', 'malignant melanoma', 'up', 'Suppression of connexin 43 expression by miR-106a promotes melanoma cell proliferation.'),
(6208, 'hsa-mir-10b', 'malignant melanoma', 'up', 'miR-10b promoted melanoma progression through Wnt/?-catenin pathway by repressing ITCH expression.'),
(6209, 'hsa-mir-145-5p', 'malignant melanoma', 'down', 'miR-145-5p inhibits tumor occurrence and metastasis through the NF-?B signaling pathway by targeting TLR4 in malignant melanoma.'),
(6210, 'hsa-mir-150-5p', 'malignant melanoma', 'down', 'MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.'),
(6211, 'hsa-mir-154', 'malignant melanoma', 'down', 'MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.'),
(6212, 'hsa-mir-203', 'malignant melanoma', 'up', 'MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo.'),
(6213, 'hsa-mir-217', 'malignant melanoma', 'down', 'Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217.'),
(6214, 'hsa-mir-27a', 'malignant melanoma', 'up', 'Silencing of microRNA-27a facilitates autophagy and apoptosis of melanoma cells through the activation of the SYK-dependent mTOR signaling pathway.'),
(6215, 'hsa-mir-29c', 'malignant melanoma', 'up', 'MicroRNA-29c induces G1 arrest of melanoma by targeting CDK6.'),
(6216, 'hsa-mir-30a-5p', 'malignant melanoma', 'down', 'The role of microRNA-30a and downstream snail1 on the growth and metastasis of melanoma tumor.'),
(6217, 'hsa-mir-338-3p', 'malignant melanoma', 'down', 'MicroRNA-338-3p suppresses cell proliferation, migration and invasion in human malignant melanoma by targeting MACC1.'),
(6218, 'hsa-mir-429', 'malignant melanoma', 'down', 'MicroRNA-429 inhibits cancer cell proliferation and migration by targeting the AKT1 in melanoma.'),
(6219, 'hsa-mir-431', 'malignant melanoma', 'down', 'MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.'),
(6220, 'hsa-mir-494', 'malignant melanoma', 'up', 'Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis.'),
(6221, 'hsa-mir-495-3p', 'malignant melanoma', 'down', 'lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3.'),
(6222, 'hsa-mir-221', 'malignant melanoma', 'up', 'The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&amp;222-c-FOS pathway.'),
(6223, 'hsa-mir-222', 'malignant melanoma', 'up', 'The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&amp;222-c-FOS pathway.'),
(6224, 'hsa-mir-126', 'malignant mesothelioma', 'down', 'MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with Mitochondrial Function.'),
(6225, 'hsa-mir-182', 'malignant mesothelioma', 'up', 'miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.'),
(6226, 'hsa-mir-183', 'malignant mesothelioma', 'up', 'miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.'),
(6227, 'hsa-mir-126', 'malignant mesothelioma', 'down', 'Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication.'),
(6228, 'hsa-mir-142-5p', 'malt lymphoma', 'up', 'Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.'),
(6229, 'hsa-mir-155', 'malt lymphoma', 'up', 'Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.'),
(6230, 'hsa-mir-124a', 'mantle cell lymphoma', 'up', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6231, 'hsa-mir-142-3p', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6232, 'hsa-mir-142-5p', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6233, 'hsa-mir-150', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6234, 'hsa-mir-155', 'mantle cell lymphoma', 'up', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6235, 'hsa-mir-17', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6236, 'hsa-mir-18a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6237, 'hsa-mir-19a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6238, 'hsa-mir-19b', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6239, 'hsa-mir-20a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6240, 'hsa-mir-223', 'mantle cell lymphoma', 'down', 'MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.'),
(6241, 'hsa-mir-223', 'mantle cell lymphoma', 'down', '[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].'),
(6242, 'hsa-mir-29a', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6243, 'hsa-mir-29b', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6244, 'hsa-mir-29c', 'mantle cell lymphoma', 'down', 'microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.'),
(6245, 'hsa-mir-92a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6246, 'mir-17', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6247, 'mir-18a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6248, 'mir-19a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6249, 'mir-19b', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6250, 'mir-20a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6251, 'mir-92a', 'mantle cell lymphoma', 'up', 'The miRNA-17?92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.'),
(6252, 'hsa-mir-223', 'mantle cell lymphoma', 'down', 'miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.'),
(6253, 'hsa-mir-223', 'mantle cell lymphoma', 'down', '[Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].'),
(6254, 'hsa-mir-199a', 'mantle cell lymphoma', 'down', 'MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair.'),
(6255, 'hsa-mir-129-5p', 'medullary thyroid carcinoma', 'down', 'MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.'),
(6256, 'hsa-mir-183', 'medullary thyroid carcinoma', 'up', 'MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.'),
(6257, 'hsa-mir-182', 'medullary thyroid carcinoma', 'up', 'MiR-182 promotes cancer invasion by linking RET oncogene activated NF-?B to loss of the HES1/Notch1 regulatory circuit.'),
(6258, 'hsa-mir-9-3p', 'medullary thyroid carcinoma', 'up', 'Upregulated miR-9-3p promotes cell growth and inhibits apoptosis in medullary thyroid carcinoma by targeting BLCAP.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(6259, 'hsa-mir-21', 'medullary thyroid carcinoma', 'up', 'MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.'),
(6260, 'hsa-mir-375', 'medullary thyroid carcinoma', 'up', 'Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.'),
(6261, 'hsa-mir-144', 'medullary thyroid carcinoma', 'up', 'Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.'),
(6262, 'hsa-mir-34a', 'medullary thyroid carcinoma', 'up', 'Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.'),
(6263, 'hsa-mir-31-3p', 'medullary thyroid carcinoma', 'down', 'Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.'),
(6264, 'hsa-mir-106b', 'medulloblastoma', 'up', 'miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.'),
(6265, 'hsa-mir-124', 'medulloblastoma', 'down', 'miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.'),
(6266, 'hsa-mir-128a', 'medulloblastoma', 'down', 'MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.'),
(6267, 'hsa-mir-17', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6268, 'hsa-mir-18a', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6269, 'hsa-mir-199b-5p', 'medulloblastoma', 'down', 'The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.'),
(6270, 'hsa-mir-19a', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6271, 'hsa-mir-19b', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6272, 'hsa-mir-206', 'medulloblastoma', 'down', 'MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.'),
(6273, 'hsa-mir-20a', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6274, 'hsa-mir-22', 'medulloblastoma', 'down', 'MiR-22 is Frequently Down-regulated in Medulloblastomas, and Inhibits Cell Proliferation via the Novel Target PAPST1.'),
(6275, 'hsa-mir-30b', 'medulloblastoma', 'up', 'Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.'),
(6276, 'hsa-mir-30d', 'medulloblastoma', 'up', 'Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.'),
(6277, 'hsa-mir-31', 'medulloblastoma', 'down', 'MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2.'),
(6278, 'hsa-mir-383', 'medulloblastoma', 'down', 'MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3).'),
(6279, 'hsa-mir-92', 'medulloblastoma', 'up', 'The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.'),
(6280, 'hsa-mir-367', 'medulloblastoma', 'up', 'miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.'),
(6281, 'hsa-mir-495', 'medulloblastoma', 'down', 'MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.'),
(6282, 'hsa-mir-10b', 'medulloblastoma', 'up', 'microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma.'),
(6283, 'hsa-mir-210', 'medulloblastoma', 'up', 'Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma.'),
(6284, 'hsa-mir-206', 'medulloblastoma', 'down', 'MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.'),
(6285, 'hsa-mir-101', 'medulloblastoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6286, 'hsa-mir-139', 'medulloblastoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6287, 'hsa-mir-181c', 'medulloblastoma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6288, 'hsa-mir-181d', 'medulloblastoma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6289, 'hsa-mir-1827', 'medulloblastoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6290, 'hsa-mir-221', 'medulloblastoma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6291, 'hsa-mir-222', 'medulloblastoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6292, 'hsa-mir-34c', 'medulloblastoma', 'up', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6293, 'hsa-mir-9', 'medulloblastoma', 'down', 'Identification of microRNA signature in different pediatric brain tumors.'),
(6294, 'hsa-mir-221-3p', 'medulloblastoma', 'down', 'Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells.'),
(6295, 'hsa-mir-204', 'medulloblastoma', 'down', 'Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.'),
(6296, 'hsa-mir-128', 'meningioma', 'down', 'Serum microRNA-128 as a biomarker for diagnosis of glioma.'),
(6297, 'hsa-mir-200a', 'meningioma', 'down', 'Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.'),
(6298, 'hsa-mir-224', 'meningioma', 'up', 'MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma.'),
(6299, 'hsa-mir-335', 'meningioma', 'up', 'miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.'),
(6300, 'hsa-mir-100', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6301, 'hsa-mir-125b-1-3', 'mesenchymal cancer', 'up', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6302, 'hsa-mir-141', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6303, 'hsa-mir-182', 'mesenchymal cancer', 'up', 'MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.'),
(6304, 'hsa-mir-199b-5p', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6305, 'hsa-mir-200a', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6306, 'hsa-mir-200b', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6307, 'hsa-mir-200c', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6308, 'hsa-mir-29a', 'mesenchymal cancer', 'down', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6309, 'hsa-mir-29b-1', 'mesenchymal cancer', 'down', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6310, 'hsa-mir-29b-1-5p', 'mesenchymal cancer', 'down', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6311, 'hsa-mir-29b-2', 'mesenchymal cancer', 'down', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6312, 'hsa-mir-29c', 'mesenchymal cancer', 'down', 'miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor Suppressor A20 mRNA from Degradation by HuR.'),
(6313, 'hsa-mir-335', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6314, 'hsa-mir-429', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6315, 'hsa-mir-99a', 'mesenchymal cancer', 'down', 'MicroRNA Expression Profiles in Kaposi\'s Sarcoma.'),
(6316, 'hsa-mir-505', 'mesenchymal cancer', 'down', 'MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.'),
(6317, 'hsa-mir-197-5p', 'mesenchymal cancer', 'down', 'miR-197-5p inhibits sarcomagenesis and induces cellular senescence via repression of KIAA0101.'),
(6318, 'hsa-mir-29a', 'monocytic leukemia', 'down', 'Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.'),
(6319, 'hsa-mir-29b', 'monocytic leukemia', 'down', 'Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.'),
(6320, 'hsa-mir-1', 'mucinous cystadenocarcinoma', 'down', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6321, 'hsa-mir-200b', 'mucinous cystadenocarcinoma', 'up', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6322, 'hsa-mir-200c', 'mucinous cystadenocarcinoma', 'up', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6323, 'hsa-mir-21', 'mucinous cystadenocarcinoma', 'up', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6324, 'hsa-mir-223', 'mucinous cystadenocarcinoma', 'up', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6325, 'hsa-mir-4328', 'mucinous cystadenocarcinoma', 'down', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6326, 'hsa-mir-451', 'mucinous cystadenocarcinoma', 'up', 'Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.'),
(6327, 'hsa-mir-137', 'multiple myeloma', 'down', 'miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.'),
(6328, 'hsa-mir-197', 'multiple myeloma', 'down', 'miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.'),
(6329, 'hsa-mir-21', 'multiple myeloma', 'up', 'Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.'),
(6330, 'hsa-mir-214', 'multiple myeloma', 'down', 'Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication.'),
(6331, 'hsa-mir-21', 'multiple myeloma', 'up', 'Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.'),
(6332, 'hsa-mir-152', 'multiple myeloma', 'down', 'Downregulation of MicroRNA-152 Contributes to High Expression of DKK1 in Multiple Myeloma.'),
(6333, 'hsa-mir-301a', 'multiple myeloma', 'up', 'miR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.'),
(6334, 'hsa-mir-137', 'multiple myeloma', 'down', 'miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF.'),
(6335, 'hsa-mir-186', 'multiple myeloma', 'down', 'miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.'),
(6336, 'hsa-mir-19a', 'multiple myeloma', 'up', 'MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.'),
(6337, 'hsa-mir-19a-3p', 'multiple myeloma', 'up', 'MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.'),
(6338, 'hsa-mir-203', 'multiple myeloma', 'down', 'miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells.'),
(6339, 'hsa-mir-497', 'multiple myeloma', 'down', 'MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.'),
(6340, 'hsa-mir-375', 'multiple myeloma', 'down', 'Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.'),
(6341, 'hsa-mir-144-3p', 'multiple myeloma', 'down', 'MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.'),
(6342, 'hsa-mir-138', 'multiple myeloma', 'up', 'Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.'),
(6343, 'hsa-mir-210', 'multiple myeloma', 'up', 'New role of hypoxia in pathophysiology of multiple myeloma through miR-210.'),
(6344, 'hsa-mir-22', 'multiple myeloma', 'down', 'miR-22 suppresses DNA ligase III addiction in multiple myeloma.'),
(6345, 'hsa-mir-26b-5p', 'multiple myeloma', 'down', 'miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1.'),
(6346, 'hsa-mir-19b', 'multiple myeloma', 'up', 'Differential Expression of MicroRNA-19b Promotes Proliferation of Cancer Stem Cells by Regulating the TSC1/mTOR Signaling Pathway in Multiple Myeloma.'),
(6347, 'hsa-mir-203a', 'multiple myeloma', 'down', 'Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation.'),
(6348, 'hsa-mir-497', 'multiple myeloma', 'down', 'MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.'),
(6349, 'hsa-mir-214-3p', 'multiple myeloma', 'up', 'Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.'),
(6350, 'hsa-mir-26a', 'multiple myeloma', 'down', 'MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.'),
(6351, 'hsa-mir-27a', 'multiple myeloma', 'up', 'Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma.'),
(6352, 'hsa-mir-27b', 'multiple myeloma', 'up', 'Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma.'),
(6353, 'hsa-mir-27b-3p', 'multiple myeloma', 'up', 'Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.'),
(6354, 'hsa-mir-340-5p', 'multiple myeloma', 'down', 'Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.'),
(6355, 'hsa-mir-9', 'multiple myeloma', 'up', 'MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-?B pathway.'),
(6356, 'hsa-mir-17', 'nasopharyngeal cancer', 'up', 'Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.'),
(6357, 'hsa-mir-20a', 'nasopharyngeal cancer', 'up', 'Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.'),
(6358, 'hsa-mir-218', 'nasopharyngeal cancer', 'down', 'MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.'),
(6359, 'hsa-mir-223', 'nasopharyngeal cancer', 'down', 'Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.'),
(6360, 'hsa-mir-29c', 'nasopharyngeal cancer', 'down', 'Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.'),
(6361, 'hsa-mir-92b', 'nasopharyngeal cancer', 'down', 'MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer.'),
(6362, 'hsa-mir-93', 'nasopharyngeal cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(6363, 'hsa-mir-29a', 'nasopharyngeal cancer', 'down', 'MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.'),
(6364, 'hsa-mir-29b-1', 'nasopharyngeal cancer', 'down', 'MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.'),
(6365, 'hsa-mir-29b-2', 'nasopharyngeal cancer', 'down', 'MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.'),
(6366, 'hsa-mir-29c', 'nasopharyngeal cancer', 'down', 'MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway.'),
(6367, 'hsa-let-7a', 'nasopharyngeal carcinoma', 'down', 'Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells.'),
(6368, 'hsa-let-7a-1', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6369, 'hsa-let-7a-2', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6370, 'hsa-let-7a-3', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6371, 'hsa-let-7b', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6372, 'hsa-let-7c', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6373, 'hsa-let-7c', 'nasopharyngeal carcinoma', 'down', 'Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.'),
(6374, 'hsa-let-7d', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6375, 'hsa-let-7e', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6376, 'hsa-let-7f-1', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6377, 'hsa-let-7f-2', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6378, 'hsa-let-7g', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6379, 'hsa-let-7i', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6380, 'hsa-mir-1', 'nasopharyngeal carcinoma', 'down', 'EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.'),
(6381, 'hsa-mir-101', 'nasopharyngeal carcinoma', 'down', 'miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.'),
(6382, 'hsa-mir-10b', 'nasopharyngeal carcinoma', 'up', 'Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.'),
(6383, 'hsa-mir-10b', 'nasopharyngeal carcinoma', 'up', 'miR-10b Promotes Migration and Invasion in Nasopharyngeal Carcinoma Cells.'),
(6384, 'hsa-mir-124', 'nasopharyngeal carcinoma', 'down', 'MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.'),
(6385, 'hsa-mir-138', 'nasopharyngeal carcinoma', 'down', 'MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.'),
(6386, 'hsa-mir-143', 'nasopharyngeal carcinoma', 'down', 'MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.'),
(6387, 'hsa-mir-143', 'nasopharyngeal carcinoma', 'down', 'Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.'),
(6388, 'hsa-mir-144', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.'),
(6389, 'hsa-mir-145', 'nasopharyngeal carcinoma', 'down', 'MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.'),
(6390, 'hsa-mir-145', 'nasopharyngeal carcinoma', 'down', 'miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.'),
(6391, 'hsa-mir-145', 'nasopharyngeal carcinoma', 'down', 'MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.'),
(6392, 'hsa-mir-148a', 'nasopharyngeal carcinoma', 'down', 'Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.'),
(6393, 'hsa-mir-149', 'nasopharyngeal carcinoma', 'up', 'miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.'),
(6394, 'hsa-mir-155', 'nasopharyngeal carcinoma', 'up', 'MiR-155 up-regulation by LMP1 DNA contributes to increased nasopharyngeal carcinoma cell proliferation and migration.'),
(6395, 'hsa-mir-155', 'nasopharyngeal carcinoma', 'up', 'Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.'),
(6396, 'hsa-mir-18a', 'nasopharyngeal carcinoma', 'up', 'miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.'),
(6397, 'hsa-mir-200b', 'nasopharyngeal carcinoma', 'down', 'miR-200b Suppresses Cell Growth, Migration and Invasion by Targeting Notch1 in Nasopharyngeal Carcinoma.'),
(6398, 'hsa-mir-204', 'nasopharyngeal carcinoma', 'down', 'Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.'),
(6399, 'hsa-mir-21', 'nasopharyngeal carcinoma', 'up', 'Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene.'),
(6400, 'hsa-mir-214', 'nasopharyngeal carcinoma', 'up', 'miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.'),
(6401, 'hsa-mir-214', 'nasopharyngeal carcinoma', 'up', 'Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma.'),
(6402, 'hsa-mir-216b', 'nasopharyngeal carcinoma', 'down', 'miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.'),
(6403, 'hsa-mir-216b', 'nasopharyngeal carcinoma', 'down', '[miR-216b suppresses cell proliferation and invasion by targeting PKC? in nasopharyngeal carcinoma cells].'),
(6404, 'hsa-mir-223', 'nasopharyngeal carcinoma', 'down', 'MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.'),
(6405, 'hsa-mir-24', 'nasopharyngeal carcinoma', 'up', '[Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma].'),
(6406, 'hsa-mir-29c', 'nasopharyngeal carcinoma', 'down', 'MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.'),
(6407, 'hsa-mir-320a', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma.'),
(6408, 'hsa-mir-324-3p', 'nasopharyngeal carcinoma', 'down', '[The expression and significance of miRNA-324-3p and WNT2B in nasopharyngeal carcinoma].'),
(6409, 'hsa-mir-324-3p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.'),
(6410, 'hsa-mir-34c', 'nasopharyngeal carcinoma', 'down', 'MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.'),
(6411, 'hsa-mir-375', 'nasopharyngeal carcinoma', 'down', 'Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.'),
(6412, 'hsa-mir-378', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.'),
(6413, 'hsa-mir-421', 'nasopharyngeal carcinoma', 'up', 'miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4.'),
(6414, 'hsa-mir-451', 'nasopharyngeal carcinoma', 'down', 'MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.'),
(6415, 'hsa-mir-506', 'nasopharyngeal carcinoma', 'down', 'MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.'),
(6416, 'hsa-mir-663', 'nasopharyngeal carcinoma', 'up', 'MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.'),
(6417, 'hsa-mir-744', 'nasopharyngeal carcinoma', 'up', 'MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.'),
(6418, 'hsa-mir-9', 'nasopharyngeal carcinoma', 'down', 'miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.'),
(6419, 'hsa-mir-93', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.'),
(6420, 'hsa-mir-98', 'nasopharyngeal carcinoma', 'down', 'MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression.'),
(6421, 'hsa-mir-155', 'nasopharyngeal carcinoma', 'up', 'Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.'),
(6422, 'hsa-mir-21', 'nasopharyngeal carcinoma', 'up', 'Downregulation of microRNA-21 enhances radiosensitivity in nasopharyngeal carcinoma.'),
(6423, 'hsa-mir-338', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1? in nasopharyngeal carcinoma.'),
(6424, 'hsa-mir-4649-3p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.'),
(6425, 'hsa-mir-494', 'nasopharyngeal carcinoma', 'down', 'Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node'),
(6426, 'hsa-mir-24', 'nasopharyngeal carcinoma', 'down', 'MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.'),
(6427, 'hsa-mir-4792', 'nasopharyngeal carcinoma', 'down', 'miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.'),
(6428, 'hsa-mir-497', 'nasopharyngeal carcinoma', 'down', 'The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.'),
(6429, 'hsa-mir-539', 'nasopharyngeal carcinoma', 'down', 'miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.'),
(6430, 'hsa-mir-744', 'nasopharyngeal carcinoma', 'up', 'Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma.'),
(6431, 'hsa-let-7a', 'nasopharyngeal carcinoma', 'down', 'Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.'),
(6432, 'hsa-mir-1', 'nasopharyngeal carcinoma', 'down', 'miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.'),
(6433, 'hsa-mir-142-3p', 'nasopharyngeal carcinoma', 'up', 'MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.'),
(6434, 'hsa-mir-16', 'nasopharyngeal carcinoma', 'down', 'miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.'),
(6435, 'hsa-mir-188', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-188 suppresses G 1 /S transition by targeting multiple cyclin/CDK complexes.'),
(6436, 'hsa-mir-24', 'nasopharyngeal carcinoma', 'down', 'MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.'),
(6437, 'hsa-mir-200a', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-?B.'),
(6438, 'hsa-mir-23b', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-23b regulates nasopharyngeal carcinoma cell proliferation and metastasis by targeting E-cadherin.'),
(6439, 'hsa-mir-24', 'nasopharyngeal carcinoma', 'down', 'Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3\'UTR and 5\'UTR of Jab1/CSN5.'),
(6440, 'hsa-mir-133b', 'nasopharyngeal carcinoma', 'down', 'miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.'),
(6441, 'hsa-mir-183', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.'),
(6442, 'hsa-mir-346', 'nasopharyngeal carcinoma', 'up', 'miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.'),
(6443, 'hsa-mir-34b', 'nasopharyngeal carcinoma', 'down', 'MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.'),
(6444, 'hsa-mir-34b', 'nasopharyngeal carcinoma', 'down', 'miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22.'),
(6445, 'hsa-mir-34c', 'nasopharyngeal carcinoma', 'down', 'MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.'),
(6446, 'hsa-mir-449a', 'nasopharyngeal carcinoma', 'down', 'MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.'),
(6447, 'hsa-mir-491-5p', 'nasopharyngeal carcinoma', 'down', 'miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.'),
(6448, 'hsa-mir-92a', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway.'),
(6449, 'hsa-mir-96', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.'),
(6450, 'hsa-mir-1275', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5.'),
(6451, 'hsa-mir-17-5p', 'nasopharyngeal carcinoma', 'up', 'MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.'),
(6452, 'hsa-let-7a', 'nasopharyngeal carcinoma', 'down', 'Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.'),
(6453, 'hsa-mir-101', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.'),
(6454, 'hsa-mir-138-5p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1.'),
(6455, 'hsa-mir-143', 'nasopharyngeal carcinoma', 'down', 'Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma.'),
(6456, 'hsa-mir-19b-3p', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-?B axis.'),
(6457, 'hsa-mir-26b', 'nasopharyngeal carcinoma', 'down', 'Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.'),
(6458, 'hsa-mir-324-3p', 'nasopharyngeal carcinoma', 'down', 'miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.'),
(6459, 'hsa-mir-99a', 'nasopharyngeal carcinoma', 'down', 'MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1.'),
(6460, 'hsa-mir-200c', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-200c plays an oncogenic role in nasopharyngeal carcinoma by targeting PTEN.'),
(6461, 'hsa-mir-212', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4.'),
(6462, 'hsa-mir-27a-3p', 'nasopharyngeal carcinoma', 'up', 'Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.'),
(6463, 'hsa-mir-124', 'nasopharyngeal carcinoma', 'down', 'MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.'),
(6464, 'hsa-mir-124', 'nasopharyngeal carcinoma', 'down', 'miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/?-catenin signaling pathway by targeting Capn4.'),
(6465, 'hsa-mir-125b', 'nasopharyngeal carcinoma', 'up', 'MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-?B signaling pathway.'),
(6466, 'hsa-mir-130a-3p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12.'),
(6467, 'hsa-mir-134-5p', 'nasopharyngeal carcinoma', 'down', 'Long non-coding RNA PCAT7 regulates ELF2 signaling through inhibition of miR-134-5p in nasopharyngeal carcinoma.'),
(6468, 'hsa-mir-148b', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2.'),
(6469, 'hsa-mir-17', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.'),
(6470, 'hsa-mir-183', 'nasopharyngeal carcinoma', 'down', 'MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.'),
(6471, 'hsa-mir-18a', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.'),
(6472, 'hsa-mir-19a', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.'),
(6473, 'hsa-mir-203a-3p', 'nasopharyngeal carcinoma', 'down', 'MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.'),
(6474, 'hsa-mir-20a', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-19a promotes nasopharyngeal carcinoma by targeting transforming growth factor ? receptor 2.'),
(6475, 'hsa-mir-29c', 'nasopharyngeal carcinoma', 'down', 'Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.'),
(6476, 'hsa-mir-572', 'nasopharyngeal carcinoma', 'down', 'Interaction between miR-572 and PPP2R2C, and their effects on the proliferation, migration, and invasion of nasopharyngeal carcinoma (NPC) cells.'),
(6477, 'hsa-mir-663', 'nasopharyngeal carcinoma', 'up', 'miR-663 promotes NPC cell proliferation by directly targeting CDKN2A.'),
(6478, 'hsa-mir-663b', 'nasopharyngeal carcinoma', 'up', 'miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.'),
(6479, 'hsa-mir-9-3p', 'nasopharyngeal carcinoma', 'down', 'Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.'),
(6480, 'hsa-mir-98', 'nasopharyngeal carcinoma', 'down', 'The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.'),
(6481, 'hsa-mir-222', 'nasopharyngeal carcinoma', 'up', 'microRNA-222 promotes tumor growth and confers radioresistance in nasopharyngeal carcinoma by targeting PTEN.'),
(6482, 'hsa-mir-324-3p', 'nasopharyngeal carcinoma', 'down', 'The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance.'),
(6483, 'hsa-mir-10b', 'nasopharyngeal carcinoma', 'up', 'Study of miR-10b regulatory mechanism for epithelial-mesenchymal transition, invasion and migration in nasopharyngeal carcinoma cells.'),
(6484, 'hsa-mir-124', 'nasopharyngeal carcinoma', 'down', 'Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-?B pathway.'),
(6485, 'hsa-mir-139-5p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.'),
(6486, 'hsa-mir-93', 'nasopharyngeal carcinoma', 'up', 'miR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma.'),
(6487, 'hsa-mir-1207', 'nasopharyngeal carcinoma', 'down', 'Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.'),
(6488, 'hsa-mir-135a', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17.'),
(6489, 'hsa-mir-141', 'nasopharyngeal carcinoma', 'up', 'BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.'),
(6490, 'hsa-mir-152', 'nasopharyngeal carcinoma', 'down', 'MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma.'),
(6491, 'hsa-mir-185', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-?1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.'),
(6492, 'hsa-mir-328', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.'),
(6493, 'hsa-mir-342', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1.'),
(6494, 'hsa-mir-371-5p', 'nasopharyngeal carcinoma', 'down', 'miR-371-5p suppresses the proliferative and migratory capacity of human nasopharyngeal carcinoma by targeting BCL2.'),
(6495, 'hsa-mir-379', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52.'),
(6496, 'hsa-mir-425', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma-derived growth factor.'),
(6497, 'hsa-mir-9', 'nasopharyngeal carcinoma', 'down', 'Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.'),
(6498, 'hsa-mir-184', 'nasopharyngeal carcinoma', 'down', 'miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.'),
(6499, 'hsa-mir-19b', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS.'),
(6500, 'hsa-mir-494-3p', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.'),
(6501, 'hsa-mir-597', 'nasopharyngeal carcinoma', 'up', 'MiR-597 Targeting 14-3-3? Enhances Cellular Invasion and EMT in Nasopharyngeal Carcinoma Cells.'),
(6502, 'hsa-mir-663b', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-663b promotes cell proliferation and epithelial mesenchymal transition by directly targeting SMAD7 in nasopharyngeal carcinoma.'),
(6503, 'hsa-mir-103', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-103 promotes nasopharyngeal carcinoma through targeting TIMP-3 and the Wnt/?-catenin pathway.'),
(6504, 'hsa-mir-1178-3p', 'nasopharyngeal carcinoma', 'up', 'MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.'),
(6505, 'hsa-mir-122-5p', 'nasopharyngeal carcinoma', 'down', 'MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.'),
(6506, 'hsa-mir-135a', 'nasopharyngeal carcinoma', 'down', 'Knockdown of lncRNA ZFAS1 inhibits progression of nasopharyngeal carcinoma by sponging miR-135a.'),
(6507, 'hsa-mir-142', 'nasopharyngeal carcinoma', 'up', 'MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.'),
(6508, 'hsa-mir-142-3p', 'nasopharyngeal carcinoma', 'down', 'EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma.'),
(6509, 'hsa-mir-143', 'nasopharyngeal carcinoma', 'down', 'miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings.'),
(6510, 'hsa-mir-150-5p', 'nasopharyngeal carcinoma', 'down', 'CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.'),
(6511, 'hsa-mir-18a-5p', 'nasopharyngeal carcinoma', 'up', 'Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.'),
(6512, 'hsa-mir-194', 'nasopharyngeal carcinoma', 'down', 'MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.'),
(6513, 'hsa-mir-29a', 'nasopharyngeal carcinoma', 'down', 'microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5-8F cells through targeting VEGF.'),
(6514, 'hsa-mir-32', 'nasopharyngeal carcinoma', 'up', 'Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.'),
(6515, 'hsa-mir-342-3p', 'nasopharyngeal carcinoma', 'down', 'microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.'),
(6516, 'hsa-mir-34a-5p', 'nasopharyngeal carcinoma', 'down', 'The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/?-Catenin Signaling.'),
(6517, 'hsa-mir-34c-3p', 'nasopharyngeal carcinoma', 'up', 'Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.'),
(6518, 'hsa-mir-429', 'nasopharyngeal carcinoma', 'down', 'miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1.'),
(6519, 'hsa-mir-4301', 'nasopharyngeal carcinoma', 'down', 'Long Noncoding RNA HOTTIP Promotes Nasopharyngeal Cancer Cell Proliferation, Migration, and Invasion by Inhibiting miR-4301.'),
(6520, 'hsa-mir-449b-3p', 'nasopharyngeal carcinoma', 'down', 'Feedback loop in miR-449b-3p/ADAM17/NF-?B promotes metastasis in nasopharyngeal carcinoma.'),
(6521, 'hsa-mir-449b-5p', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.'),
(6522, 'hsa-mir-506', 'nasopharyngeal carcinoma', 'down', 'MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/?-catenin signaling pathway by down-regulating LHX2.'),
(6523, 'hsa-mir-613', 'nasopharyngeal carcinoma', 'down', 'microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.'),
(6524, 'hsa-mir-874-3p', 'nasopharyngeal carcinoma', 'down', 'MiR-874-3p suppresses cell proliferation and invasion by targeting ADAM19 in nasopharyngeal carcinoma.'),
(6525, 'hsa-mir-99a', 'nasopharyngeal carcinoma', 'down', 'MiR-99a inhibits cell proliferation of nasopharyngeal carcinoma by targeting mTOR and serves as a prognostic factor.'),
(6526, 'hsa-mir-429', 'nephroblastoma', 'down', 'MiR-429 regulates the proliferation and apoptosis of nephroblastoma cells through targeting c-myc.'),
(6527, 'hsa-mir-130b-3p', 'nephroblastoma', 'up', 'Aberrant expression and mechanism of miR-130b-3p/phosphatase and tensin homolog in nephroblastoma in children.'),
(6528, 'hsa-mir-200c-3p', 'nephroblastoma', 'down', 'miR-200c-3p Suppresses the Proliferative, Migratory, and Invasive Capacities of Nephroblastoma Cells via Targeting FRS2.'),
(6529, 'hsa-let-7a-1', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6530, 'hsa-let-7a-2', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6531, 'hsa-let-7a-3', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6532, 'hsa-let-7b', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6533, 'hsa-let-7c', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6534, 'hsa-let-7d', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6535, 'hsa-let-7e', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6536, 'hsa-let-7f-1', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6537, 'hsa-let-7f-2', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6538, 'hsa-let-7g', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6539, 'hsa-let-7i', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6540, 'hsa-mir-124', 'neuroblastoma', 'down', 'Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR.'),
(6541, 'hsa-mir-125b', 'neuroblastoma', 'up', 'MicroRNA-125b is a novel negative regulator of p53.'),
(6542, 'hsa-mir-137', 'neuroblastoma', 'down', 'MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.'),
(6543, 'hsa-mir-145', 'neuroblastoma', 'down', 'NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.'),
(6544, 'hsa-mir-15a', 'neuroblastoma', 'up', 'miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.'),
(6545, 'hsa-mir-15a', 'neuroblastoma', 'up', 'MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.'),
(6546, 'hsa-mir-15b', 'neuroblastoma', 'up', 'miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.'),
(6547, 'hsa-mir-16-1', 'neuroblastoma', 'up', 'miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.'),
(6548, 'hsa-mir-16-2', 'neuroblastoma', 'up', 'miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.'),
(6549, 'hsa-mir-181c', 'neuroblastoma', 'down', 'MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.'),
(6550, 'hsa-mir-184', 'neuroblastoma', 'down', 'MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.'),
(6551, 'hsa-mir-184', 'neuroblastoma', 'down', 'MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.'),
(6552, 'hsa-mir-18a', 'neuroblastoma', 'up', 'MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.'),
(6553, 'hsa-mir-195', 'neuroblastoma', 'up', 'miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.'),
(6554, 'hsa-mir-19a', 'neuroblastoma', 'up', 'MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.'),
(6555, 'hsa-mir-200a', 'neuroblastoma', 'down', 'miR-200a inhibits tumor proliferation by targeting AP-2? in neuroblastoma cells.'),
(6556, 'hsa-mir-23a', 'neuroblastoma', 'up', 'MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1.'),
(6557, 'hsa-mir-29a', 'neuroblastoma', 'down', 'Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.'),
(6558, 'hsa-mir-335', 'neuroblastoma', 'down', 'MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-? Signalling Pathway.'),
(6559, 'hsa-mir-338-3p', 'neuroblastoma', 'down', 'miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.'),
(6560, 'hsa-mir-34a', 'neuroblastoma', 'down', 'A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.'),
(6561, 'hsa-mir-34a', 'neuroblastoma', 'down', 'MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(6562, 'hsa-mir-421', 'neuroblastoma', 'up', 'Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.'),
(6563, 'hsa-mir-449a', 'neuroblastoma', 'down', 'microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.'),
(6564, 'hsa-mir-885-5p', 'neuroblastoma', 'down', 'MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.'),
(6565, 'hsa-mir-92', 'neuroblastoma', 'up', 'MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.'),
(6566, 'hsa-mir-98', 'neuroblastoma', 'down', 'LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.'),
(6567, 'hsa-mir-337-3p', 'neuroblastoma', 'down', 'miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.'),
(6568, 'hsa-mir-362-5p', 'neuroblastoma', 'down', 'miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2?.'),
(6569, 'hsa-mir-130b', 'neuroblastoma', 'up', 'MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.'),
(6570, 'hsa-mir-558', 'neuroblastoma', 'up', 'microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5\'-untranslated region in neuroblastoma.'),
(6571, 'hsa-mir-1303', 'neuroblastoma', 'up', 'miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3? and SFRP1.'),
(6572, 'hsa-mir-21', 'neuroblastoma', 'up', 'MicroRNA-21 promotes the proliferation and invasion of neuroblastoma cells through targeting CHL1.'),
(6573, 'hsa-mir-221', 'neuroblastoma', 'up', 'microRNA-221 enhances MYCN via targeting nemo-like kinase, and functions as an oncogene related to poor prognosis in neuroblastoma.'),
(6574, 'hsa-mir-506', 'neuroblastoma', 'down', 'miR-506 suppresses neuroblastoma metastasis by targeting ROCK1.'),
(6575, 'hsa-mir-149', 'neuroblastoma', 'down', 'MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.'),
(6576, 'hsa-mir-205', 'neuroblastoma', 'down', 'MiR-205 Inhibits Growth and Invasion of Neuroblastoma by Targeting cAMP Responsive Element Binding Protein 1.'),
(6577, 'hsa-mir-513c', 'neuroblastoma', 'down', 'MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS).'),
(6578, 'hsa-mir-20a-5p', 'neuroblastoma', 'down', 'MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.'),
(6579, 'hsa-mir-675', 'neuroblastoma', 'up', 'Angelica sinensis polysaccharide inhibits proliferation, migration, and invasion by downregulating microRNA-675 in human neuroblastoma cell line SH-SY5Y.'),
(6580, 'hsa-mir-146a', 'neuroblastoma', 'down', 'miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A.'),
(6581, 'hsa-mir-181a', 'neuroblastoma', 'up', 'MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.'),
(6582, 'hsa-mir-181b', 'neuroblastoma', 'up', 'MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.'),
(6583, 'hsa-mir-204', 'neuroblastoma', 'down', 'Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.'),
(6584, 'hsa-mir-186', 'neuroblastoma', 'down', 'Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.'),
(6585, 'hsa-mir-665', 'neuroblastoma', 'down', 'miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth.'),
(6586, 'hsa-mir-144-3p', 'neuroblastoma', 'down', 'microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7.'),
(6587, 'hsa-mir-181c', 'neuroblastoma', 'down', 'miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells.'),
(6588, 'hsa-mir-34a', 'neuroblastoma', 'down', 'miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.'),
(6589, 'hsa-mir-373', 'neuroblastoma', 'up', 'miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1.'),
(6590, 'hsa-let-7a', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6591, 'hsa-let-7c', 'non-small cell lung cancer', 'down', 'MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.'),
(6592, 'hsa-mir-1', 'non-small cell lung cancer', 'down', 'MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.'),
(6593, 'hsa-mir-100', 'non-small cell lung cancer', 'down', 'MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.'),
(6594, 'hsa-mir-101', 'non-small cell lung cancer', 'down', 'MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.'),
(6595, 'hsa-mir-101', 'non-small cell lung cancer', 'down', 'MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.'),
(6596, 'hsa-mir-106a', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6597, 'hsa-mir-107', 'non-small cell lung cancer', 'down', 'Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.'),
(6598, 'hsa-mir-10b', 'non-small cell lung cancer', 'up', 'microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.'),
(6599, 'hsa-mir-10b', 'non-small cell lung cancer', 'up', 'MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin.'),
(6600, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.'),
(6601, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.'),
(6602, 'hsa-mir-125a-3p', 'non-small cell lung cancer', 'down', 'Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.'),
(6603, 'hsa-mir-125a-3p', 'non-small cell lung cancer', 'down', 'miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.'),
(6604, 'hsa-mir-125a-5p', 'non-small cell lung cancer', 'down', 'Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.'),
(6605, 'hsa-mir-125a-5p', 'non-small cell lung cancer', 'up', 'Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.'),
(6606, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.'),
(6607, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.'),
(6608, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.'),
(6609, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.'),
(6610, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.'),
(6611, 'hsa-mir-126*', 'non-small cell lung cancer', 'down', 'Clinical evaluation of microRNA expression profiling in non small cell lung cancer.'),
(6612, 'hsa-mir-1280', 'non-small cell lung cancer', 'up', 'Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues.'),
(6613, 'hsa-mir-129', 'non-small cell lung cancer', 'down', 'MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer.'),
(6614, 'hsa-mir-133a', 'non-small cell lung cancer', 'down', 'MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance.'),
(6615, 'hsa-mir-136', 'non-small cell lung cancer', 'up', 'Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.'),
(6616, 'hsa-mir-137', 'non-small cell lung cancer', 'down', 'microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.'),
(6617, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer.'),
(6618, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells.'),
(6619, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.'),
(6620, 'hsa-mir-140', 'non-small cell lung cancer', 'up', 'Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.'),
(6621, 'hsa-mir-140', 'non-small cell lung cancer', 'down', 'miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor.'),
(6622, 'hsa-mir-141', 'non-small cell lung cancer', 'up', 'High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.'),
(6623, 'hsa-mir-141', 'non-small cell lung cancer', 'up', 'MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2.'),
(6624, 'hsa-mir-141', 'non-small cell lung cancer', 'up', 'MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.'),
(6625, 'hsa-mir-142-3p', 'non-small cell lung cancer', 'up', 'MiR-142-3p represses TGF-?-induced growth inhibition through repression of TGF?R1 in non-small cell lung cancer.'),
(6626, 'hsa-mir-143', 'non-small cell lung cancer', 'down', 'miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells.'),
(6627, 'hsa-mir-143', 'non-small cell lung cancer', 'down', 'miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.'),
(6628, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.'),
(6629, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.'),
(6630, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.'),
(6631, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer.'),
(6632, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'Low miR-145 expression level is associated with poor pathological differentiation and poor prognosis in non-small cell lung cancer.'),
(6633, 'hsa-mir-145', 'non-small cell lung cancer', 'up', 'Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.'),
(6634, 'hsa-mir-146a', 'non-small cell lung cancer', 'down', 'miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.'),
(6635, 'hsa-mir-146a', 'non-small cell lung cancer', 'down', 'MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.'),
(6636, 'hsa-mir-146a', 'non-small cell lung cancer', 'up', 'Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.'),
(6637, 'hsa-mir-146b', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6638, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.'),
(6639, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.'),
(6640, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells.'),
(6641, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA).'),
(6642, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.'),
(6643, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.'),
(6644, 'hsa-mir-149', 'non-small cell lung cancer', 'down', 'miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1.'),
(6645, 'hsa-mir-150', 'non-small cell lung cancer', 'up', 'Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.'),
(6646, 'hsa-mir-152', 'non-small cell lung cancer', 'down', 'MicroRNA-152 targets ADAM17 to suppress NSCLC progression.'),
(6647, 'hsa-mir-152', 'non-small cell lung cancer', 'down', 'Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.'),
(6648, 'hsa-mir-153', 'non-small cell lung cancer', 'down', 'MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.'),
(6649, 'hsa-mir-154', 'non-small cell lung cancer', 'down', 'miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo.'),
(6650, 'hsa-mir-155', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6651, 'hsa-mir-15a', 'non-small cell lung cancer', 'down', 'MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.'),
(6652, 'hsa-mir-16', 'non-small cell lung cancer', 'down', 'Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.'),
(6653, 'hsa-mir-17-5p', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6654, 'hsa-mir-181a-1', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6655, 'hsa-mir-181a-2', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6656, 'hsa-mir-181b', 'non-small cell lung cancer', 'down', 'Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.'),
(6657, 'hsa-mir-181b-1', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6658, 'hsa-mir-181b-2', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6659, 'hsa-mir-181c', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6660, 'hsa-mir-181d', 'non-small cell lung cancer', 'down', 'MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.'),
(6661, 'hsa-mir-184', 'non-small cell lung cancer', 'down', 'MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.'),
(6662, 'hsa-mir-186', 'non-small cell lung cancer', 'down', 'miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.'),
(6663, 'hsa-mir-186', 'non-small cell lung cancer', 'down', 'MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells.'),
(6664, 'hsa-mir-18a', 'non-small cell lung cancer', 'up', 'Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.'),
(6665, 'hsa-mir-193b', 'non-small cell lung cancer', 'down', 'MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.'),
(6666, 'hsa-mir-195', 'non-small cell lung cancer', 'down', 'MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.'),
(6667, 'hsa-mir-195', 'non-small cell lung cancer', 'down', 'MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.'),
(6668, 'hsa-mir-195', 'non-small cell lung cancer', 'down', 'miR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.'),
(6669, 'hsa-mir-196a', 'non-small cell lung cancer', 'up', 'MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.'),
(6670, 'hsa-mir-199a', 'non-small cell lung cancer', 'down', 'MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1?'),
(6671, 'hsa-mir-19a', 'non-small cell lung cancer', 'up', 'Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.'),
(6672, 'hsa-mir-200a', 'non-small cell lung cancer', 'up', 'MiR-200a enhances the migrations of A549 and SK-MES-1 cells by regulating the expression of TSPAN1.'),
(6673, 'hsa-mir-200c', 'non-small cell lung cancer', 'up', 'Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.'),
(6674, 'hsa-mir-200c', 'non-small cell lung cancer', 'up', 'High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.'),
(6675, 'hsa-mir-204', 'non-small cell lung cancer', 'down', 'miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC.'),
(6676, 'hsa-mir-204', 'non-small cell lung cancer', 'down', 'MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.'),
(6677, 'hsa-mir-205', 'non-small cell lung cancer', 'up', 'Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.'),
(6678, 'hsa-mir-205', 'non-small cell lung cancer', 'up', 'miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.'),
(6679, 'hsa-mir-205-3p', 'non-small cell lung cancer', 'up', 'Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.'),
(6680, 'hsa-mir-205-5p', 'non-small cell lung cancer', 'up', 'Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.'),
(6681, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.'),
(6682, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Clinical evaluation of microRNA expression profiling in non small cell lung cancer.'),
(6683, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.'),
(6684, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.'),
(6685, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer.'),
(6686, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.'),
(6687, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features.'),
(6688, 'hsa-mir-21', 'non-small cell lung cancer', 'up', '[Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].'),
(6689, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells.'),
(6690, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.'),
(6691, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.'),
(6692, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.'),
(6693, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer.'),
(6694, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China.'),
(6695, 'hsa-mir-212', 'non-small cell lung cancer', 'down', 'miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.'),
(6696, 'hsa-mir-212', 'non-small cell lung cancer', 'up', 'MiR-212 displays Tumor Promoting properties in NSCLC Cells and targets the Hedgehog Pathway Receptor PTCH1.'),
(6697, 'hsa-mir-212', 'non-small cell lung cancer', 'up', 'Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.'),
(6698, 'hsa-mir-22', 'non-small cell lung cancer', 'up', 'Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.'),
(6699, 'hsa-mir-221', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6700, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'MicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.'),
(6701, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(6702, 'hsa-mir-222', 'non-small cell lung cancer', 'up', 'miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(6703, 'hsa-mir-222', 'non-small cell lung cancer', 'up', 'Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.'),
(6704, 'hsa-mir-224', 'non-small cell lung cancer', 'down', 'Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.'),
(6705, 'hsa-mir-24', 'non-small cell lung cancer', 'up', 'Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer.'),
(6706, 'hsa-mir-24', 'non-small cell lung cancer', 'up', 'Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.'),
(6707, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.'),
(6708, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'miR-25 targets the modulator of apoptosis 1 gene in lung cancer.'),
(6709, 'hsa-mir-26b', 'non-small cell lung cancer', 'down', 'Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.'),
(6710, 'hsa-mir-27a', 'non-small cell lung cancer', 'down', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6711, 'hsa-mir-27b', 'non-small cell lung cancer', 'down', 'MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.'),
(6712, 'hsa-mir-29a', 'non-small cell lung cancer', 'down', 'Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.'),
(6713, 'hsa-mir-29b', 'non-small cell lung cancer', 'down', 'Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.'),
(6714, 'hsa-mir-29b', 'non-small cell lung cancer', 'down', 'Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.'),
(6715, 'hsa-mir-29b', 'non-small cell lung cancer', 'down', 'MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.'),
(6716, 'hsa-mir-29c', 'non-small cell lung cancer', 'down', 'Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.'),
(6717, 'hsa-mir-29c', 'non-small cell lung cancer', 'up', 'Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.'),
(6718, 'hsa-mir-29c', 'non-small cell lung cancer', 'up', 'Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer.'),
(6719, 'hsa-mir-30a', 'non-small cell lung cancer', 'down', 'MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.'),
(6720, 'hsa-mir-30a', 'non-small cell lung cancer', 'down', 'MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.'),
(6721, 'hsa-mir-30b', 'non-small cell lung cancer', 'down', 'MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.'),
(6722, 'hsa-mir-30c', 'non-small cell lung cancer', 'down', 'MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.'),
(6723, 'hsa-mir-30c', 'non-small cell lung cancer', 'down', 'Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer.'),
(6724, 'hsa-mir-30d', 'non-small cell lung cancer', 'down', 'Clinical evaluation of microRNA expression profiling in non small cell lung cancer.'),
(6725, 'hsa-mir-30d-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer.'),
(6726, 'hsa-mir-30e-5p', 'non-small cell lung cancer', 'down', 'Clinical evaluation of microRNA expression profiling in non small cell lung cancer.'),
(6727, 'hsa-mir-31', 'non-small cell lung cancer', 'up', 'Use of Luminex xMAP bead-based suspension array for detecting microRNA in NSCLC tissues and its clinical application.'),
(6728, 'hsa-mir-32', 'non-small cell lung cancer', 'down', 'Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.'),
(6729, 'hsa-mir-32', 'non-small cell lung cancer', 'down', 'Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.'),
(6730, 'hsa-mir-328', 'non-small cell lung cancer', 'up', 'Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.'),
(6731, 'hsa-mir-330-3p', 'non-small cell lung cancer', 'up', 'miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.'),
(6732, 'hsa-mir-335', 'non-small cell lung cancer', 'down', 'Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.'),
(6733, 'hsa-mir-338-3p', 'non-small cell lung cancer', 'down', 'microRNA-338-3p functions as a tumor suppressor in human non?small?cell lung carcinoma and targets Ras-related protein 14.'),
(6734, 'hsa-mir-339', 'non-small cell lung cancer', 'up', 'Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC.'),
(6735, 'hsa-mir-340', 'non-small cell lung cancer', 'down', 'miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer.'),
(6736, 'hsa-mir-342-3p', 'non-small cell lung cancer', 'down', 'miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.'),
(6737, 'hsa-mir-34a', 'non-small cell lung cancer', 'up', 'Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.'),
(6738, 'hsa-mir-34a', 'non-small cell lung cancer', 'down', 'Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.'),
(6739, 'hsa-mir-34a', 'non-small cell lung cancer', 'down', 'The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells.'),
(6740, 'hsa-mir-34b', 'non-small cell lung cancer', 'down', 'MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.'),
(6741, 'hsa-mir-361-3p', 'non-small cell lung cancer', 'down', 'Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.'),
(6742, 'hsa-mir-365', 'non-small cell lung cancer', 'down', 'Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.'),
(6743, 'hsa-mir-373', 'non-small cell lung cancer', 'down', 'Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.'),
(6744, 'hsa-mir-375', 'non-small cell lung cancer', 'down', 'Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.'),
(6745, 'hsa-mir-375', 'non-small cell lung cancer', 'up', 'Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.'),
(6746, 'hsa-mir-429', 'non-small cell lung cancer', 'down', 'Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.'),
(6747, 'hsa-mir-449a', 'non-small cell lung cancer', 'down', 'MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met.'),
(6748, 'hsa-mir-449a', 'non-small cell lung cancer', 'down', 'microRNA-449a Suppresses Non-small Cell Lung Cancer.'),
(6749, 'hsa-mir-4500', 'non-small cell lung cancer', 'down', 'Down-regulation of miR-4500 promoted non-small cell lung cancer growth.'),
(6750, 'hsa-mir-451', 'non-small cell lung cancer', 'down', 'Clinical evaluation of microRNA expression profiling in non small cell lung cancer.'),
(6751, 'hsa-mir-451', 'non-small cell lung cancer', 'down', 'MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).'),
(6752, 'hsa-mir-451', 'non-small cell lung cancer', 'down', 'The expression and function of miRNA-451 in non-small cell lung cancer.'),
(6753, 'hsa-mir-4782-3p', 'non-small cell lung cancer', 'down', 'miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14.'),
(6754, 'hsa-mir-494', 'non-small cell lung cancer', 'up', 'Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.'),
(6755, 'hsa-mir-494', 'non-small cell lung cancer', 'up', 'Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer.'),
(6756, 'hsa-mir-497', 'non-small cell lung cancer', 'down', 'Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.'),
(6757, 'hsa-mir-503', 'non-small cell lung cancer', 'down', 'Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.'),
(6758, 'hsa-mir-512-3p', 'non-small cell lung cancer', 'down', 'Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.'),
(6759, 'hsa-mir-520a-3p', 'non-small cell lung cancer', 'down', 'The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer.'),
(6760, 'hsa-mir-526b', 'non-small cell lung cancer', 'down', 'By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.'),
(6761, 'hsa-mir-625*', 'non-small cell lung cancer', 'down', 'Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.'),
(6762, 'hsa-mir-675-5p', 'non-small cell lung cancer', 'up', 'Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.'),
(6763, 'hsa-mir-9', 'non-small cell lung cancer', 'up', 'Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.'),
(6764, 'hsa-mir-92b', 'non-small cell lung cancer', 'up', 'MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.'),
(6765, 'hsa-mir-92b', 'non-small cell lung cancer', 'up', 'Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.'),
(6766, 'hsa-mir-93', 'non-small cell lung cancer', 'up', 'Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer.'),
(6767, 'hsa-mir-95', 'non-small cell lung cancer', 'up', 'MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.'),
(6768, 'hsa-mir-96', 'non-small cell lung cancer', 'down', 'Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer.'),
(6769, 'hsa-mir-99a', 'non-small cell lung cancer', 'down', 'microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.'),
(6770, 'hsa-mir-99a', 'non-small cell lung cancer', 'down', 'miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.'),
(6771, 'hsa-mir-100', 'non-small cell lung cancer', 'down', 'Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.'),
(6772, 'hsa-mir-10a', 'non-small cell lung cancer', 'up', 'MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.'),
(6773, 'hsa-mir-1238', 'non-small cell lung cancer', 'down', 'miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.'),
(6774, 'hsa-mir-1246', 'non-small cell lung cancer', 'up', 'The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4.'),
(6775, 'hsa-mir-138', 'non-small cell lung cancer', 'up', 'MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3.'),
(6776, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.'),
(6777, 'hsa-mir-139', 'non-small cell lung cancer', 'down', 'Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.'),
(6778, 'hsa-mir-139-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.'),
(6779, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.'),
(6780, 'hsa-mir-146a', 'non-small cell lung cancer', 'down', 'MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.'),
(6781, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC.'),
(6782, 'hsa-mir-181a-5p', 'non-small cell lung cancer', 'down', 'MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.'),
(6783, 'hsa-mir-193a-3p', 'non-small cell lung cancer', 'down', 'Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues.'),
(6784, 'hsa-mir-203', 'non-small cell lung cancer', 'down', 'MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.'),
(6785, 'hsa-mir-206', 'non-small cell lung cancer', 'down', 'miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9.'),
(6786, 'hsa-mir-211', 'non-small cell lung cancer', 'up', 'miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.'),
(6787, 'hsa-mir-222', 'non-small cell lung cancer', 'up', 'MicroRNA-222 promotes human non-small cell lung cancer H460 growth by targeting p27.'),
(6788, 'hsa-mir-224', 'non-small cell lung cancer', 'up', 'MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.'),
(6789, 'hsa-mir-30a', 'non-small cell lung cancer', 'down', 'Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.'),
(6790, 'hsa-mir-32', 'non-small cell lung cancer', 'down', 'miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer.'),
(6791, 'hsa-mir-34c-3p', 'non-small cell lung cancer', 'down', 'MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.'),
(6792, 'hsa-mir-365', 'non-small cell lung cancer', 'down', 'Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.'),
(6793, 'hsa-mir-370', 'non-small cell lung cancer', 'down', 'MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.'),
(6794, 'hsa-mir-410', 'non-small cell lung cancer', 'up', 'MicroRNA-410 promotes cell proliferation by targeting BRD7 in non-small cell lung cancer.'),
(6795, 'hsa-mir-497', 'non-small cell lung cancer', 'down', 'MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer.'),
(6796, 'hsa-mir-498', 'non-small cell lung cancer', 'down', 'MicroRNA-498 is downregulated in non-small cell lung cancer and correlates with tumor progression.'),
(6797, 'hsa-mir-503', 'non-small cell lung cancer', 'down', 'Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.'),
(6798, 'hsa-mir-630', 'non-small cell lung cancer', 'down', 'miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.'),
(6799, 'hsa-mir-7', 'non-small cell lung cancer', 'down', 'MicroRNA-7 inhibits the malignant phenotypes of non?small cell lung cancer in vitro by targeting Pax6.'),
(6800, 'hsa-mir-761', 'non-small cell lung cancer', 'up', 'MiR-761 Promotes Progression and Metastasis of Non-Small Cell Lung Cancer by Targeting ING4 and TIMP2.'),
(6801, 'hsa-mir-125b', 'non-small cell lung cancer', 'up', 'MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.'),
(6802, 'hsa-mir-1260b', 'non-small cell lung cancer', 'up', 'Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.'),
(6803, 'hsa-mir-1290', 'non-small cell lung cancer', 'up', 'miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.'),
(6804, 'hsa-mir-137', 'non-small cell lung cancer', 'down', 'MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.'),
(6805, 'hsa-mir-140-3p', 'non-small cell lung cancer', 'down', 'MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.'),
(6806, 'hsa-mir-142-3p', 'non-small cell lung cancer', 'down', 'MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.'),
(6807, 'hsa-mir-147', 'non-small cell lung cancer', 'down', 'Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung caner.'),
(6808, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small-Cell Lung Cancer.'),
(6809, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.'),
(6810, 'hsa-mir-150', 'non-small cell lung cancer', 'up', 'Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.'),
(6811, 'hsa-mir-155', 'non-small cell lung cancer', 'up', 'Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas.'),
(6812, 'hsa-mir-185', 'non-small cell lung cancer', 'down', 'miR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.'),
(6813, 'hsa-mir-200a', 'non-small cell lung cancer', 'down', 'MicroRNA-200a Targets EGFR and c-Met to Inhibit Migration, Invasion, and Gefitinib Resistance in Non-Small Cell Lung Cancer.'),
(6814, 'hsa-mir-204', 'non-small cell lung cancer', 'down', 'Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.'),
(6815, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.'),
(6816, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19.'),
(6817, 'hsa-mir-23a', 'non-small cell lung cancer', 'up', 'Clinical value of microRNA-23a upregulation in non-small cell lung cancer.'),
(6818, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3.'),
(6819, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'miR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.'),
(6820, 'hsa-mir-30b', 'non-small cell lung cancer', 'down', 'microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer.'),
(6821, 'hsa-mir-449a', 'non-small cell lung cancer', 'down', 'MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.'),
(6822, 'hsa-mir-452', 'non-small cell lung cancer', 'down', 'Up-Regulation of MiR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1.'),
(6823, 'hsa-mir-497', 'non-small cell lung cancer', 'down', 'Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.'),
(6824, 'hsa-mir-9', 'non-small cell lung cancer', 'up', 'Oncogenic miR-9 is a target of erlotinib in NSCLCs.'),
(6825, 'hsa-mir-92a', 'non-small cell lung cancer', 'up', 'MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.'),
(6826, 'hsa-mir-106a', 'non-small cell lung cancer', 'up', 'miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.'),
(6827, 'hsa-mir-1246', 'non-small cell lung cancer', 'up', 'Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.'),
(6828, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.'),
(6829, 'hsa-mir-1271', 'non-small cell lung cancer', 'down', 'Inhibition of the growth of non-small cell lung cancer by miRNA-1271.'),
(6830, 'hsa-mir-1290', 'non-small cell lung cancer', 'up', 'Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.'),
(6831, 'hsa-mir-152', 'non-small cell lung cancer', 'down', 'MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1.'),
(6832, 'hsa-mir-15b-5p', 'non-small cell lung cancer', 'up', 'Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.'),
(6833, 'hsa-mir-16-5p', 'non-small cell lung cancer', 'down', 'Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.'),
(6834, 'hsa-mir-194', 'non-small cell lung cancer', 'down', 'MiR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.'),
(6835, 'hsa-mir-204', 'non-small cell lung cancer', 'down', 'miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.'),
(6836, 'hsa-mir-20a-5p', 'non-small cell lung cancer', 'down', 'Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.'),
(6837, 'hsa-mir-215', 'non-small cell lung cancer', 'down', 'miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.'),
(6838, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.'),
(6839, 'hsa-mir-26b', 'non-small cell lung cancer', 'down', 'MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-?B/MMP-9/VEGF pathways.'),
(6840, 'hsa-mir-329', 'non-small cell lung cancer', 'down', 'Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.'),
(6841, 'hsa-mir-345', 'non-small cell lung cancer', 'down', 'Prognostic significance of tissue miR-345 downregulation in non-small cell lung cancer.'),
(6842, 'hsa-mir-377', 'non-small cell lung cancer', 'down', 'microRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1.'),
(6843, 'hsa-mir-455', 'non-small cell lung cancer', 'down', 'MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1.'),
(6844, 'hsa-mir-499-5p', 'non-small cell lung cancer', 'down', 'Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.'),
(6845, 'hsa-mir-512-5p', 'non-small cell lung cancer', 'down', 'miR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.'),
(6846, 'hsa-mir-652-3p', 'non-small cell lung cancer', 'up', 'MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.'),
(6847, 'hsa-mir-96', 'non-small cell lung cancer', 'up', 'miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9.'),
(6848, 'hsa-mir-98', 'non-small cell lung cancer', 'down', 'MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1.'),
(6849, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'miRNA-124 modulates lung carcinoma cell migration and invasion.'),
(6850, 'hsa-mir-126', 'non-small cell lung cancer', 'down', 'Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.'),
(6851, 'hsa-mir-133a', 'non-small cell lung cancer', 'down', 'Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer.'),
(6852, 'hsa-mir-134', 'non-small cell lung cancer', 'down', 'miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.'),
(6853, 'hsa-mir-134', 'non-small cell lung cancer', 'down', 'Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.'),
(6854, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.'),
(6855, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.'),
(6856, 'hsa-mir-154', 'non-small cell lung cancer', 'down', 'MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer.'),
(6857, 'hsa-mir-182', 'non-small cell lung cancer', 'up', 'Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.'),
(6858, 'hsa-mir-183', 'non-small cell lung cancer', 'up', 'Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(6859, 'hsa-mir-1908', 'non-small cell lung cancer', 'down', 'miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells.'),
(6860, 'hsa-mir-203', 'non-small cell lung cancer', 'down', 'MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.'),
(6861, 'hsa-mir-203', 'non-small cell lung cancer', 'down', 'MiR-145 and miR-203 represses TGF-?-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.'),
(6862, 'hsa-mir-210', 'non-small cell lung cancer', 'up', 'Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.'),
(6863, 'hsa-mir-320', 'non-small cell lung cancer', 'down', 'MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.'),
(6864, 'hsa-mir-361-3p', 'non-small cell lung cancer', 'down', 'MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.'),
(6865, 'hsa-mir-454', 'non-small cell lung cancer', 'up', 'MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.'),
(6866, 'hsa-mir-491-5p', 'non-small cell lung cancer', 'down', 'MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.'),
(6867, 'hsa-mir-663a', 'non-small cell lung cancer', 'down', 'MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.'),
(6868, 'hsa-mir-107', 'non-small cell lung cancer', 'down', 'MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.'),
(6869, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.'),
(6870, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.'),
(6871, 'hsa-mir-135a', 'non-small cell lung cancer', 'down', 'Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.'),
(6872, 'hsa-mir-141', 'non-small cell lung cancer', 'down', 'Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.'),
(6873, 'hsa-mir-146a-5p', 'non-small cell lung cancer', 'down', 'MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.'),
(6874, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.'),
(6875, 'hsa-mir-154', 'non-small cell lung cancer', 'down', 'miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.'),
(6876, 'hsa-mir-184', 'non-small cell lung cancer', 'up', 'Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.'),
(6877, 'hsa-mir-187-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.'),
(6878, 'hsa-mir-1976', 'non-small cell lung cancer', 'down', 'MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1.'),
(6879, 'hsa-mir-200b', 'non-small cell lung cancer', 'down', 'miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.'),
(6880, 'hsa-mir-218-5p', 'non-small cell lung cancer', 'down', 'Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.'),
(6881, 'hsa-mir-26b', 'non-small cell lung cancer', 'down', 'Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.'),
(6882, 'hsa-mir-301a', 'non-small cell lung cancer', 'up', 'Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.'),
(6883, 'hsa-mir-320a', 'non-small cell lung cancer', 'down', 'Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.'),
(6884, 'hsa-mir-328-3p', 'non-small cell lung cancer', 'down', 'Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy.'),
(6885, 'hsa-mir-338-3p', 'non-small cell lung cancer', 'down', 'miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.'),
(6886, 'hsa-mir-376c', 'non-small cell lung cancer', 'down', 'MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway.'),
(6887, 'hsa-mir-383', 'non-small cell lung cancer', 'down', 'MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.'),
(6888, 'hsa-mir-424-3p', 'non-small cell lung cancer', 'down', 'Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.'),
(6889, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'down', 'Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.'),
(6890, 'hsa-mir-509-5p', 'non-small cell lung cancer', 'down', 'The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.'),
(6891, 'hsa-mir-541-3p', 'non-small cell lung cancer', 'down', 'MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.'),
(6892, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'MicroRNA-124 suppresses Slug-mediated lung cancer metastasis.'),
(6893, 'hsa-mir-1304', 'non-small cell lung cancer', 'down', 'MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1.'),
(6894, 'hsa-mir-132', 'non-small cell lung cancer', 'down', 'MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGF?1/Smad2 in human non-small cell lung cancer.'),
(6895, 'hsa-mir-133b', 'non-small cell lung cancer', 'down', 'MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1.'),
(6896, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.'),
(6897, 'hsa-mir-143', 'non-small cell lung cancer', 'down', 'miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.'),
(6898, 'hsa-mir-154', 'non-small cell lung cancer', 'down', 'RETRACTION of articles with plagiarism in common with other publications.'),
(6899, 'hsa-mir-155', 'non-small cell lung cancer', 'up', 'MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.'),
(6900, 'hsa-mir-181b', 'non-small cell lung cancer', 'down', 'MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1.'),
(6901, 'hsa-mir-193a', 'non-small cell lung cancer', 'down', 'Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.'),
(6902, 'hsa-mir-195', 'non-small cell lung cancer', 'down', 'Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.'),
(6903, 'hsa-mir-206', 'non-small cell lung cancer', 'down', 'MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3?/STAT3/HIF-1?/VEGF signaling.'),
(6904, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.'),
(6905, 'hsa-mir-32', 'non-small cell lung cancer', 'down', 'miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer [Retraction].'),
(6906, 'hsa-mir-520a-3p', 'non-small cell lung cancer', 'down', 'microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.'),
(6907, 'hsa-mir-585', 'non-small cell lung cancer', 'down', 'MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.'),
(6908, 'hsa-mir-590', 'non-small cell lung cancer', 'down', 'microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.'),
(6909, 'hsa-mir-635', 'non-small cell lung cancer', 'down', 'The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer.'),
(6910, 'hsa-mir-7', 'non-small cell lung cancer', 'down', 'MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.'),
(6911, 'hsa-mir-92b', 'non-small cell lung cancer', 'down', 'Regulation of Twist in the metastasis of non-small cell lung cancer by miR-92b.'),
(6912, 'hsa-mir-944', 'non-small cell lung cancer', 'down', 'MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.'),
(6913, 'hsa-mir-1247', 'non-small cell lung cancer', 'down', 'Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1.'),
(6914, 'hsa-mir-133b', 'non-small cell lung cancer', 'down', 'miR-133b inhibits cell growth, migration, and invasion by targeting MMP9 in non-small cell lung cancer.'),
(6915, 'hsa-mir-134', 'non-small cell lung cancer', 'down', 'miR-134 suppresses the migration and invasion of non?small cell lung cancer by targeting ITGB1.'),
(6916, 'hsa-mir-135b', 'non-small cell lung cancer', 'up', 'LncRNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity By Suppressing miR-135b Expression in Non-Small Cell Lung Cancer.'),
(6917, 'hsa-mir-148a', 'non-small cell lung cancer', 'down', 'MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3.'),
(6918, 'hsa-mir-150', 'non-small cell lung cancer', 'up', 'MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.'),
(6919, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer.'),
(6920, 'hsa-mir-27b', 'non-small cell lung cancer', 'down', 'Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression.'),
(6921, 'hsa-mir-30a-5p', 'non-small cell lung cancer', 'down', 'CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.'),
(6922, 'hsa-mir-338-3p', 'non-small cell lung cancer', 'down', 'MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.'),
(6923, 'hsa-mir-361-5p', 'non-small cell lung cancer', 'down', 'Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.'),
(6924, 'hsa-mir-382', 'non-small cell lung cancer', 'down', 'miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.'),
(6925, 'hsa-mir-3940-5p', 'non-small cell lung cancer', 'down', 'miR-3940-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28.'),
(6926, 'hsa-mir-509-5p', 'non-small cell lung cancer', 'down', 'MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.'),
(6927, 'hsa-mir-592', 'non-small cell lung cancer', 'down', 'miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.'),
(6928, 'hsa-mir-599', 'non-small cell lung cancer', 'up', 'The miR-599 promotes non-small cell lung cancer cell invasion via SATB2.'),
(6929, 'hsa-mir-9', 'non-small cell lung cancer', 'up', 'MiR-9 is involved in TGF-?1-induced lung cancer cell invasion and adhesion by targeting SOX7.'),
(6930, 'hsa-mir-98', 'non-small cell lung cancer', 'down', 'MicroRNA-98 plays a suppressive role in non-small cell lung cancer through inhibition of SALL4 protein expression.'),
(6931, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.'),
(6932, 'hsa-mir-130a', 'non-small cell lung cancer', 'down', 'MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.'),
(6933, 'hsa-mir-130b', 'non-small cell lung cancer', 'down', 'MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.'),
(6934, 'hsa-mir-137', 'non-small cell lung cancer', 'down', 'miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.'),
(6935, 'hsa-mir-15b', 'non-small cell lung cancer', 'up', 'MicroRNA-15b promotes proliferation and invasion of non?small cell lung carcinoma cells by directly targeting TIMP2.'),
(6936, 'hsa-mir-181a-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-181a-5p Impedes IL-17-Induced Nonsmall Cell Lung Cancer Proliferation and Migration through Targeting VCAM-1.'),
(6937, 'hsa-mir-187', 'non-small cell lung cancer', 'up', 'MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.'),
(6938, 'hsa-mir-18a-5p', 'non-small cell lung cancer', 'up', 'MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer.'),
(6939, 'hsa-mir-199a-5p', 'non-small cell lung cancer', 'down', 'miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.'),
(6940, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.'),
(6941, 'hsa-mir-215', 'non-small cell lung cancer', 'down', 'miR-215 suppresses proliferation and migration of non-small cell lung cancer cells.'),
(6942, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.'),
(6943, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma.'),
(6944, 'hsa-mir-29a', 'non-small cell lung cancer', 'down', 'MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.'),
(6945, 'hsa-mir-300', 'non-small cell lung cancer', 'down', 'MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer.'),
(6946, 'hsa-mir-301a', 'non-small cell lung cancer', 'down', 'MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.'),
(6947, 'hsa-mir-301b', 'non-small cell lung cancer', 'down', 'MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN.'),
(6948, 'hsa-mir-320a', 'non-small cell lung cancer', 'down', 'MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.'),
(6949, 'hsa-mir-424', 'non-small cell lung cancer', 'up', 'MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1.'),
(6950, 'hsa-mir-495', 'non-small cell lung cancer', 'down', 'miR-199a-5p and miR-495 target GRP78 within UPR pathway of lung cancer.'),
(6951, 'hsa-mir-516b', 'non-small cell lung cancer', 'down', 'Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.'),
(6952, 'hsa-mir-589', 'non-small cell lung cancer', 'down', 'Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.'),
(6953, 'hsa-mir-615-3p', 'non-small cell lung cancer', 'down', 'Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer.'),
(6954, 'hsa-mir-92a', 'non-small cell lung cancer', 'up', 'MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.'),
(6955, 'hsa-mir-1', 'non-small cell lung cancer', 'down', 'Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.'),
(6956, 'hsa-mir-103', 'non-small cell lung cancer', 'down', 'MiR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.'),
(6957, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer.'),
(6958, 'hsa-mir-129-5p', 'non-small cell lung cancer', 'down', 'MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1.'),
(6959, 'hsa-mir-130b', 'non-small cell lung cancer', 'up', 'An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells.'),
(6960, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer Via SOX4/p53 Feedback Loop.'),
(6961, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'MicroRNA-145 inhibits migration and invasion via inhibition of fascin?1 protein expression in non-small-cell lung cancer cells.'),
(6962, 'hsa-mir-145-3p', 'non-small cell lung cancer', 'down', 'microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.'),
(6963, 'hsa-mir-146b-5p', 'non-small cell lung cancer', 'down', 'MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer.'),
(6964, 'hsa-mir-150-5p', 'non-small cell lung cancer', 'down', 'Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.'),
(6965, 'hsa-mir-17-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-17-5p inhibits proliferation and triggers apoptosis in non-small cell lung cancer by targeting transforming growth factor ? receptor 2.'),
(6966, 'hsa-mir-181a', 'non-small cell lung cancer', 'down', 'MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.'),
(6967, 'hsa-mir-181c', 'non-small cell lung cancer', 'up', 'miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.'),
(6968, 'hsa-mir-200b', 'non-small cell lung cancer', 'down', 'Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer.'),
(6969, 'hsa-mir-200c', 'non-small cell lung cancer', 'down', 'MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.'),
(6970, 'hsa-mir-202', 'non-small cell lung cancer', 'down', 'miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.'),
(6971, 'hsa-mir-212', 'non-small cell lung cancer', 'down', 'MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.'),
(6972, 'hsa-mir-219', 'non-small cell lung cancer', 'down', 'MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.'),
(6973, 'hsa-mir-224', 'non-small cell lung cancer', 'up', 'The miR-224 promotes non-small cell lung cancer cell proliferation by directly targeting RASSF8.'),
(6974, 'hsa-mir-30a', 'non-small cell lung cancer', 'down', 'MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.'),
(6975, 'hsa-mir-30d', 'non-small cell lung cancer', 'down', 'Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB.'),
(6976, 'hsa-mir-330-3p', 'non-small cell lung cancer', 'up', 'MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.'),
(6977, 'hsa-mir-330-5p', 'non-small cell lung cancer', 'down', 'Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.'),
(6978, 'hsa-mir-33a', 'non-small cell lung cancer', 'down', 'miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer.'),
(6979, 'hsa-mir-34a', 'non-small cell lung cancer', 'down', 'MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis.'),
(6980, 'hsa-mir-367', 'non-small cell lung cancer', 'up', 'miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.'),
(6981, 'hsa-mir-375', 'non-small cell lung cancer', 'down', 'Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.'),
(6982, 'hsa-mir-376a', 'non-small cell lung cancer', 'down', 'MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.'),
(6983, 'hsa-mir-384', 'non-small cell lung cancer', 'down', 'MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling.'),
(6984, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'down', 'ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.'),
(6985, 'hsa-mir-542-3p', 'non-small cell lung cancer', 'down', 'MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.'),
(6986, 'hsa-mir-542-5p', 'non-small cell lung cancer', 'down', 'The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.'),
(6987, 'hsa-mir-605', 'non-small cell lung cancer', 'up', 'microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2.'),
(6988, 'hsa-mir-616', 'non-small cell lung cancer', 'up', 'MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.'),
(6989, 'hsa-mir-661', 'non-small cell lung cancer', 'up', 'MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.'),
(6990, 'hsa-mir-661', 'non-small cell lung cancer', 'up', 'MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.'),
(6991, 'hsa-mir-7', 'non-small cell lung cancer', 'down', 'MicroRNA-7 inhibits the malignant phenotypes of non?small cell lung cancer in?vitro by targeting Pax6.'),
(6992, 'hsa-mir-708-5p', 'non-small cell lung cancer', 'down', 'Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem cell-like phenotypes through repressing Wnt/?-catenin signaling.'),
(6993, 'hsa-mir-770', 'non-small cell lung cancer', 'down', 'MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/?-catenin pathway in non-small cell lung cancer.'),
(6994, 'hsa-mir-96', 'non-small cell lung cancer', 'up', 'Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.'),
(6995, 'hsa-mir-98', 'non-small cell lung cancer', 'down', 'Low serum miR-98 as an unfavorable prognostic biomarker in patients with?non-small cell lung cancer.'),
(6996, 'hsa-mir-106b-5p', 'non-small cell lung cancer', 'up', 'MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.'),
(6997, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.'),
(6998, 'hsa-mir-125a-5p', 'non-small cell lung cancer', 'down', 'PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.'),
(6999, 'hsa-mir-126-3p', 'non-small cell lung cancer', 'down', 'miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.'),
(7000, 'hsa-mir-142-5p', 'non-small cell lung cancer', 'down', 'MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer.'),
(7001, 'hsa-mir-149', 'non-small cell lung cancer', 'down', 'miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.'),
(7002, 'hsa-mir-16', 'non-small cell lung cancer', 'down', 'miR-16 mimics inhibit TGF-?1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.'),
(7003, 'hsa-mir-186', 'non-small cell lung cancer', 'down', 'MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.'),
(7004, 'hsa-mir-205-5p', 'non-small cell lung cancer', 'up', 'miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.'),
(7005, 'hsa-mir-210-3p', 'non-small cell lung cancer', 'up', 'miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.'),
(7006, 'hsa-mir-211', 'non-small cell lung cancer', 'up', 'MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA.'),
(7007, 'hsa-mir-23b', 'non-small cell lung cancer', 'down', 'PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.'),
(7008, 'hsa-mir-30a-5p', 'non-small cell lung cancer', 'down', 'miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.'),
(7009, 'hsa-mir-30e-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.'),
(7010, 'hsa-mir-335', 'non-small cell lung cancer', 'down', 'miR-335 inhibited cell proliferation of lung cancer cells by target Tra2?.'),
(7011, 'hsa-mir-342-3p', 'non-small cell lung cancer', 'down', 'miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.'),
(7012, 'hsa-mir-34a', 'non-small cell lung cancer', 'down', 'MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.'),
(7013, 'hsa-mir-373', 'non-small cell lung cancer', 'down', 'MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.'),
(7014, 'hsa-mir-4465', 'non-small cell lung cancer', 'down', 'MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2.'),
(7015, 'hsa-mir-455-3p', 'non-small cell lung cancer', 'down', 'miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.'),
(7016, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'down', 'miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.'),
(7017, 'hsa-mir-9', 'non-small cell lung cancer', 'up', 'TGF-?1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.'),
(7018, 'hsa-mir-9-5p', 'non-small cell lung cancer', 'up', 'MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.'),
(7019, 'hsa-mir-98', 'non-small cell lung cancer', 'down', 'Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.'),
(7020, 'hsa-mir-98-5p', 'non-small cell lung cancer', 'down', 'NEAT1/has-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer (NSCLC) development.'),
(7021, 'hsa-mir-1253', 'non-small cell lung cancer', 'down', 'MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A.'),
(7022, 'hsa-mir-1290', 'non-small cell lung cancer', 'down', 'Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.'),
(7023, 'hsa-mir-135a-1', 'non-small cell lung cancer', 'up', 'Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.'),
(7024, 'hsa-mir-135a-2', 'non-small cell lung cancer', 'up', 'Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.'),
(7025, 'hsa-mir-135b', 'non-small cell lung cancer', 'up', 'Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.'),
(7026, 'hsa-mir-145-5p', 'non-small cell lung cancer', 'down', 'miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.'),
(7027, 'hsa-mir-195', 'non-small cell lung cancer', 'down', 'miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.'),
(7028, 'hsa-mir-200c', 'non-small cell lung cancer', 'down', 'The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression.'),
(7029, 'hsa-mir-20a', 'non-small cell lung cancer', 'up', 'MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non-small cell lung carcinoma.'),
(7030, 'hsa-mir-29c', 'non-small cell lung cancer', 'down', 'MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA.'),
(7031, 'hsa-mir-30a', 'non-small cell lung cancer', 'down', 'MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.'),
(7032, 'hsa-mir-381', 'non-small cell lung cancer', 'down', 'microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-?B signaling.'),
(7033, 'hsa-mir-455-5p', 'non-small cell lung cancer', 'up', 'miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.'),
(7034, 'hsa-mir-485-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.'),
(7035, 'hsa-mir-494', 'non-small cell lung cancer', 'up', 'Prognostic and clinicopathological significance of microRNA-494 overexpression in cancers: a meta-analysis.'),
(7036, 'hsa-mir-494', 'non-small cell lung cancer', 'up', 'Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.'),
(7037, 'hsa-mir-584', 'non-small cell lung cancer', 'down', 'MicroRNA-584 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting MTDH.'),
(7038, 'hsa-mir-661', 'non-small cell lung cancer', 'up', 'Clinical impact of serum miR-661 in diagnosis and prognosis of non-small cell lung cancer.'),
(7039, 'hsa-mir-760', 'non-small cell lung cancer', 'down', 'MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.'),
(7040, 'hsa-mir-769-5p', 'non-small cell lung cancer', 'down', 'miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma.'),
(7041, 'hsa-mir-93-5p', 'non-small cell lung cancer', 'up', 'MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.'),
(7042, 'hsa-mir-101', 'non-small cell lung cancer', 'down', 'MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1.'),
(7043, 'hsa-mir-106b', 'non-small cell lung cancer', 'up', 'Expression of microRNAs-106b in nonsmall cell lung cancer.'),
(7044, 'hsa-mir-1179', 'non-small cell lung cancer', 'down', 'MicroRNA-1179 suppresses cell growth and invasion by targeting sperm-associated antigen 5-mediated Akt signaling in human non-small cell lung cancer.'),
(7045, 'hsa-mir-1256', 'non-small cell lung cancer', 'down', 'MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1.'),
(7046, 'hsa-mir-1258', 'non-small cell lung cancer', 'down', 'MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.'),
(7047, 'hsa-mir-126-5p', 'non-small cell lung cancer', 'down', 'miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas.'),
(7048, 'hsa-mir-1260b', 'non-small cell lung cancer', 'up', 'MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK.'),
(7049, 'hsa-mir-1269a', 'non-small cell lung cancer', 'up', 'MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6.'),
(7050, 'hsa-mir-1275', 'non-small cell lung cancer', 'up', 'MiR-1275 promotes non-small cell lung cancer cell proliferation and metastasis by regulating LZTS3 expression.'),
(7051, 'hsa-mir-137', 'non-small cell lung cancer', 'down', 'Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer.'),
(7052, 'hsa-mir-138', 'non-small cell lung cancer', 'down', 'HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.'),
(7053, 'hsa-mir-142-5p', 'non-small cell lung cancer', 'up', 'miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.'),
(7054, 'hsa-mir-144', 'non-small cell lung cancer', 'down', 'A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.'),
(7055, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'miR-145 and miR-497 suppress TGF-?-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.'),
(7056, 'hsa-mir-148b', 'non-small cell lung cancer', 'down', 'MicroRNA-148b inhibits proliferation and the epithelial-mesenchymal transition and increases radiosensitivity in non-small cell lung carcinomas by regulating ROCK1.'),
(7057, 'hsa-mir-154', 'non-small cell lung cancer', 'down', 'MicroRNA-154 functions as a tumor suppressor in non-small cell lung cancer through directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1.'),
(7058, 'hsa-mir-17', 'non-small cell lung cancer', 'down', 'H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.'),
(7059, 'hsa-mir-182', 'non-small cell lung cancer', 'up', 'MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.'),
(7060, 'hsa-mir-182', 'non-small cell lung cancer', 'down', 'miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.'),
(7061, 'hsa-mir-185', 'non-small cell lung cancer', 'down', 'MiR-185 inhibits cell proliferation and invasion of non-small cell lung cancer by targeting KLF7.'),
(7062, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-?B Signaling Pathway in Vitro and in Vivo.'),
(7063, 'hsa-mir-214', 'non-small cell lung cancer', 'up', 'Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.'),
(7064, 'hsa-mir-223-5p', 'non-small cell lung cancer', 'down', 'MiR-223-5p suppresses tumor growth and metastasis in non-small cell lung cancer by targeting E2F8.'),
(7065, 'hsa-mir-224', 'non-small cell lung cancer', 'up', 'miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.'),
(7066, 'hsa-mir-29c', 'non-small cell lung cancer', 'down', 'MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.'),
(7067, 'hsa-mir-30b', 'non-small cell lung cancer', 'down', 'MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor.'),
(7068, 'hsa-mir-320a-3p', 'non-small cell lung cancer', 'down', 'MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.'),
(7069, 'hsa-mir-340', 'non-small cell lung cancer', 'down', 'Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.'),
(7070, 'hsa-mir-362', 'non-small cell lung cancer', 'up', 'Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.'),
(7071, 'hsa-mir-421', 'non-small cell lung cancer', 'up', 'Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.'),
(7072, 'hsa-mir-4299', 'non-small cell lung cancer', 'down', 'MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.'),
(7073, 'hsa-mir-449a', 'non-small cell lung cancer', 'down', 'MiR-449a suppresses tumor growth, migration and invasion in non-small cell lung cancer by targeting HMGB1-mediated NF-?B signaling way.'),
(7074, 'hsa-mir-449b', 'non-small cell lung cancer', 'down', 'Inhibitory Effect of MiR-449b on Cancer Cell Growth and Invasion through LGR4 in Non-Small-Cell Lung Carcinoma.'),
(7075, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'up', 'miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.'),
(7076, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'down', 'miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer.'),
(7077, 'hsa-mir-497', 'non-small cell lung cancer', 'down', 'miR-145 and miR-497 suppress TGF-?-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.'),
(7078, 'hsa-mir-498', 'non-small cell lung cancer', 'down', 'Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.'),
(7079, 'hsa-mir-550a-3p', 'non-small cell lung cancer', 'up', 'MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.'),
(7080, 'hsa-mir-577', 'non-small cell lung cancer', 'down', 'miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/?-catenin pathway in non-small cell lung cancer.'),
(7081, 'hsa-mir-598', 'non-small cell lung cancer', 'down', 'MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.'),
(7082, 'hsa-mir-760', 'non-small cell lung cancer', 'down', 'MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1.'),
(7083, 'hsa-mir-760', 'non-small cell lung cancer', 'down', 'Correction to: MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.'),
(7084, 'hsa-mir-770', 'non-small cell lung cancer', 'down', 'Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.'),
(7085, 'hsa-mir-935', 'non-small cell lung cancer', 'down', 'microRNA-935 is reduced in non-small-cell lung cancer tissue, is linked poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.'),
(7086, 'hsa-mir-936', 'non-small cell lung cancer', 'down', 'Overexpression of microRNA-936 suppresses non-small cell lung cancer cell proliferation and invasion via targeting E2F2.'),
(7087, 'hsa-mir-96', 'non-small cell lung cancer', 'up', 'miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells.'),
(7088, 'hsa-mir-1204', 'non-small cell lung cancer', 'up', 'MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.'),
(7089, 'hsa-mir-133a', 'non-small cell lung cancer', 'down', 'MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling.'),
(7090, 'hsa-mir-145', 'non-small cell lung cancer', 'down', 'Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer.'),
(7091, 'hsa-mir-148a-3p', 'non-small cell lung cancer', 'down', 'microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.'),
(7092, 'hsa-mir-149', 'non-small cell lung cancer', 'down', 'miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin?D1/MMP2 axis.'),
(7093, 'hsa-mir-19a', 'non-small cell lung cancer', 'up', 'miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.'),
(7094, 'hsa-mir-19b-1', 'non-small cell lung cancer', 'up', 'miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.'),
(7095, 'hsa-mir-19b-2', 'non-small cell lung cancer', 'up', 'miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression.'),
(7096, 'hsa-mir-21-5p', 'non-small cell lung cancer', 'up', 'MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7.'),
(7097, 'hsa-mir-217', 'non-small cell lung cancer', 'down', 'MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.'),
(7098, 'hsa-mir-24', 'non-small cell lung cancer', 'up', 'MiR-24 promotes migration and invasion of non-small cell lung cancer by targeting ZNF367.'),
(7099, 'hsa-mir-302b-3p', 'non-small cell lung cancer', 'down', 'Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.'),
(7100, 'hsa-mir-30d-5p', 'non-small cell lung cancer', 'down', 'Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.'),
(7101, 'hsa-mir-330-3p', 'non-small cell lung cancer', 'up', 'Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p.'),
(7102, 'hsa-mir-33b', 'non-small cell lung cancer', 'down', 'Downregulation of miR-33b promotes non-small cell lung cancer cell growth through reprogramming glucose metabolism miR-33b regulates non-small cell lung cancer cell growth.'),
(7103, 'hsa-mir-34c-3p', 'non-small cell lung cancer', 'down', 'Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.'),
(7104, 'hsa-mir-3607-3p', 'non-small cell lung cancer', 'down', 'miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2.'),
(7105, 'hsa-mir-383', 'non-small cell lung cancer', 'down', 'microRNA-383 regulates cell viability and apoptosis by mediating Wnt/?-catenin signaling pathway in non-small cell lung cancer.'),
(7106, 'hsa-mir-423-5p', 'non-small cell lung cancer', 'up', 'MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology.'),
(7107, 'hsa-mir-4317', 'non-small cell lung cancer', 'down', 'miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).'),
(7108, 'hsa-mir-451', 'non-small cell lung cancer', 'down', 'LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.'),
(7109, 'hsa-mir-451a', 'non-small cell lung cancer', 'down', 'Regulation by Pink1 on the mitochondrial dysfunction in endothelial cells post the hypoxia mimetic agent CoCl2 treatment.'),
(7110, 'hsa-mir-451a', 'non-small cell lung cancer', 'down', 'MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.'),
(7111, 'hsa-mir-495', 'non-small cell lung cancer', 'down', 'MicroRNA-495 inhibits the progression of non-small-cell lung cancer by targeting TCF4 and inactivating Wnt/?-catenin pathway.'),
(7112, 'hsa-mir-500a-3p', 'non-small cell lung cancer', 'down', 'MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.'),
(7113, 'hsa-mir-5195-3p', 'non-small cell lung cancer', 'down', 'MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.'),
(7114, 'hsa-mir-520b', 'non-small cell lung cancer', 'down', 'Role of miR-520b in non-small cell lung cancer.'),
(7115, 'hsa-mir-520b', 'non-small cell lung cancer', 'up', 'MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway.'),
(7116, 'hsa-mir-582-5p', 'non-small cell lung cancer', 'down', 'miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.'),
(7117, 'hsa-mir-590-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1.'),
(7118, 'hsa-mir-647', 'non-small cell lung cancer', 'down', 'MicroRNA-647 promotes the therapeutic effectiveness of argon-helium cryoablation and inhibits cell proliferation through targeting TRAF2 via the NF-?B signaling pathway in non-small cell lung cancer.'),
(7119, 'hsa-mir-758', 'non-small cell lung cancer', 'down', 'Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.'),
(7120, 'hsa-mir-98-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.'),
(7121, 'hsa-mir-101-5p', 'non-small cell lung cancer', 'down', 'miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6.'),
(7122, 'hsa-mir-1197', 'non-small cell lung cancer', 'up', 'MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.'),
(7123, 'hsa-mir-1204', 'non-small cell lung cancer', 'down', 'The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.'),
(7124, 'hsa-mir-1205', 'non-small cell lung cancer', 'down', 'MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer.'),
(7125, 'hsa-mir-122-5p', 'non-small cell lung cancer', 'up', 'MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.'),
(7126, 'hsa-mir-124', 'non-small cell lung cancer', 'down', 'Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.'),
(7127, 'hsa-mir-126-3p', 'non-small cell lung cancer', 'down', 'MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.'),
(7128, 'hsa-mir-1260b', 'non-small cell lung cancer', 'up', 'miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC.'),
(7129, 'hsa-mir-130b', 'non-small cell lung cancer', 'up', 'MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2.'),
(7130, 'hsa-mir-133a', 'non-small cell lung cancer', 'down', 'MiR-133a suppressed cell migration and invasion by targeting SOX4 in non-small cell lung cancer.'),
(7131, 'hsa-mir-139-5p', 'non-small cell lung cancer', 'down', 'Expression and clinical significance of miR-139-5p in non-small cell lung cancer.'),
(7132, 'hsa-mir-140-5p', 'non-small cell lung cancer', 'down', 'Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.'),
(7133, 'hsa-mir-141-3p', 'non-small cell lung cancer', 'down', 'MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.'),
(7134, 'hsa-mir-142-3p', 'non-small cell lung cancer', 'down', 'MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing ?-catenin expression.'),
(7135, 'hsa-mir-144-3p', 'non-small cell lung cancer', 'down', 'Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.'),
(7136, 'hsa-mir-146a-5p', 'non-small cell lung cancer', 'down', 'Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.'),
(7137, 'hsa-mir-146b', 'non-small cell lung cancer', 'up', 'Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.'),
(7138, 'hsa-mir-149-3p', 'non-small cell lung cancer', 'up', 'LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.'),
(7139, 'hsa-mir-150', 'non-small cell lung cancer', 'up', 'C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.'),
(7140, 'hsa-mir-150-5p', 'non-small cell lung cancer', 'down', 'miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and ?-Catenin Signaling.'),
(7141, 'hsa-mir-17-5p', 'non-small cell lung cancer', 'up', 'Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(7142, 'hsa-mir-181d-5p', 'non-small cell lung cancer', 'down', 'Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.'),
(7143, 'hsa-mir-183-5p', 'non-small cell lung cancer', 'up', 'MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN.'),
(7144, 'hsa-mir-191', 'non-small cell lung cancer', 'up', 'MicroRNA-191 targets CCAAT/enhanced binding protein ? and functions as an oncogenic molecule in human non-small cell lung carcinoma cells.'),
(7145, 'hsa-mir-193a-3p', 'non-small cell lung cancer', 'down', 'miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.'),
(7146, 'hsa-mir-194', 'non-small cell lung cancer', 'down', 'miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5.'),
(7147, 'hsa-mir-195-5p', 'non-small cell lung cancer', 'down', 'MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.'),
(7148, 'hsa-mir-196a', 'non-small cell lung cancer', 'up', 'Downregulation of microRNA-196a inhibits stem cell self-renewal ability and stemness in non-small-cell lung cancer through upregulating GPX3 expression.'),
(7149, 'hsa-mir-199a-5p', 'non-small cell lung cancer', 'down', 'MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11.'),
(7150, 'hsa-mir-19a', 'non-small cell lung cancer', 'up', 'MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.'),
(7151, 'hsa-mir-203', 'non-small cell lung cancer', 'up', 'MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.'),
(7152, 'hsa-mir-205', 'non-small cell lung cancer', 'up', 'Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.'),
(7153, 'hsa-mir-20b-5p', 'non-small cell lung cancer', 'up', 'Regulation of BTG3 by microRNA-20b-5p in non-small cell lung cancer.'),
(7154, 'hsa-mir-21', 'non-small cell lung cancer', 'up', 'miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3? signaling.'),
(7155, 'hsa-mir-216b', 'non-small cell lung cancer', 'down', 'MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer.'),
(7156, 'hsa-mir-217', 'non-small cell lung cancer', 'down', 'Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway.'),
(7157, 'hsa-mir-218', 'non-small cell lung cancer', 'down', 'Downregulation of miR-218 by nicotine promotes cell proliferation through targeting CDK6 in non-small cell lung cancer.'),
(7158, 'hsa-mir-223', 'non-small cell lung cancer', 'down', 'miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.'),
(7159, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'Clinical significance of serum miR-25 in non-small-cell lung cancer.'),
(7160, 'hsa-mir-25', 'non-small cell lung cancer', 'up', 'Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.'),
(7161, 'hsa-mir-296-3p', 'non-small cell lung cancer', 'down', 'MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.'),
(7162, 'hsa-mir-29c', 'non-small cell lung cancer', 'up', 'Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.'),
(7163, 'hsa-mir-302a-5p', 'non-small cell lung cancer', 'down', 'MiR-302a-5p suppresses cell proliferation and invasion in non-small cell lung carcinoma by targeting ITGA6.'),
(7164, 'hsa-mir-30a-5p', 'non-small cell lung cancer', 'down', 'p53/miR-30a-5p/ SOX4 feedback loop mediates cellular proliferation, apoptosis, and migration of non-small-cell lung cancer.'),
(7165, 'hsa-mir-30b', 'non-small cell lung cancer', 'up', 'Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.'),
(7166, 'hsa-mir-30e', 'non-small cell lung cancer', 'down', 'MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.'),
(7167, 'hsa-mir-3188', 'non-small cell lung cancer', 'down', 'MiR-3188 Inhibits Non-small Cell Lung Cancer Cell Proliferation Through FOXO1-Mediated mTOR-p-PI3K/AKT-c-JUN Signaling Pathway.'),
(7168, 'hsa-mir-330-3p', 'non-small cell lung cancer', 'up', 'The Key microRNAs Regulated the Development of Non-small Cell Lung Cancer by Targeting TGF-?-induced epithelial-mesenchymal Transition.'),
(7169, 'hsa-mir-331-3p', 'non-small cell lung cancer', 'down', 'MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/?-catenin axis in non-small-cell lung cancer.'),
(7170, 'hsa-mir-337', 'non-small cell lung cancer', 'down', 'Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.'),
(7171, 'hsa-mir-337', 'non-small cell lung cancer', 'up', 'Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.'),
(7172, 'hsa-mir-338-3p', 'non-small cell lung cancer', 'down', 'The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.'),
(7173, 'hsa-mir-340-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503.'),
(7174, 'hsa-mir-345', 'non-small cell lung cancer', 'down', 'MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.'),
(7175, 'hsa-mir-34c', 'non-small cell lung cancer', 'down', 'MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1.'),
(7176, 'hsa-mir-365', 'non-small cell lung cancer', 'down', 'Altered expression of microRNA-365 is related to the occurrence and development of non-small-cell lung cancer by inhibiting TRIM25 expression.'),
(7177, 'hsa-mir-382', 'non-small cell lung cancer', 'down', 'MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3.'),
(7178, 'hsa-mir-3934-5p', 'non-small cell lung cancer', 'up', 'Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.'),
(7179, 'hsa-mir-421', 'non-small cell lung cancer', 'up', 'MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4.'),
(7180, 'hsa-mir-422a', 'non-small cell lung cancer', 'down', 'MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-?/SMAD signaling pathway.'),
(7181, 'hsa-mir-4262', 'non-small cell lung cancer', 'up', 'Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.'),
(7182, 'hsa-mir-4270', 'non-small cell lung cancer', 'up', 'LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.'),
(7183, 'hsa-mir-4286', 'non-small cell lung cancer', 'up', 'MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.'),
(7184, 'hsa-mir-433', 'non-small cell lung cancer', 'down', 'miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer.'),
(7185, 'hsa-mir-4458', 'non-small cell lung cancer', 'down', 'MicroRNA-4458 suppresses migration and epithelial-mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells.'),
(7186, 'hsa-mir-448', 'non-small cell lung cancer', 'down', 'microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2.'),
(7187, 'hsa-mir-454-3p', 'non-small cell lung cancer', 'down', 'Downregulation of Calbindin 1 by miR-454-3p Suppresses Cell Proliferation in Nonsmall Cell Lung Cancer In Vitro.'),
(7188, 'hsa-mir-4735-3p', 'non-small cell lung cancer', 'up', 'FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancer.'),
(7189, 'hsa-mir-486-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial-mesenchymal transition by targeting twinfilin actin binding protein 1.'),
(7190, 'hsa-mir-496', 'non-small cell lung cancer', 'down', 'miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer.'),
(7191, 'hsa-mir-497-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2.'),
(7192, 'hsa-mir-5095', 'non-small cell lung cancer', 'down', 'Long noncoding RNA LINC01296 induces non-small cell lung cancer growth and progression through sponging miR-5095.'),
(7193, 'hsa-mir-510', 'non-small cell lung cancer', 'up', 'MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.'),
(7194, 'hsa-mir-516a-5p', 'non-small cell lung cancer', 'down', 'MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.'),
(7195, 'hsa-mir-582-5p', 'non-small cell lung cancer', 'down', 'MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.'),
(7196, 'hsa-mir-600', 'non-small cell lung cancer', 'down', 'miR-600 inhibits lung cancer via downregulating the expression of METTL3.'),
(7197, 'hsa-mir-615-3p', 'non-small cell lung cancer', 'down', 'Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.'),
(7198, 'hsa-mir-655-3p', 'non-small cell lung cancer', 'down', 'miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer.'),
(7199, 'hsa-mir-660-5p', 'non-small cell lung cancer', 'up', 'Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.'),
(7200, 'hsa-mir-675-5p', 'non-small cell lung cancer', 'up', 'Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.'),
(7201, 'hsa-mir-875', 'non-small cell lung cancer', 'up', 'MiR-875 can regulate the proliferation and apoptosis of non-small cell lung cancer cells via targeting SOCS2.'),
(7202, 'hsa-mir-877', 'non-small cell lung cancer', 'down', 'MicroRNA-877 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting IGF-1R.'),
(7203, 'hsa-mir-889', 'non-small cell lung cancer', 'up', 'MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9.'),
(7204, 'hsa-mir-940', 'non-small cell lung cancer', 'down', 'MiR-940 inhibits TGF-?-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer.'),
(7205, 'hsa-mir-99b-5p', 'non-small cell lung cancer', 'down', 'miRNA-99b-5p targets FZD8 to inhibit non-small cell lung cancer proliferation, migration and invasion.'),
(7206, 'hsa-mir-221', 'non-small cell lung cancer', 'up', 'miR-221&amp;222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(7207, 'hsa-mir-222', 'non-small cell lung cancer', 'up', 'miR-221&amp;222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.'),
(7208, 'hsa-let-7d', 'oral cancer', 'down', 'Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.'),
(7209, 'hsa-mir-10b', 'oral cancer', 'up', 'Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.'),
(7210, 'hsa-mir-196a-1', 'oral cancer', 'up', 'OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.'),
(7211, 'hsa-mir-196a-2', 'oral cancer', 'up', 'OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.'),
(7212, 'hsa-mir-196b', 'oral cancer', 'up', 'OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.'),
(7213, 'hsa-mir-21', 'oral cancer', 'up', 'MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/?-Catenin Pathway by Targeting DKK2.'),
(7214, 'hsa-mir-218', 'oral cancer', 'down', 'The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.'),
(7215, 'hsa-mir-34a', 'oral cancer', 'down', 'MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.'),
(7216, 'hsa-mir-375', 'oral cancer', 'down', 'MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.'),
(7217, 'hsa-mir-375', 'oral cancer', 'down', 'Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells.'),
(7218, 'hsa-mir-494', 'oral cancer', 'down', 'miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.'),
(7219, 'hsa-mir-340', 'oral cancer', 'down', 'MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1.'),
(7220, 'hsa-mir-141', 'oral cancer', 'down', 'Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.'),
(7221, 'hsa-mir-200a', 'oral cancer', 'down', 'Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.'),
(7222, 'hsa-mir-200b', 'oral cancer', 'down', 'Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.'),
(7223, 'hsa-mir-200c', 'oral cancer', 'down', 'Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.'),
(7224, 'hsa-mir-429', 'oral cancer', 'down', 'Grainyhead-like 2 regulates epithelial plasticity and stemness in oral cancer cells.'),
(7225, 'hsa-mir-223', 'oral cancer', 'up', 'Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.'),
(7226, 'hsa-mir-143', 'oral cancer', 'down', 'MicroRNA-143 suppresses oral squamous cell carcinoma (OSCC) cell growth, invasion and glucose metabolism through targeting Hexokinase2.'),
(7227, 'hsa-mir-214', 'oral cancer', 'up', 'MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5.'),
(7228, 'hsa-mir-21-3p', 'oral cancer', 'up', 'Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.'),
(7229, 'hsa-mir-218', 'oral cancer', 'down', 'MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway.'),
(7230, 'hsa-mir-222-3p', 'oral cancer', 'up', 'A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.'),
(7231, 'hsa-mir-423-5p', 'oral cancer', 'up', 'A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.'),
(7232, 'hsa-mir-650', 'oral cancer', 'up', 'MiR-650 regulates the proliferation, migration and invasion of human oral cancer by targeting growth factor independent 1 (Gfi1).'),
(7233, 'hsa-mir-101-3p', 'oral cancer', 'down', 'Exosomes derived from microRNA-101-3p-overexpressing human bone marrow mesenchymal stem cells suppress oral cancer cell proliferation, invasion, and migration.'),
(7234, 'hsa-mir-16', 'oral cancer', 'down', 'Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer.'),
(7235, 'hsa-mir-486-3p', 'oral cancer', 'down', 'MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.'),
(7236, 'hsa-mir-31', 'oral carcinoma', 'up', 'Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.'),
(7237, 'hsa-mir-31', 'oral carcinoma', 'up', 'Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.'),
(7238, 'hsa-mir-375', 'oral carcinoma', 'down', 'Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.'),
(7239, 'hsa-mir-21', 'oral carcinoma', 'up', 'MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma.'),
(7240, 'hsa-mir-100', 'oral squamous cell carcinoma', 'down', 'Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.'),
(7241, 'hsa-mir-124', 'oral squamous cell carcinoma', 'down', 'MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.'),
(7242, 'hsa-mir-1250', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7243, 'hsa-mir-125b', 'oral squamous cell carcinoma', 'down', 'Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.'),
(7244, 'hsa-mir-125b', 'oral squamous cell carcinoma', 'up', '[Expression and clinical significance of plasma microRNA-125b level in patients with oral squamous cell carcinoma].'),
(7245, 'hsa-mir-126', 'oral squamous cell carcinoma', 'up', 'Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer.'),
(7246, 'hsa-mir-126', 'oral squamous cell carcinoma', 'down', 'Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.'),
(7247, 'hsa-mir-1271', 'oral squamous cell carcinoma', 'down', 'miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK.'),
(7248, 'hsa-mir-136', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7249, 'hsa-mir-138', 'oral squamous cell carcinoma', 'down', 'Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.'),
(7250, 'hsa-mir-145', 'oral squamous cell carcinoma', 'down', 'MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.'),
(7251, 'hsa-mir-145', 'oral squamous cell carcinoma', 'down', 'Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.'),
(7252, 'hsa-mir-146a', 'oral squamous cell carcinoma', 'up', 'miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.'),
(7253, 'hsa-mir-146b', 'oral squamous cell carcinoma', 'up', 'miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.'),
(7254, 'hsa-mir-147', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7255, 'hsa-mir-148a', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7256, 'hsa-mir-155', 'oral squamous cell carcinoma', 'up', 'MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.'),
(7257, 'hsa-mir-155', 'oral squamous cell carcinoma', 'up', 'Upregulation of a potential prognostic biomarker, miR-155, enhances cell proliferation in patients with oral squamous cell carcinoma.'),
(7258, 'hsa-mir-181a', 'oral squamous cell carcinoma', 'down', 'miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.'),
(7259, 'hsa-mir-181b', 'oral squamous cell carcinoma', 'up', 'Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.'),
(7260, 'hsa-mir-196a-1', 'oral squamous cell carcinoma', 'up', 'miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.'),
(7261, 'hsa-mir-196a-2', 'oral squamous cell carcinoma', 'up', 'miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.'),
(7262, 'hsa-mir-196b', 'oral squamous cell carcinoma', 'up', 'miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas.'),
(7263, 'hsa-mir-206', 'oral squamous cell carcinoma', 'down', 'MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma.'),
(7264, 'hsa-mir-21', 'oral squamous cell carcinoma', 'up', 'Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.'),
(7265, 'hsa-mir-21', 'oral squamous cell carcinoma', 'up', 'Altered levels of miR-21, miR-125b-2*, miR-134, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.'),
(7266, 'hsa-mir-220a', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7267, 'hsa-mir-221', 'oral squamous cell carcinoma', 'up', 'miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.'),
(7268, 'hsa-mir-222', 'oral squamous cell carcinoma', 'up', 'miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.'),
(7269, 'hsa-mir-24', 'oral squamous cell carcinoma', 'up', 'miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.'),
(7270, 'hsa-mir-24', 'oral squamous cell carcinoma', 'up', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7271, 'hsa-mir-26a', 'oral squamous cell carcinoma', 'down', 'MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.'),
(7272, 'hsa-mir-26b', 'oral squamous cell carcinoma', 'down', 'MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.'),
(7273, 'hsa-mir-27b', 'oral squamous cell carcinoma', 'up', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7274, 'hsa-mir-29a', 'oral squamous cell carcinoma', 'down', 'MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis.'),
(7275, 'hsa-mir-31', 'oral squamous cell carcinoma', 'up', 'miR-31 is up-regulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes.'),
(7276, 'hsa-mir-31', 'oral squamous cell carcinoma', 'up', 'EGF up-regulates miR-31 through the C/EBP? signal cascade in oral carcinoma.'),
(7277, 'hsa-mir-32', 'oral squamous cell carcinoma', 'down', 'MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.'),
(7278, 'hsa-mir-323-5p', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7279, 'hsa-mir-329', 'oral squamous cell carcinoma', 'down', 'Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.'),
(7280, 'hsa-mir-338', 'oral squamous cell carcinoma', 'down', 'miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.'),
(7281, 'hsa-mir-345', 'oral squamous cell carcinoma', 'up', 'Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.'),
(7282, 'hsa-mir-370', 'oral squamous cell carcinoma', 'down', 'miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.'),
(7283, 'hsa-mir-410', 'oral squamous cell carcinoma', 'down', 'Downregulated miR-329 and miR-410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.'),
(7284, 'hsa-mir-429', 'oral squamous cell carcinoma', 'down', 'MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1.'),
(7285, 'hsa-mir-433', 'oral squamous cell carcinoma', 'down', 'miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.'),
(7286, 'hsa-mir-499a-5p', 'oral squamous cell carcinoma', 'down', 'The association between miR-499a polymorphism and oral squamous cell carcinoma progression.'),
(7287, 'hsa-mir-503', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7288, 'hsa-mir-506', 'oral squamous cell carcinoma', 'down', 'MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.'),
(7289, 'hsa-mir-632', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7290, 'hsa-mir-646', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7291, 'hsa-mir-668', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7292, 'hsa-mir-877', 'oral squamous cell carcinoma', 'down', 'Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.'),
(7293, 'hsa-mir-9', 'oral squamous cell carcinoma', 'down', 'MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/?-catenin signaling pathway.'),
(7294, 'hsa-mir-138', 'oral squamous cell carcinoma', 'down', 'miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.'),
(7295, 'hsa-mir-143', 'oral squamous cell carcinoma', 'down', 'Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.'),
(7296, 'hsa-mir-143', 'oral squamous cell carcinoma', 'down', 'Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.'),
(7297, 'hsa-mir-145', 'oral squamous cell carcinoma', 'down', 'Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.'),
(7298, 'hsa-mir-216a', 'oral squamous cell carcinoma', 'down', 'MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.'),
(7299, 'hsa-mir-372', 'oral squamous cell carcinoma', 'up', 'Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.'),
(7300, 'hsa-mir-373', 'oral squamous cell carcinoma', 'up', 'Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.'),
(7301, 'hsa-mir-483-5p', 'oral squamous cell carcinoma', 'up', 'Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.'),
(7302, 'hsa-mir-99b-3p', 'oral squamous cell carcinoma', 'down', 'miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3? in oral squamous cell carcinoma Tca-8113 cells.'),
(7303, 'hsa-mir-188', 'oral squamous cell carcinoma', 'down', 'microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.'),
(7304, 'hsa-mir-92b', 'oral squamous cell carcinoma', 'up', 'MicroRNA-92b promotes tumor growth and activation of NF-?B signaling via regulation of NLK in oral squamous cell carcinoma.'),
(7305, 'hsa-mir-143', 'oral squamous cell carcinoma', 'down', 'Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.'),
(7306, 'hsa-mir-20a', 'oral squamous cell carcinoma', 'up', 'HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a.'),
(7307, 'hsa-mir-221', 'oral squamous cell carcinoma', 'up', 'Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.'),
(7308, 'hsa-mir-34a', 'oral squamous cell carcinoma', 'down', 'Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.'),
(7309, 'hsa-mir-9', 'oral squamous cell carcinoma', 'down', 'Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.'),
(7310, 'hsa-mir-98', 'oral squamous cell carcinoma', 'down', 'miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.'),
(7311, 'hsa-let-7a', 'oral squamous cell carcinoma', 'down', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7312, 'hsa-let-7d', 'oral squamous cell carcinoma', 'down', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7313, 'hsa-let-7f', 'oral squamous cell carcinoma', 'down', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7314, 'hsa-mir-142-3p', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7315, 'hsa-mir-144', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7316, 'hsa-mir-16', 'oral squamous cell carcinoma', 'down', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7317, 'hsa-mir-203', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7318, 'hsa-mir-223', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7319, 'hsa-mir-29b', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.'),
(7320, 'hsa-mir-187', 'oral squamous cell carcinoma', 'up', 'Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.'),
(7321, 'hsa-mir-187*', 'oral squamous cell carcinoma', 'up', 'Plasma miR-187* is a potential biomarker for oral carcinoma.'),
(7322, 'hsa-mir-196b', 'oral squamous cell carcinoma', 'up', 'Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer.'),
(7323, 'hsa-mir-23b', 'oral squamous cell carcinoma', 'down', 'The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.'),
(7324, 'hsa-mir-27a-3p', 'oral squamous cell carcinoma', 'down', 'MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells.'),
(7325, 'hsa-mir-27b', 'oral squamous cell carcinoma', 'down', 'The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.'),
(7326, 'hsa-mir-497', 'oral squamous cell carcinoma', 'up', 'MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.'),
(7327, 'hsa-mir-206', 'oral squamous cell carcinoma', 'down', 'MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction].'),
(7328, 'hsa-mir-1', 'oral squamous cell carcinoma', 'down', 'Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas.'),
(7329, 'hsa-mir-200b-3p', 'oral squamous cell carcinoma', 'up', 'miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.'),
(7330, 'hsa-mir-221', 'oral squamous cell carcinoma', 'up', 'Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.'),
(7331, 'hsa-mir-222', 'oral squamous cell carcinoma', 'up', 'Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.'),
(7332, 'hsa-mir-377', 'oral squamous cell carcinoma', 'down', 'Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.'),
(7333, 'hsa-mir-542-3p', 'oral squamous cell carcinoma', 'up', '[Expression and correlation of survivin and hsa-miR-542-3p in patients with oral squamous cell carcinoma].'),
(7334, 'hsa-mir-138-5p', 'oral squamous cell carcinoma', 'down', 'Interplay between ?Np63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.'),
(7335, 'hsa-mir-155', 'oral squamous cell carcinoma', 'up', 'MiR-155 regulates oral squamous cell carcinoma Tca8113 cell proliferation, cycle, and apoptosis via regulating p27Kip1.'),
(7336, 'hsa-mir-21-3p', 'oral squamous cell carcinoma', 'up', 'Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.'),
(7337, 'hsa-mir-126', 'oral squamous cell carcinoma', 'down', 'Suppressive effect of microRNA-126 on oral squamous cell carcinoma in?vitro.'),
(7338, 'hsa-mir-133a-3p', 'oral squamous cell carcinoma', 'down', 'MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.'),
(7339, 'hsa-mir-139-5p', 'oral squamous cell carcinoma', 'down', 'MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.'),
(7340, 'hsa-mir-27b', 'oral squamous cell carcinoma', 'down', 'MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway.'),
(7341, 'hsa-mir-297', 'oral squamous cell carcinoma', 'down', 'Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.'),
(7342, 'hsa-mir-375', 'oral squamous cell carcinoma', 'down', 'MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.'),
(7343, 'hsa-mir-375', 'oral squamous cell carcinoma', 'down', 'MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.'),
(7344, 'hsa-mir-195-5p', 'oral squamous cell carcinoma', 'down', 'miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.'),
(7345, 'hsa-mir-21', 'oral squamous cell carcinoma', 'up', 'Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.'),
(7346, 'hsa-mir-433', 'oral squamous cell carcinoma', 'down', 'MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.'),
(7347, 'hsa-mir-542-3p', 'oral squamous cell carcinoma', 'down', 'MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-?1/Smad2/3 signaling.'),
(7348, 'hsa-mir-186', 'oral squamous cell carcinoma', 'down', 'MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.'),
(7349, 'hsa-mir-22', 'oral squamous cell carcinoma', 'down', 'MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.'),
(7350, 'hsa-mir-1294', 'oral squamous cell carcinoma', 'down', 'MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc.'),
(7351, 'hsa-mir-1297', 'oral squamous cell carcinoma', 'down', 'microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN.'),
(7352, 'hsa-mir-137', 'oral squamous cell carcinoma', 'down', 'Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.'),
(7353, 'hsa-mir-16', 'oral squamous cell carcinoma', 'down', 'MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.'),
(7354, 'hsa-mir-16', 'oral squamous cell carcinoma', 'down', 'MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt/?-catenin signaling pathway.'),
(7355, 'hsa-mir-182-5p', 'oral squamous cell carcinoma', 'up', 'miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.'),
(7356, 'hsa-mir-200c', 'oral squamous cell carcinoma', 'down', 'MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.'),
(7357, 'hsa-mir-365', 'oral squamous cell carcinoma', 'down', 'Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365.'),
(7358, 'hsa-mir-92a', 'oral squamous cell carcinoma', 'up', 'MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.'),
(7359, 'hsa-mir-16', 'oral squamous cell carcinoma', 'down', 'Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.'),
(7360, 'hsa-mir-21', 'oral squamous cell carcinoma', 'up', 'Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.'),
(7361, 'hsa-mir-211', 'oral squamous cell carcinoma', 'up', 'microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein.'),
(7362, 'hsa-mir-300', 'oral squamous cell carcinoma', 'down', 'MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition.'),
(7363, 'hsa-mir-99a', 'oral squamous cell carcinoma', 'down', 'Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.'),
(7364, 'hsa-mir-106a*', 'oral squamous cell carcinoma', 'down', 'MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/?-Catenin signaling pathway.'),
(7365, 'hsa-mir-10a', 'oral squamous cell carcinoma', 'up', 'miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.'),
(7366, 'hsa-mir-1254', 'oral squamous cell carcinoma', 'down', 'MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36.'),
(7367, 'hsa-mir-1258', 'oral squamous cell carcinoma', 'down', 'MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.'),
(7368, 'hsa-mir-125b', 'oral squamous cell carcinoma', 'down', 'miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A.'),
(7369, 'hsa-mir-138', 'oral squamous cell carcinoma', 'down', 'In situ measurement of miR-138 expression in oral squamous cell carcinoma tissue supports the role of this microRNA as a tumor suppressor.'),
(7370, 'hsa-mir-140-5p', 'oral squamous cell carcinoma', 'down', 'MicroRNA-140-5p inhibits the tumorigenesis of oral squamous cell carcinoma by targeting p21-activated kinase 4.'),
(7371, 'hsa-mir-182-5p', 'oral squamous cell carcinoma', 'up', 'MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene.'),
(7372, 'hsa-mir-200a', 'oral squamous cell carcinoma', 'down', 'QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.'),
(7373, 'hsa-mir-200b', 'oral squamous cell carcinoma', 'down', 'QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.'),
(7374, 'hsa-mir-211', 'oral squamous cell carcinoma', 'up', 'Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.'),
(7375, 'hsa-mir-214-3p', 'oral squamous cell carcinoma', 'down', 'LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.'),
(7376, 'hsa-mir-221', 'oral squamous cell carcinoma', 'up', 'Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221.'),
(7377, 'hsa-mir-223', 'oral squamous cell carcinoma', 'up', 'MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.'),
(7378, 'hsa-mir-224', 'oral squamous cell carcinoma', 'down', 'MicroRNA-224, negatively regulated by c-jun, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma.'),
(7379, 'hsa-mir-23a-3p', 'oral squamous cell carcinoma', 'down', 'miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.'),
(7380, 'hsa-mir-27b-5p', 'oral squamous cell carcinoma', 'down', 'MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p.'),
(7381, 'hsa-mir-29a-3p', 'oral squamous cell carcinoma', 'up', 'Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.'),
(7382, 'hsa-mir-342-3p', 'oral squamous cell carcinoma', 'down', 'MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.'),
(7383, 'hsa-mir-372-5p', 'oral squamous cell carcinoma', 'down', 'MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p.'),
(7384, 'hsa-mir-373', 'oral squamous cell carcinoma', 'up', 'MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.'),
(7385, 'hsa-mir-378', 'oral squamous cell carcinoma', 'up', 'MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.'),
(7386, 'hsa-mir-429', 'oral squamous cell carcinoma', 'down', 'QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.'),
(7387, 'hsa-mir-450a', 'oral squamous cell carcinoma', 'up', 'TNF-?-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.'),
(7388, 'hsa-mir-495', 'oral squamous cell carcinoma', 'down', 'MiR-495/IGF-1/AKT Signaling as a Novel Axis Is Involved in the Epithelial-to-Mesenchymal Transition of Oral Squamous Cell Carcinoma.'),
(7389, 'hsa-mir-519d', 'oral squamous cell carcinoma', 'down', 'Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3.'),
(7390, 'hsa-mir-548d-3p', 'oral squamous cell carcinoma', 'up', 'LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.'),
(7391, 'hsa-mir-610', 'oral squamous cell carcinoma', 'down', 'MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.'),
(7392, 'hsa-mir-625-3p', 'oral squamous cell carcinoma', 'up', 'MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.'),
(7393, 'hsa-mir-126', 'oral squamous cell carcinoma', 'down', 'Suppressive effect of microRNA-126 on oral squamous cell carcinoma in??vitro.'),
(7394, 'hsa-mir-200c', 'oropharyngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(7395, 'hsa-mir-21', 'oropharyngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(7396, 'hsa-mir-34a', 'oropharyngeal cancer', 'up', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(7397, 'hsa-mir-375', 'oropharyngeal cancer', 'down', 'MicroRNA profile in site-specific head and neck squamous cell cancer.'),
(7398, 'hsa-let-7a', 'osteosarcoma', 'down', 'Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.'),
(7399, 'hsa-mir-1', 'osteosarcoma', 'down', 'MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31.'),
(7400, 'hsa-mir-100', 'osteosarcoma', 'down', 'MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61.'),
(7401, 'hsa-mir-101', 'osteosarcoma', 'down', 'Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.'),
(7402, 'hsa-mir-122', 'osteosarcoma', 'down', 'Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.'),
(7403, 'hsa-mir-124', 'osteosarcoma', 'down', 'MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma.'),
(7404, 'hsa-mir-124', 'osteosarcoma', 'down', 'The tumor suppressor role of miR-124 in osteosarcoma.'),
(7405, 'hsa-mir-125b', 'osteosarcoma', 'down', 'miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.'),
(7406, 'hsa-mir-126', 'osteosarcoma', 'down', 'MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1.'),
(7407, 'hsa-mir-126', 'osteosarcoma', 'down', 'miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.'),
(7408, 'hsa-mir-127-3p', 'osteosarcoma', 'down', 'MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.'),
(7409, 'hsa-mir-128', 'osteosarcoma', 'up', 'MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.'),
(7410, 'hsa-mir-132', 'osteosarcoma', 'down', 'Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma.'),
(7411, 'hsa-mir-132', 'osteosarcoma', 'down', 'miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.'),
(7412, 'hsa-mir-133a', 'osteosarcoma', 'down', 'MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.'),
(7413, 'hsa-mir-141', 'osteosarcoma', 'down', 'Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma.'),
(7414, 'hsa-mir-142-3p', 'osteosarcoma', 'down', 'MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1.'),
(7415, 'hsa-mir-142-5p', 'osteosarcoma', 'down', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7416, 'hsa-mir-143', 'osteosarcoma', 'down', 'microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.'),
(7417, 'hsa-mir-143', 'osteosarcoma', 'down', 'A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.'),
(7418, 'hsa-mir-144', 'osteosarcoma', 'down', 'The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.'),
(7419, 'hsa-mir-144', 'osteosarcoma', 'down', 'MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.'),
(7420, 'hsa-mir-145', 'osteosarcoma', 'down', 'microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.'),
(7421, 'hsa-mir-145', 'osteosarcoma', 'down', 'miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.'),
(7422, 'hsa-mir-145', 'osteosarcoma', 'down', 'MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells.'),
(7423, 'hsa-mir-151-3p', 'osteosarcoma', 'up', 'MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.'),
(7424, 'hsa-mir-153', 'osteosarcoma', 'down', 'MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-?2.'),
(7425, 'hsa-mir-16', 'osteosarcoma', 'down', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7426, 'hsa-mir-16', 'osteosarcoma', 'down', 'miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.'),
(7427, 'hsa-mir-17', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7428, 'hsa-mir-181a', 'osteosarcoma', 'up', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7429, 'hsa-mir-181a', 'osteosarcoma', 'up', 'MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.'),
(7430, 'hsa-mir-181b', 'osteosarcoma', 'up', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7431, 'hsa-mir-181c', 'osteosarcoma', 'up', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7432, 'hsa-mir-183', 'osteosarcoma', 'down', 'Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.'),
(7433, 'hsa-mir-18a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7434, 'hsa-mir-191', 'osteosarcoma', 'up', 'MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.'),
(7435, 'hsa-mir-191', 'osteosarcoma', 'up', 'MicroRNA-191 promotes osteosarcoma cells proliferation by targeting checkpoint kinase 2.'),
(7436, 'hsa-mir-194', 'osteosarcoma', 'down', 'microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.'),
(7437, 'hsa-mir-195', 'osteosarcoma', 'down', 'MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.'),
(7438, 'hsa-mir-195', 'osteosarcoma', 'down', 'microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.'),
(7439, 'hsa-mir-195-5p', 'osteosarcoma', 'up', 'Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.'),
(7440, 'hsa-mir-199a-3p', 'osteosarcoma', 'down', 'MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.'),
(7441, 'hsa-mir-199a-3p', 'osteosarcoma', 'down', 'A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.'),
(7442, 'hsa-mir-199a-3p', 'osteosarcoma', 'up', 'Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(7443, 'hsa-mir-199a-3p', 'osteosarcoma', 'down', 'Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells.'),
(7444, 'hsa-mir-19a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7445, 'hsa-mir-19b', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7446, 'hsa-mir-204', 'osteosarcoma', 'down', 'MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.'),
(7447, 'hsa-mir-20a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7448, 'hsa-mir-21', 'osteosarcoma', 'up', 'Identification of Serum MicroRNA-21 as a Biomarker for Chemosensitivity and Prognosis in Human Osteosarcoma.'),
(7449, 'hsa-mir-21', 'osteosarcoma', 'up', 'MicroRNA-21 is involved in osteosarcoma cell invasion and migration.'),
(7450, 'hsa-mir-21', 'osteosarcoma', 'up', 'A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.'),
(7451, 'hsa-mir-210', 'osteosarcoma', 'up', 'Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma.'),
(7452, 'hsa-mir-212', 'osteosarcoma', 'down', 'MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.'),
(7453, 'hsa-mir-214', 'osteosarcoma', 'up', 'Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.'),
(7454, 'hsa-mir-217', 'osteosarcoma', 'down', 'MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.'),
(7455, 'hsa-mir-217', 'osteosarcoma', 'down', 'The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.'),
(7456, 'hsa-mir-218', 'osteosarcoma', 'down', 'miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9.'),
(7457, 'hsa-mir-22', 'osteosarcoma', 'down', 'miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy.'),
(7458, 'hsa-mir-22', 'osteosarcoma', 'down', 'Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.'),
(7459, 'hsa-mir-221', 'osteosarcoma', 'up', 'MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma.'),
(7460, 'hsa-mir-23a', 'osteosarcoma', 'down', 'miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.'),
(7461, 'hsa-mir-23a', 'osteosarcoma', 'down', 'MiR-23a Functions as a Tumor Suppressor in Osteosarcoma.'),
(7462, 'hsa-mir-24', 'osteosarcoma', 'down', 'MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAAT?.'),
(7463, 'hsa-mir-26a', 'osteosarcoma', 'down', 'Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.'),
(7464, 'hsa-mir-26b', 'osteosarcoma', 'down', 'miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.'),
(7465, 'hsa-mir-26b', 'osteosarcoma', 'down', 'MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.'),
(7466, 'hsa-mir-27a', 'osteosarcoma', 'up', 'Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.'),
(7467, 'hsa-mir-27a', 'osteosarcoma', 'up', 'MicroRNA-27a Promotes Proliferation, Migration and Invasion by Targeting MAP2K4 in Human Osteosarcoma Cells.'),
(7468, 'hsa-mir-29b', 'osteosarcoma', 'down', 'MicroRNA signatures associate with pathogenesis and progression of osteosarcoma.'),
(7469, 'hsa-mir-300', 'osteosarcoma', 'up', 'Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.'),
(7470, 'hsa-mir-32', 'osteosarcoma', 'down', 'MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.'),
(7471, 'hsa-mir-320', 'osteosarcoma', 'down', 'MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase.'),
(7472, 'hsa-mir-320a', 'osteosarcoma', 'up', 'Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.'),
(7473, 'hsa-mir-335', 'osteosarcoma', 'down', 'miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells.'),
(7474, 'hsa-mir-33b', 'osteosarcoma', 'down', 'MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells.'),
(7475, 'hsa-mir-340', 'osteosarcoma', 'down', 'MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.'),
(7476, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.'),
(7477, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether ? go-go 1 expression.'),
(7478, 'hsa-mir-34a', 'osteosarcoma', 'down', 'Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.'),
(7479, 'hsa-mir-34b', 'osteosarcoma', 'down', 'Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.'),
(7480, 'hsa-mir-34c', 'osteosarcoma', 'down', 'MiR-34c inhibits osteosarcoma metastasis and chemoresistance.'),
(7481, 'hsa-mir-34c', 'osteosarcoma', 'down', 'Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements.'),
(7482, 'hsa-mir-374a-5p', 'osteosarcoma', 'up', 'Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.'),
(7483, 'hsa-mir-375', 'osteosarcoma', 'down', 'MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.'),
(7484, 'hsa-mir-376c', 'osteosarcoma', 'down', 'MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha.'),
(7485, 'hsa-mir-376c', 'osteosarcoma', 'down', 'MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.'),
(7486, 'hsa-mir-382', 'osteosarcoma', 'down', 'miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1.'),
(7487, 'hsa-mir-382', 'osteosarcoma', 'down', 'miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.'),
(7488, 'hsa-mir-3928', 'osteosarcoma', 'down', 'Down-Regulation of miR-3928 Promoted Osteosarcoma Growth.'),
(7489, 'hsa-mir-424', 'osteosarcoma', 'down', 'Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.'),
(7490, 'hsa-mir-429', 'osteosarcoma', 'down', 'Tumor-Suppressing Effects of miR-429 on Human Osteosarcoma.'),
(7491, 'hsa-mir-449a', 'osteosarcoma', 'down', 'miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.'),
(7492, 'hsa-mir-451', 'osteosarcoma', 'down', 'Tumor-Suppressing Effects of miR451 in Human Osteosarcoma.'),
(7493, 'hsa-mir-451', 'osteosarcoma', 'down', 'MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients'),
(7494, 'hsa-mir-451', 'osteosarcoma', 'down', 'Suppression of liver receptor homolog-1 by microRNA-451 represses the proliferation of osteosarcoma cells.'),
(7495, 'hsa-mir-454', 'osteosarcoma', 'down', 'miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.'),
(7496, 'hsa-mir-503', 'osteosarcoma', 'down', 'MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.'),
(7497, 'hsa-mir-519d', 'osteosarcoma', 'down', 'CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.'),
(7498, 'hsa-mir-646', 'osteosarcoma', 'down', 'miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).'),
(7499, 'hsa-mir-802', 'osteosarcoma', 'up', 'MicroRNA-802 promotes osteosarcoma cell proliferation by targeting p27.'),
(7500, 'hsa-mir-9', 'osteosarcoma', 'up', 'Serum miR-9 as a prognostic biomarker in patients with osteosarcoma.'),
(7501, 'hsa-mir-92a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7502, 'mir-17', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7503, 'mir-18a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7504, 'mir-19a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7505, 'mir-19b', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7506, 'mir-20a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7507, 'mir-92a', 'osteosarcoma', 'up', 'Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.'),
(7508, 'hsa-mir-100', 'osteosarcoma', 'down', 'MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.'),
(7509, 'hsa-mir-125b', 'osteosarcoma', 'down', 'Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.'),
(7510, 'hsa-mir-126', 'osteosarcoma', 'down', 'Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.'),
(7511, 'hsa-mir-126', 'osteosarcoma', 'down', 'MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells.'),
(7512, 'hsa-mir-133b', 'osteosarcoma', 'down', 'Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.'),
(7513, 'hsa-mir-137', 'osteosarcoma', 'down', 'MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.'),
(7514, 'hsa-mir-15a', 'osteosarcoma', 'down', 'MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.'),
(7515, 'hsa-mir-1908', 'osteosarcoma', 'up', 'MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.'),
(7516, 'hsa-mir-199a-3p', 'osteosarcoma', 'down', 'CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.'),
(7517, 'hsa-mir-199b-5p', 'osteosarcoma', 'up', 'Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.'),
(7518, 'hsa-mir-202', 'osteosarcoma', 'up', 'TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.'),
(7519, 'hsa-mir-300', 'osteosarcoma', 'up', 'Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.'),
(7520, 'hsa-mir-490-3p', 'osteosarcoma', 'down', 'MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.'),
(7521, 'hsa-mir-497', 'osteosarcoma', 'down', 'The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma.'),
(7522, 'hsa-mir-503', 'osteosarcoma', 'down', 'Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival.'),
(7523, 'hsa-mir-539', 'osteosarcoma', 'down', 'MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8.'),
(7524, 'hsa-mir-646', 'osteosarcoma', 'down', 'Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.'),
(7525, 'hsa-mir-9', 'osteosarcoma', 'up', 'miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.'),
(7526, 'hsa-mir-93', 'osteosarcoma', 'up', 'microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.'),
(7527, 'hsa-mir-132', 'osteosarcoma', 'down', 'MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.'),
(7528, 'hsa-mir-145', 'osteosarcoma', 'down', 'MicroRNA-145 Suppresses Osteosarcoma Metastasis via Targeting MMP16.'),
(7529, 'hsa-mir-146b-5p', 'osteosarcoma', 'up', 'miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.'),
(7530, 'hsa-mir-150', 'osteosarcoma', 'down', 'MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma.'),
(7531, 'hsa-mir-150', 'osteosarcoma', 'down', 'MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.'),
(7532, 'hsa-mir-152', 'osteosarcoma', 'down', 'Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.'),
(7533, 'hsa-mir-182', 'osteosarcoma', 'down', 'The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.'),
(7534, 'hsa-mir-191', 'osteosarcoma', 'up', 'Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.'),
(7535, 'hsa-mir-203', 'osteosarcoma', 'down', 'miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.'),
(7536, 'hsa-mir-203', 'osteosarcoma', 'down', 'MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.'),
(7537, 'hsa-mir-210', 'osteosarcoma', 'up', 'Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo.'),
(7538, 'hsa-mir-221', 'osteosarcoma', 'up', 'miR-221 increases osteosarcoma?cell?proliferation, invasion and migration partly through?the downregulation of PTEN.'),
(7539, 'hsa-mir-27a', 'osteosarcoma', 'up', 'Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.'),
(7540, 'hsa-mir-29b', 'osteosarcoma', 'down', 'Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults\' age groups and their association with prediction of poor prognosis in human osteosarcoma.'),
(7541, 'hsa-mir-370', 'osteosarcoma', 'down', 'MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.'),
(7542, 'hsa-mir-422a', 'osteosarcoma', 'down', 'Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults\' age groups and their association with prediction of poor prognosis in human osteosarcoma.'),
(7543, 'hsa-mir-542-5p', 'osteosarcoma', 'up', 'MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.'),
(7544, 'hsa-mir-586', 'osteosarcoma', 'up', 'Downregulation of microRNA-586 Inhibits Proliferation, Invasion and Metastasis and Promotes Apoptosis in Human Osteosarcoma U2-OS Cell Line.'),
(7545, 'hsa-mir-664', 'osteosarcoma', 'up', 'Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.'),
(7546, 'hsa-mir-125b', 'osteosarcoma', 'down', 'MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.'),
(7547, 'hsa-mir-127-3p', 'osteosarcoma', 'down', 'MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells.'),
(7548, 'hsa-mir-128', 'osteosarcoma', 'down', 'MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin ?2.'),
(7549, 'hsa-mir-130b', 'osteosarcoma', 'up', 'miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.'),
(7550, 'hsa-mir-133a', 'osteosarcoma', 'down', 'MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R.'),
(7551, 'hsa-mir-134', 'osteosarcoma', 'down', 'Decreased miR-134 expression and its tumor-suppressive function in human osteosarcoma.'),
(7552, 'hsa-mir-154', 'osteosarcoma', 'down', 'MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.'),
(7553, 'hsa-mir-198', 'osteosarcoma', 'down', 'MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1.'),
(7554, 'hsa-mir-205', 'osteosarcoma', 'down', 'MiR-205 functions as a tumor suppressor via targeting TGF-? in osteosarcoma.'),
(7555, 'hsa-mir-21', 'osteosarcoma', 'up', 'MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.'),
(7556, 'hsa-mir-26b', 'osteosarcoma', 'down', 'MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.'),
(7557, 'hsa-mir-33a-5p', 'osteosarcoma', 'down', 'MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is downregulated in human osteosarcoma.'),
(7558, 'hsa-mir-363', 'osteosarcoma', 'down', 'microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.'),
(7559, 'hsa-mir-409-3p', 'osteosarcoma', 'down', 'MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-?1.'),
(7560, 'hsa-mir-421', 'osteosarcoma', 'up', 'miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.'),
(7561, 'hsa-mir-497', 'osteosarcoma', 'down', 'MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.'),
(7562, 'hsa-mir-497', 'osteosarcoma', 'down', 'MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells.'),
(7563, 'hsa-mir-503', 'osteosarcoma', 'down', 'MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.'),
(7564, 'hsa-mir-874', 'osteosarcoma', 'down', 'Decreased expression of tumor suppressive miR-874 and its clinical significance in human osteosarcoma.'),
(7565, 'hsa-mir-92b', 'osteosarcoma', 'up', 'miR-92b promotes tumor proliferation, migration, and invasion by targeting RECK in osteosarcoma.'),
(7566, 'hsa-mir-138', 'osteosarcoma', 'down', 'MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.'),
(7567, 'hsa-mir-224', 'osteosarcoma', 'down', 'MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.'),
(7568, 'hsa-mir-26a', 'osteosarcoma', 'down', 'MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.'),
(7569, 'hsa-mir-452', 'osteosarcoma', 'down', 'Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.'),
(7570, 'hsa-mir-99a', 'osteosarcoma', 'down', 'Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells.'),
(7571, 'hsa-mir-130a', 'osteosarcoma', 'up', 'MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.'),
(7572, 'hsa-mir-138', 'osteosarcoma', 'down', 'MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.'),
(7573, 'hsa-mir-145', 'osteosarcoma', 'up', 'miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.'),
(7574, 'hsa-mir-181b', 'osteosarcoma', 'up', '[microRNA-181b promotes migration and invasion of osteosarcoma cells by targeting N-myc downstream regulated gene 2].'),
(7575, 'hsa-mir-200b', 'osteosarcoma', 'down', 'MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.'),
(7576, 'hsa-mir-203', 'osteosarcoma', 'down', 'MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells.'),
(7577, 'hsa-mir-21', 'osteosarcoma', 'up', 'MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.'),
(7578, 'hsa-mir-22', 'osteosarcoma', 'down', 'miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.'),
(7579, 'hsa-mir-223', 'osteosarcoma', 'down', 'miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma.'),
(7580, 'hsa-mir-329', 'osteosarcoma', 'down', 'MiR-329 suppresses osteosarcoma development by downregulating Rab10.'),
(7581, 'hsa-mir-335', 'osteosarcoma', 'down', 'MiR-335 functions as a tumor suppressor and regulates survivin expression in osteosarcoma.'),
(7582, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells.'),
(7583, 'hsa-mir-367', 'osteosarcoma', 'up', 'MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4.'),
(7584, 'hsa-mir-488', 'osteosarcoma', 'up', 'Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma.'),
(7585, 'hsa-mir-513a-5p', 'osteosarcoma', 'down', 'miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease.'),
(7586, 'hsa-mir-603', 'osteosarcoma', 'up', 'MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.'),
(7587, 'hsa-mir-1', 'osteosarcoma', 'down', 'miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.'),
(7588, 'hsa-mir-10b', 'osteosarcoma', 'up', 'miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells.'),
(7589, 'hsa-mir-124', 'osteosarcoma', 'down', 'The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.'),
(7590, 'hsa-mir-148a', 'osteosarcoma', 'up', 'Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN.'),
(7591, 'hsa-mir-181a', 'osteosarcoma', 'up', 'MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma.'),
(7592, 'hsa-mir-26a', 'osteosarcoma', 'down', 'MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1.'),
(7593, 'hsa-mir-326', 'osteosarcoma', 'down', 'MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.'),
(7594, 'hsa-mir-33b', 'osteosarcoma', 'down', 'MicroRNA-33b inhibits the proliferation and migration of osteosarcoma cells via targeting hypoxia-inducible factor-1?.'),
(7595, 'hsa-mir-379', 'osteosarcoma', 'down', 'MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.'),
(7596, 'hsa-mir-451', 'osteosarcoma', 'down', 'miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R.'),
(7597, 'hsa-mir-489-3p', 'osteosarcoma', 'up', 'Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.'),
(7598, 'hsa-mir-497', 'osteosarcoma', 'down', 'miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.'),
(7599, 'hsa-mir-506', 'osteosarcoma', 'down', 'Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1.'),
(7600, 'hsa-mir-543', 'osteosarcoma', 'up', 'MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1? protein.'),
(7601, 'hsa-mir-665', 'osteosarcoma', 'down', 'MicroRNA-665 suppressed the invasion and metastasis of osteosarcoma by directly inhibiting RAB23.'),
(7602, 'hsa-mir-101', 'osteosarcoma', 'down', 'MicroRNA-101 inhibits proliferation, migration and invasion in osteosarcoma cells by targeting ROCK1.'),
(7603, 'hsa-mir-106b', 'osteosarcoma', 'up', 'The expression and function of miRNA-106 in pediatric osteosarcoma.'),
(7604, 'hsa-mir-133b', 'osteosarcoma', 'down', 'MicroRNA-133b inhibits cell proliferation and invasion in osteosarcoma by targeting to Sirt1.'),
(7605, 'hsa-mir-145', 'osteosarcoma', 'down', 'MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.'),
(7606, 'hsa-mir-150', 'osteosarcoma', 'down', '[MicroRNA-150 inhibits osteosarcoma cell proliferation by targeting RUNX2 gene].'),
(7607, 'hsa-mir-17', 'osteosarcoma', 'up', 'Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma.'),
(7608, 'hsa-mir-195-5p', 'osteosarcoma', 'down', 'MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1.'),
(7609, 'hsa-mir-199a-5p', 'osteosarcoma', 'up', 'MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma.'),
(7610, 'hsa-mir-21', 'osteosarcoma', 'up', 'MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 Via Targeting Caspase-8.'),
(7611, 'hsa-mir-212', 'osteosarcoma', 'down', 'MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1.'),
(7612, 'hsa-mir-335', 'osteosarcoma', 'down', 'miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.'),
(7613, 'hsa-mir-342-3p', 'osteosarcoma', 'down', 'MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells By Targeting Astrocyte-Elevated Gene-1 (AEG-1).'),
(7614, 'hsa-mir-34a', 'osteosarcoma', 'down', 'miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity.'),
(7615, 'hsa-mir-373', 'osteosarcoma', 'up', 'microRNA-373 promotes growth and cellular invasion in osteosarcoma cells by activation of PI3K/AKT-Rac1-JNK pathway: The potential role in spinal osteosarcoma.'),
(7616, 'hsa-mir-409-3p', 'osteosarcoma', 'down', 'MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma.'),
(7617, 'hsa-mir-490-3p', 'osteosarcoma', 'down', 'Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.'),
(7618, 'hsa-mir-497', 'osteosarcoma', 'down', 'Downregulation of microRNA-497 is associated with upregulation of synuclein ? in patients with osteosarcoma.'),
(7619, 'hsa-mir-574-3p', 'osteosarcoma', 'down', 'miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.'),
(7620, 'hsa-mir-638', 'osteosarcoma', 'down', 'MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma.'),
(7621, 'hsa-mir-93', 'osteosarcoma', 'up', '[Effects of miR-93 on proliferation and apoptosis of osteosarcoma cells].'),
(7622, 'hsa-mir-100', 'osteosarcoma', 'down', 'MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2.'),
(7623, 'hsa-mir-126', 'osteosarcoma', 'down', 'MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.'),
(7624, 'hsa-mir-150', 'osteosarcoma', 'down', 'miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1.'),
(7625, 'hsa-mir-153', 'osteosarcoma', 'down', 'Knockdown of Long Noncoding RNA TUG1 Inhibits the Proliferation and Cellular Invasion of Osteosarcoma Cells By Sponging MiR-153.'),
(7626, 'hsa-mir-19a', 'osteosarcoma', 'up', 'MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.'),
(7627, 'hsa-mir-221', 'osteosarcoma', 'up', 'Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.'),
(7628, 'hsa-mir-25-3p', 'osteosarcoma', 'up', 'Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.'),
(7629, 'hsa-mir-335', 'osteosarcoma', 'down', 'MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.'),
(7630, 'hsa-mir-34a', 'osteosarcoma', 'down', 'The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/?III-Tubulin Axis.'),
(7631, 'hsa-mir-370', 'osteosarcoma', 'down', 'DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/?-Catenin Signaling Pathway in Human Osteosarcoma Cells.'),
(7632, 'hsa-mir-107', 'osteosarcoma', 'up', 'MicroRNA-107 Promotes Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Tropomyosin 1.'),
(7633, 'hsa-mir-125a', 'osteosarcoma', 'down', 'MicroRNA-125a Regulates Cell Proliferation Via Directly Targeting E2F2 in Osteosarcoma.'),
(7634, 'hsa-mir-144-3p', 'osteosarcoma', 'down', 'TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.'),
(7635, 'hsa-mir-152', 'osteosarcoma', 'down', 'MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3.'),
(7636, 'hsa-mir-15a-3p', 'osteosarcoma', 'down', 'Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.'),
(7637, 'hsa-mir-187', 'osteosarcoma', 'down', 'miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma.'),
(7638, 'hsa-mir-19a', 'osteosarcoma', 'up', 'miR-19 promotes osteosarcoma progression by targeting SOCS6.'),
(7639, 'hsa-mir-19b-1', 'osteosarcoma', 'up', 'miR-19 promotes osteosarcoma progression by targeting SOCS6.'),
(7640, 'hsa-mir-19b-2', 'osteosarcoma', 'up', 'miR-19 promotes osteosarcoma progression by targeting SOCS6.'),
(7641, 'hsa-mir-204', 'osteosarcoma', 'down', 'MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin?1.'),
(7642, 'hsa-mir-208b', 'osteosarcoma', 'down', 'MicroRNA-208b inhibits human osteosarcoma progression by targeting ROR2.'),
(7643, 'hsa-mir-216a', 'osteosarcoma', 'down', 'miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.'),
(7644, 'hsa-mir-25', 'osteosarcoma', 'down', 'MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4.'),
(7645, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether ? go-go 1 expression.'),
(7646, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.'),
(7647, 'hsa-mir-429', 'osteosarcoma', 'down', 'MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1.'),
(7648, 'hsa-mir-433', 'osteosarcoma', 'up', 'MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells.'),
(7649, 'hsa-mir-448', 'osteosarcoma', 'down', 'MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.'),
(7650, 'hsa-mir-448', 'osteosarcoma', 'down', 'Overexpression of microRNA-448 inhibits osteosarcoma cell proliferation and invasion through targeting of astrocyte elevated gene-1.'),
(7651, 'hsa-mir-491', 'osteosarcoma', 'down', 'miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting ?B-crystallin.'),
(7652, 'hsa-mir-495', 'osteosarcoma', 'down', 'Overexpression of microRNA-495 suppresses the proliferation and invasion and induces the apoptosis of osteosarcoma cells by targeting high-mobility group nucleosome-binding domain 5.'),
(7653, 'hsa-mir-503', 'osteosarcoma', 'down', 'MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.'),
(7654, 'hsa-mir-598', 'osteosarcoma', 'down', 'MiR-598: A tumor suppressor with biomarker significance in osteosarcoma.'),
(7655, 'hsa-mir-610', 'osteosarcoma', 'down', 'MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.'),
(7656, 'hsa-mir-765', 'osteosarcoma', 'down', 'MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma.'),
(7657, 'hsa-mir-93', 'osteosarcoma', 'up', 'MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.'),
(7658, 'hsa-mir-10b*', 'osteosarcoma', 'down', 'Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma.'),
(7659, 'hsa-mir-140', 'osteosarcoma', 'down', 'MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling.'),
(7660, 'hsa-mir-141-3p', 'osteosarcoma', 'down', 'miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells.'),
(7661, 'hsa-mir-182', 'osteosarcoma', 'down', 'MicroRNA-182 downregulates Wnt/?-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.'),
(7662, 'hsa-mir-194', 'osteosarcoma', 'down', 'Knockdown of Long Non-Coding RNA NEAT1 Inhibits Proliferation and Invasion and Induces Apoptosis of Osteosarcoma by Inhibiting miR-194 Expression.'),
(7663, 'hsa-mir-203', 'osteosarcoma', 'down', 'Development and validation of nomogram based on miR-203 and clinicopathological characteristics predicting survival after neoadjuvant chemotherapy and surgery for patients with non-metastatic osteosar'),
(7664, 'hsa-mir-302b', 'osteosarcoma', 'down', 'MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.'),
(7665, 'hsa-mir-375', 'osteosarcoma', 'down', 'MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.'),
(7666, 'hsa-mir-381', 'osteosarcoma', 'down', 'MicroRNA-381 suppresses the proliferation of osteosarcoma cells through LRH-1/Wnt/?-catenin signaling pathway.'),
(7667, 'hsa-mir-497', 'osteosarcoma', 'down', 'MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway.'),
(7668, 'hsa-mir-504', 'osteosarcoma', 'up', 'miR-504 promotes tumour growth and metastasis in human osteosarcoma by targeting TP53INP1.'),
(7669, 'hsa-mir-505', 'osteosarcoma', 'down', 'MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.'),
(7670, 'hsa-mir-542-3p', 'osteosarcoma', 'up', 'Serum miR-542-3p as a prognostic biomarker in osteosarcoma.'),
(7671, 'hsa-mir-564', 'osteosarcoma', 'down', 'MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt.'),
(7672, 'hsa-mir-92b', 'osteosarcoma', 'up', 'MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3.'),
(7673, 'hsa-mir-95-3p', 'osteosarcoma', 'up', 'Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression.'),
(7674, 'hsa-mir-1271', 'osteosarcoma', 'up', 'Expression and role of microRNA-1271 in the pathogenesis of osteosarcoma.'),
(7675, 'hsa-mir-129-5p', 'osteosarcoma', 'down', 'MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma.'),
(7676, 'hsa-mir-134', 'osteosarcoma', 'down', 'MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway.'),
(7677, 'hsa-mir-143-3p', 'osteosarcoma', 'down', 'miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.'),
(7678, 'hsa-mir-183', 'osteosarcoma', 'down', 'MiR-183 inhibits osteosarcoma cell growth and invasion by regulating LRP6-Wnt/?-catenin signaling pathway.'),
(7679, 'hsa-mir-194', 'osteosarcoma', 'down', 'miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2.'),
(7680, 'hsa-mir-19a', 'osteosarcoma', 'up', 'MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.'),
(7681, 'hsa-mir-19b-1', 'osteosarcoma', 'up', 'MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.'),
(7682, 'hsa-mir-19b-2', 'osteosarcoma', 'up', 'MicroRNA-19 contributes to the malignant phenotypes of osteosarcoma in vitro by targeting Pax6.'),
(7683, 'hsa-mir-205', 'osteosarcoma', 'down', 'Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma.'),
(7684, 'hsa-mir-20a', 'osteosarcoma', 'down', 'miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.'),
(7685, 'hsa-mir-27a', 'osteosarcoma', 'up', 'MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1.'),
(7686, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether ?? go-go 1 expression.'),
(7687, 'hsa-mir-34a', 'osteosarcoma', 'down', 'MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.'),
(7688, 'hsa-mir-361', 'osteosarcoma', 'down', 'MiR-361 inhibits osteosarcoma cell lines invasion and proliferation by targeting FKBP14.'),
(7689, 'hsa-mir-363-3p', 'osteosarcoma', 'down', 'MiR-363-3p inhibits osteosarcoma cell proliferation and invasion via targeting SOX4.'),
(7690, 'hsa-mir-365', 'osteosarcoma', 'down', 'miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma.'),
(7691, 'hsa-mir-372-3p', 'osteosarcoma', 'down', 'MiR-372-3p inhibits the growth and metastasis of osteosarcoma cells by targeting FXYD6.'),
(7692, 'hsa-mir-411', 'osteosarcoma', 'up', 'MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression.'),
(7693, 'hsa-mir-422a', 'osteosarcoma', 'down', 'miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS.'),
(7694, 'hsa-mir-4443', 'osteosarcoma', 'down', 'Long non-coding RNA FEZF1-AS1 promotes osteosarcoma progression by regulating miR-4443/NUPR1 axis.'),
(7695, 'hsa-mir-663b', 'osteosarcoma', 'up', 'Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression.'),
(7696, 'hsa-mir-107', 'osteosarcoma', 'down', 'Inhibitory Effect of MicroRNA-107 on Osteosarcoma Malignancy Through Regulation of Wnt/?-catenin Signaling in Vitro.'),
(7697, 'hsa-mir-127-3p', 'osteosarcoma', 'down', 'MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.'),
(7698, 'hsa-mir-1270', 'osteosarcoma', 'up', 'MicroRNA-1270 is associated with poor prognosis and its inhibition yielded anticancer mechanisms in human osteosarcoma.'),
(7699, 'hsa-mir-1301', 'osteosarcoma', 'down', 'MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9.'),
(7700, 'hsa-mir-130b', 'osteosarcoma', 'down', 'Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior in vitro.'),
(7701, 'hsa-mir-136', 'osteosarcoma', 'down', 'MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin.'),
(7702, 'hsa-mir-139-5p', 'osteosarcoma', 'down', 'MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1.'),
(7703, 'hsa-mir-149-5p', 'osteosarcoma', 'down', 'miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.'),
(7704, 'hsa-mir-15b-5p', 'osteosarcoma', 'down', 'The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.'),
(7705, 'hsa-mir-16', 'osteosarcoma', 'down', 'MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23.'),
(7706, 'hsa-mir-17', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7707, 'hsa-mir-18a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7708, 'hsa-mir-18a', 'osteosarcoma', 'down', 'MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27.'),
(7709, 'hsa-mir-192-5p', 'osteosarcoma', 'down', 'MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1.'),
(7710, 'hsa-mir-19a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7711, 'hsa-mir-19b', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7712, 'hsa-mir-206', 'osteosarcoma', 'down', 'MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis.'),
(7713, 'hsa-mir-20a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7714, 'hsa-mir-210', 'osteosarcoma', 'up', 'miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.'),
(7715, 'hsa-mir-214', 'osteosarcoma', 'up', 'MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3.'),
(7716, 'hsa-mir-218', 'osteosarcoma', 'up', '[MicroRNA-218 promotes osteosarcoma cell apoptosis by down-regulating oncogene B lymphoma mouse Moloney leukemia virus insertion region 1].'),
(7717, 'hsa-mir-223-3p', 'osteosarcoma', 'down', 'miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.'),
(7718, 'hsa-mir-26a', 'osteosarcoma', 'down', 'miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.'),
(7719, 'hsa-mir-302a', 'osteosarcoma', 'down', 'MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R.'),
(7720, 'hsa-mir-30a', 'osteosarcoma', 'down', 'miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression.'),
(7721, 'hsa-mir-30a-5p', 'osteosarcoma', 'down', 'MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1.'),
(7722, 'hsa-mir-3200-5p', 'osteosarcoma', 'up', 'MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1.'),
(7723, 'hsa-mir-323a-3p', 'osteosarcoma', 'down', 'MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.'),
(7724, 'hsa-mir-330', 'osteosarcoma', 'down', 'MicroRNA-330-3p Expression Indicates Good Prognosis and Suppresses Cell Proliferation by Targeting Bmi-1 in Osteosarcoma.'),
(7725, 'hsa-mir-338-3p', 'osteosarcoma', 'down', 'microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1.'),
(7726, 'hsa-mir-340', 'osteosarcoma', 'down', 'Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.'),
(7727, 'hsa-mir-488', 'osteosarcoma', 'down', 'MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3.'),
(7728, 'hsa-mir-499a-5p', 'osteosarcoma', 'down', 'MicroRNA-499a-5p inhibits osteosarcoma cell proliferation and differentiation by targeting protein phosphatase 1D through protein kinase B/glycogen synthase kinase 3? signaling.'),
(7729, 'hsa-mir-506-3p', 'osteosarcoma', 'down', 'MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.'),
(7730, 'hsa-mir-520d-3p', 'osteosarcoma', 'down', 'MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.'),
(7731, 'hsa-mir-524', 'osteosarcoma', 'up', 'MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma.'),
(7732, 'hsa-mir-567', 'osteosarcoma', 'down', 'MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma.'),
(7733, 'hsa-mir-613', 'osteosarcoma', 'down', 'CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613.'),
(7734, 'hsa-mir-645', 'osteosarcoma', 'up', 'MicroRNA-645 promotes metastasis of osteosarcoma via targeting tumor suppressor NM23 nucleoside diphosphate kinase 2.'),
(7735, 'hsa-mir-874', 'osteosarcoma', 'down', 'MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma.'),
(7736, 'hsa-mir-92a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7737, 'hsa-mir-96', 'osteosarcoma', 'down', 'microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.'),
(7738, 'mir-17', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7739, 'mir-18a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7740, 'mir-19a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7741, 'mir-19b', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7742, 'mir-20a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7743, 'mir-92a', 'osteosarcoma', 'up', 'The miR-17-92 cluster/QKI2/?-catenin axis promotes osteosarcoma progression.'),
(7744, 'hsa-let-7a', 'osteosarcoma', 'down', 'Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.'),
(7745, 'hsa-let-7g', 'osteosarcoma', 'up', 'Hsa-let-7g promotes osteosarcoma by reducing HOXB1 to activate NF-kB pathway.'),
(7746, 'hsa-mir-130b', 'osteosarcoma', 'down', 'Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behaviorin vitro.'),
(7747, 'hsa-mir-150', 'osteosarcoma', 'down', 'Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.'),
(7748, 'hsa-mir-17', 'osteosarcoma', 'up', 'MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.'),
(7749, 'hsa-mir-17-5p', 'osteosarcoma', 'up', 'miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.'),
(7750, 'hsa-mir-216b', 'osteosarcoma', 'down', 'MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.'),
(7751, 'hsa-mir-217', 'osteosarcoma', 'down', 'Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8.'),
(7752, 'hsa-mir-218', 'osteosarcoma', 'down', 'MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.'),
(7753, 'hsa-mir-222-3p', 'osteosarcoma', 'up', 'miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3.'),
(7754, 'hsa-mir-31', 'osteosarcoma', 'down', 'MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A.'),
(7755, 'hsa-mir-338-3p', 'osteosarcoma', 'down', 'microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90?kDa heat shock protein ATPase homolog 1.'),
(7756, 'hsa-mir-338-3p', 'osteosarcoma', 'down', 'MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.'),
(7757, 'hsa-mir-33b', 'osteosarcoma', 'down', 'MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).'),
(7758, 'hsa-mir-423-5p', 'osteosarcoma', 'down', 'miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.'),
(7759, 'hsa-mir-466', 'osteosarcoma', 'down', 'MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1.'),
(7760, 'hsa-mir-491-5p', 'osteosarcoma', 'down', 'miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2.'),
(7761, 'hsa-mir-503', 'osteosarcoma', 'down', 'miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor.'),
(7762, 'hsa-mir-590-3p', 'osteosarcoma', 'down', 'miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9.'),
(7763, 'hsa-mir-765', 'osteosarcoma', 'down', 'LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765.'),
(7764, 'hsa-let-7a', 'osteosarcoma', 'down', 'CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.'),
(7765, 'hsa-mir-101', 'osteosarcoma', 'down', 'The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2.'),
(7766, 'hsa-mir-1258', 'osteosarcoma', 'down', 'Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma.'),
(7767, 'hsa-mir-126', 'osteosarcoma', 'down', 'Retraction: Yang, C., et al. miR-126 Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox2. Int. J. Mol. Sci. 2014, 15, 423-437, doi:10.3390/ijms15010423.'),
(7768, 'hsa-mir-1285-3p', 'osteosarcoma', 'down', 'miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.'),
(7769, 'hsa-mir-134', 'osteosarcoma', 'down', 'miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo.'),
(7770, 'hsa-mir-136', 'osteosarcoma', 'down', 'Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.'),
(7771, 'hsa-mir-139', 'osteosarcoma', 'down', 'miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1.'),
(7772, 'hsa-mir-144', 'osteosarcoma', 'down', 'MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway.'),
(7773, 'hsa-mir-185', 'osteosarcoma', 'down', 'MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(7774, 'hsa-mir-186-5p', 'osteosarcoma', 'down', 'miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.'),
(7775, 'hsa-mir-206', 'osteosarcoma', 'down', 'MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis.'),
(7776, 'hsa-mir-208a', 'osteosarcoma', 'up', 'LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis.'),
(7777, 'hsa-mir-21', 'osteosarcoma', 'up', 'lncRNA-NEF is downregulated in osteosarcoma and inhibits cancer cell migration and invasion by downregulating miRNA-21.'),
(7778, 'hsa-mir-211-5p', 'osteosarcoma', 'down', 'MicroRNA-211-5p promotes the apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11.'),
(7779, 'hsa-mir-217', 'osteosarcoma', 'down', 'MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma.'),
(7780, 'hsa-mir-218', 'osteosarcoma', 'down', 'miR-218 suppresses the proliferation of osteosarcoma through downregulation of E2F2.'),
(7781, 'hsa-mir-22', 'osteosarcoma', 'down', 'Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy.'),
(7782, 'hsa-mir-221', 'osteosarcoma', 'up', 'MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.'),
(7783, 'hsa-mir-23b-3p', 'osteosarcoma', 'up', 'miR-23b-3p suppressing PGC1? promotes proliferation through reprogramming metabolism in osteosarcoma.'),
(7784, 'hsa-mir-29a', 'osteosarcoma', 'up', 'miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.'),
(7785, 'hsa-mir-29b-1', 'osteosarcoma', 'up', 'miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.'),
(7786, 'hsa-mir-29b-2', 'osteosarcoma', 'up', 'miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.'),
(7787, 'hsa-mir-29c', 'osteosarcoma', 'down', 'BMP-2 and miR-29c in osteosarcoma tissues on proliferation and invasion of osteosarcoma cells.'),
(7788, 'hsa-mir-29c', 'osteosarcoma', 'up', 'miR-29 promotes osteosarcoma cell proliferation and migration by targeting PTEN.'),
(7789, 'hsa-mir-328-3p', 'osteosarcoma', 'down', 'Elevated expression of microRNA-328-3p suppresses aggressive malignant behaviors via targeting matrix metalloprotease 16 in osteosarcoma.'),
(7790, 'hsa-mir-340-5p', 'osteosarcoma', 'down', 'MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/?-catenin signaling pathway via targeting the STAT3 gene.'),
(7791, 'hsa-mir-424', 'osteosarcoma', 'down', 'The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.'),
(7792, 'hsa-mir-425-5p', 'osteosarcoma', 'down', 'miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/?-catenin signaling pathway.'),
(7793, 'hsa-mir-432', 'osteosarcoma', 'down', 'MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1.'),
(7794, 'hsa-mir-449a', 'osteosarcoma', 'down', 'The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.'),
(7795, 'hsa-mir-451a', 'osteosarcoma', 'down', 'miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66.'),
(7796, 'hsa-mir-504', 'osteosarcoma', 'up', 'MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53.'),
(7797, 'hsa-mir-5195-3p', 'osteosarcoma', 'down', 'miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.'),
(7798, 'hsa-mir-542-3p', 'osteosarcoma', 'down', 'MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells.'),
(7799, 'hsa-mir-548d-3p', 'osteosarcoma', 'down', 'miR-548d-3p inhibits osteosarcoma by downregulating KRAS.'),
(7800, 'hsa-mir-552', 'osteosarcoma', 'up', 'MicroRNA-552 promotes migration and invasion of osteosarcoma through targeting TIMP2.'),
(7801, 'hsa-mir-552-5p', 'osteosarcoma', 'up', 'miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1.'),
(7802, 'hsa-mir-627-3p', 'osteosarcoma', 'down', 'miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN.'),
(7803, 'hsa-mir-638', 'osteosarcoma', 'down', 'MicroRNA-638 expression change in osteosarcoma patients via PLD1 and VEGF expression.'),
(7804, 'hsa-mir-671-5p', 'osteosarcoma', 'down', 'miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma.'),
(7805, 'hsa-mir-7', 'osteosarcoma', 'down', 'Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.'),
(7806, 'hsa-mir-708-5p', 'osteosarcoma', 'down', 'MicroRNA-708-5p affects proliferation and invasion of osteosarcoma cells by targeting URGCP.'),
(7807, 'hsa-mir-876-5p', 'osteosarcoma', 'down', 'MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma.'),
(7808, 'hsa-mir-885-5p', 'osteosarcoma', 'down', 'miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of ?-catenin.'),
(7809, 'hsa-mir-885-5p', 'osteosarcoma', 'up', 'MicroRNA-885-5p promotes osteosarcoma proliferation and migration by downregulation of cell division cycle protein 73 homolog expression.'),
(7810, 'hsa-mir-889-3p', 'osteosarcoma', 'up', 'Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression.'),
(7811, 'hsa-mir-95-3p', 'osteosarcoma', 'down', 'Upregulation of miR?95-3p inhibits growth of osteosarcoma by targeting HDGF.'),
(7812, 'hsa-mir-98-5p', 'osteosarcoma', 'down', 'LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma.'),
(7813, 'hsa-let-7i', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7814, 'hsa-mir-100', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7815, 'hsa-mir-106a', 'ovarian cancer', 'up', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7816, 'hsa-mir-124', 'ovarian cancer', 'down', 'MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.'),
(7817, 'hsa-mir-125b', 'ovarian cancer', 'down', 'Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.'),
(7818, 'hsa-mir-125b', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7819, 'hsa-mir-125b', 'ovarian cancer', 'down', 'PPAR? inhibits ovarian cancer cells proliferation through upregulation of miR-125b.'),
(7820, 'hsa-mir-129-5p', 'ovarian cancer', 'down', 'A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.'),
(7821, 'hsa-mir-130b', 'ovarian cancer', 'down', 'Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.'),
(7822, 'hsa-mir-133a', 'ovarian cancer', 'down', 'miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor.'),
(7823, 'hsa-mir-137', 'ovarian cancer', 'down', 'miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1.'),
(7824, 'hsa-mir-138', 'ovarian cancer', 'down', 'MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1?'),
(7825, 'hsa-mir-141', 'ovarian cancer', 'down', 'A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.'),
(7826, 'hsa-mir-141', 'ovarian cancer', 'up', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7827, 'hsa-mir-145', 'ovarian cancer', 'down', 'MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.'),
(7828, 'hsa-mir-145', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7829, 'hsa-mir-145', 'ovarian cancer', 'down', 'miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma.'),
(7830, 'hsa-mir-145', 'ovarian cancer', 'down', 'miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.'),
(7831, 'hsa-mir-145', 'ovarian cancer', 'down', 'MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer.'),
(7832, 'hsa-mir-148a', 'ovarian cancer', 'down', 'Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.'),
(7833, 'hsa-mir-148a', 'ovarian cancer', 'down', 'MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1.'),
(7834, 'hsa-mir-148b', 'ovarian cancer', 'up', 'Increased expression of miR-148b in ovarian carcinoma and its clinical significance.'),
(7835, 'hsa-mir-152', 'ovarian cancer', 'down', 'Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.'),
(7836, 'hsa-mir-153', 'ovarian cancer', 'down', 'MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.'),
(7837, 'hsa-mir-155', 'ovarian cancer', 'down', 'MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.'),
(7838, 'hsa-mir-181b', 'ovarian cancer', 'up', 'MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.'),
(7839, 'hsa-mir-182', 'ovarian cancer', 'up', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7840, 'hsa-mir-182', 'ovarian cancer', 'up', 'Anti-MiR-182 reduces ovarian cancer burden, invasion and metastasis: An in vivo study in orthotopic xenografts of nude mice.'),
(7841, 'hsa-mir-182', 'ovarian cancer', 'up', 'The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul'),
(7842, 'hsa-mir-199a', 'ovarian cancer', 'down', 'Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis.'),
(7843, 'hsa-mir-199a', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7844, 'hsa-mir-200a', 'ovarian cancer', 'up', 'Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer.'),
(7845, 'hsa-mir-200a', 'ovarian cancer', 'down', 'A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.'),
(7846, 'hsa-mir-200b', 'ovarian cancer', 'down', 'A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.'),
(7847, 'hsa-mir-200c', 'ovarian cancer', 'down', 'A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.'),
(7848, 'hsa-mir-200c', 'ovarian cancer', 'down', 'Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.'),
(7849, 'hsa-mir-200c', 'ovarian cancer', 'up', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7850, 'hsa-mir-200c', 'ovarian cancer', 'up', 'miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.'),
(7851, 'hsa-mir-205', 'ovarian cancer', 'up', 'The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion.'),
(7852, 'hsa-mir-20a', 'ovarian cancer', 'up', 'miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells.'),
(7853, 'hsa-mir-20a', 'ovarian cancer', 'up', 'Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.'),
(7854, 'hsa-mir-21', 'ovarian cancer', 'up', 'The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.'),
(7855, 'hsa-mir-210', 'ovarian cancer', 'up', 'miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell.'),
(7856, 'hsa-mir-212', 'ovarian cancer', 'down', 'MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF.'),
(7857, 'hsa-mir-214', 'ovarian cancer', 'up', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7858, 'hsa-mir-221', 'ovarian cancer', 'up', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7859, 'hsa-mir-224-5p', 'ovarian cancer', 'up', 'Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma.'),
(7860, 'hsa-mir-23b', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7861, 'hsa-mir-25', 'ovarian cancer', 'up', 'MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.'),
(7862, 'hsa-mir-25', 'ovarian cancer', 'up', 'MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.'),
(7863, 'hsa-mir-26a', 'ovarian cancer', 'up', 'MiR-26a promotes ovarian cancer proliferation and tumorigenesis.'),
(7864, 'hsa-mir-27a', 'ovarian cancer', 'up', 'Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells.'),
(7865, 'hsa-mir-27a', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7866, 'hsa-mir-27b', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7867, 'hsa-mir-335', 'ovarian cancer', 'down', 'miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.'),
(7868, 'hsa-mir-335', 'ovarian cancer', 'down', 'Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.'),
(7869, 'hsa-mir-346', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7870, 'hsa-mir-34a', 'ovarian cancer', 'down', 'Frequent downregulation of miR-34 family in human ovarian cancers.'),
(7871, 'hsa-mir-34a', 'ovarian cancer', 'down', 'MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.'),
(7872, 'hsa-mir-34b', 'ovarian cancer', 'down', 'Frequent downregulation of miR-34 family in human ovarian cancers.'),
(7873, 'hsa-mir-34c', 'ovarian cancer', 'down', 'Frequent downregulation of miR-34 family in human ovarian cancers.'),
(7874, 'hsa-mir-378', 'ovarian cancer', 'up', 'MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.'),
(7875, 'hsa-mir-378', 'ovarian cancer', 'up', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7876, 'hsa-mir-409-3p', 'ovarian cancer', 'down', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7877, 'hsa-mir-411', 'ovarian cancer', 'down', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7878, 'hsa-mir-424', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7879, 'hsa-mir-429', 'ovarian cancer', 'down', 'Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells.'),
(7880, 'hsa-mir-429', 'ovarian cancer', 'down', 'A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.'),
(7881, 'hsa-mir-432', 'ovarian cancer', 'down', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7882, 'hsa-mir-449a', 'ovarian cancer', 'down', 'MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells.'),
(7883, 'hsa-mir-494', 'ovarian cancer', 'down', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7884, 'hsa-mir-497', 'ovarian cancer', 'down', 'MicroRNA-497 inhibition of ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase 1.'),
(7885, 'hsa-mir-497', 'ovarian cancer', 'down', 'MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.'),
(7886, 'hsa-mir-498', 'ovarian cancer', 'down', '1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498.'),
(7887, 'hsa-mir-498', 'ovarian cancer', 'down', 'MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.'),
(7888, 'hsa-mir-503', 'ovarian cancer', 'up', 'MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance.'),
(7889, 'hsa-mir-519d', 'ovarian cancer', 'down', 'MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.'),
(7890, 'hsa-mir-572', 'ovarian cancer', 'up', 'Upregulation of MiR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.'),
(7891, 'hsa-mir-655', 'ovarian cancer', 'down', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7892, 'hsa-mir-9', 'ovarian cancer', 'down', 'MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.'),
(7893, 'hsa-mir-9', 'ovarian cancer', 'up', 'MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.'),
(7894, 'hsa-mir-96', 'ovarian cancer', 'up', 'The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimul'),
(7895, 'hsa-mir-96', 'ovarian cancer', 'up', 'Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.'),
(7896, 'hsa-mir-98', 'ovarian cancer', 'down', 'EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.'),
(7897, 'hsa-mir-1181', 'ovarian cancer', 'up', 'Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer.'),
(7898, 'hsa-mir-1207', 'ovarian cancer', 'up', 'MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/?-catenin signaling pathway.'),
(7899, 'hsa-mir-126', 'ovarian cancer', 'down', 'microRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cells.'),
(7900, 'hsa-mir-137', 'ovarian cancer', 'down', 'MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.'),
(7901, 'hsa-mir-137', 'ovarian cancer', 'down', 'MicroRNA-29a inhibits cell migration and invasion by targeting Roundabout 1 in breast cancer cells.'),
(7902, 'hsa-mir-140-5p', 'ovarian cancer', 'down', 'miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.'),
(7903, 'hsa-mir-145', 'ovarian cancer', 'down', 'Quercetin induces the apoptosis of human ovarian carcinoma cells by upregulating the expression of microRNA-145.'),
(7904, 'hsa-mir-448', 'ovarian cancer', 'down', 'miR-448 negatively regulates ovarian cancer cell growth and metastasis by targeting CXCL12.'),
(7905, 'hsa-mir-661', 'ovarian cancer', 'up', 'MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression.'),
(7906, 'hsa-mir-1271', 'ovarian cancer', 'down', 'MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.'),
(7907, 'hsa-mir-17-5p', 'ovarian cancer', 'up', 'MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.'),
(7908, 'hsa-mir-29b', 'ovarian cancer', 'down', 'MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.'),
(7909, 'hsa-mir-339-5p', 'ovarian cancer', 'down', 'miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.'),
(7910, 'hsa-mir-382', 'ovarian cancer', 'down', 'miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.'),
(7911, 'hsa-mir-630', 'ovarian cancer', 'up', 'Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.'),
(7912, 'hsa-mir-101', 'ovarian cancer', 'down', 'miRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2.'),
(7913, 'hsa-mir-125a', 'ovarian cancer', 'down', 'MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.'),
(7914, 'hsa-mir-125b', 'ovarian cancer', 'down', 'MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.'),
(7915, 'hsa-mir-144', 'ovarian cancer', 'down', 'MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.'),
(7916, 'hsa-mir-181c', 'ovarian cancer', 'down', 'MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.'),
(7917, 'hsa-mir-193b', 'ovarian cancer', 'down', 'Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer.'),
(7918, 'hsa-mir-203', 'ovarian cancer', 'down', 'miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.'),
(7919, 'hsa-mir-214', 'ovarian cancer', 'down', 'MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.'),
(7920, 'hsa-mir-498', 'ovarian cancer', 'down', 'Low miR-498 expression levels are associated with poor prognosis in ovarian cancer.'),
(7921, 'hsa-mir-509-3p', 'ovarian cancer', 'down', 'MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis.'),
(7922, 'hsa-mir-548c', 'ovarian cancer', 'down', 'MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.'),
(7923, 'hsa-mir-613', 'ovarian cancer', 'down', 'MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.'),
(7924, 'hsa-mir-92a', 'ovarian cancer', 'up', 'Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.'),
(7925, 'hsa-mir-125a', 'ovarian cancer', 'down', 'MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.'),
(7926, 'hsa-mir-132', 'ovarian cancer', 'down', 'miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.'),
(7927, 'hsa-mir-551b-3p', 'ovarian cancer', 'up', 'Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.'),
(7928, 'hsa-mir-106a', 'ovarian cancer', 'up', 'MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells.'),
(7929, 'hsa-mir-125b', 'ovarian cancer', 'down', 'MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.'),
(7930, 'hsa-mir-17', 'ovarian cancer', 'down', 'miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.'),
(7931, 'hsa-mir-194', 'ovarian cancer', 'up', 'MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12.'),
(7932, 'hsa-mir-433', 'ovarian cancer', 'down', 'MicroRNA-433 inhibits migration and invasion of ovarian cancer cells via targeting Notch1.'),
(7933, 'hsa-mir-494', 'ovarian cancer', 'down', 'miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.'),
(7934, 'hsa-mir-125b', 'ovarian cancer', 'up', 'A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.'),
(7935, 'hsa-mir-137', 'ovarian cancer', 'down', 'microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.'),
(7936, 'hsa-mir-203', 'ovarian cancer', 'up', 'MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.'),
(7937, 'hsa-mir-224', 'ovarian cancer', 'up', 'Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.'),
(7938, 'hsa-mir-595', 'ovarian cancer', 'down', 'MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.'),
(7939, 'hsa-mir-760', 'ovarian cancer', 'up', 'MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.'),
(7940, 'hsa-mir-135a-3p', 'ovarian cancer', 'down', 'miR-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.'),
(7941, 'hsa-mir-200b-3p', 'ovarian cancer', 'up', 'Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival.'),
(7942, 'hsa-mir-216b', 'ovarian cancer', 'down', 'MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.'),
(7943, 'hsa-mir-3064', 'ovarian cancer', 'down', 'MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.'),
(7944, 'hsa-mir-376a', 'ovarian cancer', 'up', 'MiR-376a promotion of proliferation and metastases in ovarian cancer: Potential role as a biomarker.'),
(7945, 'hsa-mir-383', 'ovarian cancer', 'down', 'miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.'),
(7946, 'hsa-mir-532', 'ovarian cancer', 'down', 'MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.'),
(7947, 'hsa-mir-200a', 'ovarian cancer', 'up', 'The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.'),
(7948, 'hsa-mir-200b', 'ovarian cancer', 'up', 'The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.'),
(7949, 'hsa-mir-200c', 'ovarian cancer', 'up', 'The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.'),
(7950, 'hsa-mir-205', 'ovarian cancer', 'up', 'MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer.'),
(7951, 'hsa-mir-206', 'ovarian cancer', 'down', '[Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells].'),
(7952, 'hsa-mir-221', 'ovarian cancer', 'up', 'Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.'),
(7953, 'hsa-mir-27b', 'ovarian cancer', 'down', 'MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression.'),
(7954, 'hsa-mir-28-5p', 'ovarian cancer', 'up', 'miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.'),
(7955, 'hsa-mir-551a', 'ovarian cancer', 'down', 'Demethoxycurcumin inhibited human epithelia ovarian cancer cells\' growth via up-regulating miR-551a.'),
(7956, 'hsa-mir-9', 'ovarian cancer', 'up', 'Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.'),
(7957, 'hsa-mir-1', 'ovarian cancer', 'down', 'MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.'),
(7958, 'hsa-mir-139-5p', 'ovarian cancer', 'down', 'MicroRNA-139-5p Inhibit Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil Containing Protein Kinase 2 in Ovarian Cancer.'),
(7959, 'hsa-mir-141', 'ovarian cancer', 'up', 'The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.'),
(7960, 'hsa-mir-18a', 'ovarian cancer', 'down', 'MicroRNA-18a inhibits ovarian cancer growth via directly targeting TRIAP1 and IPMK.'),
(7961, 'hsa-mir-199a', 'ovarian cancer', 'down', 'Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.'),
(7962, 'hsa-mir-200a', 'ovarian cancer', 'up', 'The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.'),
(7963, 'hsa-mir-200b', 'ovarian cancer', 'up', 'The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.'),
(7964, 'hsa-mir-200c', 'ovarian cancer', 'up', 'The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.'),
(7965, 'hsa-mir-200c', 'ovarian cancer', 'down', 'Long Noncoding RNA MALAT1 Functions as a Sponge of MiR-200c in Ovarian Cancer.'),
(7966, 'hsa-mir-204', 'ovarian cancer', 'down', 'Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication.'),
(7967, 'hsa-mir-223-3p', 'ovarian cancer', 'up', 'MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.'),
(7968, 'hsa-mir-25', 'ovarian cancer', 'up', 'Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25.'),
(7969, 'hsa-mir-320', 'ovarian cancer', 'down', 'miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.'),
(7970, 'hsa-mir-330-5p', 'ovarian cancer', 'down', 'LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression.'),
(7971, 'hsa-mir-365', 'ovarian cancer', 'down', 'MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.'),
(7972, 'hsa-mir-429', 'ovarian cancer', 'up', 'The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.'),
(7973, 'hsa-mir-520b', 'ovarian cancer', 'up', 'Upregulation of miR-520b promotes ovarian cancer growth.'),
(7974, 'hsa-mir-629', 'ovarian cancer', 'up', 'Knockdown of miR-629 Inhibits Ovarian Cancer Malignant Behaviors by Targeting Testis-Specific Y-Like Protein 5.'),
(7975, 'hsa-mir-1246', 'ovarian cancer', 'up', 'Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.'),
(7976, 'hsa-mir-150', 'ovarian cancer', 'down', 'miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3.'),
(7977, 'hsa-mir-218', 'ovarian cancer', 'down', 'MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2.'),
(7978, 'hsa-mir-363', 'ovarian cancer', 'down', 'MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.'),
(7979, 'hsa-mir-424-5p', 'ovarian cancer', 'down', 'Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.'),
(7980, 'hsa-mir-488', 'ovarian cancer', 'down', 'microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function.'),
(7981, 'hsa-mir-5703', 'ovarian cancer', 'up', 'Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma.'),
(7982, 'hsa-mir-152', 'ovarian cancer', 'down', 'MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.'),
(7983, 'hsa-mir-214', 'ovarian cancer', 'down', 'MicroRNA-214 Suppresses Ovarian Cancer by Targeting ?-Catenin.'),
(7984, 'hsa-mir-340', 'ovarian cancer', 'down', 'microRNA-340 induces apoptosis by downregulation of BAG3 in ovarian cancer SKOV3 cells.'),
(7985, 'hsa-mir-509-3p', 'ovarian cancer', 'down', 'miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes.'),
(7986, 'hsa-mir-519a', 'ovarian cancer', 'down', 'MicroRNA-519a inhibits the proliferation and promotes the apoptosis of ovarian cancer cells through targeting signal transducer and activator of transcription 3.'),
(7987, 'hsa-mir-1182', 'ovarian cancer', 'down', 'MiR-1182 inhibited metastasis and proliferation of ovarian cancer by targeting hTERT.'),
(7988, 'hsa-mir-135a-3p', 'ovarian cancer', 'down', 'MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.'),
(7989, 'hsa-mir-138', 'ovarian cancer', 'down', 'MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells.'),
(7990, 'hsa-mir-142-3p', 'ovarian cancer', 'down', 'MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1.'),
(7991, 'hsa-mir-143-3p', 'ovarian cancer', 'down', 'MiR-143-3p suppresses the progression of ovarian cancer.'),
(7992, 'hsa-mir-149', 'ovarian cancer', 'down', 'MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.'),
(7993, 'hsa-mir-19a', 'ovarian cancer', 'up', 'MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.'),
(7994, 'hsa-mir-205', 'ovarian cancer', 'up', 'miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.'),
(7995, 'hsa-mir-21', 'ovarian cancer', 'up', 'Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression.'),
(7996, 'hsa-mir-27a', 'ovarian cancer', 'up', 'Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1.'),
(7997, 'hsa-mir-34a', 'ovarian cancer', 'down', 'MiRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.'),
(7998, 'hsa-mir-423-5p', 'ovarian cancer', 'down', 'miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer.'),
(7999, 'hsa-mir-514', 'ovarian cancer', 'down', 'MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.'),
(8000, 'hsa-mir-532-3p', 'ovarian cancer', 'down', 'Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.'),
(8001, 'hsa-mir-590-3p', 'ovarian cancer', 'up', 'miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.'),
(8002, 'hsa-mir-614', 'ovarian cancer', 'up', 'Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.'),
(8003, 'hsa-mir-181a-1', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8004, 'hsa-mir-181a-2', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8005, 'hsa-mir-181b-1', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8006, 'hsa-mir-181b-2', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8007, 'hsa-mir-181c', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8008, 'hsa-mir-181d', 'ovarian cancer', 'down', 'MicroRNA-181 Functions as an Antioncogene and Mediates NF-?B Pathway by Targeting RTKN2 in Ovarian Cancers.'),
(8009, 'hsa-mir-199a-5p', 'ovarian cancer', 'down', 'miRNA-199a-5p suppresses proliferation and invasion by directly targeting NF-?B1 in human ovarian cancer cells.'),
(8010, 'hsa-mir-200a', 'ovarian cancer', 'up', 'MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.'),
(8011, 'hsa-mir-203', 'ovarian cancer', 'down', 'miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGF? pathway.'),
(8012, 'hsa-mir-221', 'ovarian cancer', 'up', 'miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.'),
(8013, 'hsa-mir-324-5p', 'ovarian cancer', 'down', 'Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.'),
(8014, 'hsa-mir-374b-5p', 'ovarian cancer', 'down', 'MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer.'),
(8015, 'hsa-mir-383-5p', 'ovarian cancer', 'down', 'Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.'),
(8016, 'hsa-mir-603', 'ovarian cancer', 'down', 'miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.'),
(8017, 'hsa-mir-107', 'ovarian cancer', 'down', 'MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.'),
(8018, 'hsa-mir-1180', 'ovarian cancer', 'up', 'MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway.'),
(8019, 'hsa-mir-122-5p', 'ovarian cancer', 'down', 'MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.'),
(8020, 'hsa-mir-124', 'ovarian cancer', 'down', 'Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer.'),
(8021, 'hsa-mir-1251-5p', 'ovarian cancer', 'up', 'MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells.'),
(8022, 'hsa-mir-127', 'ovarian cancer', 'down', 'MiR-127 inhibits ovarian cancer migration and invasion by up-regulating ITGA6.'),
(8023, 'hsa-mir-145', 'ovarian cancer', 'down', 'miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.'),
(8024, 'hsa-mir-146b', 'ovarian cancer', 'up', 'miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.'),
(8025, 'hsa-mir-148a', 'ovarian cancer', 'down', 'Overexpression of miR-148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3.'),
(8026, 'hsa-mir-15a-3p', 'ovarian cancer', 'down', 'MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.'),
(8027, 'hsa-mir-16', 'ovarian cancer', 'down', 'MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/?-catenin signaling pathway in ovarian cancer.'),
(8028, 'hsa-mir-195-5p', 'ovarian cancer', 'down', 'Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3?/?-catenin signaling pathway.'),
(8029, 'hsa-mir-217', 'ovarian cancer', 'down', 'MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.'),
(8030, 'hsa-mir-27a', 'ovarian cancer', 'up', 'MiR-27a promotes EMT in ovarian cancer through active Wnt/??-catenin signalling by targeting FOXO1.'),
(8031, 'hsa-mir-30a-5p', 'ovarian cancer', 'down', 'Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.'),
(8032, 'hsa-mir-328-3p', 'ovarian cancer', 'up', 'Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.'),
(8033, 'hsa-mir-34a', 'ovarian cancer', 'down', 'MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.'),
(8034, 'hsa-mir-34b', 'ovarian cancer', 'down', 'MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.'),
(8035, 'hsa-mir-34c', 'ovarian cancer', 'down', 'MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.'),
(8036, 'hsa-mir-377-3p', 'ovarian cancer', 'down', 'MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer.'),
(8037, 'hsa-mir-4443', 'ovarian cancer', 'down', 'Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis.'),
(8038, 'hsa-mir-5195-3p', 'ovarian cancer', 'down', 'Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis.'),
(8039, 'hsa-mir-590-3p', 'ovarian cancer', 'up', 'miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation.'),
(8040, 'hsa-mir-598', 'ovarian cancer', 'down', 'The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI.'),
(8041, 'hsa-mir-654-5p', 'ovarian cancer', 'down', 'MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.'),
(8042, 'hsa-mir-663', 'ovarian cancer', 'up', 'MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2.'),
(8043, 'hsa-mir-93-5p', 'ovarian cancer', 'up', 'MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.'),
(8044, 'hsa-mir-934', 'ovarian cancer', 'up', 'Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L.'),
(8045, 'hsa-mir-99a', 'ovarian cancer', 'down', 'MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.'),
(8046, 'hsa-mir-99b-5p', 'ovarian cancer', 'down', 'MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.'),
(8047, 'hsa-mir-100', 'ovarian carcinoma', 'down', 'Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.'),
(8048, 'hsa-mir-101', 'ovarian carcinoma', 'down', 'MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.'),
(8049, 'hsa-mir-148b', 'ovarian carcinoma', 'up', 'Increased expression of miR-148b in ovarian carcinoma and its clinical significance.'),
(8050, 'hsa-mir-182', 'ovarian carcinoma', 'up', 'MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.'),
(8051, 'hsa-mir-34b', 'ovarian carcinoma', 'down', 'MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.'),
(8052, 'hsa-mir-34c', 'ovarian carcinoma', 'down', 'MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.'),
(8053, 'hsa-mir-532-5p', 'ovarian carcinoma', 'down', 'MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.'),
(8054, 'hsa-mir-196a', 'ovarian carcinoma', 'up', 'Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.'),
(8055, 'hsa-mir-761', 'ovarian carcinoma', 'down', 'miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.'),
(8056, 'hsa-mir-30a', 'ovarian carcinoma', 'down', 'miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.'),
(8057, 'hsa-mir-93', 'ovarian carcinoma', 'down', 'RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.'),
(8058, 'hsa-mir-372', 'ovarian carcinoma', 'down', 'The role of miR-372 in ovarian carcinoma cell proliferation.'),
(8059, 'hsa-mir-192', 'ovarian carcinoma', 'up', 'The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.'),
(8060, 'hsa-mir-194', 'ovarian carcinoma', 'up', 'The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.'),
(8061, 'hsa-mir-215', 'ovarian carcinoma', 'up', 'The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.'),
(8062, 'hsa-mir-222', 'ovarian carcinoma', 'up', 'miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.'),
(8063, 'hsa-mir-98', 'ovarian carcinoma', 'down', 'MiRNA-98 inhibits ovarian carcinoma cell proliferation, migration and invasion via targeting SALL4.'),
(8064, 'hsa-mir-203', 'pancreatic adenocarcinoma', 'up', 'MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.'),
(8065, 'hsa-mir-301a', 'pancreatic adenocarcinoma', 'up', 'miR-301a as an NF-?B activator in pancreatic cancer cells.'),
(8066, 'hsa-mir-21', 'pancreatic adenocarcinoma', 'up', 'Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.'),
(8067, 'hsa-mir-221', 'pancreatic adenocarcinoma', 'up', 'Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.'),
(8068, 'hsa-mir-145', 'pancreatic adenocarcinoma', 'down', 'MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.'),
(8069, 'hsa-mir-17-5p', 'pancreatic adenocarcinoma', 'up', 'MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.'),
(8070, 'hsa-mir-126', 'pancreatic adenocarcinoma', 'down', 'Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.'),
(8071, 'hsa-mir-217', 'pancreatic adenocarcinoma', 'down', 'MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.'),
(8072, 'hsa-mir-34a', 'pancreatic adenocarcinoma', 'down', 'Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.'),
(8073, 'hsa-mir-1297', 'pancreatic adenocarcinoma', 'down', 'MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.'),
(8074, 'hsa-mir-876-3p', 'pancreatic adenocarcinoma', 'down', 'MicroRNA-876-3p functions as a tumor suppressor gene and correlates with cell metastasis in pancreatic adenocarcinoma via targeting JAG2.'),
(8075, 'hsa-mir-101', 'pancreatic cancer', 'down', 'miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells.'),
(8076, 'hsa-mir-10a', 'pancreatic cancer', 'up', 'MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.'),
(8077, 'hsa-mir-10b', 'pancreatic cancer', 'up', 'MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.'),
(8078, 'hsa-mir-10b', 'pancreatic cancer', 'up', 'MicroRNA-10b is overexpressed in pancreatic cancer.'),
(8079, 'hsa-mir-1181', 'pancreatic cancer', 'down', 'MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.'),
(8080, 'hsa-mir-124', 'pancreatic cancer', 'down', 'Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.'),
(8081, 'hsa-mir-1247', 'pancreatic cancer', 'down', 'miR-1247 is Correlated with Prognosis of Pancreatic Cancer and Inhibits Cell Proliferation by Targeting Neuropilins.'),
(8082, 'hsa-mir-132', 'pancreatic cancer', 'up', 'miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.'),
(8083, 'hsa-mir-133a', 'pancreatic cancer', 'down', 'miR-133a Functions as a Tumor Suppressor and Directly Targets FSCN1 in Pancreatic Cancer.'),
(8084, 'hsa-mir-141', 'pancreatic cancer', 'down', 'MicroRNA-141, downregulated in pancreatic cancer, inhibited the cell proliferation and invasion by directly targeting MAP4K4.'),
(8085, 'hsa-mir-145', 'pancreatic cancer', 'down', 'MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.'),
(8086, 'hsa-mir-146a', 'pancreatic cancer', 'down', 'Clinical significance of miR-146a in gastric cancer cases.'),
(8087, 'hsa-mir-146a', 'pancreatic cancer', 'down', 'miR-146a suppresses invasion of pancreatic cancer cells.'),
(8088, 'hsa-mir-148a', 'pancreatic cancer', 'down', 'MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.'),
(8089, 'hsa-mir-148b', 'pancreatic cancer', 'down', 'miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPK?1.'),
(8090, 'hsa-mir-148b', 'pancreatic cancer', 'down', 'MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.'),
(8091, 'hsa-mir-150*', 'pancreatic cancer', 'down', 'Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.'),
(8092, 'hsa-mir-150-5p', 'pancreatic cancer', 'down', '[MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].'),
(8093, 'hsa-mir-152', 'pancreatic cancer', 'down', 'MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.'),
(8094, 'hsa-mir-15a', 'pancreatic cancer', 'down', 'Dysregulation of miR-15a and miR-214 in human pancreatic cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(8095, 'hsa-mir-15a', 'pancreatic cancer', 'up', 'Dysregulation of miR-15a and miR-214 in human pancreatic cancer.'),
(8096, 'hsa-mir-17-5p', 'pancreatic cancer', 'up', 'miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells.'),
(8097, 'hsa-mir-17-5p', 'pancreatic cancer', 'up', 'MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.'),
(8098, 'hsa-mir-17-5p', 'pancreatic cancer', 'up', 'MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.'),
(8099, 'hsa-mir-181a', 'pancreatic cancer', 'up', 'LPS Induced miR-181a Promotes Pancreatic Cancer Cell Migration via Targeting PTEN and MAP2K4.'),
(8100, 'hsa-mir-18a', 'pancreatic cancer', 'up', 'Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.'),
(8101, 'hsa-mir-191', 'pancreatic cancer', 'up', 'MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.'),
(8102, 'hsa-mir-196a', 'pancreatic cancer', 'up', 'MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha.'),
(8103, 'hsa-mir-198', 'pancreatic cancer', 'down', 'A Tumorigenic Factor Interactome Connected Through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer.'),
(8104, 'hsa-mir-203', 'pancreatic cancer', 'down', 'miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells.'),
(8105, 'hsa-mir-21', 'pancreatic cancer', 'up', 'MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.'),
(8106, 'hsa-mir-21', 'pancreatic cancer', 'up', 'MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.'),
(8107, 'hsa-mir-212', 'pancreatic cancer', 'up', 'miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.'),
(8108, 'hsa-mir-214', 'pancreatic cancer', 'down', 'Dysregulation of miR-15a and miR-214 in human pancreatic cancer.'),
(8109, 'hsa-mir-214', 'pancreatic cancer', 'up', 'Dysregulation of miR-15a and miR-214 in human pancreatic cancer.'),
(8110, 'hsa-mir-216a', 'pancreatic cancer', 'down', '[Expression of miR-216a in pancreatic cancer and its clinical significance].'),
(8111, 'hsa-mir-216a', 'pancreatic cancer', 'down', 'MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.'),
(8112, 'hsa-mir-221', 'pancreatic cancer', 'up', 'Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.'),
(8113, 'hsa-mir-221', 'pancreatic cancer', 'up', 'miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.'),
(8114, 'hsa-mir-221', 'pancreatic cancer', 'up', 'Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.'),
(8115, 'hsa-mir-222', 'pancreatic cancer', 'up', 'miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.'),
(8116, 'hsa-mir-27a', 'pancreatic cancer', 'up', 'Genistein Inhibits Cell Growth and Invasion Through Regulation of MiR-27a in Pancreatic Cancer Cells.'),
(8117, 'hsa-mir-29c', 'pancreatic cancer', 'down', 'miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.'),
(8118, 'hsa-mir-301a', 'pancreatic cancer', 'up', 'miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.'),
(8119, 'hsa-mir-301a-3p', 'pancreatic cancer', 'up', 'MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.'),
(8120, 'hsa-mir-335', 'pancreatic cancer', 'down', 'miR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.'),
(8121, 'hsa-mir-34a', 'pancreatic cancer', 'down', 'Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.'),
(8122, 'hsa-mir-34a', 'pancreatic cancer', 'down', 'MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.'),
(8123, 'hsa-mir-34b', 'pancreatic cancer', 'down', 'MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.'),
(8124, 'hsa-mir-34b', 'pancreatic cancer', 'down', 'MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.'),
(8125, 'hsa-mir-34c', 'pancreatic cancer', 'down', 'MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.'),
(8126, 'hsa-mir-367', 'pancreatic cancer', 'up', 'miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-? signalling pathway.'),
(8127, 'hsa-mir-373', 'pancreatic cancer', 'down', 'Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell Invasion.'),
(8128, 'hsa-mir-375', 'pancreatic cancer', 'down', 'MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.'),
(8129, 'hsa-mir-375', 'pancreatic cancer', 'down', 'Expression levels of microRNA-375 in pancreatic cancer.'),
(8130, 'hsa-mir-410', 'pancreatic cancer', 'down', 'MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.'),
(8131, 'hsa-mir-424-5p', 'pancreatic cancer', 'up', 'MicroRNA-424-5p Suppresses the Expression of SOCS6 in Pancreatic Cancer.'),
(8132, 'hsa-mir-497', 'pancreatic cancer', 'down', 'MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.'),
(8133, 'hsa-mir-497', 'pancreatic cancer', 'down', 'Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.'),
(8134, 'hsa-mir-615-5p', 'pancreatic cancer', 'down', 'MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.'),
(8135, 'hsa-mir-630', 'pancreatic cancer', 'down', 'Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R.'),
(8136, 'hsa-mir-7', 'pancreatic cancer', 'up', 'Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells.'),
(8137, 'hsa-mir-92', 'pancreatic cancer', 'up', 'MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.'),
(8138, 'hsa-mir-96', 'pancreatic cancer', 'down', 'miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.'),
(8139, 'hsa-mir-99a', 'pancreatic cancer', 'up', 'Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.'),
(8140, 'hsa-mir-15b', 'pancreatic cancer', 'up', 'miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.'),
(8141, 'hsa-mir-216a', 'pancreatic cancer', 'down', 'miR-216a may inhibit pancreatic tumor growth by targeting JAK2.'),
(8142, 'hsa-mir-33a', 'pancreatic cancer', 'down', 'miR-33a suppresses the nuclear translocation of ?-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.'),
(8143, 'hsa-mir-181c', 'pancreatic cancer', 'up', 'Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.'),
(8144, 'hsa-mir-29a', 'pancreatic cancer', 'up', 'MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin.'),
(8145, 'hsa-mir-744', 'pancreatic cancer', 'up', 'MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/?-catenin pathway.'),
(8146, 'hsa-mir-1271', 'pancreatic cancer', 'down', 'miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.'),
(8147, 'hsa-mir-150', 'pancreatic cancer', 'down', 'Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.'),
(8148, 'hsa-mir-203', 'pancreatic cancer', 'up', 'miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer.'),
(8149, 'hsa-mir-215', 'pancreatic cancer', 'down', 'MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.'),
(8150, 'hsa-mir-329', 'pancreatic cancer', 'down', 'mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer.'),
(8151, 'hsa-mir-494', 'pancreatic cancer', 'down', 'Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.'),
(8152, 'hsa-mir-320a', 'pancreatic cancer', 'up', 'MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells.'),
(8153, 'hsa-mir-375', 'pancreatic cancer', 'down', 'Deregulation of MicroRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3.'),
(8154, 'hsa-mir-145', 'pancreatic cancer', 'down', 'MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.'),
(8155, 'hsa-mir-506', 'pancreatic cancer', 'down', 'Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-?B signaling.'),
(8156, 'hsa-mir-182', 'pancreatic cancer', 'up', 'MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting ?-TrCP2.'),
(8157, 'hsa-mir-29a', 'pancreatic cancer', 'down', 'Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.'),
(8158, 'hsa-mir-29b-1', 'pancreatic cancer', 'down', 'Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.'),
(8159, 'hsa-mir-29b-2', 'pancreatic cancer', 'down', 'Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.'),
(8160, 'hsa-mir-29c', 'pancreatic cancer', 'down', 'Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.'),
(8161, 'hsa-mir-663b', 'pancreatic cancer', 'down', 'Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2.'),
(8162, 'hsa-mir-138-5p', 'pancreatic cancer', 'down', 'miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1.'),
(8163, 'hsa-mir-216a', 'pancreatic cancer', 'down', 'MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.'),
(8164, 'hsa-mir-34a', 'pancreatic cancer', 'down', 'miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway.'),
(8165, 'hsa-mir-451', 'pancreatic cancer', 'up', 'MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39.'),
(8166, 'hsa-mir-1181', 'pancreatic cancer', 'down', 'miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer.'),
(8167, 'hsa-mir-1247', 'pancreatic cancer', 'down', 'Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.'),
(8168, 'hsa-mir-196b', 'pancreatic cancer', 'up', 'MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.'),
(8169, 'hsa-mir-200a', 'pancreatic cancer', 'down', 'Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis.'),
(8170, 'hsa-mir-205', 'pancreatic cancer', 'down', 'Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.'),
(8171, 'hsa-mir-221-3p', 'pancreatic cancer', 'up', 'MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer.'),
(8172, 'hsa-mir-613', 'pancreatic cancer', 'down', 'LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.'),
(8173, 'hsa-mir-1178', 'pancreatic cancer', 'up', '[Correlation between miR-1178 expression and clinicopathological significance in human pancreatic cancer].'),
(8174, 'hsa-mir-135b-5p', 'pancreatic cancer', 'up', 'Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer.'),
(8175, 'hsa-mir-195', 'pancreatic cancer', 'down', 'MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway.'),
(8176, 'hsa-mir-205', 'pancreatic cancer', 'down', 'Chemosensitization and inhibition of pancreatic cancer stem cell?proliferation by overexpression of microRNA-205.'),
(8177, 'hsa-mir-216b-5p', 'pancreatic cancer', 'down', 'MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells.'),
(8178, 'hsa-mir-300', 'pancreatic cancer', 'down', 'MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/?-catenin signaling pathway by targeting CUL4B in pancreatic cancer ce'),
(8179, 'hsa-mir-509-5p', 'pancreatic cancer', 'down', 'miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells.'),
(8180, 'hsa-mir-181c-5p', 'pancreatic cancer', 'up', 'Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p.'),
(8181, 'hsa-mir-23a', 'pancreatic cancer', 'up', 'MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1.'),
(8182, 'hsa-mir-629', 'pancreatic cancer', 'up', 'MiR-629 promotes human pancreatic cancer progression by targeting FOXO3.'),
(8183, 'hsa-mir-1271', 'pancreatic cancer', 'down', 'MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer.'),
(8184, 'hsa-mir-137', 'pancreatic cancer', 'down', 'MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP.'),
(8185, 'hsa-mir-185', 'pancreatic cancer', 'down', 'MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer.'),
(8186, 'hsa-mir-191', 'pancreatic cancer', 'up', 'An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.'),
(8187, 'hsa-mir-21', 'pancreatic cancer', 'up', 'An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.'),
(8188, 'hsa-mir-34a', 'pancreatic cancer', 'down', 'miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.'),
(8189, 'hsa-mir-34b', 'pancreatic cancer', 'down', 'miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.'),
(8190, 'hsa-mir-34c', 'pancreatic cancer', 'down', 'miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.'),
(8191, 'hsa-mir-451a', 'pancreatic cancer', 'up', 'An elevated expression of serum exosomal microRNA-191, -?21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.'),
(8192, 'hsa-mir-455-3p', 'pancreatic cancer', 'down', 'Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ.'),
(8193, 'hsa-mir-493', 'pancreatic cancer', 'down', 'miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression.'),
(8194, 'hsa-mir-128', 'pancreatic cancer', 'down', 'miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.'),
(8195, 'hsa-mir-1297', 'pancreatic cancer', 'down', 'MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.'),
(8196, 'hsa-mir-224', 'pancreatic cancer', 'up', 'MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1? Pathway.'),
(8197, 'hsa-mir-331-3p', 'pancreatic cancer', 'up', 'miR-331-3p Functions as an Oncogene by Targeting ST7L in Pancreatic Cancer.'),
(8198, 'hsa-mir-378a-3p', 'pancreatic cancer', 'down', 'Preliminary investigation of the function of hsa_circ_0006215 in pancreatic cancer.'),
(8199, 'hsa-mir-431', 'pancreatic cancer', 'down', 'MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.'),
(8200, 'hsa-mir-449a', 'pancreatic cancer', 'down', 'MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression.'),
(8201, 'hsa-mir-1291', 'pancreatic cancer', 'down', 'Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.'),
(8202, 'hsa-mir-216b', 'pancreatic cancer', 'down', 'MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating?KRAS.'),
(8203, 'hsa-mir-222', 'pancreatic cancer', 'up', 'Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.'),
(8204, 'hsa-mir-7', 'pancreatic cancer', 'down', 'miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer.'),
(8205, 'hsa-mir-9-5p', 'pancreatic cancer', 'down', 'miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.'),
(8206, 'hsa-mir-126-3p', 'pancreatic cancer', 'down', 'Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9.'),
(8207, 'hsa-mir-137', 'pancreatic cancer', 'down', 'MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12.'),
(8208, 'hsa-mir-142-5p', 'pancreatic cancer', 'down', 'miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.'),
(8209, 'hsa-mir-19b-3p', 'pancreatic cancer', 'up', 'miR-19b-3p promotes human pancreatic cancer Capan-2 cells proliferation by targeting phosphatase and tension homolog.'),
(8210, 'hsa-mir-216b', 'pancreatic cancer', 'down', 'MiR-216b inhibits pancreatic cancer cell progression and promotes apoptosis by down-regulating KRAS.'),
(8211, 'hsa-mir-29b', 'pancreatic cancer', 'down', 'MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer.'),
(8212, 'hsa-mir-30a', 'pancreatic cancer', 'down', 'MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway.'),
(8213, 'hsa-mir-340', 'pancreatic cancer', 'down', 'MicroRNA-340 suppresses pancreatic cancer growth by targeting BICD2.'),
(8214, 'hsa-mir-345-5p', 'pancreatic cancer', 'down', 'MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.'),
(8215, 'hsa-mir-374a', 'pancreatic cancer', 'up', 'MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1.'),
(8216, 'hsa-mir-539', 'pancreatic cancer', 'down', 'MiR-539 functions as a tumor suppressor in pancreatic cancer by targeting TWIST1.'),
(8217, 'hsa-mir-634', 'pancreatic cancer', 'down', 'MicroRNA-634 functions as a tumor suppressor in pancreatic cancer via directly targeting heat shock-related 70-kDa protein 2.'),
(8218, 'hsa-mir-132', 'pancreatic carcinoma', 'down', 'Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.'),
(8219, 'hsa-mir-301b', 'pancreatic carcinoma', 'up', 'MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells.'),
(8220, 'hsa-mir-375', 'pancreatic carcinoma', 'down', 'MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway.'),
(8221, 'hsa-mir-127', 'pancreatic carcinoma', 'down', 'MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.'),
(8222, 'hsa-mir-940', 'pancreatic carcinoma', 'up', 'Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3? and sFRP1 in human pancreatic carcinoma.'),
(8223, 'hsa-mir-7', 'pancreatic carcinoma', 'down', 'MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma.'),
(8224, 'hsa-let-7a', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8225, 'hsa-let-7a-1', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8226, 'hsa-let-7a-2', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8227, 'hsa-let-7a-3', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8228, 'hsa-let-7b', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8229, 'hsa-let-7c', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8230, 'hsa-let-7d', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8231, 'hsa-let-7d', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.'),
(8232, 'hsa-let-7e', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8233, 'hsa-let-7f-1', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8234, 'hsa-let-7f-2', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8235, 'hsa-let-7g', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8236, 'hsa-let-7i', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8237, 'hsa-mir-10b', 'pancreatic ductal adenocarcinoma', 'up', 'microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma.'),
(8238, 'hsa-mir-10b', 'pancreatic ductal adenocarcinoma', 'up', 'microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-? actions.'),
(8239, 'hsa-mir-126', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.'),
(8240, 'hsa-mir-135a', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.'),
(8241, 'hsa-mir-143', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8242, 'hsa-mir-144', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8243, 'hsa-mir-145', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8244, 'hsa-mir-148a', 'pancreatic ductal adenocarcinoma', 'down', 'Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.'),
(8245, 'hsa-mir-148a', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.'),
(8246, 'hsa-mir-148a', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.'),
(8247, 'hsa-mir-150', 'pancreatic ductal adenocarcinoma', 'down', 'A Decrease in miR-150 Regulates the Malignancy of Pancreatic Cancer by Targeting c-Myb and MUC4.'),
(8248, 'hsa-mir-15a', 'pancreatic ductal adenocarcinoma', 'down', 'miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.'),
(8249, 'hsa-mir-16', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors.'),
(8250, 'hsa-mir-186', 'pancreatic ductal adenocarcinoma', 'up', 'miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells.'),
(8251, 'hsa-mir-18a', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8252, 'hsa-mir-192', 'pancreatic ductal adenocarcinoma', 'up', 'Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.'),
(8253, 'hsa-mir-194', 'pancreatic ductal adenocarcinoma', 'up', 'Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.'),
(8254, 'hsa-mir-196a', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.'),
(8255, 'hsa-mir-198', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.'),
(8256, 'hsa-mir-200a', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8257, 'hsa-mir-200b', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8258, 'hsa-mir-200c', 'pancreatic ductal adenocarcinoma', 'down', 'XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.'),
(8259, 'hsa-mir-203', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8260, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.'),
(8261, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.'),
(8262, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma.'),
(8263, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.'),
(8264, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.'),
(8265, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.'),
(8266, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.'),
(8267, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.'),
(8268, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis.'),
(8269, 'hsa-mir-212', 'pancreatic ductal adenocarcinoma', 'up', 'miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1.'),
(8270, 'hsa-mir-217', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.'),
(8271, 'hsa-mir-217', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.'),
(8272, 'hsa-mir-217', 'pancreatic ductal adenocarcinoma', 'down', 'The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.'),
(8273, 'hsa-mir-218', 'pancreatic ductal adenocarcinoma', 'down', 'Enhancer of Zeste Homolog 2 Silences miR-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin.'),
(8274, 'hsa-mir-30b-5p', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8275, 'hsa-mir-31', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8276, 'hsa-mir-337', 'pancreatic ductal adenocarcinoma', 'down', 'miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7.'),
(8277, 'hsa-mir-34a', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.'),
(8278, 'hsa-mir-369-5p', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8279, 'hsa-mir-375', 'pancreatic ductal adenocarcinoma', 'down', 'Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.'),
(8280, 'hsa-mir-375', 'pancreatic ductal adenocarcinoma', 'down', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8281, 'hsa-mir-376a', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8282, 'hsa-mir-494', 'pancreatic ductal adenocarcinoma', 'down', 'Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and ?-catenin signaling in pancreatic ductal adenocarcinoma cells.'),
(8283, 'hsa-mir-541', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas.'),
(8284, 'hsa-mir-615-5p', 'pancreatic ductal adenocarcinoma', 'down', 'miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.'),
(8285, 'hsa-mir-615-5p', 'pancreatic ductal adenocarcinoma', 'down', 'Correction: MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2.'),
(8286, 'hsa-mir-98', 'pancreatic ductal adenocarcinoma', 'down', 'let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression.'),
(8287, 'hsa-mir-200a', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene.'),
(8288, 'hsa-mir-323-3p', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.'),
(8289, 'hsa-mir-150', 'pancreatic ductal adenocarcinoma', 'down', 'The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.'),
(8290, 'hsa-mir-34a', 'pancreatic ductal adenocarcinoma', 'down', 'The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.'),
(8291, 'hsa-mir-506', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.'),
(8292, 'hsa-mir-125a-5p', 'pancreatic ductal adenocarcinoma', 'up', 'Effects of miR-125a-5p on Cell Proliferation,Apoptosis and Cell Cycle of Pancreatic Cancer Cells.'),
(8293, 'hsa-mir-34a', 'pancreatic ductal adenocarcinoma', 'down', 'EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.'),
(8294, 'hsa-mir-377', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.'),
(8295, 'hsa-mir-4787-5p', 'pancreatic ductal adenocarcinoma', 'down', 'Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF?1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.'),
(8296, 'hsa-mir-663a', 'pancreatic ductal adenocarcinoma', 'down', 'Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF?1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.'),
(8297, 'hsa-mir-124', 'pancreatic ductal adenocarcinoma', 'down', 'Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.'),
(8298, 'hsa-mir-223', 'pancreatic ductal adenocarcinoma', 'up', 'HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.'),
(8299, 'hsa-mir-217', 'pancreatic ductal adenocarcinoma', 'down', 'Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.'),
(8300, 'hsa-mir-448', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway.'),
(8301, 'hsa-mir-107', 'pancreatic ductal adenocarcinoma', 'up', 'Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.'),
(8302, 'hsa-mir-10b', 'pancreatic ductal adenocarcinoma', 'up', 'MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.'),
(8303, 'hsa-mir-216a-3p', 'pancreatic ductal adenocarcinoma', 'down', 'The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.'),
(8304, 'hsa-mir-216a-5p', 'pancreatic ductal adenocarcinoma', 'down', 'The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.'),
(8305, 'hsa-mir-216b-3p', 'pancreatic ductal adenocarcinoma', 'down', 'The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.'),
(8306, 'hsa-mir-216b-5p', 'pancreatic ductal adenocarcinoma', 'down', 'The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.'),
(8307, 'hsa-mir-27a', 'pancreatic ductal adenocarcinoma', 'up', 'MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.'),
(8308, 'hsa-mir-27b', 'pancreatic ductal adenocarcinoma', 'up', 'MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.'),
(8309, 'hsa-mir-9', 'pancreatic ductal adenocarcinoma', 'up', 'MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells.'),
(8310, 'hsa-mir-637', 'pancreatic ductal adenocarcinoma', 'down', 'Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.'),
(8311, 'hsa-mir-675', 'pancreatic ductal adenocarcinoma', 'down', 'Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma.'),
(8312, 'hsa-mir-7-5p', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.'),
(8313, 'hsa-mir-125a-3p', 'pancreatic ductal adenocarcinoma', 'down', 'miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.'),
(8314, 'hsa-mir-216b', 'pancreatic ductal adenocarcinoma', 'down', 'MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ?-associated coiled-coil containing protein kinase 1.'),
(8315, 'hsa-mir-98-5p', 'pancreatic ductal adenocarcinoma', 'down', 'Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.'),
(8316, 'hsa-mir-124', 'pancreatic ductal adenocarcinoma', 'down', 'miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.'),
(8317, 'hsa-mir-1290', 'pancreatic ductal adenocarcinoma', 'up', 'miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.'),
(8318, 'hsa-mir-200c-3p', 'pancreatic ductal adenocarcinoma', 'down', 'A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.'),
(8319, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', 'Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.'),
(8320, 'hsa-mir-429', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer.'),
(8321, 'hsa-mir-661', 'pancreatic ductal adenocarcinoma', 'up', 'MicroRNA-661 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation.'),
(8322, 'hsa-mir-101', 'pancreatic ductal adenocarcinoma', 'down', 'SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer.'),
(8323, 'hsa-mir-135a-1', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.'),
(8324, 'hsa-mir-135a-2', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.'),
(8325, 'hsa-mir-135b', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.'),
(8326, 'hsa-mir-193a-3p', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1.'),
(8327, 'hsa-mir-21', 'pancreatic ductal adenocarcinoma', 'up', '[MicroRNA-21 correlates TGF-?1 pathway of pancreatic ductal adenocarcinoma].'),
(8328, 'hsa-mir-212', 'pancreatic ductal adenocarcinoma', 'up', 'miR-212 regulated by HIF-1? promotes the progression of pancreatic cancer.'),
(8329, 'hsa-mir-23a-5p', 'pancreatic ductal adenocarcinoma', 'down', 'miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression.'),
(8330, 'hsa-mir-345-5p', 'pancreatic ductal adenocarcinoma', 'down', 'MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.'),
(8331, 'hsa-mir-708-5p', 'pancreatic ductal adenocarcinoma', 'up', 'MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.'),
(8332, 'hsa-mir-873', 'pancreatic ductal adenocarcinoma', 'down', 'The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.'),
(8333, 'hsa-let-7e', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.'),
(8334, 'hsa-mir-101', 'papillary thyroid carcinoma', 'down', 'miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.'),
(8335, 'hsa-mir-101', 'papillary thyroid carcinoma', 'down', 'Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.'),
(8336, 'hsa-mir-130b', 'papillary thyroid carcinoma', 'down', 'MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.'),
(8337, 'hsa-mir-138', 'papillary thyroid carcinoma', 'down', 'Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.'),
(8338, 'hsa-mir-146a', 'papillary thyroid carcinoma', 'down', 'MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.'),
(8339, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.'),
(8340, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.'),
(8341, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma.'),
(8342, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8343, 'hsa-mir-146b-5p', 'papillary thyroid carcinoma', 'up', 'Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.'),
(8344, 'hsa-mir-146b-5p', 'papillary thyroid carcinoma', 'up', 'MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.'),
(8345, 'hsa-mir-146b-5p', 'papillary thyroid carcinoma', 'up', 'MicroRNA miR-146b-5p regulates signal transduction of TGF-? by repressing SMAD4 in thyroid cancer.'),
(8346, 'hsa-mir-151-5p', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.'),
(8347, 'hsa-mir-155', 'papillary thyroid carcinoma', 'up', 'Upregulated miR-155 in Papillary Thyroid Carcinoma Promotes Tumor Growth by Targeting APC and Activating Wnt/?-Catenin Signaling.'),
(8348, 'hsa-mir-16', 'papillary thyroid carcinoma', 'down', 'Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.'),
(8349, 'hsa-mir-181a-1', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8350, 'hsa-mir-181a-2', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8351, 'hsa-mir-181b-1', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8352, 'hsa-mir-181b-2', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8353, 'hsa-mir-181c', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8354, 'hsa-mir-181d', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8355, 'hsa-mir-182', 'papillary thyroid carcinoma', 'up', 'miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.'),
(8356, 'hsa-mir-183', 'papillary thyroid carcinoma', 'up', 'miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.'),
(8357, 'hsa-mir-195', 'papillary thyroid carcinoma', 'down', 'microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.'),
(8358, 'hsa-mir-199a-3p', 'papillary thyroid carcinoma', 'down', 'miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.'),
(8359, 'hsa-mir-199b-5p', 'papillary thyroid carcinoma', 'up', 'Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.'),
(8360, 'hsa-mir-204-5p', 'papillary thyroid carcinoma', 'down', 'miR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.'),
(8361, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8362, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.'),
(8363, 'hsa-mir-219-5p', 'papillary thyroid carcinoma', 'down', 'miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor ?'),
(8364, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8365, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.'),
(8366, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.'),
(8367, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.'),
(8368, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma.'),
(8369, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.'),
(8370, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.'),
(8371, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.'),
(8372, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.'),
(8373, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.'),
(8374, 'hsa-mir-26a', 'papillary thyroid carcinoma', 'down', 'miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.'),
(8375, 'hsa-mir-339-5p', 'papillary thyroid carcinoma', 'up', 'microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.'),
(8376, 'hsa-mir-34a', 'papillary thyroid carcinoma', 'up', 'MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.'),
(8377, 'hsa-mir-34b', 'papillary thyroid carcinoma', 'down', 'MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.'),
(8378, 'hsa-mir-613', 'papillary thyroid carcinoma', 'down', 'Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.'),
(8379, 'hsa-mir-126', 'papillary thyroid carcinoma', 'down', 'miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.'),
(8380, 'hsa-mir-146b-5p', 'papillary thyroid carcinoma', 'up', 'In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.'),
(8381, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.'),
(8382, 'hsa-mir-138', 'papillary thyroid carcinoma', 'down', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8383, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8384, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8385, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8386, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8387, 'hsa-mir-29a', 'papillary thyroid carcinoma', 'down', 'miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.'),
(8388, 'hsa-mir-31', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(8389, 'hsa-mir-34b', 'papillary thyroid carcinoma', 'up', 'Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.'),
(8390, 'hsa-mir-3613', 'papillary thyroid carcinoma', 'up', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8391, 'hsa-mir-98', 'papillary thyroid carcinoma', 'down', 'Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.'),
(8392, 'hsa-mir-137', 'papillary thyroid carcinoma', 'down', 'miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.'),
(8393, 'hsa-mir-375', 'papillary thyroid carcinoma', 'down', 'Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.'),
(8394, 'hsa-mir-451a', 'papillary thyroid carcinoma', 'down', 'miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.'),
(8395, 'hsa-mir-663', 'papillary thyroid carcinoma', 'down', 'MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.'),
(8396, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.'),
(8397, 'hsa-mir-486-5p', 'papillary thyroid carcinoma', 'down', 'miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.'),
(8398, 'hsa-mir-613', 'papillary thyroid carcinoma', 'down', 'MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.'),
(8399, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.'),
(8400, 'hsa-mir-124-3p', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.'),
(8401, 'hsa-mir-196b-5p', 'papillary thyroid carcinoma', 'down', 'Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.'),
(8402, 'hsa-mir-5691', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.'),
(8403, 'hsa-mir-9-3p', 'papillary thyroid carcinoma', 'up', 'Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.'),
(8404, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', '[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].'),
(8405, 'hsa-mir-363-3p', 'papillary thyroid carcinoma', 'down', 'MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.'),
(8406, 'hsa-mir-195', 'papillary thyroid carcinoma', 'down', 'MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.'),
(8407, 'hsa-mir-451', 'papillary thyroid carcinoma', 'down', 'MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.'),
(8408, 'hsa-mir-577', 'papillary thyroid carcinoma', 'down', 'MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.'),
(8409, 'hsa-let-7a', 'papillary thyroid carcinoma', 'down', 'Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma.'),
(8410, 'hsa-let-7b', 'papillary thyroid carcinoma', 'down', 'Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2.'),
(8411, 'hsa-mir-139', 'papillary thyroid carcinoma', 'down', 'MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.'),
(8412, 'hsa-mir-148a', 'papillary thyroid carcinoma', 'down', 'Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.'),
(8413, 'hsa-mir-101', 'papillary thyroid carcinoma', 'down', 'Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1.'),
(8414, 'hsa-mir-144', 'papillary thyroid carcinoma', 'down', 'MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer.'),
(8415, 'hsa-mir-199a-5p', 'papillary thyroid carcinoma', 'down', 'miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.'),
(8416, 'hsa-mir-30a', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.'),
(8417, 'hsa-mir-30b', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.'),
(8418, 'hsa-mir-30c', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.'),
(8419, 'hsa-mir-30d', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.'),
(8420, 'hsa-mir-30e', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.'),
(8421, 'hsa-mir-335', 'papillary thyroid carcinoma', 'down', 'MicroRNA-335 is downregulated in papillary thyroid cancer and suppresses cancer cell growth, migration and invasion by directly targeting ZEB2.'),
(8422, 'hsa-mir-384', 'papillary thyroid carcinoma', 'down', 'LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer.'),
(8423, 'hsa-mir-1266', 'papillary thyroid carcinoma', 'down', 'MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.'),
(8424, 'hsa-mir-144-3p', 'papillary thyroid carcinoma', 'up', 'MiR-144-3p promotes the tumor growth and metastasis of papillary thyroid carcinoma by targeting paired box gene 8.'),
(8425, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.'),
(8426, 'hsa-mir-329', 'papillary thyroid carcinoma', 'down', 'miR-329 inhibits papillary thyroid cancer progression via direct targeting WNT1.'),
(8427, 'hsa-mir-361-5p', 'papillary thyroid carcinoma', 'down', 'MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.'),
(8428, 'hsa-mir-381-3p', 'papillary thyroid carcinoma', 'down', 'MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.'),
(8429, 'hsa-mir-431', 'papillary thyroid carcinoma', 'down', 'Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.'),
(8430, 'hsa-mir-4316', 'papillary thyroid carcinoma', 'down', 'DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.'),
(8431, 'hsa-mir-4429', 'papillary thyroid carcinoma', 'down', 'Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.'),
(8432, 'hsa-mir-497', 'papillary thyroid carcinoma', 'down', 'miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.'),
(8433, 'hsa-mir-622', 'papillary thyroid carcinoma', 'down', 'miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.'),
(8434, 'hsa-let-7a', 'papillary thyroid carcinoma', 'down', 'Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.'),
(8435, 'hsa-mir-146b', 'papillary thyroid carcinoma', 'up', 'Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.'),
(8436, 'hsa-mir-146b-5p', 'papillary thyroid carcinoma', 'up', 'MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.'),
(8437, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.'),
(8438, 'hsa-mir-409-3p', 'papillary thyroid carcinoma', 'down', 'MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.'),
(8439, 'hsa-mir-520c-3p', 'papillary thyroid carcinoma', 'down', 'Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.'),
(8440, 'hsa-mir-101', 'papillary thyroid carcinoma', 'down', 'MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma.'),
(8441, 'hsa-mir-10a-5p', 'papillary thyroid carcinoma', 'up', 'A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.'),
(8442, 'hsa-mir-137', 'papillary thyroid carcinoma', 'up', 'BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.'),
(8443, 'hsa-mir-155', 'papillary thyroid carcinoma', 'up', 'Sevoflurane inhibits the progression of PTC by downregulating miR-155.'),
(8444, 'hsa-mir-181b', 'papillary thyroid carcinoma', 'up', 'BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.'),
(8445, 'hsa-mir-202-3p', 'papillary thyroid carcinoma', 'down', 'MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.'),
(8446, 'hsa-mir-202-5p', 'papillary thyroid carcinoma', 'down', 'LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p.'),
(8447, 'hsa-mir-204', 'papillary thyroid carcinoma', 'down', 'DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma.'),
(8448, 'hsa-mir-206', 'papillary thyroid carcinoma', 'down', 'Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.'),
(8449, 'hsa-mir-21', 'papillary thyroid carcinoma', 'up', 'miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.'),
(8450, 'hsa-mir-214', 'papillary thyroid carcinoma', 'up', 'BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.'),
(8451, 'hsa-mir-215', 'papillary thyroid carcinoma', 'down', 'miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3?/Snail signaling by targeting ARFGEF1.'),
(8452, 'hsa-mir-221', 'papillary thyroid carcinoma', 'up', 'MicroRNA-221 promotes papillary thyroid carcinoma cell migration and invasion via targeting RECK and regulating epithelial-mesenchymal transition.'),
(8453, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas.'),
(8454, 'hsa-mir-222', 'papillary thyroid carcinoma', 'up', 'BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.'),
(8455, 'hsa-mir-23a', 'papillary thyroid carcinoma', 'down', 'MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.'),
(8456, 'hsa-mir-24-3p', 'papillary thyroid carcinoma', 'down', 'MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas.'),
(8457, 'hsa-mir-2861', 'papillary thyroid carcinoma', 'up', 'lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.'),
(8458, 'hsa-mir-296-5p', 'papillary thyroid carcinoma', 'down', 'MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.'),
(8459, 'hsa-mir-29a', 'papillary thyroid carcinoma', 'down', 'miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4.'),
(8460, 'hsa-mir-30a', 'papillary thyroid carcinoma', 'down', 'MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7.'),
(8461, 'hsa-mir-31', 'papillary thyroid carcinoma', 'down', 'MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.'),
(8462, 'hsa-mir-346', 'papillary thyroid carcinoma', 'up', 'A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.'),
(8463, 'hsa-mir-34a-5p', 'papillary thyroid carcinoma', 'up', 'A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.'),
(8464, 'hsa-mir-363-3p', 'papillary thyroid carcinoma', 'down', 'MicroRNA-363-3p suppresses anoikis resistance in human papillary thyroid carcinoma via targeting integrin alpha 6.'),
(8465, 'hsa-mir-4500', 'papillary thyroid carcinoma', 'down', 'MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression.'),
(8466, 'hsa-mir-506', 'papillary thyroid carcinoma', 'down', 'MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD.'),
(8467, 'hsa-mir-509-5p', 'papillary thyroid carcinoma', 'up', 'MiR-509-5p improves the proliferative and invasive abilities of papillary thyroid carcinoma cells by inhibiting SFRP1.'),
(8468, 'hsa-mir-539', 'papillary thyroid carcinoma', 'down', 'microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor ?1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.'),
(8469, 'hsa-mir-548c-3p', 'papillary thyroid carcinoma', 'down', 'MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1?-mediated VEGF signaling pathway.'),
(8470, 'hsa-mir-630', 'papillary thyroid carcinoma', 'down', 'MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.'),
(8471, 'hsa-mir-758-3p', 'papillary thyroid carcinoma', 'down', 'MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.'),
(8472, 'hsa-mir-106b', 'pituitary carcinoma', 'up', 'MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.'),
(8473, 'hsa-mir-122', 'pituitary carcinoma', 'up', 'MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.'),
(8474, 'hsa-mir-17-5p', 'pituitary carcinoma', 'up', 'MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.'),
(8475, 'hsa-mir-20a', 'pituitary carcinoma', 'up', 'MicroRNA involvement in a metastatic non-functioning pituitary carcinoma.'),
(8476, 'hsa-mir-493', 'pituitary carcinoma', 'up', 'MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.'),
(8477, 'hsa-mir-145', 'primary cns lymphomas', 'down', 'Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.'),
(8478, 'hsa-mir-193b', 'primary cns lymphomas', 'down', 'Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.'),
(8479, 'hsa-mir-199a', 'primary cns lymphomas', 'down', 'Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.'),
(8480, 'hsa-mir-214', 'primary cns lymphomas', 'down', 'Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.'),
(8481, 'hsa-mir-370', 'primary cns lymphomas', 'down', 'miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma.'),
(8482, 'hsa-mir-335', 'primary gallbladder carcinoma', 'down', 'Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma.'),
(8483, 'hsa-mir-146b', 'primary thyroid lymphoma', 'up', 'A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.'),
(8484, 'hsa-mir-26a', 'primary thyroid lymphoma', 'down', 'A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.'),
(8485, 'hsa-mir-199a-5p', 'prostate adenocarcinoma', 'down', 'Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1?.'),
(8486, 'hsa-let-7a-3p', 'prostate cancer', 'down', 'The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells.'),
(8487, 'hsa-let-7c', 'prostate cancer', 'down', 'MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.'),
(8488, 'hsa-let-7c', 'prostate cancer', 'down', 'MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.'),
(8489, 'hsa-mir-100', 'prostate cancer', 'down', 'Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.'),
(8490, 'hsa-mir-101', 'prostate cancer', 'down', 'Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.'),
(8491, 'hsa-mir-105', 'prostate cancer', 'down', 'miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels.'),
(8492, 'hsa-mir-124', 'prostate cancer', 'down', 'MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells.'),
(8493, 'hsa-mir-125b', 'prostate cancer', 'up', 'Widespread deregulation of microRNA expression in human prostate cancer.'),
(8494, 'hsa-mir-125b', 'prostate cancer', 'up', 'Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.'),
(8495, 'hsa-mir-128', 'prostate cancer', 'down', 'MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.'),
(8496, 'hsa-mir-128', 'prostate cancer', 'down', 'miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.'),
(8497, 'hsa-mir-1296', 'prostate cancer', 'down', 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.'),
(8498, 'hsa-mir-130b', 'prostate cancer', 'down', 'MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2.'),
(8499, 'hsa-mir-133a-1', 'prostate cancer', 'down', 'microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.'),
(8500, 'hsa-mir-133a-2', 'prostate cancer', 'down', 'microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.'),
(8501, 'hsa-mir-133b', 'prostate cancer', 'down', 'microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor.'),
(8502, 'hsa-mir-135a', 'prostate cancer', 'down', 'Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.'),
(8503, 'hsa-mir-141', 'prostate cancer', 'up', 'A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.'),
(8504, 'hsa-mir-143', 'prostate cancer', 'down', 'miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.'),
(8505, 'hsa-mir-143', 'prostate cancer', 'down', 'miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.'),
(8506, 'hsa-mir-143', 'prostate cancer', 'down', 'MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.'),
(8507, 'hsa-mir-143', 'prostate cancer', 'down', 'The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.'),
(8508, 'hsa-mir-145', 'prostate cancer', 'down', 'The functional significance of microRNA-145 in prostate cancer.'),
(8509, 'hsa-mir-145', 'prostate cancer', 'down', 'Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.'),
(8510, 'hsa-mir-145', 'prostate cancer', 'down', 'MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.'),
(8511, 'hsa-mir-145', 'prostate cancer', 'down', 'The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.'),
(8512, 'hsa-mir-145', 'prostate cancer', 'down', 'miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.'),
(8513, 'hsa-mir-146a', 'prostate cancer', 'down', 'miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1.'),
(8514, 'hsa-mir-146a', 'prostate cancer', 'down', 'Clinical significance of miR-146a in gastric cancer cases.'),
(8515, 'hsa-mir-153', 'prostate cancer', 'up', 'Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.'),
(8516, 'hsa-mir-154', 'prostate cancer', 'down', 'miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.'),
(8517, 'hsa-mir-155', 'prostate cancer', 'up', 'A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.'),
(8518, 'hsa-mir-15a', 'prostate cancer', 'down', 'Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.'),
(8519, 'hsa-mir-181a-1', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8520, 'hsa-mir-181a-2', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8521, 'hsa-mir-181b', 'prostate cancer', 'up', 'MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.'),
(8522, 'hsa-mir-181b-1', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8523, 'hsa-mir-181b-2', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8524, 'hsa-mir-181c', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8525, 'hsa-mir-181d', 'prostate cancer', 'up', 'microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression.'),
(8526, 'hsa-mir-182', 'prostate cancer', 'up', 'miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.'),
(8527, 'hsa-mir-182', 'prostate cancer', 'up', 'Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).'),
(8528, 'hsa-mir-182-5p', 'prostate cancer', 'up', 'MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer.'),
(8529, 'hsa-mir-183', 'prostate cancer', 'up', 'miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.'),
(8530, 'hsa-mir-183', 'prostate cancer', 'up', 'microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.'),
(8531, 'hsa-mir-187', 'prostate cancer', 'down', 'MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.'),
(8532, 'hsa-mir-188-5p', 'prostate cancer', 'down', 'miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.'),
(8533, 'hsa-mir-18a', 'prostate cancer', 'up', 'MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo.'),
(8534, 'hsa-mir-199b', 'prostate cancer', 'down', 'MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells.'),
(8535, 'hsa-mir-200b', 'prostate cancer', 'down', 'miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.'),
(8536, 'hsa-mir-200b', 'prostate cancer', 'down', 'miR-200b inhibits prostate cancer EMT, growth and metastasis.'),
(8537, 'hsa-mir-203', 'prostate cancer', 'down', 'MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.'),
(8538, 'hsa-mir-203', 'prostate cancer', 'down', 'Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.'),
(8539, 'hsa-mir-204', 'prostate cancer', 'up', 'Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.'),
(8540, 'hsa-mir-205', 'prostate cancer', 'down', 'miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.'),
(8541, 'hsa-mir-205', 'prostate cancer', 'down', 'Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.'),
(8542, 'hsa-mir-205', 'prostate cancer', 'down', 'MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.'),
(8543, 'hsa-mir-205', 'prostate cancer', 'down', 'Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.'),
(8544, 'hsa-mir-205', 'prostate cancer', 'down', 'Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.'),
(8545, 'hsa-mir-205', 'prostate cancer', 'down', 'MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer.'),
(8546, 'hsa-mir-20a', 'prostate cancer', 'up', 'miR-20a promotes Prostate cancer invasion and migration through targeting ABL2.'),
(8547, 'hsa-mir-21', 'prostate cancer', 'up', 'MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.'),
(8548, 'hsa-mir-21', 'prostate cancer', 'up', 'A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.'),
(8549, 'hsa-mir-212', 'prostate cancer', 'down', 'A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer.'),
(8550, 'hsa-mir-218', 'prostate cancer', 'down', 'Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.'),
(8551, 'hsa-mir-218', 'prostate cancer', 'down', 'microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.'),
(8552, 'hsa-mir-221', 'prostate cancer', 'up', 'MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.'),
(8553, 'hsa-mir-221', 'prostate cancer', 'down', 'Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.'),
(8554, 'hsa-mir-223-3p', 'prostate cancer', 'up', 'MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.'),
(8555, 'hsa-mir-224', 'prostate cancer', 'down', 'MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.'),
(8556, 'hsa-mir-224', 'prostate cancer', 'down', 'Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.'),
(8557, 'hsa-mir-224', 'prostate cancer', 'down', 'MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.'),
(8558, 'hsa-mir-23a', 'prostate cancer', 'down', 'Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.'),
(8559, 'hsa-mir-23b', 'prostate cancer', 'down', 'miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.'),
(8560, 'hsa-mir-25', 'prostate cancer', 'down', 'miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of ?v- and ?6-Integrin Expression.'),
(8561, 'hsa-mir-26a', 'prostate cancer', 'down', 'Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.'),
(8562, 'hsa-mir-26a', 'prostate cancer', 'down', 'MiR-26a inhibits prostate cancer progression by repression of Wnt5a.'),
(8563, 'hsa-mir-26b', 'prostate cancer', 'down', 'Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms.'),
(8564, 'hsa-mir-29b', 'prostate cancer', 'down', 'miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.'),
(8565, 'hsa-mir-302a', 'prostate cancer', 'down', 'MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.'),
(8566, 'hsa-mir-30a', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8567, 'hsa-mir-30b', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8568, 'hsa-mir-30c-1', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8569, 'hsa-mir-30c-2', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8570, 'hsa-mir-30d', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8571, 'hsa-mir-30d', 'prostate cancer', 'down', 'Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.'),
(8572, 'hsa-mir-30e', 'prostate cancer', 'down', 'miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.'),
(8573, 'hsa-mir-31', 'prostate cancer', 'down', 'Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells.'),
(8574, 'hsa-mir-31', 'prostate cancer', 'up', 'Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays.'),
(8575, 'hsa-mir-31', 'prostate cancer', 'down', 'Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.'),
(8576, 'hsa-mir-330', 'prostate cancer', 'down', 'MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.'),
(8577, 'hsa-mir-330', 'prostate cancer', 'down', 'microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.'),
(8578, 'hsa-mir-331-3p', 'prostate cancer', 'down', 'miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.'),
(8579, 'hsa-mir-331-3p', 'prostate cancer', 'down', 'Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.'),
(8580, 'hsa-mir-34a', 'prostate cancer', 'down', 'The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.'),
(8581, 'hsa-mir-34a', 'prostate cancer', 'down', 'MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.'),
(8582, 'hsa-mir-34a', 'prostate cancer', 'down', 'LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a.'),
(8583, 'hsa-mir-34b', 'prostate cancer', 'down', 'miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.'),
(8584, 'hsa-mir-34c', 'prostate cancer', 'down', 'miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.'),
(8585, 'hsa-mir-374b', 'prostate cancer', 'down', 'Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.'),
(8586, 'hsa-mir-429', 'prostate cancer', 'up', 'Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.'),
(8587, 'hsa-mir-449a', 'prostate cancer', 'down', 'miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.'),
(8588, 'hsa-mir-449a', 'prostate cancer', 'down', 'miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.'),
(8589, 'hsa-mir-4723-5p', 'prostate cancer', 'down', 'MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases.'),
(8590, 'hsa-mir-497', 'prostate cancer', 'down', 'MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells.'),
(8591, 'hsa-mir-628-5p', 'prostate cancer', 'down', 'Circulatory miR-628-5p is downregulated in prostate cancer patients.'),
(8592, 'hsa-mir-642a-5p', 'prostate cancer', 'down', 'Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells.'),
(8593, 'hsa-mir-765', 'prostate cancer', 'down', 'Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer.'),
(8594, 'hsa-mir-940', 'prostate cancer', 'down', 'MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.'),
(8595, 'hsa-mir-96', 'prostate cancer', 'up', 'miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.'),
(8596, 'hsa-mir-96', 'prostate cancer', 'up', 'Transforming growth factor-? promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.'),
(8597, 'hsa-mir-96', 'prostate cancer', 'up', 'miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.'),
(8598, 'hsa-mir-15a', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8599, 'hsa-mir-15b', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8600, 'hsa-mir-16', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8601, 'hsa-mir-16-1', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8602, 'hsa-mir-16-2', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8603, 'hsa-mir-182', 'prostate cancer', 'up', 'Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer.'),
(8604, 'hsa-mir-195', 'prostate cancer', 'down', 'miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.'),
(8605, 'hsa-mir-195', 'prostate cancer', 'down', 'A microRNA code for prostate cancer metastasis.'),
(8606, 'hsa-mir-205', 'prostate cancer', 'down', 'Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.'),
(8607, 'hsa-mir-21', 'prostate cancer', 'up', 'A microRNA code for prostate cancer metastasis.'),
(8608, 'hsa-mir-221', 'prostate cancer', 'up', 'Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.'),
(8609, 'hsa-mir-221', 'prostate cancer', 'down', 'MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.'),
(8610, 'hsa-mir-222', 'prostate cancer', 'up', 'Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells.'),
(8611, 'hsa-mir-222', 'prostate cancer', 'down', 'MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.'),
(8612, 'hsa-mir-323', 'prostate cancer', 'down', 'MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor.'),
(8613, 'hsa-mir-345', 'prostate cancer', 'down', 'MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.'),
(8614, 'hsa-mir-34a', 'prostate cancer', 'down', 'Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.'),
(8615, 'hsa-mir-497', 'prostate cancer', 'down', 'Tumor-suppressive microRNA-497 targets IKK? to regulate NF-?B signaling pathway in human prostate cancer cells.'),
(8616, 'hsa-mir-503', 'prostate cancer', 'down', 'miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer.'),
(8617, 'hsa-mir-7', 'prostate cancer', 'down', 'MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.'),
(8618, 'hsa-mir-125b', 'prostate cancer', 'down', 'Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.'),
(8619, 'hsa-mir-212', 'prostate cancer', 'down', 'MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence.'),
(8620, 'hsa-mir-22', 'prostate cancer', 'up', 'Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.'),
(8621, 'hsa-mir-223', 'prostate cancer', 'down', 'Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.'),
(8622, 'hsa-mir-223', 'prostate cancer', 'down', 'Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.'),
(8623, 'hsa-mir-340', 'prostate cancer', 'down', 'microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.'),
(8624, 'hsa-mir-34a', 'prostate cancer', 'down', 'Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.'),
(8625, 'hsa-mir-378', 'prostate cancer', 'down', 'MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo.'),
(8626, 'hsa-mir-573', 'prostate cancer', 'down', 'miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.'),
(8627, 'hsa-mir-103', 'prostate cancer', 'down', 'MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.'),
(8628, 'hsa-mir-135b', 'prostate cancer', 'down', 'miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6.'),
(8629, 'hsa-mir-141', 'prostate cancer', 'up', 'Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients.'),
(8630, 'hsa-mir-150', 'prostate cancer', 'up', 'MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1.'),
(8631, 'hsa-mir-195', 'prostate cancer', 'down', 'miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.'),
(8632, 'hsa-mir-24', 'prostate cancer', 'down', 'miR-24 regulates CDKN1B/p27 expression in prostate cancer.'),
(8633, 'hsa-mir-26b', 'prostate cancer', 'down', 'miR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.'),
(8634, 'hsa-mir-301a', 'prostate cancer', 'up', 'Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.'),
(8635, 'hsa-mir-301a', 'prostate cancer', 'up', 'MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.'),
(8636, 'hsa-mir-301b', 'prostate cancer', 'up', 'Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.'),
(8637, 'hsa-mir-335', 'prostate cancer', 'down', 'MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.'),
(8638, 'hsa-mir-340', 'prostate cancer', 'down', 'MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.'),
(8639, 'hsa-mir-34a', 'prostate cancer', 'down', 'miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression.'),
(8640, 'hsa-mir-421', 'prostate cancer', 'down', 'A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.'),
(8641, 'hsa-mir-543', 'prostate cancer', 'down', 'MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.'),
(8642, 'hsa-mir-613', 'prostate cancer', 'down', 'MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.'),
(8643, 'hsa-mir-129', 'prostate cancer', 'down', 'Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.'),
(8644, 'hsa-mir-1301', 'prostate cancer', 'up', 'miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C.'),
(8645, 'hsa-mir-146b', 'prostate cancer', 'down', 'MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.'),
(8646, 'hsa-mir-503', 'prostate cancer', 'down', 'GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.'),
(8647, 'hsa-mir-138', 'prostate cancer', 'down', 'MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.'),
(8648, 'hsa-mir-154-5p', 'prostate cancer', 'down', 'miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.'),
(8649, 'hsa-mir-182-5p', 'prostate cancer', 'up', 'Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway.'),
(8650, 'hsa-mir-204', 'prostate cancer', 'down', 'The dual regulatory role of miR-204 in cancer.'),
(8651, 'hsa-mir-204-5p', 'prostate cancer', 'down', 'Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.'),
(8652, 'hsa-mir-22', 'prostate cancer', 'down', 'miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.'),
(8653, 'hsa-mir-26a', 'prostate cancer', 'down', 'MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.'),
(8654, 'hsa-mir-26a-5p', 'prostate cancer', 'down', 'Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.'),
(8655, 'hsa-mir-31', 'prostate cancer', 'down', 'Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6.'),
(8656, 'hsa-mir-452', 'prostate cancer', 'down', 'Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.'),
(8657, 'hsa-mir-539', 'prostate cancer', 'down', 'miR-539 inhibits prostate cancer progression by directly targeting SPAG5.'),
(8658, 'hsa-mir-1297', 'prostate cancer', 'down', 'MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.'),
(8659, 'hsa-mir-146a', 'prostate cancer', 'down', 'LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.'),
(8660, 'hsa-mir-186', 'prostate cancer', 'down', 'miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3.'),
(8661, 'hsa-mir-26a', 'prostate cancer', 'down', 'Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2.'),
(8662, 'hsa-mir-27a', 'prostate cancer', 'down', 'Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.'),
(8663, 'hsa-mir-3619-5p', 'prostate cancer', 'down', 'miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.'),
(8664, 'hsa-mir-372', 'prostate cancer', 'down', 'microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.'),
(8665, 'hsa-mir-382', 'prostate cancer', 'down', 'MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.'),
(8666, 'hsa-mir-486-5p', 'prostate cancer', 'down', 'miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.'),
(8667, 'hsa-mir-1307', 'prostate cancer', 'up', 'miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A.'),
(8668, 'hsa-mir-130a', 'prostate cancer', 'down', 'Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1.'),
(8669, 'hsa-mir-130b', 'prostate cancer', 'down', 'Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer.'),
(8670, 'hsa-mir-141', 'prostate cancer', 'down', 'MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.'),
(8671, 'hsa-mir-141-3p', 'prostate cancer', 'up', 'MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.'),
(8672, 'hsa-mir-194', 'prostate cancer', 'down', 'MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.'),
(8673, 'hsa-mir-194', 'prostate cancer', 'up', 'MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.'),
(8674, 'hsa-mir-218', 'prostate cancer', 'down', 'MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.'),
(8675, 'hsa-mir-218', 'prostate cancer', 'down', 'Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.'),
(8676, 'hsa-mir-22', 'prostate cancer', 'up', 'MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.'),
(8677, 'hsa-mir-30d', 'prostate cancer', 'up', 'MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.'),
(8678, 'hsa-mir-34b-3p', 'prostate cancer', 'down', 'Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.'),
(8679, 'hsa-mir-466', 'prostate cancer', 'down', 'MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.'),
(8680, 'hsa-mir-509-5p', 'prostate cancer', 'down', 'Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2.'),
(8681, 'hsa-mir-543', 'prostate cancer', 'up', 'MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.'),
(8682, 'hsa-mir-744', 'prostate cancer', 'up', 'MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/?-catenin signaling.'),
(8683, 'hsa-mir-802', 'prostate cancer', 'down', 'microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.'),
(8684, 'hsa-mir-101', 'prostate cancer', 'down', 'miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in'),
(8685, 'hsa-mir-1271', 'prostate cancer', 'down', 'MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.'),
(8686, 'hsa-mir-590-3p', 'prostate cancer', 'up', 'MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.'),
(8687, 'hsa-mir-100', 'prostate cancer', 'down', 'Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute?2.'),
(8688, 'hsa-mir-141', 'prostate cancer', 'down', 'Re: MicroRNA-141 Suppresses Prostate Cancer Stem Cells and Metastasis by Targeting a Cohort of Pro-Metastasis Genes.'),
(8689, 'hsa-mir-186', 'prostate cancer', 'down', 'miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.'),
(8690, 'hsa-mir-196a-5p', 'prostate cancer', 'down', 'Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.'),
(8691, 'hsa-mir-210-3p', 'prostate cancer', 'up', 'Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-?B signaling pathway.'),
(8692, 'hsa-mir-30c', 'prostate cancer', 'down', 'Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.'),
(8693, 'hsa-mir-30e*', 'prostate cancer', 'up', 'miR-30e* is overexpressed in prostate cancer and promotes NF-?B-mediated proliferation and tumor growth.'),
(8694, 'hsa-mir-33a', 'prostate cancer', 'down', 'miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer.'),
(8695, 'hsa-mir-483-5p', 'prostate cancer', 'up', 'miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.'),
(8696, 'hsa-mir-500', 'prostate cancer', 'up', 'Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(8697, 'hsa-mir-501-3p', 'prostate cancer', 'down', 'Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.'),
(8698, 'hsa-mir-588', 'prostate cancer', 'up', 'MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications.'),
(8699, 'hsa-mir-618', 'prostate cancer', 'down', 'miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2.'),
(8700, 'hsa-let-7a', 'prostate cancer', 'down', 'MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.'),
(8701, 'hsa-mir-129', 'prostate cancer', 'down', 'MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.'),
(8702, 'hsa-mir-141-3p', 'prostate cancer', 'down', 'Downregulation of miR-141-3p promotes bone metastasis via activating NF-?B signaling in prostate cancer.'),
(8703, 'hsa-mir-181a', 'prostate cancer', 'up', 'MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.'),
(8704, 'hsa-mir-193a-3p', 'prostate cancer', 'down', 'MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.'),
(8705, 'hsa-mir-199a', 'prostate cancer', 'down', 'MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.'),
(8706, 'hsa-mir-204', 'prostate cancer', 'down', 'MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway.'),
(8707, 'hsa-mir-205-5p', 'prostate cancer', 'down', 'Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.'),
(8708, 'hsa-mir-20b', 'prostate cancer', 'up', 'miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.'),
(8709, 'hsa-mir-323', 'prostate cancer', 'up', 'microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.'),
(8710, 'hsa-mir-34a', 'prostate cancer', 'down', 'miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.'),
(8711, 'hsa-mir-454', 'prostate cancer', 'up', 'Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/?-catenin signaling.'),
(8712, 'hsa-mir-486-5p', 'prostate cancer', 'up', 'The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways.'),
(8713, 'hsa-mir-493-5p', 'prostate cancer', 'down', 'c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3?/Snail signaling in prostate cancer.'),
(8714, 'hsa-mir-1246', 'prostate cancer', 'down', 'microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.'),
(8715, 'hsa-mir-1301-3p', 'prostate cancer', 'up', 'miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3?.'),
(8716, 'hsa-mir-132', 'prostate cancer', 'down', 'Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.'),
(8717, 'hsa-mir-133b', 'prostate cancer', 'down', 'Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.'),
(8718, 'hsa-mir-141', 'prostate cancer', 'down', 'miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1.'),
(8719, 'hsa-mir-143', 'prostate cancer', 'down', 'Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer.'),
(8720, 'hsa-mir-182', 'prostate cancer', 'up', 'MiR-182 promotes prostate cancer progression through activating Wnt/?-catenin signal pathway.'),
(8721, 'hsa-mir-195', 'prostate cancer', 'down', 'miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.'),
(8722, 'hsa-mir-203', 'prostate cancer', 'down', 'The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3?/?-CATENIN signal pathway.'),
(8723, 'hsa-mir-301a', 'prostate cancer', 'up', 'Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer.'),
(8724, 'hsa-mir-491-5p', 'prostate cancer', 'down', 'MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.'),
(8725, 'hsa-mir-493-3p', 'prostate cancer', 'down', 'Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.'),
(8726, 'hsa-mir-503', 'prostate cancer', 'down', 'microRNA-503 suppresses the migration, proliferation and colony formation of prostate cancer cells by targeting tumor protein D52 like 2.'),
(8727, 'hsa-mir-615', 'prostate cancer', 'down', 'MiR-615 inhibits prostate cancer cell proliferation and invasion by directly targeting Cyclin D2.'),
(8728, 'hsa-mir-671', 'prostate cancer', 'up', 'miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6.'),
(8729, 'hsa-mir-1', 'prostate cancer', 'down', 'Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.'),
(8730, 'hsa-mir-1180', 'prostate cancer', 'down', 'MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-?B signaling pathway activation.'),
(8731, 'hsa-mir-126', 'prostate cancer', 'down', 'MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9.'),
(8732, 'hsa-mir-1266-5p', 'prostate cancer', 'down', 'Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.'),
(8733, 'hsa-mir-1266-5p', 'prostate cancer', 'down', 'miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines'),
(8734, 'hsa-mir-133a-3p', 'prostate cancer', 'down', 'Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.'),
(8735, 'hsa-mir-139-5p', 'prostate cancer', 'down', 'MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1.'),
(8736, 'hsa-mir-141', 'prostate cancer', 'up', 'Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.'),
(8737, 'hsa-mir-143', 'prostate cancer', 'down', 'Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.'),
(8738, 'hsa-mir-144-3p', 'prostate cancer', 'down', 'MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55.'),
(8739, 'hsa-mir-146b', 'prostate cancer', 'up', 'MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway.'),
(8740, 'hsa-mir-152', 'prostate cancer', 'down', '[Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer].'),
(8741, 'hsa-mir-152-3p', 'prostate cancer', 'up', 'A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.'),
(8742, 'hsa-mir-17', 'prostate cancer', 'down', 'MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.'),
(8743, 'hsa-mir-185-5p', 'prostate cancer', 'down', 'miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines'),
(8744, 'hsa-mir-185-5p', 'prostate cancer', 'down', 'Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.'),
(8745, 'hsa-mir-191', 'prostate cancer', 'up', 'Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.'),
(8746, 'hsa-mir-202', 'prostate cancer', 'down', 'miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.'),
(8747, 'hsa-mir-205-5p', 'prostate cancer', 'down', 'miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1.'),
(8748, 'hsa-mir-206', 'prostate cancer', 'down', 'MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.'),
(8749, 'hsa-mir-206', 'prostate cancer', 'up', 'MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2.'),
(8750, 'hsa-mir-21', 'prostate cancer', 'up', 'Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.'),
(8751, 'hsa-mir-211', 'prostate cancer', 'down', 'MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC.'),
(8752, 'hsa-mir-29c', 'prostate cancer', 'down', 'Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer.'),
(8753, 'hsa-mir-410-3p', 'prostate cancer', 'down', 'miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.'),
(8754, 'hsa-mir-452-5p', 'prostate cancer', 'down', 'Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.'),
(8755, 'hsa-mir-519d', 'prostate cancer', 'down', 'MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.'),
(8756, 'hsa-mir-652', 'prostate cancer', 'up', 'MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells.'),
(8757, 'hsa-mir-99a', 'prostate cancer', 'down', 'Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.'),
(8758, 'hsa-mir-1', 'prostate cancer', 'down', 'Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an?In Vivo?Hen\'s Egg Test-Chorioallantoic Membrane Model.'),
(8759, 'hsa-mir-1', 'prostate cancer', 'down', 'MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.'),
(8760, 'hsa-mir-10a', 'prostate cancer', 'down', 'MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.'),
(8761, 'hsa-mir-139-5p', 'prostate cancer', 'down', 'Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5.'),
(8762, 'hsa-mir-150', 'prostate cancer', 'down', 'MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated ?-catenin signaling pathway.'),
(8763, 'hsa-mir-192', 'prostate cancer', 'up', 'miR-192 Is Overexpressed and Promotes Cell Proliferation in Prostate Cancer.'),
(8764, 'hsa-mir-221', 'prostate cancer', 'up', 'The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients.'),
(8765, 'hsa-mir-222', 'prostate cancer', 'up', 'The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients.'),
(8766, 'hsa-mir-373-3p', 'prostate cancer', 'down', 'MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.'),
(8767, 'hsa-mir-93', 'prostate cancer', 'up', 'Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation.'),
(8768, 'hsa-mir-1', 'prostate cancer', 'down', 'Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an In Vivo Hen\'s Egg Test-Chorioallantoic Membrane Model.'),
(8769, 'hsa-mir-106a', 'prostate cancer', 'up', 'miR-106a contributes to prostate carcinoma progression through PTEN.'),
(8770, 'hsa-mir-129-5p', 'prostate cancer', 'down', 'miR-129-5p inhibits prostate cancer proliferation via targeting ETV1.'),
(8771, 'hsa-mir-135a', 'prostate cancer', 'down', 'MicroRNA-135a induces prostate cancer cell apoptosis via inhibition of STAT6.'),
(8772, 'hsa-mir-137', 'prostate cancer', 'down', 'Downregulated NOX4 underlies a novel inhibitory role of microRNA-137 in prostate cancer.'),
(8773, 'hsa-mir-139', 'prostate cancer', 'down', 'MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.'),
(8774, 'hsa-mir-140', 'prostate cancer', 'down', 'MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.'),
(8775, 'hsa-mir-15a-3p', 'prostate cancer', 'down', 'miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/?-Catenin Signaling Pathway.'),
(8776, 'hsa-mir-183-3p', 'prostate cancer', 'down', 'microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.'),
(8777, 'hsa-mir-191', 'prostate cancer', 'up', 'Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer.'),
(8778, 'hsa-mir-193b', 'prostate cancer', 'down', 'Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.'),
(8779, 'hsa-mir-200a', 'prostate cancer', 'down', 'MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.'),
(8780, 'hsa-mir-214-5p', 'prostate cancer', 'down', 'miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.'),
(8781, 'hsa-mir-301b-3p', 'prostate cancer', 'up', 'Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.'),
(8782, 'hsa-mir-338-3p', 'prostate cancer', 'down', 'miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.'),
(8783, 'hsa-mir-34a', 'prostate cancer', 'down', 'Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.'),
(8784, 'hsa-mir-34a', 'prostate cancer', 'down', 'Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.'),
(8785, 'hsa-mir-488', 'prostate cancer', 'down', 'MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.'),
(8786, 'hsa-mir-493', 'prostate cancer', 'up', 'miR-493 Promotes Prostate Cancer Cells Proliferation by Targeting PHLPP2 and Activating Akt Signaling Pathway.'),
(8787, 'hsa-mir-500', 'prostate cancer', 'up', 'miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer.'),
(8788, 'hsa-mir-501-3p', 'prostate cancer', 'down', 'MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.'),
(8789, 'hsa-mir-515-5p', 'prostate cancer', 'down', 'MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.'),
(8790, 'hsa-mir-582-3p', 'prostate cancer', 'down', 'miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-? Signaling.'),
(8791, 'hsa-mir-582-5p', 'prostate cancer', 'down', 'miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-? Signaling.'),
(8792, 'hsa-mir-608', 'prostate cancer', 'down', 'Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3\'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.'),
(8793, 'hsa-mir-628', 'prostate cancer', 'down', 'miR-628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway.'),
(8794, 'hsa-mir-708', 'prostate cancer', 'down', 'Relevance function of microRNA-708 in the pathogenesis of cancer.'),
(8795, 'hsa-mir-744', 'prostate cancer', 'up', 'Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1.'),
(8796, 'hsa-mir-9-5p', 'prostate cancer', 'up', 'Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.'),
(8797, 'hsa-mir-100', 'prostate cancer', 'down', 'Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute??2.'),
(8798, 'hsa-mir-107', 'prostate carcinoma', 'down', 'Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group.'),
(8799, 'hsa-mir-195', 'prostate carcinoma', 'down', 'MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.'),
(8800, 'hsa-mir-125a-5p', 'prostate carcinoma', 'up', 'MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.'),
(8801, 'hsa-mir-205', 'prostate carcinoma', 'down', 'microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.'),
(8802, 'hsa-mir-338-3p', 'prostate carcinoma', 'down', 'microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.'),
(8803, 'hsa-mir-155', 'rectal cancer', 'up', 'The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.'),
(8804, 'hsa-mir-200c', 'rectal cancer', 'up', 'The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.'),
(8805, 'hsa-mir-21-5p', 'rectal cancer', 'up', 'Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.'),
(8806, 'hsa-mir-34a', 'rectal cancer', 'up', 'The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer.'),
(8807, 'hsa-mir-155', 'rectal cancer', 'up', 'Expression of Circulating?miR-155, miR-21, miR-221, miR-30a, miR-34a?and?miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8808, 'hsa-mir-21', 'rectal cancer', 'up', 'Expression of Circulating?miR-155, miR-21, miR-221, miR-30a, miR-34a?and?miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8809, 'hsa-mir-221', 'rectal cancer', 'up', 'Expression of Circulating?miR-155, miR-21, miR-221, miR-30a, miR-34a?and?miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8810, 'hsa-mir-31', 'rectal cancer', 'up', 'Expression of miR-31 in rectal cancer patients and its effect on proliferation ability of rectal cancer cells SW837.'),
(8811, 'hsa-mir-155', 'rectal cancer', 'up', 'Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8812, 'hsa-mir-21', 'rectal cancer', 'up', 'Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8813, 'hsa-mir-221', 'rectal cancer', 'up', 'Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer.'),
(8814, 'hsa-mir-3174', 'rectal cancer', 'up', 'MiR-3174 functions as an oncogene in rectal cancer by targeting PCBD2.'),
(8815, 'hsa-mir-155', 'rectal carcinoma', 'up', 'The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer.'),
(8816, 'hsa-let-7a', 'renal cell carcinoma', 'down', 'Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc.'),
(8817, 'hsa-let-7d', 'renal cell carcinoma', 'down', 'Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.'),
(8818, 'hsa-mir-1', 'renal cell carcinoma', 'down', 'The functional significance of miR-1 and miR-133a in renal cell carcinoma.'),
(8819, 'hsa-mir-100', 'renal cell carcinoma', 'up', 'Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma.'),
(8820, 'hsa-mir-106a*', 'renal cell carcinoma', 'down', 'miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.'),
(8821, 'hsa-mir-1233', 'renal cell carcinoma', 'up', 'MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.'),
(8822, 'hsa-mir-126', 'renal cell carcinoma', 'down', 'Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma.'),
(8823, 'hsa-mir-1260b', 'renal cell carcinoma', 'up', 'Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.'),
(8824, 'hsa-mir-1285', 'renal cell carcinoma', 'down', 'Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma.'),
(8825, 'hsa-mir-129-3p', 'renal cell carcinoma', 'down', 'miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.'),
(8826, 'hsa-mir-1291', 'renal cell carcinoma', 'down', 'Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 (GLUT1) in renal cell carcinoma.'),
(8827, 'hsa-mir-133a', 'renal cell carcinoma', 'down', 'The functional significance of miR-1 and miR-133a in renal cell carcinoma.'),
(8828, 'hsa-mir-133b', 'renal cell carcinoma', 'down cell lines;', 'microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.'),
(8829, 'hsa-mir-135a', 'renal cell carcinoma', 'down', 'Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.'),
(8830, 'hsa-mir-138', 'renal cell carcinoma', 'down', 'MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma.'),
(8831, 'hsa-mir-141', 'renal cell carcinoma', 'down', 'MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.'),
(8832, 'hsa-mir-143', 'renal cell carcinoma', 'down', 'The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.'),
(8833, 'hsa-mir-145', 'renal cell carcinoma', 'down', 'The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.'),
(8834, 'hsa-mir-145', 'renal cell carcinoma', 'down', 'miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.'),
(8835, 'hsa-mir-146a', 'renal cell carcinoma', 'up', 'Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.'),
(8836, 'hsa-mir-146b', 'renal cell carcinoma', 'up', 'Carbamylated albumin stimulates microRNA-146, which is increased in human renal cell carcinoma.'),
(8837, 'hsa-mir-16', 'renal cell carcinoma', 'up', 'Upregulated microRNA-16 as an oncogene in renal cell carcinoma.'),
(8838, 'hsa-mir-182-5p', 'renal cell carcinoma', 'down', 'Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.'),
(8839, 'hsa-mir-193a-3p', 'renal cell carcinoma', 'up', 'A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.'),
(8840, 'hsa-mir-199a-3p', 'renal cell carcinoma', 'down', 'miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.'),
(8841, 'hsa-mir-200a', 'renal cell carcinoma', 'down', 'Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.'),
(8842, 'hsa-mir-203a', 'renal cell carcinoma', 'up', 'miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3? in human renal cell carcinoma.'),
(8843, 'hsa-mir-205', 'renal cell carcinoma', 'down', 'miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma.'),
(8844, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.'),
(8845, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'MicroRNA-21 is overexpressed in renal cell carcinoma.'),
(8846, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.'),
(8847, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.'),
(8848, 'hsa-mir-210', 'renal cell carcinoma', 'up', 'MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.'),
(8849, 'hsa-mir-218', 'renal cell carcinoma', 'down', 'MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma Through Targeting Caveolin-2 Involved in Focal Adhesion Pathway.'),
(8850, 'hsa-mir-27a', 'renal cell carcinoma', 'up', 'miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.'),
(8851, 'hsa-mir-28-5p', 'renal cell carcinoma', 'down', 'A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.'),
(8852, 'hsa-mir-30a', 'renal cell carcinoma', 'down', 'MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.'),
(8853, 'hsa-mir-30c', 'renal cell carcinoma', 'down', 'Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.'),
(8854, 'hsa-mir-30d', 'renal cell carcinoma', 'down', 'Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.'),
(8855, 'hsa-mir-34a', 'renal cell carcinoma', 'down', 'MicroRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cell.'),
(8856, 'hsa-mir-34a', 'renal cell carcinoma', 'down', 'MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.'),
(8857, 'hsa-mir-34a', 'renal cell carcinoma', 'down', 'Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma.'),
(8858, 'hsa-mir-362', 'renal cell carcinoma', 'up', 'A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.'),
(8859, 'hsa-mir-378', 'renal cell carcinoma', 'down', 'A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.'),
(8860, 'hsa-mir-429', 'renal cell carcinoma', 'down', 'MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma.'),
(8861, 'hsa-mir-509-3p', 'renal cell carcinoma', 'down', 'MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.'),
(8862, 'hsa-mir-509-5p', 'renal cell carcinoma', 'down', 'Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.'),
(8863, 'hsa-mir-572', 'renal cell carcinoma', 'up', 'A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.'),
(8864, 'hsa-mir-646', 'renal cell carcinoma', 'down', 'Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).'),
(8865, 'hsa-mir-7', 'renal cell carcinoma', 'up', 'Identification of miR-7 as an oncogene in renal cell carcinoma.'),
(8866, 'hsa-mir-183', 'renal cell carcinoma', 'up', 'High serum miR-183 level is associated with poor responsiveness of renal cancer to natural killer cells.'),
(8867, 'hsa-mir-204', 'renal cell carcinoma', 'down', 'Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4.'),
(8868, 'hsa-mir-221', 'renal cell carcinoma', 'up', 'miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.'),
(8869, 'hsa-mir-372', 'renal cell carcinoma', 'down', 'miR-372 suppresses tumour proliferation and invasion by targeting IGF2BP1 in renal cell carcinoma.'),
(8870, 'hsa-mir-510-5p', 'renal cell carcinoma', 'down', 'Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.'),
(8871, 'hsa-mir-1236', 'renal cell carcinoma', 'down', 'Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.'),
(8872, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.'),
(8873, 'hsa-mir-23b', 'renal cell carcinoma', 'down', 'MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.'),
(8874, 'hsa-mir-490-5p', 'renal cell carcinoma', 'down', 'miR-490-5p suppresses tumor growth in renal cell carcinoma through targeting PIK3CA.'),
(8875, 'hsa-mir-96', 'renal cell carcinoma', 'down', 'miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.'),
(8876, 'hsa-mir-133b', 'renal cell carcinoma', 'down cell line;', 'microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.'),
(8877, 'hsa-mir-134', 'renal cell carcinoma', 'down', 'miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells.'),
(8878, 'hsa-mir-142-3p', 'renal cell carcinoma', 'up', 'Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.'),
(8879, 'hsa-mir-200a-3p', 'renal cell carcinoma', 'down', 'MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.'),
(8880, 'hsa-mir-204', 'renal cell carcinoma', 'down', 'miR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.'),
(8881, 'hsa-mir-20b-5p', 'renal cell carcinoma', 'down', 'MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.'),
(8882, 'hsa-mir-210', 'renal cell carcinoma', 'up', 'Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion.'),
(8883, 'hsa-mir-26a', 'renal cell carcinoma', 'down', 'Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.'),
(8884, 'hsa-mir-26b', 'renal cell carcinoma', 'down', 'Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.'),
(8885, 'hsa-mir-362-3p', 'renal cell carcinoma', 'down', 'miR-362-3p targets nemo-like kinase and functions as a tumor suppressor in renal cancer cells.'),
(8886, 'hsa-mir-451', 'renal cell carcinoma', 'down', 'microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.'),
(8887, 'hsa-mir-495', 'renal cell carcinoma', 'down', 'MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.'),
(8888, 'hsa-mir-106b', 'renal cell carcinoma', 'up', 'MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.'),
(8889, 'hsa-mir-214', 'renal cell carcinoma', 'down', 'microRNA-214 Reduces IGF-1 Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.'),
(8890, 'hsa-mir-101', 'renal cell carcinoma', 'down', 'Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2? expression and cell proliferation.'),
(8891, 'hsa-mir-126', 'renal cell carcinoma', 'down', 'MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.'),
(8892, 'hsa-mir-137', 'renal cell carcinoma', 'down', 'miR-137 inhibits renal cell carcinoma growth in vitro and in vivo.'),
(8893, 'hsa-mir-144', 'renal cell carcinoma', 'down', 'MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.'),
(8894, 'hsa-mir-149-5p', 'renal cell carcinoma', 'down', 'Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.'),
(8895, 'hsa-mir-218', 'renal cell carcinoma', 'down', 'Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.'),
(8896, 'hsa-mir-27a', 'renal cell carcinoma', 'down', 'MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor.'),
(8897, 'hsa-mir-708', 'renal cell carcinoma', 'down', 'Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.'),
(8898, 'hsa-mir-106a', 'renal cell carcinoma', 'up', 'Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.'),
(8899, 'hsa-mir-144-3p', 'renal cell carcinoma', 'down', 'miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.'),
(8900, 'hsa-mir-148a', 'renal cell carcinoma', 'down', 'miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.'),
(8901, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.'),
(8902, 'hsa-mir-28-5p', 'renal cell carcinoma', 'down', 'miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.'),
(8903, 'hsa-mir-122', 'renal cell carcinoma', 'up', 'MiR-122 promotes renal cancer cell proliferation by targeting Sprouty2.'),
(8904, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21?cyclin E2?Bax/caspase-3'),
(8905, 'hsa-mir-99a', 'renal cell carcinoma', 'down', 'WITHDRAWN: MicroRNA-99a Suppresses Proliferation, Migration, Invasion and Induces G1-phase Cell Cycle Arrest via Targeting Insulin-like Growth Factor 1 Receptor Pathway in Renal Cell Carcinoma 786-0 a'),
(8906, 'hsa-mir-106b-5p', 'renal cell carcinoma', 'up', 'miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/?-catenin signalling.'),
(8907, 'hsa-mir-1247', 'renal cell carcinoma', 'down', 'Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.'),
(8908, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.'),
(8909, 'hsa-mir-217', 'renal cell carcinoma', 'down', 'LncRNA HOTAIR regulates HIF-1?/AXL signaling through inhibition of miR-217 in renal cell carcinoma.'),
(8910, 'hsa-mir-302c-3p', 'renal cell carcinoma', 'down', 'microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).'),
(8911, 'hsa-mir-497', 'renal cell carcinoma', 'down', 'MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.'),
(8912, 'hsa-mir-10a-5p', 'renal cell carcinoma', 'down', 'Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.'),
(8913, 'hsa-mir-125b', 'renal cell carcinoma', 'up', 'miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.'),
(8914, 'hsa-mir-138', 'renal cell carcinoma', 'down', 'The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.'),
(8915, 'hsa-mir-142-5p', 'renal cell carcinoma', 'up', 'MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3.'),
(8916, 'hsa-mir-149', 'renal cell carcinoma', 'down', 'Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.'),
(8917, 'hsa-mir-15a', 'renal cell carcinoma', 'down', 'Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.'),
(8918, 'hsa-mir-193a-3p', 'renal cell carcinoma', 'up', 'Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.'),
(8919, 'hsa-mir-195-5p', 'renal cell carcinoma', 'down', 'miR-195-5p is critical in REG?-mediated regulation of wnt/?-catenin pathway in renal cell carcinoma.'),
(8920, 'hsa-mir-200a', 'renal cell carcinoma', 'down', 'MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.'),
(8921, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21?cyclin?E2?Bax/caspase-3'),
(8922, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.'),
(8923, 'hsa-mir-384', 'renal cell carcinoma', 'down', 'MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.'),
(8924, 'hsa-mir-411', 'renal cell carcinoma', 'down', 'MiR-411 functions as a tumor suppressor in renal cell cancer.'),
(8925, 'hsa-mir-720', 'renal cell carcinoma', 'up', 'MicroRNA-720 regulates E-cadherin-?E-catenin complex and promotes renal cell carcinoma.'),
(8926, 'hsa-mir-766-3p', 'renal cell carcinoma', 'down', 'DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.'),
(8927, 'hsa-mir-106a-5p', 'renal cell carcinoma', 'down', 'MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.'),
(8928, 'hsa-mir-199a', 'renal cell carcinoma', 'down', 'MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.'),
(8929, 'hsa-mir-21', 'renal cell carcinoma', 'up', 'MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.'),
(8930, 'hsa-mir-212', 'renal cell carcinoma', 'down', 'MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP).'),
(8931, 'hsa-mir-338-3p', 'renal cell carcinoma', 'down', 'MicroRNA-338-3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma.'),
(8932, 'hsa-mir-514a-3p', 'renal cell carcinoma', 'down', 'miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.'),
(8933, 'hsa-mir-138', 'renal cell carcinoma', 'down', 'MicroRNA-138 suppresses cell proliferation and invasion of renal cell carcinoma by directly targeting SOX9.'),
(8934, 'hsa-mir-182', 'renal cell carcinoma', 'down', 'MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.'),
(8935, 'hsa-mir-191-5p', 'renal cell carcinoma', 'down', 'MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma.'),
(8936, 'hsa-mir-199a', 'renal cell carcinoma', 'down', 'The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1.'),
(8937, 'hsa-mir-203', 'renal cell carcinoma', 'down', 'MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.'),
(8938, 'hsa-mir-125a', 'renal cell carcinoma', 'down', 'MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.'),
(8939, 'hsa-mir-136', 'renal cell carcinoma', 'down', 'Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.'),
(8940, 'hsa-mir-148b-3p', 'renal cell carcinoma', 'down', 'MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2.'),
(8941, 'hsa-mir-18a-5p', 'renal cell carcinoma', 'up', 'Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.'),
(8942, 'hsa-mir-193a-3p', 'renal cell carcinoma', 'up', 'MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.'),
(8943, 'hsa-mir-199b-5p', 'renal cell carcinoma', 'down', 'miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.'),
(8944, 'hsa-mir-216a', 'renal cell carcinoma', 'down', 'MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.'),
(8945, 'hsa-mir-216a-5p', 'renal cell carcinoma', 'up', 'miR-216a-5p acts as an oncogene in renal cell carcinoma.'),
(8946, 'hsa-mir-224', 'renal cell carcinoma', 'up', 'MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.'),
(8947, 'hsa-mir-30a', 'renal cell carcinoma', 'down', 'MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9.'),
(8948, 'hsa-mir-425-5p', 'renal cell carcinoma', 'up', 'Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.'),
(8949, 'hsa-mir-488', 'renal cell carcinoma', 'down', 'miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5.'),
(8950, 'hsa-mir-566', 'renal cell carcinoma', 'up', 'miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.'),
(8951, 'hsa-mir-663a', 'renal cell carcinoma', 'up', 'Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.'),
(8952, 'hsa-mir-124', 'renal cell carcinoma', 'down', 'Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.'),
(8953, 'hsa-mir-23a-3p', 'renal cell carcinoma', 'up', 'MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.'),
(8954, 'hsa-mir-384', 'renal cell carcinoma', 'down', 'miR-384 suppressed renal cell carcinoma cell proliferation and migration through targeting RAB23.'),
(8955, 'hsa-mir-452-5p', 'renal cell carcinoma', 'up', 'Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.'),
(8956, 'hsa-mir-543', 'renal cell carcinoma', 'up', 'MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/?-catenin signaling pathway.'),
(8957, 'hsa-mir-106b', 'renal cell carcinoma', 'up', 'miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer.'),
(8958, 'hsa-mir-1208', 'renal cell carcinoma', 'down', 'MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.'),
(8959, 'hsa-mir-130b', 'renal cell carcinoma', 'up', 'miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.'),
(8960, 'hsa-mir-200b', 'renal cell carcinoma', 'down', 'MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.'),
(8961, 'hsa-mir-218', 'renal cell carcinoma', 'down', 'miR-218 suppresses the proliferation of osteosarcoma through downregulation of E2F2.'),
(8962, 'hsa-mir-31-5p', 'renal cell carcinoma', 'down', 'MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).'),
(8963, 'hsa-mir-33a', 'renal cell carcinoma', 'down', 'miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.'),
(8964, 'hsa-mir-372', 'renal cell carcinoma', 'down', 'MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma.'),
(8965, 'hsa-mir-376a', 'renal cell carcinoma', 'down', 'MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma.'),
(8966, 'hsa-mir-381', 'renal cell carcinoma', 'down', 'Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma.'),
(8967, 'hsa-mir-505', 'renal cell carcinoma', 'down', 'microRNA-505 negatively regulates HMGB1 to suppress cell proliferation in renal cell carcinoma.'),
(8968, 'hsa-let-7b', 'renal clear cell carcinoma', 'down', 'let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.'),
(8969, 'hsa-let-7c', 'renal clear cell carcinoma', 'down', 'let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.'),
(8970, 'hsa-mir-122', 'renal clear cell carcinoma', 'up', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8971, 'hsa-mir-138', 'renal clear cell carcinoma', 'down', 'MiR-138 suppresses expression of hypoxia-inducible factor 1? (HIF-1?) in clear cell renal cell carcinoma 786-O cells.'),
(8972, 'hsa-mir-141', 'renal clear cell carcinoma', 'down', 'Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.'),
(8973, 'hsa-mir-155', 'renal clear cell carcinoma', 'up', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8974, 'hsa-mir-200c', 'renal clear cell carcinoma', 'down', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8975, 'hsa-mir-200c', 'renal clear cell carcinoma', 'down', 'Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.'),
(8976, 'hsa-mir-204', 'renal clear cell carcinoma', 'down', 'VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.'),
(8977, 'hsa-mir-210', 'renal clear cell carcinoma', 'up', 'Overexpression of miR-210, a downstream target of HIF1?, causes centrosome amplification in renal carcinoma cells.'),
(8978, 'hsa-mir-210', 'renal clear cell carcinoma', 'up', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8979, 'hsa-mir-210', 'renal clear cell carcinoma', 'up', 'Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.'),
(8980, 'hsa-mir-218', 'renal clear cell carcinoma', 'down', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8981, 'hsa-mir-335', 'renal clear cell carcinoma', 'down', 'miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.'),
(8982, 'hsa-mir-377', 'renal clear cell carcinoma', 'down', 'miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.'),
(8983, 'hsa-mir-506', 'renal clear cell carcinoma', 'down', 'MiR-506 is down-regulated in clear cell renal cell carcinoma and inhibits cell growth and metastasis via targeting FLOT1.'),
(8984, 'hsa-mir-506', 'renal clear cell carcinoma', 'down', 'Correction: MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1.'),
(8985, 'hsa-mir-630', 'renal clear cell carcinoma', 'up', 'Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.'),
(8986, 'hsa-mir-182', 'renal clear cell carcinoma', 'down', 'MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.'),
(8987, 'hsa-mir-195', 'renal clear cell carcinoma', 'down', 'MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways.'),
(8988, 'hsa-mir-22', 'renal clear cell carcinoma', 'down', 'MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.'),
(8989, 'hsa-mir-101', 'renal clear cell carcinoma', 'up', 'Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma.'),
(8990, 'hsa-mir-1290', 'renal clear cell carcinoma', 'up', 'microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.'),
(8991, 'hsa-mir-210-3p', 'renal clear cell carcinoma', 'up', 'microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.'),
(8992, 'hsa-mir-224', 'renal clear cell carcinoma', 'up', 'microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.'),
(8993, 'hsa-mir-885-5p', 'renal clear cell carcinoma', 'up', 'microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.'),
(8994, 'hsa-mir-30e-3p', 'renal clear cell carcinoma', 'down', 'MicroRNA-30e-3p inhibits cell invasion and migration in clear cell renal cell carcinoma by targeting Snail1.'),
(8995, 'hsa-mir-1274a', 'renal clear cell carcinoma', 'up', 'Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.');
INSERT INTO `cancer` (`id`, `MIR-ID`, `Cancer`, `Profile`, `pubmed`) VALUES
(8996, 'hsa-mir-144-3p', 'renal clear cell carcinoma', 'up', 'Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.'),
(8997, 'hsa-mir-181a', 'renal clear cell carcinoma', 'up', 'Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.'),
(8998, 'hsa-mir-645', 'renal clear cell carcinoma', 'up', 'MicroRNA-645 promotes cell metastasis and proliferation of renal clear cell carcinoma by targeting GK5.'),
(8999, 'hsa-mir-224', 'renal clear cell carcinoma', 'up', 'Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.'),
(9000, 'hsa-mir-514a-3p', 'renal clear cell carcinoma', 'down', 'MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.'),
(9001, 'hsa-mir-10b', 'renal clear cell carcinoma', 'down', 'MicroRNA-10b Promotes Apoptosis via JNK Pathway in Clear Cell Renal Cell Carcinoma.'),
(9002, 'hsa-mir-137', 'renal clear cell carcinoma', 'down', 'MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma.'),
(9003, 'hsa-mir-216b', 'renal clear cell carcinoma', 'down', 'miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.'),
(9004, 'hsa-mir-218', 'renal clear cell carcinoma', 'down', 'MicroRNA-218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A.'),
(9005, 'hsa-mir-508', 'renal clear cell carcinoma', 'down', 'MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion.'),
(9006, 'hsa-mir-101', 'retinoblastoma', 'down', 'miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.'),
(9007, 'hsa-mir-181b', 'retinoblastoma', 'up', 'Hypoxia-induced miR-181b enhances angiogenesis of retinoblastoma cells by targeting PDCD10 and GATA6.'),
(9008, 'hsa-mir-183', 'retinoblastoma', 'down', 'MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.'),
(9009, 'hsa-mir-204', 'retinoblastoma', 'down', 'MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.'),
(9010, 'hsa-mir-21', 'retinoblastoma', 'up', 'Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.'),
(9011, 'hsa-mir-34a', 'retinoblastoma', 'down', 'Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.'),
(9012, 'hsa-mir-365b-3p', 'retinoblastoma', 'down', 'MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6.'),
(9013, 'hsa-mir-486-3p', 'retinoblastoma', 'down', 'Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.'),
(9014, 'hsa-mir-532-5p', 'retinoblastoma', 'down', 'Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy.'),
(9015, 'hsa-mir-145', 'retinoblastoma', 'down', 'miR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.'),
(9016, 'hsa-mir-3163', 'retinoblastoma', 'down', 'Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.'),
(9017, 'hsa-mir-124', 'retinoblastoma', 'down', 'miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.'),
(9018, 'hsa-mir-125a-5p', 'retinoblastoma', 'down', 'Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.'),
(9019, 'hsa-mir-125b', 'retinoblastoma', 'up', 'MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.'),
(9020, 'hsa-mir-433', 'retinoblastoma', 'down', 'MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.'),
(9021, 'hsa-mir-143', 'retinoblastoma', 'down', 'Suppressive effect of microRNA-143 in retinoblastoma.'),
(9022, 'hsa-mir-613', 'retinoblastoma', 'down', 'MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.'),
(9023, 'hsa-mir-320', 'retinoblastoma', 'down', 'MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1.'),
(9024, 'hsa-mir-497', 'retinoblastoma', 'down', 'microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.'),
(9025, 'hsa-mir-675', 'retinoblastoma', 'up', 'microRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.'),
(9026, 'hsa-mir-29a', 'retinoblastoma', 'down', 'miR-29a inhibits human retinoblastoma progression by targeting STAT3.'),
(9027, 'hsa-mir-498', 'retinoblastoma', 'up', 'miR-498 promotes cell proliferation and inhibits cell apoptosis in retinoblastoma by directly targeting CCPG1.'),
(9028, 'hsa-mir-138-5p', 'retinoblastoma', 'down', 'Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.'),
(9029, 'hsa-mir-186', 'retinoblastoma', 'down', 'Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.'),
(9030, 'hsa-mir-655', 'retinoblastoma', 'down', 'MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.'),
(9031, 'hsa-mir-101-3p', 'retinoblastoma', 'down', 'MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9.'),
(9032, 'hsa-mir-140-5p', 'retinoblastoma', 'down', 'miR-140-5p suppresses retinoblastoma cell proliferation, migration, and invasion by targeting CEMIP and CADM3.'),
(9033, 'hsa-mir-221', 'retinoblastoma', 'up', 'Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.'),
(9034, 'hsa-mir-222', 'retinoblastoma', 'up', 'Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma.'),
(9035, 'hsa-mir-506-3p', 'retinoblastoma', 'down', 'MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6.'),
(9036, 'hsa-mir-101', 'retinoblastoma', 'down', 'LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.'),
(9037, 'hsa-mir-106b', 'retinoblastoma', 'up', 'MicroRNA-106b promotes the proliferation, migration and invasion of retinoblastoma cells by inhibiting the expression of ZBTB4 protein.'),
(9038, 'hsa-mir-140-5p', 'retinoblastoma', 'down', 'MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.'),
(9039, 'hsa-mir-202', 'retinoblastoma', 'down', 'Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.'),
(9040, 'hsa-mir-204', 'retinoblastoma', 'down', 'Long noncoding RNA NEAT1 promotes the growth of human retinoblastoma cells via regulation of miR-204/CXCR4 axis.'),
(9041, 'hsa-mir-22', 'retinoblastoma', 'down', 'Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1.'),
(9042, 'hsa-mir-34a', 'retinoblastoma', 'down', 'Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation.'),
(9043, 'hsa-mir-655', 'retinoblastoma', 'down', 'MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38?MAPK signalling pathways.'),
(9044, 'hsa-mir-25-3p', 'retinoblastoma', 'up', 'MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.'),
(9045, 'hsa-mir-338-5p', 'retinoblastoma', 'up', 'Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma.'),
(9046, 'hsa-mir-361-3p', 'retinoblastoma', 'down', 'MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling.'),
(9047, 'hsa-mir-361-5p', 'retinoblastoma', 'down', 'MiR-361-5p inhibits cell proliferation and induces cell apoptosis in retinoblastoma by negatively regulating CLDN8.'),
(9048, 'hsa-mir-503', 'retinoblastoma', 'up', 'MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.'),
(9049, 'hsa-mir-665', 'retinoblastoma', 'down', 'MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/?-catenin pathway.'),
(9050, 'hsa-mir-203', 'rhabdomyosarcoma', 'down', 'miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in Rhabdomyosarcoma.'),
(9051, 'hsa-mir-206', 'rhabdomyosarcoma', 'down', 'Heme oxygenase-1 controls an HDAC4-miR-206 pathway of oxidative stress in rhabdomyosarcoma.'),
(9052, 'hsa-mir-874', 'rhabdomyosarcoma', 'down', 'MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT.'),
(9053, 'hsa-mir-130a', 'serous ovarian cancer', 'up', 'miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-?B in high-grade serous ovarian carcinoma.'),
(9054, 'hsa-mir-126', 'small cell lung cancer', 'down', 'miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.'),
(9055, 'hsa-mir-138', 'small cell lung cancer', 'down', 'MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.'),
(9056, 'hsa-mir-25', 'small cell lung cancer', 'up', 'MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.'),
(9057, 'hsa-mir-27a', 'small cell lung cancer', 'down', 'miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.'),
(9058, 'hsa-mir-520a-3p', 'small cell lung cancer', 'down', 'microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.'),
(9059, 'hsa-mir-216a-5p', 'small cell lung cancer', 'down', 'miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.'),
(9060, 'hsa-mir-26b', 'small cell lung cancer', 'down', 'MicroRNA-26b suppresses tumorigenicity and promotes apoptosis in small cell lung cancer cells by targeting myeloid cell leukemia 1 protein.'),
(9061, 'hsa-mir-886-3p', 'small cell lung cancer', 'down', 'MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.'),
(9062, 'hsa-mir-223', 'splenic marginal zone lymphoma', 'down', 'MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.'),
(9063, 'hsa-mir-223', 'splenic marginal zone lymphoma', 'down', '[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].'),
(9064, 'hsa-mir-137', 'squamous carcinoma', 'up', 'MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.'),
(9065, 'hsa-mir-155', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9066, 'hsa-mir-15a', 'squamous carcinoma', 'down', 'miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.'),
(9067, 'hsa-mir-16', 'squamous carcinoma', 'down', 'miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.'),
(9068, 'hsa-mir-184', 'squamous carcinoma', 'up', 'MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.'),
(9069, 'hsa-mir-196a', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9070, 'hsa-mir-203', 'squamous carcinoma', 'down', 'MicroRNA expression profiles of esophageal cancer.'),
(9071, 'hsa-mir-203', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9072, 'hsa-mir-205', 'squamous carcinoma', 'down', 'MicroRNA expression profiles of esophageal cancer.'),
(9073, 'hsa-mir-21', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9074, 'hsa-mir-221', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9075, 'hsa-mir-27a', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9076, 'hsa-mir-34a', 'squamous carcinoma', 'up', 'Unique MicroRNA Expression Profiles in Cervical Cancer.'),
(9077, 'hsa-mir-375', 'squamous carcinoma', 'down', 'Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.'),
(9078, 'hsa-mir-181b-5p', 'squamous carcinoma', 'up', 'Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.'),
(9079, 'hsa-mir-21-5p', 'squamous carcinoma', 'up', 'Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.'),
(9080, 'hsa-mir-1275', 'squamous carcinoma', 'up', 'MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.'),
(9081, 'hsa-mir-98', 'squamous carcinoma', 'down', 'MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck.'),
(9082, 'hsa-mir-340', 'squamous carcinoma', 'down', 'MicroRNA-340 inhibits squamous cell carcinoma cell proliferation, migration and invasion by downregulating RhoA.'),
(9083, 'hsa-mir-17', 't-cell lymphoblastic lymphoma', 'up', 'Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.'),
(9084, 'hsa-mir-19a', 't-cell lymphoblastic lymphoma', 'up', 'Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.'),
(9085, 'hsa-mir-19b-1', 't-cell lymphoblastic lymphoma', 'up', 'Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.'),
(9086, 'hsa-mir-19b-2', 't-cell lymphoblastic lymphoma', 'up', 'Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.'),
(9087, 'hsa-mir-374b', 't-cell lymphoblastic lymphoma', 'down', 'MicroRNA-374b suppresses proliferation and promotes apoptosis in T-cell lymphoblastic lymphoma by repressing AKT1 and Wnt-16.'),
(9088, 'hsa-mir-22', 't-cell lymphoma', 'down', 'miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.'),
(9089, 'hsa-mir-144', 'thyroid cancer', 'down', 'Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.'),
(9090, 'hsa-mir-886-3p', 'thyroid cancer', 'down', 'MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.'),
(9091, 'hsa-mir-106b', 'thyroid cancer', 'down', 'microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.'),
(9092, 'hsa-mir-126-3p', 'thyroid cancer', 'down', 'miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.'),
(9093, 'hsa-mir-205', 'thyroid cancer', 'down', 'Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.'),
(9094, 'hsa-mir-539', 'thyroid cancer', 'down', 'MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1.'),
(9095, 'hsa-mir-204', 'thyroid cancer', 'down', 'MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.'),
(9096, 'hsa-mir-137', 'thyroid cancer', 'down', 'microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.'),
(9097, 'hsa-mir-141', 'thyroid cancer', 'down', 'microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.'),
(9098, 'hsa-mir-126', 'thyroid cancer', 'down', 'Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.'),
(9099, 'hsa-mir-639', 'thyroid cancer', 'up', 'MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.'),
(9100, 'hsa-mir-497', 'thyroid cancer', 'down', 'MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.'),
(9101, 'hsa-mir-217', 'thyroid cancer', 'down', 'miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.'),
(9102, 'hsa-mir-338-3p', 'thyroid cancer', 'down', 'MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.'),
(9103, 'hsa-mir-422a', 'thyroid cancer', 'down', 'Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1.'),
(9104, 'hsa-mir-212', 'thyroid cancer', 'down', 'Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1.'),
(9105, 'hsa-mir-132', 'thyroid cancer', 'down', 'miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer.'),
(9106, 'hsa-mir-146b', 'thyroid cancer', 'up', 'MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.'),
(9107, 'hsa-mir-181a', 'thyroid cancer', 'up', 'MiR-181a promotes growth of thyroid cancer cells by targeting tumor suppressor RB1.'),
(9108, 'hsa-mir-340-5p', 'thyroid cancer', 'up', 'Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.'),
(9109, 'hsa-mir-125a-5p', 'thyroid cancer', 'down', 'Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.'),
(9110, 'hsa-mir-26a', 'thyroid cancer', 'down', 'MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19.'),
(9111, 'hsa-mir-335-5p', 'thyroid cancer', 'down', 'miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.'),
(9112, 'hsa-mir-369-3p', 'thyroid cancer', 'down', 'Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).'),
(9113, 'hsa-mir-524', 'thyroid cancer', 'down', 'MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9.'),
(9114, 'hsa-mir-146b-3p', 'thyroid cancer', 'up', 'MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.'),
(9115, 'hsa-mir-146b-5p', 'thyroid cancer', 'up', 'MicroRNA-146b-3p promotes cell metastasis by directly targeting NF2 in human papillary thyroid cancer.'),
(9116, 'hsa-mir-34a', 'thyroid cancer', 'down', 'LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.'),
(9117, 'hsa-mir-625-3p', 'thyroid cancer', 'up', 'Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells.'),
(9118, 'hsa-mir-1225-5p', 'thyroid cancer', 'down', 'MicroRNA-1225-5p inhibits the development and progression of thyroid cancer via targeting sirtuin 3.'),
(9119, 'hsa-mir-206', 'thyroid cancer', 'down', 'miR-206 inhibits thyroid cancer proliferation and invasion by targeting RAP1B.'),
(9120, 'hsa-mir-299-3p', 'thyroid cancer', 'down', 'MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2.'),
(9121, 'hsa-mir-510-5p', 'thyroid cancer', 'up', 'microRNA-510-5p promotes thyroid cancer cell proliferation, migration, and invasion through suppressing SNHG15.'),
(9122, 'hsa-mir-221', 'thyroid carcinoma', 'up', 'MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.'),
(9123, 'hsa-mir-222', 'thyroid carcinoma', 'up', 'MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.'),
(9124, 'hsa-mir-135a-5p', 'thyroid carcinoma', 'down', 'MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3\'-UTR.'),
(9125, 'hsa-mir-143', 'thyroid carcinoma', 'down', 'lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.'),
(9126, 'hsa-mir-15b', 'tongue cancer', 'down', 'MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.'),
(9127, 'hsa-mir-200b', 'tongue cancer', 'down', 'MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.'),
(9128, 'hsa-mir-197', 'uterine leiomyoma', 'down', 'Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.'),
(9129, 'hsa-mir-137', 'uveal melanoma', 'down', 'Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.'),
(9130, 'hsa-mir-144', 'uveal melanoma', 'down', 'MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.'),
(9131, 'hsa-mir-145', 'uveal melanoma', 'down', 'MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.'),
(9132, 'hsa-mir-182', 'uveal melanoma', 'down', 'Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.'),
(9133, 'hsa-mir-34a', 'uveal melanoma', 'down', 'MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.'),
(9134, 'hsa-mir-34b', 'uveal melanoma', 'down', 'MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.'),
(9135, 'hsa-mir-34c', 'uveal melanoma', 'down', 'MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.'),
(9136, 'hsa-mir-9', 'uveal melanoma', 'down', 'MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-?B1 pathway.'),
(9137, 'hsa-mir-454', 'uveal melanoma', 'up', 'MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.'),
(9138, 'hsa-mir-32', 'uveal melanoma', 'down', 'MicroRNA-32 functions as a tumor suppressor and directly targets EZH2 in uveal melanoma.'),
(9139, 'hsa-mir-140', 'uveal melanoma', 'down', 'Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.'),
(9140, 'hsa-mir-32', 'uveal melanoma', 'down', 'RETRACTION of articles with plagiarism in common with other publications.'),
(9141, 'hsa-mir-367', 'uveal melanoma', 'up', 'miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.'),
(9142, 'hsa-mir-224-5p', 'uveal melanoma', 'down', 'Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.'),
(9143, 'hsa-mir-155', 'uveal melanoma', 'up', 'MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression.'),
(9144, 'hsa-mir-21', 'uveal melanoma', 'up', 'Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein.'),
(9145, 'hsa-mir-216a-5p', 'uveal melanoma', 'down', 'MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.'),
(9146, 'hsa-mir-142-3p', 'uveal melanoma', 'down', 'miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGF?R1, GNAQ, WASL, and RAC1.'),
(9147, 'hsa-mir-224-5p', 'uveal melanoma', 'down', 'miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.'),
(9148, 'hsa-mir-155', 'waldenstrom\'s macroglobulinemia', 'up', 'MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.'),
(9149, 'hsa-mir-155', 'waldenstrom\'s macroglobulinemia', 'up', 'LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.');

-- --------------------------------------------------------

--
-- Table structure for table `genes`
--

CREATE TABLE `genes` (
  `id` int(11) NOT NULL,
  `gene-name` varchar(10) NOT NULL,
  `Marker` varchar(35) NOT NULL,
  `Study-type` varchar(10) NOT NULL,
  `Disease` varchar(54) NOT NULL,
  `Pubmed-ID` varchar(27) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `genes`
--

INSERT INTO `genes` (`id`, `gene-name`, `Marker`, `Study-type`, `Disease`, `Pubmed-ID`) VALUES
(3, 'ARID5B', 'rs10821936', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(4, 'C12orf5', 'rs10849033', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(5, 'CCND2', 'rs10849033', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(6, 'CFHR1', 'rs6428370', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(7, 'CFHR4', 'rs6428370', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(8, 'DDC', 'rs11978267', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(9, 'IKZF1', 'rs11978267', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(10, 'KCNE4', 'rs12621643', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(11, 'KCNMB2', 'rs9290663', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(12, 'MAP1LC3B2', 'rs2089222', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(13, 'METTL4', 'rs1879352', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(14, 'OR2C3', 'rs1881797', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(15, 'OR2W5', 'rs1881797', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(16, 'PARD3', 'rs563507', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(17, 'RYR2', 'rs7554607', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(18, 'ST6GALNAC3', 'rs10873876', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(19, 'ZNF230', 'rs2191566', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684603'),
(20, 'ARID5B', 'rs7089424', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684604'),
(21, 'IKZF1', 'rs4132601', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '19684604'),
(22, 'C14orf118', 'rs7156960', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(23, 'C14orf118', 'rs7156960', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(24, 'CSGALNACT1', 'rs920590', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(25, 'ESRRB', 'rs7156960', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(26, 'ESRRB', 'rs7156960', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(27, 'HTR1B', 'rs7738636', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(28, 'IMPG1', 'rs7738636', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(29, 'INTS10', 'rs920590', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(30, 'PTPRJ', 'rs3942852', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(31, 'SLCO3A1', 'rs207954', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(32, 'TP63', 'rs17505102', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(33, 'TP63', 'rs17505102', 'GWAS', 'Acute lymphoblastic leukemia (childhood)', '22076464'),
(34, 'ARHGEF10L', 'rs7538876', 'GWAS', 'Basal cell carcinoma', '18849993'),
(35, 'PADI4', 'rs7538876', 'GWAS', 'Basal cell carcinoma', '18849993'),
(36, 'RCC2', 'rs7538876', 'GWAS', 'Basal cell carcinoma', '18849993'),
(37, 'RHOU', 'rs801114', 'GWAS', 'Basal cell carcinoma', '18849993'),
(38, 'EXOC2', 'rs12210050', 'GWAS', 'Basal cell carcinoma', '21700618'),
(39, 'IRF4', 'rs12210050', 'GWAS', 'Basal cell carcinoma', '21700618'),
(40, 'MC1R', 'rs1805007', 'GWAS', 'Basal cell carcinoma', '21700618'),
(41, 'TM9SF2', 'rs7335046', 'GWAS', 'Basal cell carcinoma', '21700618'),
(42, 'UBAC2', 'rs7335046', 'GWAS', 'Basal cell carcinoma', '21700618'),
(43, 'PSCA', 'rs2294008', 'GWAS', 'Bladder cancer', '19648920'),
(44, 'C19orf12', 'rs8102137', 'GWAS', 'Bladder cancer', '20972438'),
(45, 'CBX6', 'rs1014971', 'GWAS', 'Bladder cancer', '20972438'),
(46, 'CCNE1', 'rs8102137', 'GWAS', 'Bladder cancer', '20972438'),
(47, 'CLPTM1L', 'rs401681', 'GWAS', 'Bladder cancer', '20972438'),
(48, 'FGFR3', 'rs798766', 'GWAS', 'Bladder cancer', '20972438'),
(49, 'GSTM1', 'NR', 'GWAS', 'Bladder cancer', '20972438'),
(50, 'LEPREL1', 'rs710521', 'GWAS', 'Bladder cancer', '20972438'),
(51, 'MYC', 'rs9642880', 'GWAS', 'Bladder cancer', '20972438'),
(52, 'PSCA', 'rs2294008', 'GWAS', 'Bladder cancer', '20972438'),
(53, 'PSD3', 'rs1495741', 'GWAS', 'Bladder cancer', '20972438'),
(54, 'TACC3', 'rs798766', 'GWAS', 'Bladder cancer', '20972438'),
(55, 'TERT', 'rs401681', 'GWAS', 'Bladder cancer', '20972438'),
(56, 'TMEM129', 'rs798766', 'GWAS', 'Bladder cancer', '20972438'),
(57, 'TP63', 'rs710521', 'GWAS', 'Bladder cancer', '20972438'),
(58, 'SLC14A1', 'rs17674580', 'GWAS', 'Bladder cancer', '21750109'),
(59, 'SLC14A1', 'rs7238033', 'GWAS', 'Bladder cancer', '21824976'),
(60, 'CHD9', 'rs3803662', 'GWAS', 'Breast cancer', '17529967'),
(61, 'FGFR2', 'rs2981582', 'GWAS', 'Breast cancer', '17529967'),
(62, 'HCN1', 'rs981782', 'GWAS', 'Breast cancer', '17529967'),
(63, 'LSP1', 'rs3817198', 'GWAS', 'Breast cancer', '17529967'),
(64, 'MAP3K1', 'rs889312', 'GWAS', 'Breast cancer', '17529967'),
(65, 'TOX3', 'rs3803662', 'GWAS', 'Breast cancer', '17529967'),
(66, 'FGFR2', 'rs1219648', 'GWAS', 'Breast cancer', '17529973'),
(67, 'CHD9', 'rs3803662', 'GWAS', 'Breast cancer', '17529974'),
(68, 'TOX3', 'rs3803662', 'GWAS', 'Breast cancer', '17529974'),
(69, 'ABCC4', 'rs1926657', 'GWAS', 'Breast cancer', '17903305'),
(70, 'AUTS2', 'rs10263639', 'GWAS', 'Breast cancer', '17903305'),
(71, 'BCL11A', 'rs10490113', 'GWAS', 'Breast cancer', '17903305'),
(72, 'COL1A1', 'rs2075555', 'GWAS', 'Breast cancer', '17903305'),
(73, 'FBN1', 'rs1876206', 'GWAS', 'Breast cancer', '17903305'),
(74, 'GRIK1', 'rs458685', 'GWAS', 'Breast cancer', '17903305'),
(75, 'MAT2B', 'rs6556756', 'GWAS', 'Breast cancer', '17903305'),
(76, 'TRHDE', 'rs1154865', 'GWAS', 'Breast cancer', '17903305'),
(77, 'TXNL1', 'rs1978503', 'GWAS', 'Breast cancer', '17903305'),
(78, 'ECHDC1', 'rs2180341', 'GWAS', 'Breast cancer', '18326623'),
(79, 'RNF146', 'rs2180341', 'GWAS', 'Breast cancer', '18326623'),
(80, 'CLEC18B', 'rs10871290', 'GWAS', 'Breast cancer', '18463975'),
(81, 'GLG1', 'rs10871290', 'GWAS', 'Breast cancer', '18463975'),
(82, 'ESR1', 'rs2046210', 'GWAS', 'Breast cancer', '19219042'),
(83, 'CHD9', 'rs3803662', 'GWAS', 'Breast cancer', '19330030'),
(84, 'EMBP1', 'rs11249433', 'GWAS', 'Breast cancer', '19330030'),
(85, 'FGFR2', 'rs2981579', 'GWAS', 'Breast cancer', '19330030'),
(86, 'MAP3K1', 'rs16886165', 'GWAS', 'Breast cancer', '19330030'),
(87, 'RAD51L1', 'rs999737', 'GWAS', 'Breast cancer', '19330030'),
(88, 'TOX3', 'rs3803662', 'GWAS', 'Breast cancer', '19330030'),
(89, 'ANKRD16', 'rs2380205', 'GWAS', 'Breast cancer', '20453838'),
(90, 'CCND1', 'rs614367', 'GWAS', 'Breast cancer', '20453838'),
(91, 'CDKN2A', 'rs1011970', 'GWAS', 'Breast cancer', '20453838'),
(92, 'CDKN2B', 'rs1011970', 'GWAS', 'Breast cancer', '20453838'),
(93, 'CHD9', 'rs3803662', 'GWAS', 'Breast cancer', '20453838'),
(94, 'ESR1', 'rs3757318', 'GWAS', 'Breast cancer', '20453838'),
(95, 'FBXO18', 'rs2380205', 'GWAS', 'Breast cancer', '20453838'),
(96, 'FGF3', 'rs614367', 'GWAS', 'Breast cancer', '20453838'),
(97, 'FGFR2', 'rs2981579', 'GWAS', 'Breast cancer', '20453838'),
(98, 'GDI2', 'rs2380205', 'GWAS', 'Breast cancer', '20453838'),
(99, 'LSP1', 'rs909116', 'GWAS', 'Breast cancer', '20453838'),
(100, 'MAP3K1', 'rs889312', 'GWAS', 'Breast cancer', '20453838'),
(101, 'MYEOV', 'rs614367', 'GWAS', 'Breast cancer', '20453838'),
(102, 'ORAOV1', 'rs614367', 'GWAS', 'Breast cancer', '20453838'),
(103, 'SLC4A7', 'rs4973768', 'GWAS', 'Breast cancer', '20453838'),
(104, 'TNNT3', 'rs909116', 'GWAS', 'Breast cancer', '20453838'),
(105, 'TOX3', 'rs3803662', 'GWAS', 'Breast cancer', '20453838'),
(106, 'ZMIZ1', 'rs704010', 'GWAS', 'Breast cancer', '20453838'),
(107, 'ZNF365', 'rs10995190', 'GWAS', 'Breast cancer', '20453838'),
(108, 'CHD9', 'rs4784227', 'GWAS', 'Breast cancer', '20585626'),
(109, 'TOX3', 'rs4784227', 'GWAS', 'Breast cancer', '20585626'),
(110, 'ANKLE1', 'rs8170', 'GWAS', 'Breast cancer', '20852631'),
(111, 'C19orf62', 'rs8170', 'GWAS', 'Breast cancer', '20852631'),
(112, 'CHD9', 'rs3803662', 'GWAS', 'Breast cancer', '20872241'),
(113, 'FGFR2', 'rs1219648', 'GWAS', 'Breast cancer', '20872241'),
(114, 'HCN1', 'rs7716600', 'GWAS', 'Breast cancer', '20872241'),
(115, 'TOX3', 'rs3803662', 'GWAS', 'Breast cancer', '20872241'),
(116, 'FGFR2', 'rs2981575', 'GWAS', 'Breast cancer', '21060860'),
(117, 'ACTL7A', 'rs865686', 'GWAS', 'Breast cancer', '21263130'),
(118, 'ATE1', 'rs10510102', 'GWAS', 'Breast cancer', '21263130'),
(119, 'CHD9', 'rs3112612', 'GWAS', 'Breast cancer', '21263130'),
(120, 'ESR1', 'rs3734805', 'GWAS', 'Breast cancer', '21263130'),
(121, 'FGFR2', 'rs10510102', 'GWAS', 'Breast cancer', '21263130'),
(122, 'FGFR2', 'rs1219648', 'GWAS', 'Breast cancer', '21263130'),
(123, 'KLF4', 'rs865686', 'GWAS', 'Breast cancer', '21263130'),
(124, 'RAD23B', 'rs865686', 'GWAS', 'Breast cancer', '21263130'),
(125, 'SLC4A7', 'rs4973768', 'GWAS', 'Breast cancer', '21263130'),
(126, 'TOX3', 'rs3112612', 'GWAS', 'Breast cancer', '21263130'),
(127, 'ZNF577', 'rs10411161', 'GWAS', 'Breast cancer', '21424380'),
(128, 'ZNF365', 'rs10822013', 'GWAS', 'Breast cancer', '21908515'),
(129, 'TERT', 'rs10069690', 'GWAS', 'Breast cancer', '22037553'),
(130, 'BARX2', 'rs7107217', 'GWAS', 'Breast cancer', '22383897'),
(131, 'ESR1', 'rs9383951', 'GWAS', 'Breast cancer', '22383897'),
(132, 'TAB2', 'rs9485372', 'GWAS', 'Breast cancer', '22383897'),
(133, 'TMEM45B', 'rs7107217', 'GWAS', 'Breast cancer', '22383897'),
(134, 'UST', 'rs9485372', 'GWAS', 'Breast cancer', '22383897'),
(135, 'RAD51L1', 'rs3784099', 'GWAS', 'Breast cancer (survival)', '22232737'),
(136, 'RAD51L1', 'rs3784099', 'GWAS', 'Breast cancer (survival)', '22232737'),
(137, 'ADAT2', 'rs2496585', 'GWAS', 'Breast Neoplasms', 'NA'),
(138, 'ATP10A', 'rs2930629', 'GWAS', 'Breast Neoplasms', 'NA'),
(139, 'BCL11A', 'rs7592415', 'GWAS', 'Breast Neoplasms', 'NA'),
(140, 'BMPR1B', 'rs11097457', 'GWAS', 'Breast Neoplasms', 'NA'),
(141, 'BMPR1B', 'rs4254781', 'GWAS', 'Breast Neoplasms', 'NA'),
(142, 'BMPR1B', 'rs4538488', 'GWAS', 'Breast Neoplasms', 'NA'),
(143, 'BMPR1B', 'rs6831418', 'GWAS', 'Breast Neoplasms', 'NA'),
(144, 'C17orf59', 'rs8531', 'GWAS', 'Breast Neoplasms', 'NA'),
(145, 'C4orf19', 'rs6830100', 'GWAS', 'Breast Neoplasms', 'NA'),
(146, 'C7orf62', 'rs2724463', 'GWAS', 'Breast Neoplasms', 'NA'),
(147, 'CBLN2', 'rs9953717', 'GWAS', 'Breast Neoplasms', 'NA'),
(148, 'CLEC16A', 'rs998592', 'GWAS', 'Breast Neoplasms', 'NA'),
(149, 'CNGA3', 'rs7571001', 'GWAS', 'Breast Neoplasms', 'NA'),
(150, 'CYLC2', 'rs1867347', 'GWAS', 'Breast Neoplasms', 'NA'),
(151, 'DDR1', 'rs3131043', 'GWAS', 'Breast Neoplasms', 'NA'),
(152, 'DPF3', 'rs12435382', 'GWAS', 'Breast Neoplasms', 'NA'),
(153, 'DPF3', 'rs12435412', 'GWAS', 'Breast Neoplasms', 'NA'),
(154, 'EIF3M', 'rs2450411', 'GWAS', 'Breast Neoplasms', 'NA'),
(155, 'EPHA4', 'rs10804287', 'GWAS', 'Breast Neoplasms', 'NA'),
(156, 'EPHA4', 'rs897144', 'GWAS', 'Breast Neoplasms', 'NA'),
(157, 'FGFR2', 'rs11200014', 'GWAS', 'Breast Neoplasms', 'NA'),
(158, 'FGFR2', 'rs2420946', 'GWAS', 'Breast Neoplasms', 'NA'),
(159, 'FN1', 'rs1250255', 'GWAS', 'Breast Neoplasms', 'NA'),
(160, 'GPR26', 'rs10510126', 'GWAS', 'Breast Neoplasms', 'NA'),
(161, 'GPR26', 'rs17663978', 'GWAS', 'Breast Neoplasms', 'NA'),
(162, 'GPR26', 'rs7916600', 'GWAS', 'Breast Neoplasms', 'NA'),
(163, 'GRID1', 'rs12767486', 'GWAS', 'Breast Neoplasms', 'NA'),
(164, 'HCN1', 'rs4866929', 'GWAS', 'Breast Neoplasms', 'NA'),
(165, 'IER3', 'rs3131043', 'GWAS', 'Breast Neoplasms', 'NA'),
(166, 'IL7R', 'rs2194225', 'GWAS', 'Breast Neoplasms', 'NA'),
(167, 'KIF26B', 'rs1538472', 'GWAS', 'Breast Neoplasms', 'NA'),
(168, 'KIT', 'rs11732323', 'GWAS', 'Breast Neoplasms', 'NA'),
(169, 'LPPR1', 'rs2417226', 'GWAS', 'Breast Neoplasms', 'NA'),
(170, 'MGAT5', 'rs6711228', 'GWAS', 'Breast Neoplasms', 'NA'),
(171, 'MMRN1', 'rs12233759', 'GWAS', 'Breast Neoplasms', 'NA'),
(172, 'MREG', 'rs1250255', 'GWAS', 'Breast Neoplasms', 'NA'),
(173, 'MURC', 'rs13285273', 'GWAS', 'Breast Neoplasms', 'NA'),
(174, 'NCKAP5', 'rs6711228', 'GWAS', 'Breast Neoplasms', 'NA'),
(175, 'NKAIN2', 'rs781484', 'GWAS', 'Breast Neoplasms', 'NA'),
(176, 'NKX3-1', 'rs11776817', 'GWAS', 'Breast Neoplasms', 'NA'),
(177, 'NPAS3', 'rs8014514', 'GWAS', 'Breast Neoplasms', 'NA'),
(178, 'NRSN1', 'rs2176933', 'GWAS', 'Breast Neoplasms', 'NA'),
(179, 'NTSR1', 'rs2249938', 'GWAS', 'Breast Neoplasms', 'NA'),
(180, 'NTSR1', 'rs856937', 'GWAS', 'Breast Neoplasms', 'NA'),
(181, 'PCBP3', 'rs9980967', 'GWAS', 'Breast Neoplasms', 'NA'),
(182, 'PCDH15', 'rs11004359', 'GWAS', 'Breast Neoplasms', 'NA'),
(183, 'PNPLA4', 'rs5934349', 'GWAS', 'Breast Neoplasms', 'NA'),
(184, 'POLR1A', 'rs10779967', 'GWAS', 'Breast Neoplasms', 'NA'),
(185, 'POLR1A', 'rs2288118', 'GWAS', 'Breast Neoplasms', 'NA'),
(186, 'PPM1E', 'rs16943326', 'GWAS', 'Breast Neoplasms', 'NA'),
(187, 'PPM1E', 'rs3809724', 'GWAS', 'Breast Neoplasms', 'NA'),
(188, 'PTCD3', 'rs1025104', 'GWAS', 'Breast Neoplasms', 'NA'),
(189, 'PTCD3', 'rs1075622', 'GWAS', 'Breast Neoplasms', 'NA'),
(190, 'PTCD3', 'rs2367202', 'GWAS', 'Breast Neoplasms', 'NA'),
(191, 'RAPGEF4', 'rs10187560', 'GWAS', 'Breast Neoplasms', 'NA'),
(192, 'RBMS1', 'rs197275', 'GWAS', 'Breast Neoplasms', 'NA'),
(193, 'RBMS1', 'rs2551691', 'GWAS', 'Breast Neoplasms', 'NA'),
(194, 'RPH3AL', 'rs11869174', 'GWAS', 'Breast Neoplasms', 'NA'),
(195, 'RPS24', 'rs1916400', 'GWAS', 'Breast Neoplasms', 'NA'),
(196, 'SAMD5', 'rs325105', 'GWAS', 'Breast Neoplasms', 'NA'),
(197, 'SCARB2', 'rs6532244', 'GWAS', 'Breast Neoplasms', 'NA'),
(198, 'SLC19A1', 'rs9980967', 'GWAS', 'Breast Neoplasms', 'NA'),
(199, 'SLC25A37', 'rs11776817', 'GWAS', 'Breast Neoplasms', 'NA'),
(200, 'SMC2', 'rs1867347', 'GWAS', 'Breast Neoplasms', 'NA'),
(201, 'SPOCK1', 'rs1229742', 'GWAS', 'Breast Neoplasms', 'NA'),
(202, 'SPOCK1', 'rs2005698', 'GWAS', 'Breast Neoplasms', 'NA'),
(203, 'SPTLC3', 'rs6109595', 'GWAS', 'Breast Neoplasms', 'NA'),
(204, 'SYT17', 'rs6497337', 'GWAS', 'Breast Neoplasms', 'NA'),
(205, 'TANK', 'rs197275', 'GWAS', 'Breast Neoplasms', 'NA'),
(206, 'TANK', 'rs2551691', 'GWAS', 'Breast Neoplasms', 'NA'),
(207, 'THSD4', 'rs7181587', 'GWAS', 'Breast Neoplasms', 'NA'),
(208, 'TLR6', 'rs7696175', 'GWAS', 'Breast Neoplasms', 'NA'),
(209, 'TMEM132B', 'rs7134868', 'GWAS', 'Breast Neoplasms', 'NA'),
(210, 'TRIM37', 'rs3809724', 'GWAS', 'Breast Neoplasms', 'NA'),
(211, 'UBE3A', 'rs2930629', 'GWAS', 'Breast Neoplasms', 'NA'),
(212, 'USP6NL', 'rs10508425', 'GWAS', 'Breast Neoplasms', 'NA'),
(213, 'USP6NL', 'rs4445554', 'GWAS', 'Breast Neoplasms', 'NA'),
(214, 'USP6NL', 'rs7085769', 'GWAS', 'Breast Neoplasms', 'NA'),
(215, 'VCX2', 'rs5934349', 'GWAS', 'Breast Neoplasms', 'NA'),
(216, 'VWA3B', 'rs6715989', 'GWAS', 'Breast Neoplasms', 'NA'),
(217, 'VWA3B', 'rs7571001', 'GWAS', 'Breast Neoplasms', 'NA'),
(218, 'VWA3B', 'rs7603439', 'GWAS', 'Breast Neoplasms', 'NA'),
(219, 'ZAK', 'rs10187560', 'GWAS', 'Breast Neoplasms', 'NA'),
(220, 'ZFAT', 'rs16905215', 'GWAS', 'Breast Neoplasms', 'NA'),
(221, 'ZFAT', 'rs9785140', 'GWAS', 'Breast Neoplasms', 'NA'),
(222, 'ZMIZ1', 'rs1916400', 'GWAS', 'Breast Neoplasms', 'NA'),
(223, 'ZNF516', 'rs11150911', 'GWAS', 'Breast Neoplasms', 'NA'),
(224, 'ZNF516', 'rs1460277', 'GWAS', 'Breast Neoplasms', 'NA'),
(225, 'ACOXL', 'rs17483466', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(226, 'BCL2L11', 'rs17483466', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(227, 'GRAMD1B', 'rs735665', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(228, 'IRF4', 'rs872071', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(229, 'PRKD2', 'rs11083846', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(230, 'RPLP1', 'rs7176508', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(231, 'SP110', 'rs13397985', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(232, 'SP140', 'rs13397985', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(233, 'STRN4', 'rs11083846', 'GWAS', 'Chronic lymphocytic leukemia', '18758461'),
(234, 'CPEB1', 'rs783540', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(235, 'CXXC1', 'rs1036935', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(236, 'FARP2', 'rs757978', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(237, 'FKRP', 'rs11668878', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(238, 'FOXF1', 'rs305061', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(239, 'IRF8', 'rs305061', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(240, 'MBD1', 'rs1036935', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(241, 'NEDD4', 'rs7169431', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(242, 'RFX7', 'rs7169431', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(243, 'SKA1', 'rs1036935', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(244, 'SLC1A5', 'rs11668878', 'GWAS', 'Chronic lymphocytic leukemia', '20062064'),
(245, 'EXOC2', 'rs9378805', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(246, 'HLA-DQA1', 'rs9272535', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(247, 'HLA-DQA1', 'rs674313', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(248, 'HLA-DRB1', 'rs674313', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(249, 'HLA-DRB5', 'rs674313', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(250, 'IRF4', 'rs9378805', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(251, 'IRF8', 'rs391525', 'GWAS', 'Chronic lymphocytic leukemia', '21131588'),
(252, 'AKAP12', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(253, 'C6orf211', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(254, 'ESR1', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(255, 'MTHFD1L', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(256, 'RMND1', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(257, 'WSB1', 'rs4795519', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(258, 'ZBTB2', 'rs4869742', 'GWAS', 'Chronic myeloid leukemia', '21540461'),
(259, 'SMAD7', 'rs4939827', 'GWAS', 'Colorectal cancer', '17934461'),
(260, 'SMAD7', 'rs4939827', 'GWAS', 'Colorectal cancer', '18372901'),
(261, 'EIF3H', 'rs16892766', 'GWAS', 'Colorectal cancer', '18372905'),
(262, 'GREM1', 'rs4779584', 'GWAS', 'Colorectal cancer', '18372905'),
(263, 'SCG5', 'rs4779584', 'GWAS', 'Colorectal cancer', '18372905'),
(264, 'SMAD7', 'rs4939827', 'GWAS', 'Colorectal cancer', '18372905'),
(265, 'TRPS1', 'rs16892766', 'GWAS', 'Colorectal cancer', '18372905'),
(266, 'BMP2', 'rs961253', 'GWAS', 'Colorectal cancer', '19011631'),
(267, 'BMP4', 'rs4444235', 'GWAS', 'Colorectal cancer', '19011631'),
(268, 'CDH1', 'rs9929218', 'GWAS', 'Colorectal cancer', '19011631'),
(269, 'RHPN2', 'rs10411210', 'GWAS', 'Colorectal cancer', '19011631'),
(270, 'ATF1', 'rs11169552', 'GWAS', 'Colorectal cancer', '20972440'),
(271, 'DIP2B', 'rs11169552', 'GWAS', 'Colorectal cancer', '20972440'),
(272, 'DUSP10', 'rs6687758', 'GWAS', 'Colorectal cancer', '20972440'),
(273, 'DUSP10', 'rs6691170', 'GWAS', 'Colorectal cancer', '20972440'),
(274, 'LAMA5', 'rs4925386', 'GWAS', 'Colorectal cancer', '20972440'),
(275, 'MYNN', 'rs10936599', 'GWAS', 'Colorectal cancer', '20972440'),
(276, 'SLC22A3', 'rs7758229', 'GWAS', 'Colorectal cancer', '21242260'),
(277, 'EIF3H', 'rs16892766', 'GWAS', 'Colorectal cancer', '21761138'),
(278, 'GREM1', 'rs4779584', 'GWAS', 'Colorectal cancer', '21761138'),
(279, 'MED13L', 'rs7315438', 'GWAS', 'Colorectal cancer', '21761138'),
(280, 'SCG5', 'rs4779584', 'GWAS', 'Colorectal cancer', '21761138'),
(281, 'SMAD7', 'rs4939827', 'GWAS', 'Colorectal cancer', '21761138'),
(282, 'TBX3', 'rs7315438', 'GWAS', 'Colorectal cancer', '21761138'),
(283, 'TRPS1', 'rs16892766', 'GWAS', 'Colorectal cancer', '21761138'),
(284, 'IFNE', 'rs4636294', 'GWAS', 'Cutaneous nevi', '19578365'),
(285, 'MTAP', 'rs4636294', 'GWAS', 'Cutaneous nevi', '19578365'),
(286, 'PLA2G6', 'rs2284063', 'GWAS', 'Cutaneous nevi', '19578365'),
(287, 'C11orf74', 'rs16930685', 'GWAS', 'Cutaneous nevi', '21478494'),
(288, 'NID1', 'rs3768080', 'GWAS', 'Cutaneous nevi', '21478494'),
(289, 'PLA2G6', 'rs738322', 'GWAS', 'Cutaneous nevi', '21478494'),
(290, 'HNF1B', 'rs4430796', 'GWAS', 'Endometrial cancer', '21499250'),
(291, 'SFPQ', 'rs673604', 'GWAS', 'Endometrial cancer', '21499250'),
(292, 'ZMYM4', 'rs673604', 'GWAS', 'Endometrial cancer', '21499250'),
(293, 'ADH1B', 'rs1229984', 'GWAS', 'Esophageal cancer', '19698717'),
(294, 'ADH6', 'rs1229984', 'GWAS', 'Esophageal cancer', '19698717'),
(295, 'ALDH2', 'rs671', 'GWAS', 'Esophageal cancer', '19698717'),
(296, 'BRAP', 'rs671', 'GWAS', 'Esophageal cancer', '19698717'),
(297, 'ACAD10', 'rs11066015', 'GWAS', 'Esophageal cancer', '21642993'),
(298, 'ANP32A', 'rs8030672', 'GWAS', 'Esophageal cancer', '21642993'),
(299, 'C12orf51', 'rs2074356', 'GWAS', 'Esophageal cancer', '21642993'),
(300, 'C12orf51', 'rs11066280', 'GWAS', 'Esophageal cancer', '21642993'),
(301, 'CORO2B', 'rs8030672', 'GWAS', 'Esophageal cancer', '21642993'),
(302, 'CSNK1A1', 'rs10058728', 'GWAS', 'Esophageal cancer', '21642993'),
(303, 'LRFN2', 'rs10484761', 'GWAS', 'Esophageal cancer', '21642993'),
(304, 'PDE4D', 'rs10052657', 'GWAS', 'Esophageal cancer', '21642993'),
(305, 'PLCE1', 'rs2274223', 'GWAS', 'Esophageal cancer', '21642993'),
(306, 'RPL6', 'rs11066280', 'GWAS', 'Esophageal cancer', '21642993'),
(307, 'RUNX1', 'rs2014300', 'GWAS', 'Esophageal cancer', '21642993'),
(308, 'SEMA5B', 'rs9868873', 'GWAS', 'Esophageal cancer', '21642993'),
(309, 'TBL1XR1', 'rs6772209', 'GWAS', 'Esophageal cancer', '21642993'),
(310, 'UNC5CL', 'rs10484761', 'GWAS', 'Esophageal cancer', '21642993'),
(311, 'CHEK2', 'rs738722', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(312, 'HSCB', 'rs738722', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(313, 'MUC1', 'rs4072037', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(314, 'NOC3L', 'rs3765524', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(315, 'NOC3L', 'rs3781264', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(316, 'PLCE1', 'rs3765524', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(317, 'PLCE1', 'rs3781264', 'GWAS', 'Esophageal cancer and gastric cancer', '20729852'),
(318, 'HLA-DQB1', 'rs10484561', 'GWAS', 'Follicular lymphoma', '20639881'),
(319, 'HLA-DQB1', 'rs2647012', 'GWAS', 'Follicular lymphoma', '21533074'),
(320, 'CNTN4', 'rs975334', 'GWAS', 'Gallbladder cancer', '22318345'),
(321, 'DCC', 'rs7504990', 'GWAS', 'Gallbladder cancer', '22318345'),
(322, 'EIF3IP1', 'rs10953615', 'GWAS', 'Gallbladder cancer', '22318345'),
(323, 'TUSC1', 'rs13294589', 'GWAS', 'Gallbladder cancer', '22318345'),
(324, 'PRKAA1', 'rs13361707', 'GWAS', 'Gastric cancer', '22037551'),
(325, 'PTGER4', 'rs13361707', 'GWAS', 'Gastric cancer', '22037551'),
(326, 'ZBTB20', 'rs9841504', 'GWAS', 'Gastric cancer', '22037551'),
(327, 'CDKN2A', 'rs4977756', 'GWAS', 'Glioma', '19578367'),
(328, 'CDKN2B', 'rs4977756', 'GWAS', 'Glioma', '19578367'),
(329, 'GSDMC', 'rs891835', 'GWAS', 'Glioma', '19578367'),
(330, 'GSDMC', 'rs4295627', 'GWAS', 'Glioma', '19578367'),
(331, 'PHLDB1', 'rs498872', 'GWAS', 'Glioma', '19578367'),
(332, 'RTEL1', 'rs6010620', 'GWAS', 'Glioma', '19578367'),
(333, 'TERT', 'rs2853676', 'GWAS', 'Glioma', '19578367'),
(334, 'TERT', 'rs2736100', 'GWAS', 'Glioma', '19578367'),
(335, 'CDKN2A', 'rs2157719', 'GWAS', 'Glioma', '21531791'),
(336, 'CDKN2B', 'rs2157719', 'GWAS', 'Glioma', '21531791'),
(337, 'EGFR', 'rs11979158', 'GWAS', 'Glioma', '21531791'),
(338, 'EGFR', 'rs2252586', 'GWAS', 'Glioma', '21531791'),
(339, 'GSDMC', 'rs4295627', 'GWAS', 'Glioma', '21531791'),
(340, 'PHLDB1', 'rs498872', 'GWAS', 'Glioma', '21531791'),
(341, 'RTEL1', 'rs6010620', 'GWAS', 'Glioma', '21531791'),
(342, 'SEC61G', 'rs2252586', 'GWAS', 'Glioma', '21531791'),
(343, 'TERT', 'rs2736100', 'GWAS', 'Glioma', '21531791'),
(344, 'TERT', 'rs2736100', 'GWAS', 'Glioma', '21827660'),
(345, 'RTEL1', 'rs4809324', 'GWAS', 'Glioma (high-grade)', '19578366'),
(346, 'KIF1B', 'rs17401966', 'GWAS', 'Hepatocellular carcinoma', '20676096'),
(347, 'PGD', 'rs17401966', 'GWAS', 'Hepatocellular carcinoma', '20676096'),
(348, 'UBE4B', 'rs17401966', 'GWAS', 'Hepatocellular carcinoma', '20676096'),
(349, 'C2', 'rs9267673', 'GWAS', 'Hepatocellular carcinoma', '21105107'),
(350, 'CCR4', 'rs4678680', 'GWAS', 'Hepatocellular carcinoma', '21105107'),
(351, 'GLB1', 'rs4678680', 'GWAS', 'Hepatocellular carcinoma', '21105107'),
(352, 'ZBTB12', 'rs9267673', 'GWAS', 'Hepatocellular carcinoma', '21105107'),
(353, 'HLA-DQB1', 'rs9275572', 'GWAS', 'Hepatocellular carcinoma', '21499248'),
(354, 'MICA', 'rs2596542', 'GWAS', 'Hepatocellular carcinoma', '21499248'),
(355, 'GATA3', 'rs501764', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(356, 'GSDMC', 'rs2019960', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(357, 'HLA-DRA', 'rs6903608', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(358, 'HLA-DRB5', 'rs6903608', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(359, 'PAPOLG', 'rs1432295', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(360, 'REL', 'rs1432295', 'GWAS', 'Hodgkins lymphoma', '21037568'),
(361, 'ERAP1', 'rs27524', 'GWAS', 'Hodgkins lymphoma', '22286212'),
(362, 'HLA-DRA', 'rs2395185', 'GWAS', 'Hodgkins lymphoma', '22286212'),
(363, 'HLA-DRB5', 'rs2395185', 'GWAS', 'Hodgkins lymphoma', '22286212'),
(364, 'IL13', 'rs20541', 'GWAS', 'Hodgkins lymphoma', '22286212'),
(365, 'MICB', 'rs2248462', 'GWAS', 'Hodgkins lymphoma', '22286212'),
(366, 'CDKAL1', 'rs2206734', 'GWAS', 'Ileal carcinoids', '21139019'),
(367, 'FGF12', 'rs975121', 'GWAS', 'Ileal carcinoids', '21139019'),
(368, 'KIF16B', 'rs2208059', 'GWAS', 'Ileal carcinoids', '21139019'),
(369, 'SLC12A2', 'rs10089', 'GWAS', 'Ileal carcinoids', '21139019'),
(370, 'CDC42BPB', 'rs751837', 'GWAS', 'Large B-cell lymphoma', '21471979'),
(371, 'LNX2', 'rs7097', 'GWAS', 'Large B-cell lymphoma', '21471979'),
(372, 'POLR1D', 'rs7097', 'GWAS', 'Large B-cell lymphoma', '21471979'),
(373, 'ABO', 'rs657152', 'GWAS', 'Liver enzyme levels', '18940312'),
(374, 'HNF1A', 'rs7310409', 'GWAS', 'Liver enzyme levels (gamma-glutamyl transferase)', '22001757'),
(375, 'APOM', 'rs3117582', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(376, 'BAT3', 'rs3117582', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(377, 'CHRNA3', 'rs1051730', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(378, 'CHRNA5', 'rs1051730', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(379, 'CLPTM1L', 'rs31489', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(380, 'TERT', 'rs2736100', 'GWAS', 'Lung adenocarcinoma', '19836008'),
(381, 'CLPTM1L', 'rs2736100', 'GWAS', 'Lung adenocarcinoma', '20700438'),
(382, 'TERT', 'rs2736100', 'GWAS', 'Lung adenocarcinoma', '20700438'),
(383, 'TERT', 'rs2736100', 'GWAS', 'Lung adenocarcinoma', '20871597'),
(384, 'TP63', 'rs10937405', 'GWAS', 'Lung adenocarcinoma', '20871597'),
(385, 'CHRNA3', 'rs8034191', 'GWAS', 'Lung cancer', '18385676'),
(386, 'CHRNA5', 'rs8034191', 'GWAS', 'Lung cancer', '18385676'),
(387, 'CRP', 'rs2808630', 'GWAS', 'Lung cancer', '18385676'),
(388, 'IL1RAP', 'rs7626795', 'GWAS', 'Lung cancer', '18385676'),
(389, 'PSMA4', 'rs8034191', 'GWAS', 'Lung cancer', '18385676'),
(390, 'CHRNA3', 'rs8034191', 'GWAS', 'Lung cancer', '18385738'),
(391, 'CHRNA5', 'rs8034191', 'GWAS', 'Lung cancer', '18385738'),
(392, 'CHRNB4', 'rs8034191', 'GWAS', 'Lung cancer', '18385738'),
(393, 'PSMA4', 'rs8034191', 'GWAS', 'Lung cancer', '18385738'),
(394, 'CHRNA3', 'rs8034191', 'GWAS', 'Lung cancer', '18780872'),
(395, 'CHRNA5', 'rs8034191', 'GWAS', 'Lung cancer', '18780872'),
(396, 'CHRNB4', 'rs8034191', 'GWAS', 'Lung cancer', '18780872'),
(397, 'PSMA4', 'rs8034191', 'GWAS', 'Lung cancer', '18780872'),
(398, 'BAT3', 'rs3117582', 'GWAS', 'Lung cancer', '18978787'),
(399, 'CHRNA3', 'rs8042374', 'GWAS', 'Lung cancer', '18978787'),
(400, 'CLPTM1L', 'rs401681', 'GWAS', 'Lung cancer', '18978787'),
(401, 'CHRNA3', 'rs1051730', 'GWAS', 'Lung cancer', '18978790'),
(402, 'CLPTM1L', 'rs402710', 'GWAS', 'Lung cancer', '18978790'),
(403, 'TERT', 'rs402710', 'GWAS', 'Lung cancer', '18978790'),
(404, 'ACTA2', 'rs1926203', 'GWAS', 'Lung cancer', '19654303'),
(405, 'BAT3', 'rs3117582', 'GWAS', 'Lung cancer', '19654303'),
(406, 'CHRNA3', 'rs8034191', 'GWAS', 'Lung cancer', '19654303'),
(407, 'CLPTM1L', 'rs4975616', 'GWAS', 'Lung cancer', '19654303'),
(408, 'GKN2', 'rs4254535', 'GWAS', 'Lung cancer', '19654303'),
(409, 'RBMS3', 'rs1530057', 'GWAS', 'Lung cancer', '19654303'),
(410, 'TERT', 'rs4975616', 'GWAS', 'Lung cancer', '19654303'),
(411, 'TGM5', 'rs748404', 'GWAS', 'Lung cancer', '19654303'),
(412, 'GPC5', 'rs2352028', 'GWAS', 'Lung cancer', '20304703'),
(413, 'MIPEP', 'rs753955', 'GWAS', 'Lung cancer', '21725308'),
(414, 'MTMR3', 'rs36600', 'GWAS', 'Lung cancer', '21725308'),
(415, 'TERT', 'rs2736100', 'GWAS', 'Lung cancer', '21725308'),
(416, 'TNFRSF19', 'rs753955', 'GWAS', 'Lung cancer', '21725308'),
(417, 'TP63', 'rs4488809', 'GWAS', 'Lung cancer', '21725308'),
(418, 'PIGU', 'rs910873', 'GWAS', 'Melanoma', '18488026'),
(419, 'CDK10', 'rs258322', 'GWAS', 'Melanoma', '19578364'),
(420, 'CDKN2A', 'rs7023329', 'GWAS', 'Melanoma', '19578364'),
(421, 'MC1R', 'rs4785763', 'GWAS', 'Melanoma', '19578364'),
(422, 'MC1R', 'rs258322', 'GWAS', 'Melanoma', '19578364'),
(423, 'MTAP', 'rs7023329', 'GWAS', 'Melanoma', '19578364'),
(424, 'PLA2G6', 'rs2284063', 'GWAS', 'Melanoma', '19578364'),
(425, 'TYR', 'rs1393350', 'GWAS', 'Melanoma', '19578364'),
(426, 'ARNT', 'rs7412746', 'GWAS', 'Melanoma', '21983785'),
(427, 'CTSK', 'rs7412746', 'GWAS', 'Melanoma', '21983785'),
(428, 'LASS2', 'rs7412746', 'GWAS', 'Melanoma', '21983785'),
(429, 'MCL1', 'rs7412746', 'GWAS', 'Melanoma', '21983785'),
(430, 'PARP1', 'rs3219090', 'GWAS', 'Melanoma', '21983785'),
(431, 'SETDB1', 'rs7412746', 'GWAS', 'Melanoma', '21983785'),
(432, 'ATM', 'rs1801516', 'GWAS', 'Melanoma', '21983787'),
(433, 'CASP8', 'rs13016963', 'GWAS', 'Melanoma', '21983787'),
(434, 'CDK10', 'rs258322', 'GWAS', 'Melanoma', '21983787'),
(435, 'CDKN2A', 'rs7023329', 'GWAS', 'Melanoma', '21983787'),
(436, 'CLPTM1L', 'rs401681', 'GWAS', 'Melanoma', '21983787'),
(437, 'MC1R', 'rs258322', 'GWAS', 'Melanoma', '21983787'),
(438, 'MTAP', 'rs7023329', 'GWAS', 'Melanoma', '21983787'),
(439, 'MX2', 'rs45430', 'GWAS', 'Melanoma', '21983787'),
(440, 'PLA2G6', 'rs6001027', 'GWAS', 'Melanoma', '21983787'),
(441, 'SGK1', 'rs228437', 'GWAS', 'Melanoma', '21983787'),
(442, 'SLC45A2', 'rs35390', 'GWAS', 'Melanoma', '21983787'),
(443, 'TERT', 'rs401681', 'GWAS', 'Melanoma', '21983787'),
(444, 'TYR', 'rs1393350', 'GWAS', 'Melanoma', '21983787'),
(445, 'JAK2', 'rs10974944', 'GWAS', 'Myeloproliferative neoplasms', '19287384'),
(446, 'ITGA9', 'rs189897', 'GWAS', 'Nasopharyngeal carcinoma', '19478819'),
(447, 'GABBR1', 'rs29232', 'GWAS', 'Nasopharyngeal carcinoma', '19664746'),
(448, 'HLA-A', 'rs2517713', 'GWAS', 'Nasopharyngeal carcinoma', '19664746'),
(449, 'HLA-F', 'rs3129055', 'GWAS', 'Nasopharyngeal carcinoma', '19664746'),
(450, 'MOG', 'rs29232', 'GWAS', 'Nasopharyngeal carcinoma', '19664746'),
(451, 'ZFP57', 'rs3129055', 'GWAS', 'Nasopharyngeal carcinoma', '19664746'),
(452, 'CDKN2B', 'rs1412829', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(453, 'HLA-A', 'rs2860580', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(454, 'HLA-B', 'rs2894207', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(455, 'HLA-C', 'rs2894207', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(456, 'HLA-DQA1', 'rs28421666', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(457, 'HLA-DRB1', 'rs28421666', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(458, 'MECOM', 'rs6774494', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(459, 'SACS', 'rs1572072', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(460, 'TNFRSF19', 'rs9510787', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(461, 'TNFRSF19', 'rs1572072', 'GWAS', 'Nasopharyngeal carcinoma', '20512145'),
(462, 'ABCA12', 'rs10498025', 'GWAS', 'Neuroblastoma', 'NA'),
(463, 'ABCA12', 'rs10498026', 'GWAS', 'Neuroblastoma', 'NA'),
(464, 'ABCA12', 'rs11677798', 'GWAS', 'Neuroblastoma', 'NA'),
(465, 'ABCA12', 'rs1952224', 'GWAS', 'Neuroblastoma', 'NA'),
(466, 'ABCA12', 'rs2592232', 'GWAS', 'Neuroblastoma', 'NA'),
(467, 'ABCA12', 'rs3795857', 'GWAS', 'Neuroblastoma', 'NA'),
(468, 'ACTBL2', 'rs1454909', 'GWAS', 'Neuroblastoma', 'NA'),
(469, 'ADAMTS16', 'rs13359418', 'GWAS', 'Neuroblastoma', 'NA'),
(470, 'ADAMTS16', 'rs16872251', 'GWAS', 'Neuroblastoma', 'NA'),
(471, 'ANO5', 'rs12295951', 'GWAS', 'Neuroblastoma', 'NA'),
(472, 'AQP4', 'rs8083994', 'GWAS', 'Neuroblastoma', 'NA'),
(473, 'AQP4', 'rs9653034', 'GWAS', 'Neuroblastoma', 'NA'),
(474, 'ARHGAP26', 'rs245852', 'GWAS', 'Neuroblastoma', 'NA'),
(475, 'ATF6', 'rs12745240', 'GWAS', 'Neuroblastoma', 'NA'),
(476, 'ATF6', 'rs4657121', 'GWAS', 'Neuroblastoma', 'NA'),
(477, 'ATP10B', 'rs12514981', 'GWAS', 'Neuroblastoma', 'NA'),
(478, 'BAI3', 'rs2094596', 'GWAS', 'Neuroblastoma', 'NA'),
(479, 'BARD1', 'rs10932572', 'GWAS', 'Neuroblastoma', 'NA'),
(480, 'BARD1', 'rs1374230', 'GWAS', 'Neuroblastoma', 'NA'),
(481, 'BARD1', 'rs16852600', 'GWAS', 'Neuroblastoma', 'NA'),
(482, 'BARD1', 'rs17487792', 'GWAS', 'Neuroblastoma', 'NA'),
(483, 'BARD1', 'rs2053710', 'GWAS', 'Neuroblastoma', 'NA'),
(484, 'BARD1', 'rs2121283', 'GWAS', 'Neuroblastoma', 'NA'),
(485, 'BARD1', 'rs6712055', 'GWAS', 'Neuroblastoma', 'NA'),
(486, 'BARD1', 'rs6715570', 'GWAS', 'Neuroblastoma', 'NA'),
(487, 'BARD1', 'rs6744811', 'GWAS', 'Neuroblastoma', 'NA'),
(488, 'BARD1', 'rs7557557', 'GWAS', 'Neuroblastoma', 'NA'),
(489, 'BARD1', 'rs7584646', 'GWAS', 'Neuroblastoma', 'NA'),
(490, 'BARD1', 'rs7587476', 'GWAS', 'Neuroblastoma', 'NA'),
(491, 'BARD1', 'rs895459', 'GWAS', 'Neuroblastoma', 'NA'),
(492, 'BMP2', 'rs2209761', 'GWAS', 'Neuroblastoma', 'NA'),
(493, 'BMP2', 'rs6038449', 'GWAS', 'Neuroblastoma', 'NA'),
(494, 'BMS1', 'rs2256432', 'GWAS', 'Neuroblastoma', 'NA'),
(495, 'C14orf4', 'rs17105232', 'GWAS', 'Neuroblastoma', 'NA'),
(496, 'CALCOCO2', 'rs563916', 'GWAS', 'Neuroblastoma', 'NA'),
(497, 'CBLN4', 'rs6014573', 'GWAS', 'Neuroblastoma', 'NA'),
(498, 'CBLN4', 'rs6024619', 'GWAS', 'Neuroblastoma', 'NA'),
(499, 'CBLN4', 'rs6069551', 'GWAS', 'Neuroblastoma', 'NA'),
(500, 'CHAF1B', 'rs218626', 'GWAS', 'Neuroblastoma', 'NA'),
(501, 'CHRNA7', 'rs4779984', 'GWAS', 'Neuroblastoma', 'NA'),
(502, 'CNTN6', 'rs11131168', 'GWAS', 'Neuroblastoma', 'NA'),
(503, 'CNTN6', 'rs11714239', 'GWAS', 'Neuroblastoma', 'NA'),
(504, 'CNTN6', 'rs17047538', 'GWAS', 'Neuroblastoma', 'NA'),
(505, 'COBL', 'rs17578222', 'GWAS', 'Neuroblastoma', 'NA'),
(506, 'CPZ', 'rs4696715', 'GWAS', 'Neuroblastoma', 'NA'),
(507, 'CYTL1', 'rs4234840', 'GWAS', 'Neuroblastoma', 'NA'),
(508, 'CYTL1', 'rs4566595', 'GWAS', 'Neuroblastoma', 'NA'),
(509, 'CYTL1', 'rs4689963', 'GWAS', 'Neuroblastoma', 'NA'),
(510, 'CYTL1', 'rs6446700', 'GWAS', 'Neuroblastoma', 'NA'),
(511, 'DDAH1', 'rs1523993', 'GWAS', 'Neuroblastoma', 'NA'),
(512, 'DGKI', 'rs2059320', 'GWAS', 'Neuroblastoma', 'NA'),
(513, 'DLGAP1', 'rs3915772', 'GWAS', 'Neuroblastoma', 'NA'),
(514, 'DRD1', 'rs5326', 'GWAS', 'Neuroblastoma', 'NA'),
(515, 'DUSP12', 'rs1027702', 'GWAS', 'Neuroblastoma', 'NA'),
(516, 'DUSP12', 'rs1063178', 'GWAS', 'Neuroblastoma', 'NA'),
(517, 'DUSP12', 'rs12745240', 'GWAS', 'Neuroblastoma', 'NA'),
(518, 'DUSP12', 'rs3820449', 'GWAS', 'Neuroblastoma', 'NA'),
(519, 'DYRK2', 'rs7980416', 'GWAS', 'Neuroblastoma', 'NA'),
(520, 'EGLN3', 'rs1680730', 'GWAS', 'Neuroblastoma', 'NA'),
(521, 'EMP2', 'rs4780959', 'GWAS', 'Neuroblastoma', 'NA'),
(522, 'ERBB4', 'rs16849204', 'GWAS', 'Neuroblastoma', 'NA'),
(523, 'ERICH1', 'rs1703940', 'GWAS', 'Neuroblastoma', 'NA'),
(524, 'EXT1', 'rs11562721', 'GWAS', 'Neuroblastoma', 'NA'),
(525, 'EYA4', 'rs4487594', 'GWAS', 'Neuroblastoma', 'NA'),
(526, 'FBXO33', 'rs2415603', 'GWAS', 'Neuroblastoma', 'NA'),
(527, 'FCRLA', 'rs1538972', 'GWAS', 'Neuroblastoma', 'NA'),
(528, 'FCRLB', 'rs1027702', 'GWAS', 'Neuroblastoma', 'NA'),
(529, 'FLRT2', 'rs2401711', 'GWAS', 'Neuroblastoma', 'NA'),
(530, 'FLRT2', 'rs7152233', 'GWAS', 'Neuroblastoma', 'NA'),
(531, 'FMN1', 'rs6495001', 'GWAS', 'Neuroblastoma', 'NA'),
(532, 'GALC', 'rs2401711', 'GWAS', 'Neuroblastoma', 'NA'),
(533, 'GALC', 'rs7152233', 'GWAS', 'Neuroblastoma', 'NA'),
(534, 'GBE1', 'rs2340388', 'GWAS', 'Neuroblastoma', 'NA'),
(535, 'GBE1', 'rs7641536', 'GWAS', 'Neuroblastoma', 'NA'),
(536, 'GBE1', 'rs949455', 'GWAS', 'Neuroblastoma', 'NA'),
(537, 'GLCCI1', 'rs9648623', 'GWAS', 'Neuroblastoma', 'NA'),
(538, 'GPRC5A', 'rs1056927', 'GWAS', 'Neuroblastoma', 'NA'),
(539, 'GRK5', 'rs10886492', 'GWAS', 'Neuroblastoma', 'NA'),
(540, 'GRK5', 'rs2991769', 'GWAS', 'Neuroblastoma', 'NA'),
(541, 'GRK5', 'rs2991770', 'GWAS', 'Neuroblastoma', 'NA'),
(542, 'HACE1', 'rs4336470', 'GWAS', 'Neuroblastoma', 'NA'),
(543, 'HECW2', 'rs13001220', 'GWAS', 'Neuroblastoma', 'NA'),
(544, 'HECW2', 'rs4850679', 'GWAS', 'Neuroblastoma', 'NA'),
(545, 'HSD17B12', 'rs11037575', 'GWAS', 'Neuroblastoma', 'NA'),
(546, 'HSD17B12', 'rs4620711', 'GWAS', 'Neuroblastoma', 'NA'),
(547, 'HSD17B12', 'rs4755731', 'GWAS', 'Neuroblastoma', 'NA'),
(548, 'HSPA13', 'rs2178907', 'GWAS', 'Neuroblastoma', 'NA'),
(549, 'HSPA13', 'rs2822612', 'GWAS', 'Neuroblastoma', 'NA'),
(550, 'IKZF1', 'rs10248903', 'GWAS', 'Neuroblastoma', 'NA'),
(551, 'IKZF2', 'rs16849204', 'GWAS', 'Neuroblastoma', 'NA'),
(552, 'IL31RA', 'rs162096', 'GWAS', 'Neuroblastoma', 'NA'),
(553, 'IRX5', 'rs17210989', 'GWAS', 'Neuroblastoma', 'NA'),
(554, 'IRX6', 'rs17210989', 'GWAS', 'Neuroblastoma', 'NA'),
(555, 'JARID2', 'rs16876210', 'GWAS', 'Neuroblastoma', 'NA'),
(556, 'JARID2', 'rs7765425', 'GWAS', 'Neuroblastoma', 'NA'),
(557, 'JPH2', 'rs6073330', 'GWAS', 'Neuroblastoma', 'NA'),
(558, 'KCNK10', 'rs12434331', 'GWAS', 'Neuroblastoma', 'NA'),
(559, 'KCTD10', 'rs2058804', 'GWAS', 'Neuroblastoma', 'NA'),
(560, 'KIAA2013', 'rs6682554', 'GWAS', 'Neuroblastoma', 'NA'),
(561, 'KIRREL', 'rs1925035', 'GWAS', 'Neuroblastoma', 'NA'),
(562, 'KRAS', 'rs10505975', 'GWAS', 'Neuroblastoma', 'NA'),
(563, 'LIN28B', 'rs17065417', 'GWAS', 'Neuroblastoma', 'NA'),
(564, 'LMBRD1', 'rs2094596', 'GWAS', 'Neuroblastoma', 'NA'),
(565, 'LMO1', 'rs10840002', 'GWAS', 'Neuroblastoma', 'NA'),
(566, 'LMO1', 'rs204938', 'GWAS', 'Neuroblastoma', 'NA'),
(567, 'LMO1', 'rs4758051', 'GWAS', 'Neuroblastoma', 'NA'),
(568, 'LNX2', 'rs1218885', 'GWAS', 'Neuroblastoma', 'NA'),
(569, 'LNX2', 'rs1218897', 'GWAS', 'Neuroblastoma', 'NA'),
(570, 'LRFN5', 'rs2415603', 'GWAS', 'Neuroblastoma', 'NA'),
(571, 'LRP1B', 'rs13420111', 'GWAS', 'Neuroblastoma', 'NA'),
(572, 'LRP1B', 'rs13432282', 'GWAS', 'Neuroblastoma', 'NA'),
(573, 'LRP1B', 'rs6735489', 'GWAS', 'Neuroblastoma', 'NA'),
(574, 'LRP1B', 'rs9287300', 'GWAS', 'Neuroblastoma', 'NA'),
(575, 'LRRC69', 'rs4609161', 'GWAS', 'Neuroblastoma', 'NA'),
(576, 'MAMDC2', 'rs10511979', 'GWAS', 'Neuroblastoma', 'NA'),
(577, 'MAMDC2', 'rs867595', 'GWAS', 'Neuroblastoma', 'NA'),
(578, 'MAP2K4', 'rs8068445', 'GWAS', 'Neuroblastoma', 'NA'),
(579, 'MED13L', 'rs11611238', 'GWAS', 'Neuroblastoma', 'NA'),
(580, 'MLF1', 'rs1656377', 'GWAS', 'Neuroblastoma', 'NA'),
(581, 'MLF1', 'rs1714524', 'GWAS', 'Neuroblastoma', 'NA'),
(582, 'MMAB', 'rs3759387', 'GWAS', 'Neuroblastoma', 'NA'),
(583, 'MMAB', 'rs7486178', 'GWAS', 'Neuroblastoma', 'NA'),
(584, 'MN1', 'rs5752592', 'GWAS', 'Neuroblastoma', 'NA'),
(585, 'MORC3', 'rs218626', 'GWAS', 'Neuroblastoma', 'NA'),
(586, 'MORC3', 'rs2835340', 'GWAS', 'Neuroblastoma', 'NA'),
(587, 'MSR1', 'rs8181023', 'GWAS', 'Neuroblastoma', 'NA'),
(588, 'MSRA', 'rs6992153', 'GWAS', 'Neuroblastoma', 'NA'),
(589, 'MSX1', 'rs6817411', 'GWAS', 'Neuroblastoma', 'NA'),
(590, 'MTIF3', 'rs1218885', 'GWAS', 'Neuroblastoma', 'NA'),
(591, 'MTIF3', 'rs1218897', 'GWAS', 'Neuroblastoma', 'NA'),
(592, 'MTMR6', 'rs4769414', 'GWAS', 'Neuroblastoma', 'NA'),
(593, 'MVK', 'rs3759387', 'GWAS', 'Neuroblastoma', 'NA'),
(594, 'MYOCD', 'rs8068445', 'GWAS', 'Neuroblastoma', 'NA'),
(595, 'NELL1', 'rs12295951', 'GWAS', 'Neuroblastoma', 'NA'),
(596, 'NKAIN3', 'rs1455576', 'GWAS', 'Neuroblastoma', 'NA'),
(597, 'NKAIN3', 'rs4134468', 'GWAS', 'Neuroblastoma', 'NA'),
(598, 'NR5A2', 'rs3828112', 'GWAS', 'Neuroblastoma', 'NA'),
(599, 'NRSN1', 'rs12210008', 'GWAS', 'Neuroblastoma', 'NA'),
(600, 'NXPH1', 'rs1013812', 'GWAS', 'Neuroblastoma', 'NA'),
(601, 'OVOL1', 'rs7114014', 'GWAS', 'Neuroblastoma', 'NA'),
(602, 'P4HA2', 'rs4594848', 'GWAS', 'Neuroblastoma', 'NA'),
(603, 'PCDH18', 'rs1519337', 'GWAS', 'Neuroblastoma', 'NA'),
(604, 'PDLIM4', 'rs4594848', 'GWAS', 'Neuroblastoma', 'NA'),
(605, 'PDS5B', 'rs4942925', 'GWAS', 'Neuroblastoma', 'NA'),
(606, 'PEX14', 'rs10864463', 'GWAS', 'Neuroblastoma', 'NA'),
(607, 'PEX14', 'rs2480775', 'GWAS', 'Neuroblastoma', 'NA'),
(608, 'PEX2', 'rs10091852', 'GWAS', 'Neuroblastoma', 'NA'),
(609, 'PKIA', 'rs10091852', 'GWAS', 'Neuroblastoma', 'NA'),
(610, 'PLK2', 'rs1454909', 'GWAS', 'Neuroblastoma', 'NA'),
(611, 'PLSCR3', 'rs4613118', 'GWAS', 'Neuroblastoma', 'NA'),
(612, 'PLXNA2', 'rs12145940', 'GWAS', 'Neuroblastoma', 'NA'),
(613, 'POM121L12', 'rs17578222', 'GWAS', 'Neuroblastoma', 'NA'),
(614, 'PTTG1', 'rs12514981', 'GWAS', 'Neuroblastoma', 'NA'),
(615, 'RET', 'rs2256432', 'GWAS', 'Neuroblastoma', 'NA'),
(616, 'RGS10', 'rs10886492', 'GWAS', 'Neuroblastoma', 'NA'),
(617, 'RGS10', 'rs2991769', 'GWAS', 'Neuroblastoma', 'NA'),
(618, 'RGS10', 'rs2991770', 'GWAS', 'Neuroblastoma', 'NA'),
(619, 'RIC3', 'rs10840002', 'GWAS', 'Neuroblastoma', 'NA'),
(620, 'RIC3', 'rs4758051', 'GWAS', 'Neuroblastoma', 'NA'),
(621, 'RNF216', 'rs2017620', 'GWAS', 'Neuroblastoma', 'NA'),
(622, 'RPRD2', 'rs12029359', 'GWAS', 'Neuroblastoma', 'NA'),
(623, 'RSRC1', 'rs10936131', 'GWAS', 'Neuroblastoma', 'NA'),
(624, 'RSRC1', 'rs10936142', 'GWAS', 'Neuroblastoma', 'NA'),
(625, 'RSRC1', 'rs11716327', 'GWAS', 'Neuroblastoma', 'NA'),
(626, 'RSRC1', 'rs1193510', 'GWAS', 'Neuroblastoma', 'NA'),
(627, 'RSRC1', 'rs1714518', 'GWAS', 'Neuroblastoma', 'NA'),
(628, 'RSRC1', 'rs2885663', 'GWAS', 'Neuroblastoma', 'NA'),
(629, 'RSRC1', 'rs6441188', 'GWAS', 'Neuroblastoma', 'NA'),
(630, 'RSRC1', 'rs6441201', 'GWAS', 'Neuroblastoma', 'NA'),
(631, 'RSRC1', 'rs6778370', 'GWAS', 'Neuroblastoma', 'NA'),
(632, 'RSRC1', 'rs7624303', 'GWAS', 'Neuroblastoma', 'NA'),
(633, 'RSRC1', 'rs7632059', 'GWAS', 'Neuroblastoma', 'NA'),
(634, 'RSRC1', 'rs7639867', 'GWAS', 'Neuroblastoma', 'NA'),
(635, 'RSRC1', 'rs939114', 'GWAS', 'Neuroblastoma', 'NA'),
(636, 'RSRC1', 'rs9827781', 'GWAS', 'Neuroblastoma', 'NA'),
(637, 'RSRC1', 'rs9857883', 'GWAS', 'Neuroblastoma', 'NA'),
(638, 'RYR3', 'rs6495001', 'GWAS', 'Neuroblastoma', 'NA'),
(639, 'SDK1', 'rs882362', 'GWAS', 'Neuroblastoma', 'NA'),
(640, 'SFTA3', 'rs4902467', 'GWAS', 'Neuroblastoma', 'NA'),
(641, 'SKIV2L', 'rs454212', 'GWAS', 'Neuroblastoma', 'NA'),
(642, 'SLC22A18AS', 'rs10832869', 'GWAS', 'Neuroblastoma', 'NA'),
(643, 'SLC22A4', 'rs11950562', 'GWAS', 'Neuroblastoma', 'NA'),
(644, 'SLC38A9', 'rs2897834', 'GWAS', 'Neuroblastoma', 'NA'),
(645, 'SLC39A10', 'rs4505549', 'GWAS', 'Neuroblastoma', 'NA'),
(646, 'SLC39A10', 'rs6714748', 'GWAS', 'Neuroblastoma', 'NA'),
(647, 'SLC7A11', 'rs1519337', 'GWAS', 'Neuroblastoma', 'NA'),
(648, 'SNF8', 'rs12941604', 'GWAS', 'Neuroblastoma', 'NA'),
(649, 'SNX32', 'rs7114014', 'GWAS', 'Neuroblastoma', 'NA'),
(650, 'SOX17', 'rs10089685', 'GWAS', 'Neuroblastoma', 'NA'),
(651, 'ST6GALNAC5', 'rs664576', 'GWAS', 'Neuroblastoma', 'NA'),
(652, 'STIM2', 'rs11727649', 'GWAS', 'Neuroblastoma', 'NA'),
(653, 'STIM2', 'rs12505133', 'GWAS', 'Neuroblastoma', 'NA'),
(654, 'STK17B', 'rs13001220', 'GWAS', 'Neuroblastoma', 'NA'),
(655, 'STK17B', 'rs4850679', 'GWAS', 'Neuroblastoma', 'NA'),
(656, 'STK4', 'rs17322289', 'GWAS', 'Neuroblastoma', 'NA'),
(657, 'TEKT5', 'rs4780959', 'GWAS', 'Neuroblastoma', 'NA'),
(658, 'TIAM1', 'rs2268225', 'GWAS', 'Neuroblastoma', 'NA'),
(659, 'TOX', 'rs1463142', 'GWAS', 'Neuroblastoma', 'NA'),
(660, 'TOX2', 'rs6073330', 'GWAS', 'Neuroblastoma', 'NA'),
(661, 'TTC17', 'rs4755731', 'GWAS', 'Neuroblastoma', 'NA'),
(662, 'TTLL6', 'rs8073596', 'GWAS', 'Neuroblastoma', 'NA'),
(663, 'UBE3B', 'rs7298565', 'GWAS', 'Neuroblastoma', 'NA'),
(664, 'UBE3B', 'rs7486178', 'GWAS', 'Neuroblastoma', 'NA'),
(665, 'UGT1A10', 'rs1604144', 'GWAS', 'Neuroblastoma', 'NA'),
(666, 'UGT1A6', 'rs1604144', 'GWAS', 'Neuroblastoma', 'NA'),
(667, 'UGT1A7', 'rs1604144', 'GWAS', 'Neuroblastoma', 'NA'),
(668, 'UGT1A8', 'rs1604144', 'GWAS', 'Neuroblastoma', 'NA'),
(669, 'UGT1A9', 'rs1604144', 'GWAS', 'Neuroblastoma', 'NA'),
(670, 'XPO4', 'rs4770073', 'GWAS', 'Neuroblastoma', 'NA'),
(671, 'ADAMTS1', 'rs2830495', 'GWAS', 'Neuroblastoma', '18463370'),
(672, 'AIP', 'rs4084113', 'GWAS', 'Neuroblastoma', '18463370'),
(673, 'ANK2', 'rs4834308', 'GWAS', 'Neuroblastoma', '18463370'),
(674, 'AXIN2', 'rs757558', 'GWAS', 'Neuroblastoma', '18463370'),
(675, 'AXIN2', 'rs8068707', 'GWAS', 'Neuroblastoma', '18463370'),
(676, 'C1orf94', 'rs2994598', 'GWAS', 'Neuroblastoma', '18463370'),
(677, 'CABP2', 'rs4930431', 'GWAS', 'Neuroblastoma', '18463370'),
(678, 'CABP4', 'rs11601325', 'GWAS', 'Neuroblastoma', '18463370'),
(679, 'CHRNA7', 'rs1001555', 'GWAS', 'Neuroblastoma', '18463370'),
(680, 'CNTN6', 'rs17047538', 'GWAS', 'Neuroblastoma', '18463370'),
(681, 'CXCR4', 'rs1123848', 'GWAS', 'Neuroblastoma', '18463370'),
(682, 'CXCR4', 'rs2011946', 'GWAS', 'Neuroblastoma', '18463370'),
(683, 'CXCR4', 'rs309137', 'GWAS', 'Neuroblastoma', '18463370'),
(684, 'CXCR4', 'rs4954564', 'GWAS', 'Neuroblastoma', '18463370'),
(685, 'CXCR4', 'rs6430612', 'GWAS', 'Neuroblastoma', '18463370'),
(686, 'CXCR4', 'rs749873', 'GWAS', 'Neuroblastoma', '18463370'),
(687, 'CXCR4', 'rs932206', 'GWAS', 'Neuroblastoma', '18463370'),
(688, 'CYYR1', 'rs2830495', 'GWAS', 'Neuroblastoma', '18463370'),
(689, 'DARS', 'rs2011946', 'GWAS', 'Neuroblastoma', '18463370'),
(690, 'DARS', 'rs309137', 'GWAS', 'Neuroblastoma', '18463370'),
(691, 'DARS', 'rs309160', 'GWAS', 'Neuroblastoma', '18463370'),
(692, 'DARS', 'rs749873', 'GWAS', 'Neuroblastoma', '18463370'),
(693, 'DARS', 'rs932206', 'GWAS', 'Neuroblastoma', '18463370'),
(694, 'EHBP1', 'rs2710638', 'GWAS', 'Neuroblastoma', '18463370'),
(695, 'EPHA3', 'rs1915304', 'GWAS', 'Neuroblastoma', '18463370'),
(696, 'EPHA3', 'rs6774870', 'GWAS', 'Neuroblastoma', '18463370'),
(697, 'EPHA3', 'rs6782527', 'GWAS', 'Neuroblastoma', '18463370'),
(698, 'EPHA3', 'rs907548', 'GWAS', 'Neuroblastoma', '18463370'),
(699, 'EPHA3', 'rs9832305', 'GWAS', 'Neuroblastoma', '18463370'),
(700, 'EYA4', 'rs4487594', 'GWAS', 'Neuroblastoma', '18463370'),
(701, 'FAM114A1', 'rs13150445', 'GWAS', 'Neuroblastoma', '18463370'),
(702, 'FAM78B', 'rs10753713', 'GWAS', 'Neuroblastoma', '18463370'),
(703, 'FAM83B', 'rs6911198', 'GWAS', 'Neuroblastoma', '18463370'),
(704, 'FOXF2', 'rs2745636', 'GWAS', 'Neuroblastoma', '18463370'),
(705, 'FZD1', 'rs2974129', 'GWAS', 'Neuroblastoma', '18463370'),
(706, 'GBE1', 'rs2340388', 'GWAS', 'Neuroblastoma', '18463370'),
(707, 'GPRC5A', 'rs704225', 'GWAS', 'Neuroblastoma', '18463370'),
(708, 'GRB2', 'rs16967789', 'GWAS', 'Neuroblastoma', '18463370'),
(709, 'GRB2', 'rs9892996', 'GWAS', 'Neuroblastoma', '18463370'),
(710, 'GRK5', 'rs2991769', 'GWAS', 'Neuroblastoma', '18463370'),
(711, 'GRK5', 'rs2991770', 'GWAS', 'Neuroblastoma', '18463370'),
(712, 'GSTP1', 'rs4930431', 'GWAS', 'Neuroblastoma', '18463370'),
(713, 'HKDC1', 'rs2279927', 'GWAS', 'Neuroblastoma', '18463370'),
(714, 'HSD17B12', 'rs11037575', 'GWAS', 'Neuroblastoma', '18463370'),
(715, 'HSD17B12', 'rs4755731', 'GWAS', 'Neuroblastoma', '18463370'),
(716, 'HUNK', 'rs1892577', 'GWAS', 'Neuroblastoma', '18463370'),
(717, 'IL15', 'rs4267812', 'GWAS', 'Neuroblastoma', '18463370'),
(718, 'IL6', 'rs10229203', 'GWAS', 'Neuroblastoma', '18463370'),
(719, 'IL6', 'rs1989838', 'GWAS', 'Neuroblastoma', '18463370'),
(720, 'LCT', 'rs2164210', 'GWAS', 'Neuroblastoma', '18463370'),
(721, 'LRRTM4', 'rs17012789', 'GWAS', 'Neuroblastoma', '18463370'),
(722, 'LRRTM4', 'rs1921246', 'GWAS', 'Neuroblastoma', '18463370'),
(723, 'MAFB', 'rs2224536', 'GWAS', 'Neuroblastoma', '18463370'),
(724, 'MED12L', 'rs7637803', 'GWAS', 'Neuroblastoma', '18463370'),
(725, 'MICB', 'rs12660382', 'GWAS', 'Neuroblastoma', '18463370'),
(726, 'MICB', 'rs3134899', 'GWAS', 'Neuroblastoma', '18463370'),
(727, 'MN1', 'rs5752592', 'GWAS', 'Neuroblastoma', '18463370'),
(728, 'NDST3', 'rs1489550', 'GWAS', 'Neuroblastoma', '18463370'),
(729, 'NDST3', 'rs17862054', 'GWAS', 'Neuroblastoma', '18463370'),
(730, 'NFKBIZ', 'rs17842780', 'GWAS', 'Neuroblastoma', '18463370'),
(731, 'NUP153', 'rs6929659', 'GWAS', 'Neuroblastoma', '18463370'),
(732, 'NUP153', 'rs9350051', 'GWAS', 'Neuroblastoma', '18463370'),
(733, 'NXPH2', 'rs11681160', 'GWAS', 'Neuroblastoma', '18463370'),
(734, 'P2RY2', 'rs1783596', 'GWAS', 'Neuroblastoma', '18463370'),
(735, 'PPP2R5A', 'rs351408', 'GWAS', 'Neuroblastoma', '18463370'),
(736, 'PRDM5', 'rs343166', 'GWAS', 'Neuroblastoma', '18463370'),
(737, 'PTPN3', 'rs4978813', 'GWAS', 'Neuroblastoma', '18463370'),
(738, 'PTPRM', 'rs12455846', 'GWAS', 'Neuroblastoma', '18463370'),
(739, 'PTPRM', 'rs16951664', 'GWAS', 'Neuroblastoma', '18463370'),
(740, 'R3HDM1', 'rs313519', 'GWAS', 'Neuroblastoma', '18463370'),
(741, 'R3HDM1', 'rs313528', 'GWAS', 'Neuroblastoma', '18463370'),
(742, 'RALYL', 'rs1427065', 'GWAS', 'Neuroblastoma', '18463370'),
(743, 'RALYL', 'rs731956', 'GWAS', 'Neuroblastoma', '18463370'),
(744, 'RALYL', 'rs7837606', 'GWAS', 'Neuroblastoma', '18463370'),
(745, 'RAPGEF5', 'rs4719687', 'GWAS', 'Neuroblastoma', '18463370'),
(746, 'RGS10', 'rs2991769', 'GWAS', 'Neuroblastoma', '18463370'),
(747, 'RGS10', 'rs2991770', 'GWAS', 'Neuroblastoma', '18463370'),
(748, 'RWDD3', 'rs1858111', 'GWAS', 'Neuroblastoma', '18463370'),
(749, 'RXRA', 'rs11185668', 'GWAS', 'Neuroblastoma', '18463370'),
(750, 'SGCG', 'rs3794370', 'GWAS', 'Neuroblastoma', '18463370'),
(751, 'SLC24A3', 'rs1012646', 'GWAS', 'Neuroblastoma', '18463370'),
(752, 'SLC24A3', 'rs16980240', 'GWAS', 'Neuroblastoma', '18463370'),
(753, 'SLC24A3', 'rs3790171', 'GWAS', 'Neuroblastoma', '18463370'),
(754, 'SLC24A3', 'rs7272481', 'GWAS', 'Neuroblastoma', '18463370'),
(755, 'SLC25A19', 'rs9892996', 'GWAS', 'Neuroblastoma', '18463370'),
(756, 'SLC8A1', 'rs977867', 'GWAS', 'Neuroblastoma', '18463370'),
(757, 'SNTG2', 'rs4971342', 'GWAS', 'Neuroblastoma', '18463370'),
(758, 'TBX5', 'rs1946295', 'GWAS', 'Neuroblastoma', '18463370'),
(759, 'TCF12', 'rs2733332', 'GWAS', 'Neuroblastoma', '18463370'),
(760, 'TGFBR2', 'rs1117751', 'GWAS', 'Neuroblastoma', '18463370'),
(761, 'TTC17', 'rs4755731', 'GWAS', 'Neuroblastoma', '18463370'),
(762, 'ZNF184', 'rs10456051', 'GWAS', 'Neuroblastoma', '18463370'),
(763, 'ZNF184', 'rs12189640', 'GWAS', 'Neuroblastoma', '18463370'),
(764, 'ZNF330', 'rs4267812', 'GWAS', 'Neuroblastoma', '18463370'),
(765, 'ZPLD1', 'rs17842780', 'GWAS', 'Neuroblastoma', '18463370'),
(766, 'ZRANB3', 'rs1561277', 'GWAS', 'Neuroblastoma', '18463370'),
(767, 'BARD1', 'rs3768716', 'GWAS', 'Neuroblastoma', '21124317'),
(768, 'LMO1', 'rs110419', 'GWAS', 'Neuroblastoma', '21124317'),
(769, 'BARD1', 'rs6435862', 'GWAS', 'Neuroblastoma (high-risk)', '19412175'),
(770, 'LAMA1', 'rs16951095', 'GWAS', 'Non-small cell lung cancer', '20876614'),
(771, 'WSCD1', 'rs9303196', 'GWAS', 'Non-small cell lung cancer', '20876614'),
(772, 'EIF4E2', 'rs1656402', 'GWAS', 'Non-small cell lung cancer', '21079520');
INSERT INTO `genes` (`id`, `gene-name`, `Marker`, `Study-type`, `Disease`, `Pubmed-ID`) VALUES
(773, 'ETS2', 'rs1209950', 'GWAS', 'Non-small cell lung cancer', '21079520'),
(774, 'APCDD1', 'rs11080466', 'GWAS', 'Non-small cell lung cancer', '21866343'),
(775, 'NAPG', 'rs11080466', 'GWAS', 'Non-small cell lung cancer', '21866343'),
(776, 'BNC2', 'rs3814113', 'GWAS', 'Ovarian cancer', '19648919'),
(777, 'CNTLN', 'rs3814113', 'GWAS', 'Ovarian cancer', '19648919'),
(778, 'GSDMC', 'rs10088218', 'GWAS', 'Ovarian cancer', '20852632'),
(779, 'HOXD1', 'rs2072590', 'GWAS', 'Ovarian cancer', '20852632'),
(780, 'HOXD3', 'rs2072590', 'GWAS', 'Ovarian cancer', '20852632'),
(781, 'LUZP2', 'rs12794435', 'GWAS', 'Ovarian cancer', '20852632'),
(782, 'MYC', 'rs10088218', 'GWAS', 'Ovarian cancer', '20852632'),
(783, 'TIPARP', 'rs2665390', 'GWAS', 'Ovarian cancer', '20852632'),
(784, 'WNT4', 'rs7521902', 'GWAS', 'Ovarian cancer', '20852632'),
(785, 'ZBTB40', 'rs7521902', 'GWAS', 'Ovarian cancer', '20852632'),
(786, 'ANKLE1', 'rs2363956', 'GWAS', 'Ovarian cancer', '20852633'),
(787, 'C19orf62', 'rs8170', 'GWAS', 'Ovarian cancer', '20852633'),
(788, 'ABO', 'rs505922', 'GWAS', 'Pancreatic cancer', '19648918'),
(789, 'CLPTM1L', 'rs401681', 'GWAS', 'Pancreatic cancer', '20101243'),
(790, 'KLF12', 'rs9543325', 'GWAS', 'Pancreatic cancer', '20101243'),
(791, 'KLF5', 'rs9543325', 'GWAS', 'Pancreatic cancer', '20101243'),
(792, 'NR5A2', 'rs3790844', 'GWAS', 'Pancreatic cancer', '20101243'),
(793, 'ANXA13', 'rs10088262', 'GWAS', 'Pancreatic cancer', '20686608'),
(794, 'ARL4C', 'rs6736997', 'GWAS', 'Pancreatic cancer', '20686608'),
(795, 'BICD1', 'rs708224', 'GWAS', 'Pancreatic cancer', '20686608'),
(796, 'DPP6', 'rs6464375', 'GWAS', 'Pancreatic cancer', '20686608'),
(797, 'FAM18B1', 'rs4924935', 'GWAS', 'Pancreatic cancer', '20686608'),
(798, 'FAM91A1', 'rs10088262', 'GWAS', 'Pancreatic cancer', '20686608'),
(799, 'FOXF2', 'rs9502893', 'GWAS', 'Pancreatic cancer', '20686608'),
(800, 'IRX2', 'rs6879627', 'GWAS', 'Pancreatic cancer', '20686608'),
(801, 'IRX4', 'rs6879627', 'GWAS', 'Pancreatic cancer', '20686608'),
(802, 'KLF12', 'rs1886449', 'GWAS', 'Pancreatic cancer', '20686608'),
(803, 'MYO1D', 'rs225190', 'GWAS', 'Pancreatic cancer', '20686608'),
(804, 'NDFIP2', 'rs2039553', 'GWAS', 'Pancreatic cancer', '20686608'),
(805, 'PARK2', 'rs3016539', 'GWAS', 'Pancreatic cancer', '20686608'),
(806, 'PCDH9', 'rs1585440', 'GWAS', 'Pancreatic cancer', '20686608'),
(807, 'PRPSAP2', 'rs4924935', 'GWAS', 'Pancreatic cancer', '20686608'),
(808, 'RNF149', 'rs6711606', 'GWAS', 'Pancreatic cancer', '20686608'),
(809, 'RNF43', 'rs2257205', 'GWAS', 'Pancreatic cancer', '20686608'),
(810, 'RNF5P1', 'rs7832232', 'GWAS', 'Pancreatic cancer', '20686608'),
(811, 'SH3BP4', 'rs6736997', 'GWAS', 'Pancreatic cancer', '20686608'),
(812, 'SPRY2', 'rs2039553', 'GWAS', 'Pancreatic cancer', '20686608'),
(813, 'TACC1', 'rs7832232', 'GWAS', 'Pancreatic cancer', '20686608'),
(814, 'THSD7B', 'rs1427593', 'GWAS', 'Pancreatic cancer', '20686608'),
(815, 'ARID1B', 'rs4269383', 'GWAS', 'Pancreatic cancer', '22158540'),
(816, 'BACH1', 'rs372883', 'GWAS', 'Pancreatic cancer', '22158540'),
(817, 'BAI3', 'rs9363918', 'GWAS', 'Pancreatic cancer', '22158540'),
(818, 'DAB2', 'rs2255280', 'GWAS', 'Pancreatic cancer', '22158540'),
(819, 'FAM19A5', 'rs5768709', 'GWAS', 'Pancreatic cancer', '22158540'),
(820, 'KLF12', 'rs9573163', 'GWAS', 'Pancreatic cancer', '22158540'),
(821, 'PRLHR', 'rs12413624', 'GWAS', 'Pancreatic cancer', '22158540'),
(822, 'SLC1A1', 'rs10974531', 'GWAS', 'Pancreatic cancer', '22158540'),
(823, 'TFF2', 'rs1547374', 'GWAS', 'Pancreatic cancer', '22158540'),
(824, 'TFRC', 'rs4927850', 'GWAS', 'Pancreatic cancer', '22158540'),
(825, 'ABO', 'rs2073828', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(826, 'ABO', 'rs630014', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(827, 'ABO', 'rs630014', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(828, 'ADAMTS20', 'rs7310342', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(829, 'ANKRD12', 'rs1114591', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(830, 'ANKRD12', 'rs1114591', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(831, 'ANKRD7', 'rs41943', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(832, 'APTX', 'rs10971259', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(833, 'ARL4C', 'rs10167927', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(834, 'ATP13A4', 'rs7630292', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(835, 'ATP1B2', 'rs1642763', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(836, 'ATP8B1', 'rs1893673', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(837, 'ATPBD4', 'rs4130461', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(838, 'ATPBD4', 'rs4459505', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(839, 'ATPBD4', 'rs8028529', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(840, 'AVEN', 'rs525243', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(841, 'BACH2', 'rs1145724', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(842, 'BCAR1', 'rs13337397', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(843, 'BCAR1', 'rs13337397', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(844, 'C10orf67', 'rs10734046', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(845, 'C14orf180', 'rs4983568', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(846, 'C1orf94', 'rs2359631', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(847, 'CAB39L', 'rs7328100', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(848, 'CDKN1A', 'rs236448', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(849, 'CDKN1A', 'rs236449', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(850, 'CFDP1', 'rs13337397', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(851, 'CHST3', 'rs4148912', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(852, 'CRBN', 'rs9829721', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(853, 'CTNNA2', 'rs12471455', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(854, 'CTTNBP2', 'rs12706164', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(855, 'CTTNBP2', 'rs7456706', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(856, 'DAPK3', 'rs7255123', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(857, 'DNAJA1', 'rs10758179', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(858, 'DNAJA1', 'rs10813923', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(859, 'EBF1', 'rs1145625', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(860, 'EBF1', 'rs202793', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(861, 'EBF1', 'rs202793', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(862, 'EBF1', 'rs2172745', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(863, 'EDNRB', 'rs2248525', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(864, 'EDNRB', 'rs2248525', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(865, 'EDNRB', 'rs2265775', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(866, 'EDNRB', 'rs2987526', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(867, 'EDNRB', 'rs6563036', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(868, 'EDNRB', 'rs7996252', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(869, 'EDNRB', 'rs7996252', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(870, 'ELF3', 'rs2819358', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(871, 'EML6', 'rs13401661', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(872, 'ENPP2', 'rs11782176', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(873, 'ENPP2', 'rs6991756', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(874, 'ENPP2', 'rs6993464', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(875, 'ENPP2', 'rs7000665', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(876, 'ENPP2', 'rs9643136', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(877, 'FAM149A', 'rs2276919', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(878, 'FAM84B', 'rs7012891', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(879, 'FGF12', 'rs6444558', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(880, 'FNBP1L', 'rs237425', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(881, 'GHITM', 'rs17689242', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(882, 'GJB5', 'rs2359631', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(883, 'GPR45', 'rs7584136', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(884, 'GSDMC', 'rs10505508', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(885, 'HNF4G', 'rs1531462', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(886, 'HNF4G', 'rs1805100', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(887, 'IMPG2', 'rs3732893', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(888, 'INHBA', 'rs11505535', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(889, 'JPH1', 'rs12679744', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(890, 'KCND2', 'rs41943', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(891, 'KCNH8', 'rs997384', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(892, 'KIAA0232', 'rs4626203', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(893, 'KIAA1217', 'rs11014058', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(894, 'KIAA1549', 'rs12670097', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(895, 'KIAA1549', 'rs12670097', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(896, 'KIF26A', 'rs4983568', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(897, 'KLF12', 'rs12870000', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(898, 'KLF12', 'rs1411327', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(899, 'KLF12', 'rs287553', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(900, 'KLF12', 'rs9318166', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(901, 'KLF12', 'rs9564966', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(902, 'KLF3', 'rs6838905', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(903, 'KLF3', 'rs6838905', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(904, 'L3MBTL4', 'rs636589', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(905, 'LPAR1', 'rs1536435', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(906, 'LPAR1', 'rs1536435', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(907, 'LPIN2', 'rs2282636', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(908, 'LPIN2', 'rs3819090', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(909, 'LPIN2', 'rs3826637', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(910, 'LRRN1', 'rs9829721', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(911, 'MAFB', 'rs3092685', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(912, 'MAP3K7', 'rs1145724', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(913, 'MAP4K2', 'rs670358', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(914, 'MEF2B', 'rs10896', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(915, 'MEN1', 'rs670358', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(916, 'MGST2', 'rs8192013', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(917, 'MN1', 'rs926837', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(918, 'MRPS9', 'rs7584136', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(919, 'MSX1', 'rs7679624', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(920, 'MYC', 'rs4404878', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(921, 'MYC', 'rs4404878', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(922, 'NAA38', 'rs12706164', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(923, 'NAA38', 'rs7456706', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(924, 'NDST3', 'rs1380376', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(925, 'NDST3', 'rs1459544', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(926, 'NOV', 'rs11782176', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(927, 'NOV', 'rs6991756', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(928, 'NOV', 'rs6993464', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(929, 'NOV', 'rs7000665', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(930, 'NOV', 'rs9643136', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(931, 'NPVF', 'rs7791702', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(932, 'NPVF', 'rs7791702', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(933, 'NR5A2', 'rs10919791', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(934, 'NR5A2', 'rs12029406', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(935, 'NR5A2', 'rs17664308', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(936, 'NR5A2', 'rs2737621', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(937, 'NR5A2', 'rs2816939', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(938, 'NR5A2', 'rs2821347', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(939, 'NR5A2', 'rs2821367', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(940, 'NR5A2', 'rs3790843', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(941, 'NR5A2', 'rs4244145', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(942, 'NR5A2', 'rs4465241', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(943, 'NR5A2', 'rs60636333', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(944, 'NR5A2', 'rs60636333', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(945, 'NRG3', 'rs17689242', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(946, 'NXPH1', 'rs10253965', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(947, 'OTUD1', 'rs10734046', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(948, 'PFKP', 'rs2388097', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(949, 'POC1B', 'rs770374', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(950, 'PREX2', 'rs1369165', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(951, 'PREX2', 'rs7839608', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(952, 'PREX2', 'rs874805', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(953, 'PRKCA', 'rs17634425', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(954, 'PRLHR', 'rs11198446', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(955, 'RAC2', 'rs2284037', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(956, 'RFXANK', 'rs10896', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(957, 'RGS7', 'rs7531849', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(958, 'RIOK1', 'rs9379104', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(959, 'RNPEP', 'rs2819358', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(960, 'RORB', 'rs1398307', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(961, 'RPL38', 'rs7219464', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(962, 'SEC11C', 'rs1517037', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(963, 'SEC11C', 'rs9319943', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(964, 'SEC11C', 'rs9961404', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(965, 'SEMA3D', 'rs10277279', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(966, 'SEMA3D', 'rs10277279', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(967, 'SEMA3D', 'rs782895', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(968, 'SGMS1', 'rs3011777', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(969, 'SH3BP4', 'rs10167927', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(970, 'SIM1', 'rs17060530', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(971, 'SIPA1L2', 'rs16856874', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(972, 'SLC10A2', 'rs1331519', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(973, 'SLC10A2', 'rs1757387', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(974, 'SLC10A2', 'rs1757387', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(975, 'SLMO2', 'rs6070706', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(976, 'SMOC1', 'rs227446', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(977, 'SMTN', 'rs5753454', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(978, 'SMU1', 'rs10813928', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(979, 'SOX11', 'rs17363613', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(980, 'STX18', 'rs7679624', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(981, 'TGFBR2', 'rs2043136', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(982, 'TGFBR2', 'rs4613502', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(983, 'TLR10', 'rs6838905', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(984, 'TLR10', 'rs6838905', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(985, 'TMEM132C', 'rs4765114', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(986, 'TMEM213', 'rs12670097', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(987, 'TMEM213', 'rs12670097', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(988, 'TMEM213', 'rs6969815', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(989, 'TMEM90B', 'rs1883924', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(990, 'TMPO', 'rs249851', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(991, 'TOM1L1', 'rs7207449', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(992, 'TOP1', 'rs3092685', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(993, 'TP63', 'rs1515496', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(994, 'TRIB1', 'rs7012891', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(995, 'TWSG1', 'rs1114591', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(996, 'ZNF608', 'rs1494671', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(997, 'ZNF608', 'rs1494672', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(998, 'ZNF831', 'rs6070744', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(999, 'ZWINT', 'rs11005196', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(1000, 'ZWINT', 'rs11005240', 'GWAS', 'Pancreatic Neoplasms', 'NA'),
(1001, 'DENND1A', 'rs10818854', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1002, 'DENND1A', 'rs2479106', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1003, 'FSHR', 'rs13405728', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1004, 'LHCGR', 'rs13405728', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1005, 'THADA', 'rs13429458', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1006, 'THADA', 'rs12478601', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1007, 'ZFP36L2', 'rs13429458', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1008, 'ZFP36L2', 'rs12478601', 'GWAS', 'Polycystic ovary syndrome', '21151128'),
(1009, 'MYC', 'rs1447295', 'GWAS', 'Prostate cancer', '17401363'),
(1010, 'MYC', 'rs1447295', 'GWAS', 'Prostate cancer', '17401366'),
(1011, 'HNF1B', 'rs4430796', 'GWAS', 'Prostate cancer', '17603485'),
(1012, 'SOX9', 'rs1859962', 'GWAS', 'Prostate cancer', '17603485'),
(1013, 'C3orf58', 'rs345013', 'GWAS', 'Prostate cancer', '17903305'),
(1014, 'CTDSPL', 'rs9311171', 'GWAS', 'Prostate cancer', '17903305'),
(1015, 'HAPLN1', 'rs4466137', 'GWAS', 'Prostate cancer', '17903305'),
(1016, 'PKHD1', 'rs10498792', 'GWAS', 'Prostate cancer', '17903305'),
(1017, 'SLC10A2', 'rs1529276', 'GWAS', 'Prostate cancer', '17903305'),
(1018, 'CTBP2', 'rs4962416', 'GWAS', 'Prostate cancer', '18264096'),
(1019, 'HNF1B', 'rs4430796', 'GWAS', 'Prostate cancer', '18264096'),
(1020, 'JAZF1', 'rs10486567', 'GWAS', 'Prostate cancer', '18264096'),
(1021, 'MYC', 'rs4242382', 'GWAS', 'Prostate cancer', '18264096'),
(1022, 'MYEOV', 'rs10896449', 'GWAS', 'Prostate cancer', '18264096'),
(1023, 'TPCN2', 'rs10896449', 'GWAS', 'Prostate cancer', '18264096'),
(1024, 'CHMP2B', 'rs2660753', 'GWAS', 'Prostate cancer', '18264097'),
(1025, 'FAM84B', 'rs1016343', 'GWAS', 'Prostate cancer', '18264097'),
(1026, 'HNF1B', 'rs7501939', 'GWAS', 'Prostate cancer', '18264097'),
(1027, 'KLK2', 'rs2735839', 'GWAS', 'Prostate cancer', '18264097'),
(1028, 'KLK3', 'rs2735839', 'GWAS', 'Prostate cancer', '18264097'),
(1029, 'LMTK2', 'rs6465657', 'GWAS', 'Prostate cancer', '18264097'),
(1030, 'MYC', 'rs4242384', 'GWAS', 'Prostate cancer', '18264097'),
(1031, 'MYEOV', 'rs7931342', 'GWAS', 'Prostate cancer', '18264097'),
(1032, 'SLC22A3', 'rs9364554', 'GWAS', 'Prostate cancer', '18264097'),
(1033, 'SOX9', 'rs1859962', 'GWAS', 'Prostate cancer', '18264097'),
(1034, 'TPCN2', 'rs7931342', 'GWAS', 'Prostate cancer', '18264097'),
(1035, 'VGLL3', 'rs2660753', 'GWAS', 'Prostate cancer', '18264097'),
(1036, 'EHBP1', 'rs721048', 'GWAS', 'Prostate cancer', '18264098'),
(1037, 'TNRC6B', 'rs9623117', 'GWAS', 'Prostate cancer', '19117981'),
(1038, 'CHMP2B', 'rs17181170', 'GWAS', 'Prostate cancer', '19767753'),
(1039, 'EHBP1', 'rs6545977', 'GWAS', 'Prostate cancer', '19767753'),
(1040, 'HNF1B', 'rs7501939', 'GWAS', 'Prostate cancer', '19767753'),
(1041, 'IGF2', 'rs7127900', 'GWAS', 'Prostate cancer', '19767753'),
(1042, 'INS', 'rs7127900', 'GWAS', 'Prostate cancer', '19767753'),
(1043, 'ITGA6', 'rs12621278', 'GWAS', 'Prostate cancer', '19767753'),
(1044, 'LMTK2', 'rs6465657', 'GWAS', 'Prostate cancer', '19767753'),
(1045, 'MYC', 'rs4242384', 'GWAS', 'Prostate cancer', '19767753'),
(1046, 'MYEOV', 'rs7130881', 'GWAS', 'Prostate cancer', '19767753'),
(1047, 'NKX3-1', 'rs1512268', 'GWAS', 'Prostate cancer', '19767753'),
(1048, 'OTX1', 'rs6545977', 'GWAS', 'Prostate cancer', '19767753'),
(1049, 'PDLIM5', 'rs17021918', 'GWAS', 'Prostate cancer', '19767753'),
(1050, 'PDLIM5', 'rs12500426', 'GWAS', 'Prostate cancer', '19767753'),
(1051, 'SLC25A37', 'rs1512268', 'GWAS', 'Prostate cancer', '19767753'),
(1052, 'SOX9', 'rs1859962', 'GWAS', 'Prostate cancer', '19767753'),
(1053, 'TET2', 'rs7679673', 'GWAS', 'Prostate cancer', '19767753'),
(1054, 'THADA', 'rs1465618', 'GWAS', 'Prostate cancer', '19767753'),
(1055, 'TPCN2', 'rs7130881', 'GWAS', 'Prostate cancer', '19767753'),
(1056, 'VGLL3', 'rs17181170', 'GWAS', 'Prostate cancer', '19767753'),
(1057, 'DPF1', 'rs8102476', 'GWAS', 'Prostate cancer', '19767754'),
(1058, 'EEFSEC', 'rs10934853', 'GWAS', 'Prostate cancer', '19767754'),
(1059, 'HNF1B', 'rs4430796', 'GWAS', 'Prostate cancer', '19767754'),
(1060, 'MYC', 'rs1447295', 'GWAS', 'Prostate cancer', '19767754'),
(1061, 'MYEOV', 'rs11228565', 'GWAS', 'Prostate cancer', '19767754'),
(1062, 'TPCN2', 'rs11228565', 'GWAS', 'Prostate cancer', '19767754'),
(1063, 'C2orf43', 'rs13385191', 'GWAS', 'Prostate cancer', '20676098'),
(1064, 'CHMP2B', 'rs9284813', 'GWAS', 'Prostate cancer', '20676098'),
(1065, 'FOXP4', 'rs1983891', 'GWAS', 'Prostate cancer', '20676098'),
(1066, 'HNF1B', 'rs7501939', 'GWAS', 'Prostate cancer', '20676098'),
(1067, 'IRX2', 'rs12653946', 'GWAS', 'Prostate cancer', '20676098'),
(1068, 'IRX4', 'rs12653946', 'GWAS', 'Prostate cancer', '20676098'),
(1069, 'KLF12', 'rs9600079', 'GWAS', 'Prostate cancer', '20676098'),
(1070, 'MYC', 'rs7837688', 'GWAS', 'Prostate cancer', '20676098'),
(1071, 'NKX3-1', 'rs1512268', 'GWAS', 'Prostate cancer', '20676098'),
(1072, 'RFX6', 'rs339331', 'GWAS', 'Prostate cancer', '20676098'),
(1073, 'SLC25A37', 'rs1512268', 'GWAS', 'Prostate cancer', '20676098'),
(1074, 'VGLL3', 'rs9284813', 'GWAS', 'Prostate cancer', '20676098'),
(1075, 'ZNF652', 'rs7210100', 'GWAS', 'Prostate cancer', '21602798'),
(1076, 'CHMP2B', 'rs7629490', 'GWAS', 'Prostate cancer', '21743057'),
(1077, 'EIF4B', 'rs902774', 'GWAS', 'Prostate cancer', '21743057'),
(1078, 'FAM84B', 'rs13252298', 'GWAS', 'Prostate cancer', '21743057'),
(1079, 'FAM84B', 'rs1016343', 'GWAS', 'Prostate cancer', '21743057'),
(1080, 'HNF1B', 'rs7501939', 'GWAS', 'Prostate cancer', '21743057'),
(1081, 'KRT8', 'rs902774', 'GWAS', 'Prostate cancer', '21743057'),
(1082, 'MLPH', 'rs2292884', 'GWAS', 'Prostate cancer', '21743057'),
(1083, 'MYC', 'rs4242384', 'GWAS', 'Prostate cancer', '21743057'),
(1084, 'MYEOV', 'rs7130881', 'GWAS', 'Prostate cancer', '21743057'),
(1085, 'SLC22A1', 'rs651164', 'GWAS', 'Prostate cancer', '21743057'),
(1086, 'SOX9', 'rs1859962', 'GWAS', 'Prostate cancer', '21743057'),
(1087, 'TENC1', 'rs902774', 'GWAS', 'Prostate cancer', '21743057'),
(1088, 'TPCN2', 'rs7130881', 'GWAS', 'Prostate cancer', '21743057'),
(1089, 'VGLL3', 'rs7629490', 'GWAS', 'Prostate cancer', '21743057'),
(1090, 'AR', 'rs5919432', 'GWAS', 'Prostate cancer', '21743467'),
(1091, 'CCHCR1', 'rs130067', 'GWAS', 'Prostate cancer', '21743467'),
(1092, 'CLDN11', 'rs10936632', 'GWAS', 'Prostate cancer', '21743467'),
(1093, 'COL6A3', 'rs7584330', 'GWAS', 'Prostate cancer', '21743467'),
(1094, 'GGCX', 'rs10187424', 'GWAS', 'Prostate cancer', '21743467'),
(1095, 'MLPH', 'rs7584330', 'GWAS', 'Prostate cancer', '21743467'),
(1096, 'OPHN1', 'rs5919432', 'GWAS', 'Prostate cancer', '21743467'),
(1097, 'PRPH', 'rs10875943', 'GWAS', 'Prostate cancer', '21743467'),
(1098, 'RNF181', 'rs10187424', 'GWAS', 'Prostate cancer', '21743467'),
(1099, 'SKIL', 'rs10936632', 'GWAS', 'Prostate cancer', '21743467'),
(1100, 'TERT', 'rs2242652', 'GWAS', 'Prostate cancer', '21743467'),
(1101, 'TUBA1C', 'rs10875943', 'GWAS', 'Prostate cancer', '21743467'),
(1102, 'VAMP8', 'rs10187424', 'GWAS', 'Prostate cancer', '21743467'),
(1103, 'ZBTB38', 'rs6763931', 'GWAS', 'Prostate cancer', '21743467'),
(1104, 'FGFR2', 'rs11199874', 'GWAS', 'Prostate cancer', '22130093'),
(1105, 'SEMA6D', 'rs4775302', 'GWAS', 'Prostate cancer', '22130093'),
(1106, 'SQRDL', 'rs4775302', 'GWAS', 'Prostate cancer', '22130093'),
(1107, 'ABLIM1', 'rs10885582', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1108, 'ACOXL', 'rs3789080', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1109, 'ACTBL2', 'rs10940579', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1110, 'ACTC1', 'rs543686', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1111, 'AMIGO2', 'rs2711721', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1112, 'ANK2', 'rs7694725', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1113, 'ANP32D', 'rs4489787', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1114, 'ANXA13', 'rs13258681', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1115, 'BAI3', 'rs9351730', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1116, 'BAIAP2L1', 'rs9649213', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1117, 'BHLHE23', 'rs6089829', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1118, 'CADM2', 'rs9757252', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1119, 'CBLN1', 'rs8057939', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1120, 'CCDC80', 'rs1002979', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1121, 'CD180', 'rs7717572', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1122, 'CD200R1L', 'rs1002979', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1123, 'CEP152', 'rs784411', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1124, 'CHL1', 'rs12485321', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1125, 'CLVS2', 'rs13192613', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1126, 'CNTN6', 'rs6763848', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1127, 'CWC22', 'rs16867225', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1128, 'DNAH12', 'rs1916284', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1129, 'DNAH5', 'rs4463179', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1130, 'EIF3IP1', 'rs10277209', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1131, 'EPHA10', 'rs731174', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1132, 'EVC', 'rs735172', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1133, 'INHBA', 'rs7789197', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1134, 'INSC', 'rs11605083', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1135, 'KIF13A', 'rs10456809', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1136, 'MATN1', 'rs1866967', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1137, 'MIR622', 'rs16944141', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1138, 'MIR656', 'rs2400997', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1139, 'MN1', 'rs6005451', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1140, 'NR2F2', 'rs11637980', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1141, 'PEX2', 'rs2219968', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1142, 'PKIA', 'rs2219968', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1143, 'PLCL1', 'rs13398206', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1144, 'PLK2', 'rs10940579', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1145, 'PTPRD', 'rs12682851', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1146, 'PTPRU', 'rs1866967', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1147, 'SATB2', 'rs13398206', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1148, 'SERP2', 'rs9567349', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1149, 'SETBP1', 'rs998124', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1150, 'SLC14A2', 'rs998124', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1151, 'SLC38A4', 'rs2711721', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1152, 'SNX16', 'rs13264970', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1153, 'SOX6', 'rs11605083', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1154, 'SPATA8', 'rs11637980', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1155, 'SYK', 'rs290258', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1156, 'TMTC2', 'rs12317459', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1157, 'TNC', 'rs7847271', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1158, 'TNRC6B', 'rs12628051', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1159, 'TNRC6B', 'rs4821941', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1160, 'TSEN2', 'rs6766510', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1161, 'UPF2', 'rs10795917', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1162, 'VGLL3', 'rs9757252', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1163, 'ZNF280B', 'rs5751168', 'GWAS', 'Prostate cancer (gene x gene interaction)', '22219177'),
(1164, 'FGFR2', 'rs10788160', 'GWAS', 'Prostate-specific antigen levels', '21160077'),
(1165, 'KLK15', 'rs266849', 'GWAS', 'Prostate-specific antigen levels', '21160077'),
(1166, 'KLK3', 'rs17632542', 'GWAS', 'Prostate-specific antigen levels', '21160077'),
(1167, 'KLK3', 'rs266849', 'GWAS', 'Prostate-specific antigen levels', '21160077'),
(1168, 'TBX3', 'rs11067228', 'GWAS', 'Prostate-specific antigen levels', '21160077'),
(1169, 'ADARB2', 'rs11250464', 'GWAS', 'Radiation response', '20923822'),
(1170, 'C8orf38', 'rs7000734', 'GWAS', 'Radiation response', '20923822'),
(1171, 'C8orf38', 'rs4392868', 'GWAS', 'Radiation response', '20923822'),
(1172, 'FSHR', 'rs7591064', 'GWAS', 'Radiation response', '20923822'),
(1173, 'KDM4C', 'rs4742269', 'GWAS', 'Radiation response', '20923822'),
(1174, 'KIAA0319', 'rs16889440', 'GWAS', 'Radiation response', '20923822'),
(1175, 'LHCGR', 'rs7591064', 'GWAS', 'Radiation response', '20923822'),
(1176, 'PLEKHF2', 'rs7000734', 'GWAS', 'Radiation response', '20923822'),
(1177, 'PLEKHF2', 'rs4392868', 'GWAS', 'Radiation response', '20923822'),
(1178, 'SHFM1', 'rs17598306', 'GWAS', 'Radiation response', '20923822'),
(1179, 'TINAG', 'rs16885294', 'GWAS', 'Radiation response', '20923822'),
(1180, 'ULBP1', 'rs1853665', 'GWAS', 'Radiation response', '20923822'),
(1181, 'VRK1', 'rs1471356', 'GWAS', 'Radiation response', '20923822'),
(1182, 'WDR64', 'rs12569163', 'GWAS', 'Radiation response', '20923822'),
(1183, 'WWOX', 'rs2859631', 'GWAS', 'Radiation response', '20923822'),
(1184, 'CCND1', 'rs7105934', 'GWAS', 'Renal cell carcinoma', '21131975'),
(1185, 'EPAS1', 'rs7579899', 'GWAS', 'Renal cell carcinoma', '21131975'),
(1186, 'SCARB1', 'rs4765623', 'GWAS', 'Renal cell carcinoma', '21131975'),
(1187, 'CCND1', 'rs4980785', 'GWAS', 'Renal cell carcinoma', '22010048'),
(1188, 'ITPR2', 'rs718314', 'GWAS', 'Renal cell carcinoma', '22010048'),
(1189, 'SSPN', 'rs718314', 'GWAS', 'Renal cell carcinoma', '22010048'),
(1190, 'ACOX3', 'rs1949733', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1191, 'BRMS1L', 'rs1168987', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1192, 'CENPF', 'rs438034', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1193, 'CYLC2', 'rs1342899', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1194, 'DISC1', 'rs2793086', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1195, 'GPR78', 'rs1949733', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1196, 'MBIP', 'rs1168987', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1197, 'OPRK1', 'rs10958369', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1198, 'P2RY1', 'rs6785504', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1199, 'P2RY1', 'rs9883654', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1200, 'PPP2R5E', 'rs11158493', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1201, 'RAP2B', 'rs6785504', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1202, 'RAP2B', 'rs9883654', 'GWAS', 'Response to antineoplastic agents', '21659360'),
(1203, 'DCP1B', 'rs11062040', 'GWAS', 'Response to gemcitabine in pancreatic cancer', '22142827'),
(1204, 'IL17F', 'rs763780', 'GWAS', 'Response to gemcitabine in pancreatic cancer', '22142827'),
(1205, 'DAPK1', 'rs11141915', 'GWAS', 'Response to gemcitabine in pancreatic cancer', '22293537'),
(1206, 'MGAT5', 'rs1901440', 'GWAS', 'Response to gemcitabine in pancreatic cancer', '22293537'),
(1207, 'NCKAP5', 'rs1901440', 'GWAS', 'Response to gemcitabine in pancreatic cancer', '22293537'),
(1208, 'C10orf11', 'rs10509373', 'GWAS', 'Response to tamoxifen in breast cancer', '22180457'),
(1209, 'ARAP2', 'rs437943', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1210, 'C6orf118', 'rs10945919', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1211, 'CST2', 'rs6138150', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1212, 'LMO4', 'rs983332', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1213, 'MAFB', 'rs6028945', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1214, 'PON1', 'rs854555', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1215, 'QKI', 'rs10945919', 'GWAS', 'Response to TNF antagonist treatment', '18615156'),
(1216, 'C2orf47', 'rs1569175', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1217, 'DGKB', 'rs6971925', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1218, 'ELMO1', 'rs4723619', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1219, 'FGFR2', 'rs2901286', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1220, 'GATA3', 'rs10508343', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1221, 'IL15', 'rs17007695', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1222, 'INPP4B', 'rs17007695', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1223, 'LMBRD2', 'rs267759', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1224, 'MAML2', 'rs7115578', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1225, 'NCOA3', 'rs6125048', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1226, 'SPATS2L', 'rs1569175', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1227, 'ST8SIA6', 'rs359312', 'GWAS', 'Response to treatment for acute lymphoblastic leukemia', '19176441'),
(1228, 'DYNC2H1', 'rs716274', 'GWAS', 'Small-cell lung cancer', '21118971'),
(1229, 'PDGFD', 'rs716274', 'GWAS', 'Small-cell lung cancer', '21118971'),
(1230, 'KITLG', 'rs4474514', 'GWAS', 'Testicular cancer', '19483682'),
(1231, 'DMRT1', 'rs755383', 'GWAS', 'Testicular cancer', '21551455'),
(1232, 'DMRT1', 'rs7040024', 'GWAS', 'Testicular cancer', '21551455'),
(1233, 'ATF7IP', 'rs2900333', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1234, 'CLPTM1L', 'rs4635969', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1235, 'DMRT1', 'rs755383', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1236, 'KITLG', 'rs3782181', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1237, 'NDFIP1', 'rs4624820', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1238, 'PLBD1', 'rs2900333', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1239, 'SPRY4', 'rs4624820', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1240, 'TERT', 'rs2736100', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1241, 'TERT', 'rs4635969', 'GWAS', 'Testicular germ cell cancer', '20543847'),
(1242, 'BAK1', 'rs210138', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1243, 'CENPE', 'rs4699052', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1244, 'KITLG', 'rs995030', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1245, 'KITLG', 'rs995030', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1246, 'NDFIP1', 'rs4624820', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1247, 'SPRY4', 'rs4624820', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1248, 'TACR3', 'rs4699052', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1249, 'UCK2', 'rs4657482', 'GWAS', 'Testicular germ cell tumor', '19483681'),
(1250, 'BRMS1L', 'rs944289', 'GWAS', 'Thyroid cancer', '19198613'),
(1251, 'FOXE1', 'rs965513', 'GWAS', 'Thyroid cancer', '19198613'),
(1252, 'MBIP', 'rs944289', 'GWAS', 'Thyroid cancer', '19198613'),
(1253, 'NKX2-1', 'rs944289', 'GWAS', 'Thyroid cancer', '19198613'),
(1254, 'BRMS1L', 'rs116909374', 'GWAS', 'Thyroid cancer', '22267200'),
(1255, 'MBIP', 'rs116909374', 'GWAS', 'Thyroid cancer', '22267200'),
(1256, 'NRG1', 'rs2439302', 'GWAS', 'Thyroid cancer', '22267200'),
(1257, 'ADH1B', 'rs1229984', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1258, 'ADH1C', 'rs1789924', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1259, 'ADH7', 'rs971074', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1260, 'ALDH2', 'rs4767364', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1261, 'FAM175A', 'rs1494961', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1262, 'HELQ', 'rs1494961', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1263, 'NAA25', 'rs4767364', 'GWAS', 'Upper aerodigestive tract cancers', '21437268'),
(1264, 'LEPREL1', 'rs710521', 'GWAS', 'Urinary bladder cancer', '18794855'),
(1265, 'MYC', 'rs9642880', 'GWAS', 'Urinary bladder cancer', '18794855'),
(1266, 'TP63', 'rs710521', 'GWAS', 'Urinary bladder cancer', '18794855'),
(1267, 'FGFR3', 'rs798766', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1268, 'LEPREL1', 'rs710521', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1269, 'MYC', 'rs9642880', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1270, 'SLBP', 'rs798766', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1271, 'TACC3', 'rs798766', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1272, 'TMEM129', 'rs798766', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1273, 'TP63', 'rs710521', 'GWAS', 'Urinary bladder cancer', '20348956'),
(1274, 'XRCC3', '-1843', 'CGAS', 'melanoma', '20601096'),
(1275, 'HLA-DRB1', '101', 'CGAS', 'Cervical Cancer', '16720214'),
(1276, 'HLA-DRB1', '102', 'CGAS', 'Cervical Cancer', '16720214'),
(1277, 'HLA-DRB1', '103', 'CGAS', 'Cervical Cancer', '16720214'),
(1278, 'HLA-DRB1', '301', 'CGAS', 'Cervical Cancer', '16720214'),
(1279, 'HLA-DRB1', '302', 'CGAS', 'Cervical Cancer', '16720214'),
(1280, 'HLA-DRB1', '401', 'CGAS', 'Cervical Cancer', '16720214'),
(1281, 'HLA-DRB1', '402', 'CGAS', 'Cervical Cancer', '16720214'),
(1282, 'HLA-DRB1', '403', 'CGAS', 'Cervical Cancer', '16720214'),
(1283, 'HLA-DRB1', '404', 'CGAS', 'Cervical Cancer', '16720214'),
(1284, 'HLA-DRB1', '405', 'CGAS', 'Cervical Cancer', '16720214'),
(1285, 'HLA-DRB1', '406', 'CGAS', 'Cervical Cancer', '16720214'),
(1286, 'HLA-DRB1', '407', 'CGAS', 'Cervical Cancer', '16720214'),
(1287, 'HLA-DRB1', '408', 'CGAS', 'Cervical Cancer', '16720214'),
(1288, 'HLA-DRB1', '701', 'CGAS', 'Cervical Cancer', '16720214'),
(1289, 'HLA-DRB1', '801', 'CGAS', 'Cervical Cancer', '16720214'),
(1290, 'HLA-DRB1', '802', 'CGAS', 'Cervical Cancer', '16720214'),
(1291, 'HLA-DRB1', '803', 'CGAS', 'Cervical Cancer', '16720214'),
(1292, 'HLA-DRB1', '804', 'CGAS', 'Cervical Cancer', '16720214'),
(1293, 'HLA-DRB1', '806', 'CGAS', 'Cervical Cancer', '16720214'),
(1294, 'HLA-DRB1', '901', 'CGAS', 'Cervical Cancer', '16720214'),
(1295, 'HLA-DRB1', '1001', 'CGAS', 'Cervical Cancer', '16720214'),
(1296, 'HLA-DRB1', '1101', 'CGAS', 'Cervical Cancer', '16720214'),
(1297, 'HLA-DRB1', '1102', 'CGAS', 'Cervical Cancer', '16720214'),
(1298, 'HLA-DRB1', '1103', 'CGAS', 'Cervical Cancer', '16720214'),
(1299, 'HLA-DRB1', '1104', 'CGAS', 'Cervical Cancer', '16720214'),
(1300, 'HLA-DRB1', '1201', 'CGAS', 'Cervical Cancer', '16720214'),
(1301, 'HLA-DRB1', '1202', 'CGAS', 'Cervical Cancer', '16720214'),
(1302, 'HLA-DRB1', '1301', 'CGAS', 'Cervical Cancer', '16720214'),
(1303, 'HLA-DRB1', '1302', 'CGAS', 'Cervical Cancer', '16720214'),
(1304, 'HLA-DRB1', '1303', 'CGAS', 'Cervical Cancer', '16720214'),
(1305, 'HLA-DRB1', '1305', 'CGAS', 'Cervical Cancer', '16720214'),
(1306, 'HLA-DRB1', '1401', 'CGAS', 'Cervical Cancer', '16720214'),
(1307, 'HLA-DRB1', '1402', 'CGAS', 'Cervical Cancer', '16720214'),
(1308, 'HLA-DRB1', '1404', 'CGAS', 'Cervical Cancer', '16720214'),
(1309, 'HLA-DRB1', '1407', 'CGAS', 'Cervical Cancer', '16720214'),
(1310, 'HLA-DRB1', '1501', 'CGAS', 'Cervical Cancer', '16720214'),
(1311, 'HLA-DRB1', '1502', 'CGAS', 'Cervical Cancer', '16720214'),
(1312, 'HLA-DRB1', '1503', 'CGAS', 'Cervical Cancer', '16720214'),
(1313, 'HLA-DRB1', '1601', 'CGAS', 'Cervical Cancer', '16720214'),
(1314, 'HLA-DRB1', '1602', 'CGAS', 'Cervical Cancer', '16720214'),
(1315, 'IGF1', '(CA)n repeat', 'CGAS', 'Breast Cancer', '21390492'),
(1316, 'CYP19A1', '(TTA)10', 'CGAS', 'Breast Cancer', '20052540'),
(1317, 'CYP19A1', '(TTA)12', 'CGAS', 'Breast Cancer', '20052540'),
(1318, 'HLA-DQB1', '*02 allele', 'CGAS', 'Hepatocellular Carcinoma', '21633537'),
(1319, 'HLA-DQB1', '*03 allele', 'CGAS', 'Hepatocellular Carcinoma', '21633537'),
(1320, 'HLA-DQB1', '*0502 allele', 'CGAS', 'Hepatocellular Carcinoma', '21633537'),
(1321, 'HLA-DQB1', '*0602 allele', 'CGAS', 'Hepatocellular Carcinoma', '21633537'),
(1322, 'ALDH2', '*1*2 allele', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1323, 'CHEK2', '*1100delC carrier', 'CGAS', 'Breast Cancer', '15122511'),
(1324, 'CHEK2', '*1100delC carrier', 'CGAS', 'Breast Cancer', '19124502'),
(1325, 'ALDH2', '*2*2 allele', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1326, 'PTGS2', '*2430C>T', 'CGAS', 'Stomach Cancer', '21086572'),
(1327, 'UGT1A7', '*3 allele', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1328, 'PTGS2', '*429T>C', 'CGAS', 'Gastric Cancer', '19060633'),
(1329, 'PTGS2', '*429T>C', 'CGAS', 'Stomach Cancer', '21086572'),
(1330, 'TGFBR1', '*6A', 'CGAS', 'Breast Cancer', '14966109'),
(1331, 'TGFBR1', '*6A', 'CGAS', 'Colorectal Cancer', '14966109'),
(1332, 'TGFBR1', '*6A', 'CGAS', 'Colorectal Cancer', '17575241'),
(1333, 'TGFBR1', '*6A', 'CGAS', 'Breast Cancer', '19390964'),
(1334, 'TLR4', '1063A>G', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1335, 'CHEK2', '1100delC', 'CGAS', 'Colorectal Cancer', '15852425'),
(1336, 'CHEK2', '1100delC', 'CGAS', 'Melanoma', '21956126'),
(1337, 'CHEK2', '1100delC', 'CGAS', 'Colorectal Cancer', '21805700'),
(1338, 'PTGS2', '-1195G>A', 'CGAS', 'Stomach Cancer', '21086572'),
(1339, 'TNF', '1210 (A>T)', 'CGAS', 'Breast Cancer', '20882404'),
(1340, 'TNF', '1211 (A>T)', 'CGAS', 'Breast Cancer', '20882404'),
(1341, 'TNF', '1212 (A>T)', 'CGAS', 'Breast Cancer', '20882404'),
(1342, 'TNF', '1213 (A>T)', 'CGAS', 'Breast Cancer', '20882404'),
(1343, 'TNF', '1214 (A>T)', 'CGAS', 'Breast Cancer', '20882404'),
(1344, 'IL1A', '1264C>T', 'CGAS', 'Gastric Cancer', '19375306'),
(1345, 'IFNGR2', '-128T>C', 'CGAS', 'Gastric Cancer', '19375306'),
(1346, 'PTGS2', '-1290A>G', 'CGAS', 'Stomach Cancer', '21086572'),
(1347, 'PTGS2', '-1329G>A', 'CGAS', 'Gastric Cancer', '19060633'),
(1348, 'MMP9', '1562 C>T', 'CGAS', 'Lung Cancer', '20360147'),
(1349, 'MMP9', '1562 C>T', 'CGAS', 'Breast Cancer', '20360147'),
(1350, 'MMP9', '1562 C>T', 'CGAS', 'Stomach Cancer', '20360147'),
(1351, 'MMP9', '1562 C>T', 'CGAS', 'Cancer', '20360147'),
(1352, 'MMP9', '1562 C>T', 'CGAS', 'Colorectal Cancer', '20360147'),
(1353, 'MMP9', '1562 C>T', 'CGAS', 'Head and Neck Cancer', '20360147'),
(1354, 'MMP3', '1562 C>T', 'CGAS', 'Colorectal Cancer', '21538057'),
(1355, 'CDH1', '-160C>A', 'CGAS', 'Gastric Cancer', '19506726'),
(1356, 'CDH1', '-160C>A', 'CGAS', 'Breast Cancer', '17971340'),
(1357, 'CDH1', '-160C>A', 'CGAS', 'Bladder Cancer', '17971340'),
(1358, 'CDH1', '-160C>A', 'CGAS', 'Colorectal Cancer', '17971340'),
(1359, 'CDH1', '-160C>A', 'CGAS', 'Gastric Cancer', '17971340'),
(1360, 'CDH1', '-160C>A', 'CGAS', 'Prostate Cancer', '17971340'),
(1361, 'CDH1', '-160C>A', 'CGAS', 'Prostate Cancer', '18781193'),
(1362, 'CDH1', '-160C>A', 'CGAS', 'Gastric Cancer', '18544073'),
(1363, 'CDH1', '-160C>A', 'CGAS', 'Gastric Cancer', '19375306'),
(1364, 'MMP3', '1612 5A>6A', 'CGAS', 'Colorectal Cancer', '21538057'),
(1365, 'TP53', '21226bp3\' of STPC>T', 'CGAS', 'Breast Cancer', '17683073'),
(1366, 'TP53', '22342bp3\' of STPT>C', 'CGAS', 'Breast Cancer', '17683073'),
(1367, 'TP53', '22369bp3\'of STP A>G', 'CGAS', 'Breast Cancer', '17683073'),
(1368, 'MBL2', '226G>A', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1369, 'TNF', '238 G/A', 'CGAS', 'LCC - Liver cell carcinoma', '21107607'),
(1370, 'CYBA', '242C>T', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1371, 'XRCC1', '26304C>T', 'CGAS', 'Gastric Cancer', '18949424'),
(1372, 'EPHX1', '-28T>C', 'CGAS', 'Gastric Cancer', '19375306'),
(1373, 'TGFB1', '29T/C', 'CGAS', 'Breast Cancer', '20845106'),
(1374, 'NOD2', '3020insC', 'CGAS', 'Colorectal Cancer', '19787357'),
(1375, 'TNF', '308 G/A', 'CGAS', 'LCC - Liver cell carcinoma', '21107607'),
(1376, 'PPARG', '34 C > G', 'CGAS', 'Colorectal Cancer', '20440859'),
(1377, 'CDH1', '-347G>A', 'CGAS', 'Gastric Cancer', '19375306'),
(1378, 'IL2', '348T>G', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(1379, 'IL10', '-3575T>A', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(1380, 'CYP19A1', '3-bp Del/Ins', 'CGAS', 'Breast Cancer', '20052540'),
(1381, 'ADH1B', '3\'UTRA>G', 'CGAS', 'Breast Cancer', '17293864'),
(1382, 'TIMP2', '-418G>C', 'CGAS', 'Gastric Cancer', '18949424'),
(1383, 'NOS3', '4b/a', 'CGAS', 'Breast Cancer', '20720556'),
(1384, 'LTBP1', '-509C>T', 'CGAS', 'Gastric Cancer', '19375306'),
(1385, 'ATM', '5557G>A', 'CGAS', 'Breast Cancer', '20665102'),
(1386, 'PTGS2', '587codonG>A', 'CGAS', 'Stomach Cancer', '21086572'),
(1387, 'IL1A', '5953C>A', 'CGAS', 'Gastric Cancer', '19375306'),
(1388, 'EGF', '61A>G', 'CGAS', 'Stomach Cancer', '20207214'),
(1389, 'EGF', '61A>G', 'CGAS', 'Cancer', '20207214'),
(1390, 'EGF', '61A>G', 'CGAS', 'Glioma', '20207214'),
(1391, 'VEGFA', '634 G>C', 'CGAS', 'Cancer (General)', '21174216'),
(1392, 'VEGFA', '634 G>C', 'CGAS', 'Breast Cancer', '21174216'),
(1393, 'VEGFA', '634 G>C', 'CGAS', 'Gastric Cancer', '21174216'),
(1394, 'VEGFA', '634 G>C', 'CGAS', 'Colorectal Cancer', '21174216'),
(1395, 'CYBA', '640A>G', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1396, 'NBN', '657del5', 'CGAS', 'Breast Cancer', '16770759'),
(1397, 'ARL6IP5', '-76G>C', 'CGAS', 'Gastric Cancer', '19375306'),
(1398, 'XRCC1', '-77T>C', 'CGAS', 'Lung Cancer', '19116388'),
(1399, 'FASLG', '-844 T/C', 'CGAS', 'Cervical Cancer', '19403301'),
(1400, 'FASLG', '-844T/C', 'CGAS', 'Lung Cancer', '19403301'),
(1401, 'FASLG', '-844T/C', 'CGAS', 'Breast Cancer', '19403301'),
(1402, 'PTGS2', '8473T/C', 'CGAS', 'Stomach Cancer', '21086572'),
(1403, 'LTBP1', '869T>C', 'CGAS', 'Gastric Cancer', '19375306'),
(1404, 'NOS3', '894 G>T', 'CGAS', 'Breast Cancer', '20428939'),
(1405, 'PTGS2', '-899G>C', 'CGAS', 'Gastric Cancer', '19060633'),
(1406, 'PTGS2', '-899G>C', 'CGAS', 'Prostate Cancer', '19488068'),
(1407, 'IL1RN', '-9091A>C', 'CGAS', 'Gastric Cancer', '18949424'),
(1408, 'VEGFA', '936C>T', 'CGAS', 'Mouth Cancer', '20303008'),
(1409, 'VEGFA', '936C>T', 'CGAS', 'Cancer', '20303008'),
(1410, 'IL1RN', '-9739ins/del', 'CGAS', 'Gastric Cancer', '18949424'),
(1411, 'IL1RN', '-9876G>A', 'CGAS', 'Gastric Cancer', '18949424'),
(1412, 'HLA-A', 'A*01', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1413, 'HLA-A', 'A*02', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1414, 'HLA-A', 'A*03', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1415, 'HLA-A', 'A*11', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1416, 'HLA-A', 'A*24', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1417, 'HLA-A', 'A*26', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1418, 'HLA-A', 'A*29', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1419, 'HLA-A', 'A*30', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1420, 'HLA-A', 'A*31', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1421, 'HLA-A', 'A*32', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1422, 'HLA-A', 'A*33', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1423, 'HLA-A', 'A*68', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1424, 'GSTP1', 'A114V', 'CGAS', 'Lung Cancer', '16509765'),
(1425, 'ACE', 'A240T', 'CGAS', 'Breast Cancer', '21638051'),
(1426, 'XPC', 'A33512C', 'CGAS', 'Lung Cancer', '18097734'),
(1427, 'NUMA1', 'A794G', 'CGAS', 'Breast Cancer', '17293864'),
(1428, 'ACE', 'ACE', 'CGAS', 'Gastric Cancer', '19375306'),
(1429, 'ADH1C', 'ADH1C', 'CGAS', 'Head and Neck Cancer', '14693654'),
(1430, 'SOD2', 'Ala16Val', 'CGAS', 'Prostate Cancer', '19647296'),
(1431, 'ELAC2', 'Ala541Thr', 'CGAS', 'Prostate Cancer', '12783937'),
(1432, 'ELAC2', 'Ala541Thr', 'CGAS', 'Prostate Cancer', '12515253'),
(1433, 'ELAC2', 'Ala541Thr', 'CGAS', 'Prostate Cancer', '12373607'),
(1434, 'ELAC2', 'Ala541Thr', 'CGAS', 'Prostatic Cancer', '20231859'),
(1435, 'SOD2', 'Ala9Val', 'CGAS', 'Prostate Cancer', '19647296'),
(1436, 'SOD2', 'Ala9Val', 'CGAS', 'Prostate Cancer', '19467856'),
(1437, 'BRCA1', 'Any variant', 'CGAS', 'Prostate Cancer', '21520156'),
(1438, 'AR', 'AR', 'CGAS', 'Breast Cancer', '16987421'),
(1439, 'SULT1A1', 'Arg213His', 'CGAS', 'Breast Cancer', '20505990'),
(1440, 'HLA-B', 'B*07', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1441, 'HLA-B', 'B*08', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1442, 'HLA-B', 'B*13', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1443, 'HLA-B', 'B*15', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1444, 'HLA-B', 'B*18', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1445, 'HLA-B', 'B*27', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1446, 'HLA-B', 'B*35', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1447, 'HLA-B', 'B*37', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1448, 'HLA-B', 'B*38', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1449, 'HLA-B', 'B*40', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1450, 'HLA-B', 'B*44', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1451, 'HLA-B', 'B*49', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1452, 'HLA-B', 'B*50', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1453, 'HLA-B', 'B*51', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1454, 'HLA-B', 'B*52', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1455, 'HLA-B', 'B*55', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1456, 'HLA-B', 'B*57', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1457, 'HLA-B', 'B*58', 'CGAS', 'Myeloid Leukemia Chronic', '20388056'),
(1458, 'BRAF', 'BRAF', 'CGAS', 'Thyroid Cancer', '17520704'),
(1459, 'BRCA1', 'BRCA1', 'CGAS', 'Breast Cancer', '17416853'),
(1460, 'BRCA1', 'BRCA1', 'CGAS', 'Ovarian Cancer', '17416853'),
(1461, 'BRCA2', 'BRCA2', 'CGAS', 'Breast Cancer', '17416853'),
(1462, 'BRCA2', 'BRCA2', 'CGAS', 'Ovarian Cancer', '17416853'),
(1463, 'ATM', 'C.1066-6T > G', 'CGAS', 'Breast Cancer', '20544271'),
(1464, 'BRCA1', 'c.5266dupC', 'CGAS', 'Prostate Cancer', '21520156'),
(1465, 'BRCA1', 'c.68_69delAG', 'CGAS', 'Prostate Cancer', '21520156'),
(1466, 'ERCC1', 'C118T', 'CGAS', 'Lung Cancer', '20143185'),
(1467, 'XPC', 'C21151T', 'CGAS', 'Lung Cancer', '18097734'),
(1468, 'TGFB1', 'C-509T', 'CGAS', 'Breast Cancer', '20309626'),
(1469, 'TGFB1', 'C-509T', 'CGAS', 'Breast Cancer', '20349216'),
(1470, 'TNFRSF10A', 'C626G', 'CGAS', 'Digestive System Neoplasms', '19643596'),
(1471, 'AR', 'CAG21', 'CGAS', 'Prostate Cancer', '15533905'),
(1472, 'CYP1A1', 'CYP1A1', 'CGAS', 'Prostate Cancer', '19472123'),
(1473, 'CYP1A1', 'CYP1A1', 'CGAS', 'Lung Cancer', '17307802'),
(1474, 'CYP1A1', 'CYP1A1', 'CGAS', 'Breast Cancer', '16614098'),
(1475, 'LIG4', 'D501D', 'CGAS', 'Breast Cancer', '17018785'),
(1476, 'HLA-DRB1', 'DRB1*07', 'CGAS', 'Hepatocellular Carcinoma', '21172035');
INSERT INTO `genes` (`id`, `gene-name`, `Marker`, `Study-type`, `Disease`, `Pubmed-ID`) VALUES
(1477, 'HLA-DRB1', 'DRB1*12', 'CGAS', 'Hepatocellular Carcinoma', '21172035'),
(1478, 'HLA-DRB1', 'DRB1*15', 'CGAS', 'Hepatocellular Carcinoma', '21172035'),
(1479, 'APC', 'E1317Q', 'CGAS', 'Colorectal Cancer', '17119068'),
(1480, 'VDR', 'EcoRV', 'CGAS', 'Skin Cancer', '18816636'),
(1481, 'EGFR', 'EGFR', 'CGAS', 'Lung Cancer', '19430813'),
(1482, 'EGFR', 'EGFR TK+', 'CGAS', 'Lung Cancer', '19430813'),
(1483, 'NOD2', 'Ex11-35>C', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(1484, 'MTHFR', 'Ex5+79T', 'CGAS', 'Non-Hodgkin Lymphoma', '17891500'),
(1485, 'CYP1A1', 'Exon 7', 'CGAS', 'Laryngeal Cancer', '19252926'),
(1486, 'CYP1A1', 'exon7', 'CGAS', 'Oral Cancer', '18496222'),
(1487, 'CYP1A1', 'exon7', 'CGAS', 'Oral Cancer', '19160101'),
(1488, 'WRAP53', 'F150F', 'CGAS', 'Breast Cancer', '17683073'),
(1489, 'NAT1', 'Fast acetylator', 'CGAS', 'Colorectal Cancer', '12433710'),
(1490, 'XPA', 'G23A', 'CGAS', 'Lung Cancer', '17299578'),
(1491, 'XPA', 'G23A', 'CGAS', 'Lung Cancer', '19116388'),
(1492, 'XPA', 'G23A', 'CGAS', 'Lung Cancer', '18990748'),
(1493, 'MUTYH', 'G382D', 'CGAS', 'Colorectal Cancer', '17368238'),
(1494, 'MUTYH', 'G382D Y165C', 'CGAS', 'Colorectal Cancer', '17368238'),
(1495, 'MUTYH', 'G396D', 'CGAS', 'Colorectal Cancer', '21063410'),
(1496, 'MUTYH', 'G396D Y179C', 'CGAS', 'Colorectal Cancer', '21063410'),
(1497, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Squamous Cell Carcinoma of the Head and Neck', '22011187'),
(1498, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Oral Cancer', '22011187'),
(1499, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Lung Cancer', '22011187'),
(1500, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Epithelial Ovarian Gastric Cervical Squamous Cell C', '22011187'),
(1501, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Colorectal Cancer', '22011187'),
(1502, 'TP53', 'G4C14-to-A4T14', 'CGAS', 'Cancer (General)', '22011187'),
(1503, 'POR', 'G5G', 'CGAS', 'Breast Cancer', '17440066'),
(1504, 'CCND1', 'G870A', 'CGAS', 'Cervical Cancer', '20473525'),
(1505, 'QRSL1', 'GATA', 'CGAS', 'Skin Cancer', '19615888'),
(1506, 'AR', 'GGN16', 'CGAS', 'Prostate Cancer', '15533905'),
(1507, 'RNASEL', 'Glu265X', 'CGAS', 'Prostate Cancer', '15824169'),
(1508, 'RNASEL', 'Glu265X', 'CGAS', 'Prostate Cancer', '17020975'),
(1509, 'PTGS2', 'Gly587Arg(G>A)', 'CGAS', 'Stomach Cancer', '21086572'),
(1510, 'GPX1', 'GPX1', 'CGAS', 'Lung Cancer', '15829318'),
(1511, 'GSTA1', 'GSTA1', 'CGAS', 'Colorectal Cancer', '20207535'),
(1512, 'GSTM1', 'GSTM null', 'CGAS', 'Lung Cancer', '20027111'),
(1513, 'GSTM1', 'GSTM null', 'CGAS', 'Cancer', '20027111'),
(1514, 'GSTM1', 'GSTM1 null', 'CGAS', 'Leukemia', '19860557'),
(1515, 'GSTM1', 'GSTM1 null', 'CGAS', 'Colorectal Cancer', '15637738'),
(1516, 'GSTM1', 'GSTM1 null', 'CGAS', 'Head and Neck Cancer', '16302194'),
(1517, 'GSTM1', 'GSTM1 null', 'CGAS', 'Glioma', '16030117'),
(1518, 'GSTM1', 'GSTM1 null', 'CGAS', 'Leukemia', '15862746'),
(1519, 'GSTM1', 'GSTM1 null', 'CGAS', 'Esophageal Cancer', '15849806'),
(1520, 'GSTM1', 'GSTM1 null', 'CGAS', 'Prostate Cancer', '15668493'),
(1521, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '15342448'),
(1522, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '14973092'),
(1523, 'GSTM1', 'GSTM1 null', 'CGAS', 'Colorectal Cancer', '14523342'),
(1524, 'GSTM1', 'GSTM1 null', 'CGAS', 'Colorectal Cancer', '12433710'),
(1525, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '11950848'),
(1526, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '16509765'),
(1527, 'GSTM1', 'GSTM1 null', 'CGAS', 'LCC - Liver cell carcinoma', '18065725'),
(1528, 'GSTM1', 'GSTM1 null', 'CGAS', 'Oral Cancer', '18496222'),
(1529, 'GSTM1', 'GSTM1 null', 'CGAS', 'Nasopharyngeal Cancer', '19338664'),
(1530, 'GSTM1', 'GSTM1 null', 'CGAS', 'Laryngeal Cancer', '19252926'),
(1531, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '19228880'),
(1532, 'GSTM1', 'GSTM1 null', 'CGAS', 'Oral Cancer', '19160101'),
(1533, 'GSTM1', 'GSTM1 null', 'CGAS', 'Prostate Cancer', '19143011'),
(1534, 'GSTM1', 'GSTM1 null', 'CGAS', 'Bladder Cancer', '10970445'),
(1535, 'GSTM1', 'GSTM1 null', 'CGAS', 'Leukemia', '19811334'),
(1536, 'GSTM1', 'GSTM1 null', 'CGAS', 'Bladder Cancer', '21082260'),
(1537, 'GSTM1', 'GSTM1 null', 'CGAS', 'Stomach Cancer', '19763824'),
(1538, 'GSTM1', 'GSTM1 null', 'CGAS', 'Esophageal Cancer', '19618282'),
(1539, 'GSTM1', 'GSTM1 null', 'CGAS', 'Gastric Cancer', '19506726'),
(1540, 'GSTM1', 'GSTM1 null', 'CGAS', 'Bladder Cancer', '16112301'),
(1541, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '16009381'),
(1542, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '15829318'),
(1543, 'GSTM1', 'GSTM1 null', 'CGAS', 'Gastric Cancer', '15596296'),
(1544, 'GSTM1', 'GSTM1 null', 'CGAS', 'Head and Neck Cancer', '15121774'),
(1545, 'GSTM1', 'GSTM1 null', 'CGAS', 'Head and Neck Cancer', '14693745'),
(1546, 'GSTM1', 'GSTM1 null', 'CGAS', 'Colorectal Cancer', '12944179'),
(1547, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '12771031'),
(1548, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '12151353'),
(1549, 'GSTM1', 'GSTM1 null', 'CGAS', 'Bladder Cancer', '12117698'),
(1550, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '16614098'),
(1551, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '17900751'),
(1552, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '17428724'),
(1553, 'GSTM1', 'GSTM1 null', 'CGAS', 'Ovarian Cancer', '18768514'),
(1554, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '18463401'),
(1555, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '18270371'),
(1556, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '19124497'),
(1557, 'GSTM1', 'GSTM1 null', 'CGAS', 'Lung Cancer', '11751442'),
(1558, 'GSTM1', 'GSTM1 null', 'CGAS', 'Colorectal Cancer', '11487538'),
(1559, 'GSTM1', 'GSTM1 null', 'CGAS', 'Oral Cancer', '21436184'),
(1560, 'GSTM1', 'GSTM1 null', 'CGAS', 'Gastric Cancer', '21553222'),
(1561, 'GSTM1', 'GSTM1 null', 'CGAS', 'Ovarian Cancer', '20966642'),
(1562, 'GSTM1', 'GSTM1 Null', 'CGAS', 'Colorectal Cancer', '20207535'),
(1563, 'GSTM1', 'GSTM1 null', 'CGAS', 'Breast Cancer', '19936916'),
(1564, 'GSTM1', 'GSTM1 null', 'CGAS', 'Preleukemia', '19816935'),
(1565, 'GSTM1', 'GSTM1 null', 'CGAS', 'Cervical Cancer', '21150818'),
(1566, 'GSTM1', 'GSTM1 null', 'CGAS', 'Hepatocellular Carcinoma', '21912475'),
(1567, 'GSTM1', 'GSTM1 null', 'CGAS', 'Cervical Cancer', '21962942'),
(1568, 'GSTM1', 'GSTM1 null', 'CGAS', 'Cervical Cancer', '21520994'),
(1569, 'GSTM1', 'GSTM1 null', 'CGAS', 'Squamous cell carcinoma (Cervical Cancer)', '21520994'),
(1570, 'GSTM1', 'GSTM1 null', 'CGAS', 'Adenocarcinoma (Cervical Cancer)', '21520994'),
(1571, 'GSTM1', 'GSTM1 null', 'CGAS', 'Gallbladder Cancer', '21708280'),
(1572, 'GSTM1', 'GSTM1 null', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1573, 'GSTM1', 'GSTM1 null', 'CGAS', 'Cervical Cancer', '21629772'),
(1574, 'GSTM1', 'GSTM1 null GSTT1 null', 'CGAS', 'Lung Cancer', '19124497'),
(1575, 'GSTM1', 'GSTM1 null GSTT1 null', 'CGAS', 'Oral Cancer', '21436184'),
(1576, 'GSTM1', 'GSTM1 present', 'CGAS', 'Lung Cancer', '19124497'),
(1577, 'GSTM1', 'GSTM1 present GSTT1 present', 'CGAS', 'Lung Cancer', '19124497'),
(1578, 'GSTM1', 'GSTM1null', 'CGAS', 'Colorectal Cancer', '20123161'),
(1579, 'GSTM3', 'GSTM3', 'CGAS', 'Lung Cancer', '15829318'),
(1580, 'GSTP1', 'GSTP1', 'CGAS', 'Prostate Cancer', '19143011'),
(1581, 'GSTP1', 'GSTP1', 'CGAS', 'Lung Cancer', '15829318'),
(1582, 'HLA-A', 'HLA-A*11', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1583, 'HLA-A', 'HLA-A*74', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1584, 'HLA-B', 'HLA-B*40', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1585, 'HLA-B', 'HLA-B*47', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1586, 'HLA-B', 'HLA-B*55', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1587, 'HLA-B', 'HLA-B*81', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1588, 'HLA-DRB1', 'HLA-DRB1*13', 'CGAS', 'Chronic Myelogenous Leukemia', '21840597'),
(1589, 'RASSF7', 'HRAS1', 'CGAS', 'Breast Cancer', '11950848'),
(1590, 'IGF1', 'IGF1', 'CGAS', 'Pancreatic Cancer', '19491931'),
(1591, 'IGF1', 'IGF1', 'CGAS', 'Endometrial Cancer', '19491931'),
(1592, 'IGF1', 'IGF1', 'CGAS', 'Ovarian Cancer', '19491931'),
(1593, 'IGF1', 'IGF1', 'CGAS', 'Lung Cancer', '19491931'),
(1594, 'IGF1', 'IGF1', 'CGAS', 'Prostate Cancer', '19491931'),
(1595, 'IGF1', 'IGF-1', 'CGAS', 'Breast Cancer', '19491931'),
(1596, 'IGF1', 'IGF-1', 'CGAS', 'Colorectal Cancer', '19491931'),
(1597, 'IL1A', 'IL1B-511', 'CGAS', 'Stomach Cancer', '20200422'),
(1598, 'IL1RN', 'IL1RN', 'CGAS', 'Gastric Cancer', '19506726'),
(1599, 'IL1RN', 'IL1RN VNTR', 'CGAS', 'Stomach Cancer', '20200422'),
(1600, 'IL1A', 'IL1RN VNTR', 'CGAS', 'Stomach Cancer', '20200422'),
(1601, 'NBN', 'Ile171Val', 'CGAS', 'Breast Cancer', '18049891'),
(1602, 'MSR1', 'Indel 7 delTTA', 'CGAS', 'Prostate Cancer', '16425212'),
(1603, 'MSR1', 'INDEL1', 'CGAS', 'Prostate Cancer', '16425212'),
(1604, 'ACE', 'insertion/deletion', 'CGAS', 'Cancer (General)', '21395549'),
(1605, 'FLT3', 'Internal tandem duplication (ITD)', 'CGAS', 'Leukemia', '20096459'),
(1606, 'TP53', 'Intron 6', 'CGAS', 'Breast Cancer', '19116388'),
(1607, 'ATM', 'IVS1+19A>T', 'CGAS', 'Breast Cancer', '20665102'),
(1608, 'TP53', 'IVS3 16 bp Del/Ins', 'CGAS', 'Breast Cancer', '19657731'),
(1609, 'ATM', 'IVS38-8T>C', 'CGAS', 'Breast Cancer', '20665102'),
(1610, 'PTGS2', 'IVS5-275T>G', 'CGAS', 'Stomach Cancer', '21086572'),
(1611, 'MSR1', 'IVS5-59 C/A', 'CGAS', 'Prostate Cancer', '15824169'),
(1612, 'MSR1', 'IVS5-59 C/A', 'CGAS', 'Prostate Cancer', '16425212'),
(1613, 'XRCC3', 'IVS7 17893 A>G', 'CGAS', 'Breast Cancer', '19116388'),
(1614, 'MSR1', 'IVS7 delTTA', 'CGAS', 'Prostate Cancer', '15824169'),
(1615, 'PTGS2', 'IVS7+111T>C', 'CGAS', 'Stomach Cancer', '21086572'),
(1616, 'PARP1', 'IVS9 + 104 A>G', 'CGAS', 'Breast Cancer', '19116388'),
(1617, 'ERCC2', 'K752Q', 'CGAS', 'melanoma', '20601096'),
(1618, 'TGFB1', 'L10P', 'CGAS', 'Breast Cancer', '17293864'),
(1619, 'TGFB1', 'L10P', 'CGAS', 'Breast Cancer', '17018785'),
(1620, 'TGFB1', 'L10P', 'CGAS', 'Breast Cancer', '20349130'),
(1621, 'TGFB1', 'L10P', 'CGAS', 'Breast Cancer', '20143152'),
(1622, 'AGT', 'M235T', 'CGAS', 'Breast Cancer', '21638051'),
(1623, 'POLH', 'M595V', 'CGAS', 'Skin Cancer', '19477635'),
(1624, 'ALDH2', 'Mboll', 'CGAS', 'Gastric Cancer', '19375306'),
(1625, 'MC1R', 'MC1R copy', 'CGAS', 'Melanoma', '20189796'),
(1626, 'SOD2', 'MnSOD2', 'CGAS', 'Breast Cancer', '16614098'),
(1627, 'MPO', 'MPO', 'CGAS', 'Lung Cancer', '15829318'),
(1628, 'MSR1', 'MSR1', 'CGAS', 'Prostate Cancer', '15824169'),
(1629, 'MUTYH', 'MUTYH', 'CGAS', 'Colorectal Cancer', '16804517'),
(1630, 'MUTYH', 'MUTYH', 'CGAS', 'Colorectal Cancer', '21063410'),
(1631, 'NAT1', 'NAT1', 'CGAS', 'Breast Cancer', '16614098'),
(1632, 'NBN', 'NBS1 8360', 'CGAS', 'Breast Cancer', '20143155'),
(1633, 'NQO1', 'NQ01', 'CGAS', 'Leukemia', '18945694'),
(1634, 'TGFB1', 'NR', 'CGAS', 'Colorectal Cancer', '20012233'),
(1635, 'CASP9', 'NR', 'CGAS', 'Non-Hodgkin Lymphoma', '19414860'),
(1636, 'KIT', 'NR', 'CGAS', 'Gastrointestinal Stromal Tumors', '20806443'),
(1637, 'KRAS', 'NR', 'CGAS', 'Colorectal Cancer', '20580219'),
(1638, 'BRCA2', 'NR', 'CGAS', 'Ovarian Cancer', '20537530'),
(1639, 'BRCA2', 'NR', 'CGAS', 'Breast Cancer', '20537530'),
(1640, 'KRAS', 'NR', 'CGAS', 'Lung Cancer', '20022659'),
(1641, 'BRCA1', 'NR', 'CGAS', 'Breast Cancer', '20537530'),
(1642, 'BRCA1', 'NR', 'CGAS', 'Ovarian Cancer', '20537530'),
(1643, 'BRAF', 'NR', 'CGAS', 'Colorectal Cancer', '20514492'),
(1644, 'CYP1A1', 'NR', 'CGAS', 'Lung Cancer', '20027111'),
(1645, 'CYP1A1', 'NR', 'CGAS', 'Cancer', '20027111'),
(1646, 'CYP1A1', 'NR', 'CGAS', 'Breast Cancer', '20027111'),
(1647, 'MC1R', 'NR', 'CGAS', 'Melanoma', '20189796'),
(1648, 'GSTA1', 'NR', 'CGAS', 'Colorectal Cancer', '20207535'),
(1649, 'MC1R', 'NRHC', 'CGAS', 'melanoma', '21128237'),
(1650, 'NOD2', 'P286S', 'CGAS', 'Colorectal Cancer', '19787357'),
(1651, 'TP53', 'P53', 'CGAS', 'Lung Cancer', '12840112'),
(1652, 'XPC', 'PAT +/-', 'CGAS', 'Lung Cancer', '18097734'),
(1653, 'XPC', 'PAT +/-', 'CGAS', 'Lung Cancer', '18771913'),
(1654, 'XPC', 'PAT+', 'CGAS', 'Breast Cancer', '21318603'),
(1655, 'XPC', 'Pat+/-', 'CGAS', 'Bladder Cancer', '18097734'),
(1656, 'XPC', 'PAT+/-', 'CGAS', 'Head and Neck Cancer', '18097734'),
(1657, 'XPC', 'Pat+/-', 'CGAS', 'Bladder Cancer', '18771913'),
(1658, 'GPX1', 'Pro198Leu', 'CGAS', 'Breast Cancer', '20306294'),
(1659, 'MSR1', 'PRO3 AG', 'CGAS', 'Prostate Cancer', '16425212'),
(1660, 'SPINK1', 'Pro55Ser', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1661, 'MSR1', 'R293X', 'CGAS', 'Prostate Cancer', '15824169'),
(1662, 'MSR1', 'R293X', 'CGAS', 'Prostate Cancer', '15734964'),
(1663, 'MSR1', 'R293X', 'CGAS', 'Prostate Cancer', '16425212'),
(1664, 'NAT1', 'Rapid acetylator', 'CGAS', 'Bladder Cancer', '17675654'),
(1665, 'NAT1', 'Rapid acetylator', 'CGAS', 'Prostatic Cancer', '20099048'),
(1666, 'RASSF7', 'rare allele', 'CGAS', 'Breast Cancer', '21221763'),
(1667, 'MC1R', 'RHC (+)', 'CGAS', 'melanoma', '21128237'),
(1668, 'MC1R', 'RHC core', 'CGAS', 'melanoma', '21128237'),
(1669, 'FGFR2', 'rs10003827', 'CGAS', 'Ovarian Cancer', '19456219'),
(1670, 'CAT', 'rs1001179', 'CGAS', 'Non-Hodgkin Lymphoma', '16956821'),
(1671, 'CYP1B1', 'rs10012', 'CGAS', 'Endometrial Cancer', '21191305'),
(1672, 'CYP1B1', 'rs10012', 'CGAS', 'Lung Cancer', '21674184'),
(1673, 'CYP19A1', 'rs10046', 'CGAS', 'Breast Cancer', '17325027'),
(1674, 'CYP19A1', 'rs1004984', 'CGAS', 'Breast Cancer', '17325027'),
(1675, 'CYP19A1', 'rs1008805', 'CGAS', 'Breast Cancer', '17325027'),
(1676, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '19682377'),
(1677, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '19657731'),
(1678, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '19629678'),
(1679, 'TP53', 'rs1042522', 'CGAS', 'Cervical Cancer', '19625214'),
(1680, 'TP53', 'rs1042522', 'CGAS', 'Nasopharyngeal Cancer', '19608020'),
(1681, 'TP53', 'rs1042522', 'CGAS', 'Gastric Cancer', '19536170'),
(1682, 'TP53', 'rs1042522', 'CGAS', 'Gastric Cancer', '19506726'),
(1683, 'TP53', 'rs1042522', 'CGAS', 'Prostate Cancer', '19499352'),
(1684, 'TP53', 'rs1042522', 'CGAS', 'Cervical Cancer', '15145278'),
(1685, 'TP53', 'rs1042522', 'CGAS', 'Cervical Cancer', '14744727'),
(1686, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '11950848'),
(1687, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '17018785'),
(1688, 'TP53', 'rs1042522', 'CGAS', 'Cervical Cancer', '17912468'),
(1689, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '17909070'),
(1690, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '17683073'),
(1691, 'TP53', 'rs1042522', 'CGAS', 'Gastric Cancer', '17546594'),
(1692, 'TP53', 'rs1042522', 'CGAS', 'Ovarian Cancer', '19276375'),
(1693, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '20564066'),
(1694, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '20564066'),
(1695, 'TP53', 'rs1042522', 'CGAS', 'Mouth Cancer', '20082880'),
(1696, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '19623649'),
(1697, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '12840112'),
(1698, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '18990748'),
(1699, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '19357867'),
(1700, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '19178978'),
(1701, 'TP53', 'rs1042522', 'CGAS', 'Lung Cancer', '19116388'),
(1702, 'TP53', 'rs1042522', 'CGAS', 'Bladder Cancer', '20730711'),
(1703, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '20496166'),
(1704, 'TP53', 'rs1042522', 'CGAS', 'Oesophageal Cancer', '20389250'),
(1705, 'TP53', 'rs1042522', 'CGAS', 'Bladder Cancer', '20630574'),
(1706, 'TP53', 'rs1042522', 'CGAS', 'Colorectal Cancer', '20615891'),
(1707, 'TP53', 'rs1042522', 'CGAS', 'Colorectal Cancer', '20363586'),
(1708, 'TP53', 'rs1042522', 'CGAS', 'Endometrial Cancer', '20552298'),
(1709, 'TP53', 'rs1042522', 'CGAS', 'Skin Cancer', '20861852'),
(1710, 'TP53', 'rs1042522', 'CGAS', 'Prostatic Cancer', '20842446'),
(1711, 'TP53', 'rs1042522', 'CGAS', 'Oesophageal Cancer', '20827430'),
(1712, 'TP53', 'rs1042522', 'CGAS', 'Colorectal Cancer', '21140221'),
(1713, 'TP53', 'rs1042522', 'CGAS', 'Ovarian Cancer', '21952824'),
(1714, 'TP53', 'rs1042522', 'CGAS', 'Gallbladder Cancer', '21708280'),
(1715, 'TP53', 'rs1042522', 'CGAS', 'Breast Cancer', '21604156'),
(1716, 'TP53', 'rs1042523', 'CGAS', 'Prostate Cancer', '19499352'),
(1717, 'TP53', 'rs1042524', 'CGAS', 'Prostate Cancer', '19499352'),
(1718, 'TP53', 'rs1042525', 'CGAS', 'Prostate Cancer', '19499352'),
(1719, 'TP53', 'rs1042526', 'CGAS', 'Prostate Cancer', '19499352'),
(1720, 'PGR', 'rs1042838', 'CGAS', 'Breast Cancer', '17018785'),
(1721, 'PGR', 'rs1042838', 'CGAS', 'Breast Cancer', '16614108'),
(1722, 'PGR', 'rs1042838', 'CGAS', 'Ovarian Cancer', '18219286'),
(1723, 'PGR', 'rs1042838', 'CGAS', 'Breast Cancer', '17592773'),
(1724, 'PGR', 'rs1042838', 'CGAS', 'Breast Cancer', '19423537'),
(1725, 'FGFR2', 'rs10452197', 'CGAS', 'Ovarian Cancer', '19456219'),
(1726, 'CASP8', 'rs1045485', 'CGAS', 'Breast Cancer', '17293864'),
(1727, 'CASP8', 'rs1045485', 'CGAS', 'Breast Cancer', '17018785'),
(1728, 'CASP8', 'rs1045485', 'CGAS', 'Ovarian Cancer', '18431743'),
(1729, 'CASP8', 'rs1045485', 'CGAS', 'Breast Cancer', '19629679'),
(1730, 'ABCB1', 'rs1045642', 'CGAS', 'Breast Cancer', '20625815'),
(1731, 'JAZF1', 'rs10486567', 'CGAS', 'Prostate Cancer', '21343373'),
(1732, 'CYP1A1', 'rs1048943', 'CGAS', 'Esophageal Cancer', '15849806'),
(1733, 'CYP1A1', 'rs1048943', 'CGAS', 'Breast Cancer', '11950848'),
(1734, 'CYP1A1', 'rs1048943', 'CGAS', 'Breast Cancer', '17427032'),
(1735, 'CYP1A1', 'rs1048943', 'CGAS', 'Ovarian Cancer', '19127255'),
(1736, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '10761998'),
(1737, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '22014025'),
(1738, 'CYP1A1', 'rs1048943', 'CGAS', 'Breast Cancer', '15870154'),
(1739, 'CYP1A1', 'rs1048943', 'CGAS', 'Head and Neck Cancer', '14693745'),
(1740, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '12846365'),
(1741, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '12771031'),
(1742, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '17900751'),
(1743, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '18463401'),
(1744, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '21402622'),
(1745, 'CYP1A1', 'rs1048943', 'CGAS', 'Cancer', '20027111'),
(1746, 'CYP1A1', 'rs1048943', 'CGAS', 'Breast Cancer', '20027111'),
(1747, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '20428802'),
(1748, 'CYP1A1', 'rs1048943', 'CGAS', 'Squamous Lung Cancer', '22025136'),
(1749, 'CYP1A1', 'rs1048943', 'CGAS', 'Small Cell Lung Cancer', '22025136'),
(1750, 'CYP1A1', 'rs1048943', 'CGAS', 'Small Cell Lung Cancer', '22014025'),
(1751, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung squamous carcinoma', '22014025'),
(1752, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '22025136'),
(1753, 'CYP1A1', 'rs1048943', 'CGAS', 'AdenocarcinomaLung Cancer', '22025136'),
(1754, 'CYP1A1', 'rs1048943', 'CGAS', 'Adenocarcinoma of Lung', '22014025'),
(1755, 'CYP1A1', 'rs1048943', 'CGAS', 'Gallbladder Cancer', '21708280'),
(1756, 'CYP1A1', 'rs1048943', 'CGAS', 'Endometrial Cancer', '21270613'),
(1757, 'CYP1A1', 'rs1048943', 'CGAS', 'Colorectal Cancer', '21246002'),
(1758, 'CYP1A1', 'rs1048943', 'CGAS', 'Pancreatic Cancer', '21383623'),
(1759, 'GSTM1', 'rs1048943', 'CGAS', 'Lung Cancer', '21859547'),
(1760, 'CYP1A1', 'rs1048943', 'CGAS', 'Lung Cancer', '21859547'),
(1761, 'CHAF1A', 'rs105038', 'CGAS', 'Glioma', '18048407'),
(1762, 'GPX1', 'rs1050450', 'CGAS', 'Non-Hodgkin Lymphoma', '16956821'),
(1763, 'GPX1', 'rs1050450', 'CGAS', 'Prostate Cancer', '21842217'),
(1764, 'GPX1', 'rs1050450', 'CGAS', 'Multiple', '21842217'),
(1765, 'GPX1', 'rs1050450', 'CGAS', 'Lung Cancer', '21842217'),
(1766, 'GPX1', 'rs1050450', 'CGAS', 'Colorectal Cancer', '21842217'),
(1767, 'GPX1', 'rs1050450', 'CGAS', 'Cancer (General)', '21842217'),
(1768, 'GPX1', 'rs1050450', 'CGAS', 'Breast Cancer', '21842217'),
(1769, 'GPX1', 'rs1050450', 'CGAS', 'Bladder Cancer', '21842217'),
(1770, 'EPHX1', 'rs1051740', 'CGAS', 'Lung Cancer', '12141066'),
(1771, 'EPHX1', 'rs1051740', 'CGAS', 'Lung Cancer', '16357600'),
(1772, 'OGG1', 'rs1052133', 'CGAS', 'Breast Cancer', '20054639'),
(1773, 'OGG1', 'rs1052133', 'CGAS', 'Breast Cancer', '20058067'),
(1774, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer', '21790253'),
(1775, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer', '16221808'),
(1776, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer', '16982113'),
(1777, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer', '18990748'),
(1778, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer', '20981350'),
(1779, 'OGG1', 'rs1052133', 'CGAS', 'Prostate Cancer', '21914193'),
(1780, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer (Adenocarcinoma)', '21790253'),
(1781, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer (Squamous Cell Carcinoma)', '21790253'),
(1782, 'OGG1', 'rs1052133', 'CGAS', 'Lung Cancer (Small Cell)', '21790253'),
(1783, 'OGG1', 'rs1052133', 'CGAS', 'Gallbladder Cancer', '21708280'),
(1784, 'OGG1', 'rs1052133', 'CGAS', 'Colorectal Cancer', '21695387'),
(1785, 'OGG1', 'rs1052134', 'CGAS', 'Digestive System Neoplasms', '16221808'),
(1786, 'ICAM5', 'rs1056538', 'CGAS', 'Breast Cancer', '17293864'),
(1787, 'CTBP2', 'rs4962416', 'CGAS', 'Prostatic Cancer', '20564319'),
(1788, 'CTBP2', 'rs4962416', 'CGAS', 'Prostate Cancer', '21343373'),
(1789, 'CYP1A1', 'rs1048943', 'CGAS', 'Breast Cancer', '20035380'),
(1790, 'BRIP1', 'rs4968451', 'CGAS', 'Meningioma', '18270339'),
(1791, 'SLC4A7', 'rs4973768', 'CGAS', 'Breast Cancer', '21194473'),
(1792, 'SLC4A7', 'rs4973768', 'CGAS', 'Breast Cancer', '21118973'),
(1793, 'CYP1A1', 'rs4986883', 'CGAS', 'Breast Cancer', '20035380'),
(1794, 'ESR2', 'rs4986938', 'CGAS', 'Breast Cancer', '17935138'),
(1795, 'ESR2', 'rs4986938', 'CGAS', 'Prostate Cancer', '17932344'),
(1796, 'ESR2', 'rs4986938', 'CGAS', 'Breast Cancer', '20390341'),
(1797, 'BRCA2', 'rs4987117', 'CGAS', 'Breast Cancer', '19116388'),
(1798, 'CDH1', 'rs5030625', 'CGAS', 'Colorectal Cancer', '21997289'),
(1799, 'CDH1', 'rs5030625', 'CGAS', 'Gastric Cancer', '21570316'),
(1800, 'DCN', 'rs516115', 'CGAS', 'Ovarian Cancer', '21637745'),
(1801, 'AGTR1', 'rs5186', 'CGAS', 'Breast Cancer', '21638051'),
(1802, 'SRD5A2', 'rs523349', 'CGAS', 'Prostate Cancer', '12869400'),
(1803, 'SRD5A2', 'rs523349', 'CGAS', 'Prostatic Cancer', '19914946'),
(1804, 'SRD5A2', 'rs523349', 'CGAS', 'Prostatic Cancer', '19760631'),
(1805, 'SRD5A2', 'rs523349', 'CGAS', 'Prostate Cancer', '21177315'),
(1806, 'PTGS2', 'rs5275', 'CGAS', 'Breast Cancer', '20033767'),
(1807, 'PTGS2', 'rs5275', 'CGAS', 'Breast Cancer', '17214885'),
(1808, 'PTGS2', 'rs5275', 'CGAS', 'Prostate Cancer', '17999989'),
(1809, 'PTGS2', 'rs5275', 'CGAS', 'Ovarian Cancer', '20559705'),
(1810, 'PTGS2', 'rs5275', 'CGAS', 'Lung Cancer', '21198273'),
(1811, 'PTGS2', 'rs5275', 'CGAS', 'Cancer', '20594217'),
(1812, 'PTGS2', 'rs5275', 'CGAS', 'Digestive System Neoplasms', '20594217'),
(1813, 'PTGS2', 'rs5275', 'CGAS', 'Esophageal Cancer', '21304218'),
(1814, 'PTGS2', 'rs5277', 'CGAS', 'Breast Cancer', '20033767'),
(1815, 'PTGS2', 'rs5277', 'CGAS', 'Prostate Cancer', '17999989'),
(1816, 'PTGS2', 'rs5277', 'CGAS', 'Gastric Cancer', '19060633'),
(1817, 'PTGS2', 'rs5277', 'CGAS', 'Stomach Cancer', '21086572'),
(1818, 'IL12A', 'rs568408', 'CGAS', 'Glioma', '17916900'),
(1819, 'GATA3', 'rs570613', 'CGAS', 'Breast Cancer', '18006915'),
(1820, 'GATA3', 'rs570613', 'CGAS', 'Breast Cancer', '19082709'),
(1821, 'CTLA4', 'rs5742909', 'CGAS', 'Cancer (General)', '21387262'),
(1822, 'CTLA4', 'rs5742909', 'CGAS', 'Cervical Cancer', '21387262'),
(1823, 'NOD2', 'rs5743260', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1824, 'CCND1', 'rs603965', 'CGAS', 'Ovarian Cancer', '17409409'),
(1825, 'CCND1', 'rs603965', 'CGAS', 'Head and Neck Cancer', '19116388'),
(1826, 'PGR', 'rs608995', 'CGAS', 'Ovarian Cancer', '18219286'),
(1827, 'AR', 'rs6152', 'CGAS', 'Breast Cancer', '16987421'),
(1828, 'DRD2', 'rs6277', 'CGAS', 'Gastric Cancer', '19375306'),
(1829, 'RNASEL', 'rs627928', 'CGAS', 'Prostate Cancer', '17020975'),
(1830, 'RNASEL', 'rs627928', 'CGAS', 'Prostate Cancer', '21656378'),
(1831, 'SRD5A2', 'rs632148', 'CGAS', 'Ovarian Cancer', '18431743'),
(1832, 'CYP2E1', 'rs6413432', 'CGAS', 'Lung Cancer', '20031389'),
(1833, 'CYP2E1', 'rs6413432', 'CGAS', 'Head and Neck Cancer', '20969746'),
(1834, 'LMTK2', 'rs6465657', 'CGAS', 'Prostatic Cancer', '20564319'),
(1835, 'CYP19A1', 'rs6493494', 'CGAS', 'Breast Cancer', '17325027'),
(1836, 'COX11', 'rs6504950', 'CGAS', 'Breast Cancer', '21194473'),
(1837, 'STXBP4', 'rs6504950', 'CGAS', 'Breast Cancer', '21194473'),
(1838, 'STXBP4', 'rs6504950', 'CGAS', 'Breast Cancer', '21118973'),
(1839, 'COX11', 'rs6504950', 'CGAS', 'Breast Cancer', '21118973'),
(1840, 'PON1', 'rs662', 'CGAS', 'Breast Cancer', '21887553'),
(1841, 'ATM', 'rs664143', 'CGAS', 'Breast Cancer', '20665102'),
(1842, 'ALDH2', 'rs671', 'CGAS', 'Colorectal Cancer', '21114754'),
(1843, 'ALDH2', 'rs671', 'CGAS', 'Oesophageal Cancer', '20806441'),
(1844, 'ALDH2', 'rs671', 'CGAS', 'Esophageal Cancer', '16103445'),
(1845, 'ALDH2', 'rs671', 'CGAS', 'Head and Neck Cancer', '19124505'),
(1846, 'CASP8', 'rs6736233', 'CGAS', 'Non-Hodgkin Lymphoma', '19414860'),
(1847, 'FGFR2', 'rs6819187', 'CGAS', 'Ovarian Cancer', '19456219'),
(1848, 'PTGS2', 'rs689465', 'CGAS', 'Esophageal Cancer', '21304218'),
(1849, 'PTGS2', 'rs689466', 'CGAS', 'Digestive System Neoplasms', '20594217'),
(1850, 'PTGS2', 'rs689466', 'CGAS', 'Cancer', '20594217'),
(1851, 'PTGS2', 'rs689470', 'CGAS', 'Prostate Cancer', '17999989'),
(1852, 'RPA3', 'rs6947203', 'CGAS', 'Glioma', '18048407'),
(1853, 'AKAP9', 'rs6964587', 'CGAS', 'Breast Cancer', '18334708'),
(1854, 'AKAP9', 'rs6964587', 'CGAS', 'Breast Cancer', '21931171'),
(1855, 'ADH1C', 'rs698', 'CGAS', 'Breast Cancer', '17018785'),
(1856, 'ADH1C', 'rs698', 'CGAS', 'Gastric Cancer', '19375306'),
(1857, 'VEGFA', 'rs699947', 'CGAS', 'Cancer', '20635170'),
(1858, 'VEGFA', 'rs699947', 'CGAS', 'Stomach Cancer', '20635170'),
(1859, 'VEGFA', 'rs699947', 'CGAS', 'Nasopharyngeal Cancer', '20635170'),
(1860, 'VEGFA', 'rs699947', 'CGAS', 'Breast Cancer', '20635170'),
(1861, 'VEGFA', 'rs699947', 'CGAS', 'Colorectal Cancer', '20635170'),
(1862, 'CYP19A1', 'rs700519', 'CGAS', 'Breast Cancer', '17325027'),
(1863, 'CYP19A1', 'rs700519', 'CGAS', 'Breast Cancer', '20052540'),
(1864, 'CCND1', 'rs7178', 'CGAS', 'Ovarian Cancer', '17409409'),
(1865, 'CDH1', 'rs7203904', 'CGAS', 'Gastric Cancer', '21570316'),
(1866, 'EHBP1', 'rs721048', 'CGAS', 'Prostatic Cancer', '20564319'),
(1867, 'CYP19A1', 'rs727479', 'CGAS', 'Breast Cancer', '17325027'),
(1868, 'CYP19A1', 'rs727479', 'CGAS', 'Endometrial Cancer', '19124504'),
(1869, 'VDR', 'rs731236', 'CGAS', 'Prostate Cancer', '19684888'),
(1870, 'VDR', 'rs731236', 'CGAS', 'Breast Cancer', '11950848'),
(1871, 'VDR', 'rs731236', 'CGAS', 'Prostate Cancer', '16600714'),
(1872, 'VDR', 'rs731236', 'CGAS', 'Skin Cancer', '18816636'),
(1873, 'VDR', 'rs731236', 'CGAS', 'Breast Cancer', '19145484'),
(1874, 'VDR', 'rs731236', 'CGAS', 'Prostatic Cancer', '19861519'),
(1875, 'PTHLH', 'rs7313833', 'CGAS', 'Ovarian Cancer', '19304784'),
(1876, 'DCN', 'rs741212', 'CGAS', 'Ovarian Cancer', '21637745'),
(1877, 'ERCC4', 'rs744154', 'CGAS', 'Breast Cancer', '19423537'),
(1878, 'CYP19A1', 'rs749292', 'CGAS', 'Breast Cancer', '17325027'),
(1879, 'CYP19A1', 'rs749292', 'CGAS', 'Endometrial Cancer', '19124504'),
(1880, 'MIF', 'rs755622', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(1881, 'FASLG', 'rs763110', 'CGAS', 'Lung Cancer', '19337311'),
(1882, 'FASLG', 'rs763110', 'CGAS', 'Cervical Cancer', '19337311'),
(1883, 'FASLG', 'rs763110', 'CGAS', 'Breast Cancer', '19337311'),
(1884, 'TET2', 'rs7679673', 'CGAS', 'Prostatic Cancer', '20564319'),
(1885, 'FGFR2', 'rs7694627', 'CGAS', 'Ovarian Cancer', '19456219'),
(1886, 'FGFR2', 'rs7700205', 'CGAS', 'Ovarian Cancer', '19456219'),
(1887, 'LEP', 'rs7799039', 'CGAS', 'Breast Cancer', '21887553'),
(1888, 'VDR', 'rs7975232', 'CGAS', 'Prostate Cancer', '19684888'),
(1889, 'VDR', 'rs7975232', 'CGAS', 'Prostate Cancer', '16600714'),
(1890, 'VDR', 'rs7975232', 'CGAS', 'Breast Cancer', '19145484'),
(1891, 'VDR', 'rs7975232', 'CGAS', 'Prostatic Cancer', '19861519'),
(1892, 'CDK6', 'rs8', 'CGAS', 'Ovarian Cancer', '17409409'),
(1893, 'TOX3', 'rs8051542', 'CGAS', 'Breast Cancer', '20703937'),
(1894, 'TP53', 'rs8079544', 'CGAS', 'Glioma', '18048407'),
(1895, 'TP53', 'rs8079544', 'CGAS', 'Breast Cancer', '17683073'),
(1896, 'MC1R', 'rs11547464', 'CGAS', 'melanoma', '21128237'),
(1897, 'TGFBR1', 'rs11568785', 'CGAS', 'Cancer', '19882361'),
(1898, 'TGFBR1', 'rs11568785', 'CGAS', 'Breast Cancer', '19882361'),
(1899, 'TGFBR1', 'rs11568785', 'CGAS', 'Ovarian Cancer', '19882361'),
(1900, 'TGFBR1', 'rs11568785', 'CGAS', 'Prostatic Cancer', '19882361'),
(1901, 'TGFBR1', 'rs11568785', 'CGAS', 'Colorectal Cancer', '19882361'),
(1902, 'TGFBR1', 'rs11568785', 'CGAS', 'Bladder Cancer', '19882361'),
(1903, 'VDR', 'rs11568820', 'CGAS', 'Skin Cancer', '18816636'),
(1904, 'VDR', 'rs11568820', 'CGAS', 'Ovarian Cancer', '19223536'),
(1905, 'EGF', 'rs11568835', 'CGAS', 'Cancer', '20033794'),
(1906, 'MIR196A2', 'rs11614913', 'CGAS', 'Lung Cancer', '21907588'),
(1907, 'MIR196A2', 'rs11614913', 'CGAS', 'Hepatocellular Carcinoma', '21907588'),
(1908, 'MIR196A2', 'rs11614913', 'CGAS', 'Cancer (General)', '21907588'),
(1909, 'MIR196A2', 'rs11614913', 'CGAS', 'Breast Cancer', '21907588'),
(1910, 'ERCC1', 'rs11615', 'CGAS', 'Lung Cancer', '21075476'),
(1911, 'ERCC1', 'rs11615', 'CGAS', 'Lung Cancer', '17299578'),
(1912, 'ERCC1', 'rs11615', 'CGAS', 'Lung Cancer', '17522621'),
(1913, 'ERCC1', 'rs11615', 'CGAS', 'Bladder Cancer', '19116388'),
(1914, 'ERCC1', 'rs11615', 'CGAS', 'Colorectal Cancer Gastric Cancer', '21278243'),
(1915, 'ERCC1', 'rs11615', 'CGAS', 'Colorectal Cancer Gastric Cancer', '21278243'),
(1916, 'ERCC1', 'rs11615', 'CGAS', 'Colorectal Cancer', '21278243'),
(1917, 'ERCC1', 'rs11615', 'CGAS', 'Smoking-related (Lung Bladder Esophageal Head and N', '22002622'),
(1918, 'ERCC1', 'rs11615', 'CGAS', 'Skin Cancer', '22002622'),
(1919, 'ERCC1', 'rs11615', 'CGAS', 'Multiple', '22002622'),
(1920, 'ERCC1', 'rs11615', 'CGAS', 'Lung Cancer', '22002622'),
(1921, 'ERCC1', 'rs11615', 'CGAS', 'Head and Neck Cancers', '22002622'),
(1922, 'ERCC1', 'rs11615', 'CGAS', 'Digestive Cancers', '22002622'),
(1923, 'ERCC1', 'rs11615', 'CGAS', 'Cancer (General)', '22002622'),
(1924, 'ERCC1', 'rs11615', 'CGAS', 'Bladder Cancer', '22002622'),
(1925, 'ERCC1', 'rs11615', 'CGAS', 'Lung Cancer', '21933627'),
(1926, 'UGT1A7', 'rs11692021', 'CGAS', 'Hepatocellular Carcinoma', '21240526'),
(1927, 'FGFR2', 'rs11737764', 'CGAS', 'Ovarian Cancer', '19456219'),
(1928, 'CYP1B1', 'rs1056836', 'CGAS', 'Breast Cancer', '20033481'),
(1929, 'CYP1B1', 'rs1056836', 'CGAS', 'Breast Cancer', '15734954'),
(1930, 'CYP1B1', 'rs1056836', 'CGAS', 'Breast Cancer', '11950848'),
(1931, 'CYP1B1', 'rs1056836', 'CGAS', 'Breast Cancer', '17053044'),
(1932, 'CYP1B1', 'rs1056836', 'CGAS', 'Ovarian Cancer', '19127255'),
(1933, 'CYP1B1', 'rs1056836', 'CGAS', 'Lung Cancer', '20395011'),
(1934, 'CYP1B1', 'rs1056836', 'CGAS', 'Cancer', '20027111'),
(1935, 'CYP1B1', 'rs1056836', 'CGAS', 'Breast Cancer', '20027111'),
(1936, 'CYP1B1', 'rs1056836', 'CGAS', 'Endometrial Cancer', '21191305'),
(1937, 'CYP1B1', 'rs1056836', 'CGAS', 'Lung Cancer', '21674184'),
(1938, 'NAT1', 'rs1057126', 'CGAS', 'Colorectal Cancer', '15637738'),
(1939, 'NAT1', 'rs1057126', 'CGAS', 'Breast Cancer', '11950848'),
(1940, 'NAT1', 'rs1057126', 'CGAS', 'Colorectal Cancer', '11487538'),
(1941, 'VDR', 'rs10735810', 'CGAS', 'Prostatic Cancer', '19861519'),
(1942, 'PGR', 'rs10895068', 'CGAS', 'Ovarian Cancer', '18219286'),
(1943, 'PGR', 'rs10895068', 'CGAS', 'Breast Cancer', '20082859'),
(1944, 'PGR', 'rs10895068', 'CGAS', 'Breast Cancer', '20076999'),
(1945, 'MC1R', 'rs1110400', 'CGAS', 'melanoma', '21128237'),
(1946, 'XPC', 'rs1118001', 'CGAS', 'Esophageal Cancer', '18097734'),
(1947, 'APEX1', 'rs1130409', 'CGAS', 'Bladder Cancer', '19706757'),
(1948, 'APEX1', 'rs1130409', 'CGAS', 'Lung Cancer', '16982113'),
(1949, 'APEX1', 'rs1130409', 'CGAS', 'Lung Cancer', '18990748'),
(1950, 'APEX1', 'rs1130409', 'CGAS', 'melanoma', '20601096'),
(1951, 'ERBB2', 'rs1136201', 'CGAS', 'Breast Cancer', '18438707'),
(1952, 'ERBB2', 'rs1136201', 'CGAS', 'Gastric Cancer', '19375306'),
(1953, 'ERBB2', 'rs1136201', 'CGAS', 'Breast Cancer', '20401632'),
(1954, 'ERBB2', 'rs1136201', 'CGAS', 'Breast Cancer', '21474413'),
(1955, 'PARP1', 'rs1136410', 'CGAS', 'Gastric Cancer', '18949424'),
(1956, 'LEPR', 'rs1137100', 'CGAS', 'Breast Cancer', '21887553'),
(1957, 'LEPR', 'rs1137101', 'CGAS', 'Breast Cancer', '21887553'),
(1958, 'LEPR', 'rs1137101', 'CGAS', 'Breast Cancer', '21698367'),
(1959, 'GSTP1', 'rs1138272', 'CGAS', 'Glioma', '16030117'),
(1960, 'CYP1B1', 'rs1056827', 'CGAS', 'Breast Cancer', '20054638'),
(1961, 'CYP1B1', 'rs1056827', 'CGAS', 'Breast Cancer', '15734954'),
(1962, 'CYP1B1', 'rs1056827', 'CGAS', 'Lung Cancer', '21674184'),
(1963, 'CYP1B1', 'rs10012', 'CGAS', 'Breast Cancer', '20054638'),
(1964, 'BID', 'rs8190315', 'CGAS', 'Breast Cancer', '19423537'),
(1965, 'ATR', 'rs11920625', 'CGAS', 'Glioma', '18048407'),
(1966, 'FGFR2', 'rs11938826', 'CGAS', 'Ovarian Cancer', '19456219'),
(1967, 'DCLRE1B', 'rs12022378', 'CGAS', 'Glioma', '18048407'),
(1968, 'AR', 'rs1204038', 'CGAS', 'Breast Cancer', '16987421'),
(1969, 'LIN28B', 'rs12194974', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(1970, 'FGFR2', 'rs1219648', 'CGAS', 'Ovarian Cancer', '18973230'),
(1971, 'FGFR2', 'rs1219648', 'CGAS', 'Breast Cancer', '20300826'),
(1972, 'FGFR2', 'rs1219648', 'CGAS', 'Breast Cancer', '20364400'),
(1973, 'MGMT', 'rs12268840', 'CGAS', 'Lung Cancer', '19507256'),
(1974, 'MGMT', 'rs12268840', 'CGAS', 'Lung Cancer', '17957803'),
(1975, 'ADH1B', 'rs1229984', 'CGAS', 'Oral Pharynx Larynx Esophagus Cancer', '21895720'),
(1976, 'ADH1B', 'rs1229984', 'CGAS', 'Oesophageal Cancer', '20806441'),
(1977, 'ADH1B', 'rs1229984 rs671', 'CGAS', 'Oral Pharynx Larynx Esophagus Cancer', '21895720'),
(1978, 'ALDH2', 'rs1229984 rs671', 'CGAS', 'Oral Pharynx Larynx Esophagus Cancer', '21895720'),
(1979, 'TOX3', 'rs12443621', 'CGAS', 'Ovarian Cancer', '18431743'),
(1980, 'TOX3', 'rs12443621', 'CGAS', 'Breast Cancer', '20703937'),
(1981, 'HSPA13', 'rs12479', 'CGAS', 'Gastric Cancer', '18949424'),
(1982, 'FGFR2', 'rs12506776', 'CGAS', 'Ovarian Cancer', '19456219'),
(1983, 'ESR2', 'rs1256031', 'CGAS', 'Breast Cancer', '17935138'),
(1984, 'ESR2', 'rs1256031', 'CGAS', 'Prostate Cancer', '17932344'),
(1985, 'ESR2', 'rs1256049', 'CGAS', 'Breast Cancer', '17935138'),
(1986, 'ESR2', 'rs1256049', 'CGAS', 'Prostate Cancer', '17932344'),
(1987, 'ESR2', 'rs1256049', 'CGAS', 'Breast Cancer', '20390341'),
(1988, 'ITGA6', 'rs12621278', 'CGAS', 'Prostatic Cancer', '20564319'),
(1989, 'NEIL3', 'rs12645561', 'CGAS', 'Glioma', '18048407'),
(1990, 'ESR2', 'rs1271572', 'CGAS', 'Ovarian Cancer', '21673961'),
(1991, 'LIN28A', 'rs12728900', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(1992, 'MGMT', 'rs12917', 'CGAS', 'Head and Neck Cancer', '15121774'),
(1993, 'MGMT', 'rs12917', 'CGAS', 'Lung Cancer', '18990748'),
(1994, 'MGMT', 'rs12917', 'CGAS', 'Lung Cancer', '19892775'),
(1995, 'MGMT', 'rs12917', 'CGAS', 'Colorectal Cancer', '19892775'),
(1996, 'MGMT', 'rs12917', 'CGAS', 'Cancer', '19892775'),
(1997, 'TP53', 'rs12947788', 'CGAS', 'Breast Cancer', '17683073'),
(1998, 'TP53', 'rs12947788', 'CGAS', 'Liver Cancer', '21448428'),
(1999, 'TP53', 'rs12947788', 'CGAS', 'Esophageal Cancer', '21448430'),
(2000, 'TP53', 'rs12951053', 'CGAS', 'Breast Cancer', '17683073'),
(2001, 'TP53', 'rs12951053', 'CGAS', 'Ovarian Cancer', '19276375'),
(2002, 'CASP10', 'rs13010627', 'CGAS', 'Breast Cancer', '19423537'),
(2003, 'ERCC2', 'rs13181', 'CGAS', 'Esophageal Cancer', '16707649'),
(2004, 'ERCC2', 'rs13181', 'CGAS', 'Skin Cancer', '19706646'),
(2005, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '16707649'),
(2006, 'ERCC2', 'rs13181', 'CGAS', 'Leukemia', '16707649'),
(2007, 'ERCC2', 'rs13181', 'CGAS', 'Bladder Cancer', '16707649'),
(2008, 'ERCC2', 'rs13181', 'CGAS', 'Breast Cancer', '16707649'),
(2009, 'ERCC2', 'rs13181', 'CGAS', 'Stomach Cancer', '20981556'),
(2010, 'ERCC2', 'rs13181', 'CGAS', 'Breast Cancer', '20379847'),
(2011, 'ERCC2', 'rs13181', 'CGAS', 'Bladder Cancer', '19492231'),
(2012, 'ERCC2', 'rs13181', 'CGAS', 'Head and Neck Cancer', '16030112'),
(2013, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '15615908'),
(2014, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '15364127'),
(2015, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '17299578'),
(2016, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '18349268'),
(2017, 'ERCC2', 'rs13181', 'CGAS', 'Skin Cancer', '18349268'),
(2018, 'ERCC2', 'rs13181', 'CGAS', 'Colorectal Cancer', '18349268'),
(2019, 'ERCC2', 'rs13181', 'CGAS', 'Esophageal Cancer', '18349268'),
(2020, 'ERCC2', 'rs13181', 'CGAS', 'Breast Cancer', '18349268'),
(2021, 'ERCC2', 'rs13181', 'CGAS', 'Prostate Cancer', '18349268'),
(2022, 'ERCC2', 'rs13181', 'CGAS', 'Bladder Cancer', '18349268'),
(2023, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '19116388'),
(2024, 'ERCC2', 'rs13181', 'CGAS', 'Skin Cancer', '18990748'),
(2025, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '21075476'),
(2026, 'ERCC2', 'rs13181', 'CGAS', 'Colorectal Cancer Gastric Cancer', '21278243'),
(2027, 'ERCC2', 'rs13181', 'CGAS', 'Colorectal Cancer', '21278243'),
(2028, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '21614524'),
(2029, 'ERCC2', 'rs13181', 'CGAS', 'Breast Cancer', '20204500'),
(2030, 'ERCC2', 'rs13181', 'CGAS', 'Breast Cancer', '20111903'),
(2031, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '20627704'),
(2032, 'ERCC2', 'rs13181', 'CGAS', 'Bladder Cancer', '19669592'),
(2033, 'ERCC2', 'rs13181', 'CGAS', 'Lung Cancer', '20981350'),
(2034, 'DROSHA', 'rs13186629', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(2035, 'CYP2C8', 'rs13281615', 'CGAS', 'Ovarian Cancer', '18594024'),
(2036, 'DCN', 'rs13312816', 'CGAS', 'Ovarian Cancer', '21637745'),
(2037, 'AR', 'rs1337080', 'CGAS', 'Breast Cancer', '16987421'),
(2038, 'AR', 'rs1337082', 'CGAS', 'Breast Cancer', '16987421'),
(2039, 'CYP2C8', 'rs13387042', 'CGAS', 'Ovarian Cancer', '18973230'),
(2040, 'IL6', 'rs13447446', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2041, 'IL6', 'rs13447446', 'CGAS', 'Gastric Cancer', '19375306'),
(2042, 'IL6', 'rs13447446', 'CGAS', 'Stomach Cancer', '20222161'),
(2043, 'BRCA2', 'rs144848', 'CGAS', 'Ovarian Cancer', '12471628'),
(2044, 'BRCA2', 'rs144848', 'CGAS', 'Ovarian Cancer', '18431743'),
(2045, 'BRCA2', 'rs144848', 'CGAS', 'Breast Cancer', '20135345'),
(2046, 'THADA', 'rs1465618', 'CGAS', 'Prostatic Cancer', '20564319'),
(2047, 'TGFBR1', 'rs1466445', 'CGAS', 'Colorectal Cancer', '21858550'),
(2048, 'FGFR2', 'rs1476214', 'CGAS', 'Ovarian Cancer', '19456219'),
(2049, 'FGFR2', 'rs1476217', 'CGAS', 'Ovarian Cancer', '19456219'),
(2050, 'NKX3-1', 'rs1512268', 'CGAS', 'Prostatic Cancer', '20564319'),
(2051, 'VDR', 'rs1544410', 'CGAS', 'Prostate Cancer', '19684888'),
(2052, 'VDR', 'rs1544410', 'CGAS', 'Prostate Cancer', '14693728'),
(2053, 'VDR', 'rs1544410', 'CGAS', 'Prostate Cancer', '16600714'),
(2054, 'VDR', 'rs1544410', 'CGAS', 'Skin Cancer', '18816636'),
(2055, 'VDR', 'rs1544410', 'CGAS', 'Ovarian Cancer', '19223536'),
(2056, 'VDR', 'rs1544410', 'CGAS', 'Breast Cancer', '19145484'),
(2057, 'VDR', 'rs1544410', 'CGAS', 'Breast Cancer', '19124512'),
(2058, 'VDR', 'rs1544410', 'CGAS', 'Skin Cancer', '19008093'),
(2059, 'VDR', 'rs1544410', 'CGAS', 'Prostate Cancer', '19403841'),
(2060, 'VDR', 'rs1544410', 'CGAS', 'Skin Cancer', '19403841'),
(2061, 'VDR', 'rs1544410', 'CGAS', 'Breast Cancer', '19403841'),
(2062, 'VDR', 'rs1544410', 'CGAS', 'Colorectal Cancer', '19403841'),
(2063, 'VDR', 'rs1544410', 'CGAS', 'Prostatic Cancer', '19861519'),
(2064, 'DNMT3B', 'rs1569686', 'CGAS', 'Squamous Cell Carcinoma of the Head and Neck', '21938431'),
(2065, 'DNMT3B', 'rs1569686', 'CGAS', 'Lung Esophageal Nasopharyngeal Gallbladder Squamou', '21938431'),
(2066, 'DNMT3B', 'rs1569686', 'CGAS', 'Colorectal Cancer', '21938431'),
(2067, 'DNMT3B', 'rs1569686', 'CGAS', 'Cancer (General)', '21938431'),
(2068, 'TP53', 'rs1625895', 'CGAS', 'Breast Cancer', '19657731'),
(2069, 'TP53', 'rs1625895', 'CGAS', 'Breast Cancer', '11950848'),
(2070, 'TP53', 'rs1625895', 'CGAS', 'Breast Cancer', '17683073'),
(2071, 'TP53', 'rs1625895', 'CGAS', 'Ovarian Cancer', '19276375'),
(2072, 'TP53', 'rs1625895', 'CGAS', 'Lung Cancer', '12840112'),
(2073, 'CDH1', 'rs16260', 'CGAS', 'Gastric Cancer', '21214416'),
(2074, 'CDH1', 'rs16260', 'CGAS', 'Gastric Cancer', '21570316'),
(2075, 'CDH1', 'rs16260', 'CGAS', 'Distal Colorectal Cancer', '21997289'),
(2076, 'CDH1', 'rs16260', 'CGAS', 'Colorectal Cancer', '21997289'),
(2077, 'CDH1', 'rs16260', 'CGAS', 'Stomach Cancer', '21625863'),
(2078, 'CDH1', 'rs16260', 'CGAS', 'Gastric Cancer', '21612411'),
(2079, 'ATP1B2', 'rs1641512', 'CGAS', 'Breast Cancer', '17683073'),
(2080, 'ATP1B2', 'rs1641535', 'CGAS', 'Breast Cancer', '17683073'),
(2081, 'ATP1B2', 'rs1641536', 'CGAS', 'Breast Cancer', '17683073'),
(2082, 'TP53', 'rs1642785', 'CGAS', 'Breast Cancer', '17683073'),
(2083, 'ADIPOQ', 'rs1648707', 'CGAS', 'Colorectal Cancer', '19264763'),
(2084, 'POLD1', 'rs1673041', 'CGAS', 'Glioma', '18048407'),
(2085, 'FGFR2', 'rs167428', 'CGAS', 'Ovarian Cancer', '19456219'),
(2086, 'ADH1C', 'rs1693482', 'CGAS', 'Head and Neck Cancers', '22042713'),
(2087, 'ADH1C', 'rs1693482', 'CGAS', 'Pharynx Cancer', '22042713'),
(2088, 'ADH1C', 'rs1693482', 'CGAS', 'Oral Cancer', '22042713'),
(2089, 'ADH1C', 'rs1693482', 'CGAS', 'Larynx Cancer', '22042713'),
(2090, 'GSTP1', 'rs1695', 'CGAS', 'Colorectal Cancer', '19643601'),
(2091, 'GSTP1', 'rs1695', 'CGAS', 'Glioma', '16030117'),
(2092, 'GSTP1', 'rs1695', 'CGAS', 'Leukemia', '15862746'),
(2093, 'GSTP1', 'rs1695', 'CGAS', 'Prostate Cancer', '15668493'),
(2094, 'GSTP1', 'rs1695', 'CGAS', 'Colorectal Cancer', '15637738'),
(2095, 'GSTP1', 'rs1695', 'CGAS', 'Breast Cancer', '14973092'),
(2096, 'GSTP1', 'rs1695', 'CGAS', 'Colorectal Cancer', '12433710'),
(2097, 'GSTP1', 'rs1695', 'CGAS', 'Breast Cancer', '11950848'),
(2098, 'GSTP1', 'rs1695', 'CGAS', 'Lung Cancer', '16509765'),
(2099, 'GSTP1', 'rs1695', 'CGAS', 'Gastric Cancer', '19157859'),
(2100, 'GSTP1', 'rs1695', 'CGAS', 'Leukemia', '19811334'),
(2101, 'GSTP1', 'rs1695', 'CGAS', 'Esophageal Cancer', '19618282'),
(2102, 'GSTP1', 'rs1695', 'CGAS', 'Breast Cancer', '15342448'),
(2103, 'GSTP1', 'rs1695', 'CGAS', 'Head and Neck Cancer', '14693745'),
(2104, 'GSTP1', 'rs1695', 'CGAS', 'Lung Cancer', '17428724'),
(2105, 'GSTP1', 'rs1695', 'CGAS', 'Bladder Cancer', '17404387'),
(2106, 'GSTP1', 'rs1695', 'CGAS', 'Lung Cancer', '19240225'),
(2107, 'GSTP1', 'rs1695', 'CGAS', 'Ovarian Cancer', '20966642'),
(2108, 'GSTP1', 'rs1695', 'CGAS', 'Oesophageal Cancer', '20827430'),
(2109, 'GSTP1', 'rs1695', 'CGAS', 'Breast Cancer', '20526737'),
(2110, 'GSTP1', 'rs1695', 'CGAS', 'Colorectal Cancer', '20207535'),
(2111, 'GSTP1', 'rs1695', 'CGAS', 'Breast Cancer', '19760040'),
(2112, 'LUM', 'rs17018765', 'CGAS', 'Ovarian Cancer', '21637745'),
(2113, 'FGFR2', 'rs17473132', 'CGAS', 'Ovarian Cancer', '19456219'),
(2114, 'CYP19A1', 'rs17601241', 'CGAS', 'Breast Cancer', '17325027'),
(2115, 'ERCC4', 'rs17655', 'CGAS', 'Breast Cancer', '21424776'),
(2116, 'CCND1', 'rs17852153', 'CGAS', 'Breast Cancer', '18819000'),
(2117, 'CCND1', 'rs17852153', 'CGAS', 'Gastric Cancer', '19375306'),
(2118, 'CCND1', 'rs17852153', 'CGAS', 'Colorectal Cancer', '18196581'),
(2119, 'CCND1', 'rs17852153', 'CGAS', 'Cancer', '18843022'),
(2120, 'CCND1', 'rs17852153', 'CGAS', 'Genitourinary Cancer', '18843022'),
(2121, 'CCND1', 'rs17852153', 'CGAS', 'Breast Cancer', '18843022'),
(2122, 'CCND1', 'rs17852153', 'CGAS', 'Blood-Related Cancer', '18843022'),
(2123, 'CCND1', 'rs17852153', 'CGAS', 'Head and Neck Cancer', '18843022'),
(2124, 'CCND1', 'rs17852153', 'CGAS', 'Colorectal Cancer', '18843022'),
(2125, 'CCND1', 'rs17852153', 'CGAS', 'Digestive System Neoplasms', '18843022'),
(2126, 'CCND1', 'rs17852153', 'CGAS', 'Lung Cancer', '18843022'),
(2127, 'CCND1', 'rs17852153', 'CGAS', 'Gastric Cancer', '21606015'),
(2128, 'CCND1', 'rs17852153', 'CGAS', 'Colorectal Cancer', '21606015'),
(2129, 'CCND1', 'rs17852153', 'CGAS', 'Head and Neck Cancer', '20443083'),
(2130, 'CCND1', 'rs17852153', 'CGAS', 'Bladder Cancer', '20575692'),
(2131, 'CCND1', 'rs17852153', 'CGAS', 'Colorectal Cancer', '21517236'),
(2132, 'CCND1', 'rs17852153', 'CGAS', 'Esophageal Cancer', '21517236'),
(2133, 'CCND1', 'rs17852153', 'CGAS', 'Gastric Cancer', '21517236'),
(2134, 'CCND1', 'rs17852153', 'CGAS', 'Colorectal Cancer', '21544737?????????????????? '),
(2135, 'CCND1', 'rs17852153', 'CGAS', 'Hepatic Cancer', '21606015'),
(2136, 'CCND1', 'rs17852153', 'CGAS', 'Esophageal Cancer', '21606015'),
(2137, 'CCND1', 'rs17852153', 'CGAS', 'Digestive Tract Cancers', '21606015'),
(2138, 'CASP1', 'rs1785882', 'CGAS', 'Non-Hodgkin Lymphoma', '19414860'),
(2139, 'UGT1A7', 'rs17868323', 'CGAS', 'Hepatocellular Carcinoma', '21240526'),
(2140, 'TP53', 'rs17878362', 'CGAS', 'Lung Cancer', '20089604'),
(2141, 'TP53', 'rs17878362', 'CGAS', 'Colorectal Cancer', '20089604'),
(2142, 'TP53', 'rs17878362', 'CGAS', 'Cancer', '20089604'),
(2143, 'TP53', 'rs17878362', 'CGAS', 'Breast Cancer', '20089604'),
(2144, 'WRAP53', 'rs17885803', 'CGAS', 'Breast Cancer', '17683073'),
(2145, 'WRAP53', 'rs17886268', 'CGAS', 'Breast Cancer', '17683073'),
(2146, 'IL1RN', 'rs1794068', 'CGAS', 'Gastric Cancer', '18949424'),
(2147, 'TNF', 'rs1799724', 'CGAS', 'Prostate Cancer', '18196539'),
(2148, 'TNF', 'rs1799724', 'CGAS', 'Gastric Cancer', '18350251'),
(2149, 'TNF', 'rs1799724', 'CGAS', 'Gastric Cancer', '18319718'),
(2150, 'TNF', 'rs1799724', 'CGAS', 'Breast Cancer', '20882404'),
(2151, 'TNF', 'rs1799724', 'CGAS', 'Hepatocellular Carcinoma', '21336601'),
(2152, 'TNF', 'rs1799724', 'CGAS', 'Breast Cancer', '21476000'),
(2153, 'GSTM3', 'rs17997335', 'CGAS', 'Lung Cancer', '16509765'),
(2154, 'MMP1', 'rs1799750', 'CGAS', 'Kidney Cancer', '19843588'),
(2155, 'MMP1', 'rs1799750', 'CGAS', 'Ovarian Cancer', '19843588'),
(2156, 'MMP1', 'rs1799750', 'CGAS', 'Lung Cancer', '19843588'),
(2157, 'MMP1', 'rs1799750', 'CGAS', 'Head and Neck Cancer', '19843588'),
(2158, 'MMP1', 'rs1799750', 'CGAS', 'Endometrial Cancer', '19843588'),
(2159, 'MMP1', 'rs1799750', 'CGAS', 'Colorectal Cancer', '19843588'),
(2160, 'MMP1', 'rs1799750', 'CGAS', 'Cervical Cancer', '19843588'),
(2161, 'MMP1', 'rs1799750', 'CGAS', 'Cancer', '19843588'),
(2162, 'MMP1', 'rs1799750', 'CGAS', 'Breast Cancer', '19843588'),
(2163, 'MMP1', 'rs1799750', 'CGAS', 'Bladder Cancer', '19843588'),
(2164, 'MMP1', 'rs1799750', 'CGAS', 'Colorectal Cancer', '21538057'),
(2165, 'MMP1', 'rs1799750', 'CGAS', 'Lung Cancer', '21523769'),
(2166, 'ACE', 'rs1799752', 'CGAS', 'Breast Cancer', '21546404'),
(2167, 'ACE', 'rs1799752', 'CGAS', 'Breast Cancer', '21638051'),
(2168, 'XRCC1', 'rs1799782', 'CGAS', 'Breast Cancer', '16221808'),
(2169, 'XRCC1', 'rs1799782', 'CGAS', 'Gastric Cancer', '16030121'),
(2170, 'XRCC1', 'rs1799782', 'CGAS', 'Bladder Cancer', '18336890'),
(2171, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '19329222'),
(2172, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '19481337'),
(2173, 'XRCC1', 'rs1799782', 'CGAS', 'Breast Cancer', '19465687'),
(2174, 'XRCC1', 'rs1799782', 'CGAS', 'Breast Cancer', '19446452'),
(2175, 'XRCC1', 'rs1799782', 'CGAS', 'Esophageal Cancer', '19444915'),
(2176, 'XRCC1', 'rs1799782', 'CGAS', 'Esophageal Cancer', '19436829'),
(2177, 'XRCC1', 'rs1799782', 'CGAS', 'Bladder Cancer', '19706757'),
(2178, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '16221808'),
(2179, 'XRCC1', 'rs1799782', 'CGAS', 'Digestive System Neoplasms', '16221808'),
(2180, 'XRCC1', 'rs1799782', 'CGAS', 'Breast Cancer', '16030121'),
(2181, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '16030121'),
(2182, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '16982113'),
(2183, 'XRCC1', 'rs1799782', 'CGAS', 'Bladder Cancer', '18765423'),
(2184, 'XRCC1', 'rs1799782', 'CGAS', 'Head and Neck Cancer', '19116388'),
(2185, 'XRCC1', 'rs1799782', 'CGAS', 'Gastric Cancer', '19116388'),
(2186, 'XRCC1', 'rs1799782', 'CGAS', 'Esophageal Cancer', '19116388'),
(2187, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '18990748'),
(2188, 'XRCC1', 'rs1799782', 'CGAS', 'Skin Cancer', '19116388'),
(2189, 'XRCC1', 'rs1799782', 'CGAS', 'Gastric Cancer', '21604176'),
(2190, 'XRCC1', 'rs1799782', 'CGAS', 'Colorectal Cancer', '20033188'),
(2191, 'XRCC1', 'rs1799782', 'CGAS', 'Colorectal Cancer', '19915856'),
(2192, 'XRCC1', 'rs1799782', 'CGAS', 'Lung Cancer', '20981350'),
(2193, 'XRCC1', 'rs1799782', 'CGAS', 'Pancreatic Cancer', '21383623'),
(2194, 'XRCC1', 'rs1799782', 'CGAS', 'Prostate Cancer', '21647176'),
(2195, 'XRCC1', 'rs1799782 and rs25487', 'CGAS', 'Breast Cancer', '20411322'),
(2196, 'ERCC2', 'rs1799793', 'CGAS', 'Breast Cancer', '17018785'),
(2197, 'ERCC2', 'rs1799793', 'CGAS', 'Breast Cancer', '16707649'),
(2198, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '16707649'),
(2199, 'ERCC2', 'rs1799793', 'CGAS', 'Breast Cancer', '20379847'),
(2200, 'ERCC2', 'rs1799793', 'CGAS', 'Bladder Cancer', '19706757'),
(2201, 'ERCC2', 'rs1799793', 'CGAS', 'Bladder Cancer', '19492231'),
(2202, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '15615908'),
(2203, 'ERCC2', 'rs1799793', 'CGAS', 'Skin Cancer', '18349268'),
(2204, 'ERCC2', 'rs1799793', 'CGAS', 'Breast Cancer', '18349268'),
(2205, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '18349268'),
(2206, 'ERCC2', 'rs1799793', 'CGAS', 'Esophageal Cancer', '18349268'),
(2207, 'ERCC2', 'rs1799793', 'CGAS', 'Bladder Cancer', '18349268'),
(2208, 'ERCC2', 'rs1799793', 'CGAS', 'Colorectal Cancer', '18349268'),
(2209, 'ERCC2', 'rs1799793', 'CGAS', 'Bladder Cancer', '19116388'),
(2210, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '19116388'),
(2211, 'ERCC2', 'rs1799793', 'CGAS', 'Skin Cancer', '18990748'),
(2212, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '15364127'),
(2213, 'ERCC2', 'rs1799793', 'CGAS', 'Stomach Cancer', '20981556'),
(2214, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '21075476'),
(2215, 'ERCC2', 'rs1799793', 'CGAS', 'Non-Small Cell Lung Cancer', '21195504'),
(2216, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '21614524'),
(2217, 'ERCC2', 'rs1799793', 'CGAS', 'Breast Cancer', '20111903'),
(2218, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '20354818'),
(2219, 'ERCC2', 'rs1799793', 'CGAS', 'Bladder Cancer', '19669592'),
(2220, 'ERCC2', 'rs1799793', 'CGAS', 'melanoma', '20601096'),
(2221, 'ERCC2', 'rs1799793', 'CGAS', 'Lung Cancer', '20981350'),
(2222, 'XRCC3', 'rs1799794', 'CGAS', 'Breast Cancer', '17018785'),
(2223, 'XRCC3', 'rs1799794', 'CGAS', 'Breast Cancer', '19116388'),
(2224, 'XRCC3', 'rs1799794', 'CGAS', 'Breast Cancer', '20049524'),
(2225, 'XRCC3', 'rs1799796', 'CGAS', 'Breast Cancer', '17018785'),
(2226, 'XRCC3', 'rs1799796', 'CGAS', 'Breast Cancer', '20049524'),
(2227, 'ERCC4', 'rs1799801', 'CGAS', 'Bladder Cancer', '19706757'),
(2228, 'ERCC2', 'rs1799801', 'CGAS', 'Bladder Cancer', '19706757'),
(2229, 'CYP1A1', 'rs1799814', 'CGAS', 'Breast Cancer', '20035380'),
(2230, 'CYP1A1', 'rs1799814', 'CGAS', 'Breast Cancer', '15870154'),
(2231, 'CYP1A1', 'rs1799814', 'CGAS', 'Endometrial Cancer', '21270613'),
(2232, 'CCR2', 'rs1799864', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2233, 'RET', 'rs1799939', 'CGAS', 'Thyroid Cancer', '16230779');
INSERT INTO `genes` (`id`, `gene-name`, `Marker`, `Study-type`, `Disease`, `Pubmed-ID`) VALUES
(2234, 'HFE', 'rs1799945', 'CGAS', 'Breast Cancer', '17828789'),
(2235, 'HFE', 'rs1799945', 'CGAS', 'Colorectal Cancer', '17828789'),
(2236, 'HFE', 'rs1799945', 'CGAS', 'Liver Cancer', '20196837'),
(2237, 'TNF', 'rs1799964', 'CGAS', 'Prostate Cancer', '18196539'),
(2238, 'TNF', 'rs1799964', 'CGAS', 'Gastric Cancer', '18949424'),
(2239, 'TNF', 'rs1799964', 'CGAS', 'Hepatocellular Carcinoma', '21336601'),
(2240, 'TNF', 'rs1799964', 'CGAS', 'Breast Cancer', '21476000'),
(2241, 'NOS3', 'rs1799983', 'CGAS', 'Breast Cancer', '20720556'),
(2242, 'NOS3', 'rs1799983', 'CGAS', 'Breast Cancer', '20204503'),
(2243, 'CCR5', 'rs1799987', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2244, 'CCR5', 'rs1799988', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2245, 'CCR5', 'rs1800024', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2246, 'ATM', 'rs1800054', 'CGAS', 'Breast Cancer', '17293864'),
(2247, 'ERCC4', 'rs1800067', 'CGAS', 'Breast Cancer', '19116388'),
(2248, 'ERCC4', 'rs1800067', 'CGAS', 'Skin Cancer', '18990748'),
(2249, 'CYP1B1', 'rs1800440', 'CGAS', 'Breast Cancer', '20054638'),
(2250, 'CYP1B1', 'rs1800440', 'CGAS', 'Breast Cancer', '15734954'),
(2251, 'CYP1B1', 'rs1800440', 'CGAS', 'Endometrial Cancer', '21191305'),
(2252, 'CYP1B1', 'rs1800440', 'CGAS', 'Lung Cancer', '21674184'),
(2253, 'TGFB1', 'rs1800470', 'CGAS', 'Breast Cancer', '21673823'),
(2254, 'HFE', 'rs1800562', 'CGAS', 'Colorectal Cancer', '12433710'),
(2255, 'HFE', 'rs1800562', 'CGAS', 'Colorectal Cancer', '17828789'),
(2256, 'HFE', 'rs1800562', 'CGAS', 'Liver Cancer', '20196837'),
(2257, 'HFE', 'rs1800562', 'CGAS', 'Hepatocellular Carcinoma', '21240526'),
(2258, 'NQO1', 'rs1800566', 'CGAS', 'Colorectal Cancer', '12433710'),
(2259, 'NQO1', 'rs1800566', 'CGAS', 'Lung Cancer', '16170238'),
(2260, 'NQO1', 'rs1800566', 'CGAS', 'Bladder Cancer', '16702380'),
(2261, 'NQO1', 'rs1800566', 'CGAS', 'Lung Cancer', '16702380'),
(2262, 'NQO1', 'rs1800566', 'CGAS', 'Colorectal Cancer', '16702380'),
(2263, 'NQO1', 'rs1800566', 'CGAS', 'Breast Cancer', '20526805'),
(2264, 'NQO1', 'rs1800566', 'CGAS', 'Lung Cancer', '20027111'),
(2265, 'NQO1', 'rs1800566', 'CGAS', 'Esophageal Cancer', '22017531'),
(2266, 'IL1A', 'rs1800587', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2267, 'TNF', 'rs1800610', 'CGAS', 'Prostate Cancer', '18196539'),
(2268, 'TNF', 'rs1800629', 'CGAS', 'Breast Cancer', '20035378'),
(2269, 'TNF', 'rs1800629', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2270, 'TNF', 'rs1800629', 'CGAS', 'Prostate Cancer', '18196539'),
(2271, 'TNF', 'rs1800629', 'CGAS', 'Gastric Cancer', '18949424'),
(2272, 'TNF', 'rs1800629', 'CGAS', 'Gastric Cancer', '18350251'),
(2273, 'TNF', 'rs1800629', 'CGAS', 'Gastric Cancer', '18319718'),
(2274, 'TNF', 'rs1800629', 'CGAS', 'LCC - Liver cell carcinoma', '20819413'),
(2275, 'TNF', 'rs1800629', 'CGAS', 'Colorectal Cancer', '21248737'),
(2276, 'TNF', 'rs1800629', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20047977'),
(2277, 'TNF', 'rs1800629', 'CGAS', 'Breast Cancer', '20882404'),
(2278, 'TNF', 'rs1800629', 'CGAS', 'Gastric Cancer', '21178102'),
(2279, 'TNF', 'rs1800629', 'CGAS', 'Several Cancer', '21624061'),
(2280, 'TNF', 'rs1800629', 'CGAS', 'Breast Cancer', '21624061'),
(2281, 'TNF', 'rs1800629', 'CGAS', 'Prostate Cancer', '21624061'),
(2282, 'TNF', 'rs1800629', 'CGAS', 'Colorectal Cancer', '21624061'),
(2283, 'TNF', 'rs1800629', 'CGAS', 'Lung Cancer', '21624061'),
(2284, 'TNF', 'rs1800629', 'CGAS', 'Hepatocellular Carcinoma', '21336601'),
(2285, 'TNF', 'rs1800629', 'CGAS', 'Breast Cancer', '21221765'),
(2286, 'TNF', 'rs1800629', 'CGAS', 'Breast Cancer', '21476000'),
(2287, 'TNF', 'rs1800629', 'CGAS', 'Pancreatic Cancer', '21383623'),
(2288, 'TNF', 'rs1800630', 'CGAS', 'Prostate Cancer', '18196539'),
(2289, 'TNF', 'rs1800630', 'CGAS', 'Breast Cancer', '20882404'),
(2290, 'FAS', 'rs1800682', 'CGAS', 'Esophageal Cancer', '19168581'),
(2291, 'FAS', 'rs1800682', 'CGAS', 'Gastric Cancer', '19168581'),
(2292, 'FAS', 'rs1800682', 'CGAS', 'Lung Cancer', '19168581'),
(2293, 'FAS', 'rs1800682', 'CGAS', 'Breast Cancer', '19168581'),
(2294, 'FAS', 'rs1800682', 'CGAS', 'Skin Cancer', '19168581'),
(2295, 'FAS', 'rs1800682', 'CGAS', 'Cervical Cancer', '19168581'),
(2296, 'MLH1', 'rs1800734', 'CGAS', 'Cancer (General)', '21745804'),
(2297, 'MLH1', 'rs1800734', 'CGAS', 'Colorectal Cancer', '21745804'),
(2298, 'MLH1', 'rs1800734', 'CGAS', 'Lung Cancer', '21745804'),
(2299, 'IL6', 'rs1800795', 'CGAS', 'Breast Cancer', '20043205'),
(2300, 'IL6', 'rs1800795', 'CGAS', 'Glioma', '17916900'),
(2301, 'IL6', 'rs1800797', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2302, 'IL10', 'rs1800871', 'CGAS', 'Glioma', '17916900'),
(2303, 'IL10', 'rs1800871', 'CGAS', 'Hepatocellular Carcinoma', '22025883'),
(2304, 'IL10', 'rs1800871', 'CGAS', 'Prostate Cancer', '21211963'),
(2305, 'IL10', 'rs1800872', 'CGAS', 'Gastric Cancer', '19669876'),
(2306, 'IL10', 'rs1800872', 'CGAS', 'Glioma', '17916900'),
(2307, 'IL10', 'rs1800872', 'CGAS', 'Gastric Cancer', '19375306'),
(2308, 'IL10', 'rs1800872', 'CGAS', 'Breast Cancer', '20799949'),
(2309, 'IL10', 'rs1800872', 'CGAS', 'Stomach Cancer', '20087693'),
(2310, 'IL10', 'rs1800872', 'CGAS', 'Gastric Cancer', '21178102'),
(2311, 'IL10', 'rs1800872', 'CGAS', 'Hepatocellular Carcinoma', '22025883'),
(2312, 'IL10', 'rs1800872', 'CGAS', 'Prostate Cancer', '21211963'),
(2313, 'IL10', 'rs1800890', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20047977'),
(2314, 'IL10', 'rs1800896', 'CGAS', 'Glioma', '17916900'),
(2315, 'IL10', 'rs1800896', 'CGAS', 'Gastric Cancer', '18707865'),
(2316, 'IL10', 'rs1800896', 'CGAS', 'Gastric Cancer', '19375306'),
(2317, 'IL10', 'rs1800896', 'CGAS', 'Breast Cancer', '20799949'),
(2318, 'IL10', 'rs1800896', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20047977'),
(2319, 'IL10', 'rs1800896', 'CGAS', 'Gastric Cancer', '21178102'),
(2320, 'IL10', 'rs1800896', 'CGAS', 'Hepatocellular Carcinoma', '22025883'),
(2321, 'IL10', 'rs1800896', 'CGAS', 'Prostate Cancer', '21211963'),
(2322, 'XPA', 'rs1800975', 'CGAS', 'Lung Cancer', '20981350'),
(2323, 'XPA', 'rs1800975', 'CGAS', 'Non-Small Cell Lung Cancer', '21195504'),
(2324, 'XPA', 'rs1800975', 'CGAS', 'Lung Cancer', '21611749'),
(2325, 'MTHFR', 'rs1801131', 'CGAS', 'Gastric Cancer', '19506726'),
(2326, 'MTHFR', 'rs1801131', 'CGAS', 'Colorectal Cancer', '17089070'),
(2327, 'MTHFR', 'rs1801131', 'CGAS', 'Leukemia', '17035405'),
(2328, 'MTHFR', 'rs1801131', 'CGAS', 'Leukemia', '16897583'),
(2329, 'MTHFR', 'rs1801131', 'CGAS', 'Gastric Cancer', '16758123'),
(2330, 'MTHFR', 'rs1801131', 'CGAS', 'Breast Cancer', '16630166'),
(2331, 'MTHFR', 'rs1801131', 'CGAS', 'Bladder Cancer', '18815869'),
(2332, 'MTHFR', 'rs1801131', 'CGAS', 'Lung Cancer', '18340404'),
(2333, 'MTHFR', 'rs1801131', 'CGAS', 'Prostate Cancer', '19223177'),
(2334, 'MTHFR', 'rs1801131', 'CGAS', 'Precursor Cell Lymphoblastic Leukemia Lymphoma', '19775302'),
(2335, 'MTHFR', 'rs1801131', 'CGAS', 'Breast Cancer', '17311260'),
(2336, 'MTHFR', 'rs1801131', 'CGAS', 'Gastric Cancer', '18162478'),
(2337, 'MTHFR', 'rs1801131', 'CGAS', 'Lung Cancer', '18789576'),
(2338, 'MTHFR', 'rs1801131', 'CGAS', 'Head and Neck Cancer', '18789576'),
(2339, 'MTHFR', 'rs1801131', 'CGAS', 'Gastric Cancer', '18714187'),
(2340, 'MTHFR', 'rs1801131', 'CGAS', 'Stomach Cancer', '20470942'),
(2341, 'MTHFR', 'rs1801131', 'CGAS', 'Breast Cancer', '20135343'),
(2342, 'MTHFR', 'rs1801131', 'CGAS', 'Breast Cancer', '21052845'),
(2343, 'MTHFR', 'rs1801131', 'CGAS', 'Lymphoma', '21055808'),
(2344, 'MTHFR', 'rs1801131', 'CGAS', 'Acute Lymphoblastic Leukemia', '21702646'),
(2345, 'MTHFR', 'rs1801131', 'CGAS', 'Pancreatic Cancer', '21383623'),
(2346, 'ESR1', 'rs1801132', 'CGAS', 'Breast Cancer', '11950848'),
(2347, 'ESR1', 'rs1801132', 'CGAS', 'Breast Cancer', '19760036'),
(2348, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '19507256'),
(2349, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '12433710'),
(2350, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '17260091'),
(2351, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '17131337'),
(2352, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '17089070'),
(2353, 'MTHFR', 'rs1801133', 'CGAS', 'Leukemia', '17035405'),
(2354, 'MTHFR', 'rs1801133', 'CGAS', 'Leukemia', '16897583'),
(2355, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '16758123'),
(2356, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '16630166'),
(2357, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '18949424'),
(2358, 'MTHFR', 'rs1801133', 'CGAS', 'Bladder Cancer', '18815869'),
(2359, 'MTHFR', 'rs1801133', 'CGAS', 'Lung Cancer', '18340404'),
(2360, 'MTHFR', 'rs1801133', 'CGAS', 'Prostate Cancer', '19223177'),
(2361, 'MTHFR', 'rs1801133', 'CGAS', 'Precursor Cell Lymphoblastic Leukemia Lymphoma', '19775302'),
(2362, 'MTHFR', 'rs1801133', 'CGAS', 'LCC - Liver cell carcinoma', '19930673'),
(2363, 'MTHFR', 'rs1801133', 'CGAS', 'Esophageal Cancer', '21517266'),
(2364, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '19846566'),
(2365, 'MTHFR', 'rs1801133', 'CGAS', 'Prostate Cancer', '19706844'),
(2366, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '19506726'),
(2367, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '17311260'),
(2368, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '17105984'),
(2369, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '17030196'),
(2370, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '18162478'),
(2371, 'MTHFR', 'rs1801133', 'CGAS', 'Esophageal Cancer', '18840514'),
(2372, 'MTHFR', 'rs1801133', 'CGAS', 'Head and Neck Cancer', '18789576'),
(2373, 'MTHFR', 'rs1801133', 'CGAS', 'Lung Cancer', '18789576'),
(2374, 'MTHFR', 'rs1801133', 'CGAS', 'Gastric Cancer', '18714187'),
(2375, 'MTHFR', 'rs1801133', 'CGAS', 'Colorectal Cancer', '11487538'),
(2376, 'MTHFR', 'rs1801133', 'CGAS', 'Pancreatic Cancer', '21383623'),
(2377, 'MTHFR', 'rs1801133', 'CGAS', 'Leukemia Lymphocytic Acute L1', '20409583'),
(2378, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '20143151'),
(2379, 'MTHFR', 'rs1801133', 'CGAS', 'Breast Cancer', '20135343'),
(2380, 'MTHFR', 'rs1801133', 'CGAS', 'Lymphoma', '21055808'),
(2381, 'MTHFR', 'rs1801133', 'CGAS', 'Acute Lymphoblastic Leukemia', '21702646'),
(2382, 'CXCL12', 'rs1801157', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2383, 'CXCL12', 'rs1801157', 'CGAS', 'Breast Cancer', '21643956'),
(2384, 'TP73', 'rs1801173 rs2273953', 'CGAS', 'Cancer (General)', '21976716'),
(2385, 'TP73', 'rs1801173 rs2273953', 'CGAS', 'Oesophageal Cancer', '21976716'),
(2386, 'TP73', 'rs1801173 rs2273953', 'CGAS', 'Lung Cancer', '21976716'),
(2387, 'TP73', 'rs1801173 rs2273953', 'CGAS', 'Head and Neck Cancer', '21976716'),
(2388, 'TP73', 'rs1801173 rs2273953', 'CGAS', 'Gastric Cancer', '21976716'),
(2389, 'TP53', 'rs1801173 rs2273953 rs1042522', 'CGAS', 'Cancer (General)', '21976716'),
(2390, 'TP73', 'rs1801173 rs2273953 rs1042522', 'CGAS', 'Cancer (General)', '21976716'),
(2391, 'ERBB2', 'rs1801200', 'CGAS', 'Breast Cancer', '20524057'),
(2392, 'CDKN1A', 'rs1801270', 'CGAS', 'Breast Cancer', '17293864'),
(2393, 'CDKN1A', 'rs1801270', 'CGAS', 'Lung Cancer', '22009857'),
(2394, 'IL4R', 'rs1801275', 'CGAS', 'Glioma', '17916900'),
(2395, 'PPARG', 'rs1801282', 'CGAS', 'Colorectal Cancer', '20596649'),
(2396, 'PPARG', 'rs1801282', 'CGAS', 'Cancer', '20596649'),
(2397, 'PPARG', 'rs1801282', 'CGAS', 'Endometrial Cancer', '20596649'),
(2398, 'PPARG', 'rs1801282', 'CGAS', 'Bladder Cancer', '20596649'),
(2399, 'PPARG', 'rs1801282', 'CGAS', 'Lung Cancer', '20596649'),
(2400, 'PPARG', 'rs1801282', 'CGAS', 'Ovarian Cancer', '20596649'),
(2401, 'PPARG', 'rs1801282', 'CGAS', 'Prostatic Cancer', '20596649'),
(2402, 'PPARG', 'rs1801282', 'CGAS', 'Stomach Cancer', '20596649'),
(2403, 'PPARG', 'rs1801282', 'CGAS', 'Breast Cancer', '20596649'),
(2404, 'RAD51', 'rs1801320', 'CGAS', 'Breast Cancer', '20640595'),
(2405, 'RAD51', 'rs1801320', 'CGAS', 'Breast Cancer', '20454923'),
(2406, 'RAD51', 'rs1801320', 'CGAS', 'Breast Cancer', '20461453'),
(2407, 'RAD51', 'rs1801320', 'CGAS', 'Breast Cancer', '20623332'),
(2408, 'RAD51', 'rs1801320', 'CGAS', 'Breast Cancer', '20396943'),
(2409, 'MTRR', 'rs1801394', 'CGAS', 'Breast Cancer', '20411324'),
(2410, 'MTRR', 'rs1801394', 'CGAS', 'Lymphoma', '21055808'),
(2411, 'MTRR', 'rs1801394', 'CGAS', 'Cancer (General)', '21547363'),
(2412, 'MTRR', 'rs1801394', 'CGAS', 'Colorectal Cancer', '21547363'),
(2413, 'MTRR', 'rs1801394', 'CGAS', 'Lymphoid Leukemia', '21547363'),
(2414, 'MTRR', 'rs1801394', 'CGAS', 'Breast Cancer', '21547363'),
(2415, 'ATM', 'rs1801516', 'CGAS', 'Breast Cancer', '20799949'),
(2416, 'ATM', 'rs1801516', 'CGAS', 'Breast Cancer', '21603857'),
(2417, 'CDH1', 'rs1801552', 'CGAS', 'Gastric Cancer', '21570316'),
(2418, 'MC1R', 'rs1805005', 'CGAS', 'melanoma', '21128237'),
(2419, 'MC1R', 'rs1805006', 'CGAS', 'melanoma', '21128237'),
(2420, 'MC1R', 'rs1805007', 'CGAS', 'melanoma', '21128237'),
(2421, 'MC1R', 'rs1805008', 'CGAS', 'melanoma', '21128237'),
(2422, 'MC1R', 'rs1805009', 'CGAS', 'melanoma', '21128237'),
(2423, 'MTR', 'rs1805087', 'CGAS', 'Colorectal Cancer', '19507256'),
(2424, 'MTR', 'rs1805087', 'CGAS', 'Multiple Myeloma', '19826453'),
(2425, 'MTR', 'rs1805087', 'CGAS', 'Meningioma', '19826453'),
(2426, 'MTR', 'rs1805087', 'CGAS', 'Lymphoma', '19826453'),
(2427, 'MTR', 'rs1805087', 'CGAS', 'Lung Cancer', '19826453'),
(2428, 'MTR', 'rs1805087', 'CGAS', 'Glioma', '19826453'),
(2429, 'MTR', 'rs1805087', 'CGAS', 'Colorectal Cancer', '19826453'),
(2430, 'MTR', 'rs1805087', 'CGAS', 'adenoma', '19826453'),
(2431, 'MTR', 'rs1805087', 'CGAS', 'Cancer', '19826453'),
(2432, 'MTR', 'rs1805087', 'CGAS', 'Breast Cancer', '19826453'),
(2433, 'MTR', 'rs1805087', 'CGAS', 'Bladder Cancer', '19826453'),
(2434, 'MTR', 'rs1805087', 'CGAS', 'acute lymphocytic leukemia', '19826453'),
(2435, 'MTR', 'rs1805087', 'CGAS', 'Prostate Cancer', '19706844'),
(2436, 'MTR', 'rs1805087', 'CGAS', 'Breast Cancer', '20111902'),
(2437, 'MTR', 'rs1805087', 'CGAS', 'Lymphoma', '21055808'),
(2438, 'XRCC4', 'rs1805377', 'CGAS', 'Bladder Cancer', '17557904'),
(2439, 'LIG4', 'rs1805386', 'CGAS', 'Ovarian Cancer', '19127255'),
(2440, 'NBN', 'rs1805794', 'CGAS', 'Bladder Cancer', '19116388'),
(2441, 'NBN', 'rs1805794', 'CGAS', 'Bladder Cancer', '19393077'),
(2442, 'NBN', 'rs1805794', 'CGAS', 'Breast Cancer', '19393077'),
(2443, 'NBN', 'rs1805794', 'CGAS', 'Lung Cancer', '19393077'),
(2444, 'NBN', 'rs1805794', 'CGAS', 'Bladder Cancer', '19706757'),
(2445, 'IL18', 'rs183441', 'CGAS', 'Ovarian Cancer', '19064572'),
(2446, 'GTF2A1', 'rs1864169', 'CGAS', 'Gastric Cancer', '19375306'),
(2447, 'IL18', 'rs187238', 'CGAS', 'Cancer', '20490717'),
(2448, 'IL18', 'rs187238', 'CGAS', 'Colorectal Cancer', '20490717'),
(2449, 'IL18', 'rs187238', 'CGAS', 'Nasopharyngeal Cancer', '20490717'),
(2450, 'HSPA13', 'rs1882881', 'CGAS', 'Gastric Cancer', '18949424'),
(2451, 'CD40', 'rs1883832', 'CGAS', 'Skin Cancer', '18287517'),
(2452, 'CYP19A1', 'rs1902584', 'CGAS', 'Breast Cancer', '17325027'),
(2453, 'CYP19A1', 'rs1902586', 'CGAS', 'Breast Cancer', '17325027'),
(2454, 'IL18', 'rs1946518', 'CGAS', 'Cancer', '20490717'),
(2455, 'IL18', 'rs1946518', 'CGAS', 'Colorectal Cancer', '20490717'),
(2456, 'IL18', 'rs1946518', 'CGAS', 'Nasopharyngeal Cancer', '20490717'),
(2457, 'FGFR2', 'rs17407577', 'CGAS', 'Ovarian Cancer', '19456219'),
(2458, 'CASP8', 'rs17468277', 'CGAS', 'Breast Cancer', '21194473'),
(2459, 'FGFR2', 'rs1960669', 'CGAS', 'Ovarian Cancer', '19456219'),
(2460, 'SHMT1', 'rs1979277', 'CGAS', 'Prostate Cancer', '19706844'),
(2461, 'SHMT1', 'rs1979277', 'CGAS', 'Lymphoma', '21055808'),
(2462, 'TGFB1', 'rs1982073', 'CGAS', 'Ovarian Cancer', '18431743'),
(2463, 'TGFB1', 'rs1982073', 'CGAS', 'Breast Cancer', '21194473'),
(2464, 'TGFB1', 'rs1982073', 'CGAS', 'Breast Cancer', '20309626'),
(2465, 'TGFB1', 'rs1982073', 'CGAS', 'Cancer', '19963138'),
(2466, 'TGFB1', 'rs1982073', 'CGAS', 'Breast Cancer', '19963138'),
(2467, 'TGFB1', 'rs1982073', 'CGAS', 'Stomach Cancer', '19963138'),
(2468, 'TGFB1', 'rs1982073', 'CGAS', 'Prostatic Cancer', '19963138'),
(2469, 'TGFB1', 'rs1982073', 'CGAS', 'Lung Cancer', '19963138'),
(2470, 'TGFB1', 'rs1982073', 'CGAS', 'Liver Cancer', '19963138'),
(2471, 'TGFB1', 'rs1982073', 'CGAS', 'Colorectal Cancer', '19963138'),
(2472, 'TGFB1', 'rs1982073', 'CGAS', 'Breast Cancer', '21527583'),
(2473, 'CDH1', 'rs2010724', 'CGAS', 'Gastric Cancer', '21570316'),
(2474, 'CYP2E1', 'rs2031920', 'CGAS', 'Lung Cancer', '19796841'),
(2475, 'CYP2E1', 'rs2031920', 'CGAS', 'Gastric Cancer', '19506726'),
(2476, 'CYP2E1', 'rs2031920', 'CGAS', 'Gastric Cancer', '16837478'),
(2477, 'CYP2E1', 'rs2031920', 'CGAS', 'Head and Neck Cancer', '21076874'),
(2478, 'CYP2E1', 'rs2031920', 'CGAS', 'Colorectal Cancer', '20556843'),
(2479, 'CYP2E1', 'rs2031920', 'CGAS', 'Lung Cancer', '20031389'),
(2480, 'CYP2E1', 'rs2031920 rs3813867', 'CGAS', 'Oral Cancer', '21553050'),
(2481, 'PTGS2', 'rs20417', 'CGAS', 'Breast Cancer', '20033767'),
(2482, 'PTGS2', 'rs20417', 'CGAS', 'Esophageal Cancer', '19669667'),
(2483, 'PTGS2', 'rs20417', 'CGAS', 'Colorectal Cancer', '19669667'),
(2484, 'PTGS2', 'rs20417', 'CGAS', 'Stomach Cancer', '21086572'),
(2485, 'PTGS2', 'rs20417', 'CGAS', 'Colorectal Cancer', '20808059'),
(2486, 'PTGS2', 'rs20417', 'CGAS', 'Digestive System Neoplasms', '20594217'),
(2487, 'PTGS2', 'rs20417', 'CGAS', 'Cancer', '20594217'),
(2488, 'PTGS2', 'rs20417', 'CGAS', 'Esophageal Cancer', '21304218'),
(2489, 'PTGS2', 'rs20432', 'CGAS', 'Prostate Cancer', '17999989'),
(2490, 'PTGS2', 'rs20432', 'CGAS', 'Gastric Cancer', '19060633'),
(2491, 'PDLIM5', 'rs17021918', 'CGAS', 'Prostatic Cancer', '20564319'),
(2492, 'SPINK1', 'rs17107315', 'CGAS', 'Pancreatic Cancer', '21383623'),
(2493, 'MMP2', 'rs17301608', 'CGAS', 'Prostate Cancer', '18398039'),
(2494, 'DROSHA', 'rs17404622', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(2495, 'IL13', 'rs20541', 'CGAS', 'Glioma', '17916900'),
(2496, 'LTA', 'rs909253', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2497, 'LTA', 'rs909253', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20047977'),
(2498, 'SRD5A2', 'rs9282858', 'CGAS', 'Prostate Cancer', '12869400'),
(2499, 'SRD5A2', 'rs9282858', 'CGAS', 'Prostate Cancer', '18469342'),
(2500, 'SRD5A2', 'rs9282858', 'CGAS', 'Prostatic Cancer', '19914946'),
(2501, 'SRD5A2', 'rs9282858', 'CGAS', 'Prostate Cancer', '21177315'),
(2502, 'SULT1A1', 'rs9282861', 'CGAS', 'Breast Cancer', '19949855'),
(2503, 'SULT1A1', 'rs9282861', 'CGAS', 'Gastric Cancer', '18949424'),
(2504, 'SULT1A1', 'rs9282861', 'CGAS', 'Cancer (General)', '21670965'),
(2505, 'SULT1A1', 'rs9282861', 'CGAS', 'Lung Cancer', '21670965'),
(2506, 'SULT1A1', 'rs9282861', 'CGAS', 'Esophageal Cancer', '21670965'),
(2507, 'SULT1A1', 'rs9282861', 'CGAS', 'Colorectal Cancer', '21670965'),
(2508, 'SULT1A1', 'rs9282861', 'CGAS', 'Genitourinary Cancer', '18854828'),
(2509, 'SULT1A1', 'rs9282861', 'CGAS', 'Colorectal Cancer', '18854828'),
(2510, 'SULT1A1', 'rs9282861', 'CGAS', 'Breast Cancer', '18854828'),
(2511, 'SULT1A1', 'rs9282861', 'CGAS', 'Lung Cancer', '18854828'),
(2512, 'SULT1A1', 'rs9282861', 'CGAS', 'Breast Cancer', '20663177'),
(2513, 'SULT1A1', 'rs9282861', 'CGAS', 'Breast Cancer', '22011087'),
(2514, 'SULT1A1', 'rs9282861', 'CGAS', 'Colorectal Cancer', '21695180'),
(2515, 'SULT1A1', 'rs9282861', 'CGAS', 'Gastric Cancer', '21670965'),
(2516, 'ESR1', 'rs9340799', 'CGAS', 'Breast Cancer', '17453340'),
(2517, 'CYP19A1', 'rs936306', 'CGAS', 'Breast Cancer', '17325027'),
(2518, 'AR', 'rs962458', 'CGAS', 'Breast Cancer', '16987421'),
(2519, 'TP53', 'rs9894946', 'CGAS', 'Ovarian Cancer', '19276375'),
(2520, 'TP53', 'rs9895829', 'CGAS', 'Breast Cancer', '17683073'),
(2521, 'BIRC5', 'rs9904341', 'CGAS', 'Cancer (General)', '21611748'),
(2522, 'BIRC5', 'rs9904341', 'CGAS', 'Esophageal Cancer', '21611748'),
(2523, 'BIRC5', 'rs9904341', 'CGAS', 'Gastric Cancer', '21611748'),
(2524, 'CCNE1', 'rs997669', 'CGAS', 'Breast Cancer', '19005751'),
(2525, 'HSPA13', 'rs9982492', 'CGAS', 'Gastric Cancer', '18949424'),
(2526, 'CYP2E1', 'Rsa I/Pst I', 'CGAS', 'Head and Neck Cancer', '20969746'),
(2527, 'CYP2E1', 'Rsa I/Pst I', 'CGAS', 'Oesophageal Cancer', '20195803'),
(2528, 'BID', 'S56G', 'CGAS', 'Breast Cancer', '19423537'),
(2529, 'CDKN1A', 'Ser31Arg', 'CGAS', 'Breast Cancer', '20349127'),
(2530, 'SRD5A2', 'SRD5A2', 'CGAS', 'Prostate Cancer', '12869400'),
(2531, 'TGFB1', 'T29C', 'CGAS', 'Breast Cancer', '20157775'),
(2532, 'ERCC1', 'T354C', 'CGAS', 'Lung Cancer', '18990748'),
(2533, 'NOS3', 'T786C', 'CGAS', 'Breast Cancer', '20720556'),
(2534, 'AURKA', 'T91A', 'CGAS', 'Breast Cancer', '20464476'),
(2535, 'SRD5A2', 'TA repeat', 'CGAS', 'Prostate Cancer', '21177315'),
(2536, 'VDR', 'TaqI2', 'CGAS', 'Prostate Cancer', '14693728'),
(2537, 'UGT1A1', 'TA-repeat polymorphism', 'CGAS', 'Breast Cancer', '20087647'),
(2538, 'TGFB1', 'TGF-B1-509', 'CGAS', 'Breast Cancer', '20361250'),
(2539, 'TNF', 'TNFA-308', 'CGAS', 'Stomach Cancer', '20200422'),
(2540, 'CYP19A1', 'TTTA10', 'CGAS', 'Breast Cancer', '11950848'),
(2541, 'CYP19A1', 'TTTA12', 'CGAS', 'Breast Cancer', '11950848'),
(2542, 'UGT1A1', 'UGT1A1', 'CGAS', 'Breast Cancer', '11950848'),
(2543, 'SOD2', 'Val-9Ala', 'CGAS', 'Breast Cancer', '19467856'),
(2544, 'IL1RN', 'Variable number of tandem repeats', 'CGAS', 'Gastric Cancer', '21178102'),
(2545, 'VDR', 'VDR', 'CGAS', 'Prostate Cancer', '14693728'),
(2546, 'VDR', 'VDR', 'CGAS', 'Prostate Cancer', '16600714'),
(2547, 'IL1RN', 'VNTR', 'CGAS', 'Gastric Cancer', '17096351'),
(2548, 'IL1RN', 'VNTR', 'CGAS', 'Gastric Cancer', '17035400'),
(2549, 'IL1RN', 'VNTR', 'CGAS', 'Gastric Cancer', '16985030'),
(2550, 'ERCC2', 'XPD312', 'CGAS', 'Lung Cancer', '20143185'),
(2551, 'ERCC2', 'XPD751', 'CGAS', 'Lung Cancer', '20143185'),
(2552, 'MUTYH', 'Y165C', 'CGAS', 'Colorectal Cancer', '17368238'),
(2553, 'MUTYH', 'Y165C G382D IVS10+3A>C 1395-7delGGA', 'CGAS', 'Colorectal Cancer', '18495334'),
(2554, 'MUTYH', 'Y179C', 'CGAS', 'Colorectal Cancer', '21063410'),
(2555, 'POLI', 'rs8305', 'CGAS', 'Lung Cancer', '19116388'),
(2556, 'VEGFA', 'rs833061', 'CGAS', 'Cancer', '19816815'),
(2557, 'VEGFA', 'rs833061', 'CGAS', 'Breast Cancer', '19816815'),
(2558, 'VEGFA', 'rs833061', 'CGAS', 'Stomach Cancer', '19816815'),
(2559, 'VEGFA', 'rs833061', 'CGAS', 'Prostatic Cancer', '19816815'),
(2560, 'VEGFA', 'rs833061', 'CGAS', 'Endometrial Cancer', '19816815'),
(2561, 'VEGFA', 'rs833061', 'CGAS', 'Colorectal Cancer', '19816815'),
(2562, 'PON1', 'rs854560', 'CGAS', 'Breast Cancer', '21887553'),
(2563, 'XRCC3', 'rs861530', 'CGAS', 'melanoma', '20601096'),
(2564, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '17063279'),
(2565, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '17018785'),
(2566, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '16791138'),
(2567, 'XRCC3', 'rs861539', 'CGAS', 'Skin Cancer', '16791138'),
(2568, 'XRCC3', 'rs861539', 'CGAS', 'Head and Neck Cancer', '16791138'),
(2569, 'XRCC3', 'rs861539', 'CGAS', 'Colorectal Cancer', '16791138'),
(2570, 'XRCC3', 'rs861539', 'CGAS', 'Bladder Cancer', '16791138'),
(2571, 'XRCC3', 'rs861539', 'CGAS', 'Lung Cancer', '16791138'),
(2572, 'XRCC3', 'rs861539', 'CGAS', 'Leukemia', '16791138'),
(2573, 'XRCC3', 'rs861539', 'CGAS', 'Gastric Cancer', '16791138'),
(2574, 'XRCC3', 'rs861539', 'CGAS', 'Skin Cancer', '16707649'),
(2575, 'XRCC3', 'rs861539', 'CGAS', 'Lung Cancer', '16707649'),
(2576, 'XRCC3', 'rs861539', 'CGAS', 'Bladder Cancer', '16707649'),
(2577, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '16707649'),
(2578, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '16485136'),
(2579, 'XRCC3', 'rs861539', 'CGAS', 'Ovarian Cancer', '19127255'),
(2580, 'XRCC3', 'rs861539', 'CGAS', 'Lung Cancer', '20500515'),
(2581, 'XRCC3', 'rs861539', 'CGAS', 'Bladder Cancer', '20500515'),
(2582, 'XRCC3', 'rs861539', 'CGAS', 'Bladder Cancer', '19706757'),
(2583, 'XRCC3', 'rs861539', 'CGAS', 'Bladder Cancer', '17557904'),
(2584, 'XRCC3', 'rs861539', 'CGAS', 'Head and Neck Cancer', '19116388'),
(2585, 'XRCC3', 'rs861539', 'CGAS', 'Gastric Cancer', '19116388'),
(2586, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '19116388'),
(2587, 'XRCC3', 'rs861539', 'CGAS', 'Lung Cancer', '18990748'),
(2588, 'XRCC3', 'rs861539', 'CGAS', 'Stomach Cancer', '20549576'),
(2589, 'XRCC3', 'rs861539', 'CGAS', 'Colorectal Cancer', '19915856'),
(2590, 'XRCC3', 'rs861539', 'CGAS', 'Breast Cancer', '19789975'),
(2591, 'MC1R', 'rs885479', 'CGAS', 'melanoma', '21128237'),
(2592, 'MAP3K1', 'rs889312', 'CGAS', 'Ovarian Cancer', '18973230'),
(2593, 'MAP3K1', 'rs889312', 'CGAS', 'Breast Cancer', '18437204'),
(2594, 'MAP3K1', 'rs889312', 'CGAS', 'Ovarian Cancer', '19304784'),
(2595, 'MAP3K1', 'rs889312', 'CGAS', 'Breast Cancer', '21194473'),
(2596, 'MAP3K1', 'rs889312', 'CGAS', 'Breast Cancer', '21118973'),
(2597, 'MAP3K1', 'rs889312', 'CGAS', 'Breast Cancer', '20809358'),
(2598, 'CDKN1B', 'rs4415084', 'CGAS', 'Breast Cancer', '19005751'),
(2599, 'HNF1B', 'rs4430796', 'CGAS', 'Prostatic Cancer', '20564319'),
(2600, 'HNF1B', 'rs4430796', 'CGAS', 'Prostate Cancer', '21343373'),
(2601, 'EGF', 'rs4444903', 'CGAS', 'Melanoma', '20033794'),
(2602, 'EGF', 'rs4444903', 'CGAS', 'Liver cell carcinoma', '20033794'),
(2603, 'EGF', 'rs4444903', 'CGAS', 'Glioma', '20033794'),
(2604, 'EGF', 'rs4444903', 'CGAS', 'Stomach Cancer', '20033794'),
(2605, 'EGF', 'rs4444903', 'CGAS', 'Oesophageal Cancer', '20033794'),
(2606, 'EGF', 'rs4444903', 'CGAS', 'Cancer', '20033794'),
(2607, 'EGF', 'rs4444903', 'CGAS', 'Breast Cancer', '20033794'),
(2608, 'EGF', 'rs4444903', 'CGAS', 'Gastric Cancer', '19375306'),
(2609, 'IL1RN', 'rs454078', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2610, 'IL1RN', 'rs454078', 'CGAS', 'Non-Hodgkin Lymphoma', '21250972'),
(2611, 'CYP19A1', 'rs4646', 'CGAS', 'Breast Cancer', '17325027'),
(2612, 'CYP19A1', 'rs4646', 'CGAS', 'Gastric Cancer', '19375306'),
(2613, 'CYP1A1', 'rs4646903', 'CGAS', 'Breast Cancer', '20035380'),
(2614, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '15764294'),
(2615, 'CYP1A1', 'rs4646903', 'CGAS', 'Colorectal Cancer', '12433710'),
(2616, 'CYP1A1', 'rs4646903', 'CGAS', 'Breast Cancer', '11950848'),
(2617, 'CYP1A1', 'rs4646903', 'CGAS', 'Breast Cancer', '17453340'),
(2618, 'CYP1A1', 'rs4646903', 'CGAS', 'Oral Cancer', '18496222'),
(2619, 'CYP1A1', 'rs4646903', 'CGAS', 'Laryngeal Cancer', '19252926'),
(2620, 'CYP1A1', 'rs4646903', 'CGAS', 'Oral Cancer', '19160101'),
(2621, 'CYP1A1', 'rs4646903', 'CGAS', 'Ovarian Cancer', '19127255'),
(2622, 'CYP1A1', 'rs4646903', 'CGAS', 'Prostate Cancer', '19472123'),
(2623, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '10761998'),
(2624, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '22014025'),
(2625, 'CYP1A1', 'rs4646903', 'CGAS', 'Breast Cancer', '15870154'),
(2626, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '12771031'),
(2627, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '12594823'),
(2628, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '17900751'),
(2629, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '18463401'),
(2630, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '21402622'),
(2631, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '20027111'),
(2632, 'CYP1A1', 'rs4646903', 'CGAS', 'Cancer', '20027111'),
(2633, 'CYP1A1', 'rs4646903', 'CGAS', 'Breast Cancer', '20027111'),
(2634, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '20428802'),
(2635, 'CYP1A1', 'rs4646903', 'CGAS', 'Small Cell Lung Cancer', '22014025'),
(2636, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung squamous carcinoma', '22014025'),
(2637, 'CYP1A1', 'rs4646903', 'CGAS', 'Adenocarcinoma of Lung', '22014025'),
(2638, 'CYP1A1', 'rs4646903', 'CGAS', 'Endometrial Cancer', '21270613'),
(2639, 'GSTM1', 'rs4646903', 'CGAS', 'Lung Cancer', '21859547'),
(2640, 'CYP1A1', 'rs4646903', 'CGAS', 'Lung Cancer', '21859547'),
(2641, 'TNF', 'rs4647198', 'CGAS', 'Breast Cancer', '20882404'),
(2642, 'TNF', 'rs4647198', 'CGAS', 'Breast Cancer', '21476000'),
(2643, 'CYP1A1', 'rs464903', 'CGAS', 'Breast Cancer', '20052535'),
(2644, 'CASP9', 'rs4661636', 'CGAS', 'Non-Hodgkin Lymphoma', '19414860'),
(2645, 'COMT', 'rs4680', 'CGAS', 'Breast Cancer', '15734954'),
(2646, 'COMT', 'rs4680', 'CGAS', 'Breast Cancer', '11950848'),
(2647, 'COMT', 'rs4680', 'CGAS', 'Breast Cancer', '18194538'),
(2648, 'COMT', 'rs4680', 'CGAS', 'Ovarian Cancer', '19127255'),
(2649, 'COMT', 'rs4680', 'CGAS', 'Breast Cancer', '20464630'),
(2650, 'CDH13', 'rs4782726', 'CGAS', 'Prostate Cancer', '21343373'),
(2651, 'ELAC2', 'rs4792311', 'CGAS', 'Prostate Cancer', '12783937'),
(2652, 'ELAC2', 'rs4792311', 'CGAS', 'Prostate Cancer', '12515253'),
(2653, 'ELAC2', 'rs4792311', 'CGAS', 'Prostatic Cancer', '20231859'),
(2654, 'RNASEL', 'rs486907', 'CGAS', 'Prostate Cancer', '15824169'),
(2655, 'RNASEL', 'rs486907', 'CGAS', 'Prostate Cancer', '17020975'),
(2656, 'RNASEL', 'rs486907', 'CGAS', 'Prostate Cancer', '21656378'),
(2657, 'RNASEL', 'rs486987', 'CGAS', 'Cancer (General)', '21221811'),
(2658, 'SOD2', 'rs4880', 'CGAS', 'Breast Cancer', '17293864'),
(2659, 'SOD2', 'rs4880', 'CGAS', 'Breast Cancer', '17018785'),
(2660, 'SOD2', 'rs4880', 'CGAS', 'Non-Hodgkin Lymphoma', '16956821'),
(2661, 'SOD2', 'rs4880', 'CGAS', 'Breast Cancer', '20567899'),
(2662, 'SOD2', 'rs4880', 'CGAS', 'Breast Cancer', '20143154'),
(2663, 'SOD2', 'rs4880', 'CGAS', 'Prostatic Cancer', '20012093'),
(2664, 'SOD2', 'rs4880', 'CGAS', 'Breast Cancer', '20052533'),
(2665, 'SOD2', 'rs4880', 'CGAS', 'Hepatocellular Carcinoma', '21240526'),
(2666, 'NXPH2', 'rs4954956', 'CGAS', 'Ovarian Cancer', '19304784'),
(2667, 'MSR1', 'rs3747531', 'CGAS', 'Prostate Cancer', '16425212'),
(2668, 'CYP19A1', 'rs3751591', 'CGAS', 'Breast Cancer', '17325027'),
(2669, 'EGF', 'rs3756261', 'CGAS', 'Cancer', '20033794'),
(2670, 'DCLRE1B', 'rs3761936', 'CGAS', 'Glioma', '18048407'),
(2671, 'CASP8', 'rs3769821', 'CGAS', 'Non-Hodgkin Lymphoma', '19414860'),
(2672, 'FGFR2', 'rs3789138', 'CGAS', 'Ovarian Cancer', '19456219'),
(2673, 'GATA3', 'rs3802604', 'CGAS', 'Breast Cancer', '18006915'),
(2674, 'TOX3', 'rs3803662', 'CGAS', 'Ovarian Cancer', '18973230'),
(2675, 'TOX3', 'rs3803662', 'CGAS', 'Ovarian Cancer', '18431743'),
(2676, 'TOX3', 'rs3803662', 'CGAS', 'Breast Cancer', '21194473'),
(2677, 'TOX3', 'rs3803662', 'CGAS', 'Breast Cancer', '21118973'),
(2678, 'TOX3', 'rs3803662', 'CGAS', 'Breast Cancer', '20703937'),
(2679, 'FGFR2', 'rs3804158', 'CGAS', 'Ovarian Cancer', '19456219'),
(2680, 'LSP1', 'rs3817198', 'CGAS', 'Ovarian Cancer', '18973230'),
(2681, 'LSP1', 'rs3817198', 'CGAS', 'Breast Cancer', '18437204'),
(2682, 'LSP1', 'rs3817198', 'CGAS', 'Ovarian Cancer', '19304784'),
(2683, 'LSP1', 'rs3817198', 'CGAS', 'Breast Cancer', '19005751'),
(2684, 'LSP1', 'rs3817198', 'CGAS', 'Breast Cancer', '21194473'),
(2685, 'LSP1', 'rs3817198', 'CGAS', 'Breast Cancer', '21118973'),
(2686, 'LSP1', 'rs3817198', 'CGAS', 'Breast Cancer', '21127985'),
(2687, 'CASP8', 'rs3834129', 'CGAS', 'Breast Cancer', '19629679'),
(2688, 'PPARG', 'rs3856806', 'CGAS', 'Cancer', '20596649'),
(2689, 'PPARG', 'rs3856806', 'CGAS', 'Biliary Tract Neoplasm', '20596649'),
(2690, 'PPARG', 'rs3856806', 'CGAS', 'Colorectal Cancer', '20596649'),
(2691, 'MMP9', 'rs3918242', 'CGAS', 'Cancer (General)', '21717058'),
(2692, 'MMP9', 'rs3918242', 'CGAS', 'Breast Cancer', '21717058'),
(2693, 'MMP9', 'rs3918242', 'CGAS', 'Colorectal Cancer', '21717058'),
(2694, 'MMP9', 'rs3918242', 'CGAS', 'Gastric Cancer', '21717058'),
(2695, 'MMP9', 'rs3918242', 'CGAS', 'Lung Cancer', '21717058'),
(2696, 'AR', 'rs4045402', 'CGAS', 'Prostate Cancer', '21667251'),
(2697, 'IL16', 'rs4072111', 'CGAS', 'Prostate Cancer', '21343373'),
(2698, 'RPA3', 'rs4140805', 'CGAS', 'Glioma', '18048407'),
(2699, 'GATA3', 'rs422628', 'CGAS', 'Breast Cancer', '18006915'),
(2700, 'NKX3-1', 'rs2928679', 'CGAS', 'Prostatic Cancer', '20564319'),
(2701, 'FGFR2', 'rs2981582', 'CGAS', 'Ovarian Cancer', '18973230'),
(2702, 'FGFR2', 'rs2981582', 'CGAS', 'Breast Cancer', '18437204'),
(2703, 'FGFR2', 'rs2981582', 'CGAS', 'Ovarian Cancer', '19304784'),
(2704, 'FGFR2', 'rs2981582', 'CGAS', 'Breast Cancer', '21194473'),
(2705, 'FGFR2', 'rs2981582', 'CGAS', 'Breast Cancer', '21118973'),
(2706, 'FGFR2', 'rs2981582', 'CGAS', 'Breast Cancer', '20364400'),
(2707, 'CHAF1A', 'rs2992', 'CGAS', 'Glioma', '18048407'),
(2708, 'ESR1', 'rs3020314', 'CGAS', 'Breast Cancer', '21194473'),
(2709, 'ESR2', 'rs3020450', 'CGAS', 'Breast Cancer', '17935138'),
(2710, 'ESR2', 'rs3020450', 'CGAS', 'Prostate Cancer', '17932344'),
(2711, 'ESR2', 'rs3020450', 'CGAS', 'Ovarian Cancer', '19127255'),
(2712, 'IL10', 'rs3021097', 'CGAS', 'Gastric Cancer', '21178102'),
(2713, 'IL10', 'rs3024491', 'CGAS', 'Non-Hodgkin Lymphoma', '16389181'),
(2714, 'VEGFA', 'rs3025039', 'CGAS', 'Breast Cancer', '20563637'),
(2715, 'VEGFA', 'rs3025039', 'CGAS', 'Breast Cancer', '20652396'),
(2716, 'MMP3', 'rs3025058', 'CGAS', 'Ovarian Cancer', '19843588'),
(2717, 'MMP3', 'rs3025058', 'CGAS', 'Lung Cancer', '19843588'),
(2718, 'MMP3', 'rs3025058', 'CGAS', 'Head and Neck Cancer', '19843588'),
(2719, 'MMP3', 'rs3025058', 'CGAS', 'Colorectal Cancer', '19843588'),
(2720, 'MMP3', 'rs3025058', 'CGAS', 'Cancer', '19843588'),
(2721, 'MMP3', 'rs3025058', 'CGAS', 'Breast Cancer', '19843588'),
(2722, 'MMP3', 'rs3025058', 'CGAS', 'Colorectal Cancer', '21538057'),
(2723, 'FGFR2', 'rs308379', 'CGAS', 'Ovarian Cancer', '19456219'),
(2724, 'FGFR2', 'rs308382', 'CGAS', 'Ovarian Cancer', '19456219'),
(2725, 'FGFR2', 'rs308420', 'CGAS', 'Ovarian Cancer', '19456219'),
(2726, 'FGFR2', 'rs308428', 'CGAS', 'Ovarian Cancer', '19456219'),
(2727, 'FGFR2', 'rs308435', 'CGAS', 'Ovarian Cancer', '19456219'),
(2728, 'FGFR2', 'rs308439', 'CGAS', 'Ovarian Cancer', '19456219'),
(2729, 'FGFR2', 'rs308441', 'CGAS', 'Ovarian Cancer', '19456219'),
(2730, 'FGFR2', 'rs308443', 'CGAS', 'Ovarian Cancer', '19456219'),
(2731, 'FGFR2', 'rs308447', 'CGAS', 'Ovarian Cancer', '19456219'),
(2732, 'CTLA4', 'rs3087243', 'CGAS', 'Cancer (General)', '21387262'),
(2733, 'XRCC2', 'rs3128536', 'CGAS', 'Ovarian Cancer', '19127255'),
(2734, 'TNF', 'rs3136597', 'CGAS', 'Hepatocellular Carcinoma', '21336601'),
(2735, 'TNF', 'rs3136597', 'CGAS', 'Breast Cancer', '21476000'),
(2736, 'APEX1', 'rs3136820', 'CGAS', 'Breast Cancer', '19762350'),
(2737, 'APEX1', 'rs3136820', 'CGAS', 'Cancer', '19762350'),
(2738, 'APEX1', 'rs3136820', 'CGAS', 'Lung Cancer', '19762350'),
(2739, 'APEX1', 'rs3136820', 'CGAS', 'Colorectal Cancer', '19762350'),
(2740, 'APEX1', 'rs3136820', 'CGAS', 'Bladder Cancer', '19762350'),
(2741, 'DCN', 'rs3138165', 'CGAS', 'Ovarian Cancer', '21637745'),
(2742, 'CDKN1A', 'rs3176336', 'CGAS', 'Breast Cancer', '19005751'),
(2743, 'ERCC1', 'rs3212955', 'CGAS', 'Glioma', '18048407'),
(2744, 'ERCC1', 'rs3212961', 'CGAS', 'Cancer (General)', '22002622'),
(2745, 'ERCC1', 'rs3212986', 'CGAS', 'Glioma', '18048407'),
(2746, 'ERCC1', 'rs3212986', 'CGAS', 'Lung Cancer', '18990748'),
(2747, 'ERCC1', 'rs3212986', 'CGAS', 'Lung Cancer', '21075476'),
(2748, 'ERCC1', 'rs3212986', 'CGAS', 'Smoking-related (Lung Bladder Esophageal Head and N', '22002622'),
(2749, 'ERCC1', 'rs3212986', 'CGAS', 'Multiple', '22002622'),
(2750, 'ERCC1', 'rs3212986', 'CGAS', 'Lung Cancer', '22002622'),
(2751, 'ERCC1', 'rs3212986', 'CGAS', 'Head and Neck Cancers', '22002622'),
(2752, 'ERCC1', 'rs3212986', 'CGAS', 'Estrogen-related (Breast Cervical Ovarian Cancers)', '22002622'),
(2753, 'ERCC1', 'rs3212986', 'CGAS', 'Digestive Cancers', '22002622'),
(2754, 'ERCC1', 'rs3212986', 'CGAS', 'Cancer (General)', '22002622'),
(2755, 'ERCC1', 'rs3212986', 'CGAS', 'Brain Cancer', '22002622'),
(2756, 'ERCC1', 'rs3212986', 'CGAS', 'Lung Cancer', '21933627'),
(2757, 'XRCC2', 'rs3218408', 'CGAS', 'Breast Cancer', '21632523'),
(2758, 'XRCC2', 'rs3218499', 'CGAS', 'Colorectal Cancer', '19690184'),
(2759, 'XRCC2', 'rs3218536', 'CGAS', 'Breast Cancer', '17018785'),
(2760, 'XRCC2', 'rs3218536', 'CGAS', 'Breast Cancer', '16485136'),
(2761, 'XRCC2', 'rs3218536', 'CGAS', 'Colorectal Cancer', '19116388'),
(2762, 'XRCC2', 'rs3218536', 'CGAS', 'Lung Cancer', '18990748'),
(2763, 'CCR5', 'rs333', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2764, 'TGFBR1', 'rs334354', 'CGAS', 'Colorectal Cancer', '21858550'),
(2765, 'CDKN1B', 'rs34330', 'CGAS', 'Breast Cancer', '19005751'),
(2766, 'TYMS', 'rs34489327', 'CGAS', 'Breast Cancer', '21188629'),
(2767, 'TYMS', 'rs34743033', 'CGAS', 'Breast Cancer', '21188629'),
(2768, 'FGFR4', 'rs351855', 'CGAS', 'Breast Cancer', '16012724'),
(2769, 'FGFR4', 'rs351855', 'CGAS', 'Colorectal Cancer', '16012724'),
(2770, 'FGFR4', 'rs351855', 'CGAS', 'Cancer', '20638838'),
(2771, 'FGFR4', 'rs351855', 'CGAS', 'LCC - Liver cell carcinoma', '20638838'),
(2772, 'FGFR4', 'rs351855', 'CGAS', 'Colorectal Cancer', '20638838'),
(2773, 'FGFR4', 'rs351855', 'CGAS', 'Breast Cancer', '20638838'),
(2774, 'FGFR4', 'rs351855', 'CGAS', 'Prostatic Cancer', '20638838'),
(2775, 'FGFR4', 'rs351855', 'CGAS', 'Prostate Cancer', '21349172'),
(2776, 'FGFR4', 'rs351855', 'CGAS', 'Prostate Cancer', '21625079'),
(2777, 'TNF', 'rs361525', 'CGAS', 'Gastric Cancer', '18319718'),
(2778, 'TNF', 'rs361525', 'CGAS', 'Breast Cancer', '19423537'),
(2779, 'TNF', 'rs361525', 'CGAS', 'LCC - Liver cell carcinoma', '20953524'),
(2780, 'TNF', 'rs361525', 'CGAS', 'Breast Cancer', '20882404'),
(2781, 'TNF', 'rs361525', 'CGAS', 'Gastric Cancer', '21178102'),
(2782, 'TNF', 'rs361525', 'CGAS', 'Cancer (General)', '21818296'),
(2783, 'TNF', 'rs361525', 'CGAS', 'Breast Cancer', '21673823'),
(2784, 'TNF', 'rs361525', 'CGAS', 'Breast Cancer', '21818296'),
(2785, 'TNF', 'rs361525', 'CGAS', 'Multiple', '21818296'),
(2786, 'TNF', 'rs361525', 'CGAS', 'Gastric Cancer', '21818296'),
(2787, 'TNF', 'rs361525', 'CGAS', 'Hepatocellular Cancer', '21818296'),
(2788, 'TNF', 'rs361525', 'CGAS', 'Hepatocellular Carcinoma', '21336601'),
(2789, 'TNF', 'rs361525', 'CGAS', 'Breast Cancer', '21476000'),
(2790, 'CDKN2A', 'rs3731257', 'CGAS', 'Ovarian Cancer', '17409409'),
(2791, 'CDKN2B', 'rs3731257', 'CGAS', 'Ovarian Cancer', '17409409'),
(2792, 'CX3CR1', 'rs3732378', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2793, 'CX3CR1', 'rs3732379', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2794, 'CDH1', 'rs3743674', 'CGAS', 'Gastric Cancer', '21570316'),
(2795, 'CPNE3', 'rs4961199', 'CGAS', 'Prostate Cancer', '21343373'),
(2796, 'ADH1B', 'rs2066702', 'CGAS', 'Head and Neck Cancers', '22042713'),
(2797, 'ADH1B', 'rs2066702', 'CGAS', 'Pharynx Cancer', '22042713'),
(2798, 'ADH1B', 'rs2066702', 'CGAS', 'Oral Cancer', '22042713'),
(2799, 'ADH1B', 'rs2066702', 'CGAS', 'Larynx Cancer', '22042713'),
(2800, 'CDKN1B', 'rs2066827', 'CGAS', 'Ovarian Cancer', '17409409'),
(2801, 'NOD2', 'rs2066844', 'CGAS', 'Colorectal Cancer', '19787357'),
(2802, 'NOD2', 'rs2066845', 'CGAS', 'Colorectal Cancer', '19787357'),
(2803, 'NOD2', 'rs2066847', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20047977'),
(2804, 'NOS3', 'rs2070744', 'CGAS', 'Breast Cancer', '20204503'),
(2805, 'MRPL23', 'rs2107425', 'CGAS', 'Ovarian Cancer', '19304784'),
(2806, 'CCL5', 'rs2107538', 'CGAS', 'Lymphoma Non-Hodgkin\'s', '20038229'),
(2807, 'RPA3', 'rs2160138', 'CGAS', 'Glioma', '18048407'),
(2808, 'DROSHA', 'rs2161006', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(2809, 'ABCB1', 'rs2214102', 'CGAS', 'Breast Cancer', '20625815'),
(2810, 'XPC', 'rs2228000', 'CGAS', 'Bladder Cancer', '18097734'),
(2811, 'XPC', 'rs2228000', 'CGAS', 'Lung Cancer', '18285822'),
(2812, 'XPC', 'rs2228000', 'CGAS', 'Skin Cancer', '18285822'),
(2813, 'XPC', 'rs2228000', 'CGAS', 'Bladder Cancer', '19706757'),
(2814, 'XPC', 'rs2228000', 'CGAS', 'Bladder Cancer', '18771913'),
(2815, 'XPC', 'rs2228000', 'CGAS', 'Lung Cancer', '18771913'),
(2816, 'XPC', 'rs2228000', 'CGAS', 'melanoma', '20601096'),
(2817, 'XPC', 'rs2228000', 'CGAS', 'Breast Cancer', '21318603'),
(2818, 'XPC', 'rs2228001', 'CGAS', 'Breast Cancer', '18097734'),
(2819, 'XPC', 'rs2228001', 'CGAS', 'Colorectal Cancer', '18097734'),
(2820, 'XPC', 'rs2228001', 'CGAS', 'Bladder Cancer', '18097734'),
(2821, 'XPC', 'rs2228001', 'CGAS', 'Skin Cancer', '18097734'),
(2822, 'XPC', 'rs2228001', 'CGAS', 'Skin Cancer', '18285822'),
(2823, 'XPC', 'rs2228001', 'CGAS', 'Head and Neck Cancer', '18285822'),
(2824, 'XPC', 'rs2228001', 'CGAS', 'Gastric Cancer', '18285822'),
(2825, 'XPC', 'rs2228001', 'CGAS', 'Lung Cancer', '18285822'),
(2826, 'XPC', 'rs2228001', 'CGAS', 'Bladder Cancer', '18285822'),
(2827, 'XPC', 'rs2228001', 'CGAS', 'Breast Cancer', '18285822'),
(2828, 'XPC', 'rs2228001', 'CGAS', 'Bladder Cancer', '19706757'),
(2829, 'XPC', 'rs2228001', 'CGAS', 'Lung Cancer', '18771913'),
(2830, 'XPC', 'rs2228001', 'CGAS', 'Bladder Cancer', '18771913'),
(2831, 'XPC', 'rs2228001', 'CGAS', 'melanoma', '20601096'),
(2832, 'XPC', 'rs2228001', 'CGAS', 'Breast Cancer', '21318603'),
(2833, 'MC1R', 'rs2228479', 'CGAS', 'melanoma', '21128237'),
(2834, 'VDR', 'rs2228570', 'CGAS', 'Prostate Cancer', '19684888'),
(2835, 'VDR', 'rs2228570', 'CGAS', 'Prostate Cancer', '14693728'),
(2836, 'VDR', 'rs2228570', 'CGAS', 'Prostate Cancer', '16600714'),
(2837, 'VDR', 'rs2228570', 'CGAS', 'Skin Cancer', '18816636'),
(2838, 'VDR', 'rs2228570', 'CGAS', 'Ovarian Cancer', '19223536'),
(2839, 'VDR', 'rs2228570', 'CGAS', 'Breast Cancer', '19145484'),
(2840, 'VDR', 'rs2228570', 'CGAS', 'Breast Cancer', '19124512'),
(2841, 'VDR', 'rs2228570', 'CGAS', 'Skin Cancer', '19008093'),
(2842, 'VDR', 'rs2228570', 'CGAS', 'Skin Cancer', '19403841'),
(2843, 'VDR', 'rs2228570', 'CGAS', 'Prostate Cancer', '19403841'),
(2844, 'VDR', 'rs2228570', 'CGAS', 'Breast Cancer', '19403841'),
(2845, 'VDR', 'rs2228570', 'CGAS', 'Colorectal Cancer', '19403841'),
(2846, 'ESR1', 'rs2234693', 'CGAS', 'Breast Cancer', '16215870'),
(2847, 'ESR1', 'rs2234693', 'CGAS', 'Breast Cancer', '17309937'),
(2848, 'ESR1', 'rs2234693', 'CGAS', 'Breast Cancer', '17453340'),
(2849, 'FAS', 'rs2234767', 'CGAS', 'Lung Cancer', '19225810'),
(2850, 'FAS', 'rs2234767', 'CGAS', 'Breast Cancer', '19225810'),
(2851, 'FAS', 'rs2234767', 'CGAS', 'Cervical Cancer', '19225810'),
(2852, 'FAS', 'rs2234767', 'CGAS', 'Skin Cancer', '19168581'),
(2853, 'FAS', 'rs2234767', 'CGAS', 'Lung Cancer', '19168581'),
(2854, 'FAS', 'rs2234767', 'CGAS', 'Breast Cancer', '19168581'),
(2855, 'FAS', 'rs2234767', 'CGAS', 'Cervical Cancer', '19168581'),
(2856, 'EPHX1', 'rs2234922', 'CGAS', 'Lung Cancer', '12141066'),
(2857, 'EPHX1', 'rs2234922', 'CGAS', 'Lung Cancer', '16357600'),
(2858, 'HSPA13', 'rs2242661', 'CGAS', 'Gastric Cancer', '18949424'),
(2859, 'AURKA', 'rs2273535', 'CGAS', 'Breast Cancer', '19823929'),
(2860, 'AURKA', 'rs2273535', 'CGAS', 'Colorectal Cancer', '15802297'),
(2861, 'AURKA', 'rs2273535', 'CGAS', 'Breast Cancer', '15802297'),
(2862, 'AURKA', 'rs2273535', 'CGAS', 'Breast Cancer', '17018785'),
(2863, 'AURKA', 'rs2273535', 'CGAS', 'Colorectal Cancer', '17003782'),
(2864, 'AURKA', 'rs2273535', 'CGAS', 'Breast Cancer', '16849685'),
(2865, 'AURKA', 'rs2273535', 'CGAS', 'Breast Cancer', '16411056'),
(2866, 'AURKA', 'rs2273535', 'CGAS', 'Ovarian Cancer', '18431743'),
(2867, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Cancer (General)', '21502193'),
(2868, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Cancer (General)', '21617940'),
(2869, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Cancer (General)', '21672615'),
(2870, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Lung Cancer', '21672615'),
(2871, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Colorectal Cancer', '21672615'),
(2872, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Esophageal Cancer', '21672615'),
(2873, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Gastric Cancer', '21672615'),
(2874, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Breast Cancer', '21672615'),
(2875, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Head and Neck Cancers', '21502193'),
(2876, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Lung Cancer', '21502193'),
(2877, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Gastric Cancer', '21502193'),
(2878, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Colorectal Cancer', '21502193'),
(2879, 'ARHGAP24', 'rs2273953 rs1801173', 'CGAS', 'Esophageal Cancer', '21502193'),
(2880, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Head and Neck Cancer', '21617940'),
(2881, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Lung Cancer', '21617940'),
(2882, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Skin Cancer', '21617940'),
(2883, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Gastric Cancer', '21617940'),
(2884, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Esophageal Cancer', '21617940'),
(2885, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Colorectal Cancer', '21617940'),
(2886, 'TP73', 'rs2273953 rs1801173', 'CGAS', 'Cervical Cancer', '21617940'),
(2887, 'MDM2', 'rs2279744', 'CGAS', 'Colorectal Cancer', '18086778'),
(2888, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '18086778'),
(2889, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '17909070'),
(2890, 'MDM2', 'rs2279744', 'CGAS', 'Colorectal Cancer', '17827408'),
(2891, 'MDM2', 'rs2279744', 'CGAS', 'Lung Cancer', '17827408'),
(2892, 'MDM2', 'rs2279744', 'CGAS', 'Lung Cancer', '19264476'),
(2893, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '17827408'),
(2894, 'MDM2', 'rs2279744', 'CGAS', 'Lung Cancer', '19492228'),
(2895, 'MDM2', 'rs2279744', 'CGAS', 'Lung Cancer', '18086778'),
(2896, 'MDM2', 'rs2279744', 'CGAS', 'Colorectal Cancer', '20503107'),
(2897, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '19590949'),
(2898, 'MDM2', 'rs2279744', 'CGAS', 'Prostate Cancer', '21867960'),
(2899, 'MDM2', 'rs2279744', 'CGAS', 'Oral Squamous Cell Carcinoma', '21867960'),
(2900, 'MDM2', 'rs2279744', 'CGAS', 'Multiple', '21867960'),
(2901, 'MDM2', 'rs2279744', 'CGAS', 'Lung Cancer', '21867960'),
(2902, 'MDM2', 'rs2279744', 'CGAS', 'Hepatoceullar Carcinoma', '21867960'),
(2903, 'MDM2', 'rs2279744', 'CGAS', 'Gastric Cancer', '21867960'),
(2904, 'MDM2', 'rs2279744', 'CGAS', 'Endometrial Cancer', '21867960'),
(2905, 'MDM2', 'rs2279744', 'CGAS', 'Colorectal Cancer', '21867960'),
(2906, 'MDM2', 'rs2279744', 'CGAS', 'Cancer (General)', '21867960'),
(2907, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '21867960'),
(2908, 'MDM2', 'rs2279744', 'CGAS', 'Bladder Cancer', '21867960'),
(2909, 'MDM2', 'rs2279744', 'CGAS', 'Acute Myeloid Leukemia', '21867960'),
(2910, 'MDM2', 'rs2279744', 'CGAS', 'Breast Cancer', '21725850'),
(2911, 'MDM2', 'rs2279744', 'CGAS', 'Endometrial Cancer', '21547352'),
(2912, 'MDM2', 'rs2279744', 'CGAS', 'Hepatocellular Carcinoma', '21240526'),
(2913, 'MMP2', 'rs2285053', 'CGAS', 'Lung Cancer', '20360147'),
(2914, 'MMP2', 'rs2285053', 'CGAS', 'Oesophageal Cancer', '20360147'),
(2915, 'MMP2', 'rs2285053', 'CGAS', 'Cancer', '20360147'),
(2916, 'TP53', 'rs2287498', 'CGAS', 'Ovarian Cancer', '19276375'),
(2917, 'WRAP53', 'rs2287499', 'CGAS', 'Breast Cancer', '17683073'),
(2918, 'ESR1', 'rs2295190', 'CGAS', 'Ovarian Cancer', '20056644'),
(2919, 'MGMT', 'rs2308321', 'CGAS', 'Head and Neck Cancer', '15121774'),
(2920, 'MGMT', 'rs2308321', 'CGAS', 'Prostate Cancer', '19116388'),
(2921, 'MGMT', 'rs2308321', 'CGAS', 'Lung Cancer', '19892775'),
(2922, 'MGMT', 'rs2308321', 'CGAS', 'Colorectal Cancer', '19892775'),
(2923, 'MGMT', 'rs2308321', 'CGAS', 'Cancer', '19892775'),
(2924, 'MGMT', 'rs2308327', 'CGAS', 'Lung Cancer', '18990748'),
(2925, 'MGMT', 'rs2308327', 'CGAS', 'Lung Cancer', '17957803'),
(2926, 'MGMT', 'rs23083321', 'CGAS', 'Lung Cancer', '18990748'),
(2927, 'CTLA4', 'rs231775', 'CGAS', 'Non-Hodgkin Lymphoma', '16740140'),
(2928, 'CTLA4', 'rs231775', 'CGAS', 'Skin Cancer', '20920330'),
(2929, 'CTLA4', 'rs231775', 'CGAS', 'Stomach Cancer', '20920330'),
(2930, 'CTLA4', 'rs231775', 'CGAS', 'Colorectal Cancer', '20920330'),
(2931, 'CTLA4', 'rs231775', 'CGAS', 'Breast Cancer', '20920330'),
(2932, 'CTLA4', 'rs231775', 'CGAS', 'Cancer', '20920330'),
(2933, 'CTLA4', 'rs231775', 'CGAS', 'Cancer (General)', '21387262'),
(2934, 'CTLA4', 'rs231775', 'CGAS', 'Cervical Cancer', '21387262'),
(2935, 'CTLA4', 'rs231775', 'CGAS', 'Breast Cancer', '21387262'),
(2936, 'CTLA4', 'rs231775', 'CGAS', 'Lung Cancer', '21387262'),
(2937, 'CTLA4', 'rs231775', 'CGAS', 'Gastric Cancer', '21387262'),
(2938, 'CTLA4', 'rs231775', 'CGAS', 'Colorectal Cancer', '21387262'),
(2939, 'MPO', 'rs2333227', 'CGAS', 'Lung Cancer', '16170238'),
(2940, 'MPO', 'rs2333227', 'CGAS', 'Lung Cancer', '12496042'),
(2941, 'MPO', 'rs2333227', 'CGAS', 'Lung Cancer', '17304047'),
(2942, 'MPO', 'rs2333227', 'CGAS', 'Breast Cancer', '20418356'),
(2943, 'MPO', 'rs2333227', 'CGAS', 'leukemia', '20418356'),
(2944, 'MPO', 'rs2333227', 'CGAS', 'Lung Cancer', '20418356'),
(2945, 'MPO', 'rs2333227', 'CGAS', 'Cancer', '20418356'),
(2946, 'GPC5', 'rs2352028', 'CGAS', 'Lung Cancer', '20688270'),
(2947, 'AR', 'rs2361634', 'CGAS', 'Breast Cancer', '16987421'),
(2948, 'CYP19A1', 'rs2414096', 'CGAS', 'Breast Cancer', '17325027'),
(2949, 'FGFR2', 'rs2420946', 'CGAS', 'Breast Cancer', '20300826'),
(2950, 'FGFR2', 'rs2420946', 'CGAS', 'Breast Cancer', '20364400'),
(2951, 'DNMT3B', 'rs2424913', 'CGAS', 'Lung Acute Leukemia Prostate Breast Cancer', '21938431'),
(2952, 'DNMT3B', 'rs2424913', 'CGAS', 'Hepatocellular Carcinoma', '21938431'),
(2953, 'DNMT3B', 'rs2424913', 'CGAS', 'Gastric Cancer', '21938431'),
(2954, 'DNMT3B', 'rs2424913', 'CGAS', 'Colorectal Cancer', '21938431'),
(2955, 'DNMT3B', 'rs2424913', 'CGAS', 'Cancer (General)', '21938431'),
(2956, 'IFNG', 'rs2430561', 'CGAS', 'Cancer (General)', '21798758'),
(2957, 'IFNG', 'rs2430561', 'CGAS', 'Multiple', '21798758'),
(2958, 'IFNG', 'rs2430561', 'CGAS', 'Cervical Cancer', '21798758'),
(2959, 'IFNG', 'rs2430561', 'CGAS', 'Breast Cancer', '21798758'),
(2960, 'IFNG', 'rs2430561', 'CGAS', 'Melanoma', '21798758'),
(2961, 'IFNG', 'rs2430561', 'CGAS', 'Lymphoma', '21798758'),
(2962, 'IFNG', 'rs2430561', 'CGAS', 'Liver Cancer', '21798758'),
(2963, 'IFNG', 'rs2430561', 'CGAS', 'Leukemia', '21798758'),
(2964, 'IFNG', 'rs2430561', 'CGAS', 'Colorectal Cancer', '21798758'),
(2965, 'CHAF1A', 'rs243341', 'CGAS', 'Glioma', '18048407'),
(2966, 'CHAF1A', 'rs243356', 'CGAS', 'Glioma', '18048407'),
(2967, 'MMP2', 'rs243865', 'CGAS', 'Gastric Cancer', '18949424'),
(2968, 'MMP2', 'rs243865', 'CGAS', 'Gastric Cancer', '19375306'),
(2969, 'MMP2', 'rs243865', 'CGAS', 'Digestive Cancer (General)', '21722821'),
(2970, 'MMP2', 'rs243865', 'CGAS', 'Colorectal Cancer', '20360147'),
(2971, 'MMP2', 'rs243865', 'CGAS', 'Oesophageal Cancer', '20360147'),
(2972, 'MMP2', 'rs243865', 'CGAS', 'Stomach Cancer', '20360147'),
(2973, 'MMP2', 'rs243865', 'CGAS', 'Lung Cancer', '20360147'),
(2974, 'MMP2', 'rs243865', 'CGAS', 'Breast Cancer', '20360147'),
(2975, 'MMP2', 'rs243865', 'CGAS', 'Cancer', '20360147'),
(2976, 'MMP2', 'rs243865', 'CGAS', 'Head and Neck Cancer', '20360147'),
(2977, 'MMP2', 'rs243865', 'CGAS', 'Gastric Cancer', '21722821'),
(2978, 'MMP2', 'rs243865', 'CGAS', 'Esophageal Cancer', '21722821'),
(2979, 'MMP2', 'rs243865', 'CGAS', 'Colorectal Cancer', '21722821'),
(2980, 'MMP2', 'rs243865', 'CGAS', 'Colorectal Cancer', '21538057'),
(2981, 'CYP19A1', 'rs2445759', 'CGAS', 'Breast Cancer', '17325027'),
(2982, 'CYP19A1', 'rs2445762', 'CGAS', 'Breast Cancer', '17325027'),
(2983, 'CYP19A1', 'rs2445765', 'CGAS', 'Breast Cancer', '17325027'),
(2984, 'CYP19A1', 'rs2446405', 'CGAS', 'Breast Cancer', '17325027'),
(2985, 'CYP19A1', 'rs2470144', 'CGAS', 'Breast Cancer', '17325027'),
(2986, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '16221808'),
(2987, 'XRCC1', 'rs25487', 'CGAS', 'Gastric Cancer', '16030121'),
(2988, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '16030121'),
(2989, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '17018785');
INSERT INTO `genes` (`id`, `gene-name`, `Marker`, `Study-type`, `Disease`, `Pubmed-ID`) VALUES
(2990, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '18481169'),
(2991, 'XRCC1', 'rs25487', 'CGAS', 'Bladder Cancer', '18336890'),
(2992, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '19329222'),
(2993, 'XRCC1', 'rs25487', 'CGAS', 'Gastric Cancer', '19034980'),
(2994, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '19481337'),
(2995, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '19465687'),
(2996, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '19446452'),
(2997, 'XRCC1', 'rs25487', 'CGAS', 'Esophageal Cancer', '19444915'),
(2998, 'XRCC1', 'rs25487', 'CGAS', 'Esophageal Cancer', '19436829'),
(2999, 'XRCC1', 'rs25487', 'CGAS', 'Prostate Cancer', '19428062'),
(3000, 'XRCC1', 'rs25487', 'CGAS', 'Gastric Cancer', '21604176'),
(3001, 'XRCC1', 'rs25487', 'CGAS', 'Bladder Cancer', '19706757'),
(3002, 'XRCC1', 'rs25487', 'CGAS', 'Breast Cancer', '16030121'),
(3003, 'XRCC1', 'rs25487', 'CGAS', 'Digestive System Neoplasms', '16221808'),
(3004, 'XRCC1', 'rs25487', 'CGAS', 'Skin Cancer', '16221808'),
(3005, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '16221808'),
(3006, 'XRCC1', 'rs25487', 'CGAS', 'Bladder Cancer', '16221808'),
(3007, 'XRCC1', 'rs25487', 'CGAS', 'Head and Neck Cancer', '16030112'),
(3008, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '16982113'),
(3009, 'XRCC1', 'rs25487', 'CGAS', 'Bladder Cancer', '18765423'),
(3010, 'XRCC1', 'rs25487', 'CGAS', 'Cervical Cancer', '19116388'),
(3011, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '18990748'),
(3012, 'XRCC1', 'rs25487', 'CGAS', 'Colorectal Cancer', '20033188'),
(3013, 'XRCC1', 'rs25487', 'CGAS', 'Colorectal Cancer', '19915856'),
(3014, 'XRCC1', 'rs25487', 'CGAS', 'melanoma', '20601096'),
(3015, 'XRCC1', 'rs25487', 'CGAS', 'Lung Cancer', '20981350'),
(3016, 'XRCC1', 'rs25487', 'CGAS', 'Pancreatic Cancer', '21383623'),
(3017, 'XRCC1', 'rs25487', 'CGAS', 'Prostate Cancer', '21647176'),
(3018, 'XRCC1', 'rs25487', 'CGAS', 'Hepatocellular Carcinoma', '21645210'),
(3019, 'XRCC1', 'rs25489', 'CGAS', 'Bladder Cancer', '18336890'),
(3020, 'XRCC1', 'rs25489', 'CGAS', 'Lung Cancer', '19329222'),
(3021, 'XRCC1', 'rs25489', 'CGAS', 'Breast Cancer', '19465687'),
(3022, 'XRCC1', 'rs25489', 'CGAS', 'Breast Cancer', '19446452'),
(3023, 'XRCC1', 'rs25489', 'CGAS', 'Lung Cancer', '16221808'),
(3024, 'XRCC1', 'rs25489', 'CGAS', 'Digestive System Neoplasms', '16221808'),
(3025, 'XRCC1', 'rs25489', 'CGAS', 'Lung Cancer', '16982113'),
(3026, 'XRCC1', 'rs25489', 'CGAS', 'Lung Cancer', '18990748'),
(3027, 'XRCC1', 'rs25489', 'CGAS', 'Colorectal Cancer', '20033188'),
(3028, 'XRCC1', 'rs25489', 'CGAS', 'Lung Cancer', '20981350'),
(3029, 'XRCC1', 'rs25489', 'CGAS', 'Gastric Cancer', '21604176'),
(3030, 'FMR1', 'rs25704', 'CGAS', 'Epithelial Ovarian Cancer', '21482675'),
(3031, 'IL1RN', 'rs2637988', 'CGAS', 'Non-Hodgkin Lymphoma', '21250972'),
(3032, 'ADIPOQ', 'rs266729', 'CGAS', 'Colorectal Cancer', '19264763'),
(3033, 'KLK3', 'rs266882', 'CGAS', 'Prostate Cancer', '18827812'),
(3034, 'KLK3', 'rs2735839', 'CGAS', 'Prostatic Cancer', '20564319'),
(3035, 'CYP3A4', 'rs2740574', 'CGAS', 'Ovarian Cancer', '19127255'),
(3036, 'CYP3A4', 'rs2740574', 'CGAS', 'Prostatic Cancer', '20027111'),
(3037, 'CDKN2A', 'rs2811712', 'CGAS', 'Ovarian Cancer', '18431743'),
(3038, 'IGFBP3', 'rs2854744', 'CGAS', 'Prostate Cancer', '19491931'),
(3039, 'IGFBP3', 'rs2854744', 'CGAS', 'Colorectal Cancer', '19491931'),
(3040, 'IGFBP3', 'rs2854744', 'CGAS', 'Breast Cancer', '19491931'),
(3041, 'IGFBP3', 'rs2854744', 'CGAS', 'Breast Cancer', '17293864'),
(3042, 'IGFBP3', 'rs2854744', 'CGAS', 'Breast Cancer', '17018785'),
(3043, 'IGFBP3', 'rs2854744', 'CGAS', 'Breast Cancer', '20084546'),
(3044, 'IGFBP3', 'rs2854744', 'CGAS', 'Colorectal Cancer', '19449212'),
(3045, 'IGFBP3', 'rs2854744', 'CGAS', 'Prostate Cancer', '19449212'),
(3046, 'IGFBP3', 'rs2854744', 'CGAS', 'Breast Cancer', '19449212'),
(3047, 'IGFBP3', 'rs2854744', 'CGAS', 'Bladder Cancer', '21892705'),
(3048, 'CYP19A1', 'rs28566535', 'CGAS', 'Breast Cancer', '17325027'),
(3049, 'CYP19A1', 'rs28757184', 'CGAS', 'Breast Cancer', '17325027'),
(3050, 'BARD1', 'rs28997576', 'CGAS', 'Breast Cancer', '21809034'),
(3051, 'TP53', 'rs2909430', 'CGAS', 'Breast Cancer', '17683073');

-- --------------------------------------------------------

--
-- Table structure for table `region`
--

CREATE TABLE `region` (
  `id` int(11) NOT NULL,
  `miRNA-name` varchar(17) NOT NULL,
  `chr_number` varchar(10) NOT NULL,
  `strand` varchar(6) NOT NULL,
  `allele` varchar(20) NOT NULL,
  `Sequence` varchar(31) NOT NULL,
  `Region` varchar(9) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `region`
--

INSERT INTO `region` (`id`, `miRNA-name`, `chr_number`, `strand`, `allele`, `Sequence`, `Region`) VALUES
(2, 'hsa-miR-6777-3p', 'chr17', '-', 'C/T', 'CCACU[C/T]U', 'Seed'),
(3, 'hsa-miR-6814-5p', 'chr21', '-', 'G/A', 'CCCAA[G/A]G', 'Seed'),
(4, 'hsa-miR-662', 'chr16', '+', 'G/A', 'CCCAC[G/A]U', 'Seed'),
(5, 'hsa-miR-4301', 'chr11', '-', 'C/A', '[C/A]CCACUA', 'Seed'),
(6, 'hsa-miR-6803-3p', 'chr19', '-', 'C/T', 'CCCU[C/T]GC', 'Seed'),
(7, 'hsa-miR-125a-5p', 'chr19', '+', 'G/T', 'CCCUGA[G/T]', 'Seed'),
(8, 'hsa-miR-671-3p', 'chr7', '+', 'G/A', 'CC[G/A]GUUC', 'Seed'),
(9, 'hsa-miR-6761-3p', 'chr12', '+', 'C/T', '[C/T]CUACGC', 'Seed'),
(10, 'hsa-miR-6761-3p', 'chr12', '+', 'C/T', 'CCUA[C/T]GC', 'Seed'),
(11, 'hsa-miR-6767-5p', 'chr16', '+', 'C/T', '[C/T]GCAGAC', 'Seed'),
(12, 'hsa-miR-1292-3p', 'chr20', '+', 'C/T', '[C/T]GCGCCC', 'Seed'),
(13, 'hsa-miR-6499-5p', 'chr5', '-', 'G/A', 'CGGGC[G/A]C', 'Seed'),
(14, 'hsa-miR-6889-5p', 'chr22', '-', 'G/A', 'C[G/A]GGGAG', 'Seed'),
(15, 'hsa-miR-6774-3p', 'chr16', '+', 'G/A', 'C[G/A]UGUCC', 'Seed'),
(16, 'hsa-miR-520g-5p', 'chr19', '+', 'C/G', '[C/G]UAGAGG', 'Seed'),
(17, 'hsa-miR-520g-5p', 'chr19', '+', 'G/A', 'CUAGA[G/A]G', 'Seed'),
(18, 'hsa-miR-645', 'chr20', '+', 'C/G', '[C/G]UAGGCU', 'Seed'),
(19, 'hsa-miR-6787-3p', 'chr17', '+', 'C/A', '[C/A]UCAGCU', 'Seed'),
(20, 'hsa-miR-6787-3p', 'chr17', '+', 'C/A', 'CUCAG[C/A]U', 'Seed'),
(21, 'hsa-miR-3615', 'chr17', '+', 'C/T', 'CU[C/T]UCGG', 'Seed'),
(22, 'hsa-miR-6515-3p', 'chr19', '+', 'C/T', '[C/T]UCUUCA', 'Seed'),
(23, 'hsa-miR-550b-3p', 'chr7', '-', 'C/T', 'CUUA[C/T]UC', 'Seed'),
(24, 'hsa-miR-4778-3p', 'chr2', '-', 'C/T', 'CUUCUU[C/T]', 'Seed'),
(25, 'hsa-miR-4738-3p', 'chr17', '-', 'C/T', 'GAAA[C/T]UG', 'Seed'),
(26, 'hsa-miR-6859-3p', 'chr1', '-', 'C/T', 'GACCC[C/T]C', 'Seed'),
(27, 'hsa-miR-6859-3p', 'chr1', '-', 'C/T', 'GACCC[C/T]C', 'Seed'),
(28, 'hsa-miR-6859-3p', 'chr1', '-', 'C/T', 'GACCC[C/T]C', 'Seed'),
(29, 'hsa-miR-3126-5p', 'chr2', '+', 'G/A', '[G/A]AGGGAC', 'Seed'),
(30, 'hsa-miR-3126-5p', 'chr2', '+', 'A/T', 'G[A/T]GGGAC', 'Seed'),
(31, 'hsa-miR-7854-3p', 'chr16', '+', 'A/G', 'GAGGUG[A/G]', 'Seed'),
(32, 'hsa-miR-5589-3p', 'chr19', '+', 'A/G', 'GCAC[A/G]UG', 'Seed'),
(33, 'hsa-miR-4641', 'chr6', '+', 'G/A', 'GCCCAU[G/A]', 'Seed'),
(34, 'hsa-miR-4290', 'chr9', '-', 'C/T', 'G[C/T]CCUCC', 'Seed'),
(35, 'hsa-miR-938', 'chr10', '-', 'G/A', '[G/A]CCCUUA', 'Seed'),
(36, 'hsa-miR-6791-3p', 'chr19', '-', 'G/T', '[G/T]CCUCCU', 'Seed'),
(37, 'hsa-miR-3116', 'chr1', '+', 'G/A', '[G/A]CCUGGA', 'Seed'),
(38, 'hsa-miR-668-5p', 'chr14', '+', 'C/T', 'GCGCCU[C/T]', 'Seed'),
(39, 'hsa-miR-4683', 'chr10', '-', 'C/A', 'GGAGAU[C/A]', 'Seed'),
(40, 'hsa-miR-4683', 'chr10', '-', 'A/T', 'GGAG[A/T]UC', 'Seed'),
(41, 'hsa-miR-4743-5p', 'chr18', '+', 'C/T', 'GGC[C/T]GGA', 'Seed'),
(42, 'hsa-miR-4467', 'chr7', '+', 'G/A', 'GGC[G/A]GCG', 'Seed'),
(43, 'hsa-miR-6762-3p', 'chr12', '+', 'G/A', 'GGCU[G/A]CU', 'Seed'),
(44, 'hsa-miR-6721-5p', 'chr6', '-', 'C/T', 'GGG[C/T]AGG', 'Seed'),
(45, 'hsa-miR-6729-5p', 'chr1', '+', 'G/A', 'GGGC[G/A]AG', 'Seed'),
(46, 'hsa-miR-585-3p', 'chr5', '-', 'G/A', 'GG[G/A]CGUA', 'Seed'),
(47, 'hsa-miR-379-5p', 'chr14', '+', 'A/G', 'GGUAG[A/G]C', 'Seed'),
(48, 'hsa-miR-412-5p', 'chr14', '+', 'C/T', 'GGU[C/T]GAC', 'Seed'),
(49, 'hsa-miR-8065', 'chr16', '+', 'A/G', 'GU[A/G]GGAA', 'Seed'),
(50, 'hsa-miR-6879-3p', 'chr11', '+', 'C/T', 'GUCA[C/T]CC', 'Seed'),
(51, 'hsa-miR-6879-3p', 'chr11', '+', 'C/T', 'GUCACC[C/T]', 'Seed'),
(52, 'hsa-miR-3618', 'chr22', '+', 'C/G', 'GU[C/G]UACA', 'Seed'),
(53, 'hsa-miR-6895-3p', 'chrX', '-', 'C/T', 'GUCUCU[C/T]', 'Seed'),
(54, 'hsa-miR-3118', 'chr1', '+', 'G/C', 'GUGACU[G/C]', 'Seed'),
(55, 'hsa-miR-3118', 'chr1', '+', 'G/A', 'GUGACU[G/A]', 'Seed'),
(56, 'hsa-miR-3118', 'chr1', '+', 'G/C', 'GUGACU[G/C]', 'Seed'),
(57, 'hsa-miR-3118', 'chr1', '+', 'G/A', 'GUGACU[G/A]', 'Seed'),
(58, 'hsa-miR-3118', 'chr1', '-', 'G/C', 'GUGACU[G/C]', 'Seed'),
(59, 'hsa-miR-3118', 'chr1', '-', 'G/A', 'GUGACU[G/A]', 'Seed'),
(60, 'hsa-miR-3118', 'chr15', '+', 'C/G', 'GUGA[C/G]UG', 'Seed'),
(61, 'hsa-miR-3118', 'chr15', '+', 'C/G', 'GUGA[C/G]UG', 'Seed'),
(62, 'hsa-miR-3118', 'chr15', '+', 'C/G', 'GUGA[C/G]UG', 'Seed'),
(63, 'hsa-miR-3118', 'chr21', '-', 'G/A', 'GUGACU[G/A]', 'Seed'),
(64, 'hsa-miR-3689f', 'chr9', '-', 'A/G', 'GUG[A/G]UAU', 'Seed'),
(65, 'hsa-miR-933', 'chr2', '-', 'A/G', 'GUGCGC[A/G]', 'Seed'),
(66, 'hsa-miR-4669', 'chr9', '+', 'G/A', 'GUGUCC[G/A]', 'Seed'),
(67, 'hsa-miR-4788', 'chr3', '+', 'G/A', 'UAC[G/A]GAC', 'Seed'),
(68, 'hsa-miR-4662a-5p', 'chr8', '+', 'A/G', 'UAGCCA[A/G]', 'Seed'),
(69, 'hsa-miR-4540', 'chr9', '-', 'C/T', 'UAGUC[C/T]U', 'Seed'),
(70, 'hsa-miR-3157-5p', 'chr10', '-', 'C/T', 'U[C/T]AGCCA', 'Seed'),
(71, 'hsa-miR-664b-3p', 'chrX', '+', 'G/A', 'UCAUUU[G/A]', 'Seed'),
(72, 'hsa-miR-6509-3p', 'chr7', '-', 'C/T', 'UC[C/T]ACUG', 'Seed'),
(73, 'hsa-miR-6883-3p', 'chr17', '-', 'C/T', 'UC[C/T]CUAU', 'Seed'),
(74, 'hsa-miR-6788-3p', 'chr18', '-', 'C/T', 'U[C/T]GCCAC', 'Seed'),
(75, 'hsa-miR-3124-5p', 'chr1', '+', 'C/T', 'U[C/T]GCGGG', 'Seed'),
(76, 'hsa-miR-4804-5p', 'chr5', '+', 'C/G', 'UGGA[C/G]GG', 'Seed'),
(77, 'hsa-miR-1302', 'chr12', '-', 'C/T', 'UGGGA[C/T]A', 'Seed'),
(78, 'hsa-miR-6818-5p', 'chr22', '+', 'G/T', 'U[G/T]UGUGA', 'Seed'),
(79, 'hsa-miR-122-3p', 'chr18', '+', 'C/T', 'A[C/T]GCCAU', 'Seed'),
(80, 'hsa-miR-181d-3p', 'chr19', '+', 'C/T', 'CAC[C/T]GGG', 'Seed'),
(81, 'hsa-miR-1324', 'chr3', '+', 'C/T', '[C/T]AGACAG', 'Seed'),
(82, 'hsa-miR-1324', 'chr3', '+', 'C/T', '[C/T]AGACAG', 'Seed'),
(83, 'hsa-miR-1324', 'chr3', '+', 'C/T', '[C/T]AGACAG', 'Seed'),
(84, 'hsa-miR-1324', 'chr3', '+', 'C/T', 'CAGA[C/T]AG', 'Seed'),
(85, 'hsa-miR-4257', 'chr1', '+', 'G/A', 'CAGA[G/A]GU', 'Seed'),
(86, 'hsa-miR-4691-3p', 'chr11', '+', 'C/T', 'CAG[C/T]CAC', 'Seed'),
(87, 'hsa-miR-6754-5p', 'chr11', '+', 'G/A', 'CAG[G/A]GAG', 'Seed'),
(88, 'hsa-miR-4302', 'chr12', '-', 'G/A', 'CAGU[G/A]UG', 'Seed'),
(89, 'hsa-miR-488-5p', 'chr1', '-', 'G/A', 'CCA[G/A]AUA', 'Seed'),
(90, 'hsa-miR-488-5p', 'chr1', '-', 'A/G', 'CC[A/G]GAUA', 'Seed'),
(91, 'hsa-miR-4532', 'chr20', '+', 'C/T', '[C/T]CCGGGG', 'Seed'),
(92, 'hsa-miR-4532', 'chr20', '+', 'G/A', 'CCC[G/A]GGG', 'Seed'),
(93, 'hsa-miR-6886-5p', 'chr19', '+', 'C/T', '[C/T]CGCAGG', 'Seed'),
(94, 'hsa-miR-6886-5p', 'chr19', '+', 'C/T', 'C[C/T]GCAGG', 'Seed'),
(95, 'hsa-miR-6850-3p', 'chr8', '-', 'C/T', 'C[C/T]GGCCG', 'Seed'),
(96, 'hsa-miR-6891-3p', 'chr6', '-', 'A/C', 'CCUC[A/C]UC', 'Seed'),
(97, 'hsa-miR-4723-3p', 'chr17', '+', 'C/G', 'C[C/G]UCUCU', 'Seed'),
(98, 'hsa-miR-6769b-3p', 'chr1', '+', 'C/T', 'CCUCU[C/T]U', 'Seed'),
(99, 'hsa-miR-6078', 'chr10', '+', 'C/T', '[C/T]GCCUGA', 'Seed'),
(100, 'hsa-miR-4315', 'chr17', '-', 'G/A', 'C[G/A]CUUUC', 'Seed'),
(101, 'hsa-miR-4315', 'chr17', '-', 'C/T', '[C/T]GCUUUC', 'Seed'),
(102, 'hsa-miR-6746-5p', 'chr11', '-', 'G/A', 'C[G/A]GGAGA', 'Seed'),
(103, 'hsa-miR-5090', 'chr7', '+', 'G/A', 'C[G/A]GGGCA', 'Seed'),
(104, 'hsa-miR-4305', 'chr13', '-', 'C/A', 'CUAGA[C/A]A', 'Seed'),
(105, 'hsa-miR-4305', 'chr13', '-', 'A/G', 'CUAG[A/G]CA', 'Seed'),
(106, 'hsa-miR-4305', 'chr13', '-', 'G/C', 'CUA[G/C]ACA', 'Seed'),
(107, 'hsa-miR-3605-3p', 'chr1', '-', 'G/A', 'CUCCGU[G/A]', 'Seed'),
(108, 'hsa-miR-8088', 'chrX', '-', 'G/A', 'CUC[G/A]GUA', 'Seed'),
(109, 'hsa-miR-8088', 'chrX', '-', 'C/T', 'CU[C/T]GGUA', 'Seed'),
(110, 'hsa-miR-146a-3p', 'chr5', '+', 'C/G', 'CU[C/G]UGAA', 'Seed'),
(111, 'hsa-miR-1236-3p', 'chr6', '-', 'C/G', 'CUCUU[C/G]C', 'Seed'),
(112, 'hsa-miR-3692-5p', 'chr6', '+', 'G/A', 'CUGCU[G/A]G', 'Seed'),
(113, 'hsa-miR-15b-3p', 'chr3', '+', 'G/A', '[G/A]AAUCAU', 'Seed'),
(114, 'hsa-miR-3166', 'chr11', '+', 'C/T', 'G[C/T]AGACA', 'Seed'),
(115, 'hsa-miR-4749-3p', 'chr19', '+', 'G/A', '[G/A]CCCCUC', 'Seed'),
(116, 'hsa-miR-4749-3p', 'chr19', '+', 'C/T', 'GC[C/T]CCUC', 'Seed'),
(117, 'hsa-miR-2682-3p', 'chr1', '-', 'G/A', '[G/A]CCUCUU', 'Seed'),
(118, 'hsa-miR-6720-3p', 'chr6', '-', 'C/T', 'GCG[C/T]CUG', 'Seed'),
(119, 'hsa-miR-1255b-5p', 'chr1', '+', 'G/C', '[G/C]GAUGAG', 'Seed'),
(120, 'hsa-miR-1255b-5p', 'chr4', '-', 'G/T', 'G[G/T]AUGAG', 'Seed'),
(121, 'hsa-miR-6726-5p', 'chr1', '-', 'G/A', '[G/A]GGAGCU', 'Seed'),
(122, 'hsa-miR-6781-5p', 'chr17', '-', 'G/A', '[G/A]GGCCGG', 'Seed'),
(123, 'hsa-miR-1268a', 'chr15', '-', 'G/A', 'GGGC[G/A]UG', 'Seed'),
(124, 'hsa-miR-4741', 'chr18', '+', 'C/T', 'GGG[C/T]UGU', 'Seed'),
(125, 'hsa-miR-4741', 'chr18', '+', 'C/T', 'GGG[C/T]UGU', 'Seed'),
(126, 'hsa-miR-4741', 'chr18', '+', 'G/A', 'GGGCU[G/A]U', 'Seed'),
(127, 'hsa-miR-128-1-5p', 'chr2', '+', 'G/A', 'GGGGCC[G/A]', 'Seed'),
(128, 'hsa-miR-3196', 'chr20', '+', 'G/A', '[G/A]GGGCGG', 'Seed'),
(129, 'hsa-miR-1237-5p', 'chr11', '+', 'G/A', 'GGGGGC[G/A]', 'Seed'),
(130, 'hsa-miR-505-3p', 'chrX', '-', 'G/A', '[G/A]UCAACA', 'Seed'),
(131, 'hsa-miR-4433b-3p', 'chr2', '-', 'G/C', 'AGGAGU[G/C]', 'Seed'),
(132, 'hsa-miR-7847-3p', 'chr11', '+', 'G/A', '[G/A]UGGAGG', 'Seed'),
(133, 'hsa-miR-3682-5p', 'chr2', '-', 'A/G', 'U[A/G]CUUCU', 'Seed'),
(134, 'hsa-miR-8074', 'chr19', '-', 'C/T', 'UAUGG[C/T]G', 'Seed'),
(135, 'hsa-miR-4477a', 'chr9', '-', 'G/A', 'UAUUAA[G/A]', 'Seed'),
(136, 'hsa-miR-188-3p', 'chrX', '+', 'C/T', 'UCCCA[C/T]A', 'Seed'),
(137, 'hsa-miR-3156-3p', 'chr18', '+', 'C/T', 'U[C/T]CCACU', 'Seed'),
(138, 'hsa-miR-6763-3p', 'chr12', '+', 'C/T', 'UCCC[C/T]GG', 'Seed'),
(139, 'hsa-miR-155-3p', 'chr21', '+', 'A/G', 'UCCUAC[A/G]', 'Seed'),
(140, 'hsa-miR-6749-3p', 'chr11', '-', 'C/A', 'UCCU[C/A]CC', 'Seed'),
(141, 'hsa-miR-6726-3p', 'chr1', '-', 'C/T', 'U[C/T]GCCCU', 'Seed'),
(142, 'hsa-miR-6727-5p', 'chr1', '-', 'C/T', 'U[C/T]GGGGC', 'Seed'),
(143, 'hsa-miR-3677-3p', 'chr16', '+', 'G/A', 'UC[G/A]UGGG', 'Seed'),
(144, 'hsa-miR-943', 'chr4', '-', 'G/T', 'UGACU[G/T]U', 'Seed'),
(145, 'hsa-miR-1269b', 'chr17', '-', 'C/G', 'UGGA[C/G]UG', 'Seed'),
(146, 'hsa-miR-432-3p', 'chr14', '+', 'G/C', 'UGGAU[G/C]G', 'Seed'),
(147, 'hsa-miR-7109-5p', 'chr22', '-', 'G/A', 'UG[G/A]GGGG', 'Seed'),
(148, 'hsa-miR-4322', 'chr19', '+', 'G/A', 'UGUGG[G/A]C', 'Seed'),
(149, 'hsa-miR-1238-3p', 'chr19', '+', 'G/A', 'UUCCUC[G/A]', 'Seed'),
(150, 'hsa-miR-8081', 'chr9', '+', 'C/T', 'UUGAGU[C/T]', 'Seed'),
(151, 'hsa-miR-518a-3p', 'chr19', '+', 'G/A', 'AAAGC[G/A]C', 'Seed'),
(152, 'hsa-miR-518a-3p', 'chr19', '+', 'G/A', 'AAAGC[G/A]C', 'Seed'),
(153, 'hsa-miR-548aq-5p', 'chr3', '-', 'A/G', 'AA[A/G]GUAA', 'Seed'),
(154, 'hsa-miR-523-3p', 'chr19', '+', 'A/C', '[A/C]ACGCGC', 'Seed'),
(155, 'hsa-miR-523-3p', 'chr19', '+', 'G/A', 'AAC[G/A]CGC', 'Seed'),
(156, 'hsa-miR-6796-3p', 'chr19', '+', 'C/G', 'AAGCU[C/G]U', 'Seed'),
(157, 'hsa-miR-525-3p', 'chr19', '+', 'C/T', 'AAGG[C/T]GC', 'Seed'),
(158, 'hsa-miR-3610', 'chr8', '-', 'A/C', 'AAUCGG[A/C]', 'Seed'),
(159, 'hsa-miR-602', 'chr9', '+', 'C/T', 'A[C/T]ACGGG', 'Seed'),
(160, 'hsa-miR-602', 'chr9', '+', 'C/T', 'ACA[C/T]GGG', 'Seed'),
(161, 'hsa-miR-4676-5p', 'chr10', '+', 'C/T', 'AGC[C/T]AGU', 'Seed'),
(162, 'hsa-miR-575', 'chr4', '-', 'C/T', 'AG[C/T]CAGU', 'Seed'),
(163, 'hsa-miR-590-5p', 'chr7', '+', 'C/T', 'AG[C/T]UUAU', 'Seed'),
(164, 'hsa-miR-4538', 'chr14', '-', 'G/C', 'A[G/C]CUUGG', 'Seed'),
(165, 'hsa-miR-759', 'chr13', '+', 'C/G', '[C/G]AGAGUG', 'Seed'),
(166, 'hsa-miR-551a', 'chr1', '-', 'G/A', 'C[G/A]ACCCA', 'Seed'),
(167, 'hsa-miR-5739', 'chr22', '+', 'G/A', 'CG[G/A]AGAG', 'Seed'),
(168, 'hsa-miR-3655', 'chr5', '+', 'C/T', 'CUUGU[C/T]G', 'Seed'),
(169, 'hsa-miR-4454', 'chr4', '-', 'C/T', 'GAUC[C/T]GA', 'Seed'),
(170, 'hsa-miR-145-3p', 'chr5', '+', 'C/T', 'GAUU[C/T]CU', 'Seed'),
(171, 'hsa-miR-5589-5p', 'chr19', '+', 'G/A', 'GCUGG[G/A]U', 'Seed'),
(172, 'hsa-miR-3689d', 'chr9', '-', 'G/A', 'GGAGGU[G/A]', 'Seed'),
(173, 'hsa-miR-4284', 'chr7', '+', 'C/T', 'GGCUCA[C/T]', 'Seed'),
(174, 'hsa-miR-4271', 'chr3', '+', 'G/C', 'G[G/C]GGAAG', 'Seed'),
(175, 'hsa-miR-8078', 'chr18', '-', 'A/T', 'GUCU[A/T]GG', 'Seed'),
(176, 'hsa-miR-4472', 'chr8', '+', 'G/C', 'GU[G/C]GGGG', 'Seed'),
(177, 'hsa-miR-6892-5p', 'chr7', '+', 'A/G', 'U[A/G]AGGGA', 'Seed'),
(178, 'hsa-miR-642b-3p', 'chr19', '-', 'C/T', 'GA[C/T]ACAU', 'Seed'),
(179, 'hsa-miR-6850-5p', 'chr8', '-', 'G/C', 'U[G/C]CGGAA', 'Seed'),
(180, 'hsa-miR-3620-5p', 'chr1', '+', 'C/T', 'UGGG[C/T]UG', 'Seed'),
(181, 'hsa-miR-1227-5p', 'chr19', '-', 'G/C', 'U[G/C]GGGCC', 'Seed'),
(182, 'hsa-miR-6741-5p', 'chr1', '-', 'G/A', 'U[G/A]GGUGC', 'Seed'),
(183, 'hsa-miR-2909', 'chr17', '+', 'G/A', 'UUAGG[G/A]C', 'Seed'),
(184, 'hsa-miR-557', 'chr1', '+', 'C/T', 'UUUGCA[C/T]', 'Seed'),
(185, 'hsa-miR-605-5p', 'chr10', '+', 'A/G', '[A/G]AAUCCC', 'Seed'),
(186, 'hsa-miR-124-3p', 'chr20', '+', 'G/T', 'AA[G/T]GCAC', 'Seed'),
(187, 'hsa-miR-3939', 'chr6', '-', 'C/G', 'ACGCG[C/G]A', 'Seed'),
(188, 'hsa-miR-3939', 'chr6', '-', 'G/A', 'ACGC[G/A]CA', 'Seed'),
(189, 'hsa-miR-3939', 'chr6', '-', 'C/T', 'A[C/T]GCGCA', 'Seed'),
(190, 'hsa-miR-6863', 'chr16', '+', 'G/A', 'AGAC[G/A]UG', 'Seed'),
(191, 'hsa-miR-3125', 'chr2', '+', 'A/G', 'AG[A/G]GGAA', 'Seed'),
(192, 'hsa-miR-5007-5p', 'chr13', '+', 'A/G', '[A/G]GAGUCU', 'Seed'),
(193, 'hsa-miR-4759', 'chr21', '+', 'G/A', 'A[G/A]GACUA', 'Seed'),
(194, 'hsa-miR-2392', 'chr14', '+', 'A/G', 'AGG[A/G]UGG', 'Seed'),
(195, 'hsa-miR-6805-5p', 'chr19', '+', 'C/T', 'AGGGGG[C/T]', 'Seed'),
(196, 'hsa-miR-4802-5p', 'chr4', '-', 'A/G', '[A/G]UGGAGG', 'Seed'),
(197, 'hsa-miR-3675-5p', 'chr1', '-', 'G/A', 'AUGG[G/A]GC', 'Seed'),
(198, 'hsa-miR-3622b-5p', 'chr8', '-', 'G/T', '[G/T]GCAUGG', 'Seed'),
(199, 'hsa-miR-3622a-5p', 'chr8', '+', 'G/A', 'AGGCAC[G/A]', 'Seed'),
(200, 'hsa-miR-6736-3p', 'chr1', '+', 'C/T', 'CAGCU[C/T]C', 'Seed'),
(201, 'hsa-miR-548ap-3p', 'chr15', '+', 'C/A', 'AAAAC[C/A]A', 'Seed'),
(202, 'hsa-miR-548aa', 'chr17', '+', 'C/T', 'AAAAC[C/T]A', 'Seed'),
(203, 'hsa-miR-548t-3p', 'chr4', '+', 'A/C', 'AAA[A/C]CCA', 'Seed'),
(204, 'hsa-miR-553', 'chr1', '+', 'A/G', 'A[A/G]ACGGU', 'Seed'),
(205, 'hsa-miR-4484', 'chr10', '+', 'G/A', 'AAAGGC[G/A]', 'Seed'),
(206, 'hsa-miR-548i', 'chr3', '-', 'G/A', 'AAA[G/A]UAA', 'Seed'),
(207, 'hsa-miR-548ap-5p', 'chr15', '+', 'G/C', 'AAA[G/C]UAA', 'Seed'),
(208, 'hsa-miR-548ao-3p', 'chr8', '-', 'C/T', 'AAGAC[C/T]G', 'Seed'),
(209, 'hsa-miR-520d-3p', 'chr19', '+', 'G/C', 'AAGU[G/C]CU', 'Seed'),
(210, 'hsa-miR-499a-3p', 'chr20', '+', 'A/G', 'AC[A/G]UCAC', 'Seed'),
(211, 'hsa-miR-499a-3p', 'chr20', '+', 'C/T', 'ACAUCA[C/T]', 'Seed'),
(212, 'hsa-miR-4482-5p', 'chr10', '-', 'C/T', 'A[C/T]CCAGU', 'Seed'),
(213, 'hsa-miR-548al', 'chr11', '+', 'A/G', 'ACGGCA[A/G]', 'Seed'),
(214, 'hsa-miR-5197-3p', 'chr5', '+', 'G/T', 'AGAAGA[G/T]', 'Seed'),
(215, 'hsa-miR-4499', 'chr13', '-', 'G/A', 'AGACU[G/A]A', 'Seed'),
(216, 'hsa-miR-940', 'chr16', '+', 'G/A', 'A[G/A]GCAGG', 'Seed'),
(217, 'hsa-miR-4747-3p', 'chr19', '+', 'C/T', 'AGGCC[C/T]G', 'Seed'),
(218, 'hsa-miR-5692b', 'chr21', '-', 'A/G', '[A/G]UAAUAU', 'Seed'),
(219, 'hsa-miR-501-3p', 'chrX', '+', 'A/G', '[A/G]UGCACC', 'Seed'),
(220, 'hsa-miR-4781-3p', 'chr1', '+', 'G/A', 'AU[G/A]UUGG', 'Seed'),
(221, 'hsa-miR-936', 'chr10', '-', 'A/G', 'C[A/G]GUAGA', 'Seed'),
(222, 'hsa-miR-1973', 'chr4', '+', 'G/A', 'CC[G/A]UGCA', 'Seed'),
(223, 'hsa-miR-660-3p', 'chrX', '+', 'G/C', 'CCUCCU[G/C]', 'Seed'),
(224, 'hsa-miR-3690', 'chrX', '+', 'C/G', '[C/G]CUGGAC', 'Seed'),
(225, 'hsa-miR-3690', 'chrY', '+', 'C/G', '[C/G]CUGGAC', 'Seed'),
(226, 'hsa-miR-8073', 'chr13', '+', 'G/T', 'CCU[G/T]GCA', 'Seed'),
(227, 'hsa-miR-221-5p', 'chrX', '-', 'G/T', 'CCU[G/T]GCA', 'Seed'),
(228, 'hsa-miR-6742-3p', 'chr1', '-', 'G/A', 'CCUGG[G/A]U', 'Seed'),
(229, 'hsa-miR-1248', 'chr3', '+', 'C/T', 'CCUU[C/T]UU', 'Seed'),
(230, 'hsa-miR-6777-5p', 'chr17', '-', 'C/T', '[C/T]GGGGAG', 'Seed'),
(231, 'hsa-miR-637', 'chr19', '-', 'G/C', 'CU[G/C]GGGG', 'Seed'),
(232, 'hsa-miR-642a-3p', 'chr19', '+', 'A/G', 'G[A/G]CACAU', 'Seed'),
(233, 'hsa-miR-6855-3p', 'chr9', '+', 'C/T', 'GACUGA[C/T]', 'Seed'),
(234, 'hsa-miR-4513', 'chr15', '-', 'C/T', 'GACUGA[C/T]', 'Seed'),
(235, 'hsa-miR-8064', 'chr3', '-', 'A/G', 'GCAC[A/G]CU', 'Seed'),
(236, 'hsa-miR-4707-3p', 'chr14', '-', 'G/T', 'GCCC[G/T]CC', 'Seed'),
(237, 'hsa-miR-1254', 'chr10', '+', 'G/A', '[G/A]CCUGGA', 'Seed'),
(238, 'hsa-miR-4706', 'chr14', '+', 'G/A', 'GC[G/A]GGGA', 'Seed'),
(239, 'hsa-miR-4706', 'chr14', '+', 'G/T', 'GCGGG[G/T]A', 'Seed'),
(240, 'hsa-miR-593-5p', 'chr7', '+', 'C/T', 'GGCAC[C/T]A', 'Seed'),
(241, 'hsa-miR-6717-5p', 'chr14', '-', 'G/A', 'GGC[G/A]AUG', 'Seed'),
(242, 'hsa-miR-6717-5p', 'chr14', '-', 'C/T', 'GG[C/T]GAUG', 'Seed'),
(243, 'hsa-miR-604', 'chr10', '-', 'G/A', 'GGCUGC[G/A]', 'Seed'),
(244, 'hsa-miR-3199', 'chr22', '-', 'G/A', '[G/A]GGACUG', 'Seed'),
(245, 'hsa-miR-6883-5p', 'chr17', '-', 'G/T', 'GGGAGG[G/T]', 'Seed'),
(246, 'hsa-miR-3117-3p', 'chr1', '+', 'G/A', 'UA[G/A]GACU', 'Seed'),
(247, 'hsa-miR-4460', 'chr5', '-', 'G/T', 'UAGU[G/T]GU', 'Seed'),
(248, 'hsa-miR-5007-3p', 'chr13', '+', 'A/G', 'UCAU[A/G]UG', 'Seed'),
(249, 'hsa-miR-5007-3p', 'chr13', '+', 'G/C', 'UCAUAU[G/C]', 'Seed'),
(250, 'hsa-miR-6516-3p', 'chr17', '+', 'A/C', 'UC[A/C]UGUA', 'Seed'),
(251, 'hsa-miR-5089-3p', 'chr17', '+', 'G/A', 'U[G/A]CUACU', 'Seed'),
(252, 'hsa-miR-6810-5p', 'chr2', '+', 'A/G', 'UGGGG[A/G]C', 'Seed'),
(253, 'hsa-miR-6810-5p', 'chr2', '+', 'C/T', 'UGGGGA[C/T]', 'Seed'),
(254, 'hsa-miR-8070', 'chr11', '-', 'G/A', 'U[G/A]UGAUU', 'Seed'),
(255, 'hsa-miR-4296', 'chr10', '-', 'G/T', 'UGUGG[G/T]C', 'Seed'),
(256, 'hsa-miR-4477b', 'chr9', '+', 'G/A', 'UUAA[G/A]GA', 'Seed'),
(257, 'hsa-miR-4529-3p', 'chr18', '+', 'G/A', 'UUG[G/A]ACU', 'Seed'),
(258, 'hsa-miR-450a-1-3p', 'chrX', '-', 'G/C', 'UUG[G/C]GAA', 'Seed'),
(259, 'hsa-miR-450a-2-3p', 'chrX', '-', 'G/C', 'UUG[G/C]GGA', 'Seed'),
(260, 'hsa-miR-518d-3p', 'chr19', '+', 'G/A', 'AAAGC[G/A]C', 'Seed'),
(261, 'hsa-miR-33a-3p', 'chr22', '+', 'A/G', 'A[A/G]UGUUU', 'Seed'),
(262, 'hsa-miR-4731-3p', 'chr17', '-', 'A/T', 'ACACA[A/T]G', 'Seed'),
(263, 'hsa-miR-4687-5p', 'chr11', '+', 'C/G', 'AGCC[C/G]UC', 'Seed'),
(264, 'hsa-miR-6746-3p', 'chr11', '-', 'C/T', 'AGCCGC[C/T]', 'Seed'),
(265, 'hsa-miR-4293', 'chr10', '-', 'C/G', 'AGC[C/G]UGA', 'Seed'),
(266, 'hsa-miR-7846-3p', 'chr1', '+', 'G/T', 'AGCGGA[G/T]', 'Seed'),
(267, 'hsa-miR-4695-5p', 'chr1', '-', 'G/A', 'AGGAG[G/A]C', 'Seed'),
(268, 'hsa-miR-4661-3p', 'chr8', '+', 'G/T', 'AG[G/T]AUCC', 'Seed'),
(269, 'hsa-miR-6808-5p', 'chr1', '-', 'A/G', '[A/G]GGCAGG', 'Seed'),
(270, 'hsa-miR-431-3p', 'chr14', '+', 'G/A', 'A[G/A]GUCGU', 'Seed'),
(271, 'hsa-miR-6874-3p', 'chr7', '-', 'A/G', '[A/G]GUUCUG', 'Seed'),
(272, 'hsa-miR-136-3p', 'chr14', '+', 'A/C', '[A/C]UCAUCG', 'Seed'),
(273, 'hsa-miR-5194', 'chr8', '-', 'G/-', 'GAGGG[G/-]U', 'Seed'),
(274, 'hsa-miR-574-5p', 'chr4', '+', 'GT/-', 'GA[GT/-]UGUG', 'Seed'),
(275, 'hsa-miR-4656', 'chr7', '-', 'G/-', 'GG[G/-]CUGA', 'Seed'),
(276, 'hsa-miR-518e-5p', 'chr19', '+', 'C/-', 'U[C/-]UAGAG', 'Seed'),
(277, 'hsa-miR-4311', 'chr15', '+', 'AG/-', 'AA[AG/-]GAGA', 'Seed'),
(278, 'hsa-miR-4472', 'chr12', '-', 'TG/-', 'GU[TG/-]GGGG', 'Seed'),
(279, 'hsa-miR-302c-3p', 'chr4', '-', 'AAGT/-', 'AAG[AAGT/-]GCU', 'Seed'),
(280, 'hsa-miR-3910', 'chr9', '-', 'GGCAT/-', 'AAGGCA[GGCAT/-]', 'Seed'),
(281, 'hsa-miR-562', 'chr2', '+', 'CTGTACCATTTGCACTCC/-', 'AAGUAG[CTGTACCATTTGCACTCC/-]', 'Seed'),
(282, 'hsa-miR-4423-5p', 'chr1', '+', 'T/-', 'GUUGCC[T/-]', 'Seed'),
(283, 'hsa-miR-4640-3p', 'chr6', '+', 'CT/-', 'ACCCC[CT/-]U', 'Seed'),
(284, 'hsa-miR-7152-5p', 'chr10', '+', '-/C', 'U[-/C]CCUGU', 'Seed'),
(285, 'hsa-miR-4433-5p', 'chr2', '+', '-/C', 'GU[-/C]CCAC', 'Seed'),
(286, 'hsa-miR-518e-5p', 'chr19', '+', '-/A', 'UCU[-/A]GAG', 'Seed'),
(287, 'hsa-miR-518e-5p', 'chr19', '+', '-/G', 'UCUA[-/G]AG', 'Seed'),
(288, 'hsa-miR-3161', 'chr11', '+', '-/A', 'UG[-/A]UAAG', 'Seed'),
(289, 'hsa-miR-3161', 'chr11', '+', '-/A', 'UGAU[-/A]AG', 'Seed'),
(290, 'hsa-miR-4525', 'chr17', '-', '-/G', 'GGGGG[-/G]U', 'Seed'),
(291, 'hsa-miR-1276', 'chr15', '-', '-/A', 'AAAG[-/A]GC', 'Seed'),
(292, 'hsa-miR-6831-5p', 'chr5', '-', '-/A', 'AGGU[-/A]GA', 'Seed'),
(293, 'hsa-miR-4464', 'chr6', '+', '-/G', 'A[-/G]GUUUG', 'Seed'),
(294, 'hsa-miR-1233-5p', 'chr15', '-', '-/G', 'GU[-/G]GGAG', 'Seed'),
(295, 'hsa-miR-4274', 'chr4', '+', '-/CCC', 'AGCAG[-/CCC]C', 'Seed'),
(296, 'hsa-miR-9-5p', 'chr15', '+', 'C/G', 'U[C/G]UUUGGUUAUCUAGCUGUAUGA', 'Seed'),
(297, 'hsa-miR-99a-5p', 'chr21', '+', 'G/A', 'AACCC[G/A]UAGAUCCGAUCUUGUG', 'Seed'),
(298, 'hsa-miR-134-3p', 'chr14', '+', 'C/A', 'CCUGUGGGCCACCUAGU[C/A]ACCAA', 'Mature'),
(299, 'hsa-miR-1307-5p', 'chr10', '-', 'C/G', 'UCGA[C/G]CGGACCUCGACCGGCU', 'Seed'),
(300, 'hsa-miR-4533', 'chr20', '+', 'C/U', 'UGGAAGGAGGUUGCCGGA[C/U]GCU', 'Mature'),
(301, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(302, 'hsa-miR-3142', 'chr5', '+', '', '', 'Seed'),
(303, 'hsa-miR-323a-5p', 'chr14', '+', 'G/A', 'AGGUGGUCC[G/A]UGGCGCGUUCGC', 'Mature'),
(304, 'hsa-miR-653-5p', 'chr7', '-', 'A/C', 'GUGUUGAAAC[A/C]AUCUCUACUG', 'Mature'),
(305, 'hsa-miR-627-5p', 'chr15', '-', 'A/C', 'GUGAGUCUCUA[A/C]GAAAAGAGGA', 'Mature'),
(306, 'hsa-miR-875-5p', 'chr8', '-', 'C/G', 'UAUACCU[C/G]AGUUUUAUCAGGUG', 'Mature'),
(307, 'hsa-miR-516a-5p', 'chr19', '+', 'G/A', 'UUCUC[G/A]AGGAAAGAAGCACUUUC', 'Seed'),
(308, 'hsa-miR-3939', 'chr6', '-', 'U/C', 'UACGCGCAGACCACAGGA[U/C]GUC', 'Mature'),
(309, 'hsa-miR-4280', 'chr5', '-', 'G/A', 'GAGUGUAGUUCUGA[G/A]CAGAGC', 'Mature'),
(310, 'hsa-miR-6775-5p', 'chr16', '-', 'A/U', 'UCGGGGCAUGGGGG[A/U]GGGAGGCUGG', 'Mature'),
(311, 'hsa-miR-329-3p', 'chr14', '+', 'U/C', 'AACACACCUGGU[U/C]AACCUCUUU', 'Mature'),
(312, 'hsa-miR-1307-3p', 'chr10', '-', 'C/A', 'ACU[C/A]GGCGUGGCGUCGGUCGUG', 'Seed'),
(313, 'hsa-miR-10b-5p', 'chr2', '+', 'C/U', 'UACCCUGUAGAAC[C/U]GAAUUUGUG', 'Mature'),
(314, 'hsa-miR-3683', 'chr7', '-', 'U/C', 'UGCGACA[U/C]UGGAAGUAGUAUCA', 'Mature'),
(315, 'hsa-miR-802', 'chr21', '+', 'C/A', 'CAGUAACAAAGAUU[C/A]AUCCUUGU', 'Mature'),
(316, 'hsa-miR-518e-5p', 'chr19', '+', 'G/U', 'CUCUA[G/U]AGGGAAGCGCUUUCUG', 'Seed'),
(317, 'hsa-miR-570-3p', 'chr3', '+', '-/C', 'CGAAAACAGCAAUUACCUUU[-/C]C', 'Mature'),
(318, 'hsa-miR-330-3p', 'chr19', '-', 'G/A', 'GCAAAGCACACGGCCUGCA[G/A]AGA', 'Mature'),
(319, 'hsa-miR-485-5p', 'chr14', '+', 'G/U', 'AGAGGCUGGCCGUGAU[G/U]AAUUC', 'Mature'),
(320, 'hsa-miR-519d-5p', 'chr19', '+', 'C/A', 'CCUCCAAAGGGAAGCGCUUU[C/A]UGUU', 'Mature'),
(321, 'hsa-miR-383-3p', 'chr8', '-', 'A/U', 'ACAGCACUGCCUGGUC[A/U]GA', 'Mature'),
(322, 'hsa-miR-10b-5p', 'chr2', '+', 'G/A', 'UACCCUGUAGAACCGAAUUU[G/A]UG', 'Mature'),
(323, 'hsa-miR-541-3p', 'chr14', '+', 'C/A', 'UGGUGGG[C/A]ACAGAAUCUGGACU', 'Mature'),
(324, 'hsa-miR-299-5p', 'chr14', '+', 'G/A', 'UG[G/A]UUUACCGUCCCACAUACAU', 'Seed'),
(325, 'hsa-miR-520d-3p', 'chr19', '+', 'G/U', 'AAA[G/U]UGCUUCUCUUUGGUGGGU', 'Seed'),
(326, 'hsa-miR-611', 'chr11', '-', 'G/A', 'GC[G/A]AGGACCCCUCGGGGUCUGAC', 'Seed'),
(327, 'hsa-miR-4796-3p', 'chr3', '-', 'C/U', 'UAAAGUGG[C/U]AGAGUAUAGACAC', 'Mature'),
(328, 'hsa-miR-134-3p', 'chr14', '+', 'A/U', 'CCUGUGGGCCACCU[A/U]GUCACCAA', 'Mature'),
(329, 'hsa-miR-192-5p', 'chr11', '-', 'C/U', 'CUGAC[C/U]UAUGAAUUGACAGCC', 'Seed'),
(330, 'hsa-miR-518b', 'chr19', '+', 'G/U', 'CAAAGC[G/U]CUCCCCUUUAGAGGU', 'Seed'),
(331, 'hsa-miR-885-3p', 'chr3', '-', 'G/A', 'AGGCAGC[G/A]GGGUGUAGUGGAUA', 'Mature'),
(332, 'hsa-miR-539-3p', 'chr14', '+', 'C/A', 'AUCAUACAAGGACAAUUU[C/A]UUU', 'Mature'),
(333, 'hsa-miR-516b-5p', 'chr19', '+', 'A/C', 'AUCUGGAGGUAAG[A/C]AGCACUUU', 'Mature'),
(334, 'hsa-miR-519a-5p', 'chr19', '+', 'C/U', 'CUCUAGAGGGAAG[C/U]GCUUUCUG', 'Mature'),
(335, 'hsa-miR-650', 'chr22', '+', 'G/U', 'AGGAGGCAGCGCUCUCAG[G/U]AC', 'Mature'),
(336, 'hsa-miR-517c-3p', 'chr19', '+', 'A/U', 'AUCGUGC[A/U]UCCUUUUAGAGUGU', 'Mature'),
(337, 'hsa-miR-218-2-3p', 'chr5', '-', 'C/U', 'CAUGGUUCUGUCAAGCACCG[C/U]G', 'Mature'),
(338, 'hsa-miR-563', 'chr3', '+', 'C/U', 'AGGUUGACAUACGUUU[C/U]CC', 'Mature'),
(339, 'hsa-miR-323b-5p', 'chr14', '+', 'C/G', 'AGGUUGUC[C/G]GUGGUGAGUUCGCA', 'Mature'),
(340, 'hsa-miR-548i', 'chr3', '-', 'A/G', 'AAAAGU[A/G]AUUGCGGAUUUUGCC', 'Seed'),
(341, 'hsa-miR-523-5p', 'chr19', '+', 'C/U', 'CUCUAGAGGGAAGCGCUUU[C/U]UG', 'Mature'),
(342, 'hsa-miR-3939', 'chr6', '-', 'G/A', 'UACGCGCAGACCACAGGAU[G/A]UC', 'Mature'),
(343, 'hsa-miR-124-5p', 'chr8', '-', 'G/C', 'CGUGUUCACAGCGGACCUU[G/C]AU', 'Mature'),
(344, 'hsa-miR-376a-5p', 'chr14', '+', 'C/A', 'GUAGAUU[C/A]UCCUUCUAUGAGUA', 'Mature'),
(345, 'hsa-miR-518a-3p', 'chr19', '+', 'C/U', 'GAAAG[C/U]GCUUCCCUUUGCUGGA', 'Seed'),
(346, 'hsa-miR-192-3p', 'chr11', '-', 'U/C', 'CUGCCAAUUCCAUAGG[U/C]CACAG', 'Mature'),
(347, 'hsa-miR-4740-3p', 'chr17', '-', 'C/A', 'GCCCGAGAGGAUC[C/A]GUCCCUGC', 'Mature'),
(348, 'hsa-miR-329-5p', 'chr14', '+', 'G/U', 'GAGGUUUUCU[G/U]GGUUUCUGUUUC', 'Mature'),
(349, 'hsa-miR-596', 'chr8', '+', 'C/U', 'AAGCCUGCCCGGCU[C/U]CUCGGG', 'Mature'),
(350, 'hsa-miR-299-3p', 'chr14', '+', 'G/U', 'UAU[G/U]UGGGAUGGUAAACCGCUU', 'Seed'),
(351, 'hsa-miR-142-3p', 'chr17', '-', 'C/U', 'UGUAGUGUUUC[C/U]UACUUUAUGGA', 'Mature'),
(352, 'hsa-miR-3142', 'chr5', '+', '', '', 'Seed'),
(353, 'hsa-miR-4458', 'chr5', '+', 'G/U', 'A[G/U]AGGUAGGUGUGGAAGAA', 'Seed'),
(354, 'hsa-miR-873-3p', 'chr9', '-', 'G/U', 'GGAGACUGAUGAGUUCCCG[G/U]GA', 'Mature'),
(355, 'hsa-miR-487a-5p', 'chr14', '+', 'C/U', 'GUGGUUAUCCCUGCUGUGUU[C/U]G', 'Mature'),
(356, 'hsa-miR-1324', 'chr3', '+', 'C/G', 'CCAGACAGAAUU[C/G]UAUGCACUUUC', 'Mature'),
(357, 'hsa-miR-517-5p', 'chr19', '+', 'C/A', 'CCUCUAGAUGGAAGCACUGU[C/A]U', 'Mature'),
(358, 'hsa-miR-371a-3p', 'chr19', '+', 'G/A', 'AAGUGCC[G/A]CCAUCUUUUGAGUGU', 'Mature'),
(359, 'hsa-miR-371b-5p', 'chr19', '-', 'C/U', 'ACUCAAAAGAUGG[C/U]GGCACUUU', 'Mature'),
(360, 'hsa-miR-10b-3p', 'chr2', '+', 'G/A', 'ACAGAUUC[G/A]AUUCUAGGGGAAU', 'Mature'),
(361, 'hsa-miR-4738-5p', 'chr17', '-', 'U/A', 'ACCAGCGCGUUUUCAGUU[U/A]CAU', 'Mature'),
(362, 'hsa-miR-548g-5p', 'chr4', '-', 'U/C', 'UGCAAAAG[U/C]AAUUGCAGUUUUUG', 'Mature'),
(363, 'hsa-miR-942-3p', 'chr1', '+', 'G/A', 'CACAUGGCC[G/A]AAACAGAGAAGU', 'Mature'),
(364, 'hsa-miR-492', 'chr12', '+', 'C/U', 'AGGACCUG[C/U]GGGACAAGAUUCUU', 'Mature'),
(365, 'hsa-miR-122-5p', 'chr18', '+', 'G/U', 'UGGAGUGUGACAAUGGU[G/U]UUUG', 'Mature'),
(366, 'hsa-miR-3591-3p', 'chr18', '-', 'C/A', 'AAA[C/A]ACCAUUGUCACACUCCAC', 'Seed'),
(367, 'hsa-miR-1324', 'chr3', '+', 'A/G', 'CCAGACAGAAUUCU[A/G]UGCACUUUC', 'Mature'),
(368, 'hsa-miR-548ae-5p', 'chr5', '-', 'U/C', 'AAAAGUAAUUG[U/C]GGUUUUUG', 'Mature'),
(369, 'hsa-miR-1244', 'chr12', '-', 'U/C', 'AAGUAGUUGGUUUG[U/C]AUGAGAUGGUU', 'Mature'),
(370, 'hsa-miR-6510-5p', 'chr17', '-', 'G/C', 'CAGCAGGGGA[G/C]AGAGAGGAGUC', 'Mature'),
(371, 'hsa-miR-1307-5p', 'chr10', '-', 'C/G', 'UCGA[C/G]CGGACCUCGACCGGCU', 'Seed'),
(372, 'hsa-miR-548i', 'chr4', '-', 'A/C', 'AAA[A/C]GUAAUUGCGGAUUUUGCC', 'Seed'),
(373, 'hsa-let-7c-3p', 'chr21', '+', 'U/C', 'CUGUACAACCUUCUAGC[U/C]UUCC', 'Mature'),
(374, 'hsa-miR-4520-5p', 'chr17', '-', '-/G', 'CCUGCGU[-/G]UUUUCUGUCCAA', 'Mature'),
(375, 'hsa-miR-4520-2-3p', 'chr17', '+', '-/C', 'UUUGGACAGAAA[-/C]CACGCAGGU', 'Mature'),
(376, 'hsa-let-7f-1-3p', 'chr9', '+', 'A/C', 'CUAUACA[A/C]UCUAUUGCCUUCCC', 'Mature'),
(377, 'hsa-miR-6890-3p', 'chr3', '-', 'G/U', 'CCACU[G/U]CCUAUGCCCCACAG', 'Seed'),
(378, 'hsa-miR-802', 'chr21', '+', 'C/A', 'CAGUAACAAAGAUU[C/A]AUCCUUGU', 'Mature'),
(379, 'hsa-miR-6863', 'chr16', '+', 'G/A', 'UAGAC[G/A]UGGUGAAGGAUUGAGUG', 'Seed'),
(380, 'hsa-miR-329-3p', 'chr14', '+', 'A/C', 'A[A/C]CACACCUGGUUAACCUCUUU', 'Seed'),
(381, 'hsa-miR-19a-3p', 'chr13', '+', 'A/C', 'UGUGCAAAUCUAUGCA[A/C]AACUGA', 'Mature'),
(382, 'hsa-miR-128-1-5p', 'chr2', '+', 'G/C', 'CGGGGCCGUAGCACUGUCUGA[G/C]A', 'Mature'),
(383, 'hsa-miR-1303', 'chr5', '+', 'G/A', 'UUUAGAGAC[G/A]GGGUCUUGCUCU', 'Mature'),
(384, 'hsa-miR-570-3p', 'chr3', '+', 'G/A', 'C[G/A]AAAACAGCAAUUACCUUUGC', 'Seed'),
(385, 'hsa-miR-3675-5p', 'chr1', '-', 'G/A', 'UAUGG[G/A]GCUUCUGUAGAGAUUUC', 'Seed'),
(386, 'hsa-miR-320a', 'chr8', '-', 'G/U', 'AAAAGCUGG[G/U]UUGAGAGGGCGA', 'Mature'),
(387, 'hsa-miR-873-3p', 'chr9', '-', 'G/A', 'GGAGACU[G/A]AUGAGUUCCCGGGA', 'Mature'),
(388, 'hsa-miR-548d-3p', 'chr8', '-', 'C/A', 'CAAAAACCACAGUUU[C/A]UUUUGC', 'Mature'),
(389, 'hsa-miR-758-3p', 'chr14', '+', 'C/U', 'UUUGUGACCUGGU[C/U]CACUAACC', 'Mature'),
(390, 'hsa-miR-516b-5p', 'chr19', '+', 'C/U', 'AU[C/U]UGGAGGUAAGAAGCACUUU', 'Seed'),
(391, 'hsa-miR-517a-3p', 'chr19', '+', 'C/G', 'AUCGUGCAUCC[C/G]UUUAGAGUGU', 'Mature'),
(392, 'hsa-miR-3940-3p', 'chr19', '-', 'G/A', 'CAGCCC[G/A]GAUCCCAGCCCACUU', 'Seed'),
(393, 'hsa-miR-24-3p', 'chr19', '-', 'A/G', 'UGGCUCAGUUCAGC[A/G]GGAACAG', 'Mature'),
(394, 'hsa-miR-20a-3p', 'chr13', '+', '-/A', 'ACUGCAUUAUGAGCACUU[-/A]AAG', 'Mature'),
(395, 'hsa-miR-4533', 'chr20', '+', 'C/U', 'UGGAAGGAGGUUGCCGGA[C/U]GCU', 'Mature'),
(396, 'hsa-miR-218-5p', 'chr5', '-', 'C/A', 'UUGUGCUUGAU[C/A]UAACCAUGU', 'Mature'),
(397, 'hsa-miR-148a-5p', 'chr7', '-', 'G/U', 'AAAGUUCUGAGACACUCC[G/U]ACU', 'Mature'),
(398, 'hsa-miR-155-3p', 'chr21', '+', 'C/U', 'CUC[C/U]UACAUAUUAGCAUUAACA', 'Seed'),
(399, 'hsa-miR-1269a', 'chr4', '+', 'G/A', 'CUGGACUGAGCC[G/A]UGCUACUGG', 'Mature'),
(400, 'hsa-miR-490-3p', 'chr7', '+', 'U/A', 'CAACCUGGAGGAC[U/A]CCAUGCUG', 'Mature'),
(401, 'hsa-miR-1295b-3p', 'chr1', '+', 'A/G', 'A[A/G]UAGGCCACGGAUCUGGGCAA', 'Seed'),
(402, 'hsa-miR-541-3p', 'chr14', '+', 'C/A', 'UGGUGGG[C/A]ACAGAAUCUGGACU', 'Mature'),
(403, 'hsa-miR-135a-5p', 'chr3', '-', 'G/C', 'UAUGGCUUUUUAUUCCUAUGU[G/C]A', 'Mature'),
(404, 'hsa-miR-21-3p', 'chr17', '+', 'G/A', 'CAACACCAGUC[G/A]AUGGGCUGU', 'Mature'),
(405, 'hsa-miR-196b-3p', 'chr7', '-', 'C/A', 'U[C/A]GACAGCACGACACUGCCUUC', 'Seed'),
(406, 'hsa-miR-6869-3p', 'chr20', '-', 'G/U', 'CGCCGCGC[G/U]CAUCGGCUCAGC', 'Mature'),
(407, 'hsa-miR-487b-3p', 'chr14', '+', 'C/U', 'AAU[C/U]GUACAGGGUCAUCCACUU', 'Seed'),
(408, 'hsa-miR-335-3p', 'chr7', '+', 'C/A', 'UUUUUCAUUAUUGCUCCUGA[C/A]C', 'Mature'),
(409, 'hsa-miR-543', 'chr14', '+', 'G/A', 'AAACAUUCGCGGU[G/A]CACUUCUU', 'Mature'),
(410, 'hsa-miR-6832-5p', 'chr6', '+', 'G/A', 'AGUAGAGAGGAAAAGUUAG[G/A]GUC', 'Mature'),
(411, 'hsa-miR-211-3p', 'chr15', '-', 'G/A', 'GCAGGGACAGCAAA[G/A]GGGUGC', 'Mature'),
(412, 'hsa-miR-4760-3p', 'chr21', '-', 'A/U', 'AAAUUCAUGUUCAAUCU[A/U]AACC', 'Mature'),
(413, 'hsa-miR-27a-3p', 'chr19', '-', 'G/A', 'UUCACAGUGGCUAAGUUCC[G/A]C', 'Mature'),
(414, 'hsa-miR-10b-3p', 'chr2', '+', 'G/A', 'ACAGAUUC[G/A]AUUCUAGGGGAAU', 'Mature'),
(415, 'hsa-miR-3683', 'chr7', '-', 'A/G', 'UGCGACAUUGG[A/G]AGUAGUAUCA', 'Mature'),
(416, 'hsa-miR-4738-5p', 'chr17', '-', 'C/U', 'ACCAGCGCGUUUUCAGUUU[C/U]AU', 'Mature'),
(417, 'hsa-miR-602', 'chr9', '+', 'C/U', 'GACA[C/U]GGGCGACAGCUGCGGCCC', 'Seed'),
(418, 'hsa-miR-518e-5p', 'chr19', '+', 'C/U', 'CUCUAGAGGGAAG[C/U]GCUUUCUG', 'Mature'),
(419, 'hsa-miR-569', 'chr3', '-', 'G/U', 'AGUUAAU[G/U]AAUCCUGGAAAGU', 'Mature'),
(420, 'hsa-miR-4757-3p', 'chr2', '+', 'A/G', 'C[A/G]UGACGUCACAGAGGCUUCGC', 'Seed'),
(421, 'hsa-miR-196b-3p', 'chr7', '-', 'C/A', 'U[C/A]GACAGCACGACACUGCCUUC', 'Seed'),
(422, 'hsa-miR-6861-5p', 'chr12', '-', 'G/U', 'ACUGGGUAG[G/U]UGGGGCUCCAGG', 'Mature'),
(423, 'hsa-miR-636', 'chr17', '-', 'C/G', 'UGUGCUUGCU[C/G]GUCCCGCCCGCA', 'Mature'),
(424, 'hsa-miR-3921', 'chr3', '-', 'G/A', 'UCUCU[G/A]AGUACCAUAUGCCUUGU', 'Seed'),
(425, 'hsa-miR-525-3p', 'chr19', '+', 'G/A', 'GAAGGC[G/A]CUUCCCUUUAGAGCG', 'Seed'),
(426, 'hsa-miR-154-5p', 'chr14', '+', 'C/U', 'UAGGUUAUCCGUGUUGCCUU[C/U]G', 'Mature'),
(427, 'hsa-miR-520c-5p', 'chr19', '+', 'G/A', 'CUCUAGAG[G/A]GAAGCACUUUCUG', 'Mature'),
(428, 'hsa-miR-329-3p', 'chr14', '+', 'A/C', 'A[A/C]CACACCUGGUUAACCUCUUU', 'Seed'),
(429, 'hsa-miR-665', 'chr14', '+', 'A/G', 'ACC[A/G]GGAGGCUGAGGCCCCU', 'Seed'),
(430, 'hsa-miR-519e-5p', 'chr19', '+', 'G/A', 'UUCUCCAAAAG[G/A]GAGCACUUUC', 'Mature'),
(431, 'hsa-miR-146a-3p', 'chr5', '+', 'G/U', 'CCUCU[G/U]AAAUUCAGUUCUUCAG', 'Seed'),
(432, 'hsa-miR-4755-5p', 'chr20', '+', 'C/G', 'UUUCCCUUCAGAGC[C/G]UGGCUUU', 'Mature'),
(433, 'hsa-miR-204-5p', 'chr9', '-', 'C/U', 'UUC[C/U]CUUUGUCAUCCUAUGCCU', 'Seed'),
(434, 'hsa-miR-376a-3p', 'chr14', '+', 'A/C', 'AUCAUAGAGG[A/C]AAAUCCACGU', 'Mature'),
(435, 'hsa-miR-642a-5p', 'chr19', '+', 'C/G', 'GUCCCU[C/G]UCCAAAUGUGUCUUG', 'Seed'),
(436, 'hsa-miR-642b-3p', 'chr19', '-', 'G/C', 'AGACACAUUUGGA[G/C]AGGGACCC', 'Mature'),
(437, 'hsa-miR-802', 'chr21', '+', 'A/G', 'CAGUA[A/G]CAAAGAUUCAUCCUUGU', 'Seed'),
(438, 'hsa-miR-4256', 'chr1', '-', 'A/C', 'AUCUGACCUGAUGA[A/C]GGU', 'Mature'),
(439, 'hsa-miR-422a', 'chr15', '-', 'G/U', 'ACUGGACUUAG[G/U]GUCAGAAGGC', 'Mature'),
(440, 'hsa-miR-517-5p', 'chr19', '+', 'G/C', 'CCUCUA[G/C]AUGGAAGCACUGUCU', 'Seed'),
(441, 'hsa-miR-31-5p', 'chr9', '-', 'G/A', 'AGGCAA[G/A]AUGCUGGCAUAGCU', 'Seed'),
(442, 'hsa-miR-215-5p', 'chr1', '-', 'C/A', 'AUGAC[C/A]UAUGAAUUGACAGAC', 'Seed'),
(443, 'hsa-miR-6832-5p', 'chr6', '+', 'G/A', 'AGUAGAGAGGAAAAGUUAG[G/A]GUC', 'Mature'),
(444, 'hsa-miR-153-3p', 'chr7', '-', 'A/G', 'UUGCAU[A/G]GUCACAAAAGUGAUC', 'Seed'),
(445, 'hsa-miR-3939', 'chr6', '-', 'G/A', 'UACGC[G/A]CAGACCACAGGAUGUC', 'Seed'),
(446, 'hsa-miR-485-3p', 'chr14', '+', 'C/A', 'GUCAUACACGGCUCUCCUCU[C/A]U', 'Mature'),
(447, 'hsa-miR-519b-3p', 'chr19', '+', 'C/U', 'AAAGUGCAU[C/U]CUUUUAGAGGUU', 'Mature'),
(448, 'hsa-miR-153-3p', 'chr7', '-', 'A/G', 'UUGCAUAGUCACAA[A/G]AGUGAUC', 'Mature'),
(449, 'hsa-miR-196a-3p', 'chr12', '+', 'C/U', 'CGGCAACAAGAAA[C/U]UGCCUGAG', 'Mature'),
(450, 'hsa-miR-4740-3p', 'chr17', '-', 'C/A', 'GCCCGAGAGGAUC[C/A]GUCCCUGC', 'Mature'),
(451, 'hsa-miR-378e', 'chr5', '+', 'U/C', 'ACUGGAC[U/C]UGGAGUCAGGA', 'Mature'),
(452, 'hsa-miR-6838-3p', 'chr7', '-', 'C/U', 'AAGU[C/U]CUGCUUCUGUUGCAG', 'Seed'),
(453, 'hsa-miR-4465', 'chr6', '+', 'G/C', 'CUCAAGUAGUCUGACCA[G/C]GGGA', 'Mature'),
(454, 'hsa-miR-217', 'chr2', '-', 'G/U', 'UACUGCAUCAGGAACUGAUUG[G/U]A', 'Mature'),
(455, 'hsa-miR-518a-5p', 'chr19', '+', 'A/U', 'CUGCAA[A/U]GGGAAGCCCUUUC', 'Seed'),
(456, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(457, 'hsa-miR-635', 'chr17', '-', 'A/U', 'ACUUGGGCACUGAAACA[A/U]UGUCC', 'Mature'),
(458, 'hsa-miR-4312', 'chr15', '-', 'C/U', 'GGCCUUGUU[C/U]CUGUCCCCA', 'Mature'),
(459, 'hsa-miR-631', 'chr15', '-', 'A/U', 'AGACCUGGCCC[A/U]GACCUCAGC', 'Mature'),
(460, 'hsa-miR-3939', 'chr6', '-', 'C/U', 'UACGCG[C/U]AGACCACAGGAUGUC', 'Seed'),
(461, 'hsa-miR-520d-3p', 'chr19', '+', 'G/U', 'AAAGUGCUUCUCUUUGGUG[G/U]GU', 'Mature'),
(462, 'hsa-miR-449b-5p', 'chr5', '-', 'U/C', 'AGGCAGUGUAU[U/C]GUUAGCUGGC', 'Mature'),
(463, 'hsa-miR-769-3p', 'chr19', '+', 'G/A', 'CUGGGAUCUCC[G/A]GGGUCUUGGUU', 'Mature'),
(464, 'hsa-miR-1185-1-3p', 'chr14', '+', 'U/C', 'AUAUACAGGGGGAGACUC[U/C]UAU', 'Mature'),
(465, 'hsa-miR-379-5p', 'chr14', '+', 'G/U', 'UGGUAGACUAUGGAAC[G/U]UAGG', 'Mature'),
(466, 'hsa-miR-485-5p', 'chr14', '+', 'G/A', 'AGAGGCUGGCC[G/A]UGAUGAAUUC', 'Mature'),
(467, 'hsa-miR-603', 'chr10', '+', 'U/A', 'CACACACUGCAAUUACUU[U/A]UGC', 'Mature'),
(468, 'hsa-miR-128-2-5p', 'chr3', '+', 'G/U', 'GGGGGCCGAUACACUGUACGA[G/U]A', 'Mature'),
(469, 'hsa-miR-548x-3p', 'chr13', '-', 'G/U', 'UAAAAACU[G/U]CAAUUACUUUC', 'Mature'),
(470, 'hsa-let-7a-5p', 'chr22', '+', 'A/G', 'UGAGGUAGUAGGUUGU[A/G]UAGUU', 'Mature'),
(471, 'hsa-miR-512-3p', 'chr19', '+', 'U/C', 'AAGUGCUGUCAUAGCUGAGG[U/C]C', 'Mature'),
(472, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCCGGCC[G/A]UGCCUGAGG', 'Mature'),
(473, 'hsa-miR-95-5p', 'chr4', '-', 'C/U', 'UCAAUAAAUGU[C/U]UGUUGAAUU', 'Mature'),
(474, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACU[C/G]AAAACCCUUCAGUGACUU', 'Seed'),
(475, 'hsa-miR-622', 'chr13', '+', 'G/U', 'ACAGUCUGCUGA[G/U]GUUGGAGC', 'Mature'),
(476, 'hsa-miR-30c-5p', 'chr1', '+', 'C/G', 'UGUAAACAUCCUACACUCU[C/G]AGC', 'Mature'),
(477, 'hsa-miR-4745-5p', 'chr19', '+', 'C/U', 'UGAGUGGGGCUCCCGGGA[C/U]GGCG', 'Mature'),
(478, 'hsa-miR-1910-5p', 'chr16', '-', 'G/A', 'CCAGUCCUGUGCCUGCC[G/A]CCU', 'Mature'),
(479, 'hsa-miR-93-5p', 'chr7', '-', 'C/U', 'CAAAGUGCUGUU[C/U]GUGCAGGUAG', 'Mature'),
(480, 'hsa-miR-3145-5p', 'chr6', '-', 'C/U', 'AA[C/U]UCCAAACACUCAAAACUCA', 'Seed'),
(481, 'hsa-miR-328-5p', 'chr16', '-', 'A/G', 'GGGGGGGC[A/G]GGAGGGGCUCAGGG', 'Mature'),
(482, 'hsa-miR-3652', 'chr12', '+', 'G/U', 'CGGCUGGAGGUGUGAG[G/U]A', 'Mature'),
(483, 'hsa-miR-515-5p', 'chr19', '+', 'C/G', 'UUCU[C/G]CAAAAGAAAGCACUUUCUG', 'Seed'),
(484, 'hsa-miR-335-5p', 'chr7', '+', 'G/A', 'UCAAGAGCAAUAAC[G/A]AAAAAUGU', 'Mature'),
(485, 'hsa-miR-616-3p', 'chr12', '-', 'G/U', 'AGUCAUU[G/U]GAGGGUUUGAGCAG', 'Mature'),
(486, 'hsa-miR-142-3p', 'chr17', '-', 'U/A', 'UGUAGUGUUUCCUACU[U/A]UAUGGA', 'Mature'),
(487, 'hsa-miR-663b', 'chr2', '-', 'C/A', 'GGUGG[C/A]CCGGCCGUGCCUGAGG', 'Seed'),
(488, 'hsa-miR-6871-3p', 'chr20', '+', 'U/C', 'CAGCACCC[U/C]GUGGCUCCCACAG', 'Mature'),
(489, 'hsa-miR-668-3p', 'chr14', '+', 'G/A', 'UGUCACUCGGCUC[G/A]GCCCACUAC', 'Mature'),
(490, 'hsa-miR-95-5p', 'chr4', '-', 'C/A', 'UCAAUAAAUGU[C/A]UGUUGAAUU', 'Mature'),
(491, 'hsa-miR-1257', 'chr20', '-', 'U/C', 'AGUGAAUGAUGGGUUC[U/C]GACC', 'Mature'),
(492, 'hsa-miR-517-5p', 'chr19', '+', 'A/C', 'CCUCUAGAUGGAAGC[A/C]CUGUCU', 'Mature'),
(493, 'hsa-miR-138-2-3p', 'chr16', '+', 'C/U', 'GCUAUUUCA[C/U]GACACCAGGGUU', 'Mature'),
(494, 'hsa-miR-320a', 'chr8', '-', 'G/A', 'AAAAGCUGG[G/A]UUGAGAGGGCGA', 'Mature'),
(495, 'hsa-miR-518a-5p', 'chr19', '+', 'C/U', 'CUGCAAAGGGAAGC[C/U]CUUUC', 'Mature'),
(496, 'hsa-miR-575', 'chr4', '-', 'G/A', 'GAGCCAGUUGGACA[G/A]GAGC', 'Mature'),
(497, 'hsa-miR-4755-5p', 'chr20', '+', 'C/G', 'UUUCCCUUCAGAGC[C/G]UGGCUUU', 'Mature'),
(498, 'hsa-miR-320b', 'chr1', '+', 'G/A', 'AAAAGCUGGGUUGAGAGG[G/A]CAA', 'Mature'),
(499, 'hsa-miR-217', 'chr2', '-', 'G/U', 'UACUGCAUCAGGAACUGAUUG[G/U]A', 'Mature'),
(500, 'hsa-miR-664a-5p', 'chr1', '-', 'G/U', 'ACUGGCUAGGGAAAAU[G/U]AUUGGAU', 'Mature'),
(501, 'hsa-miR-142-3p', 'chr17', '-', 'G/C', 'UGUA[G/C]UGUUUCCUACUUUAUGGA', 'Seed'),
(502, 'hsa-miR-5196-3p', 'chr19', '+', 'C/A', 'UCAUCCU[C/A]GUCUCCCUCCCAG', 'Mature'),
(503, 'hsa-miR-2113', 'chr6', '+', 'G/A', 'AUUU[G/A]UGCUUGGCUCUGUCAC', 'Seed'),
(504, 'hsa-miR-142-3p', 'chr17', '-', 'U/C', 'UGUAG[U/C]GUUUCCUACUUUAUGGA', 'Seed'),
(505, 'hsa-miR-3118', 'chr15', '+', 'C/G', 'UGUGA[C/G]UGCAUUAUGAAAAUUCU', 'Seed'),
(506, 'hsa-miR-129-5p', 'chr11', '+', 'C/U', 'CUUUUUG[C/U]GGUCUGGGCUUGC', 'Mature'),
(507, 'hsa-miR-492', 'chr12', '+', 'G/A', 'AGGACCUGCG[G/A]GACAAGAUUCUU', 'Mature'),
(508, 'hsa-miR-196b-5p', 'chr7', '-', 'C/U', 'UAGGUAGUUU[C/U]CUGUUGUUGGG', 'Mature'),
(509, 'hsa-miR-3940-3p', 'chr19', '-', 'C/G', 'CAGCCCGGAUC[C/G]CAGCCCACUU', 'Mature'),
(510, 'hsa-miR-646', 'chr20', '+', 'U/G', 'AAGCAGCUGCCUC[U/G]GAGGC', 'Mature'),
(511, 'hsa-miR-216b-3p', 'chr2', '-', 'A/G', 'ACACACUUACCCGU[A/G]GAGAUUCUA', 'Mature'),
(512, 'hsa-miR-153-3p', 'chr2', '-', 'G/U', 'UUGCAUAGUCACAAAAGU[G/U]AUC', 'Mature'),
(513, 'hsa-miR-1183', 'chr7', '+', 'G/U', 'CACUGUAGGUGAUGGU[G/U]AGAGUGGGCA', 'Mature'),
(514, 'hsa-miR-4745-5p', 'chr19', '+', 'C/U', 'UGAGUGGGGCUCCCGGGA[C/U]GGCG', 'Mature'),
(515, 'hsa-miR-323a-5p', 'chr14', '+', 'G/A', 'AGGUGGUCC[G/A]UGGCGCGUUCGC', 'Mature'),
(516, 'hsa-miR-937-3p', 'chr8', '-', 'C/G', 'AUCCGCGCUCUGACU[C/G]UCUGCC', 'Mature'),
(517, 'hsa-miR-193b-5p', 'chr16', '+', 'G/A', 'CG[G/A]GGUUUUGAGGGCGAGAUGA', 'Seed'),
(518, 'hsa-miR-8074', 'chr19', '-', 'G/A', 'CUAUGGC[G/A]AGACUGGCAUGUACUC', 'Mature'),
(519, 'hsa-miR-524-5p', 'chr19', '+', 'C/A', 'CUACAAAGGGAAGCACUUU[C/A]UC', 'Mature'),
(520, 'hsa-miR-4280', 'chr5', '-', 'U/A', 'GAG[U/A]GUAGUUCUGAGCAGAGC', 'Seed'),
(521, 'hsa-miR-3940-5p', 'chr19', '-', 'G/C', 'GUGGGUUGGGGCGG[G/C]CUCUG', 'Mature'),
(522, 'hsa-miR-99a-3p', 'chr21', '+', 'C/A', 'CAAGCUCGCUUCUAUGGGU[C/A]UG', 'Mature'),
(523, 'hsa-miR-624-3p', 'chr14', '-', 'G/A', 'CACAAGGUAUU[G/A]GUAUUACCU', 'Mature'),
(524, 'hsa-miR-142-3p', 'chr17', '-', 'U/C', 'UGUAGUGUU[U/C]CCUACUUUAUGGA', 'Mature'),
(525, 'hsa-miR-519d-5p', 'chr19', '+', 'G/A', 'CCUCCAAAG[G/A]GAAGCGCUUUCUGUU', 'Mature'),
(526, 'hsa-miR-335-3p', 'chr7', '+', 'A/U', 'UUUUUCAUUAUUGCUCCUG[A/U]CC', 'Mature'),
(527, 'hsa-miR-10a-3p', 'chr17', '-', 'U/A', 'CAAAUUCG[U/A]AUCUAGGGGAAUA', 'Mature'),
(528, 'hsa-miR-376a-3p', 'chr14', '+', 'G/C', 'AUCAUA[G/C]AGGAAAAUCCACGU', 'Seed'),
(529, 'hsa-miR-410-5p', 'chr14', '+', 'U/A', 'AGG[U/A]UGUCUGUGAUGAGUUCG', 'Seed'),
(530, 'hsa-miR-3924', 'chr10', '-', 'G/A', 'AUAUGUAUAU[G/A]UGACUGCUACU', 'Mature'),
(531, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(532, 'hsa-miR-181a-5p', 'chr1', '-', 'C/U', 'AACAUUCAACGCUGU[C/U]GGUGAGU', 'Mature'),
(533, 'hsa-miR-4740-5p', 'chr17', '-', 'A/G', 'AGGACUGAUCCUCUCGGGC[A/G]GG', 'Mature'),
(534, 'hsa-miR-520g-3p', 'chr19', '+', 'U/C', 'ACAAAGUGCU[U/C]CCCUUUAGAGUGU', 'Mature'),
(535, 'hsa-miR-887-3p', 'chr5', '+', '', '', 'Mature'),
(536, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACU[C/G]AAAACCCUUCAGUGACUU', 'Seed'),
(537, 'hsa-miR-30d-5p', 'chr8', '-', 'U/C', 'UGUAAACA[U/C]CCCCGACUGGAAG', 'Mature'),
(538, 'hsa-miR-632', 'chr17', '+', 'C/U', 'GUGUCUGCUUC[C/U]UGUGGGA', 'Mature'),
(539, 'hsa-miR-1283', 'chr19', '+', 'G/A', 'UCUACAAAG[G/A]AAAGCGCUUUCU', 'Mature'),
(540, 'hsa-miR-4520-5p', 'chr17', '-', '-/G', 'CCUGCGU[-/G]UUUUCUGUCCAA', 'Mature'),
(541, 'hsa-miR-4520-2-3p', 'chr17', '+', '-/C', 'UUUGGACAGAAA[-/C]CACGCAGGU', 'Mature'),
(542, 'hsa-miR-3939', 'chr6', '-', 'C/U', 'UA[C/U]GCGCAGACCACAGGAUGUC', 'Seed'),
(543, 'hsa-miR-195-3p', 'chr17', '-', 'C/G', 'C[C/G]AAUAUUGGCUGUGCUGCUCC', 'Seed'),
(544, 'hsa-miR-1291', 'chr12', '-', 'G/A', 'UGGCCCUGACUGAA[G/A]ACCAGCAGU', 'Mature'),
(545, 'hsa-miR-1913', 'chr6', '-', 'G/A', 'UCUGCCCCCUCC[G/A]CUGCUGCCA', 'Mature'),
(546, 'hsa-miR-3683', 'chr7', '-', 'U/C', 'UGCGACA[U/C]UGGAAGUAGUAUCA', 'Mature'),
(547, 'hsa-miR-129-5p', 'chr7', '+', 'G/A', 'CUUUUUGC[G/A]GUCUGGGCUUGC', 'Mature'),
(548, 'hsa-miR-147a', 'chr9', '-', 'G/U', 'GUGUGUGGAAAUGCUUCU[G/U]C', 'Mature'),
(549, 'hsa-miR-128-2-5p', 'chr3', '+', 'G/A', 'GGGGGCC[G/A]AUACACUGUACGAGA', 'Mature'),
(550, 'hsa-miR-499a-3p', 'chr20', '+', 'A/G', 'AAC[A/G]UCACAGCAAGUCUGUGCU', 'Seed'),
(551, 'hsa-miR-499b-5p', 'chr20', '-', 'U/C', 'ACAGACUUGCUGUGA[U/C]GUUCA', 'Mature'),
(552, 'hsa-miR-1324', 'chr3', '+', 'C/U', 'CCAGACAGAAUUCUAUGCA[C/U]UUUC', 'Mature'),
(553, 'hsa-miR-941', 'chr20', '+', 'C/G', 'CACCCGGCUGUGUG[C/G]ACAUGUGC', 'Mature'),
(554, 'hsa-miR-383-3p', 'chr8', '-', 'A/U', 'ACAGCACUGCCUGGUC[A/U]GA', 'Mature'),
(555, 'hsa-miR-4636', 'chr5', '-', 'G/A', 'AACUC[G/A]UGUUCAAAGCCUUUAG', 'Seed'),
(556, 'hsa-miR-616-3p', 'chr12', '-', 'G/U', 'AGUCAUU[G/U]GAGGGUUUGAGCAG', 'Mature'),
(557, 'hsa-miR-668-3p', 'chr14', '+', 'U/C', 'UG[U/C]CACUCGGCUCGGCCCACUAC', 'Seed'),
(558, 'hsa-miR-494-5p', 'chr14', '+', 'G/A', 'AGGUUGUCC[G/A]UGUUGUCUUCUCU', 'Mature'),
(559, 'hsa-miR-941', 'chr20', '+', 'C/G', 'CACCCGGCUGUGUG[C/G]ACAUGUGC', 'Mature'),
(560, 'hsa-miR-3688-5p', 'chr4', '+', 'A/U', 'AGUGGCAAAGUCUUUCCAU[A/U]U', 'Mature'),
(561, 'hsa-miR-1289', 'chr5', '-', 'U/G', 'UGGAGUCCAGGAAUCUGCAU[U/G]UU', 'Mature'),
(562, 'hsa-miR-3130-3p', 'chr2', '-', 'G/A', 'GCUGCACC[G/A]GAGACUGGGUAA', 'Mature'),
(563, 'hsa-miR-3130-5p', 'chr2', '+', 'C/U', 'UACCCAGUCUC[C/U]GGUGCAGCC', 'Mature'),
(564, 'hsa-miR-323a-3p', 'chr14', '+', 'C/G', 'CACAUUACACGGUCGACCU[C/G]U', 'Mature'),
(565, 'hsa-miR-342-3p', 'chr14', '+', 'C/U', 'UCUCACACAGAAAU[C/U]GCACCCGU', 'Mature'),
(566, 'hsa-miR-548au-5p', 'chr9', '+', 'C/U', 'AAAAGUAAUUG[C/U]GGUUUUUGC', 'Mature'),
(567, 'hsa-miR-125b-5p', 'chr11', '-', 'G/C', 'UCCCUGA[G/C]ACCCUAACUUGUGA', 'Mature'),
(568, 'hsa-miR-548d-3p', 'chr17', '-', 'C/G', 'CAAAAACCACAGUUU[C/G]UUUUGC', 'Mature'),
(569, 'hsa-miR-1193', 'chr14', '+', 'G/A', 'GGGAUGGUAGACCGGUGAC[G/A]UGC', 'Mature'),
(570, 'hsa-miR-524-5p', 'chr19', '+', 'G/A', 'CUACAAA[G/A]GGAAGCACUUUCUC', 'Mature'),
(571, 'hsa-miR-548k', 'chr11', '+', 'G/A', 'AAAAGUACUUGC[G/A]GAUUUUGCU', 'Mature'),
(572, 'hsa-miR-409-3p', 'chr14', '+', 'G/A', 'GAAU[G/A]UUGCUCGGUGAACCCCU', 'Seed'),
(573, 'hsa-miR-124-3p', 'chr20', '+', 'G/A', 'UAAGGCACGCGGUGAAU[G/A]CC', 'Mature'),
(574, 'hsa-miR-1272', 'chr15', '-', 'A/G', 'GAUGAUGAUGGCAGCA[A/G]AUUCUGAAA', 'Mature'),
(575, 'hsa-miR-197-3p', 'chr1', '+', 'C/A', 'UUCACCAC[C/A]UUCUCCACCCAGC', 'Mature'),
(576, 'hsa-miR-516a-3p', 'chr19', '+', 'G/U', 'U[G/U]CUUCCUUUCAGAGGGU', 'Seed'),
(577, 'hsa-miR-519d-5p', 'chr19', '+', 'G/A', 'CCUCCAAAG[G/A]GAAGCGCUUUCUGUU', 'Mature'),
(578, 'hsa-miR-124-5p', 'chr8', '+', 'C/U', 'CGUGUUCACAGCGGA[C/U]CUUGAU', 'Mature'),
(579, 'hsa-miR-218-5p', 'chr4', '+', 'A/C', 'UUGUGCUUGAUCU[A/C]ACCAUGU', 'Mature'),
(580, 'hsa-miR-553', 'chr1', '+', 'G/C', 'AAAACGGUGA[G/C]AUUUUGUUUU', 'Mature'),
(581, 'hsa-miR-142-3p', 'chr17', '-', 'U/C', 'UGUAGUG[U/C]UUCCUACUUUAUGGA', 'Mature'),
(582, 'hsa-miR-556-3p', 'chr1', '+', '-/U', 'AUAUUACCAUUAGCUCAU[-/U]UUU', 'Mature'),
(583, 'hsa-miR-622', 'chr13', '+', 'G/U', 'ACAGUCUGCUGAGGUUG[G/U]AGC', 'Mature'),
(584, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACUCAAAAC[C/G]CUUCAGUGACUU', 'Mature'),
(585, 'hsa-miR-379-5p', 'chr14', '+', 'G/U', 'UGGUAGACUAUGGAAC[G/U]UAGG', 'Mature'),
(586, 'hsa-miR-563', 'chr3', '+', 'C/U', 'AGGUUGACAUACGUUUC[C/U]C', 'Mature'),
(587, 'hsa-miR-124-3p', 'chr20', '+', 'U/A', 'UAAGGCACGCGG[U/A]GAAUGCC', 'Mature'),
(588, 'hsa-miR-518a-5p', 'chr19', '+', 'A/U', 'CUGCAAAGGGA[A/U]GCCCUUUC', 'Mature'),
(589, 'hsa-miR-1183', 'chr7', '+', 'G/U', 'CACUGUAGGUGAUGGU[G/U]AGAGUGGGCA', 'Mature'),
(590, 'hsa-miR-593-5p', 'chr7', '+', 'C/A', 'AGGCACCAGCCAGGCAUUG[C/A]UCAGC', 'Mature'),
(591, 'hsa-miR-3121-3p', 'chr1', '-', 'C/G', 'UAAAUAGAGUAGG[C/G]AAAGGACA', 'Mature'),
(592, 'hsa-miR-616-3p', 'chr12', '-', 'C/A', 'AGU[C/A]AUUGGAGGGUUUGAGCAG', 'Seed'),
(593, 'hsa-miR-205-5p', 'chr1', '+', 'C/U', 'U[C/U]CUUCAUUCCACCGGAGUCUG', 'Seed'),
(594, 'hsa-miR-517b-3p', 'chr19', '+', 'C/U', 'AU[C/U]GUGCAUCCCUUUAGAGUGU', 'Seed'),
(595, 'hsa-miR-9-3p', 'chr5', '-', 'U/A', 'A[U/A]AAAGCUAGAUAACCGAAAGU', 'Seed'),
(596, 'hsa-miR-521', 'chr19', '+', 'G/A', 'AAC[G/A]CACUUCCCUUUAGAGUGU', 'Seed'),
(597, 'hsa-miR-489-5p', 'chr7', '-', 'C/U', 'GGUCGUAUGUGUGA[C/U]GCCAUUU', 'Mature'),
(598, 'hsa-miR-551a', 'chr1', '-', 'G/U', 'GC[G/U]ACCCACUCUUGGUUUCCA', 'Seed'),
(599, 'hsa-miR-3942-3p', 'chr15', '-', 'C/U', 'UUUCAGAUAACAGUAUUA[C/U]AU', 'Mature'),
(600, 'hsa-miR-556-3p', 'chr1', '+', '-/U', 'AUAUUACCAUUAGCUCAUC[-/U]UU', 'Mature'),
(601, 'hsa-miR-345-3p', 'chr14', '+', 'G/U', 'GCCCUGAACGAG[G/U]GGUCUGGAG', 'Mature'),
(602, 'hsa-miR-30c-5p', 'chr1', '+', 'C/G', 'UGUAAACAUCCUACACUCU[C/G]AGC', 'Mature'),
(603, 'hsa-miR-656-3p', 'chr14', '+', 'C/U', 'AAUAUUAUACAGUCAAC[C/U]UCU', 'Mature'),
(604, 'hsa-miR-1296-3p', 'chr10', '-', 'C/U', 'GAGUGGGGCUU[C/U]GACCCUAACC', 'Mature'),
(605, 'hsa-miR-519d-5p', 'chr19', '+', 'C/U', 'CCUCCAAAGGGAAGCGCUUU[C/U]UGUU', 'Mature'),
(606, 'hsa-miR-142-3p', 'chr17', '-', 'G/C', 'UGUAGU[G/C]UUUCCUACUUUAUGGA', 'Seed'),
(607, 'hsa-miR-1228-3p', 'chr12', '+', 'C/U', 'UCACACCUGC[C/U]UCGCCCCCC', 'Mature'),
(608, 'hsa-miR-1324', 'chr3', '+', 'C/A', 'C[C/A]AGACAGAAUUCUAUGCACUUUC', 'Seed'),
(609, 'hsa-miR-488-5p', 'chr1', '-', 'C/A', 'C[C/A]CAGAUAAUGGCACUCUCAA', 'Seed'),
(610, 'hsa-miR-138-2-3p', 'chr16', '+', 'C/U', 'GCUAUUUCA[C/U]GACACCAGGGUU', 'Mature'),
(611, 'hsa-miR-129-5p', 'chr11', '+', 'G/A', 'CUUUUUGC[G/A]GUCUGGGCUUGC', 'Mature'),
(612, 'hsa-miR-133b', 'chr6', '+', 'U/C', 'U[U/C]UGGUCCCCUUCAACCAGCUA', 'Seed'),
(613, 'hsa-miR-645', 'chr20', '+', 'C/A', 'U[C/A]UAGGCUGGUACUGCUGA', 'Seed'),
(614, 'hsa-miR-1263', 'chr3', '-', 'C/A', 'AUGGUAC[C/A]CUGGCAUACUGAGU', 'Mature'),
(615, 'hsa-miR-1307-3p', 'chr10', '-', 'C/A', 'ACU[C/A]GGCGUGGCGUCGGUCGUG', 'Seed'),
(616, 'hsa-miR-449a', 'chr5', '-', 'U/C', 'UGGCAG[U/C]GUAUUGUUAGCUGGU', 'Seed'),
(617, 'hsa-miR-367-3p', 'chr4', '-', 'U/C', 'AAUUGCACUUUAGCAA[U/C]GGUGA', 'Mature'),
(618, 'hsa-miR-20a-3p', 'chr13', '+', 'G/C', 'ACUGCAUUAU[G/C]AGCACUUAAAG', 'Mature'),
(619, 'hsa-miR-523-3p', 'chr19', '+', 'G/A', 'GAACGC[G/A]CUUCCCUAUAGAGGGU', 'Seed'),
(620, 'hsa-miR-645', 'chr20', '+', 'C/A', 'U[C/A]UAGGCUGGUACUGCUGA', 'Seed'),
(621, 'hsa-miR-520a-3p', 'chr19', '+', 'C/U', 'AAAGUGCUUC[C/U]CUUUGGACUGU', 'Mature'),
(622, 'hsa-miR-1279', 'chr12', '-', 'U/G', 'UCAUAUUGC[U/G]UCUUUCU', 'Mature'),
(623, 'hsa-miR-410-5p', 'chr14', '+', 'G/A', 'AGGUUGUCU[G/A]UGAUGAGUUCG', 'Mature'),
(624, 'hsa-miR-302c-3p', 'chr4', '-', 'C/A', 'UAAGUG[C/A]UUCCAUGUUUCAGUGG', 'Seed'),
(625, 'hsa-miR-520f-3p', 'chr19', '+', 'C/U', 'AAGUGCUU[C/U]CUUUUAGAGGGUU', 'Mature'),
(626, 'hsa-miR-665', 'chr14', '+', 'G/U', 'ACCAG[G/U]AGGCUGAGGCCCCU', 'Seed'),
(627, 'hsa-miR-548ae-3p', 'chr5', '-', 'A/C', 'CAAAA[A/C]CUGCAAUUACUUUCA', 'Seed'),
(628, 'hsa-miR-520f-5p', 'chr19', '+', 'G/A', 'CCUCUAAAGGGAAGC[G/A]CUUUCU', 'Mature'),
(629, 'hsa-miR-4304', 'chr12', '-', 'U/C', 'CCGGCAUG[U/C]CCAGGGCA', 'Mature'),
(630, 'hsa-miR-489-5p', 'chr7', '-', 'C/U', 'GGUCGUAUGUGUGA[C/U]GCCAUUU', 'Mature'),
(631, 'hsa-miR-518a-5p', 'chr19', '+', 'A/G', 'CUGCA[A/G]AGGGAAGCCCUUUC', 'Seed'),
(632, 'hsa-miR-551b-5p', 'chr3', '+', 'G/A', 'GAAAUCAAGC[G/A]UGGGUGAGACC', 'Mature'),
(633, 'hsa-miR-873-3p', 'chr9', '-', 'G/A', 'GGAGACUGAUGAGUUCCC[G/A]GGA', 'Mature'),
(634, 'hsa-miR-202-5p', 'chr10', '-', 'C/A', 'UUCCUAUGCAUAUACUU[C/A]UUUG', 'Mature'),
(635, 'hsa-miR-409-5p', 'chr14', '+', 'G/A', 'AGGUUACCC[G/A]AGCAACUUUGCAU', 'Mature'),
(636, 'hsa-miR-3683', 'chr7', '-', 'A/G', 'UGCGACAUUGG[A/G]AGUAGUAUCA', 'Mature'),
(637, 'hsa-miR-4538', 'chr14', '-', 'G/A', 'GAGCUUGGAUGAGCUGG[G/A]CUGA', 'Mature'),
(638, 'hsa-miR-125b-1-3p', 'chr11', '-', 'G/U', 'ACGGGUUAGGCUCUUGGGA[G/U]CU', 'Mature'),
(639, 'hsa-miR-4537', 'chr14', '-', 'G/A', 'UGAGCCGAGCUGA[G/A]CUUAGCUG', 'Mature'),
(640, 'hsa-miR-409-5p', 'chr14', '+', 'C/A', 'AGGUUA[C/A]CCGAGCAACUUUGCAU', 'Seed'),
(641, 'hsa-miR-6885-5p', 'chr19', '-', 'G/A', 'AGGG[G/A]GGCACUGCGCAAGCAAAGCC', 'Seed'),
(642, 'hsa-miR-663b', 'chr2', '-', 'G/C', 'GGUGGCCCGGCCGUGCCU[G/C]AGG', 'Mature'),
(643, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(644, 'hsa-miR-95-3p', 'chr4', '-', 'U/C', 'U[U/C]CAACGGGUAUUUAUUGAGCA', 'Seed'),
(645, 'hsa-miR-182-3p', 'chr7', '-', 'C/U', 'UGGUUCUAGACUUG[C/U]CAACUA', 'Mature'),
(646, 'hsa-miR-597-3p', 'chr8', '+', 'C/U', 'UGGUUCUCUUGUGGCUCAAG[C/U]GU', 'Mature'),
(647, 'hsa-miR-16-5p', 'chr3', '+', 'C/U', 'UAGCAGCACGUAAAUAUUGG[C/U]G', 'Mature'),
(648, 'hsa-miR-30b-3p', 'chr8', '-', 'G/A', 'CU[G/A]GGAGGUGGAUGUUUACUUC', 'Seed'),
(649, 'hsa-miR-19a-5p', 'chr13', '+', 'G/A', 'AGUUUUGCAUAGUU[G/A]CACUACA', 'Mature'),
(650, 'hsa-miR-3677-5p', 'chr16', '+', 'A/U', 'CAGUGGCCAGAGCCCUGC[A/U]GUG', 'Mature'),
(651, 'hsa-miR-135a-5p', 'chr3', '-', 'A/U', 'UAUGGCUUUUUAUUCCU[A/U]UGUGA', 'Mature'),
(652, 'hsa-miR-494-5p', 'chr14', '+', 'C/A', 'AGGUUGUCCGUGUUGUCUU[C/A]UCU', 'Mature'),
(653, 'hsa-miR-142-3p', 'chr17', '-', 'G/A', 'UGUA[G/A]UGUUUCCUACUUUAUGGA', 'Seed'),
(654, 'hsa-miR-543', 'chr14', '+', 'G/A', 'AAACAUUCGC[G/A]GUGCACUUCUU', 'Mature'),
(655, 'hsa-miR-520a-5p', 'chr19', '+', 'G/A', 'CUCCAGAG[G/A]GAAGUACUUUCU', 'Mature'),
(656, 'hsa-miR-125b-5p', 'chr11', '-', 'G/C', 'UCCCUGA[G/C]ACCCUAACUUGUGA', 'Mature'),
(657, 'hsa-miR-637', 'chr19', '-', 'G/A', 'ACUGGGGGCUUUC[G/A]GGCUCUGCGU', 'Mature'),
(658, 'hsa-miR-129-2-3p', 'chr11', '+', 'G/U', 'AAGCCCUUACCCCAAAAA[G/U]CAU', 'Mature'),
(659, 'hsa-miR-590-5p', 'chr7', '+', 'G/A', 'GAGCUUAUUCAUAAAAGU[G/A]CAG', 'Mature'),
(660, 'hsa-miR-6516-5p', 'chr17', '+', 'U/A', 'UUUGCAG[U/A]AACAGGUGUGAGCA', 'Mature'),
(661, 'hsa-miR-486-5p', 'chr8', '-', 'C/U', 'UCCUGUACUGAGCUGCC[C/U]CGAG', 'Mature'),
(662, 'hsa-miR-486-3p', 'chr8', '+', 'G/A', 'CG[G/A]GGCAGCUCAGUACAGGAU', 'Seed'),
(663, 'hsa-miR-3160-3p', 'chr11', '-', 'A/C', 'AG[A/C]GCUGAGACUAGAAAGCCCA', 'Seed'),
(664, 'hsa-miR-3160-5p', 'chr11', '+', 'U/G', 'GGCUUUCUAGUCUCAGC[U/G]CUCC', 'Mature');
INSERT INTO `region` (`id`, `miRNA-name`, `chr_number`, `strand`, `allele`, `Sequence`, `Region`) VALUES
(665, 'hsa-miR-4454', 'chr4', '-', 'G/A', 'GGAUCC[G/A]AGUCACGGCACCA', 'Seed'),
(666, 'hsa-miR-218-2-3p', 'chr5', '-', 'G/A', 'CAUGGUUCUGUCAA[G/A]CACCGCG', 'Mature'),
(667, 'hsa-miR-129-1-3p', 'chr7', '+', 'G/U', 'AAGCCCUUACCCCAAAAA[G/U]UAU', 'Mature'),
(668, 'hsa-miR-517b-3p', 'chr19', '+', 'C/A', 'AUCGUGCAUCC[C/A]UUUAGAGUGU', 'Mature'),
(669, 'hsa-miR-193a-5p', 'chr17', '+', 'C/U', 'UGGGU[C/U]UUUGCGGGCGAGAUGA', 'Seed'),
(670, 'hsa-miR-578', 'chr4', '+', 'G/U', 'CUUCUUGUGCUCUAGGAUU[G/U]U', 'Mature'),
(671, 'hsa-miR-208a-3p', 'chr14', '-', 'G/A', 'AUAAGAC[G/A]AGCAAAAAGCUUGU', 'Mature'),
(672, 'hsa-miR-526b-3p', 'chr19', '+', 'G/U', 'GAAAGUGCUUCCUUUUAGA[G/U]GC', 'Mature'),
(673, 'hsa-miR-517b-3p', 'chr19', '+', 'C/U', 'AU[C/U]GUGCAUCCCUUUAGAGUGU', 'Seed'),
(674, 'hsa-miR-4999-3p', 'chr19', '-', 'A/G', 'UCACU[A/G]CCUGACAAUACAGU', 'Seed'),
(675, 'hsa-miR-4465', 'chr6', '+', 'G/C', 'CUCAAGUAGUCUGACCA[G/C]GGGA', 'Mature'),
(676, 'hsa-miR-6825-3p', 'chr3', '-', 'A/C', 'GCGCUG[A/C]CCCGCCUUCUCCGCA', 'Seed'),
(677, 'hsa-miR-548i', 'chr3', '-', 'C/U', 'AAAAGUAAUUGCGGAUUUUG[C/U]C', 'Mature'),
(678, 'hsa-miR-593-5p', 'chr7', '+', 'C/U', 'AGGCACCAG[C/U]CAGGCAUUGCUCAGC', 'Mature'),
(679, 'hsa-miR-1269a', 'chr4', '+', 'G/A', 'CU[G/A]GACUGAGCCGUGCUACUGG', 'Seed'),
(680, 'hsa-miR-489-3p', 'chr7', '-', 'C/A', 'GUGACAUCACAUAUA[C/A]GGCAGC', 'Mature'),
(681, 'hsa-miR-125a-3p', 'chr19', '+', 'G/U', 'ACA[G/U]GUGAGGUUCUUGGGAGCC', 'Seed'),
(682, 'hsa-miR-335-5p', 'chr7', '+', 'A/G', 'UCAAGAGCAAUA[A/G]CGAAAAAUGU', 'Mature'),
(683, 'hsa-miR-6755-5p', 'chr11', '+', 'G/U', 'UAG[G/U]GUAGACACUGACAACGUU', 'Seed'),
(684, 'hsa-miR-4520-5p', 'chr17', '-', '-/G', 'CCUGCGU[-/G]UUUUCUGUCCAA', 'Mature'),
(685, 'hsa-miR-4520-2-3p', 'chr17', '+', '-/C', 'UUUGGACAGAAA[-/C]CACGCAGGU', 'Mature'),
(686, 'hsa-miR-612', 'chr11', '+', 'G/A', 'GCUGGGCAGGGCUUCUGA[G/A]CUCCUU', 'Mature'),
(687, 'hsa-miR-3617-3p', 'chr20', '-', 'C/U', 'CAUCAGCA[C/U]CCUAUGUCCUUUCU', 'Mature'),
(688, 'hsa-miR-4280', 'chr5', '-', 'G/A', 'GAGUGUAGUUCUGA[G/A]CAGAGC', 'Mature'),
(689, 'hsa-miR-519d-5p', 'chr19', '+', 'C/A', 'CCUCCAAAGGGAAGCGCUUU[C/A]UGUU', 'Mature'),
(690, 'hsa-miR-489-3p', 'chr7', '-', 'C/A', 'GUGACAUCACAUAUA[C/A]GGCAGC', 'Mature'),
(691, 'hsa-miR-4677-5p', 'chr1', '+', 'U/A', 'UUGUUCU[U/A]UGGUCUUUCAGCCA', 'Mature'),
(692, 'hsa-miR-589-3p', 'chr7', '-', 'C/G', 'UCAGAACAAAUGC[C/G]GGUUCCCAGA', 'Mature'),
(693, 'hsa-miR-195-3p', 'chr17', '-', 'C/G', 'C[C/G]AAUAUUGGCUGUGCUGCUCC', 'Seed'),
(694, 'hsa-miR-298', 'chr20', '-', 'G/C', 'AGCAGAAGCA[G/C]GGAGGUUCUCCCA', 'Mature'),
(695, 'hsa-miR-216a-3p', 'chr2', '-', 'C/A', 'UCACAGUGGU[C/A]UCUGGGAUUAU', 'Mature'),
(696, 'hsa-miR-100-5p', 'chr11', '-', 'C/U', 'AACC[C/U]GUAGAUCCGAACUUGUG', 'Seed'),
(697, 'hsa-miR-125b-1-3p', 'chr11', '-', 'G/U', 'ACGGGUUAGGCUCUUGGGA[G/U]CU', 'Mature'),
(698, 'hsa-miR-4533', 'chr20', '+', 'C/U', 'UGGAAGGAGGUUGCCGGA[C/U]GCU', 'Mature'),
(699, 'hsa-miR-194-5p', 'chr11', '-', 'G/A', 'UGUAACAGCAACUCCAUGUG[G/A]A', 'Mature'),
(700, 'hsa-miR-550a-5p', 'chr7', '+', 'G/C', 'AGUGCCU[G/C]AGGGAGUAAGAGCCC', 'Mature'),
(701, 'hsa-miR-550b-3p', 'chr7', '-', 'C/G', 'UCUUACUCCCU[C/G]AGGCACUG', 'Mature'),
(702, 'hsa-miR-3142', 'chr5', '+', '', '', 'Seed'),
(703, 'hsa-miR-4743-5p', 'chr18', '+', 'G/C', 'UGGCC[G/C]GAUGGGACAGGAGGCAU', 'Seed'),
(704, 'hsa-miR-125b-1-3p', 'chr11', '-', 'G/U', 'ACGGGUUAGGCUCUUGGGA[G/U]CU', 'Mature'),
(705, 'hsa-miR-555', 'chr1', '-', 'G/C', 'AGGGUAAGCUGAACCUCU[G/C]AU', 'Mature'),
(706, 'hsa-miR-518a-5p', 'chr19', '+', 'C/A', 'CUGCAAAGGGAAGC[C/A]CUUUC', 'Mature'),
(707, 'hsa-miR-517b-3p', 'chr19', '+', 'C/A', 'AU[C/A]GUGCAUCCCUUUAGAGUGU', 'Seed'),
(708, 'hsa-let-7a-5p', 'chr22', '+', 'A/G', 'UGAGGUAGUAGGUUGU[A/G]UAGUU', 'Mature'),
(709, 'hsa-miR-25-3p', 'chr7', '-', 'G/A', 'CAUUGCACUUGUCUCGGUCU[G/A]A', 'Mature'),
(710, 'hsa-miR-1250-3p', 'chr17', '-', 'U/A', 'ACAU[U/A]UUCCAGCCCAUUCA', 'Seed'),
(711, 'hsa-miR-541-5p', 'chr14', '+', 'A/G', 'A[A/G]AGGAUUCUGCUGUCGGUCCCACU', 'Seed'),
(712, 'hsa-miR-192-3p', 'chr11', '-', 'U/C', 'CUGCCAAUUCCAUAGG[U/C]CACAG', 'Mature'),
(713, 'hsa-miR-146a-5p', 'chr5', '+', 'G/U', 'UGA[G/U]AACUGAAUUCCAUGGGUU', 'Seed'),
(714, 'hsa-miR-142-3p', 'chr17', '-', 'G/C', 'UGUAGU[G/C]UUUCCUACUUUAUGGA', 'Seed'),
(715, 'hsa-miR-492', 'chr12', '+', 'C/U', 'AGGACCUG[C/U]GGGACAAGAUUCUU', 'Mature'),
(716, 'hsa-miR-601', 'chr9', '-', 'C/A', 'UGGU[C/A]UAGGAUUGUUGGAGGAG', 'Seed'),
(717, 'hsa-miR-328-5p', 'chr16', '-', 'G/C', 'GGGGGGGCAG[G/C]AGGGGCUCAGGG', 'Mature'),
(718, 'hsa-miR-1179', 'chr15', '+', 'C/U', 'AAGCAUUCUUU[C/U]AUUGGUUGG', 'Mature'),
(719, 'hsa-miR-380-5p', 'chr14', '+', 'G/U', 'UGGUU[G/U]ACCAUAGAACAUGCGC', 'Seed'),
(720, 'hsa-miR-323a-5p', 'chr14', '+', 'G/A', 'AGGUGGUCCGUGGCGCGUUC[G/A]C', 'Mature'),
(721, 'hsa-miR-1247-5p', 'chr14', '-', 'C/U', 'ACCCGUCCCGUUCGUCCC[C/U]GGA', 'Mature'),
(722, 'hsa-miR-369-5p', 'chr14', '+', 'C/U', 'AGAUCGAC[C/U]GUGUUAUAUUCGC', 'Mature'),
(723, 'hsa-miR-4668-5p', 'chr9', '+', 'A/-', 'AGGG[A/-]AAAAAAAAAGGAUUUGUC', 'Seed'),
(724, 'hsa-miR-1288-5p', 'chr17', '+', 'U/G', 'GCAGAUCAGGACUG[U/G]AACUCACC', 'Mature'),
(725, 'hsa-miR-524-3p', 'chr19', '+', 'C/U', 'GAAGG[C/U]GCUUCCCUUUGGAGU', 'Seed'),
(726, 'hsa-miR-524-3p', 'chr19', '+', 'G/C', 'GAAGGCGCUUCCCUUUG[G/C]AGU', 'Mature'),
(727, 'hsa-miR-516a-3p', 'chr19', '+', 'G/C', 'UGCUUCCUUUCAGAGG[G/C]U', 'Mature'),
(728, 'hsa-miR-5189-3p', 'chr16', '+', 'C/G', 'UGCCAACCGUCAGAG[C/G]CCAGA', 'Mature'),
(729, 'hsa-miR-548h-5p', 'chr17', '-', 'C/U', 'AAAAGUAAUCG[C/U]GGUUUUUGUC', 'Mature'),
(730, 'hsa-miR-196a-3p', 'chr12', '+', 'G/U', 'CGGCAACAA[G/U]AAACUGCCUGAG', 'Mature'),
(731, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACUCAAAAC[C/G]CUUCAGUGACUU', 'Mature'),
(732, 'hsa-miR-95-3p', 'chr4', '-', 'U/A', 'UUCAACGGGUAUU[U/A]AUUGAGCA', 'Mature'),
(733, 'hsa-miR-132-5p', 'chr17', '-', 'U/C', 'ACCGUGGCUUUCGA[U/C]UGUUACU', 'Mature'),
(734, 'hsa-miR-371a-3p', 'chr19', '+', 'C/A', 'AAGUGCCG[C/A]CAUCUUUUGAGUGU', 'Mature'),
(735, 'hsa-miR-371b-5p', 'chr19', '-', 'G/U', 'ACUCAAAAGAUG[G/U]CGGCACUUU', 'Mature'),
(736, 'hsa-miR-6075', 'chr5', '-', 'C/U', 'ACGGCCCAGG[C/U]GGCAUUGGUG', 'Mature'),
(737, 'hsa-miR-6869-3p', 'chr20', '-', 'G/U', 'CGCCGCGC[G/U]CAUCGGCUCAGC', 'Mature'),
(738, 'hsa-miR-3689b-3p', 'chr9', '-', 'U/C', 'CUGGGAGGUGUGAUAU[U/C]GUGGU', 'Mature'),
(739, 'hsa-miR-548h-5p', 'chr17', '-', 'C/U', 'AAAAGUAAUCG[C/U]GGUUUUUGUC', 'Mature'),
(740, 'hsa-miR-10b-3p', 'chr2', '+', 'G/A', 'ACAGAUUC[G/A]AUUCUAGGGGAAU', 'Mature'),
(741, 'hsa-miR-1283', 'chr19', '+', 'G/A', 'UCUACAAAGGAAAGC[G/A]CUUUCU', 'Mature'),
(742, 'hsa-miR-485-3p', 'chr14', '+', 'G/U', 'GUCAUACAC[G/U]GCUCUCCUCUCU', 'Mature'),
(743, 'hsa-miR-142-3p', 'chr17', '-', 'G/C', 'UGUAGU[G/C]UUUCCUACUUUAUGGA', 'Seed'),
(744, 'hsa-miR-330-3p', 'chr19', '-', 'G/A', 'GCAAAGCACACGGCCUGCA[G/A]AGA', 'Mature'),
(745, 'hsa-miR-411-3p', 'chr14', '+', 'C/A', 'UAUGUAACACGGUCCACUAA[C/A]C', 'Mature'),
(746, 'hsa-miR-196b-5p', 'chr7', '-', 'C/U', 'UAGGUAGUUU[C/U]CUGUUGUUGGG', 'Mature'),
(747, 'hsa-miR-519e-5p', 'chr19', '+', 'G/A', 'UUCUCCAAAAGG[G/A]AGCACUUUC', 'Mature'),
(748, 'hsa-miR-483-5p', 'chr11', '-', 'A/G', 'A[A/G]GACGGGAGGAAAGAAGGGAG', 'Seed'),
(749, 'hsa-miR-1207-3p', 'chr8', '+', 'C/A', 'UCAGCUGGCCCU[C/A]AUUUC', 'Mature'),
(750, 'hsa-miR-1307-3p', 'chr10', '-', 'C/U', 'ACUCGGCGUGGCGU[C/U]GGUCGUG', 'Mature'),
(751, 'hsa-miR-124-5p', 'chr8', '-', 'A/U', 'CGUGUUCAC[A/U]GCGGACCUUGAU', 'Mature'),
(752, 'hsa-miR-517c-3p', 'chr19', '+', 'G/U', 'AUCGUGCAUCCUUUUA[G/U]AGUGU', 'Mature'),
(753, 'hsa-miR-519a-5p', 'chr19', '+', 'G/A', 'CUCUAGAGGGAAGC[G/A]CUUUCUG', 'Mature'),
(754, 'hsa-miR-196a-3p', 'chr12', '+', 'C/U', 'CGGCAACAAGAAA[C/U]UGCCUGAG', 'Mature'),
(755, 'hsa-miR-124-3p', 'chr20', '+', 'G/A', 'UAAGGCACGC[G/A]GUGAAUGCC', 'Mature'),
(756, 'hsa-miR-486-3p', 'chr8', '-', 'C/A', 'CGGGG[C/A]AGCUCAGUACAGGAU', 'Seed'),
(757, 'hsa-miR-486-5p', 'chr8', '+', 'G/U', 'UCCUGUACUGAGCU[G/U]CCCCGAG', 'Mature'),
(758, 'hsa-miR-518a-5p', 'chr19', '+', 'G/U', 'CUGCAAA[G/U]GGAAGCCCUUUC', 'Mature'),
(759, 'hsa-miR-650', 'chr22', '+', 'G/A', 'AGGAGGCAGC[G/A]CUCUCAGGAC', 'Mature'),
(760, 'hsa-miR-557', 'chr1', '+', 'G/A', 'GUUUGCAC[G/A]GGUGGGCCUUGUCU', 'Mature'),
(761, 'hsa-miR-520a-3p', 'chr19', '+', 'G/A', 'AAAGUGCUUCCCUUU[G/A]GACUGU', 'Mature'),
(762, 'hsa-miR-29b-2-5p', 'chr1', '-', '', '', 'Seed'),
(763, 'hsa-miR-181b-5p', 'chr9', '+', 'C/U', 'AACAUUCAUUGCUGU[C/U]GGUGGGU', 'Mature'),
(764, 'hsa-miR-181a-5p', 'chr1', '-', 'G/C', 'AACAUUCAACGCUGUC[G/C]GUGAGU', 'Mature'),
(765, 'hsa-miR-153-3p', 'chr2', '-', 'A/G', 'UUGCAUAGUCACAA[A/G]AGUGAUC', 'Mature'),
(766, 'hsa-miR-522-3p', 'chr19', '+', 'C/G', 'AAAAUGGUUCC[C/G]UUUAGAGUGU', 'Mature'),
(767, 'hsa-miR-483-5p', 'chr11', '-', 'A/G', 'A[A/G]GACGGGAGGAAAGAAGGGAG', 'Seed'),
(768, 'hsa-miR-634', 'chr17', '+', 'C/U', 'AAC[C/U]AGCACCCCAACUUUGGAC', 'Seed'),
(769, 'hsa-miR-642a-5p', 'chr19', '+', 'G/A', 'GUCCCUCUCCAAAU[G/A]UGUCUUG', 'Mature'),
(770, 'hsa-miR-642b-3p', 'chr19', '-', 'C/U', 'AGACA[C/U]AUUUGGAGAGGGACCC', 'Seed'),
(771, 'hsa-miR-1203', 'chr17', '-', 'G/A', 'CCC[G/A]GAGCCAGGAUGCAGCUC', 'Seed'),
(772, 'hsa-miR-153-3p', 'chr7', '-', 'U/A', 'UUGCAUAGUCACAAAAGUGA[U/A]C', 'Mature'),
(773, 'hsa-miR-567', 'chr3', '+', 'G/U', 'AGUAUGUUCUUCCAGGACA[G/U]AAC', 'Mature'),
(774, 'hsa-miR-558', 'chr2', '+', 'A/U', 'UGAGCUGCUGU[A/U]CCAAAAU', 'Mature'),
(775, 'hsa-miR-488-3p', 'chr1', '-', 'U/G', 'UUGAAAGGCUA[U/G]UUCUUGGUC', 'Mature'),
(776, 'hsa-miR-616-3p', 'chr12', '-', 'C/A', 'AGU[C/A]AUUGGAGGGUUUGAGCAG', 'Seed'),
(777, 'hsa-miR-493-3p', 'chr14', '+', 'G/U', 'UGAAGGUCUACUGU[G/U]UGCCAGG', 'Mature'),
(778, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(779, 'hsa-miR-4520-5p', 'chr17', '-', '-/G', 'CCUGCGU[-/G]UUUUCUGUCCAA', 'Mature'),
(780, 'hsa-miR-4520-2-3p', 'chr17', '+', '-/C', 'UUUGGACAGAAA[-/C]CACGCAGGU', 'Mature'),
(781, 'hsa-miR-487a-3p', 'chr14', '+', 'A/G', 'AAUCAU[A/G]CAGGGACAUCCAGUU', 'Seed'),
(782, 'hsa-miR-1247-5p', 'chr14', '-', 'C/U', 'ACCCGUCCCGUUCGUCCC[C/U]GGA', 'Mature'),
(783, 'hsa-miR-495-5p', 'chr14', '+', 'C/U', 'GAAGUUGCCCAUGUUAUUUU[C/U]G', 'Mature'),
(784, 'hsa-miR-371a-3p', 'chr19', '+', 'C/A', 'AAGUG[C/A]CGCCAUCUUUUGAGUGU', 'Seed'),
(785, 'hsa-miR-371b-5p', 'chr19', '-', 'G/U', 'ACUCAAAAGAUGGCG[G/U]CACUUU', 'Mature'),
(786, 'hsa-miR-519a-5p', 'chr19', '+', 'C/U', 'CUCUAGAGGGAAGCGCUUU[C/U]UG', 'Mature'),
(787, 'hsa-miR-548f-3p', 'chr7', '-', 'U/G', 'AAAAACUGUAA[U/G]UACUUUU', 'Mature'),
(788, 'hsa-miR-365a-5p', 'chr16', '+', 'G/U', 'AGGGACUUUUGGGG[G/U]CAGAUGUG', 'Mature'),
(789, 'hsa-miR-122-5p', 'chr18', '+', 'G/U', 'UGGAGUGUGACAAUGGU[G/U]UUUG', 'Mature'),
(790, 'hsa-miR-3591-3p', 'chr18', '-', 'C/A', 'AAA[C/A]ACCAUUGUCACACUCCAC', 'Seed'),
(791, 'hsa-miR-134-3p', 'chr14', '+', 'C/A', 'CCUGUGGGCCACCUAGU[C/A]ACCAA', 'Mature'),
(792, 'hsa-miR-653-5p', 'chr7', '-', 'A/G', 'GUGUUGAA[A/G]CAAUCUCUACUG', 'Mature'),
(793, 'hsa-miR-1269a', 'chr4', '+', 'G/A', 'CU[G/A]GACUGAGCCGUGCUACUGG', 'Seed'),
(794, 'hsa-miR-6856-3p', 'chr9', '+', 'G/U', 'UACA[G/U]CCCUGUGAUCUUUCCAG', 'Seed'),
(795, 'hsa-miR-517-5p', 'chr19', '+', 'C/G', 'CCUCUAGAUGGAAGCA[C/G]UGUCU', 'Mature'),
(796, 'hsa-miR-3939', 'chr6', '-', 'G/A', 'UACGC[G/A]CAGACCACAGGAUGUC', 'Seed'),
(797, 'hsa-miR-186-3p', 'chr1', '-', 'U/-', 'GCCCAAAGGUGAAUUUUU[U/-]GGG', 'Mature'),
(798, 'hsa-miR-380-5p', 'chr14', '+', 'U/C', 'UGG[U/C]UGACCAUAGAACAUGCGC', 'Seed'),
(799, 'hsa-miR-523-5p', 'chr19', '+', 'C/A', 'CU[C/A]UAGAGGGAAGCGCUUUCUG', 'Seed'),
(800, 'hsa-miR-410-5p', 'chr14', '+', 'C/A', 'AGGUUGU[C/A]UGUGAUGAGUUCG', 'Mature'),
(801, 'hsa-miR-518d-3p', 'chr19', '+', 'C/U', 'CAAAG[C/U]GCUUCCCUUUGGAGC', 'Seed'),
(802, 'hsa-miR-663b', 'chr2', '-', 'G/A', 'GGUGGCCC[G/A]GCCGUGCCUGAGG', 'Mature'),
(803, 'hsa-miR-3677-5p', 'chr16', '+', 'U/A', 'CAGUGGCCAGAGCCCUGCAG[U/A]G', 'Mature'),
(804, 'hsa-miR-769-3p', 'chr19', '+', 'G/A', 'CUGGGAUCUCC[G/A]GGGUCUUGGUU', 'Mature'),
(805, 'hsa-miR-124-3p', 'chr8', '+', 'C/U', 'UAAGGCA[C/U]GCGGUGAAUGCC', 'Mature'),
(806, 'hsa-miR-297', 'chr4', '-', '', '', 'Seed'),
(807, 'hsa-miR-128-3p', 'chr3', '+', 'U/C', 'UCACAGUGAACCGGUCUC[U/C]UU', 'Mature'),
(808, 'hsa-miR-519e-3p', 'chr19', '+', 'C/U', 'AAGUGC[C/U]UCCUUUUAGAGUGUU', 'Seed'),
(809, 'hsa-miR-598-3p', 'chr8', '-', '', '', 'Mature'),
(810, 'hsa-miR-345-3p', 'chr14', '+', 'G/U', 'GCCCUGAACGAG[G/U]GGUCUGGAG', 'Mature'),
(811, 'hsa-miR-4700-3p', 'chr12', '+', 'C/U', 'CACAGGACUGACUC[C/U]UCACCCCAGUG', 'Mature'),
(812, 'hsa-miR-205-5p', 'chr1', '+', 'C/U', 'U[C/U]CUUCAUUCCACCGGAGUCUG', 'Seed'),
(813, 'hsa-miR-296-5p', 'chr20', '-', 'C/U', 'AGGGCCCCCCCUCAAU[C/U]CUGU', 'Mature'),
(814, 'hsa-miR-3689b-3p', 'chr9', '-', 'U/C', 'CUGGGAGGUGUGAUA[U/C]UGUGGU', 'Mature'),
(815, 'hsa-miR-4755-5p', 'chr20', '+', 'C/G', 'UUUCCCUUCAGAGC[C/G]UGGCUUU', 'Mature'),
(816, 'hsa-miR-300', 'chr14', '+', 'G/U', 'UAUACAAGGGCA[G/U]ACUCUCUCU', 'Mature'),
(817, 'hsa-miR-526a', 'chr19', '+', 'C/G', 'CU[C/G]UAGAGGGAAGCACUUUCUG', 'Seed'),
(818, 'hsa-miR-365b-3p', 'chr17', '+', 'C/U', 'UAAUGCCCCUAAAAAU[C/U]CUUAU', 'Mature'),
(819, 'hsa-miR-6730-5p', 'chr1', '-', 'G/A', 'AGAAA[G/A]GUGGAGGGGUUGUCAGA', 'Seed'),
(820, 'hsa-miR-208b-3p', 'chr14', '-', 'G/U', 'AUAAGACGAACAAAA[G/U]GUUUGU', 'Mature'),
(821, 'hsa-miR-30e-5p', 'chr1', '+', 'C/A', 'UGUAAACAUC[C/A]UUGACUGGAAG', 'Mature'),
(822, 'hsa-miR-548k', 'chr11', '+', 'A/G', 'AAAAGUACUUGCGG[A/G]UUUUGCU', 'Mature'),
(823, 'hsa-miR-622', 'chr13', '+', 'G/U', 'ACAGUCUGCUGA[G/U]GUUGGAGC', 'Mature'),
(824, 'hsa-miR-4804-5p', 'chr5', '+', 'C/G', 'UUGGA[C/G]GGUAAGGUUAAGCAA', 'Seed'),
(825, 'hsa-miR-517c-3p', 'chr19', '+', 'U/C', 'AUCGUGCAUCCUU[U/C]UAGAGUGU', 'Mature'),
(826, 'hsa-miR-211-5p', 'chr15', '-', 'C/A', 'UUCCCUUUGUCAUCCUUCGC[C/A]U', 'Mature'),
(827, 'hsa-miR-550a-5p', 'chr7', '+', 'G/C', 'AGUGCCU[G/C]AGGGAGUAAGAGCCC', 'Mature'),
(828, 'hsa-miR-550b-3p', 'chr7', '-', 'C/G', 'UCUUACUCCCU[C/G]AGGCACUG', 'Mature'),
(829, 'hsa-miR-26b-3p', 'chr2', '+', 'U/C', 'CCUGUUCUCCAUUACUUGGC[U/C]C', 'Mature'),
(830, 'hsa-miR-3689b-3p', 'chr9', '-', 'U/C', 'CUGGGAGGUGUGAUA[U/C]UGUGGU', 'Mature'),
(831, 'hsa-miR-346', 'chr10', '-', 'U/A', 'UGUCUGCCCGCAUGCC[U/A]GCCUCU', 'Mature'),
(832, 'hsa-miR-195-3p', 'chr17', '-', 'C/G', 'C[C/G]AAUAUUGGCUGUGCUGCUCC', 'Seed'),
(833, 'hsa-miR-6861-5p', 'chr12', '-', 'G/U', 'ACUGGGUAG[G/U]UGGGGCUCCAGG', 'Mature'),
(834, 'hsa-miR-518a-5p', 'chr19', '+', 'U/A', 'CUGCAAAGGGAAGCCCU[U/A]UC', 'Mature'),
(835, 'hsa-miR-520a-3p', 'chr19', '+', 'A/C', 'AA[A/C]GUGCUUCCCUUUGGACUGU', 'Seed'),
(836, 'hsa-miR-518a-3p', 'chr19', '+', 'C/U', 'GAAAG[C/U]GCUUCCCUUUGCUGGA', 'Seed'),
(837, 'hsa-miR-411-3p', 'chr14', '+', 'C/A', 'UAUGUAACACGGUCCACUAA[C/A]C', 'Mature'),
(838, 'hsa-miR-616-3p', 'chr12', '-', 'G/U', 'AGUCAUU[G/U]GAGGGUUUGAGCAG', 'Mature'),
(839, 'hsa-miR-205-3p', 'chr1', '+', 'C/U', 'GAUUU[C/U]AGUGGAGUGAAGUUC', 'Seed'),
(840, 'hsa-miR-556-3p', 'chr1', '+', '-/U', 'AUAUUACCAUUAGCUCAU[-/U]UUU', 'Mature'),
(841, 'hsa-miR-543', 'chr14', '+', 'G/A', 'AAACAUUCGC[G/A]GUGCACUUCUU', 'Mature'),
(842, 'hsa-miR-124-3p', 'chr8', '+', 'C/U', 'UAAGGCA[C/U]GCGGUGAAUGCC', 'Mature'),
(843, 'hsa-miR-521', 'chr19', '+', 'C/U', 'AACGCACUUCC[C/U]UUUAGAGUGU', 'Mature'),
(844, 'hsa-miR-1324', 'chr3', '+', 'C/A', 'CCAGACAGAAUU[C/A]UAUGCACUUUC', 'Mature'),
(845, 'hsa-miR-647', 'chr20', '-', 'C/U', 'GUGGCUGCACUCACUU[C/U]CUUC', 'Mature'),
(846, 'hsa-miR-518e-5p', 'chr19', '+', 'C/U', 'CUCUAGAGGGAAG[C/U]GCUUUCUG', 'Mature'),
(847, 'hsa-miR-551b-3p', 'chr3', '+', 'C/U', 'G[C/U]GACCCAUACUUGGUUUCAG', 'Seed'),
(848, 'hsa-miR-585-5p', 'chr5', '-', 'C/U', 'CUAGCACACAGAUA[C/U]GCCCAGA', 'Mature'),
(849, 'hsa-miR-100-5p', 'chr11', '-', 'C/A', 'AACCCGUAGAU[C/A]CGAACUUGUG', 'Mature'),
(850, 'hsa-miR-10b-5p', 'chr2', '+', 'G/A', 'UACCCUGUAGAACCGAAUUU[G/A]UG', 'Mature'),
(851, 'hsa-miR-1203', 'chr17', '-', 'C/U', 'CCCGGAGCCAGGAUG[C/U]AGCUC', 'Mature'),
(852, 'hsa-miR-412-5p', 'chr14', '+', 'C/U', 'UGGU[C/U]GACCAGUUGGAAAGUAAU', 'Seed'),
(853, 'hsa-miR-516a-3p', 'chr19', '+', 'G/U', 'U[G/U]CUUCCUUUCAGAGGGU', 'Seed'),
(854, 'hsa-miR-142-3p', 'chr17', '-', 'U/A', 'UGUAGUGU[U/A]UCCUACUUUAUGGA', 'Mature'),
(855, 'hsa-miR-1251-5p', 'chr12', '+', 'C/U', 'ACU[C/U]UAGCUGCCAAAGGCGCU', 'Seed'),
(856, 'hsa-miR-516b-3p', 'chr19', '+', 'G/A', 'UGCUUCCUUUCAGAG[G/A]GU', 'Mature'),
(857, 'hsa-miR-1255a', 'chr4', '-', 'G/U', 'AGGAUGAGCAAA[G/U]AAAGUAGAUU', 'Mature'),
(858, 'hsa-miR-409-5p', 'chr14', '+', 'C/A', 'AGGUUA[C/A]CCGAGCAACUUUGCAU', 'Seed'),
(859, 'hsa-miR-3939', 'chr6', '-', 'A/G', 'UACGCGCAGACCACAGG[A/G]UGUC', 'Mature'),
(860, 'hsa-miR-103a-2-5p', 'chr20', '+', 'G/C', 'A[G/C]CUUCUUUACAGUGCUGCCUUG', 'Seed'),
(861, 'hsa-miR-637', 'chr19', '-', 'C/U', 'A[C/U]UGGGGGCUUUCGGGCUCUGCGU', 'Seed'),
(862, 'hsa-miR-4323', 'chr19', '-', 'U/G', 'CAGCCCCACAGCC[U/G]CAGA', 'Mature'),
(863, 'hsa-miR-7150', 'chr9', '-', 'A/C', 'CUGGC[A/C]GGGGGAGAGGUA', 'Seed'),
(864, 'hsa-miR-485-3p', 'chr14', '+', 'G/U', 'GUCAUACAC[G/U]GCUCUCCUCUCU', 'Mature'),
(865, 'hsa-miR-579-5p', 'chr5', '-', 'C/U', 'UCGCGGUUUGUGCCAGAUGA[C/U]G', 'Mature'),
(866, 'hsa-miR-596', 'chr8', '+', 'C/U', 'AAGCCUGCCCGGCUCCU[C/U]GGG', 'Mature'),
(867, 'hsa-miR-519d-5p', 'chr19', '+', 'C/U', 'CCUCCAAAGGGAAG[C/U]GCUUUCUGUU', 'Mature'),
(868, 'hsa-miR-663b', 'chr2', '-', 'C/G', 'GGUGGCCCGGCCGUG[C/G]CUGAGG', 'Mature'),
(869, 'hsa-miR-1307-3p', 'chr10', '-', 'C/U', 'ACUCGGCGUGGCGU[C/U]GGUCGUG', 'Mature'),
(870, 'hsa-miR-376b-3p', 'chr14', '+', 'C/G', 'AUCAUAGAGGAAAAU[C/G]CAUGUU', 'Mature'),
(871, 'hsa-miR-10b-5p', 'chr2', '+', 'C/U', 'UACCCUGUAGAAC[C/U]GAAUUUGUG', 'Mature'),
(872, 'hsa-miR-142-3p', 'chr17', '-', 'A/G', 'UGU[A/G]GUGUUUCCUACUUUAUGGA', 'Seed'),
(873, 'hsa-miR-125b-2-3p', 'chr21', '+', 'C/A', 'UCACAAGUCAGG[C/A]UCUUGGGAC', 'Mature'),
(874, 'hsa-miR-1261', 'chr11', '-', 'G/A', 'AUG[G/A]AUAAGGCUUUGGCUU', 'Seed'),
(875, 'hsa-miR-548g-5p', 'chr4', '-', 'U/C', 'UGCAAAAG[U/C]AAUUGCAGUUUUUG', 'Mature'),
(876, 'hsa-miR-30c-5p', 'chr6', '-', 'C/A', 'UGUAAACAUCCUACACU[C/A]UCAGC', 'Mature'),
(877, 'hsa-miR-602', 'chr9', '+', 'G/A', 'GACAC[G/A]GGCGACAGCUGCGGCCC', 'Seed'),
(878, 'hsa-miR-3607-3p', 'chr5', '+', 'A/U', 'ACUGUAAACGCUUUCUG[A/U]UG', 'Mature'),
(879, 'hsa-miR-4733-3p', 'chr17', '-', 'C/A', 'CCAC[C/A]AGGUCUAGCAUUGGGAU', 'Seed'),
(880, 'hsa-miR-876-5p', 'chr9', '-', 'U/C', 'UGGAUUUC[U/C]UUGUGAAUCACCA', 'Mature'),
(881, 'hsa-miR-603', 'chr10', '+', 'C/U', 'CA[C/U]ACACUGCAAUUACUUUUGC', 'Seed'),
(882, 'hsa-miR-642a-3p', 'chr19', '+', 'A/G', 'AGAC[A/G]CAUUUGGAGAGGGAACC', 'Seed'),
(883, 'hsa-miR-642b-5p', 'chr19', '-', 'U/C', 'GGUUCCCUCUCCAAAUG[U/C]GUCU', 'Mature'),
(884, 'hsa-miR-4256', 'chr1', '-', 'A/C', 'AUCUGACCUGAUGA[A/C]GGU', 'Mature'),
(885, 'hsa-miR-802', 'chr21', '+', 'C/U', 'CAGUAACAAAGAUUCAU[C/U]CUUGU', 'Mature'),
(886, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACU[C/G]AAAACCCUUCAGUGACUU', 'Seed'),
(887, 'hsa-miR-193b-5p', 'chr16', '+', 'G/C', 'CGGGGUUUU[G/C]AGGGCGAGAUGA', 'Mature'),
(888, 'hsa-miR-302f', 'chr18', '+', 'G/U', 'UAAUU[G/U]CUUCCAUGUUU', 'Seed'),
(889, 'hsa-miR-887-3p', 'chr5', '+', 'C/U', 'GUGAACGGG[C/U]GCCAUCCCGAGG', 'Mature'),
(890, 'hsa-miR-519d-5p', 'chr19', '+', 'C/U', 'CCUCCAAAGGGAAG[C/U]GCUUUCUGUU', 'Mature'),
(891, 'hsa-miR-6755-5p', 'chr11', '+', 'G/U', 'UAG[G/U]GUAGACACUGACAACGUU', 'Seed'),
(892, 'hsa-miR-302d-5p', 'chr4', '-', 'U/C', 'AC[U/C]UUAACAUGGAGGCACUUGC', 'Seed'),
(893, 'hsa-miR-342-3p', 'chr14', '+', 'C/U', 'UCUCACACAGAAAUCGCACC[C/U]GU', 'Mature'),
(894, 'hsa-miR-519a-3p', 'chr19', '+', 'G/U', 'AAA[G/U]UGCAUCCUUUUAGAGUGU', 'Seed'),
(895, 'hsa-miR-20a-3p', 'chr13', '+', '-/A', 'ACUGCAUUAUGAGCACU[-/A]AAAG', 'Mature'),
(896, 'hsa-miR-616-5p', 'chr12', '-', 'C/G', 'ACUCAAAAC[C/G]CUUCAGUGACUU', 'Mature'),
(897, 'hsa-miR-519d-3p', 'chr19', '+', 'G/A', 'CAAAGU[G/A]CCUCCCUUUAGAGUG', 'Seed'),
(898, 'hsa-miR-412-5p', 'chr14', '+', 'C/A', 'UGGUCGAC[C/A]AGUUGGAAAGUAAU', 'Mature'),
(899, 'hsa-miR-637', 'chr19', '-', 'G/A', 'ACUGG[G/A]GGCUUUCGGGCUCUGCGU', 'Seed'),
(900, 'hsa-let-7g-5p', 'chr3', '-', 'G/U', 'UGAG[G/U]UAGUAGUUUGUACAGUU', 'Seed'),
(901, 'hsa-miR-146a-5p', 'chr5', '+', 'G/U', 'UGA[G/U]AACUGAAUUCCAUGGGUU', 'Seed'),
(902, 'hsa-miR-616-3p', 'chr12', '-', 'C/A', 'AGU[C/A]AUUGGAGGGUUUGAGCAG', 'Seed'),
(903, 'hsa-miR-548a-3p', 'chr6', '+', 'C/U', 'CAAAACUGGCAAUUA[C/U]UUUUGC', 'Mature'),
(904, 'hsa-miR-640', 'chr19', '+', 'A/C', 'AUGAUCCAGGA[A/C]CCUGCCUCU', 'Mature'),
(905, 'hsa-miR-548g-5p', 'chr4', '-', 'G/A', 'UGCAAAA[G/A]UAAUUGCAGUUUUUG', 'Mature'),
(906, 'hsa-miR-371a-3p', 'chr19', '+', 'C/U', 'AAGUGCCGC[C/U]AUCUUUUGAGUGU', 'Mature'),
(907, 'hsa-miR-371b-5p', 'chr19', '-', 'G/A', 'ACUCAAAAGAU[G/A]GCGGCACUUU', 'Mature'),
(908, 'hsa-miR-412-5p', 'chr14', '+', 'C/A', 'UGGUCGAC[C/A]AGUUGGAAAGUAAU', 'Mature'),
(909, 'hsa-miR-518a-3p', 'chr19', '+', 'A/U', 'GAA[A/U]GCGCUUCCCUUUGCUGGA', 'Seed'),
(910, 'hsa-miR-518c-3p', 'chr19', '+', 'A/C', 'CAA[A/C]GCGCUUCUCUUUAGAGUGU', 'Seed'),
(911, 'hsa-miR-328-3p', 'chr16', '-', 'C/U', 'CUGGCCCUCU[C/U]UGCCCUUCCGU', 'Mature'),
(912, 'hsa-miR-155-3p', 'chr21', '+', 'C/A', 'CU[C/A]CUACAUAUUAGCAUUAACA', 'Seed'),
(913, 'hsa-miR-937-3p', 'chr8', '-', 'C/G', 'AUCCGCGCUCUGACU[C/G]UCUGCC', 'Mature'),
(914, 'hsa-miR-371a-3p', 'chr19', '+', 'C/A', 'AAGUG[C/A]CGCCAUCUUUUGAGUGU', 'Seed'),
(915, 'hsa-miR-371b-5p', 'chr19', '-', 'G/U', 'ACUCAAAAGAUGGCG[G/U]CACUUU', 'Mature'),
(916, 'hsa-miR-494-5p', 'chr14', '+', 'C/U', 'AGGUUGU[C/U]CGUGUUGUCUUCUCU', 'Mature'),
(917, 'hsa-miR-3689a-3p', 'chr9', '-', 'C/U', 'CUGGGAGGUGUGAUAU[C/U]GUGGU', 'Mature'),
(918, 'hsa-miR-133a-5p', 'chr20', '+', 'G/U', 'AGCUGGUAAAAU[G/U]GAACCAAAU', 'Mature'),
(919, 'hsa-miR-4454', 'chr4', '-', 'G/A', 'GGAUCC[G/A]AGUCACGGCACCA', 'Seed'),
(920, 'hsa-miR-1246', 'chr2', '-', 'G/A', 'AAUG[G/A]AUUUUUGGAGCAGG', 'Seed'),
(921, 'hsa-miR-376c-5p', 'chr14', '+', 'G/U', 'GGUG[G/U]AUAUUCCUUCUAUGUU', 'Seed'),
(922, 'hsa-miR-216b-5p', 'chr2', '-', 'G/A', 'AAAUCUCUGCA[G/A]GCAAAUGUGA', 'Mature'),
(923, 'hsa-miR-10b-3p', 'chr2', '+', 'G/A', 'ACAGAUUC[G/A]AUUCUAGGGGAAU', 'Mature'),
(924, 'hsa-miR-3939', 'chr6', '-', 'C/U', 'UACGCGCAGA[C/U]CACAGGAUGUC', 'Mature'),
(925, 'hsa-miR-411-5p', 'chr14', '+', 'A/U', 'UAGUAGACCGUAUAGCGU[A/U]CG', 'Mature'),
(926, 'hsa-miR-302f', 'chr18', '+', 'G/U', 'UAAUU[G/U]CUUCCAUGUUU', 'Seed'),
(927, 'hsa-miR-6081', 'chr9', '+', 'G/A', 'AGGAGCAGUGCCGGCCAA[G/A]GCGCC', 'Mature'),
(928, 'hsa-miR-3622b-3p', 'chr8', '-', 'G/A', 'UCACCUGAGCUCCC[G/A]UGCCUG', 'Mature'),
(929, 'hsa-miR-3622a-5p', 'chr8', '+', 'C/U', 'CAGGCA[C/U]GGGAGCUCAGGUGAG', 'Seed'),
(930, 'hsa-miR-196a-3p', 'chr12', '+', 'C/U', 'CGGCAACAAGAAA[C/U]UGCCUGAG', 'Mature'),
(931, 'hsa-miR-409-3p', 'chr14', '+', 'G/A', 'GAAU[G/A]UUGCUCGGUGAACCCCU', 'Seed'),
(932, 'hsa-miR-1252-5p', 'chr12', '+', 'G/A', 'AGAA[G/A]GAAAUUGAAUUCAUUUA', 'Seed'),
(933, 'hsa-miR-101-3p', 'chr1', '-', 'G/A', 'UACAGUACUGUGAUAACU[G/A]AA', 'Mature'),
(934, 'hsa-miR-1243', 'chr4', '+', 'G/U', 'AACUG[G/U]AUCAAUUAUAGGAGUG', 'Seed'),
(935, 'hsa-miR-4518', 'chr16', '+', 'C/G', 'GCUCAGGGAUGAUAA[C/G]UGUGCUGAGA', 'Mature'),
(936, 'hsa-miR-1233-3p', 'chr15', '-', 'U/C', 'UGAGCCC[U/C]GUCCUCCCGCAG', 'Mature'),
(937, 'hsa-miR-1251-5p', 'chr12', '+', 'A/C', 'ACUCUAGCUGCCAA[A/C]GGCGCU', 'Mature'),
(938, 'hsa-miR-1294', 'chr5', '+', 'G/A', 'UGUGAGGUUG[G/A]CAUUGUUGUCU', 'Mature'),
(939, 'hsa-miR-302b-5p', 'chr4', '-', 'U/C', 'ACUUUAACA[U/C]GGAAGUGCUUUC', 'Mature'),
(940, 'hsa-mir-9-3', 'chr15', '+', '', '', 'Pre-miRNA'),
(941, 'hsa-mir-192', 'chr11', '-', '', '', 'Pre-miRNA'),
(942, 'hsa-mir-99a', 'chr21', '+', '', '', 'Pre-miRNA'),
(943, 'hsa-mir-1208', 'chr8', '+', '', '', 'Pre-miRNA'),
(944, 'hsa-mir-656', 'chr14', '+', '', '', 'Pre-miRNA'),
(945, 'hsa-mir-134', 'chr14', '+', '', '', 'Pre-miRNA'),
(946, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(947, 'hsa-mir-548f-1', 'chr10', '-', '', '', 'Pre-miRNA'),
(948, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(949, 'hsa-mir-101-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(950, 'hsa-mir-192', 'chr11', '-', '', '', 'Pre-miRNA'),
(951, 'hsa-mir-4533', 'chr20', '+', '', '', 'Pre-miRNA'),
(952, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(953, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(954, 'hsa-mir-1185-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(955, 'hsa-mir-520h', 'chr19', '+', '', '', 'Pre-miRNA'),
(956, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(957, 'hsa-mir-376c', 'chr14', '+', '', '', 'Pre-miRNA'),
(958, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(959, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(960, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(961, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(962, 'hsa-mir-521-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(963, 'hsa-mir-653', 'chr7', '-', '', '', 'Pre-miRNA'),
(964, 'hsa-mir-106b', 'chr7', '-', '', '', 'Pre-miRNA'),
(965, 'hsa-mir-627', 'chr15', '-', '', '', 'Pre-miRNA'),
(966, 'hsa-mir-875', 'chr8', '-', '', '', 'Pre-miRNA'),
(967, 'hsa-mir-516a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(968, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(969, 'hsa-mir-4280', 'chr5', '-', '', '', 'Pre-miRNA'),
(970, 'hsa-mir-6775', 'chr16', '-', '', '', 'Pre-miRNA'),
(971, 'hsa-mir-329-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(972, 'hsa-mir-578', 'chr4', '+', '', '', 'Pre-miRNA'),
(973, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(974, 'hsa-mir-483', 'chr11', '-', '', '', 'Pre-miRNA'),
(975, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(976, 'hsa-mir-4468', 'chr7', '+', '', '', 'Pre-miRNA'),
(977, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(978, 'hsa-mir-7-3', 'chr19', '+', '', '', 'Pre-miRNA'),
(979, 'hsa-mir-585', 'chr5', '-', '', '', 'Pre-miRNA'),
(980, 'hsa-mir-3683', 'chr7', '-', '', '', 'Pre-miRNA'),
(981, 'hsa-mir-5681a', 'chr8', '+', '', '', 'Pre-miRNA'),
(982, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(983, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(984, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(985, 'hsa-mir-940', 'chr16', '+', '', '', 'Pre-miRNA'),
(986, 'hsa-mir-1825', 'chr20', '+', '', '', 'Pre-miRNA'),
(987, 'hsa-mir-196a-1', 'chr17', '-', '', '', 'Pre-miRNA'),
(988, 'hsa-mir-570', 'chr3', '+', '', '', 'Pre-miRNA'),
(989, 'hsa-mir-330', 'chr19', '-', '', '', 'Pre-miRNA'),
(990, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(991, 'hsa-mir-6083', 'chr3', '+', '', '', 'Pre-miRNA'),
(992, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(993, 'hsa-mir-493', 'chr14', '+', '', '', 'Pre-miRNA'),
(994, 'hsa-mir-1185-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(995, 'hsa-mir-496', 'chr14', '+', '', '', 'Pre-miRNA'),
(996, 'hsa-mir-383', 'chr8', '-', '', '', 'Pre-miRNA'),
(997, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(998, 'hsa-mir-1322', 'chr8', '-', '', '', 'Pre-miRNA'),
(999, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(1000, 'hsa-mir-206', 'chr6', '+', '', '', 'Pre-miRNA'),
(1001, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1002, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(1003, 'hsa-mir-541', 'chr14', '+', '', '', 'Pre-miRNA'),
(1004, 'hsa-mir-4646', 'chr6', '-', '', '', 'Pre-miRNA'),
(1005, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1006, 'hsa-mir-668', 'chr14', '+', '', '', 'Pre-miRNA'),
(1007, 'hsa-mir-647', 'chr20', '-', '', '', 'Pre-miRNA'),
(1008, 'hsa-mir-521-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1009, 'hsa-mir-617', 'chr12', '-', '', '', 'Pre-miRNA'),
(1010, 'hsa-mir-299', 'chr14', '+', '', '', 'Pre-miRNA'),
(1011, 'hsa-mir-1304', 'chr11', '-', '', '', 'Pre-miRNA'),
(1012, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1013, 'hsa-mir-611', 'chr11', '-', '', '', 'Pre-miRNA'),
(1014, 'hsa-mir-1-2', 'chr18', '-', '', '', 'Pre-miRNA'),
(1015, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1016, 'hsa-mir-4796', 'chr3', '-', '', '', 'Pre-miRNA'),
(1017, 'hsa-mir-3611', 'chr10', '-', '', '', 'Pre-miRNA'),
(1018, 'hsa-mir-569', 'chr3', '-', '', '', 'Pre-miRNA'),
(1019, 'hsa-mir-219a-1', 'chr6', '+', '', '', 'Pre-miRNA'),
(1020, 'hsa-mir-134', 'chr14', '+', '', '', 'Pre-miRNA'),
(1021, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(1022, 'hsa-mir-518d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1023, 'hsa-mir-192', 'chr11', '-', '', '', 'Pre-miRNA'),
(1024, 'hsa-mir-187', 'chr18', '-', '', '', 'Pre-miRNA'),
(1025, 'hsa-mir-643', 'chr19', '+', '', '', 'Pre-miRNA'),
(1026, 'hsa-mir-518b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1027, 'hsa-mir-885', 'chr3', '-', '', '', 'Pre-miRNA'),
(1028, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1029, 'hsa-mir-539', 'chr14', '+', '', '', 'Pre-miRNA'),
(1030, 'hsa-mir-548w', 'chr16', '+', '', '', 'Pre-miRNA'),
(1031, 'hsa-mir-30d', 'chr8', '-', '', '', 'Pre-miRNA'),
(1032, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1033, 'hsa-mir-604', 'chr10', '-', '', '', 'Pre-miRNA'),
(1034, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1035, 'hsa-mir-650', 'chr22', '+', '', '', 'Pre-miRNA'),
(1036, 'hsa-mir-3682', 'chr2', '-', '', '', 'Pre-miRNA'),
(1037, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(1038, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1039, 'hsa-mir-1-1', 'chr20', '+', '', '', 'Pre-miRNA'),
(1040, 'hsa-mir-619', 'chr12', '-', '', '', 'Pre-miRNA'),
(1041, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1042, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1043, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1044, 'hsa-mir-563', 'chr3', '+', '', '', 'Pre-miRNA'),
(1045, 'hsa-mir-323b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1046, 'hsa-mir-4634', 'chr5', '+', '', '', 'Pre-miRNA'),
(1047, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1048, 'hsa-mir-99b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1049, 'hsa-mir-1290', 'chr1', '-', '', '', 'Pre-miRNA'),
(1050, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1051, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1052, 'hsa-mir-523', 'chr19', '+', '', '', 'Pre-miRNA'),
(1053, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1054, 'hsa-mir-124-1', 'chr8', '-', '', '', 'Pre-miRNA'),
(1055, 'hsa-mir-376a-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1056, 'hsa-mir-516a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1057, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1058, 'hsa-mir-192', 'chr11', '-', '', '', 'Pre-miRNA'),
(1059, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1060, 'hsa-mir-4740', 'chr17', '-', '', '', 'Pre-miRNA'),
(1061, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(1062, 'hsa-mir-337', 'chr14', '+', '', '', 'Pre-miRNA'),
(1063, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1064, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1065, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(1066, 'hsa-mir-526a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1067, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1068, 'hsa-mir-760', 'chr1', '+', '', '', 'Pre-miRNA'),
(1069, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1070, 'hsa-mir-596', 'chr8', '+', '', '', 'Pre-miRNA'),
(1071, 'hsa-mir-299', 'chr14', '+', '', '', 'Pre-miRNA'),
(1072, 'hsa-mir-199b', 'chr9', '-', '', '', 'Pre-miRNA'),
(1073, 'hsa-mir-548h-4', 'chr8', '-', '', '', 'Pre-miRNA'),
(1074, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1075, 'hsa-mir-143', 'chr5', '+', '', '', 'Pre-miRNA'),
(1076, 'hsa-mir-4440', 'chr2', '-', '', '', 'Pre-miRNA'),
(1077, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1078, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(1079, 'hsa-mir-585', 'chr5', '-', '', '', 'Pre-miRNA'),
(1080, 'hsa-mir-4458', 'chr5', '+', '', '', 'Pre-miRNA'),
(1081, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(1082, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1083, 'hsa-mir-6165', 'chr17', '+', '', '', 'Pre-miRNA'),
(1084, 'hsa-mir-873', 'chr9', '-', '', '', 'Pre-miRNA'),
(1085, 'hsa-mir-487a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1086, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(1087, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1088, 'hsa-mir-3178', 'chr16', '-', '', '', 'Pre-miRNA'),
(1089, 'hsa-mir-1244-3', 'chr12', '-', '', '', 'Pre-miRNA'),
(1090, 'hsa-mir-137', 'chr1', '-', '', '', 'Pre-miRNA'),
(1091, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1092, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1093, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(1094, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1095, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1096, 'hsa-mir-4738', 'chr17', '-', '', '', 'Pre-miRNA'),
(1097, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(1098, 'hsa-mir-4447', 'chr3', '-', '', '', 'Pre-miRNA'),
(1099, 'hsa-mir-526a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1100, 'hsa-mir-548g', 'chr4', '-', '', '', 'Pre-miRNA'),
(1101, 'hsa-mir-1253', 'chr17', '-', '', '', 'Pre-miRNA'),
(1102, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1103, 'hsa-mir-942', 'chr1', '+', '', '', 'Pre-miRNA'),
(1104, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(1105, 'hsa-mir-6757', 'chr12', '+', '', '', 'Pre-miRNA'),
(1106, 'hsa-mir-199b', 'chr9', '-', '', '', 'Pre-miRNA'),
(1107, 'hsa-mir-208a', 'chr14', '-', '', '', 'Pre-miRNA'),
(1108, 'hsa-mir-1289-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1109, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1110, 'hsa-mir-133a-1', 'chr18', '-', '', '', 'Pre-miRNA'),
(1111, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(1112, 'hsa-mir-4458', 'chr5', '+', '', '', 'Pre-miRNA'),
(1113, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1114, 'hsa-mir-122', 'chr18', '+', '', '', 'Pre-miRNA'),
(1115, 'hsa-mir-3591', 'chr18', '-', '', '', 'Pre-miRNA'),
(1116, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1117, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1118, 'hsa-mir-8068', 'chr11', '-', '', '', 'Pre-miRNA'),
(1119, 'hsa-mir-4432', 'chr2', '-', '', '', 'Pre-miRNA'),
(1120, 'hsa-mir-548ae-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1121, 'hsa-mir-1244-3', 'chr12', '-', '', '', 'Pre-miRNA'),
(1122, 'hsa-mir-548az', 'chr8', '+', '', '', 'Pre-miRNA'),
(1123, 'hsa-mir-619', 'chr12', '-', '', '', 'Pre-miRNA'),
(1124, 'hsa-mir-5591', 'chr4', '+', '', '', 'Pre-miRNA'),
(1125, 'hsa-mir-6510', 'chr17', '-', '', '', 'Pre-miRNA'),
(1126, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(1127, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1128, 'hsa-mir-3147', 'chr7', '+', '', '', 'Pre-miRNA'),
(1129, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(1130, 'hsa-mir-650', 'chr22', '+', '', '', 'Pre-miRNA'),
(1131, 'hsa-let-7c', 'chr21', '+', '', '', 'Pre-miRNA'),
(1132, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1133, 'hsa-mir-4472-1', 'chr8', '+', '', '', 'Pre-miRNA'),
(1134, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1135, 'hsa-mir-4520-1', 'chr17', '-', '', '', 'Pre-miRNA'),
(1136, 'hsa-mir-4520-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(1137, 'hsa-mir-4437', 'chr2', '-', '', '', 'Pre-miRNA'),
(1138, 'hsa-let-7f-1', 'chr9', '+', '', '', 'Pre-miRNA'),
(1139, 'hsa-mir-6890', 'chr3', '-', '', '', 'Pre-miRNA'),
(1140, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(1141, 'hsa-mir-6863', 'chr16', '+', '', '', 'Pre-miRNA'),
(1142, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1143, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1144, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1145, 'hsa-mir-19a', 'chr13', '+', '', '', 'Pre-miRNA'),
(1146, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1147, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1148, 'hsa-mir-3151', 'chr8', '+', '', '', 'Pre-miRNA'),
(1149, 'hsa-mir-8066', 'chr4', '-', '', '', 'Pre-miRNA'),
(1150, 'hsa-mir-216a', 'chr2', '-', '', '', 'Pre-miRNA'),
(1151, 'hsa-mir-128-1', 'chr2', '+', '', '', 'Pre-miRNA'),
(1152, 'hsa-mir-1303', 'chr5', '+', '', '', 'Pre-miRNA'),
(1153, 'hsa-mir-1289-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1154, 'hsa-mir-570', 'chr3', '+', '', '', 'Pre-miRNA'),
(1155, 'hsa-mir-6811', 'chr2', '+', '', '', 'Pre-miRNA'),
(1156, 'hsa-mir-3675', 'chr1', '-', '', '', 'Pre-miRNA'),
(1157, 'hsa-mir-620', 'chr12', '-', '', '', 'Pre-miRNA'),
(1158, 'hsa-mir-548h-3', 'chr17', '-', '', '', 'Pre-miRNA'),
(1159, 'hsa-mir-1302-8', 'chr9', '-', '', '', 'Pre-miRNA'),
(1160, 'hsa-mir-629', 'chr15', '-', '', '', 'Pre-miRNA'),
(1161, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(1162, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(1163, 'hsa-mir-320a', 'chr8', '-', '', '', 'Pre-miRNA'),
(1164, 'hsa-mir-873', 'chr9', '-', '', '', 'Pre-miRNA'),
(1165, 'hsa-mir-3650', 'chr5', '-', '', '', 'Pre-miRNA'),
(1166, 'hsa-mir-378c', 'chr10', '-', '', '', 'Pre-miRNA'),
(1167, 'hsa-mir-301a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1168, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1169, 'hsa-mir-548d-1', 'chr8', '-', '', '', 'Pre-miRNA'),
(1170, 'hsa-mir-548aa-1', 'chr8', '+', '', '', 'Pre-miRNA'),
(1171, 'hsa-mir-5691', 'chr11', '-', '', '', 'Pre-miRNA'),
(1172, 'hsa-mir-181a-2', 'chr9', '+', '', '', 'Pre-miRNA'),
(1173, 'hsa-mir-758', 'chr14', '+', '', '', 'Pre-miRNA'),
(1174, 'hsa-mir-588', 'chr6', '+', '', '', 'Pre-miRNA'),
(1175, 'hsa-mir-4305', 'chr13', '-', '', '', 'Pre-miRNA'),
(1176, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1177, 'hsa-mir-1908', 'chr11', '-', '', '', 'Pre-miRNA'),
(1178, 'hsa-mir-1322', 'chr8', '-', '', '', 'Pre-miRNA'),
(1179, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1180, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(1181, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1182, 'hsa-mir-3940', 'chr19', '-', '', '', 'Pre-miRNA'),
(1183, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(1184, 'hsa-mir-619', 'chr12', '-', '', '', 'Pre-miRNA'),
(1185, 'hsa-mir-1-1', 'chr20', '+', '', '', 'Pre-miRNA'),
(1186, 'hsa-mir-876', 'chr9', '-', '', '', 'Pre-miRNA'),
(1187, 'hsa-mir-921', 'chr1', '-', '', '', 'Pre-miRNA'),
(1188, 'hsa-mir-24-2', 'chr19', '-', '', '', 'Pre-miRNA'),
(1189, 'hsa-mir-301a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1190, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1191, 'hsa-mir-653', 'chr7', '-', '', '', 'Pre-miRNA'),
(1192, 'hsa-mir-519a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1193, 'hsa-mir-548f-1', 'chr10', '-', '', '', 'Pre-miRNA'),
(1194, 'hsa-mir-20a', 'chr13', '+', '', '', 'Pre-miRNA'),
(1195, 'hsa-mir-922', 'chr3', '-', '', '', 'Pre-miRNA'),
(1196, 'hsa-mir-548a-1', 'chr6', '+', '', '', 'Pre-miRNA'),
(1197, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1198, 'hsa-mir-16-1', 'chr13', '-', '', '', 'Pre-miRNA'),
(1199, 'hsa-mir-4533', 'chr20', '+', '', '', 'Pre-miRNA'),
(1200, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1201, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(1202, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1203, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1204, 'hsa-mir-148a', 'chr7', '-', '', '', 'Pre-miRNA'),
(1205, 'hsa-mir-155', 'chr21', '+', '', '', 'Pre-miRNA'),
(1206, 'hsa-mir-6723', 'chr1', '-', '', '', 'Pre-miRNA'),
(1207, 'hsa-mir-1203', 'chr17', '-', '', '', 'Pre-miRNA'),
(1208, 'hsa-mir-941-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(1209, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(1210, 'hsa-mir-7515', 'chr2', '+', '', '', 'Pre-miRNA'),
(1211, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(1212, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1213, 'hsa-mir-1295a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1214, 'hsa-mir-1295b', 'chr1', '+', '', '', 'Pre-miRNA'),
(1215, 'hsa-mir-567', 'chr3', '+', '', '', 'Pre-miRNA'),
(1216, 'hsa-mir-541', 'chr14', '+', '', '', 'Pre-miRNA'),
(1217, 'hsa-mir-1302-7', 'chr8', '-', '', '', 'Pre-miRNA'),
(1218, 'hsa-mir-920', 'chr12', '+', '', '', 'Pre-miRNA'),
(1219, 'hsa-mir-135a-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1220, 'hsa-mir-185', 'chr22', '+', '', '', 'Pre-miRNA'),
(1221, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1222, 'hsa-mir-21', 'chr17', '+', '', '', 'Pre-miRNA'),
(1223, 'hsa-mir-1289-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1224, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1225, 'hsa-mir-4537', 'chr14', '-', '', '', 'Pre-miRNA'),
(1226, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1227, 'hsa-mir-34a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1228, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1229, 'hsa-mir-6844', 'chr8', '-', '', '', 'Pre-miRNA'),
(1230, 'hsa-mir-548w', 'chr16', '+', '', '', 'Pre-miRNA'),
(1231, 'hsa-mir-520c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1232, 'hsa-mir-4434', 'chr2', '+', '', '', 'Pre-miRNA'),
(1233, 'hsa-mir-6869', 'chr20', '-', '', '', 'Pre-miRNA'),
(1234, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1235, 'hsa-mir-1303', 'chr5', '+', '', '', 'Pre-miRNA'),
(1236, 'hsa-mir-487b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1237, 'hsa-mir-4675', 'chr10', '+', '', '', 'Pre-miRNA'),
(1238, 'hsa-mir-3689d-2', 'chr9', '-', '', '', 'Pre-miRNA'),
(1239, 'hsa-mir-335', 'chr7', '+', '', '', 'Pre-miRNA'),
(1240, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(1241, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1242, 'hsa-mir-5189', 'chr16', '+', '', '', 'Pre-miRNA'),
(1243, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1244, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1245, 'hsa-mir-6832', 'chr6', '+', '', '', 'Pre-miRNA'),
(1246, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1247, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(1248, 'hsa-mir-548ao', 'chr8', '-', '', '', 'Pre-miRNA'),
(1249, 'hsa-mir-211', 'chr15', '-', '', '', 'Pre-miRNA'),
(1250, 'hsa-mir-4423', 'chr1', '+', '', '', 'Pre-miRNA'),
(1251, 'hsa-mir-758', 'chr14', '+', '', '', 'Pre-miRNA'),
(1252, 'hsa-mir-573', 'chr4', '-', '', '', 'Pre-miRNA'),
(1253, 'hsa-mir-520e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1254, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1255, 'hsa-mir-4760', 'chr21', '-', '', '', 'Pre-miRNA'),
(1256, 'hsa-mir-518b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1257, 'hsa-mir-31', 'chr9', '-', '', '', 'Pre-miRNA'),
(1258, 'hsa-mir-633', 'chr17', '+', '', '', 'Pre-miRNA'),
(1259, 'hsa-mir-27a', 'chr19', '-', '', '', 'Pre-miRNA'),
(1260, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1261, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1262, 'hsa-mir-3683', 'chr7', '-', '', '', 'Pre-miRNA'),
(1263, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1264, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1265, 'hsa-mir-4738', 'chr17', '-', '', '', 'Pre-miRNA'),
(1266, 'hsa-mir-602', 'chr9', '+', '', '', 'Pre-miRNA'),
(1267, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1268, 'hsa-mir-4682', 'chr10', '+', '', '', 'Pre-miRNA'),
(1269, 'hsa-mir-569', 'chr3', '-', '', '', 'Pre-miRNA'),
(1270, 'hsa-mir-8081', 'chr9', '+', '', '', 'Pre-miRNA'),
(1271, 'hsa-mir-379', 'chr14', '+', '', '', 'Pre-miRNA'),
(1272, 'hsa-mir-4757', 'chr2', '+', '', '', 'Pre-miRNA'),
(1273, 'hsa-mir-1203', 'chr17', '-', '', '', 'Pre-miRNA'),
(1274, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1275, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1276, 'hsa-mir-6861', 'chr12', '-', '', '', 'Pre-miRNA'),
(1277, 'hsa-mir-342', 'chr14', '+', '', '', 'Pre-miRNA'),
(1278, 'hsa-mir-636', 'chr17', '-', '', '', 'Pre-miRNA'),
(1279, 'hsa-mir-199a-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(1280, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1281, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1282, 'hsa-mir-4305', 'chr13', '-', '', '', 'Pre-miRNA'),
(1283, 'hsa-mir-1183', 'chr7', '+', '', '', 'Pre-miRNA'),
(1284, 'hsa-mir-3921', 'chr3', '-', '', '', 'Pre-miRNA'),
(1285, 'hsa-mir-644a', 'chr20', '+', '', '', 'Pre-miRNA'),
(1286, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1287, 'hsa-mir-487b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1288, 'hsa-mir-569', 'chr3', '-', '', '', 'Pre-miRNA'),
(1289, 'hsa-mir-541', 'chr14', '+', '', '', 'Pre-miRNA'),
(1290, 'hsa-mir-548h-3', 'chr17', '-', '', '', 'Pre-miRNA'),
(1291, 'hsa-mir-100', 'chr11', '-', '', '', 'Pre-miRNA'),
(1292, 'hsa-mir-4801', 'chr4', '-', '', '', 'Pre-miRNA'),
(1293, 'hsa-mir-1275', 'chr6', '-', '', '', 'Pre-miRNA'),
(1294, 'hsa-mir-1275', 'chr6', '-', '', '', 'Pre-miRNA'),
(1295, 'hsa-mir-525', 'chr19', '+', '', '', 'Pre-miRNA'),
(1296, 'hsa-mir-1204', 'chr8', '+', '', '', 'Pre-miRNA'),
(1297, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1298, 'hsa-mir-498', 'chr19', '+', '', '', 'Pre-miRNA'),
(1299, 'hsa-mir-154', 'chr14', '+', '', '', 'Pre-miRNA'),
(1300, 'hsa-mir-520c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1301, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(1302, 'hsa-mir-518d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1303, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1304, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(1305, 'hsa-mir-665', 'chr14', '+', '', '', 'Pre-miRNA'),
(1306, 'hsa-mir-519e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1307, 'hsa-mir-146a', 'chr5', '+', '', '', 'Pre-miRNA'),
(1308, 'hsa-mir-125a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1309, 'hsa-mir-644a', 'chr20', '+', '', '', 'Pre-miRNA'),
(1310, 'hsa-mir-329-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1311, 'hsa-mir-4755', 'chr20', '+', '', '', 'Pre-miRNA'),
(1312, 'hsa-mir-1291', 'chr12', '-', '', '', 'Pre-miRNA'),
(1313, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1314, 'hsa-mir-211', 'chr15', '-', '', '', 'Pre-miRNA'),
(1315, 'hsa-mir-518c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1316, 'hsa-mir-3181', 'chr16', '+', '', '', 'Pre-miRNA'),
(1317, 'hsa-mir-376a-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1318, 'hsa-mir-642a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1319, 'hsa-mir-642b', 'chr19', '-', '', '', 'Pre-miRNA'),
(1320, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(1321, 'hsa-mir-4256', 'chr1', '-', '', '', 'Pre-miRNA'),
(1322, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(1323, 'hsa-mir-378c', 'chr10', '-', '', '', 'Pre-miRNA'),
(1324, 'hsa-mir-1203', 'chr17', '-', '', '', 'Pre-miRNA'),
(1325, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1326, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1327, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1328, 'hsa-mir-548n', 'chr7', '-', '', '', 'Pre-miRNA'),
(1329, 'hsa-mir-31', 'chr9', '-', '', '', 'Pre-miRNA'),
(1330, 'hsa-mir-526a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1331, 'hsa-mir-215', 'chr1', '-', '', '', 'Pre-miRNA'),
(1332, 'hsa-mir-6832', 'chr6', '+', '', '', 'Pre-miRNA'),
(1333, 'hsa-mir-153-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(1334, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1335, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(1336, 'hsa-mir-1251', 'chr12', '+', '', '', 'Pre-miRNA'),
(1337, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1338, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1339, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(1340, 'hsa-mir-519b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1341, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1342, 'hsa-mir-449b', 'chr5', '-', '', '', 'Pre-miRNA'),
(1343, 'hsa-mir-153-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(1344, 'hsa-mir-196a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(1345, 'hsa-mir-4740', 'chr17', '-', '', '', 'Pre-miRNA'),
(1346, 'hsa-mir-3188', 'chr19', '+', '', '', 'Pre-miRNA'),
(1347, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(1348, 'hsa-mir-181a-2', 'chr9', '+', '', '', 'Pre-miRNA'),
(1349, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1350, 'hsa-mir-4282', 'chr6', '-', '', '', 'Pre-miRNA'),
(1351, 'hsa-mir-3196', 'chr20', '+', '', '', 'Pre-miRNA'),
(1352, 'hsa-mir-1238', 'chr19', '+', '', '', 'Pre-miRNA'),
(1353, 'hsa-mir-135a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(1354, 'hsa-mir-378e', 'chr5', '+', '', '', 'Pre-miRNA'),
(1355, 'hsa-mir-7161', 'chr6', '+', '', '', 'Pre-miRNA'),
(1356, 'hsa-mir-181d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1357, 'hsa-mir-484', 'chr16', '+', '', '', 'Pre-miRNA'),
(1358, 'hsa-mir-887', 'chr5', '+', '', '', 'Pre-miRNA'),
(1359, 'hsa-mir-6838', 'chr7', '-', '', '', 'Pre-miRNA'),
(1360, 'hsa-mir-4465', 'chr6', '+', '', '', 'Pre-miRNA'),
(1361, 'hsa-mir-3914-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1362, 'hsa-mir-3914-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(1363, 'hsa-mir-217', 'chr2', '-', '', '', 'Pre-miRNA'),
(1364, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1365, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1366, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(1367, 'hsa-mir-635', 'chr17', '-', '', '', 'Pre-miRNA'),
(1368, 'hsa-mir-16-1', 'chr13', '-', '', '', 'Pre-miRNA'),
(1369, 'hsa-mir-630', 'chr15', '+', '', '', 'Pre-miRNA'),
(1370, 'hsa-mir-181b-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(1371, 'hsa-mir-582', 'chr5', '-', '', '', 'Pre-miRNA'),
(1372, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(1373, 'hsa-mir-4312', 'chr15', '-', '', '', 'Pre-miRNA'),
(1374, 'hsa-mir-631', 'chr15', '-', '', '', 'Pre-miRNA'),
(1375, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1376, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1377, 'hsa-mir-520d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1378, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(1379, 'hsa-mir-591', 'chr7', '-', '', '', 'Pre-miRNA'),
(1380, 'hsa-mir-4519', 'chr16', '-', '', '', 'Pre-miRNA'),
(1381, 'hsa-mir-449b', 'chr5', '-', '', '', 'Pre-miRNA'),
(1382, 'hsa-mir-769', 'chr19', '+', '', '', 'Pre-miRNA'),
(1383, 'hsa-mir-3163', 'chr11', '-', '', '', 'Pre-miRNA'),
(1384, 'hsa-mir-1185-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1385, 'hsa-mir-1302-6', 'chr7', '-', '', '', 'Pre-miRNA'),
(1386, 'hsa-mir-379', 'chr14', '+', '', '', 'Pre-miRNA'),
(1387, 'hsa-mir-520f', 'chr19', '+', '', '', 'Pre-miRNA'),
(1388, 'hsa-mir-25', 'chr7', '-', '', '', 'Pre-miRNA'),
(1389, 'hsa-mir-4307', 'chr14', '+', '', '', 'Pre-miRNA'),
(1390, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(1391, 'hsa-mir-544a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1392, 'hsa-mir-323b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1393, 'hsa-mir-296', 'chr20', '-', '', '', 'Pre-miRNA'),
(1394, 'hsa-mir-1207', 'chr8', '+', '', '', 'Pre-miRNA'),
(1395, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1396, 'hsa-mir-429', 'chr1', '+', '', '', 'Pre-miRNA'),
(1397, 'hsa-mir-554', 'chr1', '+', '', '', 'Pre-miRNA'),
(1398, 'hsa-mir-590', 'chr7', '+', '', '', 'Pre-miRNA'),
(1399, 'hsa-mir-4282', 'chr6', '-', '', '', 'Pre-miRNA'),
(1400, 'hsa-mir-1238', 'chr19', '+', '', '', 'Pre-miRNA'),
(1401, 'hsa-mir-1185-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1402, 'hsa-mir-8061', 'chr19', '+', '', '', 'Pre-miRNA'),
(1403, 'hsa-mir-644a', 'chr20', '+', '', '', 'Pre-miRNA'),
(1404, 'hsa-mir-185', 'chr22', '+', '', '', 'Pre-miRNA'),
(1405, 'hsa-mir-3682', 'chr2', '-', '', '', 'Pre-miRNA'),
(1406, 'hsa-mir-603', 'chr10', '+', '', '', 'Pre-miRNA'),
(1407, 'hsa-mir-342', 'chr14', '+', '', '', 'Pre-miRNA'),
(1408, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(1409, 'hsa-mir-548x-2', 'chr13', '-', '', '', 'Pre-miRNA'),
(1410, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(1411, 'hsa-let-7a-3', 'chr22', '+', '', '', 'Pre-miRNA'),
(1412, 'hsa-mir-548p', 'chr5', '-', '', '', 'Pre-miRNA'),
(1413, 'hsa-mir-1233-1', 'chr15', '-', '', '', 'Pre-miRNA'),
(1414, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(1415, 'hsa-mir-512-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1416, 'hsa-mir-208a', 'chr14', '-', '', '', 'Pre-miRNA'),
(1417, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(1418, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(1419, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(1420, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1421, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA');
INSERT INTO `region` (`id`, `miRNA-name`, `chr_number`, `strand`, `allele`, `Sequence`, `Region`) VALUES
(1422, 'hsa-mir-4252', 'chr1', '-', '', '', 'Pre-miRNA'),
(1423, 'hsa-mir-520c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1424, 'hsa-mir-588', 'chr6', '+', '', '', 'Pre-miRNA'),
(1425, 'hsa-mir-4697', 'chr11', '-', '', '', 'Pre-miRNA'),
(1426, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1427, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(1428, 'hsa-mir-30c-1', 'chr1', '+', '', '', 'Pre-miRNA'),
(1429, 'hsa-mir-873', 'chr9', '-', '', '', 'Pre-miRNA'),
(1430, 'hsa-mir-199a-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(1431, 'hsa-mir-4745', 'chr19', '+', '', '', 'Pre-miRNA'),
(1432, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(1433, 'hsa-mir-1305', 'chr4', '+', '', '', 'Pre-miRNA'),
(1434, 'hsa-mir-26b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1435, 'hsa-mir-1910', 'chr16', '-', '', '', 'Pre-miRNA'),
(1436, 'hsa-mir-16-1', 'chr13', '-', '', '', 'Pre-miRNA'),
(1437, 'hsa-mir-93', 'chr7', '-', '', '', 'Pre-miRNA'),
(1438, 'hsa-mir-3145', 'chr6', '-', '', '', 'Pre-miRNA'),
(1439, 'hsa-mir-328', 'chr16', '-', '', '', 'Pre-miRNA'),
(1440, 'hsa-mir-1284', 'chr3', '-', '', '', 'Pre-miRNA'),
(1441, 'hsa-mir-3652', 'chr12', '+', '', '', 'Pre-miRNA'),
(1442, 'hsa-mir-148a', 'chr7', '-', '', '', 'Pre-miRNA'),
(1443, 'hsa-mir-1243', 'chr4', '+', '', '', 'Pre-miRNA'),
(1444, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1445, 'hsa-mir-515-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1446, 'hsa-mir-496', 'chr14', '+', '', '', 'Pre-miRNA'),
(1447, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1448, 'hsa-mir-335', 'chr7', '+', '', '', 'Pre-miRNA'),
(1449, 'hsa-mir-519b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1450, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1451, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1452, 'hsa-mir-4797', 'chr3', '-', '', '', 'Pre-miRNA'),
(1453, 'hsa-mir-612', 'chr11', '+', '', '', 'Pre-miRNA'),
(1454, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(1455, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1456, 'hsa-mir-27b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1457, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1458, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1459, 'hsa-mir-758', 'chr14', '+', '', '', 'Pre-miRNA'),
(1460, 'hsa-mir-6871', 'chr20', '+', '', '', 'Pre-miRNA'),
(1461, 'hsa-mir-668', 'chr14', '+', '', '', 'Pre-miRNA'),
(1462, 'hsa-mir-598', 'chr8', '-', '', '', 'Pre-miRNA'),
(1463, 'hsa-mir-4675', 'chr10', '+', '', '', 'Pre-miRNA'),
(1464, 'hsa-mir-200a', 'chr1', '+', '', '', 'Pre-miRNA'),
(1465, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1466, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(1467, 'hsa-mir-563', 'chr3', '+', '', '', 'Pre-miRNA'),
(1468, 'hsa-mir-1257', 'chr20', '-', '', '', 'Pre-miRNA'),
(1469, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1470, 'hsa-mir-620', 'chr12', '-', '', '', 'Pre-miRNA'),
(1471, 'hsa-mir-138-2', 'chr16', '+', '', '', 'Pre-miRNA'),
(1472, 'hsa-mir-1246', 'chr2', '-', '', '', 'Pre-miRNA'),
(1473, 'hsa-mir-320a', 'chr8', '-', '', '', 'Pre-miRNA'),
(1474, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1475, 'hsa-mir-567', 'chr3', '+', '', '', 'Pre-miRNA'),
(1476, 'hsa-mir-449b', 'chr5', '-', '', '', 'Pre-miRNA'),
(1477, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(1478, 'hsa-mir-575', 'chr4', '-', '', '', 'Pre-miRNA'),
(1479, 'hsa-mir-491', 'chr9', '+', '', '', 'Pre-miRNA'),
(1480, 'hsa-mir-612', 'chr11', '+', '', '', 'Pre-miRNA'),
(1481, 'hsa-mir-637', 'chr19', '-', '', '', 'Pre-miRNA'),
(1482, 'hsa-mir-4755', 'chr20', '+', '', '', 'Pre-miRNA'),
(1483, 'hsa-mir-206', 'chr6', '+', '', '', 'Pre-miRNA'),
(1484, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1485, 'hsa-mir-320b-1', 'chr1', '+', '', '', 'Pre-miRNA'),
(1486, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1487, 'hsa-mir-217', 'chr2', '-', '', '', 'Pre-miRNA'),
(1488, 'hsa-mir-648', 'chr22', '-', '', '', 'Pre-miRNA'),
(1489, 'hsa-mir-4454', 'chr4', '-', '', '', 'Pre-miRNA'),
(1490, 'hsa-mir-1185-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1491, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1492, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1493, 'hsa-mir-604', 'chr10', '-', '', '', 'Pre-miRNA'),
(1494, 'hsa-mir-206', 'chr6', '+', '', '', 'Pre-miRNA'),
(1495, 'hsa-mir-135b', 'chr1', '-', '', '', 'Pre-miRNA'),
(1496, 'hsa-mir-604', 'chr10', '-', '', '', 'Pre-miRNA'),
(1497, 'hsa-mir-664a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1498, 'hsa-mir-497', 'chr17', '-', '', '', 'Pre-miRNA'),
(1499, 'hsa-mir-1284', 'chr3', '-', '', '', 'Pre-miRNA'),
(1500, 'hsa-mir-544a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1501, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(1502, 'hsa-mir-4804', 'chr5', '+', '', '', 'Pre-miRNA'),
(1503, 'hsa-mir-4487', 'chr11', '+', '', '', 'Pre-miRNA'),
(1504, 'hsa-mir-8062', 'chr20', '+', '', '', 'Pre-miRNA'),
(1505, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1506, 'hsa-mir-605', 'chr10', '+', '', '', 'Pre-miRNA'),
(1507, 'hsa-mir-549a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1508, 'hsa-mir-30e', 'chr1', '+', '', '', 'Pre-miRNA'),
(1509, 'hsa-mir-6723', 'chr1', '-', '', '', 'Pre-miRNA'),
(1510, 'hsa-mir-5196', 'chr19', '+', '', '', 'Pre-miRNA'),
(1511, 'hsa-mir-148b', 'chr12', '+', '', '', 'Pre-miRNA'),
(1512, 'hsa-mir-7-3', 'chr19', '+', '', '', 'Pre-miRNA'),
(1513, 'hsa-mir-2113', 'chr6', '+', '', '', 'Pre-miRNA'),
(1514, 'hsa-mir-630', 'chr15', '+', '', '', 'Pre-miRNA'),
(1515, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1516, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1517, 'hsa-mir-1272', 'chr15', '-', '', '', 'Pre-miRNA'),
(1518, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1519, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1520, 'hsa-mir-7852', 'chr1', '+', '', '', 'Pre-miRNA'),
(1521, 'hsa-mir-3118-4', 'chr15', '+', '', '', 'Pre-miRNA'),
(1522, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(1523, 'hsa-mir-656', 'chr14', '+', '', '', 'Pre-miRNA'),
(1524, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(1525, 'hsa-mir-548f-2', 'chr2', '-', '', '', 'Pre-miRNA'),
(1526, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(1527, 'hsa-mir-1290', 'chr1', '-', '', '', 'Pre-miRNA'),
(1528, 'hsa-mir-199b', 'chr9', '-', '', '', 'Pre-miRNA'),
(1529, 'hsa-mir-135a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(1530, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(1531, 'hsa-mir-6830', 'chr5', '-', '', '', 'Pre-miRNA'),
(1532, 'hsa-mir-527', 'chr19', '+', '', '', 'Pre-miRNA'),
(1533, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1534, 'hsa-mir-484', 'chr16', '+', '', '', 'Pre-miRNA'),
(1535, 'hsa-mir-3940', 'chr19', '-', '', '', 'Pre-miRNA'),
(1536, 'hsa-mir-646', 'chr20', '+', '', '', 'Pre-miRNA'),
(1537, 'hsa-mir-8082', 'chr4', '+', '', '', 'Pre-miRNA'),
(1538, 'hsa-mir-1-2', 'chr18', '-', '', '', 'Pre-miRNA'),
(1539, 'hsa-mir-548h-4', 'chr8', '-', '', '', 'Pre-miRNA'),
(1540, 'hsa-mir-4283-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1541, 'hsa-mir-216b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1542, 'hsa-mir-153-1', 'chr2', '-', '', '', 'Pre-miRNA'),
(1543, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(1544, 'hsa-mir-4438', 'chr2', '+', '', '', 'Pre-miRNA'),
(1545, 'hsa-mir-567', 'chr3', '+', '', '', 'Pre-miRNA'),
(1546, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(1547, 'hsa-mir-8084', 'chr8', '+', '', '', 'Pre-miRNA'),
(1548, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1549, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(1550, 'hsa-mir-548j', 'chr22', '-', '', '', 'Pre-miRNA'),
(1551, 'hsa-mir-632', 'chr17', '+', '', '', 'Pre-miRNA'),
(1552, 'hsa-mir-1183', 'chr7', '+', '', '', 'Pre-miRNA'),
(1553, 'hsa-mir-217', 'chr2', '-', '', '', 'Pre-miRNA'),
(1554, 'hsa-mir-601', 'chr9', '-', '', '', 'Pre-miRNA'),
(1555, 'hsa-mir-4745', 'chr19', '+', '', '', 'Pre-miRNA'),
(1556, 'hsa-mir-4303', 'chr12', '-', '', '', 'Pre-miRNA'),
(1557, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1558, 'hsa-mir-649', 'chr22', '-', '', '', 'Pre-miRNA'),
(1559, 'hsa-mir-1-2', 'chr18', '-', '', '', 'Pre-miRNA'),
(1560, 'hsa-mir-1302-5', 'chr20', '-', '', '', 'Pre-miRNA'),
(1561, 'hsa-mir-4729', 'chr17', '+', '', '', 'Pre-miRNA'),
(1562, 'hsa-mir-937', 'chr8', '-', '', '', 'Pre-miRNA'),
(1563, 'hsa-mir-101-2', 'chr9', '+', '', '', 'Pre-miRNA'),
(1564, 'hsa-mir-1262', 'chr1', '-', '', '', 'Pre-miRNA'),
(1565, 'hsa-mir-193b', 'chr16', '+', '', '', 'Pre-miRNA'),
(1566, 'hsa-mir-6811', 'chr2', '+', '', '', 'Pre-miRNA'),
(1567, 'hsa-mir-8074', 'chr19', '-', '', '', 'Pre-miRNA'),
(1568, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1569, 'hsa-mir-588', 'chr6', '+', '', '', 'Pre-miRNA'),
(1570, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(1571, 'hsa-mir-2113', 'chr6', '+', '', '', 'Pre-miRNA'),
(1572, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(1573, 'hsa-mir-3198-2', 'chr12', '-', '', '', 'Pre-miRNA'),
(1574, 'hsa-mir-2110', 'chr10', '-', '', '', 'Pre-miRNA'),
(1575, 'hsa-mir-4280', 'chr5', '-', '', '', 'Pre-miRNA'),
(1576, 'hsa-mir-1305', 'chr4', '+', '', '', 'Pre-miRNA'),
(1577, 'hsa-mir-218-1', 'chr4', '+', '', '', 'Pre-miRNA'),
(1578, 'hsa-mir-516b-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1579, 'hsa-mir-581', 'chr5', '-', '', '', 'Pre-miRNA'),
(1580, 'hsa-mir-1178', 'chr12', '-', '', '', 'Pre-miRNA'),
(1581, 'hsa-mir-647', 'chr20', '-', '', '', 'Pre-miRNA'),
(1582, 'hsa-mir-3940', 'chr19', '-', '', '', 'Pre-miRNA'),
(1583, 'hsa-mir-99a', 'chr21', '+', '', '', 'Pre-miRNA'),
(1584, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1585, 'hsa-mir-1275', 'chr6', '-', '', '', 'Pre-miRNA'),
(1586, 'hsa-mir-518a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1587, 'hsa-mir-624', 'chr14', '-', '', '', 'Pre-miRNA'),
(1588, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1589, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(1590, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1591, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1592, 'hsa-mir-335', 'chr7', '+', '', '', 'Pre-miRNA'),
(1593, 'hsa-mir-181d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1594, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1595, 'hsa-mir-376a-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1596, 'hsa-mir-410', 'chr14', '+', '', '', 'Pre-miRNA'),
(1597, 'hsa-mir-3924', 'chr10', '-', '', '', 'Pre-miRNA'),
(1598, 'hsa-mir-516a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1599, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1600, 'hsa-mir-7846', 'chr1', '+', '', '', 'Pre-miRNA'),
(1601, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1602, 'hsa-mir-181a-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(1603, 'hsa-mir-4740', 'chr17', '-', '', '', 'Pre-miRNA'),
(1604, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(1605, 'hsa-mir-887', 'chr5', '+', '', '', 'Pre-miRNA'),
(1606, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1607, 'hsa-mir-744', 'chr17', '+', '', '', 'Pre-miRNA'),
(1608, 'hsa-mir-1246', 'chr2', '-', '', '', 'Pre-miRNA'),
(1609, 'hsa-mir-1295a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1610, 'hsa-mir-1295b', 'chr1', '+', '', '', 'Pre-miRNA'),
(1611, 'hsa-mir-30d', 'chr8', '-', '', '', 'Pre-miRNA'),
(1612, 'hsa-mir-584', 'chr5', '-', '', '', 'Pre-miRNA'),
(1613, 'hsa-mir-301a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1614, 'hsa-mir-140', 'chr16', '+', '', '', 'Pre-miRNA'),
(1615, 'hsa-mir-569', 'chr3', '-', '', '', 'Pre-miRNA'),
(1616, 'hsa-mir-571', 'chr4', '+', '', '', 'Pre-miRNA'),
(1617, 'hsa-mir-454', 'chr17', '-', '', '', 'Pre-miRNA'),
(1618, 'hsa-mir-632', 'chr17', '+', '', '', 'Pre-miRNA'),
(1619, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1620, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1621, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(1622, 'hsa-mir-1302-6', 'chr7', '-', '', '', 'Pre-miRNA'),
(1623, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(1624, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1625, 'hsa-mir-320e', 'chr19', '-', '', '', 'Pre-miRNA'),
(1626, 'hsa-mir-670', 'chr11', '+', '', '', 'Pre-miRNA'),
(1627, 'hsa-mir-323b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1628, 'hsa-mir-626', 'chr15', '+', '', '', 'Pre-miRNA'),
(1629, 'hsa-mir-4520-1', 'chr17', '-', '', '', 'Pre-miRNA'),
(1630, 'hsa-mir-4520-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(1631, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1632, 'hsa-mir-195', 'chr17', '-', '', '', 'Pre-miRNA'),
(1633, 'hsa-mir-3171', 'chr14', '-', '', '', 'Pre-miRNA'),
(1634, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(1635, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1636, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1637, 'hsa-mir-1291', 'chr12', '-', '', '', 'Pre-miRNA'),
(1638, 'hsa-mir-1238', 'chr19', '+', '', '', 'Pre-miRNA'),
(1639, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1640, 'hsa-mir-132', 'chr17', '-', '', '', 'Pre-miRNA'),
(1641, 'hsa-mir-527', 'chr19', '+', '', '', 'Pre-miRNA'),
(1642, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(1643, 'hsa-mir-329-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1644, 'hsa-mir-1913', 'chr6', '-', '', '', 'Pre-miRNA'),
(1645, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1646, 'hsa-mir-3683', 'chr7', '-', '', '', 'Pre-miRNA'),
(1647, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1648, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1649, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1650, 'hsa-mir-147a', 'chr9', '-', '', '', 'Pre-miRNA'),
(1651, 'hsa-mir-1231', 'chr1', '+', '', '', 'Pre-miRNA'),
(1652, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(1653, 'hsa-mir-567', 'chr3', '+', '', '', 'Pre-miRNA'),
(1654, 'hsa-mir-1253', 'chr17', '-', '', '', 'Pre-miRNA'),
(1655, 'hsa-mir-3682', 'chr2', '-', '', '', 'Pre-miRNA'),
(1656, 'hsa-mir-646', 'chr20', '+', '', '', 'Pre-miRNA'),
(1657, 'hsa-mir-499a', 'chr20', '+', '', '', 'Pre-miRNA'),
(1658, 'hsa-mir-499b', 'chr20', '-', '', '', 'Pre-miRNA'),
(1659, 'hsa-mir-938', 'chr10', '-', '', '', 'Pre-miRNA'),
(1660, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1661, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1662, 'hsa-mir-3151', 'chr8', '+', '', '', 'Pre-miRNA'),
(1663, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1664, 'hsa-mir-522', 'chr19', '+', '', '', 'Pre-miRNA'),
(1665, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1666, 'hsa-mir-941-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(1667, 'hsa-mir-941-3', 'chr20', '+', '', '', 'Pre-miRNA'),
(1668, 'hsa-mir-383', 'chr8', '-', '', '', 'Pre-miRNA'),
(1669, 'hsa-mir-422a', 'chr15', '-', '', '', 'Pre-miRNA'),
(1670, 'hsa-mir-4636', 'chr5', '-', '', '', 'Pre-miRNA'),
(1671, 'hsa-mir-633', 'chr17', '+', '', '', 'Pre-miRNA'),
(1672, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1673, 'hsa-mir-548d-2', 'chr17', '-', '', '', 'Pre-miRNA'),
(1674, 'hsa-mir-548aa-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(1675, 'hsa-mir-320c-2', 'chr18', '+', '', '', 'Pre-miRNA'),
(1676, 'hsa-mir-668', 'chr14', '+', '', '', 'Pre-miRNA'),
(1677, 'hsa-mir-494', 'chr14', '+', '', '', 'Pre-miRNA'),
(1678, 'hsa-mir-941-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(1679, 'hsa-mir-941-3', 'chr20', '+', '', '', 'Pre-miRNA'),
(1680, 'hsa-mir-4801', 'chr4', '-', '', '', 'Pre-miRNA'),
(1681, 'hsa-mir-3688-1', 'chr4', '-', '', '', 'Pre-miRNA'),
(1682, 'hsa-mir-3688-2', 'chr4', '+', '', '', 'Pre-miRNA'),
(1683, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(1684, 'hsa-mir-1289-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1685, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(1686, 'hsa-mir-558', 'chr2', '+', '', '', 'Pre-miRNA'),
(1687, 'hsa-mir-4792', 'chr3', '-', '', '', 'Pre-miRNA'),
(1688, 'hsa-mir-633', 'chr17', '+', '', '', 'Pre-miRNA'),
(1689, 'hsa-mir-1296', 'chr10', '-', '', '', 'Pre-miRNA'),
(1690, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1691, 'hsa-mir-3130-1', 'chr2', '-', '', '', 'Pre-miRNA'),
(1692, 'hsa-mir-3130-2', 'chr2', '+', '', '', 'Pre-miRNA'),
(1693, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(1694, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1695, 'hsa-mir-342', 'chr14', '+', '', '', 'Pre-miRNA'),
(1696, 'hsa-mir-548au', 'chr9', '+', '', '', 'Pre-miRNA'),
(1697, 'hsa-mir-21', 'chr17', '+', '', '', 'Pre-miRNA'),
(1698, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(1699, 'hsa-mir-217', 'chr2', '-', '', '', 'Pre-miRNA'),
(1700, 'hsa-mir-548d-2', 'chr17', '-', '', '', 'Pre-miRNA'),
(1701, 'hsa-mir-548aa-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(1702, 'hsa-mir-548h-3', 'chr17', '-', '', '', 'Pre-miRNA'),
(1703, 'hsa-mir-1193', 'chr14', '+', '', '', 'Pre-miRNA'),
(1704, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(1705, 'hsa-mir-4788', 'chr3', '+', '', '', 'Pre-miRNA'),
(1706, 'hsa-mir-1302-4', 'chr2', '-', '', '', 'Pre-miRNA'),
(1707, 'hsa-mir-3689b', 'chr9', '-', '', '', 'Pre-miRNA'),
(1708, 'hsa-mir-497', 'chr17', '-', '', '', 'Pre-miRNA'),
(1709, 'hsa-mir-2355', 'chr2', '-', '', '', 'Pre-miRNA'),
(1710, 'hsa-mir-548k', 'chr11', '+', '', '', 'Pre-miRNA'),
(1711, 'hsa-mir-23b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1712, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1713, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(1714, 'hsa-mir-124-3', 'chr20', '+', '', '', 'Pre-miRNA'),
(1715, 'hsa-mir-1272', 'chr15', '-', '', '', 'Pre-miRNA'),
(1716, 'hsa-mir-149', 'chr2', '+', '', '', 'Pre-miRNA'),
(1717, 'hsa-mir-3612', 'chr12', '+', '', '', 'Pre-miRNA'),
(1718, 'hsa-let-7a-2', 'chr11', '-', '', '', 'Pre-miRNA'),
(1719, 'hsa-mir-197', 'chr1', '+', '', '', 'Pre-miRNA'),
(1720, 'hsa-mir-1278', 'chr1', '+', '', '', 'Pre-miRNA'),
(1721, 'hsa-mir-516a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1722, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1723, 'hsa-mir-1205', 'chr8', '+', '', '', 'Pre-miRNA'),
(1724, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1725, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1726, 'hsa-mir-199b', 'chr9', '-', '', '', 'Pre-miRNA'),
(1727, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(1728, 'hsa-mir-99b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1729, 'hsa-mir-298', 'chr20', '-', '', '', 'Pre-miRNA'),
(1730, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(1731, 'hsa-mir-218-1', 'chr4', '+', '', '', 'Pre-miRNA'),
(1732, 'hsa-mir-519b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1733, 'hsa-mir-655', 'chr14', '+', '', '', 'Pre-miRNA'),
(1734, 'hsa-mir-548u', 'chr6', '+', '', '', 'Pre-miRNA'),
(1735, 'hsa-mir-518d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1736, 'hsa-mir-635', 'chr17', '-', '', '', 'Pre-miRNA'),
(1737, 'hsa-mir-1263', 'chr3', '-', '', '', 'Pre-miRNA'),
(1738, 'hsa-mir-1913', 'chr6', '-', '', '', 'Pre-miRNA'),
(1739, 'hsa-mir-553', 'chr1', '+', '', '', 'Pre-miRNA'),
(1740, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1741, 'hsa-mir-556', 'chr1', '+', '', '', 'Pre-miRNA'),
(1742, 'hsa-mir-8080', 'chr2', '-', '', '', 'Pre-miRNA'),
(1743, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(1744, 'hsa-mir-520e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1745, 'hsa-mir-599', 'chr8', '-', '', '', 'Pre-miRNA'),
(1746, 'hsa-mir-630', 'chr15', '+', '', '', 'Pre-miRNA'),
(1747, 'hsa-mir-599', 'chr8', '-', '', '', 'Pre-miRNA'),
(1748, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1749, 'hsa-mir-3192', 'chr20', '+', '', '', 'Pre-miRNA'),
(1750, 'hsa-mir-1178', 'chr12', '-', '', '', 'Pre-miRNA'),
(1751, 'hsa-mir-195', 'chr17', '-', '', '', 'Pre-miRNA'),
(1752, 'hsa-mir-641', 'chr19', '-', '', '', 'Pre-miRNA'),
(1753, 'hsa-mir-379', 'chr14', '+', '', '', 'Pre-miRNA'),
(1754, 'hsa-mir-563', 'chr3', '+', '', '', 'Pre-miRNA'),
(1755, 'hsa-mir-124-3', 'chr20', '+', '', '', 'Pre-miRNA'),
(1756, 'hsa-mir-568', 'chr3', '-', '', '', 'Pre-miRNA'),
(1757, 'hsa-mir-1290', 'chr1', '-', '', '', 'Pre-miRNA'),
(1758, 'hsa-mir-518a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1759, 'hsa-mir-378c', 'chr10', '-', '', '', 'Pre-miRNA'),
(1760, 'hsa-mir-656', 'chr14', '+', '', '', 'Pre-miRNA'),
(1761, 'hsa-mir-1183', 'chr7', '+', '', '', 'Pre-miRNA'),
(1762, 'hsa-mir-31', 'chr9', '-', '', '', 'Pre-miRNA'),
(1763, 'hsa-mir-326', 'chr11', '-', '', '', 'Pre-miRNA'),
(1764, 'hsa-mir-593', 'chr7', '+', '', '', 'Pre-miRNA'),
(1765, 'hsa-mir-3121', 'chr1', '-', '', '', 'Pre-miRNA'),
(1766, 'hsa-mir-620', 'chr12', '-', '', '', 'Pre-miRNA'),
(1767, 'hsa-mir-522', 'chr19', '+', '', '', 'Pre-miRNA'),
(1768, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(1769, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(1770, 'hsa-mir-1224', 'chr3', '+', '', '', 'Pre-miRNA'),
(1771, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(1772, 'hsa-mir-2278', 'chr9', '+', '', '', 'Pre-miRNA'),
(1773, 'hsa-mir-1250', 'chr17', '-', '', '', 'Pre-miRNA'),
(1774, 'hsa-mir-1269b', 'chr17', '-', '', '', 'Pre-miRNA'),
(1775, 'hsa-mir-573', 'chr4', '-', '', '', 'Pre-miRNA'),
(1776, 'hsa-mir-551b', 'chr3', '+', '', '', 'Pre-miRNA'),
(1777, 'hsa-mir-875', 'chr8', '-', '', '', 'Pre-miRNA'),
(1778, 'hsa-mir-517b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1779, 'hsa-mir-9-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1780, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1781, 'hsa-mir-4797', 'chr3', '-', '', '', 'Pre-miRNA'),
(1782, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1783, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1784, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(1785, 'hsa-mir-8071-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1786, 'hsa-mir-570', 'chr3', '+', '', '', 'Pre-miRNA'),
(1787, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1788, 'hsa-mir-551a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1789, 'hsa-mir-103a-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(1790, 'hsa-mir-103b-2', 'chr20', '-', '', '', 'Pre-miRNA'),
(1791, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1792, 'hsa-mir-326', 'chr11', '-', '', '', 'Pre-miRNA'),
(1793, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(1794, 'hsa-mir-943', 'chr4', '-', '', '', 'Pre-miRNA'),
(1795, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(1796, 'hsa-mir-3942', 'chr15', '-', '', '', 'Pre-miRNA'),
(1797, 'hsa-mir-556', 'chr1', '+', '', '', 'Pre-miRNA'),
(1798, 'hsa-mir-379', 'chr14', '+', '', '', 'Pre-miRNA'),
(1799, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1800, 'hsa-mir-345', 'chr14', '+', '', '', 'Pre-miRNA'),
(1801, 'hsa-mir-30c-1', 'chr1', '+', '', '', 'Pre-miRNA'),
(1802, 'hsa-mir-656', 'chr14', '+', '', '', 'Pre-miRNA'),
(1803, 'hsa-mir-4746', 'chr19', '+', '', '', 'Pre-miRNA'),
(1804, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1805, 'hsa-mir-3167', 'chr11', '-', '', '', 'Pre-miRNA'),
(1806, 'hsa-mir-1296', 'chr10', '-', '', '', 'Pre-miRNA'),
(1807, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(1808, 'hsa-mir-3666', 'chr7', '+', '', '', 'Pre-miRNA'),
(1809, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1810, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(1811, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1812, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1813, 'hsa-mir-1228', 'chr12', '+', '', '', 'Pre-miRNA'),
(1814, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1815, 'hsa-mir-488', 'chr1', '-', '', '', 'Pre-miRNA'),
(1816, 'hsa-mir-3074', 'chr9', '-', '', '', 'Pre-miRNA'),
(1817, 'hsa-mir-24-1', 'chr9', '+', '', '', 'Pre-miRNA'),
(1818, 'hsa-mir-4485', 'chr11', '-', '', '', 'Pre-miRNA'),
(1819, 'hsa-mir-138-2', 'chr16', '+', '', '', 'Pre-miRNA'),
(1820, 'hsa-mir-1284', 'chr3', '-', '', '', 'Pre-miRNA'),
(1821, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(1822, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(1823, 'hsa-mir-33b', 'chr17', '-', '', '', 'Pre-miRNA'),
(1824, 'hsa-mir-645', 'chr20', '+', '', '', 'Pre-miRNA'),
(1825, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(1826, 'hsa-mir-1263', 'chr3', '-', '', '', 'Pre-miRNA'),
(1827, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1828, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(1829, 'hsa-mir-219a-1', 'chr6', '+', '', '', 'Pre-miRNA'),
(1830, 'hsa-mir-518b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1831, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(1832, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(1833, 'hsa-mir-449a', 'chr5', '-', '', '', 'Pre-miRNA'),
(1834, 'hsa-mir-516a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1835, 'hsa-mir-493', 'chr14', '+', '', '', 'Pre-miRNA'),
(1836, 'hsa-mir-367', 'chr4', '-', '', '', 'Pre-miRNA'),
(1837, 'hsa-mir-20a', 'chr13', '+', '', '', 'Pre-miRNA'),
(1838, 'hsa-mir-876', 'chr9', '-', '', '', 'Pre-miRNA'),
(1839, 'hsa-mir-523', 'chr19', '+', '', '', 'Pre-miRNA'),
(1840, 'hsa-mir-645', 'chr20', '+', '', '', 'Pre-miRNA'),
(1841, 'hsa-mir-24-2', 'chr19', '-', '', '', 'Pre-miRNA'),
(1842, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1843, 'hsa-mir-1279', 'chr12', '-', '', '', 'Pre-miRNA'),
(1844, 'hsa-mir-410', 'chr14', '+', '', '', 'Pre-miRNA'),
(1845, 'hsa-mir-3651', 'chr9', '-', '', '', 'Pre-miRNA'),
(1846, 'hsa-mir-302c', 'chr4', '-', '', '', 'Pre-miRNA'),
(1847, 'hsa-mir-329-2', 'chr14', '+', '', '', 'Pre-miRNA'),
(1848, 'hsa-mir-4705', 'chr13', '-', '', '', 'Pre-miRNA'),
(1849, 'hsa-mir-4423', 'chr1', '+', '', '', 'Pre-miRNA'),
(1850, 'hsa-mir-4274', 'chr4', '+', '', '', 'Pre-miRNA'),
(1851, 'hsa-mir-1284', 'chr3', '-', '', '', 'Pre-miRNA'),
(1852, 'hsa-mir-4461', 'chr5', '+', '', '', 'Pre-miRNA'),
(1853, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1854, 'hsa-mir-378e', 'chr5', '+', '', '', 'Pre-miRNA'),
(1855, 'hsa-mir-18a', 'chr13', '+', '', '', 'Pre-miRNA'),
(1856, 'hsa-mir-378c', 'chr10', '-', '', '', 'Pre-miRNA'),
(1857, 'hsa-mir-548ai', 'chr6', '+', '', '', 'Pre-miRNA'),
(1858, 'hsa-mir-760', 'chr1', '+', '', '', 'Pre-miRNA'),
(1859, 'hsa-mir-520f', 'chr19', '+', '', '', 'Pre-miRNA'),
(1860, 'hsa-mir-25', 'chr7', '-', '', '', 'Pre-miRNA'),
(1861, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(1862, 'hsa-mir-665', 'chr14', '+', '', '', 'Pre-miRNA'),
(1863, 'hsa-mir-630', 'chr15', '+', '', '', 'Pre-miRNA'),
(1864, 'hsa-mir-512-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1865, 'hsa-mir-7-2', 'chr15', '+', '', '', 'Pre-miRNA'),
(1866, 'hsa-mir-4513', 'chr15', '-', '', '', 'Pre-miRNA'),
(1867, 'hsa-mir-7-3', 'chr19', '+', '', '', 'Pre-miRNA'),
(1868, 'hsa-mir-548ae-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1869, 'hsa-mir-4713', 'chr15', '+', '', '', 'Pre-miRNA'),
(1870, 'hsa-mir-154', 'chr14', '+', '', '', 'Pre-miRNA'),
(1871, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(1872, 'hsa-mir-520f', 'chr19', '+', '', '', 'Pre-miRNA'),
(1873, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(1874, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(1875, 'hsa-mir-130a', 'chr11', '+', '', '', 'Pre-miRNA'),
(1876, 'hsa-mir-4304', 'chr12', '-', '', '', 'Pre-miRNA'),
(1877, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(1878, 'hsa-mir-1267', 'chr13', '-', '', '', 'Pre-miRNA'),
(1879, 'hsa-mir-3943', 'chr7', '+', '', '', 'Pre-miRNA'),
(1880, 'hsa-mir-27b', 'chr9', '+', '', '', 'Pre-miRNA'),
(1881, 'hsa-mir-518a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1882, 'hsa-mir-551b', 'chr3', '+', '', '', 'Pre-miRNA'),
(1883, 'hsa-mir-873', 'chr9', '-', '', '', 'Pre-miRNA'),
(1884, 'hsa-mir-202', 'chr10', '-', '', '', 'Pre-miRNA'),
(1885, 'hsa-mir-7-2', 'chr15', '+', '', '', 'Pre-miRNA'),
(1886, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(1887, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1888, 'hsa-mir-202', 'chr10', '-', '', '', 'Pre-miRNA'),
(1889, 'hsa-mir-654', 'chr14', '+', '', '', 'Pre-miRNA'),
(1890, 'hsa-mir-3683', 'chr7', '-', '', '', 'Pre-miRNA'),
(1891, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1892, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(1893, 'hsa-mir-185', 'chr22', '+', '', '', 'Pre-miRNA'),
(1894, 'hsa-mir-1205', 'chr8', '+', '', '', 'Pre-miRNA'),
(1895, 'hsa-mir-4538', 'chr14', '-', '', '', 'Pre-miRNA'),
(1896, 'hsa-mir-1322', 'chr8', '-', '', '', 'Pre-miRNA'),
(1897, 'hsa-mir-30c-2', 'chr6', '-', '', '', 'Pre-miRNA'),
(1898, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(1899, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(1900, 'hsa-mir-4537', 'chr14', '-', '', '', 'Pre-miRNA'),
(1901, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(1902, 'hsa-mir-206', 'chr6', '+', '', '', 'Pre-miRNA'),
(1903, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(1904, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(1905, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(1906, 'hsa-mir-525', 'chr19', '+', '', '', 'Pre-miRNA'),
(1907, 'hsa-mir-6885', 'chr19', '-', '', '', 'Pre-miRNA'),
(1908, 'hsa-mir-606', 'chr10', '+', '', '', 'Pre-miRNA'),
(1909, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1910, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1911, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1912, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(1913, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(1914, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(1915, 'hsa-mir-8061', 'chr19', '+', '', '', 'Pre-miRNA'),
(1916, 'hsa-mir-182', 'chr7', '-', '', '', 'Pre-miRNA'),
(1917, 'hsa-mir-612', 'chr11', '+', '', '', 'Pre-miRNA'),
(1918, 'hsa-mir-199a-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(1919, 'hsa-mir-369', 'chr14', '+', '', '', 'Pre-miRNA'),
(1920, 'hsa-mir-597', 'chr8', '+', '', '', 'Pre-miRNA'),
(1921, 'hsa-mir-6088', 'chr19', '+', '', '', 'Pre-miRNA'),
(1922, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1923, 'hsa-mir-16-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(1924, 'hsa-mir-30b', 'chr8', '-', '', '', 'Pre-miRNA'),
(1925, 'hsa-mir-19a', 'chr13', '+', '', '', 'Pre-miRNA'),
(1926, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(1927, 'hsa-mir-569', 'chr3', '-', '', '', 'Pre-miRNA'),
(1928, 'hsa-mir-520c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1929, 'hsa-mir-3677', 'chr16', '+', '', '', 'Pre-miRNA'),
(1930, 'hsa-mir-4796', 'chr3', '-', '', '', 'Pre-miRNA'),
(1931, 'hsa-mir-135a-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(1932, 'hsa-mir-494', 'chr14', '+', '', '', 'Pre-miRNA'),
(1933, 'hsa-mir-525', 'chr19', '+', '', '', 'Pre-miRNA'),
(1934, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(1935, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(1936, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(1937, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(1938, 'hsa-mir-520c', 'chr19', '+', '', '', 'Pre-miRNA'),
(1939, 'hsa-mir-34a', 'chr1', '-', '', '', 'Pre-miRNA'),
(1940, 'hsa-mir-641', 'chr19', '-', '', '', 'Pre-miRNA'),
(1941, 'hsa-mir-5094', 'chr15', '-', '', '', 'Pre-miRNA'),
(1942, 'hsa-mir-1237', 'chr11', '+', '', '', 'Pre-miRNA'),
(1943, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1944, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(1945, 'hsa-mir-135a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(1946, 'hsa-mir-487b', 'chr14', '+', '', '', 'Pre-miRNA'),
(1947, 'hsa-mir-6127', 'chr1', '-', '', '', 'Pre-miRNA'),
(1948, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(1949, 'hsa-mir-3141', 'chr5', '-', '', '', 'Pre-miRNA'),
(1950, 'hsa-mir-637', 'chr19', '-', '', '', 'Pre-miRNA'),
(1951, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(1952, 'hsa-mir-557', 'chr1', '+', '', '', 'Pre-miRNA'),
(1953, 'hsa-mir-590', 'chr7', '+', '', '', 'Pre-miRNA'),
(1954, 'hsa-mir-147a', 'chr9', '-', '', '', 'Pre-miRNA'),
(1955, 'hsa-mir-211', 'chr15', '-', '', '', 'Pre-miRNA'),
(1956, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(1957, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(1958, 'hsa-mir-551b', 'chr3', '+', '', '', 'Pre-miRNA'),
(1959, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(1960, 'hsa-mir-876', 'chr9', '-', '', '', 'Pre-miRNA'),
(1961, 'hsa-mir-4792', 'chr3', '-', '', '', 'Pre-miRNA'),
(1962, 'hsa-mir-6516', 'chr17', '+', '', '', 'Pre-miRNA'),
(1963, 'hsa-mir-486-1', 'chr8', '-', '', '', 'Pre-miRNA'),
(1964, 'hsa-mir-486-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(1965, 'hsa-mir-154', 'chr14', '+', '', '', 'Pre-miRNA'),
(1966, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(1967, 'hsa-mir-665', 'chr14', '+', '', '', 'Pre-miRNA'),
(1968, 'hsa-mir-518b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1969, 'hsa-mir-182', 'chr7', '-', '', '', 'Pre-miRNA'),
(1970, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1971, 'hsa-mir-3160-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(1972, 'hsa-mir-3160-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(1973, 'hsa-mir-548f-4', 'chr7', '-', '', '', 'Pre-miRNA'),
(1974, 'hsa-mir-4454', 'chr4', '-', '', '', 'Pre-miRNA'),
(1975, 'hsa-mir-182', 'chr7', '-', '', '', 'Pre-miRNA'),
(1976, 'hsa-mir-4283-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1977, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(1978, 'hsa-mir-619', 'chr12', '-', '', '', 'Pre-miRNA'),
(1979, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1980, 'hsa-mir-340', 'chr5', '-', '', '', 'Pre-miRNA'),
(1981, 'hsa-mir-517b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1982, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(1983, 'hsa-mir-337', 'chr14', '+', '', '', 'Pre-miRNA'),
(1984, 'hsa-mir-193a', 'chr17', '+', '', '', 'Pre-miRNA'),
(1985, 'hsa-mir-134', 'chr14', '+', '', '', 'Pre-miRNA'),
(1986, 'hsa-mir-607', 'chr10', '-', '', '', 'Pre-miRNA'),
(1987, 'hsa-mir-1238', 'chr19', '+', '', '', 'Pre-miRNA'),
(1988, 'hsa-mir-515-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(1989, 'hsa-mir-548y', 'chr14', '-', '', '', 'Pre-miRNA'),
(1990, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(1991, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(1992, 'hsa-mir-5701-3', 'chr15', '+', '', '', 'Pre-miRNA'),
(1993, 'hsa-mir-4485', 'chr11', '-', '', '', 'Pre-miRNA'),
(1994, 'hsa-mir-578', 'chr4', '+', '', '', 'Pre-miRNA'),
(1995, 'hsa-mir-208a', 'chr14', '-', '', '', 'Pre-miRNA'),
(1996, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(1997, 'hsa-mir-526b', 'chr19', '+', '', '', 'Pre-miRNA'),
(1998, 'hsa-mir-573', 'chr4', '-', '', '', 'Pre-miRNA'),
(1999, 'hsa-mir-1285-2', 'chr2', '-', '', '', 'Pre-miRNA'),
(2000, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(2001, 'hsa-mir-517b', 'chr19', '+', '', '', 'Pre-miRNA'),
(2002, 'hsa-mir-578', 'chr4', '+', '', '', 'Pre-miRNA'),
(2003, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(2004, 'hsa-mir-4999', 'chr19', '-', '', '', 'Pre-miRNA'),
(2005, 'hsa-mir-557', 'chr1', '+', '', '', 'Pre-miRNA'),
(2006, 'hsa-mir-4465', 'chr6', '+', '', '', 'Pre-miRNA'),
(2007, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2008, 'hsa-mir-6825', 'chr3', '-', '', '', 'Pre-miRNA'),
(2009, 'hsa-mir-519e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2010, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2011, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2012, 'hsa-mir-320a', 'chr8', '-', '', '', 'Pre-miRNA'),
(2013, 'hsa-mir-526a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2014, 'hsa-mir-634', 'chr17', '+', '', '', 'Pre-miRNA'),
(2015, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(2016, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(2017, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(2018, 'hsa-mir-516b-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2019, 'hsa-mir-593', 'chr7', '+', '', '', 'Pre-miRNA'),
(2020, 'hsa-mir-920', 'chr12', '+', '', '', 'Pre-miRNA'),
(2021, 'hsa-mir-3652', 'chr12', '+', '', '', 'Pre-miRNA'),
(2022, 'hsa-mir-6859-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(2023, 'hsa-mir-378f', 'chr1', '+', '', '', 'Pre-miRNA'),
(2024, 'hsa-mir-126', 'chr9', '+', '', '', 'Pre-miRNA'),
(2025, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(2026, 'hsa-mir-623', 'chr13', '+', '', '', 'Pre-miRNA'),
(2027, 'hsa-mir-6859-4', 'chr16', '-', '', '', 'Pre-miRNA'),
(2028, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(2029, 'hsa-mir-202', 'chr10', '-', '', '', 'Pre-miRNA'),
(2030, 'hsa-mir-125a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2031, 'hsa-mir-335', 'chr7', '+', '', '', 'Pre-miRNA'),
(2032, 'hsa-mir-2054', 'chr4', '+', '', '', 'Pre-miRNA'),
(2033, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2034, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2035, 'hsa-mir-6755', 'chr11', '+', '', '', 'Pre-miRNA'),
(2036, 'hsa-mir-16-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(2037, 'hsa-mir-920', 'chr12', '+', '', '', 'Pre-miRNA'),
(2038, 'hsa-mir-658', 'chr22', '-', '', '', 'Pre-miRNA'),
(2039, 'hsa-mir-4520-1', 'chr17', '-', '', '', 'Pre-miRNA'),
(2040, 'hsa-mir-4520-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(2041, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(2042, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2043, 'hsa-mir-6082', 'chr4', '+', '', '', 'Pre-miRNA'),
(2044, 'hsa-mir-548n', 'chr7', '-', '', '', 'Pre-miRNA'),
(2045, 'hsa-mir-320e', 'chr19', '-', '', '', 'Pre-miRNA'),
(2046, 'hsa-mir-612', 'chr11', '+', '', '', 'Pre-miRNA'),
(2047, 'hsa-mir-1185-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2048, 'hsa-mir-1302-5', 'chr20', '-', '', '', 'Pre-miRNA'),
(2049, 'hsa-mir-3617', 'chr20', '-', '', '', 'Pre-miRNA'),
(2050, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2051, 'hsa-mir-603', 'chr10', '+', '', '', 'Pre-miRNA'),
(2052, 'hsa-mir-202', 'chr10', '-', '', '', 'Pre-miRNA'),
(2053, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(2054, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(2055, 'hsa-mir-4280', 'chr5', '-', '', '', 'Pre-miRNA'),
(2056, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2057, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(2058, 'hsa-let-7g', 'chr3', '-', '', '', 'Pre-miRNA'),
(2059, 'hsa-mir-4677', 'chr1', '+', '', '', 'Pre-miRNA'),
(2060, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(2061, 'hsa-mir-1293', 'chr12', '-', '', '', 'Pre-miRNA'),
(2062, 'hsa-mir-218-2', 'chr5', '-', '', '', 'Pre-miRNA'),
(2063, 'hsa-mir-589', 'chr7', '-', '', '', 'Pre-miRNA'),
(2064, 'hsa-mir-550a-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2065, 'hsa-mir-550b-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(2066, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2067, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(2068, 'hsa-mir-195', 'chr17', '-', '', '', 'Pre-miRNA'),
(2069, 'hsa-mir-151b', 'chr14', '-', '', '', 'Pre-miRNA'),
(2070, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(2071, 'hsa-mir-128-1', 'chr2', '+', '', '', 'Pre-miRNA'),
(2072, 'hsa-mir-298', 'chr20', '-', '', '', 'Pre-miRNA'),
(2073, 'hsa-mir-216a', 'chr2', '-', '', '', 'Pre-miRNA'),
(2074, 'hsa-mir-7703', 'chr14', '-', '', '', 'Pre-miRNA'),
(2075, 'hsa-mir-520h', 'chr19', '+', '', '', 'Pre-miRNA'),
(2076, 'hsa-mir-216a', 'chr2', '-', '', '', 'Pre-miRNA'),
(2077, 'hsa-mir-100', 'chr11', '-', '', '', 'Pre-miRNA'),
(2078, 'hsa-mir-4465', 'chr6', '+', '', '', 'Pre-miRNA'),
(2079, 'hsa-mir-555', 'chr1', '-', '', '', 'Pre-miRNA'),
(2080, 'hsa-mir-198', 'chr3', '-', '', '', 'Pre-miRNA'),
(2081, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(2082, 'hsa-mir-4533', 'chr20', '+', '', '', 'Pre-miRNA'),
(2083, 'hsa-mir-154', 'chr14', '+', '', '', 'Pre-miRNA'),
(2084, 'hsa-mir-493', 'chr14', '+', '', '', 'Pre-miRNA'),
(2085, 'hsa-mir-194-2', 'chr11', '-', '', '', 'Pre-miRNA'),
(2086, 'hsa-mir-382', 'chr14', '+', '', '', 'Pre-miRNA'),
(2087, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2088, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(2089, 'hsa-mir-548o', 'chr7', '-', '', '', 'Pre-miRNA'),
(2090, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(2091, 'hsa-mir-661', 'chr8', '-', '', '', 'Pre-miRNA'),
(2092, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2093, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2094, 'hsa-mir-320b-1', 'chr1', '+', '', '', 'Pre-miRNA'),
(2095, 'hsa-mir-340', 'chr5', '-', '', '', 'Pre-miRNA'),
(2096, 'hsa-mir-571', 'chr4', '+', '', '', 'Pre-miRNA'),
(2097, 'hsa-mir-4743', 'chr18', '+', '', '', 'Pre-miRNA'),
(2098, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(2099, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(2100, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(2101, 'hsa-mir-555', 'chr1', '-', '', '', 'Pre-miRNA'),
(2102, 'hsa-let-7c', 'chr21', '+', '', '', 'Pre-miRNA'),
(2103, 'hsa-mir-518a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2104, 'hsa-mir-141', 'chr12', '+', '', '', 'Pre-miRNA'),
(2105, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2106, 'hsa-mir-370', 'chr14', '+', '', '', 'Pre-miRNA'),
(2107, 'hsa-mir-517b', 'chr19', '+', '', '', 'Pre-miRNA'),
(2108, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(2109, 'hsa-let-7a-3', 'chr22', '+', '', '', 'Pre-miRNA'),
(2110, 'hsa-mir-523', 'chr19', '+', '', '', 'Pre-miRNA'),
(2111, 'hsa-mir-922', 'chr3', '-', '', '', 'Pre-miRNA'),
(2112, 'hsa-mir-1185-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2113, 'hsa-mir-6880', 'chr12', '-', '', '', 'Pre-miRNA'),
(2114, 'hsa-mir-25', 'chr7', '-', '', '', 'Pre-miRNA'),
(2115, 'hsa-mir-1250', 'chr17', '-', '', '', 'Pre-miRNA'),
(2116, 'hsa-mir-541', 'chr14', '+', '', '', 'Pre-miRNA'),
(2117, 'hsa-mir-192', 'chr11', '-', '', '', 'Pre-miRNA'),
(2118, 'hsa-mir-941-1', 'chr20', '+', '', '', 'Pre-miRNA'),
(2119, 'hsa-mir-146a', 'chr5', '+', '', '', 'Pre-miRNA'),
(2120, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2121, 'hsa-mir-380', 'chr14', '+', '', '', 'Pre-miRNA'),
(2122, 'hsa-mir-492', 'chr12', '+', '', '', 'Pre-miRNA'),
(2123, 'hsa-mir-601', 'chr9', '-', '', '', 'Pre-miRNA'),
(2124, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(2125, 'hsa-mir-562', 'chr2', '+', '', '', 'Pre-miRNA'),
(2126, 'hsa-mir-498', 'chr19', '+', '', '', 'Pre-miRNA'),
(2127, 'hsa-mir-548i-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(2128, 'hsa-mir-328', 'chr16', '-', '', '', 'Pre-miRNA'),
(2129, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(2130, 'hsa-mir-1265', 'chr10', '+', '', '', 'Pre-miRNA'),
(2131, 'hsa-mir-944', 'chr3', '+', '', '', 'Pre-miRNA'),
(2132, 'hsa-mir-4791', 'chr3', '-', '', '', 'Pre-miRNA'),
(2133, 'hsa-mir-1233-1', 'chr15', '-', '', '', 'Pre-miRNA'),
(2134, 'hsa-mir-380', 'chr14', '+', '', '', 'Pre-miRNA'),
(2135, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2136, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2137, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(2138, 'hsa-mir-627', 'chr15', '-', '', '', 'Pre-miRNA'),
(2139, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(2140, 'hsa-mir-1825', 'chr20', '+', '', '', 'Pre-miRNA'),
(2141, 'hsa-mir-3164', 'chr11', '+', '', '', 'Pre-miRNA'),
(2142, 'hsa-mir-30c-1', 'chr1', '+', '', '', 'Pre-miRNA'),
(2143, 'hsa-mir-369', 'chr14', '+', '', '', 'Pre-miRNA'),
(2144, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2145, 'hsa-mir-4668', 'chr9', '+', '', '', 'Pre-miRNA'),
(2146, 'hsa-mir-7160', 'chr8', '+', '', '', 'Pre-miRNA'),
(2147, 'hsa-mir-1246', 'chr2', '-', '', '', 'Pre-miRNA'),
(2148, 'hsa-mir-1283-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2149, 'hsa-mir-1288', 'chr17', '+', '', '', 'Pre-miRNA'),
(2150, 'hsa-mir-129-2', 'chr11', '+', '', '', 'Pre-miRNA'),
(2151, 'hsa-mir-2115', 'chr3', '-', '', '', 'Pre-miRNA'),
(2152, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(2153, 'hsa-mir-518c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2154, 'hsa-mir-7515', 'chr2', '+', '', '', 'Pre-miRNA'),
(2155, 'hsa-mir-199b', 'chr9', '-', '', '', 'Pre-miRNA'),
(2156, 'hsa-mir-524', 'chr19', '+', '', '', 'Pre-miRNA'),
(2157, 'hsa-mir-516a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2158, 'hsa-mir-5189', 'chr16', '+', '', '', 'Pre-miRNA'),
(2159, 'hsa-mir-548h-3', 'chr17', '-', '', '', 'Pre-miRNA'),
(2160, 'hsa-mir-196a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(2161, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2162, 'hsa-mir-3153', 'chr9', '+', '', '', 'Pre-miRNA'),
(2163, 'hsa-mir-95', 'chr4', '-', '', '', 'Pre-miRNA'),
(2164, 'hsa-mir-132', 'chr17', '-', '', '', 'Pre-miRNA'),
(2165, 'hsa-mir-498', 'chr19', '+', '', '', 'Pre-miRNA'),
(2166, 'hsa-mir-29b-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(2167, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2168, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2169, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2170, 'hsa-mir-515-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2171, 'hsa-mir-3152', 'chr9', '+', '', '', 'Pre-miRNA'),
(2172, 'hsa-mir-219a-1', 'chr6', '+', '', '', 'Pre-miRNA'),
(2173, 'hsa-mir-6079', 'chr1', '+', '', '', 'Pre-miRNA'),
(2174, 'hsa-mir-4537', 'chr14', '-', '', '', 'Pre-miRNA'),
(2175, 'hsa-mir-4669', 'chr9', '+', '', '', 'Pre-miRNA'),
(2176, 'hsa-mir-498', 'chr19', '+', '', '', 'Pre-miRNA'),
(2177, 'hsa-mir-6075', 'chr5', '-', '', '', 'Pre-miRNA'),
(2178, 'hsa-mir-6869', 'chr20', '-', '', '', 'Pre-miRNA'),
(2179, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(2180, 'hsa-mir-3689b', 'chr9', '-', '', '', 'Pre-miRNA'),
(2181, 'hsa-mir-548h-3', 'chr17', '-', '', '', 'Pre-miRNA'),
(2182, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2183, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2184, 'hsa-mir-410', 'chr14', '+', '', '', 'Pre-miRNA'),
(2185, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(2186, 'hsa-mir-1283-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2187, 'hsa-mir-518b', 'chr19', '+', '', '', 'Pre-miRNA'),
(2188, 'hsa-mir-1269b', 'chr17', '-', '', '', 'Pre-miRNA'),
(2189, 'hsa-mir-340', 'chr5', '-', '', '', 'Pre-miRNA'),
(2190, 'hsa-mir-550a-3', 'chr7', '-', '', '', 'Pre-miRNA'),
(2191, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(2192, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2193, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2194, 'hsa-mir-330', 'chr19', '-', '', '', 'Pre-miRNA'),
(2195, 'hsa-mir-516a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2196, 'hsa-mir-3144', 'chr6', '+', '', '', 'Pre-miRNA'),
(2197, 'hsa-mir-411', 'chr14', '+', '', '', 'Pre-miRNA'),
(2198, 'hsa-mir-7-3', 'chr19', '+', '', '', 'Pre-miRNA'),
(2199, 'hsa-mir-30e', 'chr1', '+', '', '', 'Pre-miRNA'),
(2200, 'hsa-mir-197', 'chr1', '+', '', '', 'Pre-miRNA'),
(2201, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(2202, 'hsa-mir-519e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2203, 'hsa-mir-1302-6', 'chr7', '-', '', '', 'Pre-miRNA'),
(2204, 'hsa-mir-483', 'chr11', '-', '', '', 'Pre-miRNA'),
(2205, 'hsa-mir-1207', 'chr8', '+', '', '', 'Pre-miRNA'),
(2206, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2207, 'hsa-mir-130a', 'chr11', '+', '', '', 'Pre-miRNA'),
(2208, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(2209, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2210, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2211, 'hsa-mir-1273a', 'chr8', '-', '', '', 'Pre-miRNA'),
(2212, 'hsa-mir-124-1', 'chr8', '-', '', '', 'Pre-miRNA'),
(2213, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2214, 'hsa-mir-548f-1', 'chr10', '-', '', '', 'Pre-miRNA'),
(2215, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2216, 'hsa-mir-558', 'chr2', '+', '', '', 'Pre-miRNA'),
(2217, 'hsa-mir-626', 'chr15', '+', '', '', 'Pre-miRNA'),
(2218, 'hsa-mir-523', 'chr19', '+', '', '', 'Pre-miRNA'),
(2219, 'hsa-mir-196a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(2220, 'hsa-mir-4647', 'chr6', '-', '', '', 'Pre-miRNA'),
(2221, 'hsa-mir-124-3', 'chr20', '+', '', '', 'Pre-miRNA'),
(2222, 'hsa-mir-486-1', 'chr8', '-', '', '', 'Pre-miRNA'),
(2223, 'hsa-mir-486-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(2224, 'hsa-mir-199a-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(2225, 'hsa-mir-548av', 'chr18', '-', '', '', 'Pre-miRNA'),
(2226, 'hsa-mir-4312', 'chr15', '-', '', '', 'Pre-miRNA'),
(2227, 'hsa-mir-518a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2228, 'hsa-mir-3655', 'chr5', '+', '', '', 'Pre-miRNA'),
(2229, 'hsa-mir-620', 'chr12', '-', '', '', 'Pre-miRNA'),
(2230, 'hsa-mir-1244-2', 'chr5', '+', '', '', 'Pre-miRNA'),
(2231, 'hsa-mir-650', 'chr22', '+', '', '', 'Pre-miRNA'),
(2232, 'hsa-mir-3682', 'chr2', '-', '', '', 'Pre-miRNA'),
(2233, 'hsa-mir-4763', 'chr22', '+', '', '', 'Pre-miRNA'),
(2234, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2235, 'hsa-mir-557', 'chr1', '+', '', '', 'Pre-miRNA'),
(2236, 'hsa-mir-1267', 'chr13', '-', '', '', 'Pre-miRNA'),
(2237, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2238, 'hsa-mir-4760', 'chr21', '-', '', '', 'Pre-miRNA'),
(2239, 'hsa-mir-7-2', 'chr15', '+', '', '', 'Pre-miRNA'),
(2240, 'hsa-mir-29b-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(2241, 'hsa-mir-1973', 'chr4', '+', '', '', 'Pre-miRNA'),
(2242, 'hsa-mir-181b-2', 'chr9', '+', '', '', 'Pre-miRNA'),
(2243, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2244, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2245, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2246, 'hsa-mir-181a-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(2247, 'hsa-mir-153-1', 'chr2', '-', '', '', 'Pre-miRNA'),
(2248, 'hsa-mir-522', 'chr19', '+', '', '', 'Pre-miRNA'),
(2249, 'hsa-mir-1246', 'chr2', '-', '', '', 'Pre-miRNA'),
(2250, 'hsa-mir-103a-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(2251, 'hsa-mir-103b-2', 'chr20', '-', '', '', 'Pre-miRNA'),
(2252, 'hsa-mir-483', 'chr11', '-', '', '', 'Pre-miRNA'),
(2253, 'hsa-mir-6128', 'chr11', '+', '', '', 'Pre-miRNA'),
(2254, 'hsa-mir-634', 'chr17', '+', '', '', 'Pre-miRNA'),
(2255, 'hsa-mir-4697', 'chr11', '-', '', '', 'Pre-miRNA'),
(2256, 'hsa-mir-598', 'chr8', '-', '', '', 'Pre-miRNA'),
(2257, 'hsa-mir-135a-1', 'chr3', '-', '', '', 'Pre-miRNA'),
(2258, 'hsa-mir-3914-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(2259, 'hsa-mir-3914-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2260, 'hsa-mir-320b-2', 'chr1', '-', '', '', 'Pre-miRNA'),
(2261, 'hsa-mir-632', 'chr17', '+', '', '', 'Pre-miRNA'),
(2262, 'hsa-mir-4783', 'chr2', '-', '', '', 'Pre-miRNA'),
(2263, 'hsa-mir-7844', 'chr12', '-', '', '', 'Pre-miRNA'),
(2264, 'hsa-mir-206', 'chr6', '+', '', '', 'Pre-miRNA'),
(2265, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(2266, 'hsa-mir-4305', 'chr13', '-', '', '', 'Pre-miRNA'),
(2267, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2268, 'hsa-mir-642a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2269, 'hsa-mir-642b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2270, 'hsa-mir-1203', 'chr17', '-', '', '', 'Pre-miRNA'),
(2271, 'hsa-mir-4709', 'chr14', '-', '', '', 'Pre-miRNA'),
(2272, 'hsa-mir-941-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(2273, 'hsa-mir-1233-1', 'chr15', '-', '', '', 'Pre-miRNA'),
(2274, 'hsa-mir-18a', 'chr13', '+', '', '', 'Pre-miRNA'),
(2275, 'hsa-mir-3196', 'chr20', '+', '', '', 'Pre-miRNA'),
(2276, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2277, 'hsa-mir-153-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(2278, 'hsa-mir-567', 'chr3', '+', '', '', 'Pre-miRNA'),
(2279, 'hsa-mir-558', 'chr2', '+', '', '', 'Pre-miRNA'),
(2280, 'hsa-mir-613', 'chr12', '+', '', '', 'Pre-miRNA'),
(2281, 'hsa-mir-1244-2', 'chr5', '+', '', '', 'Pre-miRNA'),
(2282, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2283, 'hsa-mir-488', 'chr1', '-', '', '', 'Pre-miRNA'),
(2284, 'hsa-mir-664a', 'chr1', '-', '', '', 'Pre-miRNA'),
(2285, 'hsa-mir-765', 'chr1', '-', '', '', 'Pre-miRNA'),
(2286, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2287, 'hsa-mir-3689e', 'chr9', '-', '', '', 'Pre-miRNA'),
(2288, 'hsa-mir-3142', 'chr5', '+', '', '', 'Pre-miRNA'),
(2289, 'hsa-mir-493', 'chr14', '+', '', '', 'Pre-miRNA'),
(2290, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2291, 'hsa-mir-4729', 'chr17', '+', '', '', 'Pre-miRNA'),
(2292, 'hsa-mir-4520-1', 'chr17', '-', '', '', 'Pre-miRNA'),
(2293, 'hsa-mir-4520-2', 'chr17', '+', '', '', 'Pre-miRNA'),
(2294, 'hsa-mir-606', 'chr10', '+', '', '', 'Pre-miRNA'),
(2295, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(2296, 'hsa-mir-487a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2297, 'hsa-mir-493', 'chr14', '+', '', '', 'Pre-miRNA'),
(2298, 'hsa-mir-1247', 'chr14', '-', '', '', 'Pre-miRNA'),
(2299, 'hsa-mir-550a-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2300, 'hsa-mir-550b-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(2301, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(2302, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(2303, 'hsa-mir-887', 'chr5', '+', '', '', 'Pre-miRNA');
INSERT INTO `region` (`id`, `miRNA-name`, `chr_number`, `strand`, `allele`, `Sequence`, `Region`) VALUES
(2304, 'hsa-mir-495', 'chr14', '+', '', '', 'Pre-miRNA'),
(2305, 'hsa-mir-1233-1', 'chr15', '-', '', '', 'Pre-miRNA'),
(2306, 'hsa-mir-298', 'chr20', '-', '', '', 'Pre-miRNA'),
(2307, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2308, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(2309, 'hsa-mir-1294', 'chr5', '+', '', '', 'Pre-miRNA'),
(2310, 'hsa-mir-548u', 'chr6', '+', '', '', 'Pre-miRNA'),
(2311, 'hsa-mir-218-1', 'chr4', '+', '', '', 'Pre-miRNA'),
(2312, 'hsa-mir-496', 'chr14', '+', '', '', 'Pre-miRNA'),
(2313, 'hsa-mir-130a', 'chr11', '+', '', '', 'Pre-miRNA'),
(2314, 'hsa-mir-1294', 'chr5', '+', '', '', 'Pre-miRNA'),
(2315, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2316, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2317, 'hsa-mir-7852', 'chr1', '+', '', '', 'Pre-miRNA'),
(2318, 'hsa-mir-5706', 'chr5', '+', '', '', 'Pre-miRNA'),
(2319, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2320, 'hsa-mir-593', 'chr7', '+', '', '', 'Pre-miRNA'),
(2321, 'hsa-mir-887', 'chr5', '+', '', '', 'Pre-miRNA'),
(2322, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(2323, 'hsa-mir-760', 'chr1', '+', '', '', 'Pre-miRNA'),
(2324, 'hsa-mir-4449', 'chr4', '+', '', '', 'Pre-miRNA'),
(2325, 'hsa-mir-548f-4', 'chr7', '-', '', '', 'Pre-miRNA'),
(2326, 'hsa-mir-1303', 'chr5', '+', '', '', 'Pre-miRNA'),
(2327, 'hsa-mir-365a', 'chr16', '+', '', '', 'Pre-miRNA'),
(2328, 'hsa-mir-122', 'chr18', '+', '', '', 'Pre-miRNA'),
(2329, 'hsa-mir-3591', 'chr18', '-', '', '', 'Pre-miRNA'),
(2330, 'hsa-mir-623', 'chr13', '+', '', '', 'Pre-miRNA'),
(2331, 'hsa-mir-1279', 'chr12', '-', '', '', 'Pre-miRNA'),
(2332, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(2333, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(2334, 'hsa-mir-519c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2335, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2336, 'hsa-mir-320e', 'chr19', '-', '', '', 'Pre-miRNA'),
(2337, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(2338, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(2339, 'hsa-mir-134', 'chr14', '+', '', '', 'Pre-miRNA'),
(2340, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2341, 'hsa-mir-653', 'chr7', '-', '', '', 'Pre-miRNA'),
(2342, 'hsa-mir-4791', 'chr3', '-', '', '', 'Pre-miRNA'),
(2343, 'hsa-mir-1269a', 'chr4', '+', '', '', 'Pre-miRNA'),
(2344, 'hsa-mir-6856', 'chr9', '+', '', '', 'Pre-miRNA'),
(2345, 'hsa-mir-519e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2346, 'hsa-mir-181b-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(2347, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(2348, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2349, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2350, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2351, 'hsa-mir-3689c', 'chr9', '-', '', '', 'Pre-miRNA'),
(2352, 'hsa-mir-548q', 'chr10', '-', '', '', 'Pre-miRNA'),
(2353, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2354, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2355, 'hsa-mir-22', 'chr17', '-', '', '', 'Pre-miRNA'),
(2356, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(2357, 'hsa-mir-518f', 'chr19', '+', '', '', 'Pre-miRNA'),
(2358, 'hsa-mir-186', 'chr1', '-', '', '', 'Pre-miRNA'),
(2359, 'hsa-mir-143', 'chr5', '+', '', '', 'Pre-miRNA'),
(2360, 'hsa-mir-380', 'chr14', '+', '', '', 'Pre-miRNA'),
(2361, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2362, 'hsa-mir-523', 'chr19', '+', '', '', 'Pre-miRNA'),
(2363, 'hsa-mir-410', 'chr14', '+', '', '', 'Pre-miRNA'),
(2364, 'hsa-mir-1261', 'chr11', '-', '', '', 'Pre-miRNA'),
(2365, 'hsa-mir-216a', 'chr2', '-', '', '', 'Pre-miRNA'),
(2366, 'hsa-mir-216a', 'chr2', '-', '', '', 'Pre-miRNA'),
(2367, 'hsa-mir-196b', 'chr7', '-', '', '', 'Pre-miRNA'),
(2368, 'hsa-mir-518d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2369, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2370, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(2371, 'hsa-mir-3677', 'chr16', '+', '', '', 'Pre-miRNA'),
(2372, 'hsa-mir-1182', 'chr1', '-', '', '', 'Pre-miRNA'),
(2373, 'hsa-mir-769', 'chr19', '+', '', '', 'Pre-miRNA'),
(2374, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(2375, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(2376, 'hsa-mir-520g', 'chr19', '+', '', '', 'Pre-miRNA'),
(2377, 'hsa-mir-544a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2378, 'hsa-mir-297', 'chr4', '-', '', '', 'Pre-miRNA'),
(2379, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(2380, 'hsa-mir-635', 'chr17', '-', '', '', 'Pre-miRNA'),
(2381, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2382, 'hsa-mir-759', 'chr13', '+', '', '', 'Pre-miRNA'),
(2383, 'hsa-mir-516b-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2384, 'hsa-mir-1283-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2385, 'hsa-mir-548ao', 'chr8', '-', '', '', 'Pre-miRNA'),
(2386, 'hsa-mir-3183', 'chr17', '-', '', '', 'Pre-miRNA'),
(2387, 'hsa-mir-519e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2388, 'hsa-mir-598', 'chr8', '-', '', '', 'Pre-miRNA'),
(2389, 'hsa-mir-1302-8', 'chr9', '-', '', '', 'Pre-miRNA'),
(2390, 'hsa-mir-550a-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2391, 'hsa-mir-550b-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(2392, 'hsa-mir-550a-3', 'chr7', '-', '', '', 'Pre-miRNA'),
(2393, 'hsa-mir-345', 'chr14', '+', '', '', 'Pre-miRNA'),
(2394, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2395, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2396, 'hsa-mir-4700', 'chr12', '+', '', '', 'Pre-miRNA'),
(2397, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(2398, 'hsa-mir-296', 'chr20', '-', '', '', 'Pre-miRNA'),
(2399, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(2400, 'hsa-mir-3689b', 'chr9', '-', '', '', 'Pre-miRNA'),
(2401, 'hsa-mir-4454', 'chr4', '-', '', '', 'Pre-miRNA'),
(2402, 'hsa-mir-495', 'chr14', '+', '', '', 'Pre-miRNA'),
(2403, 'hsa-mir-4755', 'chr20', '+', '', '', 'Pre-miRNA'),
(2404, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2405, 'hsa-mir-1255b-1', 'chr4', '-', '', '', 'Pre-miRNA'),
(2406, 'hsa-mir-1272', 'chr15', '-', '', '', 'Pre-miRNA'),
(2407, 'hsa-mir-18a', 'chr13', '+', '', '', 'Pre-miRNA'),
(2408, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2409, 'hsa-mir-30b', 'chr8', '-', '', '', 'Pre-miRNA'),
(2410, 'hsa-mir-300', 'chr14', '+', '', '', 'Pre-miRNA'),
(2411, 'hsa-mir-626', 'chr15', '+', '', '', 'Pre-miRNA'),
(2412, 'hsa-mir-490', 'chr7', '+', '', '', 'Pre-miRNA'),
(2413, 'hsa-mir-526a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2414, 'hsa-mir-302e', 'chr11', '+', '', '', 'Pre-miRNA'),
(2415, 'hsa-mir-6843', 'chr8', '-', '', '', 'Pre-miRNA'),
(2416, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(2417, 'hsa-mir-589', 'chr7', '-', '', '', 'Pre-miRNA'),
(2418, 'hsa-mir-365b', 'chr17', '+', '', '', 'Pre-miRNA'),
(2419, 'hsa-mir-544a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2420, 'hsa-mir-370', 'chr14', '+', '', '', 'Pre-miRNA'),
(2421, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(2422, 'hsa-mir-4322', 'chr19', '+', '', '', 'Pre-miRNA'),
(2423, 'hsa-mir-624', 'chr14', '-', '', '', 'Pre-miRNA'),
(2424, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2425, 'hsa-mir-6730', 'chr1', '-', '', '', 'Pre-miRNA'),
(2426, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(2427, 'hsa-mir-15b', 'chr3', '+', '', '', 'Pre-miRNA'),
(2428, 'hsa-mir-30e', 'chr1', '+', '', '', 'Pre-miRNA'),
(2429, 'hsa-mir-548k', 'chr11', '+', '', '', 'Pre-miRNA'),
(2430, 'hsa-mir-1291', 'chr12', '-', '', '', 'Pre-miRNA'),
(2431, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(2432, 'hsa-mir-614', 'chr12', '+', '', '', 'Pre-miRNA'),
(2433, 'hsa-mir-557', 'chr1', '+', '', '', 'Pre-miRNA'),
(2434, 'hsa-mir-550a-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2435, 'hsa-mir-550b-2', 'chr7', '-', '', '', 'Pre-miRNA'),
(2436, 'hsa-mir-552', 'chr1', '-', '', '', 'Pre-miRNA'),
(2437, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(2438, 'hsa-mir-4804', 'chr5', '+', '', '', 'Pre-miRNA'),
(2439, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2440, 'hsa-mir-1257', 'chr20', '-', '', '', 'Pre-miRNA'),
(2441, 'hsa-mir-520b', 'chr19', '+', '', '', 'Pre-miRNA'),
(2442, 'hsa-mir-211', 'chr15', '-', '', '', 'Pre-miRNA'),
(2443, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2444, 'hsa-mir-570', 'chr3', '+', '', '', 'Pre-miRNA'),
(2445, 'hsa-mir-4264', 'chr2', '-', '', '', 'Pre-miRNA'),
(2446, 'hsa-mir-550a-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2447, 'hsa-mir-550b-1', 'chr7', '-', '', '', 'Pre-miRNA'),
(2448, 'hsa-mir-6795', 'chr19', '-', '', '', 'Pre-miRNA'),
(2449, 'hsa-mir-1262', 'chr1', '-', '', '', 'Pre-miRNA'),
(2450, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2451, 'hsa-mir-26b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2452, 'hsa-mir-3689b', 'chr9', '-', '', '', 'Pre-miRNA'),
(2453, 'hsa-mir-549a', 'chr15', '-', '', '', 'Pre-miRNA'),
(2454, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(2455, 'hsa-mir-744', 'chr17', '+', '', '', 'Pre-miRNA'),
(2456, 'hsa-mir-4493', 'chr11', '-', '', '', 'Pre-miRNA'),
(2457, 'hsa-mir-346', 'chr10', '-', '', '', 'Pre-miRNA'),
(2458, 'hsa-mir-190b', 'chr1', '-', '', '', 'Pre-miRNA'),
(2459, 'hsa-mir-27a', 'chr19', '-', '', '', 'Pre-miRNA'),
(2460, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2461, 'hsa-mir-429', 'chr1', '+', '', '', 'Pre-miRNA'),
(2462, 'hsa-mir-1252', 'chr12', '+', '', '', 'Pre-miRNA'),
(2463, 'hsa-mir-520h', 'chr19', '+', '', '', 'Pre-miRNA'),
(2464, 'hsa-mir-516b-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2465, 'hsa-mir-195', 'chr17', '-', '', '', 'Pre-miRNA'),
(2466, 'hsa-mir-134', 'chr14', '+', '', '', 'Pre-miRNA'),
(2467, 'hsa-mir-622', 'chr13', '+', '', '', 'Pre-miRNA'),
(2468, 'hsa-mir-125a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2469, 'hsa-mir-6861', 'chr12', '-', '', '', 'Pre-miRNA'),
(2470, 'hsa-mir-770', 'chr14', '+', '', '', 'Pre-miRNA'),
(2471, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2472, 'hsa-mir-548h-4', 'chr8', '-', '', '', 'Pre-miRNA'),
(2473, 'hsa-mir-558', 'chr2', '+', '', '', 'Pre-miRNA'),
(2474, 'hsa-mir-517c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2475, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(2476, 'hsa-mir-24-2', 'chr19', '-', '', '', 'Pre-miRNA'),
(2477, 'hsa-mir-575', 'chr4', '-', '', '', 'Pre-miRNA'),
(2478, 'hsa-mir-595', 'chr7', '-', '', '', 'Pre-miRNA'),
(2479, 'hsa-mir-1248', 'chr3', '+', '', '', 'Pre-miRNA'),
(2480, 'hsa-mir-520a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2481, 'hsa-mir-204', 'chr9', '-', '', '', 'Pre-miRNA'),
(2482, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2483, 'hsa-mir-520e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2484, 'hsa-mir-411', 'chr14', '+', '', '', 'Pre-miRNA'),
(2485, 'hsa-mir-526a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2486, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2487, 'hsa-mir-205', 'chr1', '+', '', '', 'Pre-miRNA'),
(2488, 'hsa-mir-1283-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2489, 'hsa-mir-646', 'chr20', '+', '', '', 'Pre-miRNA'),
(2490, 'hsa-mir-556', 'chr1', '+', '', '', 'Pre-miRNA'),
(2491, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(2492, 'hsa-mir-124-2', 'chr8', '+', '', '', 'Pre-miRNA'),
(2493, 'hsa-mir-499a', 'chr20', '+', '', '', 'Pre-miRNA'),
(2494, 'hsa-mir-578', 'chr4', '+', '', '', 'Pre-miRNA'),
(2495, 'hsa-mir-383', 'chr8', '-', '', '', 'Pre-miRNA'),
(2496, 'hsa-mir-4539', 'chr14', '-', '', '', 'Pre-miRNA'),
(2497, 'hsa-mir-634', 'chr17', '+', '', '', 'Pre-miRNA'),
(2498, 'hsa-mir-1179', 'chr15', '+', '', '', 'Pre-miRNA'),
(2499, 'hsa-mir-521-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2500, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2501, 'hsa-let-7a-3', 'chr22', '+', '', '', 'Pre-miRNA'),
(2502, 'hsa-mir-944', 'chr3', '+', '', '', 'Pre-miRNA'),
(2503, 'hsa-mir-602', 'chr9', '+', '', '', 'Pre-miRNA'),
(2504, 'hsa-mir-647', 'chr20', '-', '', '', 'Pre-miRNA'),
(2505, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2506, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2507, 'hsa-mir-518e', 'chr19', '+', '', '', 'Pre-miRNA'),
(2508, 'hsa-mir-491', 'chr9', '+', '', '', 'Pre-miRNA'),
(2509, 'hsa-mir-548i-2', 'chr4', '-', '', '', 'Pre-miRNA'),
(2510, 'hsa-mir-10a', 'chr17', '-', '', '', 'Pre-miRNA'),
(2511, 'hsa-mir-551b', 'chr3', '+', '', '', 'Pre-miRNA'),
(2512, 'hsa-mir-24-2', 'chr19', '-', '', '', 'Pre-miRNA'),
(2513, 'hsa-mir-585', 'chr5', '-', '', '', 'Pre-miRNA'),
(2514, 'hsa-mir-100', 'chr11', '-', '', '', 'Pre-miRNA'),
(2515, 'hsa-mir-522', 'chr19', '+', '', '', 'Pre-miRNA'),
(2516, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2517, 'hsa-mir-7-3', 'chr19', '+', '', '', 'Pre-miRNA'),
(2518, 'hsa-mir-1203', 'chr17', '-', '', '', 'Pre-miRNA'),
(2519, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(2520, 'hsa-mir-412', 'chr14', '+', '', '', 'Pre-miRNA'),
(2521, 'hsa-mir-129-1', 'chr7', '+', '', '', 'Pre-miRNA'),
(2522, 'hsa-mir-1290', 'chr1', '-', '', '', 'Pre-miRNA'),
(2523, 'hsa-mir-4783', 'chr2', '-', '', '', 'Pre-miRNA'),
(2524, 'hsa-mir-6765', 'chr14', '-', '', '', 'Pre-miRNA'),
(2525, 'hsa-mir-7973-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(2526, 'hsa-mir-7973-1', 'chr15', '+', '', '', 'Pre-miRNA'),
(2527, 'hsa-mir-516a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2528, 'hsa-mir-1304', 'chr11', '-', '', '', 'Pre-miRNA'),
(2529, 'hsa-mir-4432', 'chr2', '-', '', '', 'Pre-miRNA'),
(2530, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2531, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2532, 'hsa-mir-1251', 'chr12', '+', '', '', 'Pre-miRNA'),
(2533, 'hsa-mir-543', 'chr14', '+', '', '', 'Pre-miRNA'),
(2534, 'hsa-mir-519a-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2535, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2536, 'hsa-mir-3611', 'chr10', '-', '', '', 'Pre-miRNA'),
(2537, 'hsa-mir-1255a', 'chr4', '-', '', '', 'Pre-miRNA'),
(2538, 'hsa-mir-381', 'chr14', '+', '', '', 'Pre-miRNA'),
(2539, 'hsa-mir-5195', 'chr14', '-', '', '', 'Pre-miRNA'),
(2540, 'hsa-mir-1197', 'chr14', '+', '', '', 'Pre-miRNA'),
(2541, 'hsa-mir-369', 'chr14', '+', '', '', 'Pre-miRNA'),
(2542, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(2543, 'hsa-mir-1289-1', 'chr20', '-', '', '', 'Pre-miRNA'),
(2544, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2545, 'hsa-mir-6774', 'chr16', '+', '', '', 'Pre-miRNA'),
(2546, 'hsa-mir-103a-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(2547, 'hsa-mir-103b-2', 'chr20', '-', '', '', 'Pre-miRNA'),
(2548, 'hsa-mir-637', 'chr19', '-', '', '', 'Pre-miRNA'),
(2549, 'hsa-mir-4323', 'chr19', '-', '', '', 'Pre-miRNA'),
(2550, 'hsa-mir-548h-4', 'chr8', '-', '', '', 'Pre-miRNA'),
(2551, 'hsa-mir-7150', 'chr9', '-', '', '', 'Pre-miRNA'),
(2552, 'hsa-mir-485', 'chr14', '+', '', '', 'Pre-miRNA'),
(2553, 'hsa-mir-579', 'chr5', '-', '', '', 'Pre-miRNA'),
(2554, 'hsa-mir-596', 'chr8', '+', '', '', 'Pre-miRNA'),
(2555, 'hsa-mir-4298', 'chr11', '-', '', '', 'Pre-miRNA'),
(2556, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2557, 'hsa-mir-411', 'chr14', '+', '', '', 'Pre-miRNA'),
(2558, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2559, 'hsa-mir-1266', 'chr15', '-', '', '', 'Pre-miRNA'),
(2560, 'hsa-mir-1307', 'chr10', '-', '', '', 'Pre-miRNA'),
(2561, 'hsa-mir-376b', 'chr14', '+', '', '', 'Pre-miRNA'),
(2562, 'hsa-mir-548y', 'chr14', '-', '', '', 'Pre-miRNA'),
(2563, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2564, 'hsa-mir-1238', 'chr19', '+', '', '', 'Pre-miRNA'),
(2565, 'hsa-mir-142', 'chr17', '-', '', '', 'Pre-miRNA'),
(2566, 'hsa-mir-520h', 'chr19', '+', '', '', 'Pre-miRNA'),
(2567, 'hsa-mir-522', 'chr19', '+', '', '', 'Pre-miRNA'),
(2568, 'hsa-mir-300', 'chr14', '+', '', '', 'Pre-miRNA'),
(2569, 'hsa-mir-125b-2', 'chr21', '+', '', '', 'Pre-miRNA'),
(2570, 'hsa-mir-1261', 'chr11', '-', '', '', 'Pre-miRNA'),
(2571, 'hsa-mir-548g', 'chr4', '-', '', '', 'Pre-miRNA'),
(2572, 'hsa-let-7a-2', 'chr11', '-', '', '', 'Pre-miRNA'),
(2573, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2574, 'hsa-mir-592', 'chr7', '-', '', '', 'Pre-miRNA'),
(2575, 'hsa-mir-489', 'chr7', '-', '', '', 'Pre-miRNA'),
(2576, 'hsa-mir-30c-2', 'chr6', '-', '', '', 'Pre-miRNA'),
(2577, 'hsa-mir-602', 'chr9', '+', '', '', 'Pre-miRNA'),
(2578, 'hsa-mir-3607', 'chr5', '+', '', '', 'Pre-miRNA'),
(2579, 'hsa-mir-323a', 'chr14', '+', '', '', 'Pre-miRNA'),
(2580, 'hsa-mir-4733', 'chr17', '-', '', '', 'Pre-miRNA'),
(2581, 'hsa-mir-553', 'chr1', '+', '', '', 'Pre-miRNA'),
(2582, 'hsa-mir-876', 'chr9', '-', '', '', 'Pre-miRNA'),
(2583, 'hsa-mir-548n', 'chr7', '-', '', '', 'Pre-miRNA'),
(2584, 'hsa-mir-1302-1', 'chr12', '-', '', '', 'Pre-miRNA'),
(2585, 'hsa-mir-603', 'chr10', '+', '', '', 'Pre-miRNA'),
(2586, 'hsa-mir-154', 'chr14', '+', '', '', 'Pre-miRNA'),
(2587, 'hsa-mir-320c-1', 'chr18', '+', '', '', 'Pre-miRNA'),
(2588, 'hsa-mir-642a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2589, 'hsa-mir-642b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2590, 'hsa-mir-1267', 'chr13', '-', '', '', 'Pre-miRNA'),
(2591, 'hsa-mir-4256', 'chr1', '-', '', '', 'Pre-miRNA'),
(2592, 'hsa-mir-5189', 'chr16', '+', '', '', 'Pre-miRNA'),
(2593, 'hsa-mir-23a', 'chr19', '-', '', '', 'Pre-miRNA'),
(2594, 'hsa-mir-100', 'chr11', '-', '', '', 'Pre-miRNA'),
(2595, 'hsa-mir-943', 'chr4', '-', '', '', 'Pre-miRNA'),
(2596, 'hsa-mir-133b', 'chr6', '+', '', '', 'Pre-miRNA'),
(2597, 'hsa-mir-297', 'chr4', '-', '', '', 'Pre-miRNA'),
(2598, 'hsa-mir-802', 'chr21', '+', '', '', 'Pre-miRNA'),
(2599, 'hsa-mir-7853', 'chr6', '-', '', '', 'Pre-miRNA'),
(2600, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2601, 'hsa-mir-193b', 'chr16', '+', '', '', 'Pre-miRNA'),
(2602, 'hsa-mir-1200', 'chr7', '-', '', '', 'Pre-miRNA'),
(2603, 'hsa-mir-2278', 'chr9', '+', '', '', 'Pre-miRNA'),
(2604, 'hsa-mir-320e', 'chr19', '-', '', '', 'Pre-miRNA'),
(2605, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(2606, 'hsa-mir-4283-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2607, 'hsa-mir-629', 'chr15', '-', '', '', 'Pre-miRNA'),
(2608, 'hsa-mir-302f', 'chr18', '+', '', '', 'Pre-miRNA'),
(2609, 'hsa-mir-9-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(2610, 'hsa-mir-518c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2611, 'hsa-mir-887', 'chr5', '+', '', '', 'Pre-miRNA'),
(2612, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2613, 'hsa-mir-6755', 'chr11', '+', '', '', 'Pre-miRNA'),
(2614, 'hsa-mir-128-2', 'chr3', '+', '', '', 'Pre-miRNA'),
(2615, 'hsa-mir-302d', 'chr4', '-', '', '', 'Pre-miRNA'),
(2616, 'hsa-mir-125b-1', 'chr11', '-', '', '', 'Pre-miRNA'),
(2617, 'hsa-mir-342', 'chr14', '+', '', '', 'Pre-miRNA'),
(2618, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2619, 'hsa-mir-146a', 'chr5', '+', '', '', 'Pre-miRNA'),
(2620, 'hsa-mir-3197', 'chr21', '+', '', '', 'Pre-miRNA'),
(2621, 'hsa-mir-519a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2622, 'hsa-mir-20a', 'chr13', '+', '', '', 'Pre-miRNA'),
(2623, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2624, 'hsa-mir-519d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2625, 'hsa-mir-181c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2626, 'hsa-mir-412', 'chr14', '+', '', '', 'Pre-miRNA'),
(2627, 'hsa-mir-637', 'chr19', '-', '', '', 'Pre-miRNA'),
(2628, 'hsa-let-7g', 'chr3', '-', '', '', 'Pre-miRNA'),
(2629, 'hsa-mir-632', 'chr17', '+', '', '', 'Pre-miRNA'),
(2630, 'hsa-mir-146a', 'chr5', '+', '', '', 'Pre-miRNA'),
(2631, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(2632, 'hsa-mir-616', 'chr12', '-', '', '', 'Pre-miRNA'),
(2633, 'hsa-mir-1302-3', 'chr2', '-', '', '', 'Pre-miRNA'),
(2634, 'hsa-mir-1324', 'chr3', '+', '', '', 'Pre-miRNA'),
(2635, 'hsa-mir-548a-2', 'chr6', '+', '', '', 'Pre-miRNA'),
(2636, 'hsa-mir-100', 'chr11', '-', '', '', 'Pre-miRNA'),
(2637, 'hsa-mir-4431', 'chr2', '-', '', '', 'Pre-miRNA'),
(2638, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(2639, 'hsa-mir-640', 'chr19', '+', '', '', 'Pre-miRNA'),
(2640, 'hsa-mir-548g', 'chr4', '-', '', '', 'Pre-miRNA'),
(2641, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2642, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2643, 'hsa-mir-412', 'chr14', '+', '', '', 'Pre-miRNA'),
(2644, 'hsa-mir-1244-1', 'chr2', '+', '', '', 'Pre-miRNA'),
(2645, 'hsa-mir-518a-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2646, 'hsa-mir-518c', 'chr19', '+', '', '', 'Pre-miRNA'),
(2647, 'hsa-mir-328', 'chr16', '-', '', '', 'Pre-miRNA'),
(2648, 'hsa-mir-1272', 'chr15', '-', '', '', 'Pre-miRNA'),
(2649, 'hsa-mir-1257', 'chr20', '-', '', '', 'Pre-miRNA'),
(2650, 'hsa-mir-155', 'chr21', '+', '', '', 'Pre-miRNA'),
(2651, 'hsa-mir-320a', 'chr8', '-', '', '', 'Pre-miRNA'),
(2652, 'hsa-mir-181d', 'chr19', '+', '', '', 'Pre-miRNA'),
(2653, 'hsa-mir-937', 'chr8', '-', '', '', 'Pre-miRNA'),
(2654, 'hsa-mir-371a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2655, 'hsa-mir-371b', 'chr19', '-', '', '', 'Pre-miRNA'),
(2656, 'hsa-mir-494', 'chr14', '+', '', '', 'Pre-miRNA'),
(2657, 'hsa-mir-3689a', 'chr9', '-', '', '', 'Pre-miRNA'),
(2658, 'hsa-mir-133a-2', 'chr20', '+', '', '', 'Pre-miRNA'),
(2659, 'hsa-mir-613', 'chr12', '+', '', '', 'Pre-miRNA'),
(2660, 'hsa-mir-4454', 'chr4', '-', '', '', 'Pre-miRNA'),
(2661, 'hsa-mir-1246', 'chr2', '-', '', '', 'Pre-miRNA'),
(2662, 'hsa-mir-512-2', 'chr19', '+', '', '', 'Pre-miRNA'),
(2663, 'hsa-mir-376c', 'chr14', '+', '', '', 'Pre-miRNA'),
(2664, 'hsa-mir-520f', 'chr19', '+', '', '', 'Pre-miRNA'),
(2665, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2666, 'hsa-mir-216b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2667, 'hsa-mir-10b', 'chr2', '+', '', '', 'Pre-miRNA'),
(2668, 'hsa-mir-1297', 'chr13', '-', '', '', 'Pre-miRNA'),
(2669, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2670, 'hsa-mir-3908', 'chr12', '+', '', '', 'Pre-miRNA'),
(2671, 'hsa-mir-516b-1', 'chr19', '+', '', '', 'Pre-miRNA'),
(2672, 'hsa-mir-4485', 'chr11', '-', '', '', 'Pre-miRNA'),
(2673, 'hsa-mir-411', 'chr14', '+', '', '', 'Pre-miRNA'),
(2674, 'hsa-mir-1208', 'chr8', '+', '', '', 'Pre-miRNA'),
(2675, 'hsa-mir-1272', 'chr15', '-', '', '', 'Pre-miRNA'),
(2676, 'hsa-mir-302f', 'chr18', '+', '', '', 'Pre-miRNA'),
(2677, 'hsa-mir-146a', 'chr5', '+', '', '', 'Pre-miRNA'),
(2678, 'hsa-mir-6081', 'chr9', '+', '', '', 'Pre-miRNA'),
(2679, 'hsa-mir-3622b', 'chr8', '-', '', '', 'Pre-miRNA'),
(2680, 'hsa-mir-3622a', 'chr8', '+', '', '', 'Pre-miRNA'),
(2681, 'hsa-mir-138-1', 'chr3', '+', '', '', 'Pre-miRNA'),
(2682, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(2683, 'hsa-mir-196a-2', 'chr12', '+', '', '', 'Pre-miRNA'),
(2684, 'hsa-mir-517a', 'chr19', '+', '', '', 'Pre-miRNA'),
(2685, 'hsa-mir-941-1', 'chr20', '+', '', '', 'Pre-miRNA'),
(2686, 'hsa-mir-4464', 'chr6', '+', '', '', 'Pre-miRNA'),
(2687, 'hsa-mir-3939', 'chr6', '-', '', '', 'Pre-miRNA'),
(2688, 'hsa-mir-409', 'chr14', '+', '', '', 'Pre-miRNA'),
(2689, 'hsa-mir-633', 'chr17', '+', '', '', 'Pre-miRNA'),
(2690, 'hsa-mir-520h', 'chr19', '+', '', '', 'Pre-miRNA'),
(2691, 'hsa-mir-211', 'chr15', '-', '', '', 'Pre-miRNA'),
(2692, 'hsa-mir-1252', 'chr12', '+', '', '', 'Pre-miRNA'),
(2693, 'hsa-mir-4487', 'chr11', '+', '', '', 'Pre-miRNA'),
(2694, 'hsa-mir-3147', 'chr7', '+', '', '', 'Pre-miRNA'),
(2695, 'hsa-mir-551b', 'chr3', '+', '', '', 'Pre-miRNA'),
(2696, 'hsa-mir-587', 'chr6', '+', '', '', 'Pre-miRNA'),
(2697, 'hsa-mir-4477b', 'chr9', '+', '', '', 'Pre-miRNA'),
(2698, 'hsa-mir-588', 'chr6', '+', '', '', 'Pre-miRNA'),
(2699, 'hsa-mir-7846', 'chr1', '+', '', '', 'Pre-miRNA'),
(2700, 'hsa-mir-208b', 'chr14', '-', '', '', 'Pre-miRNA'),
(2701, 'hsa-mir-4283-2', 'chr7', '+', '', '', 'Pre-miRNA'),
(2702, 'hsa-mir-598', 'chr8', '-', '', '', 'Pre-miRNA'),
(2703, 'hsa-mir-941-1', 'chr20', '+', '', '', 'Pre-miRNA'),
(2704, 'hsa-mir-302f', 'chr18', '+', '', '', 'Pre-miRNA'),
(2705, 'hsa-mir-101-1', 'chr1', '-', '', '', 'Pre-miRNA'),
(2706, 'hsa-mir-329-1', 'chr14', '+', '', '', 'Pre-miRNA'),
(2707, 'hsa-mir-1243', 'chr4', '+', '', '', 'Pre-miRNA'),
(2708, 'hsa-mir-659', 'chr22', '-', '', '', 'Pre-miRNA'),
(2709, 'hsa-mir-4518', 'chr16', '+', '', '', 'Pre-miRNA'),
(2710, 'hsa-mir-617', 'chr12', '-', '', '', 'Pre-miRNA'),
(2711, 'hsa-mir-197', 'chr1', '+', '', '', 'Pre-miRNA'),
(2712, 'hsa-mir-1233-2', 'chr15', '-', '', '', 'Pre-miRNA'),
(2713, 'hsa-mir-663b', 'chr2', '-', '', '', 'Pre-miRNA'),
(2714, 'hsa-mir-1251', 'chr12', '+', '', '', 'Pre-miRNA'),
(2715, 'hsa-mir-1294', 'chr5', '+', '', '', 'Pre-miRNA'),
(2716, 'hsa-mir-148b', 'chr12', '+', '', '', 'Pre-miRNA'),
(2717, 'hsa-mir-4537', 'chr14', '-', '', '', 'Pre-miRNA'),
(2718, 'hsa-mir-302b', 'chr4', '-', '', '', 'Pre-miRNA');

--
-- Indexes for dumped tables
--

--
-- Indexes for table `cancer`
--
ALTER TABLE `cancer`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `genes`
--
ALTER TABLE `genes`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `region`
--
ALTER TABLE `region`
  ADD PRIMARY KEY (`id`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `cancer`
--
ALTER TABLE `cancer`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=9150;

--
-- AUTO_INCREMENT for table `genes`
--
ALTER TABLE `genes`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3052;

--
-- AUTO_INCREMENT for table `region`
--
ALTER TABLE `region`
  MODIFY `id` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2719;
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
